id	sid	tid	token	lemma	pos
cord-273505-pcsw3vmx	1	1	key	key	JJ
cord-273505-pcsw3vmx	2	1	:	:	:
cord-273505-pcsw3vmx	2	2	cord-273505-pcsw3vmx	cord-273505-pcsw3vmx	NN
cord-273505-pcsw3vmx	2	3	authors	author	NNS
cord-273505-pcsw3vmx	2	4	:	:	:
cord-273505-pcsw3vmx	2	5	Liu	Liu	NNP
cord-273505-pcsw3vmx	2	6	,	,	,
cord-273505-pcsw3vmx	2	7	Xiaosheng	Xiaosheng	NNP
cord-273505-pcsw3vmx	2	8	;	;	:
cord-273505-pcsw3vmx	2	9	Cao	Cao	NNP
cord-273505-pcsw3vmx	2	10	,	,	,
cord-273505-pcsw3vmx	2	11	Wei	Wei	NNP
cord-273505-pcsw3vmx	2	12	;	;	:
cord-273505-pcsw3vmx	2	13	Li	Li	NNP
cord-273505-pcsw3vmx	2	14	,	,	,
cord-273505-pcsw3vmx	3	1	Taisheng	Taisheng	NNP
cord-273505-pcsw3vmx	3	2	title	title	NN
cord-273505-pcsw3vmx	3	3	:	:	:
cord-273505-pcsw3vmx	3	4	High	high	JJ
cord-273505-pcsw3vmx	3	5	-	-	HYPH
cord-273505-pcsw3vmx	3	6	Dose	dose	NN
cord-273505-pcsw3vmx	3	7	Intravenous	Intravenous	NNP
cord-273505-pcsw3vmx	3	8	Immunoglobulins	Immunoglobulins	NNP
cord-273505-pcsw3vmx	3	9	in	in	IN
cord-273505-pcsw3vmx	3	10	the	the	DT
cord-273505-pcsw3vmx	3	11	Treatment	Treatment	NNP
cord-273505-pcsw3vmx	3	12	of	of	IN
cord-273505-pcsw3vmx	3	13	Severe	severe	JJ
cord-273505-pcsw3vmx	3	14	Acute	acute	JJ
cord-273505-pcsw3vmx	3	15	Viral	viral	JJ
cord-273505-pcsw3vmx	3	16	Pneumonia	pneumonia	NN
cord-273505-pcsw3vmx	3	17	:	:	:
cord-273505-pcsw3vmx	4	1	The	the	DT
cord-273505-pcsw3vmx	4	2	Known	Known	NNP
cord-273505-pcsw3vmx	4	3	Mechanisms	Mechanisms	NNPS
cord-273505-pcsw3vmx	4	4	and	and	CC
cord-273505-pcsw3vmx	4	5	Clinical	clinical	JJ
cord-273505-pcsw3vmx	4	6	Effects	effect	NNS
cord-273505-pcsw3vmx	4	7	date	date	NN
cord-273505-pcsw3vmx	4	8	:	:	:
cord-273505-pcsw3vmx	4	9	2020	2020	CD
cord-273505-pcsw3vmx	4	10	-	-	HYPH
cord-273505-pcsw3vmx	4	11	07	07	CD
cord-273505-pcsw3vmx	4	12	-	-	SYM
cord-273505-pcsw3vmx	4	13	14	14	CD
cord-273505-pcsw3vmx	4	14	journal	journal	NN
cord-273505-pcsw3vmx	4	15	:	:	:
cord-273505-pcsw3vmx	5	1	Front	Front	NNP
cord-273505-pcsw3vmx	5	2	Immunol	Immunol	NNP
cord-273505-pcsw3vmx	5	3	DOI	doi	NN
cord-273505-pcsw3vmx	5	4	:	:	:
cord-273505-pcsw3vmx	6	1	10.3389/	10.3389/	CD
cord-273505-pcsw3vmx	7	1	fimmu.2020.01660	fimmu.2020.01660	CD
cord-273505-pcsw3vmx	7	2	sha	sha	NNP
cord-273505-pcsw3vmx	7	3	:	:	:
cord-273505-pcsw3vmx	8	1	19a425b10c474b22402d5668b661bf76a4406aee	19a425b10c474b22402d5668b661bf76a4406aee	CD
cord-273505-pcsw3vmx	8	2	doc_id	doc_id	CD
cord-273505-pcsw3vmx	8	3	:	:	:
cord-273505-pcsw3vmx	8	4	273505	273505	CD
cord-273505-pcsw3vmx	8	5	cord_uid	cord_uid	NNS
cord-273505-pcsw3vmx	8	6	:	:	:
cord-273505-pcsw3vmx	9	1	pcsw3vmx	pcsw3vmx	NN
cord-273505-pcsw3vmx	10	1	The	the	DT
cord-273505-pcsw3vmx	10	2	current	current	JJ
cord-273505-pcsw3vmx	10	3	outbreak	outbreak	NN
cord-273505-pcsw3vmx	10	4	of	of	IN
cord-273505-pcsw3vmx	10	5	viral	viral	JJ
cord-273505-pcsw3vmx	10	6	pneumonia	pneumonia	NN
cord-273505-pcsw3vmx	10	7	,	,	,
cord-273505-pcsw3vmx	10	8	caused	cause	VBN
cord-273505-pcsw3vmx	10	9	by	by	IN
cord-273505-pcsw3vmx	10	10	novel	novel	JJ
cord-273505-pcsw3vmx	10	11	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	10	12	SARS	SARS	NNP
cord-273505-pcsw3vmx	10	13	-	-	HYPH
cord-273505-pcsw3vmx	10	14	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	10	15	,	,	,
cord-273505-pcsw3vmx	10	16	is	be	VBZ
cord-273505-pcsw3vmx	10	17	the	the	DT
cord-273505-pcsw3vmx	10	18	focus	focus	NN
cord-273505-pcsw3vmx	10	19	of	of	IN
cord-273505-pcsw3vmx	10	20	worldwide	worldwide	JJ
cord-273505-pcsw3vmx	10	21	attention	attention	NN
cord-273505-pcsw3vmx	10	22	.	.	.
cord-273505-pcsw3vmx	11	1	The	the	DT
cord-273505-pcsw3vmx	11	2	WHO	who	WP
cord-273505-pcsw3vmx	11	3	declared	declare	VBD
cord-273505-pcsw3vmx	11	4	the	the	DT
cord-273505-pcsw3vmx	11	5	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	11	6	outbreak	outbreak	NN
cord-273505-pcsw3vmx	11	7	a	a	DT
cord-273505-pcsw3vmx	11	8	pandemic	pandemic	NN
cord-273505-pcsw3vmx	11	9	event	event	NN
cord-273505-pcsw3vmx	11	10	on	on	IN
cord-273505-pcsw3vmx	11	11	Mar	Mar	NNP
cord-273505-pcsw3vmx	11	12	12	12	CD
cord-273505-pcsw3vmx	11	13	,	,	,
cord-273505-pcsw3vmx	11	14	2020	2020	CD
cord-273505-pcsw3vmx	11	15	,	,	,
cord-273505-pcsw3vmx	11	16	and	and	CC
cord-273505-pcsw3vmx	11	17	the	the	DT
cord-273505-pcsw3vmx	11	18	number	number	NN
cord-273505-pcsw3vmx	11	19	of	of	IN
cord-273505-pcsw3vmx	11	20	confirmed	confirm	VBN
cord-273505-pcsw3vmx	11	21	cases	case	NNS
cord-273505-pcsw3vmx	11	22	is	be	VBZ
cord-273505-pcsw3vmx	11	23	still	still	RB
cord-273505-pcsw3vmx	11	24	on	on	IN
cord-273505-pcsw3vmx	11	25	the	the	DT
cord-273505-pcsw3vmx	11	26	rise	rise	NN
cord-273505-pcsw3vmx	11	27	worldwide	worldwide	RB
cord-273505-pcsw3vmx	11	28	.	.	.
cord-273505-pcsw3vmx	12	1	While	while	IN
cord-273505-pcsw3vmx	12	2	most	most	RBS
cord-273505-pcsw3vmx	12	3	infected	infected	JJ
cord-273505-pcsw3vmx	12	4	individuals	individual	NNS
cord-273505-pcsw3vmx	12	5	only	only	RB
cord-273505-pcsw3vmx	12	6	experience	experience	VBP
cord-273505-pcsw3vmx	12	7	mild	mild	JJ
cord-273505-pcsw3vmx	12	8	symptoms	symptom	NNS
cord-273505-pcsw3vmx	12	9	or	or	CC
cord-273505-pcsw3vmx	12	10	may	may	MD
cord-273505-pcsw3vmx	12	11	even	even	RB
cord-273505-pcsw3vmx	12	12	be	be	VB
cord-273505-pcsw3vmx	12	13	asymptomatic	asymptomatic	JJ
cord-273505-pcsw3vmx	12	14	,	,	,
cord-273505-pcsw3vmx	12	15	some	some	DT
cord-273505-pcsw3vmx	12	16	patients	patient	NNS
cord-273505-pcsw3vmx	12	17	rapidly	rapidly	RB
cord-273505-pcsw3vmx	12	18	progress	progress	VBP
cord-273505-pcsw3vmx	12	19	to	to	IN
cord-273505-pcsw3vmx	12	20	severe	severe	JJ
cord-273505-pcsw3vmx	12	21	acute	acute	JJ
cord-273505-pcsw3vmx	12	22	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	12	23	failure	failure	NN
cord-273505-pcsw3vmx	12	24	with	with	IN
cord-273505-pcsw3vmx	12	25	substantial	substantial	JJ
cord-273505-pcsw3vmx	12	26	mortality	mortality	NN
cord-273505-pcsw3vmx	12	27	,	,	,
cord-273505-pcsw3vmx	12	28	making	make	VBG
cord-273505-pcsw3vmx	12	29	it	-PRON-	PRP
cord-273505-pcsw3vmx	12	30	imperative	imperative	JJ
cord-273505-pcsw3vmx	12	31	to	to	TO
cord-273505-pcsw3vmx	12	32	develop	develop	VB
cord-273505-pcsw3vmx	12	33	an	an	DT
cord-273505-pcsw3vmx	12	34	efficient	efficient	JJ
cord-273505-pcsw3vmx	12	35	treatment	treatment	NN
cord-273505-pcsw3vmx	12	36	for	for	IN
cord-273505-pcsw3vmx	12	37	severe	severe	JJ
cord-273505-pcsw3vmx	12	38	SARS	SARS	NNP
cord-273505-pcsw3vmx	12	39	-	-	HYPH
cord-273505-pcsw3vmx	12	40	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	12	41	pneumonia	pneumonia	NN
cord-273505-pcsw3vmx	12	42	alongside	alongside	IN
cord-273505-pcsw3vmx	12	43	supportive	supportive	JJ
cord-273505-pcsw3vmx	12	44	care	care	NN
cord-273505-pcsw3vmx	12	45	.	.	.
cord-273505-pcsw3vmx	13	1	So	so	RB
cord-273505-pcsw3vmx	13	2	far	far	RB
cord-273505-pcsw3vmx	13	3	,	,	,
cord-273505-pcsw3vmx	13	4	the	the	DT
cord-273505-pcsw3vmx	13	5	optimal	optimal	JJ
cord-273505-pcsw3vmx	13	6	treatment	treatment	NN
cord-273505-pcsw3vmx	13	7	strategy	strategy	NN
cord-273505-pcsw3vmx	13	8	for	for	IN
cord-273505-pcsw3vmx	13	9	severe	severe	JJ
cord-273505-pcsw3vmx	13	10	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	13	11	remains	remain	VBZ
cord-273505-pcsw3vmx	13	12	unknown	unknown	JJ
cord-273505-pcsw3vmx	13	13	.	.	.
cord-273505-pcsw3vmx	14	1	Intravenous	intravenous	JJ
cord-273505-pcsw3vmx	14	2	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	14	3	(	(	-LRB-
cord-273505-pcsw3vmx	14	4	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	14	5	)	)	-RRB-
cord-273505-pcsw3vmx	14	6	is	be	VBZ
cord-273505-pcsw3vmx	14	7	a	a	DT
cord-273505-pcsw3vmx	14	8	blood	blood	NN
cord-273505-pcsw3vmx	14	9	product	product	NN
cord-273505-pcsw3vmx	14	10	pooled	pool	VBN
cord-273505-pcsw3vmx	14	11	from	from	IN
cord-273505-pcsw3vmx	14	12	healthy	healthy	JJ
cord-273505-pcsw3vmx	14	13	donors	donor	NNS
cord-273505-pcsw3vmx	14	14	with	with	IN
cord-273505-pcsw3vmx	14	15	high	high	JJ
cord-273505-pcsw3vmx	14	16	concentrations	concentration	NNS
cord-273505-pcsw3vmx	14	17	of	of	IN
cord-273505-pcsw3vmx	14	18	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	14	19	G	G	NNP
cord-273505-pcsw3vmx	14	20	(	(	-LRB-
cord-273505-pcsw3vmx	14	21	IgG	IgG	NNP
cord-273505-pcsw3vmx	14	22	)	)	-RRB-
cord-273505-pcsw3vmx	14	23	and	and	CC
cord-273505-pcsw3vmx	14	24	has	have	VBZ
cord-273505-pcsw3vmx	14	25	been	be	VBN
cord-273505-pcsw3vmx	14	26	used	use	VBN
cord-273505-pcsw3vmx	14	27	in	in	IN
cord-273505-pcsw3vmx	14	28	patients	patient	NNS
cord-273505-pcsw3vmx	14	29	with	with	IN
cord-273505-pcsw3vmx	14	30	autoimmune	autoimmune	JJ
cord-273505-pcsw3vmx	14	31	and	and	CC
cord-273505-pcsw3vmx	14	32	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	14	33	diseases	disease	NNS
cord-273505-pcsw3vmx	14	34	for	for	IN
cord-273505-pcsw3vmx	14	35	more	more	JJR
cord-273505-pcsw3vmx	14	36	than	than	IN
cord-273505-pcsw3vmx	14	37	30	30	CD
cord-273505-pcsw3vmx	14	38	years	year	NNS
cord-273505-pcsw3vmx	14	39	.	.	.
cord-273505-pcsw3vmx	15	1	In	in	IN
cord-273505-pcsw3vmx	15	2	this	this	DT
cord-273505-pcsw3vmx	15	3	review	review	NN
cord-273505-pcsw3vmx	15	4	,	,	,
cord-273505-pcsw3vmx	15	5	we	-PRON-	PRP
cord-273505-pcsw3vmx	15	6	aim	aim	VBP
cord-273505-pcsw3vmx	15	7	to	to	TO
cord-273505-pcsw3vmx	15	8	highlight	highlight	VB
cord-273505-pcsw3vmx	15	9	the	the	DT
cord-273505-pcsw3vmx	15	10	known	know	VBN
cord-273505-pcsw3vmx	15	11	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	15	12	of	of	IN
cord-273505-pcsw3vmx	15	13	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	15	14	effects	effect	NNS
cord-273505-pcsw3vmx	15	15	of	of	IN
cord-273505-pcsw3vmx	15	16	high	high	JJ
cord-273505-pcsw3vmx	15	17	-	-	HYPH
cord-273505-pcsw3vmx	15	18	dose	dose	NN
cord-273505-pcsw3vmx	15	19	IVIg	ivig	NN
cord-273505-pcsw3vmx	15	20	therapy	therapy	NN
cord-273505-pcsw3vmx	15	21	,	,	,
cord-273505-pcsw3vmx	15	22	the	the	DT
cord-273505-pcsw3vmx	15	23	immunopathological	immunopathological	JJ
cord-273505-pcsw3vmx	15	24	hypothesis	hypothesis	NN
cord-273505-pcsw3vmx	15	25	of	of	IN
cord-273505-pcsw3vmx	15	26	viral	viral	JJ
cord-273505-pcsw3vmx	15	27	pneumonia	pneumonia	NN
cord-273505-pcsw3vmx	15	28	,	,	,
cord-273505-pcsw3vmx	15	29	and	and	CC
cord-273505-pcsw3vmx	15	30	the	the	DT
cord-273505-pcsw3vmx	15	31	clinical	clinical	JJ
cord-273505-pcsw3vmx	15	32	evidence	evidence	NN
cord-273505-pcsw3vmx	15	33	of	of	IN
cord-273505-pcsw3vmx	15	34	IVIg	ivig	JJ
cord-273505-pcsw3vmx	15	35	therapy	therapy	NN
cord-273505-pcsw3vmx	15	36	in	in	IN
cord-273505-pcsw3vmx	15	37	viral	viral	JJ
cord-273505-pcsw3vmx	15	38	pneumonia	pneumonia	NN
cord-273505-pcsw3vmx	15	39	.	.	.
cord-273505-pcsw3vmx	16	1	We	-PRON-	PRP
cord-273505-pcsw3vmx	16	2	then	then	RB
cord-273505-pcsw3vmx	16	3	make	make	VBP
cord-273505-pcsw3vmx	16	4	cautious	cautious	JJ
cord-273505-pcsw3vmx	16	5	therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	16	6	inferences	inference	NNS
cord-273505-pcsw3vmx	16	7	about	about	IN
cord-273505-pcsw3vmx	16	8	high	high	JJ
cord-273505-pcsw3vmx	16	9	-	-	HYPH
cord-273505-pcsw3vmx	16	10	dose	dose	NN
cord-273505-pcsw3vmx	16	11	IVIg	ivig	NN
cord-273505-pcsw3vmx	16	12	therapy	therapy	NN
cord-273505-pcsw3vmx	16	13	in	in	IN
cord-273505-pcsw3vmx	16	14	treating	treat	VBG
cord-273505-pcsw3vmx	16	15	severe	severe	JJ
cord-273505-pcsw3vmx	16	16	COVID-19	covid-19	NN
cord-273505-pcsw3vmx	16	17	.	.	.
cord-273505-pcsw3vmx	17	1	These	these	DT
cord-273505-pcsw3vmx	17	2	inferences	inference	NNS
cord-273505-pcsw3vmx	17	3	may	may	MD
cord-273505-pcsw3vmx	17	4	provide	provide	VB
cord-273505-pcsw3vmx	17	5	relevant	relevant	JJ
cord-273505-pcsw3vmx	17	6	and	and	CC
cord-273505-pcsw3vmx	17	7	useful	useful	JJ
cord-273505-pcsw3vmx	17	8	insights	insight	NNS
cord-273505-pcsw3vmx	17	9	in	in	IN
cord-273505-pcsw3vmx	17	10	order	order	NN
cord-273505-pcsw3vmx	17	11	to	to	TO
cord-273505-pcsw3vmx	17	12	aid	aid	VB
cord-273505-pcsw3vmx	17	13	treatment	treatment	NN
cord-273505-pcsw3vmx	17	14	for	for	IN
cord-273505-pcsw3vmx	17	15	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	17	16	.	.	.
cord-273505-pcsw3vmx	18	1	Recently	recently	RB
cord-273505-pcsw3vmx	18	2	,	,	,
cord-273505-pcsw3vmx	18	3	the	the	DT
cord-273505-pcsw3vmx	18	4	outbreak	outbreak	NN
cord-273505-pcsw3vmx	18	5	of	of	IN
cord-273505-pcsw3vmx	18	6	a	a	DT
cord-273505-pcsw3vmx	18	7	febrile	febrile	JJ
cord-273505-pcsw3vmx	18	8	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	18	9	disease	disease	NN
cord-273505-pcsw3vmx	18	10	caused	cause	VBN
cord-273505-pcsw3vmx	18	11	by	by	IN
cord-273505-pcsw3vmx	18	12	a	a	DT
cord-273505-pcsw3vmx	18	13	novel	novel	JJ
cord-273505-pcsw3vmx	18	14	beta	beta	NN
cord-273505-pcsw3vmx	18	15	-	-	HYPH
cord-273505-pcsw3vmx	18	16	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	18	17	,	,	,
cord-273505-pcsw3vmx	18	18	designated	designate	VBN
cord-273505-pcsw3vmx	18	19	SARS	SARS	NNP
cord-273505-pcsw3vmx	18	20	-	-	HYPH
cord-273505-pcsw3vmx	18	21	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	18	22	,	,	,
cord-273505-pcsw3vmx	18	23	has	have	VBZ
cord-273505-pcsw3vmx	18	24	become	become	VBN
cord-273505-pcsw3vmx	18	25	the	the	DT
cord-273505-pcsw3vmx	18	26	focus	focus	NN
cord-273505-pcsw3vmx	18	27	of	of	IN
cord-273505-pcsw3vmx	18	28	worldwide	worldwide	JJ
cord-273505-pcsw3vmx	18	29	attention	attention	NN
cord-273505-pcsw3vmx	18	30	.	.	.
cord-273505-pcsw3vmx	19	1	The	the	DT
cord-273505-pcsw3vmx	19	2	event	event	NN
cord-273505-pcsw3vmx	19	3	was	be	VBD
cord-273505-pcsw3vmx	19	4	declared	declare	VBN
cord-273505-pcsw3vmx	19	5	a	a	DT
cord-273505-pcsw3vmx	19	6	Pandemic	pandemic	NN
cord-273505-pcsw3vmx	19	7	by	by	IN
cord-273505-pcsw3vmx	19	8	the	the	DT
cord-273505-pcsw3vmx	19	9	WHO	WHO	NNP
cord-273505-pcsw3vmx	19	10	on	on	IN
cord-273505-pcsw3vmx	19	11	Mar	Mar	NNP
cord-273505-pcsw3vmx	19	12	12	12	CD
cord-273505-pcsw3vmx	19	13	,	,	,
cord-273505-pcsw3vmx	19	14	2020	2020	CD
cord-273505-pcsw3vmx	19	15	,	,	,
cord-273505-pcsw3vmx	19	16	and	and	CC
cord-273505-pcsw3vmx	19	17	the	the	DT
cord-273505-pcsw3vmx	19	18	number	number	NN
cord-273505-pcsw3vmx	19	19	of	of	IN
cord-273505-pcsw3vmx	19	20	confirmed	confirm	VBN
cord-273505-pcsw3vmx	19	21	cases	case	NNS
cord-273505-pcsw3vmx	19	22	is	be	VBZ
cord-273505-pcsw3vmx	19	23	still	still	RB
cord-273505-pcsw3vmx	19	24	climbing	climb	VBG
cord-273505-pcsw3vmx	19	25	worldwide	worldwide	RB
cord-273505-pcsw3vmx	19	26	.	.	.
cord-273505-pcsw3vmx	20	1	Typical	typical	JJ
cord-273505-pcsw3vmx	20	2	clinical	clinical	JJ
cord-273505-pcsw3vmx	20	3	features	feature	NNS
cord-273505-pcsw3vmx	20	4	of	of	IN
cord-273505-pcsw3vmx	20	5	COVID-19	covid-19	DT
cord-273505-pcsw3vmx	20	6	include	include	VBP
cord-273505-pcsw3vmx	20	7	fever	fever	NN
cord-273505-pcsw3vmx	20	8	,	,	,
cord-273505-pcsw3vmx	20	9	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	20	10	symptoms	symptom	NNS
cord-273505-pcsw3vmx	20	11	such	such	JJ
cord-273505-pcsw3vmx	20	12	as	as	IN
cord-273505-pcsw3vmx	20	13	dry	dry	JJ
cord-273505-pcsw3vmx	20	14	cough	cough	NN
cord-273505-pcsw3vmx	20	15	and	and	CC
cord-273505-pcsw3vmx	20	16	shortness	shortness	NN
cord-273505-pcsw3vmx	20	17	of	of	IN
cord-273505-pcsw3vmx	20	18	breath	breath	NN
cord-273505-pcsw3vmx	20	19	,	,	,
cord-273505-pcsw3vmx	20	20	and	and	CC
cord-273505-pcsw3vmx	20	21	fatigue	fatigue	NN
cord-273505-pcsw3vmx	20	22	(	(	-LRB-
cord-273505-pcsw3vmx	20	23	1	1	CD
cord-273505-pcsw3vmx	20	24	)	)	-RRB-
cord-273505-pcsw3vmx	20	25	.	.	.
cord-273505-pcsw3vmx	21	1	While	while	IN
cord-273505-pcsw3vmx	21	2	the	the	DT
cord-273505-pcsw3vmx	21	3	majority	majority	NN
cord-273505-pcsw3vmx	21	4	of	of	IN
cord-273505-pcsw3vmx	21	5	infected	infected	JJ
cord-273505-pcsw3vmx	21	6	individuals	individual	NNS
cord-273505-pcsw3vmx	21	7	experience	experience	VBP
cord-273505-pcsw3vmx	21	8	only	only	RB
cord-273505-pcsw3vmx	21	9	mild	mild	JJ
cord-273505-pcsw3vmx	21	10	symptoms	symptom	NNS
cord-273505-pcsw3vmx	21	11	or	or	CC
cord-273505-pcsw3vmx	21	12	may	may	MD
cord-273505-pcsw3vmx	21	13	even	even	RB
cord-273505-pcsw3vmx	21	14	be	be	VB
cord-273505-pcsw3vmx	21	15	asymptomatic	asymptomatic	JJ
cord-273505-pcsw3vmx	21	16	,	,	,
cord-273505-pcsw3vmx	21	17	about	about	RB
cord-273505-pcsw3vmx	21	18	10	10	CD
cord-273505-pcsw3vmx	21	19	to	to	TO
cord-273505-pcsw3vmx	21	20	20	20	CD
cord-273505-pcsw3vmx	21	21	%	%	NN
cord-273505-pcsw3vmx	21	22	of	of	IN
cord-273505-pcsw3vmx	21	23	patients	patient	NNS
cord-273505-pcsw3vmx	21	24	rapidly	rapidly	RB
cord-273505-pcsw3vmx	21	25	progress	progress	VBP
cord-273505-pcsw3vmx	21	26	to	to	IN
cord-273505-pcsw3vmx	21	27	severe	severe	JJ
cord-273505-pcsw3vmx	21	28	conditions	condition	NNS
cord-273505-pcsw3vmx	21	29	with	with	IN
cord-273505-pcsw3vmx	21	30	acute	acute	JJ
cord-273505-pcsw3vmx	21	31	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	21	32	distress	distress	NN
cord-273505-pcsw3vmx	21	33	syndrome	syndrome	NN
cord-273505-pcsw3vmx	21	34	(	(	-LRB-
cord-273505-pcsw3vmx	21	35	ARDS	ARDS	NNP
cord-273505-pcsw3vmx	21	36	)	)	-RRB-
cord-273505-pcsw3vmx	21	37	,	,	,
cord-273505-pcsw3vmx	21	38	which	which	WDT
cord-273505-pcsw3vmx	21	39	can	can	MD
cord-273505-pcsw3vmx	21	40	result	result	VB
cord-273505-pcsw3vmx	21	41	in	in	IN
cord-273505-pcsw3vmx	21	42	shock	shock	NN
cord-273505-pcsw3vmx	21	43	,	,	,
cord-273505-pcsw3vmx	21	44	sepsis	sepsis	NN
cord-273505-pcsw3vmx	21	45	,	,	,
cord-273505-pcsw3vmx	21	46	and	and	CC
cord-273505-pcsw3vmx	21	47	multiple	multiple	JJ
cord-273505-pcsw3vmx	21	48	organ	organ	NN
cord-273505-pcsw3vmx	21	49	dysfunction	dysfunction	NN
cord-273505-pcsw3vmx	21	50	(	(	-LRB-
cord-273505-pcsw3vmx	21	51	1	1	CD
cord-273505-pcsw3vmx	21	52	,	,	,
cord-273505-pcsw3vmx	21	53	2	2	CD
cord-273505-pcsw3vmx	21	54	)	)	-RRB-
cord-273505-pcsw3vmx	21	55	.	.	.
cord-273505-pcsw3vmx	22	1	In	in	IN
cord-273505-pcsw3vmx	22	2	addition	addition	NN
cord-273505-pcsw3vmx	22	3	to	to	IN
cord-273505-pcsw3vmx	22	4	supportive	supportive	JJ
cord-273505-pcsw3vmx	22	5	treatment	treatment	NN
cord-273505-pcsw3vmx	22	6	,	,	,
cord-273505-pcsw3vmx	22	7	several	several	JJ
cord-273505-pcsw3vmx	22	8	therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	22	9	approaches	approach	NNS
cord-273505-pcsw3vmx	22	10	have	have	VBP
cord-273505-pcsw3vmx	22	11	been	be	VBN
cord-273505-pcsw3vmx	22	12	proposed	propose	VBN
cord-273505-pcsw3vmx	22	13	,	,	,
cord-273505-pcsw3vmx	22	14	such	such	JJ
cord-273505-pcsw3vmx	22	15	as	as	IN
cord-273505-pcsw3vmx	22	16	antiviral	antiviral	JJ
cord-273505-pcsw3vmx	22	17	therapy	therapy	NN
cord-273505-pcsw3vmx	22	18	,	,	,
cord-273505-pcsw3vmx	22	19	immunomodulators	immunomodulator	NNS
cord-273505-pcsw3vmx	22	20	,	,	,
cord-273505-pcsw3vmx	22	21	blood	blood	NN
cord-273505-pcsw3vmx	22	22	products	product	NNS
cord-273505-pcsw3vmx	22	23	,	,	,
cord-273505-pcsw3vmx	22	24	and	and	CC
cord-273505-pcsw3vmx	22	25	traditional	traditional	JJ
cord-273505-pcsw3vmx	22	26	Chinese	chinese	JJ
cord-273505-pcsw3vmx	22	27	medicine	medicine	NN
cord-273505-pcsw3vmx	22	28	(	(	-LRB-
cord-273505-pcsw3vmx	22	29	TCM	TCM	NNP
cord-273505-pcsw3vmx	22	30	)	)	-RRB-
cord-273505-pcsw3vmx	22	31	(	(	-LRB-
cord-273505-pcsw3vmx	22	32	3	3	CD
cord-273505-pcsw3vmx	22	33	,	,	,
cord-273505-pcsw3vmx	22	34	4	4	CD
cord-273505-pcsw3vmx	22	35	)	)	-RRB-
cord-273505-pcsw3vmx	22	36	.	.	.
cord-273505-pcsw3vmx	23	1	However	however	RB
cord-273505-pcsw3vmx	23	2	,	,	,
cord-273505-pcsw3vmx	23	3	the	the	DT
cord-273505-pcsw3vmx	23	4	optimal	optimal	JJ
cord-273505-pcsw3vmx	23	5	treatment	treatment	NN
cord-273505-pcsw3vmx	23	6	strategy	strategy	NN
cord-273505-pcsw3vmx	23	7	for	for	IN
cord-273505-pcsw3vmx	23	8	severe	severe	JJ
cord-273505-pcsw3vmx	23	9	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	23	10	remains	remain	NNS
cord-273505-pcsw3vmx	23	11	debated	debate	VBN
cord-273505-pcsw3vmx	23	12	(	(	-LRB-
cord-273505-pcsw3vmx	23	13	5	5	LS
cord-273505-pcsw3vmx	23	14	)	)	-RRB-
cord-273505-pcsw3vmx	23	15	(	(	-LRB-
cord-273505-pcsw3vmx	23	16	6	6	LS
cord-273505-pcsw3vmx	23	17	)	)	-RRB-
cord-273505-pcsw3vmx	23	18	(	(	-LRB-
cord-273505-pcsw3vmx	23	19	7	7	LS
cord-273505-pcsw3vmx	23	20	)	)	-RRB-
cord-273505-pcsw3vmx	23	21	(	(	-LRB-
cord-273505-pcsw3vmx	23	22	8)	8)	NNP
cord-273505-pcsw3vmx	23	23	(	(	-LRB-
cord-273505-pcsw3vmx	23	24	9	9	CD
cord-273505-pcsw3vmx	23	25	)	)	-RRB-
cord-273505-pcsw3vmx	23	26	(	(	-LRB-
cord-273505-pcsw3vmx	23	27	10	10	CD
cord-273505-pcsw3vmx	23	28	)	)	-RRB-
cord-273505-pcsw3vmx	23	29	(	(	-LRB-
cord-273505-pcsw3vmx	23	30	11	11	CD
cord-273505-pcsw3vmx	23	31	)	)	-RRB-
cord-273505-pcsw3vmx	23	32	.	.	.
cord-273505-pcsw3vmx	24	1	To	to	IN
cord-273505-pcsw3vmx	24	2	date	date	NN
cord-273505-pcsw3vmx	24	3	,	,	,
cord-273505-pcsw3vmx	24	4	it	-PRON-	PRP
cord-273505-pcsw3vmx	24	5	remains	remain	VBZ
cord-273505-pcsw3vmx	24	6	an	an	DT
cord-273505-pcsw3vmx	24	7	urgent	urgent	JJ
cord-273505-pcsw3vmx	24	8	requirement	requirement	NN
cord-273505-pcsw3vmx	24	9	to	to	TO
cord-273505-pcsw3vmx	24	10	identify	identify	VB
cord-273505-pcsw3vmx	24	11	the	the	DT
cord-273505-pcsw3vmx	24	12	most	most	RBS
cord-273505-pcsw3vmx	24	13	effective	effective	JJ
cord-273505-pcsw3vmx	24	14	treatment	treatment	NN
cord-273505-pcsw3vmx	24	15	for	for	IN
cord-273505-pcsw3vmx	24	16	severe	severe	JJ
cord-273505-pcsw3vmx	24	17	and	and	CC
cord-273505-pcsw3vmx	24	18	critically	critically	RB
cord-273505-pcsw3vmx	24	19	ill	ill	RB
cord-273505-pcsw3vmx	24	20	COVID-19	covid-19	CD
cord-273505-pcsw3vmx	24	21	patients	patient	NNS
cord-273505-pcsw3vmx	24	22	,	,	,
cord-273505-pcsw3vmx	24	23	but	but	CC
cord-273505-pcsw3vmx	24	24	a	a	DT
cord-273505-pcsw3vmx	24	25	conclusion	conclusion	NN
cord-273505-pcsw3vmx	24	26	has	have	VBZ
cord-273505-pcsw3vmx	24	27	not	not	RB
cord-273505-pcsw3vmx	24	28	yet	yet	RB
cord-273505-pcsw3vmx	24	29	been	be	VBN
cord-273505-pcsw3vmx	24	30	drawn	draw	VBN
cord-273505-pcsw3vmx	24	31	.	.	.
cord-273505-pcsw3vmx	25	1	The	the	DT
cord-273505-pcsw3vmx	25	2	severity	severity	NN
cord-273505-pcsw3vmx	25	3	of	of	IN
cord-273505-pcsw3vmx	25	4	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	25	5	viral	viral	JJ
cord-273505-pcsw3vmx	25	6	infections	infection	NNS
cord-273505-pcsw3vmx	25	7	depends	depend	VBZ
cord-273505-pcsw3vmx	25	8	on	on	IN
cord-273505-pcsw3vmx	25	9	a	a	DT
cord-273505-pcsw3vmx	25	10	fine	fine	JJ
cord-273505-pcsw3vmx	25	11	balance	balance	NN
cord-273505-pcsw3vmx	25	12	between	between	IN
cord-273505-pcsw3vmx	25	13	the	the	DT
cord-273505-pcsw3vmx	25	14	virulence	virulence	NN
cord-273505-pcsw3vmx	25	15	of	of	IN
cord-273505-pcsw3vmx	25	16	the	the	DT
cord-273505-pcsw3vmx	25	17	pathogen	pathogen	NN
cord-273505-pcsw3vmx	25	18	and	and	CC
cord-273505-pcsw3vmx	25	19	the	the	DT
cord-273505-pcsw3vmx	25	20	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	25	21	response	response	NN
cord-273505-pcsw3vmx	25	22	of	of	IN
cord-273505-pcsw3vmx	25	23	the	the	DT
cord-273505-pcsw3vmx	25	24	host	host	NN
cord-273505-pcsw3vmx	25	25	's	's	POS
cord-273505-pcsw3vmx	25	26	immune	immune	JJ
cord-273505-pcsw3vmx	25	27	system	system	NN
cord-273505-pcsw3vmx	25	28	(	(	-LRB-
cord-273505-pcsw3vmx	25	29	12	12	CD
cord-273505-pcsw3vmx	25	30	)	)	-RRB-
cord-273505-pcsw3vmx	25	31	.	.	.
cord-273505-pcsw3vmx	26	1	Although	although	IN
cord-273505-pcsw3vmx	26	2	an	an	DT
cord-273505-pcsw3vmx	26	3	effective	effective	JJ
cord-273505-pcsw3vmx	26	4	immune	immune	JJ
cord-273505-pcsw3vmx	26	5	response	response	NN
cord-273505-pcsw3vmx	26	6	is	be	VBZ
cord-273505-pcsw3vmx	26	7	essential	essential	JJ
cord-273505-pcsw3vmx	26	8	to	to	TO
cord-273505-pcsw3vmx	26	9	eliminate	eliminate	VB
cord-273505-pcsw3vmx	26	10	viral	viral	JJ
cord-273505-pcsw3vmx	26	11	pathogens	pathogen	NNS
cord-273505-pcsw3vmx	26	12	,	,	,
cord-273505-pcsw3vmx	26	13	clinical	clinical	JJ
cord-273505-pcsw3vmx	26	14	observations	observation	NNS
cord-273505-pcsw3vmx	26	15	and	and	CC
cord-273505-pcsw3vmx	26	16	experimental	experimental	JJ
cord-273505-pcsw3vmx	26	17	data	datum	NNS
cord-273505-pcsw3vmx	26	18	indicate	indicate	VBP
cord-273505-pcsw3vmx	26	19	that	that	IN
cord-273505-pcsw3vmx	26	20	an	an	DT
cord-273505-pcsw3vmx	26	21	excessive	excessive	JJ
cord-273505-pcsw3vmx	26	22	host	host	NN
cord-273505-pcsw3vmx	26	23	immune	immune	JJ
cord-273505-pcsw3vmx	26	24	responserather	responserather	RBR
cord-273505-pcsw3vmx	26	25	than	than	IN
cord-273505-pcsw3vmx	26	26	direct	direct	JJ
cord-273505-pcsw3vmx	26	27	viral	viral	JJ
cord-273505-pcsw3vmx	26	28	damage	damage	NN
cord-273505-pcsw3vmx	26	29	-	-	:
cord-273505-pcsw3vmx	26	30	primarily	primarily	RB
cord-273505-pcsw3vmx	26	31	account	account	NN
cord-273505-pcsw3vmx	26	32	for	for	IN
cord-273505-pcsw3vmx	26	33	the	the	DT
cord-273505-pcsw3vmx	26	34	pathological	pathological	JJ
cord-273505-pcsw3vmx	26	35	injury	injury	NN
cord-273505-pcsw3vmx	26	36	and	and	CC
cord-273505-pcsw3vmx	26	37	clinical	clinical	JJ
cord-273505-pcsw3vmx	26	38	deterioration	deterioration	NN
cord-273505-pcsw3vmx	26	39	of	of	IN
cord-273505-pcsw3vmx	26	40	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	26	41	(	(	-LRB-
cord-273505-pcsw3vmx	26	42	12	12	CD
cord-273505-pcsw3vmx	26	43	)	)	-RRB-
cord-273505-pcsw3vmx	26	44	.	.	.
cord-273505-pcsw3vmx	27	1	Inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	27	2	cytokine	cytokine	NN
cord-273505-pcsw3vmx	27	3	storms	storm	NNS
cord-273505-pcsw3vmx	27	4	and	and	CC
cord-273505-pcsw3vmx	27	5	lymphopenia	lymphopenia	NNP
cord-273505-pcsw3vmx	27	6	are	be	VBP
cord-273505-pcsw3vmx	27	7	the	the	DT
cord-273505-pcsw3vmx	27	8	signature	signature	NN
cord-273505-pcsw3vmx	27	9	features	feature	NNS
cord-273505-pcsw3vmx	27	10	of	of	IN
cord-273505-pcsw3vmx	27	11	patients	patient	NNS
cord-273505-pcsw3vmx	27	12	with	with	IN
cord-273505-pcsw3vmx	27	13	severe	severe	JJ
cord-273505-pcsw3vmx	27	14	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	27	15	,	,	,
cord-273505-pcsw3vmx	27	16	indicating	indicate	VBG
cord-273505-pcsw3vmx	27	17	an	an	DT
cord-273505-pcsw3vmx	27	18	intense	intense	JJ
cord-273505-pcsw3vmx	27	19	systemic	systemic	JJ
cord-273505-pcsw3vmx	27	20	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	27	21	response	response	NN
cord-273505-pcsw3vmx	27	22	during	during	IN
cord-273505-pcsw3vmx	27	23	SARS	SARS	NNP
cord-273505-pcsw3vmx	27	24	-	-	HYPH
cord-273505-pcsw3vmx	27	25	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	27	26	infection	infection	NN
cord-273505-pcsw3vmx	27	27	(	(	-LRB-
cord-273505-pcsw3vmx	27	28	13	13	CD
cord-273505-pcsw3vmx	27	29	)	)	-RRB-
cord-273505-pcsw3vmx	27	30	.	.	.
cord-273505-pcsw3vmx	28	1	Specific	specific	JJ
cord-273505-pcsw3vmx	28	2	adjuvant	adjuvant	JJ
cord-273505-pcsw3vmx	28	3	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	28	4	treatments	treatment	NNS
cord-273505-pcsw3vmx	28	5	have	have	VBP
cord-273505-pcsw3vmx	28	6	been	be	VBN
cord-273505-pcsw3vmx	28	7	considered	consider	VBN
cord-273505-pcsw3vmx	28	8	for	for	IN
cord-273505-pcsw3vmx	28	9	severe	severe	JJ
cord-273505-pcsw3vmx	28	10	viral	viral	JJ
cord-273505-pcsw3vmx	28	11	infections	infection	NNS
cord-273505-pcsw3vmx	28	12	,	,	,
cord-273505-pcsw3vmx	28	13	but	but	CC
cord-273505-pcsw3vmx	28	14	some	some	DT
cord-273505-pcsw3vmx	28	15	of	of	IN
cord-273505-pcsw3vmx	28	16	these	these	DT
cord-273505-pcsw3vmx	28	17	were	be	VBD
cord-273505-pcsw3vmx	28	18	associated	associate	VBN
cord-273505-pcsw3vmx	28	19	with	with	IN
cord-273505-pcsw3vmx	28	20	a	a	DT
cord-273505-pcsw3vmx	28	21	worse	bad	JJR
cord-273505-pcsw3vmx	28	22	prognosis	prognosis	NN
cord-273505-pcsw3vmx	28	23	.	.	.
cord-273505-pcsw3vmx	29	1	Therefore	therefore	RB
cord-273505-pcsw3vmx	29	2	,	,	,
cord-273505-pcsw3vmx	29	3	it	-PRON-	PRP
cord-273505-pcsw3vmx	29	4	is	be	VBZ
cord-273505-pcsw3vmx	29	5	vital	vital	JJ
cord-273505-pcsw3vmx	29	6	to	to	TO
cord-273505-pcsw3vmx	29	7	select	select	VB
cord-273505-pcsw3vmx	29	8	appropriate	appropriate	JJ
cord-273505-pcsw3vmx	29	9	immunomodulators	immunomodulator	NNS
cord-273505-pcsw3vmx	29	10	in	in	IN
cord-273505-pcsw3vmx	29	11	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	29	12	patients	patient	NNS
cord-273505-pcsw3vmx	29	13	and	and	CC
cord-273505-pcsw3vmx	29	14	to	to	TO
cord-273505-pcsw3vmx	29	15	carefully	carefully	RB
cord-273505-pcsw3vmx	29	16	assess	assess	VB
cord-273505-pcsw3vmx	29	17	their	-PRON-	PRP$
cord-273505-pcsw3vmx	29	18	benefits	benefit	NNS
cord-273505-pcsw3vmx	29	19	and	and	CC
cord-273505-pcsw3vmx	29	20	risks	risk	NNS
cord-273505-pcsw3vmx	29	21	(	(	-LRB-
cord-273505-pcsw3vmx	29	22	14	14	CD
cord-273505-pcsw3vmx	29	23	,	,	,
cord-273505-pcsw3vmx	29	24	15	15	CD
cord-273505-pcsw3vmx	29	25	)	)	-RRB-
cord-273505-pcsw3vmx	29	26	.	.	.
cord-273505-pcsw3vmx	30	1	Based	base	VBN
cord-273505-pcsw3vmx	30	2	on	on	IN
cord-273505-pcsw3vmx	30	3	the	the	DT
cord-273505-pcsw3vmx	30	4	previous	previous	JJ
cord-273505-pcsw3vmx	30	5	clinical	clinical	JJ
cord-273505-pcsw3vmx	30	6	experience	experience	NN
cord-273505-pcsw3vmx	30	7	in	in	IN
cord-273505-pcsw3vmx	30	8	China	China	NNP
cord-273505-pcsw3vmx	30	9	,	,	,
cord-273505-pcsw3vmx	30	10	it	-PRON-	PRP
cord-273505-pcsw3vmx	30	11	was	be	VBD
cord-273505-pcsw3vmx	30	12	proposed	propose	VBN
cord-273505-pcsw3vmx	30	13	that	that	IN
cord-273505-pcsw3vmx	30	14	early	early	JJ
cord-273505-pcsw3vmx	30	15	initiation	initiation	NN
cord-273505-pcsw3vmx	30	16	of	of	IN
cord-273505-pcsw3vmx	30	17	high	high	JJ
cord-273505-pcsw3vmx	30	18	-	-	HYPH
cord-273505-pcsw3vmx	30	19	dose	dose	NN
cord-273505-pcsw3vmx	30	20	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	30	21	immunoglobulins	immunoglobulin	NNS
cord-273505-pcsw3vmx	30	22	(	(	-LRB-
cord-273505-pcsw3vmx	30	23	IVIg	ivig	ADD
cord-273505-pcsw3vmx	30	24	)	)	-RRB-
cord-273505-pcsw3vmx	30	25	and	and	CC
cord-273505-pcsw3vmx	30	26	low	low	JJ
cord-273505-pcsw3vmx	30	27	-	-	HYPH
cord-273505-pcsw3vmx	30	28	molecular	molecular	JJ
cord-273505-pcsw3vmx	30	29	-	-	HYPH
cord-273505-pcsw3vmx	30	30	weight	weight	NN
cord-273505-pcsw3vmx	30	31	heparin	heparin	NN
cord-273505-pcsw3vmx	30	32	might	may	MD
cord-273505-pcsw3vmx	30	33	be	be	VB
cord-273505-pcsw3vmx	30	34	effective	effective	JJ
cord-273505-pcsw3vmx	30	35	in	in	IN
cord-273505-pcsw3vmx	30	36	improving	improve	VBG
cord-273505-pcsw3vmx	30	37	the	the	DT
cord-273505-pcsw3vmx	30	38	prognosis	prognosis	NN
cord-273505-pcsw3vmx	30	39	of	of	IN
cord-273505-pcsw3vmx	30	40	severe	severe	JJ
cord-273505-pcsw3vmx	30	41	and	and	CC
cord-273505-pcsw3vmx	30	42	critically	critically	RB
cord-273505-pcsw3vmx	30	43	ill	ill	RB
cord-273505-pcsw3vmx	30	44	COVID-19	covid-19	CD
cord-273505-pcsw3vmx	30	45	patients	patient	NNS
cord-273505-pcsw3vmx	30	46	(	(	-LRB-
cord-273505-pcsw3vmx	30	47	16	16	CD
cord-273505-pcsw3vmx	30	48	,	,	,
cord-273505-pcsw3vmx	30	49	17	17	CD
cord-273505-pcsw3vmx	30	50	)	)	-RRB-
cord-273505-pcsw3vmx	30	51	.	.	.
cord-273505-pcsw3vmx	31	1	The	the	DT
cord-273505-pcsw3vmx	31	2	national	national	JJ
cord-273505-pcsw3vmx	31	3	diagnosis	diagnosis	NN
cord-273505-pcsw3vmx	31	4	and	and	CC
cord-273505-pcsw3vmx	31	5	treatment	treatment	NN
cord-273505-pcsw3vmx	31	6	protocol	protocol	NN
cord-273505-pcsw3vmx	31	7	for	for	IN
cord-273505-pcsw3vmx	31	8	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	32	1	(	(	-LRB-
cord-273505-pcsw3vmx	32	2	Trial	Trial	NNP
cord-273505-pcsw3vmx	32	3	Version	Version	NNP
cord-273505-pcsw3vmx	32	4	7	7	CD
cord-273505-pcsw3vmx	32	5	)	)	-RRB-
cord-273505-pcsw3vmx	32	6	and	and	CC
cord-273505-pcsw3vmx	32	7	recommendations	recommendation	NNS
cord-273505-pcsw3vmx	32	8	from	from	IN
cord-273505-pcsw3vmx	32	9	the	the	DT
cord-273505-pcsw3vmx	32	10	Peking	Peking	NNP
cord-273505-pcsw3vmx	32	11	Union	Union	NNP
cord-273505-pcsw3vmx	32	12	Medical	Medical	NNP
cord-273505-pcsw3vmx	32	13	College	College	NNP
cord-273505-pcsw3vmx	32	14	Hospital	Hospital	NNP
cord-273505-pcsw3vmx	33	1	recommend	recommend	VB
cord-273505-pcsw3vmx	33	2	appropriate	appropriate	JJ
cord-273505-pcsw3vmx	33	3	application	application	NN
cord-273505-pcsw3vmx	33	4	of	of	IN
cord-273505-pcsw3vmx	33	5	IVIg	ivig	JJ
cord-273505-pcsw3vmx	33	6	therapy	therapy	NN
cord-273505-pcsw3vmx	33	7	in	in	IN
cord-273505-pcsw3vmx	33	8	severe	severe	JJ
cord-273505-pcsw3vmx	33	9	and	and	CC
cord-273505-pcsw3vmx	33	10	critical	critical	JJ
cord-273505-pcsw3vmx	33	11	COVID-19	covid-19	CD
cord-273505-pcsw3vmx	33	12	cases	case	NNS
cord-273505-pcsw3vmx	33	13	(	(	-LRB-
cord-273505-pcsw3vmx	33	14	4	4	CD
cord-273505-pcsw3vmx	33	15	,	,	,
cord-273505-pcsw3vmx	33	16	18	18	CD
cord-273505-pcsw3vmx	33	17	)	)	-RRB-
cord-273505-pcsw3vmx	33	18	.	.	.
cord-273505-pcsw3vmx	34	1	However	however	RB
cord-273505-pcsw3vmx	34	2	,	,	,
cord-273505-pcsw3vmx	34	3	the	the	DT
cord-273505-pcsw3vmx	34	4	specific	specific	JJ
cord-273505-pcsw3vmx	34	5	molecular	molecular	JJ
cord-273505-pcsw3vmx	34	6	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	34	7	and	and	CC
cord-273505-pcsw3vmx	34	8	clinical	clinical	JJ
cord-273505-pcsw3vmx	34	9	effectiveness	effectiveness	NN
cord-273505-pcsw3vmx	34	10	of	of	IN
cord-273505-pcsw3vmx	34	11	IVIg	ivig	JJ
cord-273505-pcsw3vmx	34	12	treatment	treatment	NN
cord-273505-pcsw3vmx	34	13	remain	remain	VBP
cord-273505-pcsw3vmx	34	14	unclear	unclear	JJ
cord-273505-pcsw3vmx	34	15	.	.	.
cord-273505-pcsw3vmx	35	1	Here	here	RB
cord-273505-pcsw3vmx	35	2	,	,	,
cord-273505-pcsw3vmx	35	3	we	-PRON-	PRP
cord-273505-pcsw3vmx	35	4	review	review	VBP
cord-273505-pcsw3vmx	35	5	the	the	DT
cord-273505-pcsw3vmx	35	6	current	current	JJ
cord-273505-pcsw3vmx	35	7	knowledge	knowledge	NN
cord-273505-pcsw3vmx	35	8	of	of	IN
cord-273505-pcsw3vmx	35	9	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	35	10	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	35	11	of	of	IN
cord-273505-pcsw3vmx	35	12	high	high	JJ
cord-273505-pcsw3vmx	35	13	-	-	HYPH
cord-273505-pcsw3vmx	35	14	dose	dose	NN
cord-273505-pcsw3vmx	35	15	IVIg	ivig	NN
cord-273505-pcsw3vmx	35	16	and	and	CC
cord-273505-pcsw3vmx	35	17	discuss	discuss	VB
cord-273505-pcsw3vmx	35	18	its	-PRON-	PRP$
cord-273505-pcsw3vmx	35	19	potential	potential	JJ
cord-273505-pcsw3vmx	35	20	role	role	NN
cord-273505-pcsw3vmx	35	21	in	in	IN
cord-273505-pcsw3vmx	35	22	treating	treat	VBG
cord-273505-pcsw3vmx	35	23	severe	severe	JJ
cord-273505-pcsw3vmx	35	24	viral	viral	JJ
cord-273505-pcsw3vmx	35	25	infection	infection	NN
cord-273505-pcsw3vmx	35	26	.	.	.
cord-273505-pcsw3vmx	36	1	Moreover	moreover	RB
cord-273505-pcsw3vmx	36	2	,	,	,
cord-273505-pcsw3vmx	36	3	we	-PRON-	PRP
cord-273505-pcsw3vmx	36	4	summarize	summarize	VBP
cord-273505-pcsw3vmx	36	5	the	the	DT
cord-273505-pcsw3vmx	36	6	clinical	clinical	JJ
cord-273505-pcsw3vmx	36	7	efficacy	efficacy	NN
cord-273505-pcsw3vmx	36	8	of	of	IN
cord-273505-pcsw3vmx	36	9	IVIg	ivig	JJ
cord-273505-pcsw3vmx	36	10	therapy	therapy	NN
cord-273505-pcsw3vmx	36	11	in	in	IN
cord-273505-pcsw3vmx	36	12	treating	treat	VBG
cord-273505-pcsw3vmx	36	13	severe	severe	JJ
cord-273505-pcsw3vmx	36	14	viral	viral	JJ
cord-273505-pcsw3vmx	36	15	pneumonias	pneumonia	NNS
cord-273505-pcsw3vmx	36	16	such	such	JJ
cord-273505-pcsw3vmx	36	17	as	as	IN
cord-273505-pcsw3vmx	36	18	that	that	DT
cord-273505-pcsw3vmx	36	19	caused	cause	VBN
cord-273505-pcsw3vmx	36	20	by	by	IN
cord-273505-pcsw3vmx	36	21	SARS	SARS	NNP
cord-273505-pcsw3vmx	36	22	,	,	,
cord-273505-pcsw3vmx	36	23	MERS	MERS	NNP
cord-273505-pcsw3vmx	36	24	,	,	,
cord-273505-pcsw3vmx	36	25	influenza	influenza	NN
cord-273505-pcsw3vmx	36	26	,	,	,
cord-273505-pcsw3vmx	36	27	and	and	CC
cord-273505-pcsw3vmx	36	28	RSV	RSV	NNP
cord-273505-pcsw3vmx	36	29	disease	disease	NN
cord-273505-pcsw3vmx	36	30	,	,	,
cord-273505-pcsw3vmx	36	31	and	and	CC
cord-273505-pcsw3vmx	36	32	its	-PRON-	PRP$
cord-273505-pcsw3vmx	36	33	current	current	JJ
cord-273505-pcsw3vmx	36	34	application	application	NN
cord-273505-pcsw3vmx	36	35	in	in	IN
cord-273505-pcsw3vmx	36	36	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	36	37	.	.	.
cord-273505-pcsw3vmx	37	1	A	a	DT
cord-273505-pcsw3vmx	37	2	thorough	thorough	JJ
cord-273505-pcsw3vmx	37	3	understanding	understanding	NN
cord-273505-pcsw3vmx	37	4	of	of	IN
cord-273505-pcsw3vmx	37	5	the	the	DT
cord-273505-pcsw3vmx	37	6	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	37	7	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	37	8	of	of	IN
cord-273505-pcsw3vmx	37	9	IVIg	ivig	NN
cord-273505-pcsw3vmx	37	10	therapy	therapy	NN
cord-273505-pcsw3vmx	37	11	is	be	VBZ
cord-273505-pcsw3vmx	37	12	crucial	crucial	JJ
cord-273505-pcsw3vmx	37	13	for	for	IN
cord-273505-pcsw3vmx	37	14	the	the	DT
cord-273505-pcsw3vmx	37	15	timing	timing	NN
cord-273505-pcsw3vmx	37	16	and	and	CC
cord-273505-pcsw3vmx	37	17	dosing	dosing	NN
cord-273505-pcsw3vmx	37	18	of	of	IN
cord-273505-pcsw3vmx	37	19	early	early	JJ
cord-273505-pcsw3vmx	37	20	intervention	intervention	NN
cord-273505-pcsw3vmx	37	21	and	and	CC
cord-273505-pcsw3vmx	37	22	may	may	MD
cord-273505-pcsw3vmx	37	23	provide	provide	VB
cord-273505-pcsw3vmx	37	24	much	much	RB
cord-273505-pcsw3vmx	37	25	-	-	HYPH
cord-273505-pcsw3vmx	37	26	needed	need	VBN
cord-273505-pcsw3vmx	37	27	insights	insight	NNS
cord-273505-pcsw3vmx	37	28	into	into	IN
cord-273505-pcsw3vmx	37	29	the	the	DT
cord-273505-pcsw3vmx	37	30	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	37	31	treatment	treatment	NN
cord-273505-pcsw3vmx	37	32	of	of	IN
cord-273505-pcsw3vmx	37	33	severe	severe	JJ
cord-273505-pcsw3vmx	37	34	and	and	CC
cord-273505-pcsw3vmx	37	35	critically	critically	RB
cord-273505-pcsw3vmx	37	36	ill	ill	RB
cord-273505-pcsw3vmx	37	37	COVID-19	covid-19	CD
cord-273505-pcsw3vmx	37	38	patients	patient	NNS
cord-273505-pcsw3vmx	37	39	.	.	.
cord-273505-pcsw3vmx	38	1	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	38	2	is	be	VBZ
cord-273505-pcsw3vmx	38	3	a	a	DT
cord-273505-pcsw3vmx	38	4	blood	blood	NN
cord-273505-pcsw3vmx	38	5	preparation	preparation	NN
cord-273505-pcsw3vmx	38	6	isolated	isolate	VBN
cord-273505-pcsw3vmx	38	7	and	and	CC
cord-273505-pcsw3vmx	38	8	concentrated	concentrate	VBN
cord-273505-pcsw3vmx	38	9	from	from	IN
cord-273505-pcsw3vmx	38	10	healthy	healthy	JJ
cord-273505-pcsw3vmx	38	11	donors	donor	NNS
cord-273505-pcsw3vmx	38	12	consisting	consist	VBG
cord-273505-pcsw3vmx	38	13	of	of	IN
cord-273505-pcsw3vmx	38	14	over	over	IN
cord-273505-pcsw3vmx	38	15	95	95	CD
cord-273505-pcsw3vmx	38	16	%	%	NN
cord-273505-pcsw3vmx	38	17	of	of	IN
cord-273505-pcsw3vmx	38	18	IgG	igg	NN
cord-273505-pcsw3vmx	38	19	and	and	CC
cord-273505-pcsw3vmx	38	20	trace	trace	NN
cord-273505-pcsw3vmx	38	21	amounts	amount	NNS
cord-273505-pcsw3vmx	38	22	of	of	IN
cord-273505-pcsw3vmx	38	23	IgA	IgA	NNP
cord-273505-pcsw3vmx	38	24	or	or	CC
cord-273505-pcsw3vmx	38	25	IgM.	IgM.	NNP
cord-273505-pcsw3vmx	38	26	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	38	27	has	have	VBZ
cord-273505-pcsw3vmx	38	28	been	be	VBN
cord-273505-pcsw3vmx	38	29	used	use	VBN
cord-273505-pcsw3vmx	38	30	in	in	IN
cord-273505-pcsw3vmx	38	31	clinical	clinical	JJ
cord-273505-pcsw3vmx	38	32	practice	practice	NN
cord-273505-pcsw3vmx	38	33	for	for	IN
cord-273505-pcsw3vmx	38	34	many	many	JJ
cord-273505-pcsw3vmx	38	35	years	year	NNS
cord-273505-pcsw3vmx	38	36	.	.	.
cord-273505-pcsw3vmx	39	1	Different	different	JJ
cord-273505-pcsw3vmx	39	2	doses	dose	NNS
cord-273505-pcsw3vmx	39	3	of	of	IN
cord-273505-pcsw3vmx	39	4	IVIg	IVIg	NNS
cord-273505-pcsw3vmx	39	5	serve	serve	VBP
cord-273505-pcsw3vmx	39	6	diverse	diverse	JJ
cord-273505-pcsw3vmx	39	7	medical	medical	JJ
cord-273505-pcsw3vmx	39	8	indications	indication	NNS
cord-273505-pcsw3vmx	39	9	,	,	,
cord-273505-pcsw3vmx	39	10	and	and	CC
cord-273505-pcsw3vmx	39	11	the	the	DT
cord-273505-pcsw3vmx	39	12	clinical	clinical	JJ
cord-273505-pcsw3vmx	39	13	efficacy	efficacy	NN
cord-273505-pcsw3vmx	39	14	of	of	IN
cord-273505-pcsw3vmx	39	15	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	39	16	differs	differ	VBZ
cord-273505-pcsw3vmx	39	17	with	with	IN
cord-273505-pcsw3vmx	39	18	dosage	dosage	NN
cord-273505-pcsw3vmx	39	19	(	(	-LRB-
cord-273505-pcsw3vmx	39	20	19	19	CD
cord-273505-pcsw3vmx	39	21	)	)	-RRB-
cord-273505-pcsw3vmx	39	22	.	.	.
cord-273505-pcsw3vmx	40	1	At	at	IN
cord-273505-pcsw3vmx	40	2	low	low	JJ
cord-273505-pcsw3vmx	40	3	and	and	CC
cord-273505-pcsw3vmx	40	4	moderate	moderate	JJ
cord-273505-pcsw3vmx	40	5	doses	dose	NNS
cord-273505-pcsw3vmx	40	6	,	,	,
cord-273505-pcsw3vmx	40	7	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	40	8	can	can	MD
cord-273505-pcsw3vmx	40	9	be	be	VB
cord-273505-pcsw3vmx	40	10	administered	administer	VBN
cord-273505-pcsw3vmx	40	11	as	as	IN
cord-273505-pcsw3vmx	40	12	substitutional	substitutional	JJ
cord-273505-pcsw3vmx	40	13	therapy	therapy	NN
cord-273505-pcsw3vmx	40	14	for	for	IN
cord-273505-pcsw3vmx	40	15	primary	primary	JJ
cord-273505-pcsw3vmx	40	16	or	or	CC
cord-273505-pcsw3vmx	40	17	acquired	acquire	VBN
cord-273505-pcsw3vmx	40	18	immunodeficiencies	immunodeficiency	NNS
cord-273505-pcsw3vmx	40	19	in	in	IN
cord-273505-pcsw3vmx	40	20	order	order	NN
cord-273505-pcsw3vmx	40	21	to	to	TO
cord-273505-pcsw3vmx	40	22	improve	improve	VB
cord-273505-pcsw3vmx	40	23	plasma	plasma	NN
cord-273505-pcsw3vmx	40	24	IgG	igg	NN
cord-273505-pcsw3vmx	40	25	concentrations	concentration	NNS
cord-273505-pcsw3vmx	40	26	and	and	CC
cord-273505-pcsw3vmx	40	27	provide	provide	VB
cord-273505-pcsw3vmx	40	28	passive	passive	JJ
cord-273505-pcsw3vmx	40	29	immunity	immunity	NN
cord-273505-pcsw3vmx	40	30	that	that	WDT
cord-273505-pcsw3vmx	40	31	allows	allow	VBZ
cord-273505-pcsw3vmx	40	32	for	for	IN
cord-273505-pcsw3vmx	40	33	immediate	immediate	JJ
cord-273505-pcsw3vmx	40	34	protection	protection	NN
cord-273505-pcsw3vmx	40	35	against	against	IN
cord-273505-pcsw3vmx	40	36	microbes	microbe	NNS
cord-273505-pcsw3vmx	40	37	in	in	IN
cord-273505-pcsw3vmx	40	38	immunodeficient	immunodeficient	JJ
cord-273505-pcsw3vmx	40	39	patients	patient	NNS
cord-273505-pcsw3vmx	40	40	.	.	.
cord-273505-pcsw3vmx	41	1	In	in	IN
cord-273505-pcsw3vmx	41	2	vitro	vitro	FW
cord-273505-pcsw3vmx	41	3	and	and	CC
cord-273505-pcsw3vmx	41	4	preclinical	preclinical	JJ
cord-273505-pcsw3vmx	41	5	experiments	experiment	NNS
cord-273505-pcsw3vmx	41	6	confirmed	confirm	VBD
cord-273505-pcsw3vmx	41	7	that	that	IN
cord-273505-pcsw3vmx	41	8	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	41	9	contains	contain	VBZ
cord-273505-pcsw3vmx	41	10	multivalent	multivalent	JJ
cord-273505-pcsw3vmx	41	11	pathogen	pathogen	NN
cord-273505-pcsw3vmx	41	12	-	-	HYPH
cord-273505-pcsw3vmx	41	13	specific	specific	JJ
cord-273505-pcsw3vmx	41	14	neutralizing	neutralize	VBG
cord-273505-pcsw3vmx	41	15	IgG	igg	NN
cord-273505-pcsw3vmx	41	16	antibodies	antibody	NNS
cord-273505-pcsw3vmx	41	17	against	against	IN
cord-273505-pcsw3vmx	41	18	common	common	JJ
cord-273505-pcsw3vmx	41	19	opportunistic	opportunistic	JJ
cord-273505-pcsw3vmx	41	20	pathogens	pathogen	NNS
cord-273505-pcsw3vmx	41	21	and	and	CC
cord-273505-pcsw3vmx	41	22	toxins	toxin	NNS
cord-273505-pcsw3vmx	41	23	(	(	-LRB-
cord-273505-pcsw3vmx	41	24	e.g.	e.g.	RB
cord-273505-pcsw3vmx	41	25	,	,	,
cord-273505-pcsw3vmx	41	26	Enterococcus	Enterococcus	NNP
cord-273505-pcsw3vmx	41	27	spp	spp	NNS
cord-273505-pcsw3vmx	41	28	.	.	.
cord-273505-pcsw3vmx	42	1	,	,	,
cord-273505-pcsw3vmx	42	2	Haemophilus	haemophilus	JJ
cord-273505-pcsw3vmx	42	3	influenzae	influenzae	NN
cord-273505-pcsw3vmx	42	4	type	type	NN
cord-273505-pcsw3vmx	42	5	b	b	NN
cord-273505-pcsw3vmx	42	6	,	,	,
cord-273505-pcsw3vmx	42	7	Streptococcus	streptococcus	NN
cord-273505-pcsw3vmx	42	8	pyogenes	pyogene	NNS
cord-273505-pcsw3vmx	42	9	,	,	,
cord-273505-pcsw3vmx	42	10	Staphylococcus	Staphylococcus	NNP
cord-273505-pcsw3vmx	42	11	aureus	aureus	NN
cord-273505-pcsw3vmx	42	12	,	,	,
cord-273505-pcsw3vmx	42	13	cytomegalovirus	cytomegalovirus	NN
cord-273505-pcsw3vmx	42	14	,	,	,
cord-273505-pcsw3vmx	42	15	and	and	CC
cord-273505-pcsw3vmx	42	16	Shiga	Shiga	NNP
cord-273505-pcsw3vmx	42	17	toxins	toxin	NNS
cord-273505-pcsw3vmx	42	18	)	)	-RRB-
cord-273505-pcsw3vmx	42	19	(	(	-LRB-
cord-273505-pcsw3vmx	42	20	21	21	CD
cord-273505-pcsw3vmx	42	21	)	)	-RRB-
cord-273505-pcsw3vmx	42	22	(	(	-LRB-
cord-273505-pcsw3vmx	42	23	22	22	CD
cord-273505-pcsw3vmx	42	24	)	)	-RRB-
cord-273505-pcsw3vmx	42	25	(	(	-LRB-
cord-273505-pcsw3vmx	42	26	23	23	CD
cord-273505-pcsw3vmx	42	27	)	)	-RRB-
cord-273505-pcsw3vmx	42	28	(	(	-LRB-
cord-273505-pcsw3vmx	42	29	24	24	CD
cord-273505-pcsw3vmx	42	30	)	)	-RRB-
cord-273505-pcsw3vmx	42	31	(	(	-LRB-
cord-273505-pcsw3vmx	42	32	25	25	CD
cord-273505-pcsw3vmx	42	33	)	)	-RRB-
cord-273505-pcsw3vmx	42	34	(	(	-LRB-
cord-273505-pcsw3vmx	42	35	26	26	CD
cord-273505-pcsw3vmx	42	36	)	)	-RRB-
cord-273505-pcsw3vmx	42	37	.	.	.
cord-273505-pcsw3vmx	43	1	Variance	variance	NN
cord-273505-pcsw3vmx	43	2	in	in	IN
cord-273505-pcsw3vmx	43	3	pathogen	pathogen	NN
cord-273505-pcsw3vmx	43	4	-	-	HYPH
cord-273505-pcsw3vmx	43	5	specific	specific	JJ
cord-273505-pcsw3vmx	43	6	antibody	antibody	NN
cord-273505-pcsw3vmx	43	7	titer	titer	NN
cord-273505-pcsw3vmx	43	8	and	and	CC
cord-273505-pcsw3vmx	43	9	neutralizing	neutralize	VBG
cord-273505-pcsw3vmx	43	10	activity	activity	NN
cord-273505-pcsw3vmx	43	11	is	be	VBZ
cord-273505-pcsw3vmx	43	12	usually	usually	RB
cord-273505-pcsw3vmx	43	13	observed	observe	VBN
cord-273505-pcsw3vmx	43	14	among	among	IN
cord-273505-pcsw3vmx	43	15	various	various	JJ
cord-273505-pcsw3vmx	43	16	IVIg	ivig	NN
cord-273505-pcsw3vmx	43	17	preparations	preparation	NNS
cord-273505-pcsw3vmx	43	18	,	,	,
cord-273505-pcsw3vmx	43	19	and	and	CC
cord-273505-pcsw3vmx	43	20	is	be	VBZ
cord-273505-pcsw3vmx	43	21	most	most	RBS
cord-273505-pcsw3vmx	43	22	likely	likely	JJ
cord-273505-pcsw3vmx	43	23	due	due	IN
cord-273505-pcsw3vmx	43	24	to	to	IN
cord-273505-pcsw3vmx	43	25	differences	difference	NNS
cord-273505-pcsw3vmx	43	26	in	in	IN
cord-273505-pcsw3vmx	43	27	the	the	DT
cord-273505-pcsw3vmx	43	28	geographical	geographical	JJ
cord-273505-pcsw3vmx	43	29	regions	region	NNS
cord-273505-pcsw3vmx	43	30	where	where	WRB
cord-273505-pcsw3vmx	43	31	plasma	plasma	NN
cord-273505-pcsw3vmx	43	32	samples	sample	NNS
cord-273505-pcsw3vmx	43	33	were	be	VBD
cord-273505-pcsw3vmx	43	34	collected	collect	VBN
cord-273505-pcsw3vmx	43	35	,	,	,
cord-273505-pcsw3vmx	43	36	reflecting	reflect	VBG
cord-273505-pcsw3vmx	43	37	differences	difference	NNS
cord-273505-pcsw3vmx	43	38	in	in	IN
cord-273505-pcsw3vmx	43	39	pathogen	pathogen	NN
cord-273505-pcsw3vmx	43	40	exposure	exposure	NN
cord-273505-pcsw3vmx	43	41	(	(	-LRB-
cord-273505-pcsw3vmx	43	42	27	27	CD
cord-273505-pcsw3vmx	43	43	-	-	SYM
cord-273505-pcsw3vmx	43	44	29	29	CD
cord-273505-pcsw3vmx	43	45	)	)	-RRB-
cord-273505-pcsw3vmx	43	46	.	.	.
cord-273505-pcsw3vmx	44	1	In	in	IN
cord-273505-pcsw3vmx	44	2	addition	addition	NN
cord-273505-pcsw3vmx	44	3	to	to	IN
cord-273505-pcsw3vmx	44	4	microbial	microbial	JJ
cord-273505-pcsw3vmx	44	5	binding	binding	NN
cord-273505-pcsw3vmx	44	6	,	,	,
cord-273505-pcsw3vmx	44	7	a	a	DT
cord-273505-pcsw3vmx	44	8	wide	wide	JJ
cord-273505-pcsw3vmx	44	9	range	range	NN
cord-273505-pcsw3vmx	44	10	of	of	IN
cord-273505-pcsw3vmx	44	11	endogenous	endogenous	JJ
cord-273505-pcsw3vmx	44	12	antigen	antigen	NN
cord-273505-pcsw3vmx	44	13	-	-	HYPH
cord-273505-pcsw3vmx	44	14	specific	specific	JJ
cord-273505-pcsw3vmx	44	15	IgG	igg	NN
cord-273505-pcsw3vmx	44	16	are	be	VBP
cord-273505-pcsw3vmx	44	17	also	also	RB
cord-273505-pcsw3vmx	44	18	present	present	JJ
cord-273505-pcsw3vmx	44	19	in	in	IN
cord-273505-pcsw3vmx	44	20	IVIg	ivig	JJ
cord-273505-pcsw3vmx	44	21	preparations	preparation	NNS
cord-273505-pcsw3vmx	44	22	.	.	.
cord-273505-pcsw3vmx	45	1	These	these	DT
cord-273505-pcsw3vmx	45	2	endogenous	endogenous	JJ
cord-273505-pcsw3vmx	45	3	antigens	antigen	NNS
cord-273505-pcsw3vmx	45	4	may	may	MD
cord-273505-pcsw3vmx	45	5	include	include	VB
cord-273505-pcsw3vmx	45	6	:	:	:
cord-273505-pcsw3vmx	45	7	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	45	8	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	45	9	(	(	-LRB-
cord-273505-pcsw3vmx	45	10	e.g.	e.g.	RB
cord-273505-pcsw3vmx	45	11	,	,	,
cord-273505-pcsw3vmx	45	12	IL-1α	IL-1α	NNP
cord-273505-pcsw3vmx	45	13	,	,	,
cord-273505-pcsw3vmx	45	14	IFN	IFN	NNP
cord-273505-pcsw3vmx	45	15	-	-	HYPH
cord-273505-pcsw3vmx	45	16	α2a	α2a	NNP
cord-273505-pcsw3vmx	45	17	,	,	,
cord-273505-pcsw3vmx	45	18	and	and	CC
cord-273505-pcsw3vmx	45	19	GM	GM	NNP
cord-273505-pcsw3vmx	45	20	-	-	HYPH
cord-273505-pcsw3vmx	45	21	CSF	CSF	NNP
cord-273505-pcsw3vmx	45	22	)	)	-RRB-
cord-273505-pcsw3vmx	45	23	,	,	,
cord-273505-pcsw3vmx	45	24	chemokines	chemokine	NNS
cord-273505-pcsw3vmx	45	25	(	(	-LRB-
cord-273505-pcsw3vmx	45	26	e.g.	e.g.	RB
cord-273505-pcsw3vmx	45	27	,	,	,
cord-273505-pcsw3vmx	45	28	CCR5	CCR5	NNP
cord-273505-pcsw3vmx	45	29	)	)	-RRB-
cord-273505-pcsw3vmx	45	30	,	,	,
cord-273505-pcsw3vmx	45	31	apoptosis	apoptosis	NN
cord-273505-pcsw3vmx	45	32	-	-	HYPH
cord-273505-pcsw3vmx	45	33	related	relate	VBN
cord-273505-pcsw3vmx	45	34	molecules	molecule	NNS
cord-273505-pcsw3vmx	45	35	(	(	-LRB-
cord-273505-pcsw3vmx	45	36	e.g.	e.g.	RB
cord-273505-pcsw3vmx	45	37	,	,	,
cord-273505-pcsw3vmx	45	38	Siglec-8	Siglec-8	NNP
cord-273505-pcsw3vmx	45	39	,	,	,
cord-273505-pcsw3vmx	45	40	Siglec-9	Siglec-9	NNP
cord-273505-pcsw3vmx	45	41	,	,	,
cord-273505-pcsw3vmx	45	42	CD95	CD95	NNP
cord-273505-pcsw3vmx	45	43	/	/	SYM
cord-273505-pcsw3vmx	45	44	Fas	Fas	NNP
cord-273505-pcsw3vmx	45	45	,	,	,
cord-273505-pcsw3vmx	45	46	BAFF	BAFF	NNP
cord-273505-pcsw3vmx	45	47	,	,	,
cord-273505-pcsw3vmx	45	48	and	and	CC
cord-273505-pcsw3vmx	45	49	APRIL	APRIL	NNP
cord-273505-pcsw3vmx	45	50	)	)	-RRB-
cord-273505-pcsw3vmx	45	51	,	,	,
cord-273505-pcsw3vmx	45	52	complement	complement	NN
cord-273505-pcsw3vmx	45	53	fragments	fragment	NNS
cord-273505-pcsw3vmx	45	54	(	(	-LRB-
cord-273505-pcsw3vmx	45	55	C3a	c3a	NN
cord-273505-pcsw3vmx	45	56	and	and	CC
cord-273505-pcsw3vmx	45	57	C5a	C5a	NNS
cord-273505-pcsw3vmx	45	58	)	)	-RRB-
cord-273505-pcsw3vmx	45	59	,	,	,
cord-273505-pcsw3vmx	45	60	and	and	CC
cord-273505-pcsw3vmx	45	61	anti	anti	JJ
cord-273505-pcsw3vmx	45	62	-	-	JJ
cord-273505-pcsw3vmx	45	63	idiotypic	idiotypic	JJ
cord-273505-pcsw3vmx	45	64	antibodies	antibody	NNS
cord-273505-pcsw3vmx	45	65	(	(	-LRB-
cord-273505-pcsw3vmx	45	66	e.g.	e.g.	RB
cord-273505-pcsw3vmx	45	67	,	,	,
cord-273505-pcsw3vmx	45	68	anti	anti	JJ
cord-273505-pcsw3vmx	45	69	-	-	JJ
cord-273505-pcsw3vmx	45	70	amyloid	amyloid	JJ
cord-273505-pcsw3vmx	45	71	β	β	NNP
cord-273505-pcsw3vmx	45	72	antibodies	antibody	NNS
cord-273505-pcsw3vmx	45	73	and	and	CC
cord-273505-pcsw3vmx	45	74	anti	anti	JJ
cord-273505-pcsw3vmx	45	75	-	-	JJ
cord-273505-pcsw3vmx	45	76	coagulation	coagulation	JJ
cord-273505-pcsw3vmx	45	77	factor	factor	NN
cord-273505-pcsw3vmx	45	78	VIII	VIII	NNP
cord-273505-pcsw3vmx	45	79	antibodies	antibody	NNS
cord-273505-pcsw3vmx	45	80	)	)	-RRB-
cord-273505-pcsw3vmx	45	81	(	(	-LRB-
cord-273505-pcsw3vmx	45	82	30	30	CD
cord-273505-pcsw3vmx	45	83	-	-	SYM
cord-273505-pcsw3vmx	45	84	41	41	CD
cord-273505-pcsw3vmx	45	85	)	)	-RRB-
cord-273505-pcsw3vmx	45	86	.	.	.
cord-273505-pcsw3vmx	46	1	F(ab	f(ab	NN
cord-273505-pcsw3vmx	46	2	)	)	-RRB-
cord-273505-pcsw3vmx	46	3	′	′	CD
cord-273505-pcsw3vmx	46	4	2mediated	2mediated	CD
cord-273505-pcsw3vmx	46	5	neutralization	neutralization	NN
cord-273505-pcsw3vmx	46	6	of	of	IN
cord-273505-pcsw3vmx	46	7	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	46	8	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	46	9	,	,	,
cord-273505-pcsw3vmx	46	10	chemokines	chemokine	NNS
cord-273505-pcsw3vmx	46	11	,	,	,
cord-273505-pcsw3vmx	46	12	and	and	CC
cord-273505-pcsw3vmx	46	13	complement	complement	VB
cord-273505-pcsw3vmx	46	14	fragments	fragment	NNS
cord-273505-pcsw3vmx	46	15	,	,	,
cord-273505-pcsw3vmx	46	16	along	along	IN
cord-273505-pcsw3vmx	46	17	with	with	IN
cord-273505-pcsw3vmx	46	18	regulation	regulation	NN
cord-273505-pcsw3vmx	46	19	of	of	IN
cord-273505-pcsw3vmx	46	20	immune	immune	JJ
cord-273505-pcsw3vmx	46	21	cell	cell	NN
cord-273505-pcsw3vmx	46	22	apoptosis	apoptosis	NN
cord-273505-pcsw3vmx	46	23	might	may	MD
cord-273505-pcsw3vmx	46	24	contribute	contribute	VB
cord-273505-pcsw3vmx	46	25	to	to	IN
cord-273505-pcsw3vmx	46	26	the	the	DT
cord-273505-pcsw3vmx	46	27	conversion	conversion	NN
cord-273505-pcsw3vmx	46	28	of	of	IN
cord-273505-pcsw3vmx	46	29	proinflammatory	proinflammatory	JJ
cord-273505-pcsw3vmx	46	30	to	to	IN
cord-273505-pcsw3vmx	46	31	anti	anti	JJ
cord-273505-pcsw3vmx	46	32	-	-	JJ
cord-273505-pcsw3vmx	46	33	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	46	34	conditions	condition	NNS
cord-273505-pcsw3vmx	46	35	.	.	.
cord-273505-pcsw3vmx	47	1	Meanwhile	meanwhile	RB
cord-273505-pcsw3vmx	47	2	,	,	,
cord-273505-pcsw3vmx	47	3	a	a	DT
cord-273505-pcsw3vmx	47	4	possible	possible	JJ
cord-273505-pcsw3vmx	47	5	explanation	explanation	NN
cord-273505-pcsw3vmx	47	6	for	for	IN
cord-273505-pcsw3vmx	47	7	the	the	DT
cord-273505-pcsw3vmx	47	8	fact	fact	NN
cord-273505-pcsw3vmx	47	9	that	that	IN
cord-273505-pcsw3vmx	47	10	only	only	RB
cord-273505-pcsw3vmx	47	11	high	high	JJ
cord-273505-pcsw3vmx	47	12	-	-	HYPH
cord-273505-pcsw3vmx	47	13	dose	dose	NN
cord-273505-pcsw3vmx	47	14	IVIg	ivig	NN
cord-273505-pcsw3vmx	47	15	can	can	MD
cord-273505-pcsw3vmx	47	16	exert	exert	VB
cord-273505-pcsw3vmx	47	17	anti	anti	JJ
cord-273505-pcsw3vmx	47	18	-	-	JJ
cord-273505-pcsw3vmx	47	19	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	47	20	effects	effect	NNS
cord-273505-pcsw3vmx	47	21	is	be	VBZ
cord-273505-pcsw3vmx	47	22	that	that	IN
cord-273505-pcsw3vmx	47	23	a	a	DT
cord-273505-pcsw3vmx	47	24	sufficient	sufficient	JJ
cord-273505-pcsw3vmx	47	25	amount	amount	NN
cord-273505-pcsw3vmx	47	26	of	of	IN
cord-273505-pcsw3vmx	47	27	antigen	antigen	NN
cord-273505-pcsw3vmx	47	28	-	-	HYPH
cord-273505-pcsw3vmx	47	29	specific	specific	JJ
cord-273505-pcsw3vmx	47	30	IgG	igg	NN
cord-273505-pcsw3vmx	47	31	is	be	VBZ
cord-273505-pcsw3vmx	47	32	required	require	VBN
cord-273505-pcsw3vmx	47	33	to	to	TO
cord-273505-pcsw3vmx	47	34	achieve	achieve	VB
cord-273505-pcsw3vmx	47	35	therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	47	36	activity	activity	NN
cord-273505-pcsw3vmx	47	37	.	.	.
cord-273505-pcsw3vmx	48	1	However	however	RB
cord-273505-pcsw3vmx	48	2	,	,	,
cord-273505-pcsw3vmx	48	3	as	as	IN
cord-273505-pcsw3vmx	48	4	previous	previous	JJ
cord-273505-pcsw3vmx	48	5	research	research	NN
cord-273505-pcsw3vmx	48	6	revealed	reveal	VBD
cord-273505-pcsw3vmx	48	7	that	that	IN
cord-273505-pcsw3vmx	48	8	preparations	preparation	NNS
cord-273505-pcsw3vmx	48	9	with	with	IN
cord-273505-pcsw3vmx	48	10	purified	purify	VBN
cord-273505-pcsw3vmx	48	11	Fc	Fc	NNP
cord-273505-pcsw3vmx	48	12	fragments	fragment	NNS
cord-273505-pcsw3vmx	48	13	of	of	IN
cord-273505-pcsw3vmx	48	14	IgG	IgG	NNP
cord-273505-pcsw3vmx	48	15	had	have	VBD
cord-273505-pcsw3vmx	48	16	an	an	DT
cord-273505-pcsw3vmx	48	17	undamped	undamped	JJ
cord-273505-pcsw3vmx	48	18	effect	effect	NN
cord-273505-pcsw3vmx	48	19	compared	compare	VBN
cord-273505-pcsw3vmx	48	20	with	with	IN
cord-273505-pcsw3vmx	48	21	intact	intact	JJ
cord-273505-pcsw3vmx	48	22	IgG	igg	NN
cord-273505-pcsw3vmx	48	23	for	for	IN
cord-273505-pcsw3vmx	48	24	some	some	DT
cord-273505-pcsw3vmx	48	25	indications	indication	NNS
cord-273505-pcsw3vmx	48	26	,	,	,
cord-273505-pcsw3vmx	48	27	F(ab	f(ab	NN
cord-273505-pcsw3vmx	48	28	)	)	-RRB-
cord-273505-pcsw3vmx	49	1	′	′	CD
cord-273505-pcsw3vmx	49	2	2	2	CD
cord-273505-pcsw3vmx	49	3	-mediated	-mediated	JJ
cord-273505-pcsw3vmx	49	4	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	49	5	alone	alone	RB
cord-273505-pcsw3vmx	49	6	may	may	MD
cord-273505-pcsw3vmx	49	7	not	not	RB
cord-273505-pcsw3vmx	49	8	be	be	VB
cord-273505-pcsw3vmx	49	9	sufficient	sufficient	JJ
cord-273505-pcsw3vmx	49	10	for	for	IN
cord-273505-pcsw3vmx	49	11	the	the	DT
cord-273505-pcsw3vmx	49	12	extensive	extensive	JJ
cord-273505-pcsw3vmx	49	13	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	49	14	effects	effect	NNS
cord-273505-pcsw3vmx	49	15	of	of	IN
cord-273505-pcsw3vmx	49	16	high	high	JJ
cord-273505-pcsw3vmx	49	17	-	-	HYPH
cord-273505-pcsw3vmx	49	18	dose	dose	NN
cord-273505-pcsw3vmx	49	19	IVIg	ivig	NN
cord-273505-pcsw3vmx	49	20	therapy	therapy	NN
cord-273505-pcsw3vmx	49	21	(	(	-LRB-
cord-273505-pcsw3vmx	49	22	42	42	CD
cord-273505-pcsw3vmx	49	23	-	-	SYM
cord-273505-pcsw3vmx	49	24	44	44	CD
cord-273505-pcsw3vmx	49	25	)	)	-RRB-
cord-273505-pcsw3vmx	49	26	.	.	.
cord-273505-pcsw3vmx	50	1	Therefore	therefore	RB
cord-273505-pcsw3vmx	50	2	,	,	,
cord-273505-pcsw3vmx	50	3	Fc	Fc	NNP
cord-273505-pcsw3vmx	50	4	-	-	HYPH
cord-273505-pcsw3vmx	50	5	mediated	mediate	VBN
cord-273505-pcsw3vmx	50	6	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	50	7	may	may	MD
cord-273505-pcsw3vmx	50	8	play	play	VB
cord-273505-pcsw3vmx	50	9	a	a	DT
cord-273505-pcsw3vmx	50	10	decisive	decisive	JJ
cord-273505-pcsw3vmx	50	11	role	role	NN
cord-273505-pcsw3vmx	50	12	in	in	IN
cord-273505-pcsw3vmx	50	13	these	these	DT
cord-273505-pcsw3vmx	50	14	processes	process	NNS
cord-273505-pcsw3vmx	50	15	.	.	.
cord-273505-pcsw3vmx	51	1	The	the	DT
cord-273505-pcsw3vmx	51	2	Fc	Fc	NNP
cord-273505-pcsw3vmx	51	3	fragment	fragment	NN
cord-273505-pcsw3vmx	51	4	of	of	IN
cord-273505-pcsw3vmx	51	5	IgG	IgG	NNP
cord-273505-pcsw3vmx	51	6	is	be	VBZ
cord-273505-pcsw3vmx	51	7	responsible	responsible	JJ
cord-273505-pcsw3vmx	51	8	for	for	IN
cord-273505-pcsw3vmx	51	9	binding	bind	VBG
cord-273505-pcsw3vmx	51	10	to	to	IN
cord-273505-pcsw3vmx	51	11	Fc	Fc	NNP
cord-273505-pcsw3vmx	51	12	receptors	receptor	NNS
cord-273505-pcsw3vmx	51	13	(	(	-LRB-
cord-273505-pcsw3vmx	51	14	FcRs	FcRs	NNP
cord-273505-pcsw3vmx	51	15	)	)	-RRB-
cord-273505-pcsw3vmx	51	16	and	and	CC
cord-273505-pcsw3vmx	51	17	complement	complement	NN
cord-273505-pcsw3vmx	51	18	(	(	-LRB-
cord-273505-pcsw3vmx	51	19	e.g.	e.g.	RB
cord-273505-pcsw3vmx	51	20	,	,	,
cord-273505-pcsw3vmx	51	21	C1q	C1q	NNP
cord-273505-pcsw3vmx	51	22	,	,	,
cord-273505-pcsw3vmx	51	23	C3b	C3b	NNP
cord-273505-pcsw3vmx	51	24	,	,	,
cord-273505-pcsw3vmx	51	25	and	and	CC
cord-273505-pcsw3vmx	51	26	C4b	c4b	NN
cord-273505-pcsw3vmx	51	27	)	)	-RRB-
cord-273505-pcsw3vmx	51	28	.	.	.
cord-273505-pcsw3vmx	52	1	IgG	IgG	NNP
cord-273505-pcsw3vmx	52	2	-	-	HYPH
cord-273505-pcsw3vmx	52	3	specific	specific	JJ
cord-273505-pcsw3vmx	52	4	Fc	Fc	NNP
cord-273505-pcsw3vmx	52	5	receptors	receptor	NNS
cord-273505-pcsw3vmx	52	6	(	(	-LRB-
cord-273505-pcsw3vmx	52	7	FcγRs	FcγRs	NNP
cord-273505-pcsw3vmx	52	8	)	)	-RRB-
cord-273505-pcsw3vmx	52	9	belong	belong	VBP
cord-273505-pcsw3vmx	52	10	to	to	IN
cord-273505-pcsw3vmx	52	11	type	type	NN
cord-273505-pcsw3vmx	52	12	I	-PRON-	PRP
cord-273505-pcsw3vmx	52	13	FcRs	FcRs	NNP
cord-273505-pcsw3vmx	52	14	and	and	CC
cord-273505-pcsw3vmx	52	15	are	be	VBP
cord-273505-pcsw3vmx	52	16	classified	classify	VBN
cord-273505-pcsw3vmx	52	17	into	into	IN
cord-273505-pcsw3vmx	52	18	activating	activate	VBG
cord-273505-pcsw3vmx	52	19	FcγRs	FcγRs	NNP
cord-273505-pcsw3vmx	52	20	(	(	-LRB-
cord-273505-pcsw3vmx	52	21	FcγRI	FcγRI	NNP
cord-273505-pcsw3vmx	52	22	,	,	,
cord-273505-pcsw3vmx	52	23	FcγRIIA	FcγRIIA	NNP
cord-273505-pcsw3vmx	52	24	,	,	,
cord-273505-pcsw3vmx	52	25	FcγRIIC	FcγRIIC	NNP
cord-273505-pcsw3vmx	52	26	,	,	,
cord-273505-pcsw3vmx	52	27	FcγRIIIA	FcγRIIIA	NNP
cord-273505-pcsw3vmx	52	28	,	,	,
cord-273505-pcsw3vmx	52	29	and	and	CC
cord-273505-pcsw3vmx	52	30	FcγRIIIB	FcγRIIIB	NNP
cord-273505-pcsw3vmx	52	31	)	)	-RRB-
cord-273505-pcsw3vmx	52	32	and	and	CC
cord-273505-pcsw3vmx	52	33	an	an	DT
cord-273505-pcsw3vmx	52	34	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	52	35	FcγR	fcγr	NN
cord-273505-pcsw3vmx	52	36	(	(	-LRB-
cord-273505-pcsw3vmx	52	37	FcγRIIB	FcγRIIB	NNP
cord-273505-pcsw3vmx	52	38	)	)	-RRB-
cord-273505-pcsw3vmx	52	39	,	,	,
cord-273505-pcsw3vmx	52	40	depending	depend	VBG
cord-273505-pcsw3vmx	52	41	on	on	IN
cord-273505-pcsw3vmx	52	42	their	-PRON-	PRP$
cord-273505-pcsw3vmx	52	43	intracellular	intracellular	JJ
cord-273505-pcsw3vmx	52	44	motif	motif	NN
cord-273505-pcsw3vmx	52	45	and	and	CC
cord-273505-pcsw3vmx	52	46	the	the	DT
cord-273505-pcsw3vmx	52	47	function	function	NN
cord-273505-pcsw3vmx	52	48	they	-PRON-	PRP
cord-273505-pcsw3vmx	52	49	mediate	mediate	VBP
cord-273505-pcsw3vmx	52	50	.	.	.
cord-273505-pcsw3vmx	53	1	Type	Type	NNP
cord-273505-pcsw3vmx	53	2	II	II	NNP
cord-273505-pcsw3vmx	53	3	FcRs	FcRs	NNP
cord-273505-pcsw3vmx	53	4	,	,	,
cord-273505-pcsw3vmx	53	5	including	include	VBG
cord-273505-pcsw3vmx	53	6	C	c	NN
cord-273505-pcsw3vmx	53	7	-	-	HYPH
cord-273505-pcsw3vmx	53	8	type	type	NN
cord-273505-pcsw3vmx	53	9	lectins	lectin	NNS
cord-273505-pcsw3vmx	53	10	(	(	-LRB-
cord-273505-pcsw3vmx	53	11	DC	DC	NNP
cord-273505-pcsw3vmx	53	12	-	-	HYPH
cord-273505-pcsw3vmx	53	13	SIGN	SIGN	NNP
cord-273505-pcsw3vmx	53	14	,	,	,
cord-273505-pcsw3vmx	53	15	DCIR	DCIR	NNP
cord-273505-pcsw3vmx	53	16	)	)	-RRB-
cord-273505-pcsw3vmx	54	1	,	,	,
cord-273505-pcsw3vmx	54	2	type	type	NN
cord-273505-pcsw3vmx	54	3	I	-PRON-	PRP
cord-273505-pcsw3vmx	54	4	lectins	lectin	NNS
cord-273505-pcsw3vmx	54	5	(	(	-LRB-
cord-273505-pcsw3vmx	54	6	CD22	CD22	NNP
cord-273505-pcsw3vmx	54	7	)	)	-RRB-
cord-273505-pcsw3vmx	54	8	,	,	,
cord-273505-pcsw3vmx	54	9	and	and	CC
cord-273505-pcsw3vmx	54	10	non	non	JJ
cord-273505-pcsw3vmx	54	11	-	-	JJ
cord-273505-pcsw3vmx	54	12	classical	classical	JJ
cord-273505-pcsw3vmx	54	13	FcRs	FcRs	NNP
cord-273505-pcsw3vmx	54	14	,	,	,
cord-273505-pcsw3vmx	54	15	such	such	JJ
cord-273505-pcsw3vmx	54	16	as	as	IN
cord-273505-pcsw3vmx	54	17	FcRn	FcRn	NNP
cord-273505-pcsw3vmx	54	18	and	and	CC
cord-273505-pcsw3vmx	54	19	FCRL	FCRL	NNP
cord-273505-pcsw3vmx	54	20	,	,	,
cord-273505-pcsw3vmx	54	21	also	also	RB
cord-273505-pcsw3vmx	54	22	act	act	VBP
cord-273505-pcsw3vmx	54	23	as	as	IN
cord-273505-pcsw3vmx	54	24	effector	effector	JJ
cord-273505-pcsw3vmx	54	25	targets	target	NNS
cord-273505-pcsw3vmx	54	26	of	of	IN
cord-273505-pcsw3vmx	54	27	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	54	28	(	(	-LRB-
cord-273505-pcsw3vmx	54	29	Figure	figure	NN
cord-273505-pcsw3vmx	54	30	2	2	CD
cord-273505-pcsw3vmx	54	31	)	)	-RRB-
cord-273505-pcsw3vmx	54	32	.	.	.
cord-273505-pcsw3vmx	55	1	The	the	DT
cord-273505-pcsw3vmx	55	2	Fc	Fc	NNP
cord-273505-pcsw3vmx	55	3	-	-	HYPH
cord-273505-pcsw3vmx	55	4	mediated	mediate	VBN
cord-273505-pcsw3vmx	55	5	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	55	6	of	of	IN
cord-273505-pcsw3vmx	55	7	high	high	JJ
cord-273505-pcsw3vmx	55	8	-	-	HYPH
cord-273505-pcsw3vmx	55	9	dose	dose	NN
cord-273505-pcsw3vmx	55	10	IVIg	ivig	NN
cord-273505-pcsw3vmx	55	11	therapy	therapy	NN
cord-273505-pcsw3vmx	55	12	include	include	VBP
cord-273505-pcsw3vmx	55	13	saturation	saturation	NN
cord-273505-pcsw3vmx	55	14	of	of	IN
cord-273505-pcsw3vmx	55	15	activating	activate	VBG
cord-273505-pcsw3vmx	55	16	FcγRs	FcγRs	NNP
cord-273505-pcsw3vmx	55	17	and	and	CC
cord-273505-pcsw3vmx	55	18	FcRn	FcRn	NNP
cord-273505-pcsw3vmx	55	19	,	,	,
cord-273505-pcsw3vmx	55	20	upregulation	upregulation	NN
cord-273505-pcsw3vmx	55	21	of	of	IN
cord-273505-pcsw3vmx	55	22	the	the	DT
cord-273505-pcsw3vmx	55	23	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	55	24	FcγRIIB	fcγriib	NN
cord-273505-pcsw3vmx	55	25	,	,	,
cord-273505-pcsw3vmx	55	26	and	and	CC
cord-273505-pcsw3vmx	55	27	scavenging	scavenging	NN
cord-273505-pcsw3vmx	55	28	of	of	IN
cord-273505-pcsw3vmx	55	29	complement	complement	NN
cord-273505-pcsw3vmx	55	30	molecules	molecule	NNS
cord-273505-pcsw3vmx	55	31	.	.	.
cord-273505-pcsw3vmx	56	1	Given	give	VBN
cord-273505-pcsw3vmx	56	2	the	the	DT
cord-273505-pcsw3vmx	56	3	central	central	JJ
cord-273505-pcsw3vmx	56	4	role	role	NN
cord-273505-pcsw3vmx	56	5	of	of	IN
cord-273505-pcsw3vmx	56	6	activating	activate	VBG
cord-273505-pcsw3vmx	56	7	FcγRs	fcγr	NNS
cord-273505-pcsw3vmx	56	8	in	in	IN
cord-273505-pcsw3vmx	56	9	mediating	mediate	VBG
cord-273505-pcsw3vmx	56	10	excessive	excessive	JJ
cord-273505-pcsw3vmx	56	11	antibody	antibody	NN
cord-273505-pcsw3vmx	56	12	-	-	HYPH
cord-273505-pcsw3vmx	56	13	dependent	dependent	JJ
cord-273505-pcsw3vmx	56	14	effector	effector	NN
cord-273505-pcsw3vmx	56	15	functions	function	NNS
cord-273505-pcsw3vmx	56	16	,	,	,
cord-273505-pcsw3vmx	56	17	a	a	DT
cord-273505-pcsw3vmx	56	18	possible	possible	JJ
cord-273505-pcsw3vmx	56	19	explanation	explanation	NN
cord-273505-pcsw3vmx	56	20	of	of	IN
cord-273505-pcsw3vmx	56	21	the	the	DT
cord-273505-pcsw3vmx	56	22	potential	potential	JJ
cord-273505-pcsw3vmx	56	23	anti	anti	JJ
cord-273505-pcsw3vmx	56	24	-	-	JJ
cord-273505-pcsw3vmx	56	25	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	56	26	function	function	NN
cord-273505-pcsw3vmx	56	27	of	of	IN
cord-273505-pcsw3vmx	56	28	high	high	JJ
cord-273505-pcsw3vmx	56	29	-	-	HYPH
cord-273505-pcsw3vmx	56	30	dose	dose	NN
cord-273505-pcsw3vmx	56	31	IVIg	ivig	NN
cord-273505-pcsw3vmx	56	32	lies	lie	VBZ
cord-273505-pcsw3vmx	56	33	in	in	IN
cord-273505-pcsw3vmx	56	34	that	that	IN
cord-273505-pcsw3vmx	56	35	it	-PRON-	PRP
cord-273505-pcsw3vmx	56	36	significantly	significantly	RB
cord-273505-pcsw3vmx	56	37	raises	raise	VBZ
cord-273505-pcsw3vmx	56	38	the	the	DT
cord-273505-pcsw3vmx	56	39	concentration	concentration	NN
cord-273505-pcsw3vmx	56	40	of	of	IN
cord-273505-pcsw3vmx	56	41	IgG	igg	NN
cord-273505-pcsw3vmx	56	42	above	above	IN
cord-273505-pcsw3vmx	56	43	the	the	DT
cord-273505-pcsw3vmx	56	44	normal	normal	JJ
cord-273505-pcsw3vmx	56	45	plasma	plasma	NN
cord-273505-pcsw3vmx	56	46	levels	level	NNS
cord-273505-pcsw3vmx	56	47	and	and	CC
cord-273505-pcsw3vmx	56	48	contributes	contribute	VBZ
cord-273505-pcsw3vmx	56	49	to	to	IN
cord-273505-pcsw3vmx	56	50	a	a	DT
cord-273505-pcsw3vmx	56	51	functional	functional	JJ
cord-273505-pcsw3vmx	56	52	blockade	blockade	NN
cord-273505-pcsw3vmx	56	53	of	of	IN
cord-273505-pcsw3vmx	56	54	FcγRs	FcγRs	NNP
cord-273505-pcsw3vmx	56	55	,	,	,
cord-273505-pcsw3vmx	56	56	limiting	limit	VBG
cord-273505-pcsw3vmx	56	57	access	access	NN
cord-273505-pcsw3vmx	56	58	of	of	IN
cord-273505-pcsw3vmx	56	59	immune	immune	JJ
cord-273505-pcsw3vmx	56	60	complexes	complex	NNS
cord-273505-pcsw3vmx	56	61	to	to	IN
cord-273505-pcsw3vmx	56	62	these	these	DT
cord-273505-pcsw3vmx	56	63	activating	activate	VBG
cord-273505-pcsw3vmx	56	64	receptors	receptor	NNS
cord-273505-pcsw3vmx	56	65	.	.	.
cord-273505-pcsw3vmx	57	1	Moreover	moreover	RB
cord-273505-pcsw3vmx	57	2	,	,	,
cord-273505-pcsw3vmx	57	3	IgG	igg	NN
cord-273505-pcsw3vmx	57	4	from	from	IN
cord-273505-pcsw3vmx	57	5	IVIg	ivig	JJ
cord-273505-pcsw3vmx	57	6	preparations	preparation	NNS
cord-273505-pcsw3vmx	57	7	has	have	VBZ
cord-273505-pcsw3vmx	57	8	been	be	VBN
cord-273505-pcsw3vmx	57	9	proven	prove	VBN
cord-273505-pcsw3vmx	57	10	to	to	TO
cord-273505-pcsw3vmx	57	11	be	be	VB
cord-273505-pcsw3vmx	57	12	active	active	JJ
cord-273505-pcsw3vmx	57	13	through	through	IN
cord-273505-pcsw3vmx	57	14	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	57	15	ITAMi	ITAMi	NNS
cord-273505-pcsw3vmx	57	16	signaling	signal	VBG
cord-273505-pcsw3vmx	57	17	in	in	IN
cord-273505-pcsw3vmx	57	18	immune	immune	JJ
cord-273505-pcsw3vmx	57	19	regulation	regulation	NN
cord-273505-pcsw3vmx	57	20	(	(	-LRB-
cord-273505-pcsw3vmx	57	21	45	45	CD
cord-273505-pcsw3vmx	57	22	)	)	-RRB-
cord-273505-pcsw3vmx	57	23	.	.	.
cord-273505-pcsw3vmx	58	1	The	the	DT
cord-273505-pcsw3vmx	58	2	role	role	NN
cord-273505-pcsw3vmx	58	3	of	of	IN
cord-273505-pcsw3vmx	58	4	dimeric	dimeric	JJ
cord-273505-pcsw3vmx	58	5	IgG	igg	NN
cord-273505-pcsw3vmx	58	6	in	in	IN
cord-273505-pcsw3vmx	58	7	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	58	8	preparations	preparation	NNS
cord-273505-pcsw3vmx	58	9	is	be	VBZ
cord-273505-pcsw3vmx	58	10	emphasized	emphasize	VBN
cord-273505-pcsw3vmx	58	11	by	by	IN
cord-273505-pcsw3vmx	58	12	an	an	DT
cord-273505-pcsw3vmx	58	13	enhanced	enhanced	JJ
cord-273505-pcsw3vmx	58	14	understanding	understanding	NN
cord-273505-pcsw3vmx	58	15	of	of	IN
cord-273505-pcsw3vmx	58	16	the	the	DT
cord-273505-pcsw3vmx	58	17	optimal	optimal	JJ
cord-273505-pcsw3vmx	58	18	IgG	igg	NN
cord-273505-pcsw3vmx	58	19	form	form	NN
cord-273505-pcsw3vmx	58	20	to	to	TO
cord-273505-pcsw3vmx	58	21	interact	interact	VB
cord-273505-pcsw3vmx	58	22	with	with	IN
cord-273505-pcsw3vmx	58	23	activating	activate	VBG
cord-273505-pcsw3vmx	58	24	FcγRs	FcγRs	NNP
cord-273505-pcsw3vmx	58	25	.	.	.
cord-273505-pcsw3vmx	59	1	In	in	IN
cord-273505-pcsw3vmx	59	2	physiological	physiological	JJ
cord-273505-pcsw3vmx	59	3	conditions	condition	NNS
cord-273505-pcsw3vmx	59	4	,	,	,
cord-273505-pcsw3vmx	59	5	monomeric	monomeric	JJ
cord-273505-pcsw3vmx	59	6	IgG1	igg1	NN
cord-273505-pcsw3vmx	59	7	is	be	VBZ
cord-273505-pcsw3vmx	59	8	more	more	RBR
cord-273505-pcsw3vmx	59	9	likely	likely	JJ
cord-273505-pcsw3vmx	59	10	to	to	TO
cord-273505-pcsw3vmx	59	11	bind	bind	VB
cord-273505-pcsw3vmx	59	12	FcγRI	FcγRI	NNP
cord-273505-pcsw3vmx	59	13	with	with	IN
cord-273505-pcsw3vmx	59	14	high	high	JJ
cord-273505-pcsw3vmx	59	15	affinity	affinity	NN
cord-273505-pcsw3vmx	59	16	rather	rather	RB
cord-273505-pcsw3vmx	59	17	than	than	IN
cord-273505-pcsw3vmx	59	18	to	to	IN
cord-273505-pcsw3vmx	59	19	other	other	JJ
cord-273505-pcsw3vmx	59	20	FcγRs	fcγrs	XX
cord-273505-pcsw3vmx	59	21	with	with	IN
cord-273505-pcsw3vmx	59	22	low	low	JJ
cord-273505-pcsw3vmx	59	23	affinity	affinity	NN
cord-273505-pcsw3vmx	59	24	(	(	-LRB-
cord-273505-pcsw3vmx	59	25	46	46	CD
cord-273505-pcsw3vmx	59	26	)	)	-RRB-
cord-273505-pcsw3vmx	59	27	.	.	.
cord-273505-pcsw3vmx	60	1	Although	although	IN
cord-273505-pcsw3vmx	60	2	monomeric	monomeric	JJ
cord-273505-pcsw3vmx	60	3	IgG	igg	NN
cord-273505-pcsw3vmx	60	4	at	at	IN
cord-273505-pcsw3vmx	60	5	therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	60	6	levels	level	NNS
cord-273505-pcsw3vmx	60	7	are	be	VBP
cord-273505-pcsw3vmx	60	8	able	able	JJ
cord-273505-pcsw3vmx	60	9	to	to	TO
cord-273505-pcsw3vmx	60	10	saturate	saturate	VB
cord-273505-pcsw3vmx	60	11	lowaffinity	lowaffinity	NN
cord-273505-pcsw3vmx	60	12	FcγR	fcγr	NN
cord-273505-pcsw3vmx	60	13	in	in	IN
cord-273505-pcsw3vmx	60	14	a	a	DT
cord-273505-pcsw3vmx	60	15	dose	dose	NN
cord-273505-pcsw3vmx	60	16	-	-	HYPH
cord-273505-pcsw3vmx	60	17	dependent	dependent	JJ
cord-273505-pcsw3vmx	60	18	manner	manner	NN
cord-273505-pcsw3vmx	60	19	,	,	,
cord-273505-pcsw3vmx	60	20	it	-PRON-	PRP
cord-273505-pcsw3vmx	60	21	has	have	VBZ
cord-273505-pcsw3vmx	60	22	been	be	VBN
cord-273505-pcsw3vmx	60	23	suggested	suggest	VBN
cord-273505-pcsw3vmx	60	24	that	that	IN
cord-273505-pcsw3vmx	60	25	the	the	DT
cord-273505-pcsw3vmx	60	26	small	small	JJ
cord-273505-pcsw3vmx	60	27	amounts	amount	NNS
cord-273505-pcsw3vmx	60	28	of	of	IN
cord-273505-pcsw3vmx	60	29	dimeric	dimeric	JJ
cord-273505-pcsw3vmx	60	30	IgG	igg	NN
cord-273505-pcsw3vmx	60	31	bind	bind	VBP
cord-273505-pcsw3vmx	60	32	with	with	IN
cord-273505-pcsw3vmx	60	33	higher	high	JJR
cord-273505-pcsw3vmx	60	34	avidity	avidity	NN
cord-273505-pcsw3vmx	60	35	to	to	IN
cord-273505-pcsw3vmx	60	36	FcγRs	FcγRs	NNP
cord-273505-pcsw3vmx	60	37	,	,	,
cord-273505-pcsw3vmx	60	38	and	and	CC
cord-273505-pcsw3vmx	60	39	therefore	therefore	RB
cord-273505-pcsw3vmx	60	40	constitute	constitute	VBP
cord-273505-pcsw3vmx	60	41	the	the	DT
cord-273505-pcsw3vmx	60	42	main	main	JJ
cord-273505-pcsw3vmx	60	43	active	active	JJ
cord-273505-pcsw3vmx	60	44	component	component	NN
cord-273505-pcsw3vmx	60	45	of	of	IN
cord-273505-pcsw3vmx	60	46	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	60	47	mediating	mediate	VBG
cord-273505-pcsw3vmx	60	48	FcγR	fcγr	JJ
cord-273505-pcsw3vmx	60	49	blockade	blockade	NN
cord-273505-pcsw3vmx	60	50	,	,	,
cord-273505-pcsw3vmx	60	51	explaining	explain	VBG
cord-273505-pcsw3vmx	60	52	the	the	DT
cord-273505-pcsw3vmx	60	53	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	60	54	function	function	NN
cord-273505-pcsw3vmx	60	55	of	of	IN
cord-273505-pcsw3vmx	60	56	high	high	JJ
cord-273505-pcsw3vmx	60	57	-	-	HYPH
cord-273505-pcsw3vmx	60	58	dose	dose	NN
cord-273505-pcsw3vmx	60	59	IVIg	ivig	NN
cord-273505-pcsw3vmx	60	60	in	in	IN
cord-273505-pcsw3vmx	60	61	ITP	ITP	NNP
cord-273505-pcsw3vmx	60	62	,	,	,
cord-273505-pcsw3vmx	60	63	GBS	GBS	NNP
cord-273505-pcsw3vmx	60	64	,	,	,
cord-273505-pcsw3vmx	60	65	and	and	CC
cord-273505-pcsw3vmx	60	66	CIDP	CIDP	NNP
cord-273505-pcsw3vmx	60	67	patients	patient	NNS
cord-273505-pcsw3vmx	60	68	(	(	-LRB-
cord-273505-pcsw3vmx	60	69	47	47	CD
cord-273505-pcsw3vmx	60	70	-	-	SYM
cord-273505-pcsw3vmx	60	71	51	51	CD
cord-273505-pcsw3vmx	60	72	)	)	-RRB-
cord-273505-pcsw3vmx	60	73	.	.	.
cord-273505-pcsw3vmx	61	1	Endogenous	endogenous	JJ
cord-273505-pcsw3vmx	61	2	pathogenic	pathogenic	JJ
cord-273505-pcsw3vmx	61	3	autoantibodies	autoantibody	NNS
cord-273505-pcsw3vmx	61	4	,	,	,
cord-273505-pcsw3vmx	61	5	mainly	mainly	RB
cord-273505-pcsw3vmx	61	6	IgG	IgG	NNP
cord-273505-pcsw3vmx	61	7	,	,	,
cord-273505-pcsw3vmx	61	8	play	play	VB
cord-273505-pcsw3vmx	61	9	a	a	DT
cord-273505-pcsw3vmx	61	10	predominant	predominant	JJ
cord-273505-pcsw3vmx	61	11	role	role	NN
cord-273505-pcsw3vmx	61	12	in	in	IN
cord-273505-pcsw3vmx	61	13	the	the	DT
cord-273505-pcsw3vmx	61	14	immunopathogenesis	immunopathogenesis	NN
cord-273505-pcsw3vmx	61	15	of	of	IN
cord-273505-pcsw3vmx	61	16	many	many	JJ
cord-273505-pcsw3vmx	61	17	autoimmune	autoimmune	JJ
cord-273505-pcsw3vmx	61	18	and	and	CC
cord-273505-pcsw3vmx	61	19	infectious	infectious	JJ
cord-273505-pcsw3vmx	61	20	diseases	disease	NNS
cord-273505-pcsw3vmx	61	21	.	.	.
cord-273505-pcsw3vmx	62	1	A	a	DT
cord-273505-pcsw3vmx	62	2	hallmark	hallmark	JJ
cord-273505-pcsw3vmx	62	3	characteristic	characteristic	NN
cord-273505-pcsw3vmx	62	4	of	of	IN
cord-273505-pcsw3vmx	62	5	long	long	JJ
cord-273505-pcsw3vmx	62	6	serum	serum	NN
cord-273505-pcsw3vmx	62	7	half	half	JJ
cord-273505-pcsw3vmx	62	8	-	-	HYPH
cord-273505-pcsw3vmx	62	9	life	life	NN
cord-273505-pcsw3vmx	62	10	of	of	IN
cord-273505-pcsw3vmx	62	11	endogenous	endogenous	JJ
cord-273505-pcsw3vmx	62	12	pathogenic	pathogenic	JJ
cord-273505-pcsw3vmx	62	13	IgG	igg	NN
cord-273505-pcsw3vmx	62	14	is	be	VBZ
cord-273505-pcsw3vmx	62	15	mainly	mainly	RB
cord-273505-pcsw3vmx	62	16	due	due	JJ
cord-273505-pcsw3vmx	62	17	to	to	IN
cord-273505-pcsw3vmx	62	18	FcRn	FcRn	NNP
cord-273505-pcsw3vmx	62	19	.	.	.
cord-273505-pcsw3vmx	63	1	FcRn	FcRn	NNP
cord-273505-pcsw3vmx	63	2	is	be	VBZ
cord-273505-pcsw3vmx	63	3	a	a	DT
cord-273505-pcsw3vmx	63	4	non	non	JJ
cord-273505-pcsw3vmx	63	5	-	-	JJ
cord-273505-pcsw3vmx	63	6	classical	classical	JJ
cord-273505-pcsw3vmx	63	7	FcR	fcr	NN
cord-273505-pcsw3vmx	63	8	that	that	WDT
cord-273505-pcsw3vmx	63	9	can	can	MD
cord-273505-pcsw3vmx	63	10	interact	interact	VB
cord-273505-pcsw3vmx	63	11	with	with	IN
cord-273505-pcsw3vmx	63	12	IgG	IgG	NNP
cord-273505-pcsw3vmx	63	13	in	in	IN
cord-273505-pcsw3vmx	63	14	a	a	DT
cord-273505-pcsw3vmx	63	15	pH	ph	JJ
cord-273505-pcsw3vmx	63	16	-	-	HYPH
cord-273505-pcsw3vmx	63	17	dependent	dependent	JJ
cord-273505-pcsw3vmx	63	18	manner	manner	NN
cord-273505-pcsw3vmx	63	19	,	,	,
cord-273505-pcsw3vmx	63	20	which	which	WDT
cord-273505-pcsw3vmx	63	21	is	be	VBZ
cord-273505-pcsw3vmx	63	22	sufficient	sufficient	JJ
cord-273505-pcsw3vmx	63	23	in	in	IN
cord-273505-pcsw3vmx	63	24	rescuing	rescue	VBG
cord-273505-pcsw3vmx	63	25	IgG	igg	NN
cord-273505-pcsw3vmx	63	26	from	from	IN
cord-273505-pcsw3vmx	63	27	lysosomal	lysosomal	JJ
cord-273505-pcsw3vmx	63	28	degradation	degradation	NN
cord-273505-pcsw3vmx	63	29	and	and	CC
cord-273505-pcsw3vmx	63	30	recycling	recycle	VBG
cord-273505-pcsw3vmx	63	31	it	-PRON-	PRP
cord-273505-pcsw3vmx	63	32	to	to	IN
cord-273505-pcsw3vmx	63	33	the	the	DT
cord-273505-pcsw3vmx	63	34	cell	cell	NN
cord-273505-pcsw3vmx	63	35	surface	surface	NN
cord-273505-pcsw3vmx	63	36	(	(	-LRB-
cord-273505-pcsw3vmx	63	37	52	52	CD
cord-273505-pcsw3vmx	63	38	,	,	,
cord-273505-pcsw3vmx	63	39	53	53	CD
cord-273505-pcsw3vmx	63	40	)	)	-RRB-
cord-273505-pcsw3vmx	63	41	.	.	.
cord-273505-pcsw3vmx	64	1	High	high	JJ
cord-273505-pcsw3vmx	64	2	-	-	HYPH
cord-273505-pcsw3vmx	64	3	dose	dose	NN
cord-273505-pcsw3vmx	64	4	IVIg	ivig	NN
cord-273505-pcsw3vmx	64	5	therapy	therapy	NN
cord-273505-pcsw3vmx	64	6	leads	lead	VBZ
cord-273505-pcsw3vmx	64	7	to	to	IN
cord-273505-pcsw3vmx	64	8	an	an	DT
cord-273505-pcsw3vmx	64	9	increased	increase	VBN
cord-273505-pcsw3vmx	64	10	clearance	clearance	NN
cord-273505-pcsw3vmx	64	11	rate	rate	NN
cord-273505-pcsw3vmx	64	12	of	of	IN
cord-273505-pcsw3vmx	64	13	monoclonal	monoclonal	JJ
cord-273505-pcsw3vmx	64	14	antibodies	antibody	NNS
cord-273505-pcsw3vmx	64	15	and	and	CC
cord-273505-pcsw3vmx	64	16	pathogenic	pathogenic	JJ
cord-273505-pcsw3vmx	64	17	IgG	igg	NN
cord-273505-pcsw3vmx	64	18	in	in	IN
cord-273505-pcsw3vmx	64	19	different	different	JJ
cord-273505-pcsw3vmx	64	20	mouse	mouse	NN
cord-273505-pcsw3vmx	64	21	models	model	NNS
cord-273505-pcsw3vmx	64	22	,	,	,
cord-273505-pcsw3vmx	64	23	whereas	whereas	IN
cord-273505-pcsw3vmx	64	24	this	this	DT
cord-273505-pcsw3vmx	64	25	effect	effect	NN
cord-273505-pcsw3vmx	64	26	is	be	VBZ
cord-273505-pcsw3vmx	64	27	not	not	RB
cord-273505-pcsw3vmx	64	28	observed	observe	VBN
cord-273505-pcsw3vmx	64	29	in	in	IN
cord-273505-pcsw3vmx	64	30	FcRn	FcRn	NNP
cord-273505-pcsw3vmx	64	31	deficient	deficient	JJ
cord-273505-pcsw3vmx	64	32	models	model	NNS
cord-273505-pcsw3vmx	64	33	,	,	,
cord-273505-pcsw3vmx	64	34	indicating	indicate	VBG
cord-273505-pcsw3vmx	64	35	that	that	IN
cord-273505-pcsw3vmx	64	36	FcRn	FcRn	NNP
cord-273505-pcsw3vmx	64	37	is	be	VBZ
cord-273505-pcsw3vmx	64	38	involved	involve	VBN
cord-273505-pcsw3vmx	64	39	in	in	IN
cord-273505-pcsw3vmx	64	40	therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	64	41	effects	effect	NNS
cord-273505-pcsw3vmx	64	42	of	of	IN
cord-273505-pcsw3vmx	64	43	IVIg	ivig	NN
cord-273505-pcsw3vmx	64	44	therapy	therapy	NN
cord-273505-pcsw3vmx	64	45	(	(	-LRB-
cord-273505-pcsw3vmx	64	46	54	54	CD
cord-273505-pcsw3vmx	64	47	,	,	,
cord-273505-pcsw3vmx	64	48	55	55	CD
cord-273505-pcsw3vmx	64	49	)	)	-RRB-
cord-273505-pcsw3vmx	64	50	.	.	.
cord-273505-pcsw3vmx	65	1	Influences	influence	NNS
cord-273505-pcsw3vmx	65	2	of	of	IN
cord-273505-pcsw3vmx	65	3	FcRn	FcRn	NNP
cord-273505-pcsw3vmx	65	4	gene	gene	NN
cord-273505-pcsw3vmx	65	5	polymorphisms	polymorphism	NNS
cord-273505-pcsw3vmx	65	6	on	on	IN
cord-273505-pcsw3vmx	65	7	different	different	JJ
cord-273505-pcsw3vmx	65	8	IgG	IgG	NNP
cord-273505-pcsw3vmx	65	9	kinetics	kinetic	NNS
cord-273505-pcsw3vmx	65	10	and	and	CC
cord-273505-pcsw3vmx	65	11	therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	65	12	effects	effect	NNS
cord-273505-pcsw3vmx	65	13	of	of	IN
cord-273505-pcsw3vmx	65	14	IVIg	ivig	NN
cord-273505-pcsw3vmx	65	15	among	among	IN
cord-273505-pcsw3vmx	65	16	patients	patient	NNS
cord-273505-pcsw3vmx	65	17	have	have	VBP
cord-273505-pcsw3vmx	65	18	been	be	VBN
cord-273505-pcsw3vmx	65	19	observed	observe	VBN
cord-273505-pcsw3vmx	65	20	(	(	-LRB-
cord-273505-pcsw3vmx	65	21	56	56	CD
cord-273505-pcsw3vmx	65	22	)	)	-RRB-
cord-273505-pcsw3vmx	65	23	(	(	-LRB-
cord-273505-pcsw3vmx	65	24	57	57	CD
cord-273505-pcsw3vmx	65	25	)	)	-RRB-
cord-273505-pcsw3vmx	65	26	(	(	-LRB-
cord-273505-pcsw3vmx	65	27	58	58	CD
cord-273505-pcsw3vmx	65	28	)	)	-RRB-
cord-273505-pcsw3vmx	65	29	.	.	.
cord-273505-pcsw3vmx	66	1	Pharmacokinetic	pharmacokinetic	JJ
cord-273505-pcsw3vmx	66	2	models	model	NNS
cord-273505-pcsw3vmx	66	3	predicted	predict	VBD
cord-273505-pcsw3vmx	66	4	that	that	IN
cord-273505-pcsw3vmx	66	5	the	the	DT
cord-273505-pcsw3vmx	66	6	therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	66	7	effects	effect	NNS
cord-273505-pcsw3vmx	66	8	of	of	IN
cord-273505-pcsw3vmx	66	9	IVIg	ivig	NN
cord-273505-pcsw3vmx	66	10	relate	relate	VBP
cord-273505-pcsw3vmx	66	11	to	to	IN
cord-273505-pcsw3vmx	66	12	total	total	JJ
cord-273505-pcsw3vmx	66	13	serum	serum	NN
cord-273505-pcsw3vmx	66	14	IgG	igg	NN
cord-273505-pcsw3vmx	66	15	concentration	concentration	NN
cord-273505-pcsw3vmx	66	16	and	and	CC
cord-273505-pcsw3vmx	66	17	FcRn	FcRn	NNP
cord-273505-pcsw3vmx	66	18	-	-	HYPH
cord-273505-pcsw3vmx	66	19	binding	bind	VBG
cord-273505-pcsw3vmx	66	20	capacity	capacity	NN
cord-273505-pcsw3vmx	66	21	(	(	-LRB-
cord-273505-pcsw3vmx	66	22	59	59	CD
cord-273505-pcsw3vmx	66	23	)	)	-RRB-
cord-273505-pcsw3vmx	66	24	.	.	.
cord-273505-pcsw3vmx	67	1	The	the	DT
cord-273505-pcsw3vmx	67	2	substantial	substantial	JJ
cord-273505-pcsw3vmx	67	3	increase	increase	NN
cord-273505-pcsw3vmx	67	4	in	in	IN
cord-273505-pcsw3vmx	67	5	IgG	igg	NN
cord-273505-pcsw3vmx	67	6	concentration	concentration	NN
cord-273505-pcsw3vmx	67	7	may	may	MD
cord-273505-pcsw3vmx	67	8	saturate	saturate	VB
cord-273505-pcsw3vmx	67	9	FcRn	FcRn	NNP
cord-273505-pcsw3vmx	67	10	and	and	CC
cord-273505-pcsw3vmx	67	11	reduce	reduce	VB
cord-273505-pcsw3vmx	67	12	the	the	DT
cord-273505-pcsw3vmx	67	13	half	half	JJ
cord-273505-pcsw3vmx	67	14	-	-	HYPH
cord-273505-pcsw3vmx	67	15	life	life	NN
cord-273505-pcsw3vmx	67	16	of	of	IN
cord-273505-pcsw3vmx	67	17	pathogenic	pathogenic	JJ
cord-273505-pcsw3vmx	67	18	antibodies	antibody	NNS
cord-273505-pcsw3vmx	67	19	,	,	,
cord-273505-pcsw3vmx	67	20	contributing	contribute	VBG
cord-273505-pcsw3vmx	67	21	to	to	IN
cord-273505-pcsw3vmx	67	22	the	the	DT
cord-273505-pcsw3vmx	67	23	anti	anti	JJ
cord-273505-pcsw3vmx	67	24	-	-	JJ
cord-273505-pcsw3vmx	67	25	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	67	26	mechanism	mechanism	NN
cord-273505-pcsw3vmx	67	27	of	of	IN
cord-273505-pcsw3vmx	67	28	high	high	JJ
cord-273505-pcsw3vmx	67	29	-	-	HYPH
cord-273505-pcsw3vmx	67	30	dose	dose	NN
cord-273505-pcsw3vmx	67	31	IVIg	ivig	NN
cord-273505-pcsw3vmx	67	32	.	.	.
cord-273505-pcsw3vmx	68	1	A	a	DT
cord-273505-pcsw3vmx	68	2	balance	balance	NN
cord-273505-pcsw3vmx	68	3	between	between	IN
cord-273505-pcsw3vmx	68	4	activating	activate	VBG
cord-273505-pcsw3vmx	68	5	and	and	CC
cord-273505-pcsw3vmx	68	6	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	68	7	FcγRs	FcγRs	NNP
cord-273505-pcsw3vmx	68	8	is	be	VBZ
cord-273505-pcsw3vmx	68	9	critical	critical	JJ
cord-273505-pcsw3vmx	68	10	for	for	IN
cord-273505-pcsw3vmx	68	11	a	a	DT
cord-273505-pcsw3vmx	68	12	well	well	RB
cord-273505-pcsw3vmx	68	13	-	-	HYPH
cord-273505-pcsw3vmx	68	14	regulated	regulate	VBN
cord-273505-pcsw3vmx	68	15	immune	immune	JJ
cord-273505-pcsw3vmx	68	16	response	response	NN
cord-273505-pcsw3vmx	68	17	,	,	,
cord-273505-pcsw3vmx	68	18	and	and	CC
cord-273505-pcsw3vmx	68	19	a	a	DT
cord-273505-pcsw3vmx	68	20	disbalance	disbalance	NN
cord-273505-pcsw3vmx	68	21	markedly	markedly	RB
cord-273505-pcsw3vmx	68	22	influences	influence	VBZ
cord-273505-pcsw3vmx	68	23	immunopathology	immunopathology	NN
cord-273505-pcsw3vmx	68	24	in	in	IN
cord-273505-pcsw3vmx	68	25	autoimmune	autoimmune	JJ
cord-273505-pcsw3vmx	68	26	and	and	CC
cord-273505-pcsw3vmx	68	27	infectious	infectious	JJ
cord-273505-pcsw3vmx	68	28	diseases	disease	NNS
cord-273505-pcsw3vmx	68	29	.	.	.
cord-273505-pcsw3vmx	69	1	FcγRIIB	FcγRIIB	NNP
cord-273505-pcsw3vmx	69	2	is	be	VBZ
cord-273505-pcsw3vmx	69	3	the	the	DT
cord-273505-pcsw3vmx	69	4	only	only	JJ
cord-273505-pcsw3vmx	69	5	ITIM	ITIM	NNP
cord-273505-pcsw3vmx	69	6	-	-	HYPH
cord-273505-pcsw3vmx	69	7	containing	contain	VBG
cord-273505-pcsw3vmx	69	8	FcγR	fcγr	NN
cord-273505-pcsw3vmx	69	9	and	and	CC
cord-273505-pcsw3vmx	69	10	negatively	negatively	RB
cord-273505-pcsw3vmx	69	11	regulates	regulate	VBZ
cord-273505-pcsw3vmx	69	12	many	many	JJ
cord-273505-pcsw3vmx	69	13	aspects	aspect	NNS
cord-273505-pcsw3vmx	69	14	of	of	IN
cord-273505-pcsw3vmx	69	15	immune	immune	JJ
cord-273505-pcsw3vmx	69	16	and	and	CC
cord-273505-pcsw3vmx	69	17	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	69	18	responses	response	NNS
cord-273505-pcsw3vmx	69	19	.	.	.
cord-273505-pcsw3vmx	70	1	After	after	IN
cord-273505-pcsw3vmx	70	2	efficient	efficient	JJ
cord-273505-pcsw3vmx	70	3	high	high	JJ
cord-273505-pcsw3vmx	70	4	-	-	HYPH
cord-273505-pcsw3vmx	70	5	dose	dose	NN
cord-273505-pcsw3vmx	70	6	IVIg	ivig	NN
cord-273505-pcsw3vmx	70	7	therapy	therapy	NN
cord-273505-pcsw3vmx	70	8	,	,	,
cord-273505-pcsw3vmx	70	9	an	an	DT
cord-273505-pcsw3vmx	70	10	upregulation	upregulation	NN
cord-273505-pcsw3vmx	70	11	of	of	IN
cord-273505-pcsw3vmx	70	12	FcγRIIB	fcγriib	NN
cord-273505-pcsw3vmx	70	13	on	on	IN
cord-273505-pcsw3vmx	70	14	immune	immune	JJ
cord-273505-pcsw3vmx	70	15	cells	cell	NNS
cord-273505-pcsw3vmx	70	16	is	be	VBZ
cord-273505-pcsw3vmx	70	17	considered	consider	VBN
cord-273505-pcsw3vmx	70	18	to	to	TO
cord-273505-pcsw3vmx	70	19	contribute	contribute	VB
cord-273505-pcsw3vmx	70	20	to	to	IN
cord-273505-pcsw3vmx	70	21	the	the	DT
cord-273505-pcsw3vmx	70	22	anti	anti	JJ
cord-273505-pcsw3vmx	70	23	-	-	JJ
cord-273505-pcsw3vmx	70	24	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	70	25	process	process	NN
cord-273505-pcsw3vmx	70	26	(	(	-LRB-
cord-273505-pcsw3vmx	70	27	43	43	CD
cord-273505-pcsw3vmx	70	28	,	,	,
cord-273505-pcsw3vmx	70	29	60	60	CD
cord-273505-pcsw3vmx	70	30	,	,	,
cord-273505-pcsw3vmx	70	31	61	61	CD
cord-273505-pcsw3vmx	70	32	)	)	-RRB-
cord-273505-pcsw3vmx	70	33	.	.	.
cord-273505-pcsw3vmx	71	1	However	however	RB
cord-273505-pcsw3vmx	71	2	,	,	,
cord-273505-pcsw3vmx	71	3	evidence	evidence	NN
cord-273505-pcsw3vmx	71	4	of	of	IN
cord-273505-pcsw3vmx	71	5	underlying	underlie	VBG
cord-273505-pcsw3vmx	71	6	molecular	molecular	JJ
cord-273505-pcsw3vmx	71	7	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	71	8	remains	remain	VBZ
cord-273505-pcsw3vmx	71	9	sparse	sparse	JJ
cord-273505-pcsw3vmx	71	10	and	and	CC
cord-273505-pcsw3vmx	71	11	this	this	DT
cord-273505-pcsw3vmx	71	12	mechanism	mechanism	NN
cord-273505-pcsw3vmx	71	13	of	of	IN
cord-273505-pcsw3vmx	71	14	therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	71	15	action	action	NN
cord-273505-pcsw3vmx	71	16	is	be	VBZ
cord-273505-pcsw3vmx	71	17	therefore	therefore	RB
cord-273505-pcsw3vmx	71	18	controversial	controversial	JJ
cord-273505-pcsw3vmx	71	19	.	.	.
cord-273505-pcsw3vmx	72	1	In	in	IN
cord-273505-pcsw3vmx	72	2	the	the	DT
cord-273505-pcsw3vmx	72	3	last	last	JJ
cord-273505-pcsw3vmx	72	4	decade	decade	NN
cord-273505-pcsw3vmx	72	5	,	,	,
cord-273505-pcsw3vmx	72	6	a	a	DT
cord-273505-pcsw3vmx	72	7	prevailing	prevail	VBG
cord-273505-pcsw3vmx	72	8	theory	theory	NN
cord-273505-pcsw3vmx	72	9	from	from	IN
cord-273505-pcsw3vmx	72	10	murine	murine	JJ
cord-273505-pcsw3vmx	72	11	studies	study	NNS
cord-273505-pcsw3vmx	72	12	argued	argue	VBD
cord-273505-pcsw3vmx	72	13	that	that	IN
cord-273505-pcsw3vmx	72	14	a	a	DT
cord-273505-pcsw3vmx	72	15	minor	minor	JJ
cord-273505-pcsw3vmx	72	16	portion	portion	NN
cord-273505-pcsw3vmx	72	17	of	of	IN
cord-273505-pcsw3vmx	72	18	IgG	igg	NN
cord-273505-pcsw3vmx	72	19	,	,	,
cord-273505-pcsw3vmx	72	20	with	with	IN
cord-273505-pcsw3vmx	72	21	specific	specific	JJ
cord-273505-pcsw3vmx	72	22	sialylation	sialylation	NN
cord-273505-pcsw3vmx	72	23	of	of	IN
cord-273505-pcsw3vmx	72	24	the	the	DT
cord-273505-pcsw3vmx	72	25	Asn297-linked	Asn297-linked	NNP
cord-273505-pcsw3vmx	72	26	glycan	glycan	NN
cord-273505-pcsw3vmx	72	27	structure	structure	NN
cord-273505-pcsw3vmx	72	28	on	on	IN
cord-273505-pcsw3vmx	72	29	the	the	DT
cord-273505-pcsw3vmx	72	30	Fc	Fc	NNP
cord-273505-pcsw3vmx	72	31	fragment	fragment	NN
cord-273505-pcsw3vmx	72	32	,	,	,
cord-273505-pcsw3vmx	72	33	is	be	VBZ
cord-273505-pcsw3vmx	72	34	essential	essential	JJ
cord-273505-pcsw3vmx	72	35	for	for	IN
cord-273505-pcsw3vmx	72	36	anti	anti	JJ
cord-273505-pcsw3vmx	72	37	-	-	JJ
cord-273505-pcsw3vmx	72	38	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	72	39	activities	activity	NNS
cord-273505-pcsw3vmx	72	40	of	of	IN
cord-273505-pcsw3vmx	72	41	IVIg	ivig	NN
cord-273505-pcsw3vmx	72	42	via	via	IN
cord-273505-pcsw3vmx	72	43	direct	direct	JJ
cord-273505-pcsw3vmx	72	44	interaction	interaction	NN
cord-273505-pcsw3vmx	72	45	with	with	IN
cord-273505-pcsw3vmx	72	46	myeloid	myeloid	JJ
cord-273505-pcsw3vmx	72	47	regulatory	regulatory	JJ
cord-273505-pcsw3vmx	72	48	cells	cell	NNS
cord-273505-pcsw3vmx	72	49	expressing	express	VBG
cord-273505-pcsw3vmx	72	50	SIGN	sign	NN
cord-273505-pcsw3vmx	72	51	-	-	HYPH
cord-273505-pcsw3vmx	72	52	R1	r1	NN
cord-273505-pcsw3vmx	72	53	(	(	-LRB-
cord-273505-pcsw3vmx	72	54	mice	mouse	NNS
cord-273505-pcsw3vmx	72	55	)	)	-RRB-
cord-273505-pcsw3vmx	72	56	or	or	CC
cord-273505-pcsw3vmx	72	57	DC	DC	NNP
cord-273505-pcsw3vmx	72	58	-	-	HYPH
cord-273505-pcsw3vmx	72	59	SIGN	sign	NN
cord-273505-pcsw3vmx	72	60	(	(	-LRB-
cord-273505-pcsw3vmx	72	61	human	human	NN
cord-273505-pcsw3vmx	72	62	)	)	-RRB-
cord-273505-pcsw3vmx	72	63	(	(	-LRB-
cord-273505-pcsw3vmx	72	64	44	44	CD
cord-273505-pcsw3vmx	72	65	,	,	,
cord-273505-pcsw3vmx	72	66	62	62	CD
cord-273505-pcsw3vmx	72	67	,	,	,
cord-273505-pcsw3vmx	72	68	63	63	CD
cord-273505-pcsw3vmx	72	69	)	)	-RRB-
cord-273505-pcsw3vmx	72	70	.	.	.
cord-273505-pcsw3vmx	73	1	Subsequent	subsequent	JJ
cord-273505-pcsw3vmx	73	2	research	research	NN
cord-273505-pcsw3vmx	73	3	revealed	reveal	VBD
cord-273505-pcsw3vmx	73	4	that	that	IN
cord-273505-pcsw3vmx	73	5	administration	administration	NN
cord-273505-pcsw3vmx	73	6	of	of	IN
cord-273505-pcsw3vmx	73	7	sialylated	sialylated	NNP
cord-273505-pcsw3vmx	73	8	IgG	IgG	NNP
cord-273505-pcsw3vmx	73	9	resulted	result	VBD
cord-273505-pcsw3vmx	73	10	in	in	IN
cord-273505-pcsw3vmx	73	11	the	the	DT
cord-273505-pcsw3vmx	73	12	production	production	NN
cord-273505-pcsw3vmx	73	13	of	of	IN
cord-273505-pcsw3vmx	73	14	IL-33	IL-33	NNP
cord-273505-pcsw3vmx	73	15	from	from	IN
cord-273505-pcsw3vmx	73	16	hDC	hDC	NNP
cord-273505-pcsw3vmx	73	17	-	-	HYPH
cord-273505-pcsw3vmx	73	18	SIGN	sign	NN
cord-273505-pcsw3vmx	73	19	+	+	CC
cord-273505-pcsw3vmx	73	20	macrophages	macrophage	NNS
cord-273505-pcsw3vmx	73	21	or	or	CC
cord-273505-pcsw3vmx	73	22	dendritic	dendritic	JJ
cord-273505-pcsw3vmx	73	23	cells	cell	NNS
cord-273505-pcsw3vmx	73	24	and	and	CC
cord-273505-pcsw3vmx	73	25	ensuing	ensue	VBG
cord-273505-pcsw3vmx	73	26	expansion	expansion	NN
cord-273505-pcsw3vmx	73	27	of	of	IN
cord-273505-pcsw3vmx	73	28	IL-4-producing	il-4-produce	VBG
cord-273505-pcsw3vmx	73	29	basophils	basophil	NNS
cord-273505-pcsw3vmx	73	30	,	,	,
cord-273505-pcsw3vmx	73	31	and	and	CC
cord-273505-pcsw3vmx	73	32	these	these	DT
cord-273505-pcsw3vmx	73	33	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	73	34	led	lead	VBD
cord-273505-pcsw3vmx	73	35	to	to	IN
cord-273505-pcsw3vmx	73	36	FcγRIIB	FcγRIIB	NNP
cord-273505-pcsw3vmx	73	37	expression	expression	NN
cord-273505-pcsw3vmx	73	38	on	on	IN
cord-273505-pcsw3vmx	73	39	effector	effector	NN
cord-273505-pcsw3vmx	73	40	cells	cell	NNS
cord-273505-pcsw3vmx	73	41	(	(	-LRB-
cord-273505-pcsw3vmx	73	42	64	64	CD
cord-273505-pcsw3vmx	73	43	,	,	,
cord-273505-pcsw3vmx	73	44	65	65	CD
cord-273505-pcsw3vmx	73	45	)	)	-RRB-
cord-273505-pcsw3vmx	73	46	.	.	.
cord-273505-pcsw3vmx	74	1	However	however	RB
cord-273505-pcsw3vmx	74	2	,	,	,
cord-273505-pcsw3vmx	74	3	other	other	JJ
cord-273505-pcsw3vmx	74	4	studies	study	NNS
cord-273505-pcsw3vmx	74	5	have	have	VBP
cord-273505-pcsw3vmx	74	6	challenged	challenge	VBN
cord-273505-pcsw3vmx	74	7	this	this	DT
cord-273505-pcsw3vmx	74	8	hypothesis	hypothesis	NN
cord-273505-pcsw3vmx	74	9	.	.	.
cord-273505-pcsw3vmx	75	1	The	the	DT
cord-273505-pcsw3vmx	75	2	evidence	evidence	NN
cord-273505-pcsw3vmx	75	3	of	of	IN
cord-273505-pcsw3vmx	75	4	a	a	DT
cord-273505-pcsw3vmx	75	5	direct	direct	JJ
cord-273505-pcsw3vmx	75	6	interaction	interaction	NN
cord-273505-pcsw3vmx	75	7	between	between	IN
cord-273505-pcsw3vmx	75	8	sialylated	sialylated	JJ
cord-273505-pcsw3vmx	75	9	IgG	IgG	NNP
cord-273505-pcsw3vmx	75	10	and	and	CC
cord-273505-pcsw3vmx	75	11	DC	DC	NNP
cord-273505-pcsw3vmx	75	12	-	-	HYPH
cord-273505-pcsw3vmx	75	13	SIGN	SIGN	NNP
cord-273505-pcsw3vmx	75	14	is	be	VBZ
cord-273505-pcsw3vmx	75	15	not	not	RB
cord-273505-pcsw3vmx	75	16	fully	fully	RB
cord-273505-pcsw3vmx	75	17	supported	support	VBN
cord-273505-pcsw3vmx	75	18	in	in	IN
cord-273505-pcsw3vmx	75	19	the	the	DT
cord-273505-pcsw3vmx	75	20	literature	literature	NN
cord-273505-pcsw3vmx	75	21	(	(	-LRB-
cord-273505-pcsw3vmx	75	22	66	66	CD
cord-273505-pcsw3vmx	75	23	,	,	,
cord-273505-pcsw3vmx	75	24	67	67	CD
cord-273505-pcsw3vmx	75	25	)	)	-RRB-
cord-273505-pcsw3vmx	75	26	.	.	.
cord-273505-pcsw3vmx	76	1	Moreover	moreover	RB
cord-273505-pcsw3vmx	76	2	,	,	,
cord-273505-pcsw3vmx	76	3	there	there	EX
cord-273505-pcsw3vmx	76	4	is	be	VBZ
cord-273505-pcsw3vmx	76	5	conflicting	conflict	VBG
cord-273505-pcsw3vmx	76	6	evidence	evidence	NN
cord-273505-pcsw3vmx	76	7	suggesting	suggest	VBG
cord-273505-pcsw3vmx	76	8	that	that	IN
cord-273505-pcsw3vmx	76	9	the	the	DT
cord-273505-pcsw3vmx	76	10	sialylated	sialylated	JJ
cord-273505-pcsw3vmx	76	11	Fc	Fc	NNP
cord-273505-pcsw3vmx	76	12	fragment	fragment	NN
cord-273505-pcsw3vmx	76	13	of	of	IN
cord-273505-pcsw3vmx	76	14	IgG	IgG	NNP
cord-273505-pcsw3vmx	76	15	is	be	VBZ
cord-273505-pcsw3vmx	76	16	dispensable	dispensable	JJ
cord-273505-pcsw3vmx	76	17	for	for	IN
cord-273505-pcsw3vmx	76	18	the	the	DT
cord-273505-pcsw3vmx	76	19	anti	anti	JJ
cord-273505-pcsw3vmx	76	20	-	-	JJ
cord-273505-pcsw3vmx	76	21	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	76	22	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	76	23	of	of	IN
cord-273505-pcsw3vmx	76	24	high	high	JJ
cord-273505-pcsw3vmx	76	25	-	-	HYPH
cord-273505-pcsw3vmx	76	26	dose	dose	NN
cord-273505-pcsw3vmx	76	27	IVIg	IVIg	NNS
cord-273505-pcsw3vmx	76	28	(	(	-LRB-
cord-273505-pcsw3vmx	76	29	68	68	CD
cord-273505-pcsw3vmx	76	30	)	)	-RRB-
cord-273505-pcsw3vmx	76	31	(	(	-LRB-
cord-273505-pcsw3vmx	76	32	69	69	CD
cord-273505-pcsw3vmx	76	33	)	)	-RRB-
cord-273505-pcsw3vmx	76	34	(	(	-LRB-
cord-273505-pcsw3vmx	76	35	70	70	CD
cord-273505-pcsw3vmx	76	36	)	)	-RRB-
cord-273505-pcsw3vmx	76	37	(	(	-LRB-
cord-273505-pcsw3vmx	76	38	71	71	CD
cord-273505-pcsw3vmx	76	39	)	)	-RRB-
cord-273505-pcsw3vmx	76	40	(	(	-LRB-
cord-273505-pcsw3vmx	76	41	72	72	CD
cord-273505-pcsw3vmx	76	42	)	)	-RRB-
cord-273505-pcsw3vmx	76	43	.	.	.
cord-273505-pcsw3vmx	77	1	It	-PRON-	PRP
cord-273505-pcsw3vmx	77	2	should	should	MD
cord-273505-pcsw3vmx	77	3	be	be	VB
cord-273505-pcsw3vmx	77	4	noted	note	VBN
cord-273505-pcsw3vmx	77	5	that	that	IN
cord-273505-pcsw3vmx	77	6	all	all	DT
cord-273505-pcsw3vmx	77	7	evidence	evidence	NN
cord-273505-pcsw3vmx	77	8	of	of	IN
cord-273505-pcsw3vmx	77	9	this	this	DT
cord-273505-pcsw3vmx	77	10	hypothesis	hypothesis	NN
cord-273505-pcsw3vmx	77	11	derives	derive	VBZ
cord-273505-pcsw3vmx	77	12	from	from	IN
cord-273505-pcsw3vmx	77	13	murine	murine	JJ
cord-273505-pcsw3vmx	77	14	studies	study	NNS
cord-273505-pcsw3vmx	77	15	,	,	,
cord-273505-pcsw3vmx	77	16	which	which	WDT
cord-273505-pcsw3vmx	77	17	might	may	MD
cord-273505-pcsw3vmx	77	18	not	not	RB
cord-273505-pcsw3vmx	77	19	be	be	VB
cord-273505-pcsw3vmx	77	20	readily	readily	RB
cord-273505-pcsw3vmx	77	21	translated	translate	VBN
cord-273505-pcsw3vmx	77	22	to	to	IN
cord-273505-pcsw3vmx	77	23	human	human	JJ
cord-273505-pcsw3vmx	77	24	conditions	condition	NNS
cord-273505-pcsw3vmx	77	25	.	.	.
cord-273505-pcsw3vmx	78	1	These	these	DT
cord-273505-pcsw3vmx	78	2	controversial	controversial	JJ
cord-273505-pcsw3vmx	78	3	results	result	NNS
cord-273505-pcsw3vmx	78	4	warrant	warrant	VBP
cord-273505-pcsw3vmx	78	5	further	further	JJ
cord-273505-pcsw3vmx	78	6	research	research	NN
cord-273505-pcsw3vmx	78	7	to	to	TO
cord-273505-pcsw3vmx	78	8	address	address	VB
cord-273505-pcsw3vmx	78	9	the	the	DT
cord-273505-pcsw3vmx	78	10	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	78	11	and	and	CC
cord-273505-pcsw3vmx	78	12	molecular	molecular	JJ
cord-273505-pcsw3vmx	78	13	basis	basis	NN
cord-273505-pcsw3vmx	78	14	of	of	IN
cord-273505-pcsw3vmx	78	15	high	high	JJ
cord-273505-pcsw3vmx	78	16	-	-	HYPH
cord-273505-pcsw3vmx	78	17	dose	dose	NN
cord-273505-pcsw3vmx	78	18	IVIg	ivig	JJ
cord-273505-pcsw3vmx	78	19	upregulation	upregulation	NN
cord-273505-pcsw3vmx	78	20	of	of	IN
cord-273505-pcsw3vmx	78	21	the	the	DT
cord-273505-pcsw3vmx	78	22	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	78	23	FcγRIIB	fcγriib	NN
cord-273505-pcsw3vmx	78	24	.	.	.
cord-273505-pcsw3vmx	79	1	The	the	DT
cord-273505-pcsw3vmx	79	2	complement	complement	NN
cord-273505-pcsw3vmx	79	3	system	system	NN
cord-273505-pcsw3vmx	79	4	is	be	VBZ
cord-273505-pcsw3vmx	79	5	activated	activate	VBN
cord-273505-pcsw3vmx	79	6	through	through	IN
cord-273505-pcsw3vmx	79	7	three	three	CD
cord-273505-pcsw3vmx	79	8	pathways	pathway	NNS
cord-273505-pcsw3vmx	79	9	,	,	,
cord-273505-pcsw3vmx	79	10	namely	namely	RB
cord-273505-pcsw3vmx	79	11	the	the	DT
cord-273505-pcsw3vmx	79	12	classical	classical	JJ
cord-273505-pcsw3vmx	79	13	pathway	pathway	NN
cord-273505-pcsw3vmx	79	14	,	,	,
cord-273505-pcsw3vmx	79	15	the	the	DT
cord-273505-pcsw3vmx	79	16	lectin	lectin	NN
cord-273505-pcsw3vmx	79	17	pathway	pathway	NN
cord-273505-pcsw3vmx	79	18	,	,	,
cord-273505-pcsw3vmx	79	19	and	and	CC
cord-273505-pcsw3vmx	79	20	the	the	DT
cord-273505-pcsw3vmx	79	21	alternative	alternative	JJ
cord-273505-pcsw3vmx	79	22	pathway	pathway	NN
cord-273505-pcsw3vmx	79	23	.	.	.
cord-273505-pcsw3vmx	80	1	Besides	besides	IN
cord-273505-pcsw3vmx	80	2	the	the	DT
cord-273505-pcsw3vmx	80	3	F(ab	f(ab	NN
cord-273505-pcsw3vmx	80	4	)	)	-RRB-
cord-273505-pcsw3vmx	80	5	′	′	CD
cord-273505-pcsw3vmx	80	6	2	2	CD
cord-273505-pcsw3vmx	80	7	-mediated	-mediated	JJ
cord-273505-pcsw3vmx	80	8	neutralization	neutralization	NN
cord-273505-pcsw3vmx	80	9	of	of	IN
cord-273505-pcsw3vmx	80	10	complement	complement	JJ
cord-273505-pcsw3vmx	80	11	C3a	C3a	NNS
cord-273505-pcsw3vmx	80	12	and	and	CC
cord-273505-pcsw3vmx	80	13	C5a	C5a	NNS
cord-273505-pcsw3vmx	80	14	,	,	,
cord-273505-pcsw3vmx	80	15	the	the	DT
cord-273505-pcsw3vmx	80	16	interaction	interaction	NN
cord-273505-pcsw3vmx	80	17	between	between	IN
cord-273505-pcsw3vmx	80	18	the	the	DT
cord-273505-pcsw3vmx	80	19	Fc	Fc	NNP
cord-273505-pcsw3vmx	80	20	fragment	fragment	NN
cord-273505-pcsw3vmx	80	21	and	and	CC
cord-273505-pcsw3vmx	80	22	complement	complement	VB
cord-273505-pcsw3vmx	80	23	C1q	C1q	NNP
cord-273505-pcsw3vmx	80	24	,	,	,
cord-273505-pcsw3vmx	80	25	C3b	C3b	NNP
cord-273505-pcsw3vmx	80	26	,	,	,
cord-273505-pcsw3vmx	80	27	and	and	CC
cord-273505-pcsw3vmx	80	28	C4b	c4b	NN
cord-273505-pcsw3vmx	80	29	in	in	IN
cord-273505-pcsw3vmx	80	30	a	a	DT
cord-273505-pcsw3vmx	80	31	dosedependent	dosedependent	NN
cord-273505-pcsw3vmx	80	32	manner	manner	NN
cord-273505-pcsw3vmx	80	33	,	,	,
cord-273505-pcsw3vmx	80	34	contributes	contribute	VBZ
cord-273505-pcsw3vmx	80	35	to	to	IN
cord-273505-pcsw3vmx	80	36	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	80	37	effects	effect	NNS
cord-273505-pcsw3vmx	80	38	of	of	IN
cord-273505-pcsw3vmx	80	39	IVIg	ivig	NN
cord-273505-pcsw3vmx	80	40	on	on	IN
cord-273505-pcsw3vmx	80	41	the	the	DT
cord-273505-pcsw3vmx	80	42	classical	classical	JJ
cord-273505-pcsw3vmx	80	43	complement	complement	NN
cord-273505-pcsw3vmx	80	44	pathway	pathway	NN
cord-273505-pcsw3vmx	80	45	(	(	-LRB-
cord-273505-pcsw3vmx	80	46	73	73	CD
cord-273505-pcsw3vmx	80	47	)	)	-RRB-
cord-273505-pcsw3vmx	80	48	(	(	-LRB-
cord-273505-pcsw3vmx	80	49	74	74	CD
cord-273505-pcsw3vmx	80	50	)	)	-RRB-
cord-273505-pcsw3vmx	80	51	(	(	-LRB-
cord-273505-pcsw3vmx	80	52	75	75	CD
cord-273505-pcsw3vmx	80	53	)	)	-RRB-
cord-273505-pcsw3vmx	80	54	.	.	.
cord-273505-pcsw3vmx	81	1	The	the	DT
cord-273505-pcsw3vmx	81	2	binding	binding	NN
cord-273505-pcsw3vmx	81	3	site	site	NN
cord-273505-pcsw3vmx	81	4	of	of	IN
cord-273505-pcsw3vmx	81	5	C3b	c3b	NN
cord-273505-pcsw3vmx	81	6	/	/	SYM
cord-273505-pcsw3vmx	81	7	C4b	c4b	NN
cord-273505-pcsw3vmx	81	8	is	be	VBZ
cord-273505-pcsw3vmx	81	9	located	locate	VBN
cord-273505-pcsw3vmx	81	10	on	on	IN
cord-273505-pcsw3vmx	81	11	the	the	DT
cord-273505-pcsw3vmx	81	12	residues	residue	NNS
cord-273505-pcsw3vmx	81	13	381	381	CD
cord-273505-pcsw3vmx	81	14	-	-	SYM
cord-273505-pcsw3vmx	81	15	390	390	CD
cord-273505-pcsw3vmx	81	16	of	of	IN
cord-273505-pcsw3vmx	81	17	the	the	DT
cord-273505-pcsw3vmx	81	18	CH3	CH3	NNP
cord-273505-pcsw3vmx	81	19	domain	domain	NN
cord-273505-pcsw3vmx	81	20	of	of	IN
cord-273505-pcsw3vmx	81	21	the	the	DT
cord-273505-pcsw3vmx	81	22	IgG	IgG	NNP
cord-273505-pcsw3vmx	81	23	Fc	Fc	NNP
cord-273505-pcsw3vmx	81	24	fragment	fragment	NN
cord-273505-pcsw3vmx	81	25	,	,	,
cord-273505-pcsw3vmx	81	26	while	while	IN
cord-273505-pcsw3vmx	81	27	the	the	DT
cord-273505-pcsw3vmx	81	28	residues	residue	NNS
cord-273505-pcsw3vmx	81	29	318	318	CD
cord-273505-pcsw3vmx	81	30	-	-	SYM
cord-273505-pcsw3vmx	81	31	322	322	CD
cord-273505-pcsw3vmx	81	32	of	of	IN
cord-273505-pcsw3vmx	81	33	the	the	DT
cord-273505-pcsw3vmx	81	34	CH2	CH2	NNP
cord-273505-pcsw3vmx	81	35	domain	domain	NN
cord-273505-pcsw3vmx	81	36	are	be	VBP
cord-273505-pcsw3vmx	81	37	responsible	responsible	JJ
cord-273505-pcsw3vmx	81	38	for	for	IN
cord-273505-pcsw3vmx	81	39	the	the	DT
cord-273505-pcsw3vmx	81	40	binding	binding	NN
cord-273505-pcsw3vmx	81	41	of	of	IN
cord-273505-pcsw3vmx	81	42	C1q	C1q	NNP
cord-273505-pcsw3vmx	81	43	(	(	-LRB-
cord-273505-pcsw3vmx	81	44	76	76	CD
cord-273505-pcsw3vmx	81	45	,	,	,
cord-273505-pcsw3vmx	81	46	77	77	CD
cord-273505-pcsw3vmx	81	47	)	)	-RRB-
cord-273505-pcsw3vmx	81	48	.	.	.
cord-273505-pcsw3vmx	82	1	The	the	DT
cord-273505-pcsw3vmx	82	2	binding	bind	VBG
cord-273505-pcsw3vmx	82	3	domains	domain	NNS
cord-273505-pcsw3vmx	82	4	may	may	MD
cord-273505-pcsw3vmx	82	5	react	react	VB
cord-273505-pcsw3vmx	82	6	with	with	IN
cord-273505-pcsw3vmx	82	7	different	different	JJ
cord-273505-pcsw3vmx	82	8	N	n	CD
cord-273505-pcsw3vmx	82	9	-	-	HYPH
cord-273505-pcsw3vmx	82	10	glycan	glycan	NN
cord-273505-pcsw3vmx	82	11	sialylation	sialylation	NN
cord-273505-pcsw3vmx	82	12	patterns	pattern	NNS
cord-273505-pcsw3vmx	82	13	on	on	IN
cord-273505-pcsw3vmx	82	14	the	the	DT
cord-273505-pcsw3vmx	82	15	IgG	IgG	NNP
cord-273505-pcsw3vmx	82	16	structure	structure	NN
cord-273505-pcsw3vmx	82	17	and	and	CC
cord-273505-pcsw3vmx	82	18	result	result	VB
cord-273505-pcsw3vmx	82	19	in	in	IN
cord-273505-pcsw3vmx	82	20	distinct	distinct	JJ
cord-273505-pcsw3vmx	82	21	anti	anti	JJ
cord-273505-pcsw3vmx	82	22	-	-	JJ
cord-273505-pcsw3vmx	82	23	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	82	24	effects	effect	NNS
cord-273505-pcsw3vmx	82	25	through	through	IN
cord-273505-pcsw3vmx	82	26	the	the	DT
cord-273505-pcsw3vmx	82	27	complement	complement	NN
cord-273505-pcsw3vmx	82	28	pathway	pathway	NN
cord-273505-pcsw3vmx	82	29	(	(	-LRB-
cord-273505-pcsw3vmx	82	30	78	78	CD
cord-273505-pcsw3vmx	82	31	)	)	-RRB-
cord-273505-pcsw3vmx	82	32	.	.	.
cord-273505-pcsw3vmx	83	1	As	as	IN
cord-273505-pcsw3vmx	83	2	an	an	DT
cord-273505-pcsw3vmx	83	3	extremely	extremely	RB
cord-273505-pcsw3vmx	83	4	complex	complex	JJ
cord-273505-pcsw3vmx	83	5	preparation	preparation	NN
cord-273505-pcsw3vmx	83	6	,	,	,
cord-273505-pcsw3vmx	83	7	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	83	8	contains	contain	VBZ
cord-273505-pcsw3vmx	83	9	a	a	DT
cord-273505-pcsw3vmx	83	10	large	large	JJ
cord-273505-pcsw3vmx	83	11	number	number	NN
cord-273505-pcsw3vmx	83	12	of	of	IN
cord-273505-pcsw3vmx	83	13	bioactive	bioactive	JJ
cord-273505-pcsw3vmx	83	14	moieties	moiety	NNS
cord-273505-pcsw3vmx	83	15	,	,	,
cord-273505-pcsw3vmx	83	16	and	and	CC
cord-273505-pcsw3vmx	83	17	the	the	DT
cord-273505-pcsw3vmx	83	18	entirety	entirety	NN
cord-273505-pcsw3vmx	83	19	of	of	IN
cord-273505-pcsw3vmx	83	20	effects	effect	NNS
cord-273505-pcsw3vmx	83	21	from	from	IN
cord-273505-pcsw3vmx	83	22	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	83	23	is	be	VBZ
cord-273505-pcsw3vmx	83	24	therefore	therefore	RB
cord-273505-pcsw3vmx	83	25	not	not	RB
cord-273505-pcsw3vmx	83	26	fully	fully	RB
cord-273505-pcsw3vmx	83	27	understood	understand	VBN
cord-273505-pcsw3vmx	83	28	yet	yet	RB
cord-273505-pcsw3vmx	83	29	.	.	.
cord-273505-pcsw3vmx	84	1	The	the	DT
cord-273505-pcsw3vmx	84	2	proposed	propose	VBN
cord-273505-pcsw3vmx	84	3	antigen	antigen	NN
cord-273505-pcsw3vmx	84	4	-	-	HYPH
cord-273505-pcsw3vmx	84	5	specific	specific	JJ
cord-273505-pcsw3vmx	84	6	F(ab	f(ab	NN
cord-273505-pcsw3vmx	84	7	)	)	-RRB-
cord-273505-pcsw3vmx	84	8	′	′	CD
cord-273505-pcsw3vmx	84	9	2	2	CD
cord-273505-pcsw3vmx	84	10	-mediated	-mediated	JJ
cord-273505-pcsw3vmx	84	11	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	84	12	and	and	CC
cord-273505-pcsw3vmx	84	13	unspecific	unspecific	JJ
cord-273505-pcsw3vmx	84	14	Fc	Fc	NNP
cord-273505-pcsw3vmx	84	15	-	-	HYPH
cord-273505-pcsw3vmx	84	16	mediated	mediate	VBN
cord-273505-pcsw3vmx	84	17	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	84	18	are	be	VBP
cord-273505-pcsw3vmx	84	19	not	not	RB
cord-273505-pcsw3vmx	84	20	mutually	mutually	RB
cord-273505-pcsw3vmx	84	21	exclusive	exclusive	JJ
cord-273505-pcsw3vmx	84	22	,	,	,
cord-273505-pcsw3vmx	84	23	but	but	CC
cord-273505-pcsw3vmx	84	24	is	be	VBZ
cord-273505-pcsw3vmx	84	25	more	more	RBR
cord-273505-pcsw3vmx	84	26	likely	likely	JJ
cord-273505-pcsw3vmx	84	27	to	to	TO
cord-273505-pcsw3vmx	84	28	regulate	regulate	VB
cord-273505-pcsw3vmx	84	29	the	the	DT
cord-273505-pcsw3vmx	84	30	immune	immune	JJ
cord-273505-pcsw3vmx	84	31	system	system	NN
cord-273505-pcsw3vmx	84	32	in	in	IN
cord-273505-pcsw3vmx	84	33	synergy	synergy	NN
cord-273505-pcsw3vmx	84	34	,	,	,
cord-273505-pcsw3vmx	84	35	giving	give	VBG
cord-273505-pcsw3vmx	84	36	rise	rise	NN
cord-273505-pcsw3vmx	84	37	to	to	IN
cord-273505-pcsw3vmx	84	38	the	the	DT
cord-273505-pcsw3vmx	84	39	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	84	40	effects	effect	NNS
cord-273505-pcsw3vmx	84	41	of	of	IN
cord-273505-pcsw3vmx	84	42	high	high	JJ
cord-273505-pcsw3vmx	84	43	-	-	HYPH
cord-273505-pcsw3vmx	84	44	dose	dose	NN
cord-273505-pcsw3vmx	84	45	IVIg	ivig	NN
cord-273505-pcsw3vmx	84	46	in	in	IN
cord-273505-pcsw3vmx	84	47	specific	specific	JJ
cord-273505-pcsw3vmx	84	48	clinical	clinical	JJ
cord-273505-pcsw3vmx	84	49	settings	setting	NNS
cord-273505-pcsw3vmx	84	50	.	.	.
cord-273505-pcsw3vmx	85	1	Although	although	IN
cord-273505-pcsw3vmx	85	2	an	an	DT
cord-273505-pcsw3vmx	85	3	active	active	JJ
cord-273505-pcsw3vmx	85	4	immune	immune	JJ
cord-273505-pcsw3vmx	85	5	response	response	NN
cord-273505-pcsw3vmx	85	6	is	be	VBZ
cord-273505-pcsw3vmx	85	7	essential	essential	JJ
cord-273505-pcsw3vmx	85	8	for	for	IN
cord-273505-pcsw3vmx	85	9	pathogen	pathogen	NN
cord-273505-pcsw3vmx	85	10	elimination	elimination	NN
cord-273505-pcsw3vmx	85	11	in	in	IN
cord-273505-pcsw3vmx	85	12	acute	acute	JJ
cord-273505-pcsw3vmx	85	13	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	85	14	viral	viral	JJ
cord-273505-pcsw3vmx	85	15	infections	infection	NNS
cord-273505-pcsw3vmx	85	16	,	,	,
cord-273505-pcsw3vmx	85	17	excessive	excessive	JJ
cord-273505-pcsw3vmx	85	18	defensive	defensive	JJ
cord-273505-pcsw3vmx	85	19	reactions	reaction	NNS
cord-273505-pcsw3vmx	85	20	might	may	MD
cord-273505-pcsw3vmx	85	21	wreak	wreak	VB
cord-273505-pcsw3vmx	85	22	havoc	havoc	NN
cord-273505-pcsw3vmx	85	23	on	on	IN
cord-273505-pcsw3vmx	85	24	healthy	healthy	JJ
cord-273505-pcsw3vmx	85	25	cells	cell	NNS
cord-273505-pcsw3vmx	85	26	and	and	CC
cord-273505-pcsw3vmx	85	27	tissues	tissue	NNS
cord-273505-pcsw3vmx	85	28	.	.	.
cord-273505-pcsw3vmx	86	1	Complications	complication	NNS
cord-273505-pcsw3vmx	86	2	or	or	CC
cord-273505-pcsw3vmx	86	3	mortality	mortality	NN
cord-273505-pcsw3vmx	86	4	of	of	IN
cord-273505-pcsw3vmx	86	5	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	86	6	viral	viral	JJ
cord-273505-pcsw3vmx	86	7	infections	infection	NNS
cord-273505-pcsw3vmx	86	8	are	be	VBP
cord-273505-pcsw3vmx	86	9	often	often	RB
cord-273505-pcsw3vmx	86	10	associated	associate	VBN
cord-273505-pcsw3vmx	86	11	with	with	IN
cord-273505-pcsw3vmx	86	12	excessive	excessive	JJ
cord-273505-pcsw3vmx	86	13	production	production	NN
cord-273505-pcsw3vmx	86	14	of	of	IN
cord-273505-pcsw3vmx	86	15	proinflammatory	proinflammatory	JJ
cord-273505-pcsw3vmx	86	16	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	86	17	and	and	CC
cord-273505-pcsw3vmx	86	18	ensuing	ensue	VBG
cord-273505-pcsw3vmx	86	19	multiple	multiple	JJ
cord-273505-pcsw3vmx	86	20	organ	organ	NN
cord-273505-pcsw3vmx	86	21	dysfunction	dysfunction	NN
cord-273505-pcsw3vmx	86	22	.	.	.
cord-273505-pcsw3vmx	87	1	Although	although	IN
cord-273505-pcsw3vmx	87	2	the	the	DT
cord-273505-pcsw3vmx	87	3	immunopathogenesis	immunopathogenesis	NN
cord-273505-pcsw3vmx	87	4	of	of	IN
cord-273505-pcsw3vmx	87	5	SARS	SARS	NNP
cord-273505-pcsw3vmx	87	6	-	-	HYPH
cord-273505-pcsw3vmx	87	7	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	87	8	has	have	VBZ
cord-273505-pcsw3vmx	87	9	not	not	RB
cord-273505-pcsw3vmx	87	10	yet	yet	RB
cord-273505-pcsw3vmx	87	11	been	be	VBN
cord-273505-pcsw3vmx	87	12	fully	fully	RB
cord-273505-pcsw3vmx	87	13	described	describe	VBN
cord-273505-pcsw3vmx	87	14	,	,	,
cord-273505-pcsw3vmx	87	15	the	the	DT
cord-273505-pcsw3vmx	87	16	histopathological	histopathological	JJ
cord-273505-pcsw3vmx	87	17	evidence	evidence	NN
cord-273505-pcsw3vmx	87	18	strongly	strongly	RB
cord-273505-pcsw3vmx	87	19	suggests	suggest	VBZ
cord-273505-pcsw3vmx	87	20	a	a	DT
cord-273505-pcsw3vmx	87	21	critical	critical	JJ
cord-273505-pcsw3vmx	87	22	role	role	NN
cord-273505-pcsw3vmx	87	23	of	of	IN
cord-273505-pcsw3vmx	87	24	an	an	DT
cord-273505-pcsw3vmx	87	25	excessive	excessive	JJ
cord-273505-pcsw3vmx	87	26	immune	immune	JJ
cord-273505-pcsw3vmx	87	27	response	response	NN
cord-273505-pcsw3vmx	87	28	in	in	IN
cord-273505-pcsw3vmx	87	29	mediating	mediate	VBG
cord-273505-pcsw3vmx	87	30	extensive	extensive	JJ
cord-273505-pcsw3vmx	87	31	damage	damage	NN
cord-273505-pcsw3vmx	87	32	of	of	IN
cord-273505-pcsw3vmx	87	33	the	the	DT
cord-273505-pcsw3vmx	87	34	lung	lung	NN
cord-273505-pcsw3vmx	87	35	and	and	CC
cord-273505-pcsw3vmx	87	36	other	other	JJ
cord-273505-pcsw3vmx	87	37	organs	organ	NNS
cord-273505-pcsw3vmx	87	38	,	,	,
cord-273505-pcsw3vmx	87	39	similar	similar	JJ
cord-273505-pcsw3vmx	87	40	to	to	IN
cord-273505-pcsw3vmx	87	41	previous	previous	JJ
cord-273505-pcsw3vmx	87	42	observations	observation	NNS
cord-273505-pcsw3vmx	87	43	in	in	IN
cord-273505-pcsw3vmx	87	44	SARS	SARS	NNP
cord-273505-pcsw3vmx	87	45	,	,	,
cord-273505-pcsw3vmx	87	46	MERS	MERS	NNP
cord-273505-pcsw3vmx	87	47	,	,	,
cord-273505-pcsw3vmx	87	48	influenza	influenza	NN
cord-273505-pcsw3vmx	87	49	,	,	,
cord-273505-pcsw3vmx	87	50	and	and	CC
cord-273505-pcsw3vmx	87	51	RSV	RSV	NNP
cord-273505-pcsw3vmx	87	52	disease	disease	NN
cord-273505-pcsw3vmx	87	53	,	,	,
cord-273505-pcsw3vmx	87	54	where	where	WRB
cord-273505-pcsw3vmx	87	55	hyper	hyper	JJ
cord-273505-pcsw3vmx	87	56	-	-	JJ
cord-273505-pcsw3vmx	87	57	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	87	58	responses	response	NNS
cord-273505-pcsw3vmx	87	59	have	have	VBP
cord-273505-pcsw3vmx	87	60	been	be	VBN
cord-273505-pcsw3vmx	87	61	shown	show	VBN
cord-273505-pcsw3vmx	87	62	to	to	TO
cord-273505-pcsw3vmx	87	63	be	be	VB
cord-273505-pcsw3vmx	87	64	involved	involve	VBN
cord-273505-pcsw3vmx	87	65	in	in	IN
cord-273505-pcsw3vmx	87	66	the	the	DT
cord-273505-pcsw3vmx	87	67	lung	lung	NN
cord-273505-pcsw3vmx	87	68	pathology	pathology	NN
cord-273505-pcsw3vmx	87	69	.	.	.
cord-273505-pcsw3vmx	88	1	In	in	IN
cord-273505-pcsw3vmx	88	2	this	this	DT
cord-273505-pcsw3vmx	88	3	section	section	NN
cord-273505-pcsw3vmx	88	4	,	,	,
cord-273505-pcsw3vmx	88	5	we	-PRON-	PRP
cord-273505-pcsw3vmx	88	6	review	review	VBP
cord-273505-pcsw3vmx	88	7	how	how	WRB
cord-273505-pcsw3vmx	88	8	a	a	DT
cord-273505-pcsw3vmx	88	9	dysfunctional	dysfunctional	JJ
cord-273505-pcsw3vmx	88	10	immune	immune	JJ
cord-273505-pcsw3vmx	88	11	response	response	NN
cord-273505-pcsw3vmx	88	12	may	may	MD
cord-273505-pcsw3vmx	88	13	cause	cause	VB
cord-273505-pcsw3vmx	88	14	immunopathology	immunopathology	NN
cord-273505-pcsw3vmx	88	15	in	in	IN
cord-273505-pcsw3vmx	88	16	severe	severe	JJ
cord-273505-pcsw3vmx	88	17	viral	viral	JJ
cord-273505-pcsw3vmx	88	18	pneumonia	pneumonia	NN
cord-273505-pcsw3vmx	88	19	,	,	,
cord-273505-pcsw3vmx	88	20	resulting	result	VBG
cord-273505-pcsw3vmx	88	21	in	in	IN
cord-273505-pcsw3vmx	88	22	the	the	DT
cord-273505-pcsw3vmx	88	23	current	current	JJ
cord-273505-pcsw3vmx	88	24	understanding	understanding	NN
cord-273505-pcsw3vmx	88	25	of	of	IN
cord-273505-pcsw3vmx	88	26	IVIg	ivig	JJ
cord-273505-pcsw3vmx	88	27	therapy	therapy	NN
cord-273505-pcsw3vmx	88	28	in	in	IN
cord-273505-pcsw3vmx	88	29	modulating	modulate	VBG
cord-273505-pcsw3vmx	88	30	the	the	DT
cord-273505-pcsw3vmx	88	31	hyperinflammatory	hyperinflammatory	JJ
cord-273505-pcsw3vmx	88	32	conditions	condition	NNS
cord-273505-pcsw3vmx	88	33	.	.	.
cord-273505-pcsw3vmx	89	1	The	the	DT
cord-273505-pcsw3vmx	89	2	cytokine	cytokine	NN
cord-273505-pcsw3vmx	89	3	storm	storm	NN
cord-273505-pcsw3vmx	89	4	syndrome	syndrome	NN
cord-273505-pcsw3vmx	89	5	is	be	VBZ
cord-273505-pcsw3vmx	89	6	a	a	DT
cord-273505-pcsw3vmx	89	7	form	form	NN
cord-273505-pcsw3vmx	89	8	of	of	IN
cord-273505-pcsw3vmx	89	9	systemic	systemic	JJ
cord-273505-pcsw3vmx	89	10	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	89	11	response	response	NN
cord-273505-pcsw3vmx	89	12	common	common	JJ
cord-273505-pcsw3vmx	89	13	to	to	IN
cord-273505-pcsw3vmx	89	14	severe	severe	JJ
cord-273505-pcsw3vmx	89	15	acute	acute	JJ
cord-273505-pcsw3vmx	89	16	viral	viral	JJ
cord-273505-pcsw3vmx	89	17	pneumonias	pneumonia	NNS
cord-273505-pcsw3vmx	89	18	,	,	,
cord-273505-pcsw3vmx	89	19	and	and	CC
cord-273505-pcsw3vmx	89	20	its	-PRON-	PRP$
cord-273505-pcsw3vmx	89	21	presence	presence	NN
cord-273505-pcsw3vmx	89	22	has	have	VBZ
cord-273505-pcsw3vmx	89	23	also	also	RB
cord-273505-pcsw3vmx	89	24	been	be	VBN
cord-273505-pcsw3vmx	89	25	suggested	suggest	VBN
cord-273505-pcsw3vmx	89	26	in	in	IN
cord-273505-pcsw3vmx	89	27	severe	severe	JJ
cord-273505-pcsw3vmx	89	28	cases	case	NNS
cord-273505-pcsw3vmx	89	29	of	of	IN
cord-273505-pcsw3vmx	89	30	COVID-19	covid-19	NN
cord-273505-pcsw3vmx	89	31	.	.	.
cord-273505-pcsw3vmx	90	1	There	there	EX
cord-273505-pcsw3vmx	90	2	is	be	VBZ
cord-273505-pcsw3vmx	90	3	a	a	DT
cord-273505-pcsw3vmx	90	4	correlation	correlation	NN
cord-273505-pcsw3vmx	90	5	between	between	IN
cord-273505-pcsw3vmx	90	6	severity	severity	NN
cord-273505-pcsw3vmx	90	7	of	of	IN
cord-273505-pcsw3vmx	90	8	the	the	DT
cord-273505-pcsw3vmx	90	9	cytokine	cytokine	NN
cord-273505-pcsw3vmx	90	10	storm	storm	NN
cord-273505-pcsw3vmx	90	11	and	and	CC
cord-273505-pcsw3vmx	90	12	prognosis	prognosis	NN
cord-273505-pcsw3vmx	90	13	of	of	IN
cord-273505-pcsw3vmx	90	14	severe	severe	JJ
cord-273505-pcsw3vmx	90	15	illnesses	illness	NNS
cord-273505-pcsw3vmx	90	16	(	(	-LRB-
cord-273505-pcsw3vmx	90	17	13	13	CD
cord-273505-pcsw3vmx	90	18	)	)	-RRB-
cord-273505-pcsw3vmx	90	19	.	.	.
cord-273505-pcsw3vmx	91	1	At	at	IN
cord-273505-pcsw3vmx	91	2	the	the	DT
cord-273505-pcsw3vmx	91	3	initiation	initiation	NN
cord-273505-pcsw3vmx	91	4	of	of	IN
cord-273505-pcsw3vmx	91	5	infection	infection	NN
cord-273505-pcsw3vmx	91	6	,	,	,
cord-273505-pcsw3vmx	91	7	the	the	DT
cord-273505-pcsw3vmx	91	8	host	host	NN
cord-273505-pcsw3vmx	91	9	cells	cell	NNS
cord-273505-pcsw3vmx	91	10	detect	detect	VBP
cord-273505-pcsw3vmx	91	11	viruses	virus	NNS
cord-273505-pcsw3vmx	91	12	through	through	IN
cord-273505-pcsw3vmx	91	13	pattern	pattern	NN
cord-273505-pcsw3vmx	91	14	recognition	recognition	NN
cord-273505-pcsw3vmx	91	15	receptors	receptor	NNS
cord-273505-pcsw3vmx	91	16	(	(	-LRB-
cord-273505-pcsw3vmx	91	17	PRRs	PRRs	NNP
cord-273505-pcsw3vmx	91	18	)	)	-RRB-
cord-273505-pcsw3vmx	91	19	,	,	,
cord-273505-pcsw3vmx	91	20	which	which	WDT
cord-273505-pcsw3vmx	91	21	in	in	IN
cord-273505-pcsw3vmx	91	22	turn	turn	NN
cord-273505-pcsw3vmx	91	23	triggers	trigger	VBZ
cord-273505-pcsw3vmx	91	24	an	an	DT
cord-273505-pcsw3vmx	91	25	interferon	interferon	NN
cord-273505-pcsw3vmx	91	26	(	(	-LRB-
cord-273505-pcsw3vmx	91	27	IFN	IFN	NNP
cord-273505-pcsw3vmx	91	28	)	)	-RRB-
cord-273505-pcsw3vmx	91	29	response	response	NN
cord-273505-pcsw3vmx	91	30	and	and	CC
cord-273505-pcsw3vmx	91	31	produces	produce	VBZ
cord-273505-pcsw3vmx	91	32	other	other	JJ
cord-273505-pcsw3vmx	91	33	pro	pro	JJ
cord-273505-pcsw3vmx	91	34	-	-	JJ
cord-273505-pcsw3vmx	91	35	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	91	36	mediators	mediator	NNS
cord-273505-pcsw3vmx	91	37	such	such	JJ
cord-273505-pcsw3vmx	91	38	as	as	IN
cord-273505-pcsw3vmx	91	39	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	91	40	and	and	CC
cord-273505-pcsw3vmx	91	41	chemokines	chemokine	NNS
cord-273505-pcsw3vmx	91	42	,	,	,
cord-273505-pcsw3vmx	91	43	informing	inform	VBG
cord-273505-pcsw3vmx	91	44	both	both	DT
cord-273505-pcsw3vmx	91	45	innate	innate	JJ
cord-273505-pcsw3vmx	91	46	and	and	CC
cord-273505-pcsw3vmx	91	47	adaptive	adaptive	JJ
cord-273505-pcsw3vmx	91	48	immune	immune	JJ
cord-273505-pcsw3vmx	91	49	system	system	NN
cord-273505-pcsw3vmx	91	50	to	to	TO
cord-273505-pcsw3vmx	91	51	respond	respond	VB
cord-273505-pcsw3vmx	91	52	appropriately	appropriately	RB
cord-273505-pcsw3vmx	91	53	to	to	IN
cord-273505-pcsw3vmx	91	54	infectious	infectious	JJ
cord-273505-pcsw3vmx	91	55	pathogens	pathogen	NNS
cord-273505-pcsw3vmx	91	56	.	.	.
cord-273505-pcsw3vmx	92	1	A	a	DT
cord-273505-pcsw3vmx	92	2	physiological	physiological	JJ
cord-273505-pcsw3vmx	92	3	cytokine	cytokine	NN
cord-273505-pcsw3vmx	92	4	and	and	CC
cord-273505-pcsw3vmx	92	5	chemokine	chemokine	NN
cord-273505-pcsw3vmx	92	6	response	response	NN
cord-273505-pcsw3vmx	92	7	induced	induce	VBN
cord-273505-pcsw3vmx	92	8	by	by	IN
cord-273505-pcsw3vmx	92	9	viruses	virus	NNS
cord-273505-pcsw3vmx	92	10	is	be	VBZ
cord-273505-pcsw3vmx	92	11	a	a	DT
cord-273505-pcsw3vmx	92	12	sprawling	sprawl	VBG
cord-273505-pcsw3vmx	92	13	network	network	NN
cord-273505-pcsw3vmx	92	14	,	,	,
cord-273505-pcsw3vmx	92	15	which	which	WDT
cord-273505-pcsw3vmx	92	16	involves	involve	VBZ
cord-273505-pcsw3vmx	92	17	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	92	18	cells	cell	NNS
cord-273505-pcsw3vmx	92	19	,	,	,
cord-273505-pcsw3vmx	92	20	mononuclear	mononuclear	JJ
cord-273505-pcsw3vmx	92	21	macrophages	macrophage	NNS
cord-273505-pcsw3vmx	92	22	,	,	,
cord-273505-pcsw3vmx	92	23	dendritic	dendritic	JJ
cord-273505-pcsw3vmx	92	24	cells	cell	NNS
cord-273505-pcsw3vmx	92	25	,	,	,
cord-273505-pcsw3vmx	92	26	natural	natural	JJ
cord-273505-pcsw3vmx	92	27	killer	killer	NN
cord-273505-pcsw3vmx	92	28	cells	cell	NNS
cord-273505-pcsw3vmx	92	29	,	,	,
cord-273505-pcsw3vmx	92	30	and	and	CC
cord-273505-pcsw3vmx	92	31	lymphocytes	lymphocyte	NNS
cord-273505-pcsw3vmx	92	32	,	,	,
cord-273505-pcsw3vmx	92	33	contributing	contribute	VBG
cord-273505-pcsw3vmx	92	34	to	to	IN
cord-273505-pcsw3vmx	92	35	pathogen	pathogen	NN
cord-273505-pcsw3vmx	92	36	clearance	clearance	NN
cord-273505-pcsw3vmx	92	37	and	and	CC
cord-273505-pcsw3vmx	92	38	immune	immune	JJ
cord-273505-pcsw3vmx	92	39	protection	protection	NN
cord-273505-pcsw3vmx	92	40	.	.	.
cord-273505-pcsw3vmx	93	1	However	however	RB
cord-273505-pcsw3vmx	93	2	,	,	,
cord-273505-pcsw3vmx	93	3	an	an	DT
cord-273505-pcsw3vmx	93	4	uncontrolled	uncontrolled	JJ
cord-273505-pcsw3vmx	93	5	positive	positive	JJ
cord-273505-pcsw3vmx	93	6	feedback	feedback	NN
cord-273505-pcsw3vmx	93	7	involving	involve	VBG
cord-273505-pcsw3vmx	93	8	all	all	PDT
cord-273505-pcsw3vmx	93	9	the	the	DT
cord-273505-pcsw3vmx	93	10	relevant	relevant	JJ
cord-273505-pcsw3vmx	93	11	players	player	NNS
cord-273505-pcsw3vmx	93	12	leads	lead	VBZ
cord-273505-pcsw3vmx	93	13	to	to	IN
cord-273505-pcsw3vmx	93	14	pathogenic	pathogenic	JJ
cord-273505-pcsw3vmx	93	15	hyperinflammation	hyperinflammation	NN
cord-273505-pcsw3vmx	93	16	and	and	CC
cord-273505-pcsw3vmx	93	17	can	can	MD
cord-273505-pcsw3vmx	93	18	cause	cause	VB
cord-273505-pcsw3vmx	93	19	extensive	extensive	JJ
cord-273505-pcsw3vmx	93	20	damage	damage	NN
cord-273505-pcsw3vmx	93	21	to	to	IN
cord-273505-pcsw3vmx	93	22	tissues	tissue	NNS
cord-273505-pcsw3vmx	93	23	.	.	.
cord-273505-pcsw3vmx	94	1	Endothelial	endothelial	JJ
cord-273505-pcsw3vmx	94	2	cells	cell	NNS
cord-273505-pcsw3vmx	94	3	can	can	MD
cord-273505-pcsw3vmx	94	4	secrete	secrete	VB
cord-273505-pcsw3vmx	94	5	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	94	6	mediators	mediator	NNS
cord-273505-pcsw3vmx	94	7	,	,	,
cord-273505-pcsw3vmx	94	8	including	include	VBG
cord-273505-pcsw3vmx	94	9	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	94	10	,	,	,
cord-273505-pcsw3vmx	94	11	chemokines	chemokine	NNS
cord-273505-pcsw3vmx	94	12	,	,	,
cord-273505-pcsw3vmx	94	13	histamine	histamine	NN
cord-273505-pcsw3vmx	94	14	,	,	,
cord-273505-pcsw3vmx	94	15	matrix	matrix	NN
cord-273505-pcsw3vmx	94	16	metalloproteinases	metalloproteinase	NNS
cord-273505-pcsw3vmx	94	17	,	,	,
cord-273505-pcsw3vmx	94	18	and	and	CC
cord-273505-pcsw3vmx	94	19	adhesion	adhesion	NN
cord-273505-pcsw3vmx	94	20	molecules	molecule	NNS
cord-273505-pcsw3vmx	94	21	,	,	,
cord-273505-pcsw3vmx	94	22	which	which	WDT
cord-273505-pcsw3vmx	94	23	can	can	MD
cord-273505-pcsw3vmx	94	24	lead	lead	VB
cord-273505-pcsw3vmx	94	25	to	to	IN
cord-273505-pcsw3vmx	94	26	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	94	27	cell	cell	NN
cord-273505-pcsw3vmx	94	28	infiltration	infiltration	NN
cord-273505-pcsw3vmx	94	29	and	and	CC
cord-273505-pcsw3vmx	94	30	tissue	tissue	NN
cord-273505-pcsw3vmx	94	31	damage	damage	NN
cord-273505-pcsw3vmx	94	32	,	,	,
cord-273505-pcsw3vmx	94	33	and	and	CC
cord-273505-pcsw3vmx	94	34	plays	play	VBZ
cord-273505-pcsw3vmx	94	35	an	an	DT
cord-273505-pcsw3vmx	94	36	essential	essential	JJ
cord-273505-pcsw3vmx	94	37	role	role	NN
cord-273505-pcsw3vmx	94	38	in	in	IN
cord-273505-pcsw3vmx	94	39	inflammation	inflammation	NN
cord-273505-pcsw3vmx	94	40	,	,	,
cord-273505-pcsw3vmx	94	41	hemostasis	hemostasis	NN
cord-273505-pcsw3vmx	94	42	,	,	,
cord-273505-pcsw3vmx	94	43	and	and	CC
cord-273505-pcsw3vmx	94	44	angiogenesis	angiogenesis	NN
cord-273505-pcsw3vmx	94	45	.	.	.
cord-273505-pcsw3vmx	95	1	SARS	SARS	NNP
cord-273505-pcsw3vmx	95	2	-	-	HYPH
cord-273505-pcsw3vmx	95	3	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	95	4	infects	infect	VBZ
cord-273505-pcsw3vmx	95	5	host	host	NN
cord-273505-pcsw3vmx	95	6	cells	cell	NNS
cord-273505-pcsw3vmx	95	7	using	use	VBG
cord-273505-pcsw3vmx	95	8	the	the	DT
cord-273505-pcsw3vmx	95	9	ACE2	ACE2	NNP
cord-273505-pcsw3vmx	95	10	receptor	receptor	NN
cord-273505-pcsw3vmx	95	11	,	,	,
cord-273505-pcsw3vmx	95	12	which	which	WDT
cord-273505-pcsw3vmx	95	13	is	be	VBZ
cord-273505-pcsw3vmx	95	14	widely	widely	RB
cord-273505-pcsw3vmx	95	15	expressed	express	VBN
cord-273505-pcsw3vmx	95	16	on	on	IN
cord-273505-pcsw3vmx	95	17	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	95	18	cells	cell	NNS
cord-273505-pcsw3vmx	95	19	.	.	.
cord-273505-pcsw3vmx	96	1	Endothelial	endothelial	JJ
cord-273505-pcsw3vmx	96	2	cell	cell	NN
cord-273505-pcsw3vmx	96	3	infection	infection	NN
cord-273505-pcsw3vmx	96	4	and	and	CC
cord-273505-pcsw3vmx	96	5	endotheliosis	endotheliosis	NN
cord-273505-pcsw3vmx	96	6	have	have	VBP
cord-273505-pcsw3vmx	96	7	been	be	VBN
cord-273505-pcsw3vmx	96	8	observed	observe	VBN
cord-273505-pcsw3vmx	96	9	in	in	IN
cord-273505-pcsw3vmx	96	10	some	some	DT
cord-273505-pcsw3vmx	96	11	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	96	12	patients	patient	NNS
cord-273505-pcsw3vmx	96	13	(	(	-LRB-
cord-273505-pcsw3vmx	96	14	79	79	CD
cord-273505-pcsw3vmx	96	15	)	)	-RRB-
cord-273505-pcsw3vmx	96	16	.	.	.
cord-273505-pcsw3vmx	97	1	Direct	direct	JJ
cord-273505-pcsw3vmx	97	2	viral	viral	JJ
cord-273505-pcsw3vmx	97	3	infection	infection	NN
cord-273505-pcsw3vmx	97	4	of	of	IN
cord-273505-pcsw3vmx	97	5	the	the	DT
cord-273505-pcsw3vmx	97	6	endothelium	endothelium	NN
cord-273505-pcsw3vmx	97	7	may	may	MD
cord-273505-pcsw3vmx	97	8	result	result	VB
cord-273505-pcsw3vmx	97	9	in	in	IN
cord-273505-pcsw3vmx	97	10	extensive	extensive	JJ
cord-273505-pcsw3vmx	97	11	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	97	12	dysfunction	dysfunction	NN
cord-273505-pcsw3vmx	97	13	and	and	CC
cord-273505-pcsw3vmx	97	14	disseminated	disseminate	VBN
cord-273505-pcsw3vmx	97	15	intravascular	intravascular	JJ
cord-273505-pcsw3vmx	97	16	coagulation	coagulation	NN
cord-273505-pcsw3vmx	97	17	(	(	-LRB-
cord-273505-pcsw3vmx	97	18	17	17	CD
cord-273505-pcsw3vmx	97	19	,	,	,
cord-273505-pcsw3vmx	97	20	79	79	CD
cord-273505-pcsw3vmx	97	21	)	)	-RRB-
cord-273505-pcsw3vmx	97	22	.	.	.
cord-273505-pcsw3vmx	98	1	In	in	IN
cord-273505-pcsw3vmx	98	2	addition	addition	NN
cord-273505-pcsw3vmx	98	3	,	,	,
cord-273505-pcsw3vmx	98	4	abnormal	abnormal	JJ
cord-273505-pcsw3vmx	98	5	levels	level	NNS
cord-273505-pcsw3vmx	98	6	of	of	IN
cord-273505-pcsw3vmx	98	7	complement	complement	JJ
cord-273505-pcsw3vmx	98	8	factors	factor	NNS
cord-273505-pcsw3vmx	98	9	and	and	CC
cord-273505-pcsw3vmx	98	10	the	the	DT
cord-273505-pcsw3vmx	98	11	deposition	deposition	NN
cord-273505-pcsw3vmx	98	12	of	of	IN
cord-273505-pcsw3vmx	98	13	terminal	terminal	JJ
cord-273505-pcsw3vmx	98	14	complement	complement	NN
cord-273505-pcsw3vmx	98	15	complex	complex	NN
cord-273505-pcsw3vmx	98	16	also	also	RB
cord-273505-pcsw3vmx	98	17	suggested	suggest	VBD
cord-273505-pcsw3vmx	98	18	that	that	IN
cord-273505-pcsw3vmx	98	19	the	the	DT
cord-273505-pcsw3vmx	98	20	activation	activation	NN
cord-273505-pcsw3vmx	98	21	of	of	IN
cord-273505-pcsw3vmx	98	22	complement	complement	JJ
cord-273505-pcsw3vmx	98	23	pathways	pathway	NNS
cord-273505-pcsw3vmx	98	24	may	may	MD
cord-273505-pcsw3vmx	98	25	contribute	contribute	VB
cord-273505-pcsw3vmx	98	26	to	to	IN
cord-273505-pcsw3vmx	98	27	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	98	28	damage	damage	NN
cord-273505-pcsw3vmx	98	29	and	and	CC
cord-273505-pcsw3vmx	98	30	the	the	DT
cord-273505-pcsw3vmx	98	31	associated	associate	VBN
cord-273505-pcsw3vmx	98	32	pro	pro	JJ
cord-273505-pcsw3vmx	98	33	-	-	JJ
cord-273505-pcsw3vmx	98	34	coagulant	coagulant	JJ
cord-273505-pcsw3vmx	98	35	state	state	NN
cord-273505-pcsw3vmx	98	36	in	in	IN
cord-273505-pcsw3vmx	98	37	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	98	38	(	(	-LRB-
cord-273505-pcsw3vmx	98	39	80	80	CD
cord-273505-pcsw3vmx	98	40	,	,	,
cord-273505-pcsw3vmx	98	41	81	81	CD
cord-273505-pcsw3vmx	98	42	)	)	-RRB-
cord-273505-pcsw3vmx	98	43	.	.	.
cord-273505-pcsw3vmx	99	1	Although	although	IN
cord-273505-pcsw3vmx	99	2	vasculitis	vasculitis	NN
cord-273505-pcsw3vmx	99	3	and	and	CC
cord-273505-pcsw3vmx	99	4	autoantibodies	autoantibody	NNS
cord-273505-pcsw3vmx	99	5	against	against	IN
cord-273505-pcsw3vmx	99	6	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	99	7	cells	cell	NNS
cord-273505-pcsw3vmx	99	8	have	have	VBP
cord-273505-pcsw3vmx	99	9	been	be	VBN
cord-273505-pcsw3vmx	99	10	reported	report	VBN
cord-273505-pcsw3vmx	99	11	and	and	CC
cord-273505-pcsw3vmx	99	12	detected	detect	VBN
cord-273505-pcsw3vmx	99	13	in	in	IN
cord-273505-pcsw3vmx	99	14	SARS	SARS	NNP
cord-273505-pcsw3vmx	99	15	patients	patient	NNS
cord-273505-pcsw3vmx	99	16	,	,	,
cord-273505-pcsw3vmx	99	17	direct	direct	JJ
cord-273505-pcsw3vmx	99	18	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	99	19	cell	cell	NN
cord-273505-pcsw3vmx	99	20	infection	infection	NN
cord-273505-pcsw3vmx	99	21	has	have	VBZ
cord-273505-pcsw3vmx	99	22	n't	not	RB
cord-273505-pcsw3vmx	99	23	been	be	VBN
cord-273505-pcsw3vmx	99	24	demonstrated	demonstrate	VBN
cord-273505-pcsw3vmx	99	25	yet	yet	RB
cord-273505-pcsw3vmx	100	1	(	(	-LRB-
cord-273505-pcsw3vmx	100	2	82	82	CD
cord-273505-pcsw3vmx	100	3	)	)	-RRB-
cord-273505-pcsw3vmx	101	1	(	(	-LRB-
cord-273505-pcsw3vmx	101	2	83	83	CD
cord-273505-pcsw3vmx	101	3	)	)	-RRB-
cord-273505-pcsw3vmx	102	1	(	(	-LRB-
cord-273505-pcsw3vmx	102	2	84	84	CD
cord-273505-pcsw3vmx	102	3	)	)	-RRB-
cord-273505-pcsw3vmx	102	4	.	.	.
cord-273505-pcsw3vmx	103	1	These	these	DT
cord-273505-pcsw3vmx	103	2	differences	difference	NNS
cord-273505-pcsw3vmx	103	3	in	in	IN
cord-273505-pcsw3vmx	103	4	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	103	5	infections	infection	NNS
cord-273505-pcsw3vmx	103	6	may	may	MD
cord-273505-pcsw3vmx	103	7	contribute	contribute	VB
cord-273505-pcsw3vmx	103	8	to	to	IN
cord-273505-pcsw3vmx	103	9	the	the	DT
cord-273505-pcsw3vmx	103	10	different	different	JJ
cord-273505-pcsw3vmx	103	11	immunopathology	immunopathology	NN
cord-273505-pcsw3vmx	103	12	between	between	IN
cord-273505-pcsw3vmx	103	13	SARS	SARS	NNP
cord-273505-pcsw3vmx	103	14	-	-	HYPH
cord-273505-pcsw3vmx	103	15	CoV-1	CoV-1	NNP
cord-273505-pcsw3vmx	103	16	and	and	CC
cord-273505-pcsw3vmx	103	17	SARS	SARS	NNP
cord-273505-pcsw3vmx	103	18	-	-	HYPH
cord-273505-pcsw3vmx	103	19	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	103	20	.	.	.
cord-273505-pcsw3vmx	104	1	In	in	IN
cord-273505-pcsw3vmx	104	2	influenza	influenza	NN
cord-273505-pcsw3vmx	104	3	,	,	,
cord-273505-pcsw3vmx	104	4	the	the	DT
cord-273505-pcsw3vmx	104	5	central	central	JJ
cord-273505-pcsw3vmx	104	6	role	role	NN
cord-273505-pcsw3vmx	104	7	of	of	IN
cord-273505-pcsw3vmx	104	8	the	the	DT
cord-273505-pcsw3vmx	104	9	pulmonary	pulmonary	JJ
cord-273505-pcsw3vmx	104	10	endothelium	endothelium	NN
cord-273505-pcsw3vmx	104	11	for	for	IN
cord-273505-pcsw3vmx	104	12	the	the	DT
cord-273505-pcsw3vmx	104	13	regulation	regulation	NN
cord-273505-pcsw3vmx	104	14	of	of	IN
cord-273505-pcsw3vmx	104	15	innate	innate	JJ
cord-273505-pcsw3vmx	104	16	immune	immune	JJ
cord-273505-pcsw3vmx	104	17	cell	cell	NN
cord-273505-pcsw3vmx	104	18	recruitment	recruitment	NN
cord-273505-pcsw3vmx	104	19	into	into	IN
cord-273505-pcsw3vmx	104	20	the	the	DT
cord-273505-pcsw3vmx	104	21	lungs	lung	NNS
cord-273505-pcsw3vmx	104	22	,	,	,
cord-273505-pcsw3vmx	104	23	along	along	IN
cord-273505-pcsw3vmx	104	24	with	with	IN
cord-273505-pcsw3vmx	104	25	the	the	DT
cord-273505-pcsw3vmx	104	26	production	production	NN
cord-273505-pcsw3vmx	104	27	of	of	IN
cord-273505-pcsw3vmx	104	28	excessive	excessive	JJ
cord-273505-pcsw3vmx	104	29	pro	pro	JJ
cord-273505-pcsw3vmx	104	30	-	-	JJ
cord-273505-pcsw3vmx	104	31	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	104	32	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	104	33	and	and	CC
cord-273505-pcsw3vmx	104	34	chemokines	chemokine	NNS
cord-273505-pcsw3vmx	104	35	,	,	,
cord-273505-pcsw3vmx	104	36	has	have	VBZ
cord-273505-pcsw3vmx	104	37	been	be	VBN
cord-273505-pcsw3vmx	104	38	demonstrated	demonstrate	VBN
cord-273505-pcsw3vmx	104	39	(	(	-LRB-
cord-273505-pcsw3vmx	104	40	85	85	CD
cord-273505-pcsw3vmx	104	41	)	)	-RRB-
cord-273505-pcsw3vmx	104	42	(	(	-LRB-
cord-273505-pcsw3vmx	104	43	86	86	CD
cord-273505-pcsw3vmx	104	44	)	)	-RRB-
cord-273505-pcsw3vmx	104	45	(	(	-LRB-
cord-273505-pcsw3vmx	104	46	87	87	CD
cord-273505-pcsw3vmx	104	47	)	)	-RRB-
cord-273505-pcsw3vmx	104	48	.	.	.
cord-273505-pcsw3vmx	105	1	The	the	DT
cord-273505-pcsw3vmx	105	2	anti	anti	JJ
cord-273505-pcsw3vmx	105	3	-	-	JJ
cord-273505-pcsw3vmx	105	4	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	105	5	effect	effect	NN
cord-273505-pcsw3vmx	105	6	of	of	IN
cord-273505-pcsw3vmx	105	7	high	high	JJ
cord-273505-pcsw3vmx	105	8	-	-	HYPH
cord-273505-pcsw3vmx	105	9	dose	dose	NN
cord-273505-pcsw3vmx	105	10	IVIg	ivig	NN
cord-273505-pcsw3vmx	105	11	on	on	IN
cord-273505-pcsw3vmx	105	12	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	105	13	cells	cell	NNS
cord-273505-pcsw3vmx	105	14	is	be	VBZ
cord-273505-pcsw3vmx	105	15	mainly	mainly	RB
cord-273505-pcsw3vmx	105	16	inferred	infer	VBN
cord-273505-pcsw3vmx	105	17	from	from	IN
cord-273505-pcsw3vmx	105	18	in	in	IN
cord-273505-pcsw3vmx	105	19	vitro	vitro	FW
cord-273505-pcsw3vmx	105	20	observations	observation	NNS
cord-273505-pcsw3vmx	105	21	.	.	.
cord-273505-pcsw3vmx	106	1	High	high	JJ
cord-273505-pcsw3vmx	106	2	-	-	HYPH
cord-273505-pcsw3vmx	106	3	dose	dose	NN
cord-273505-pcsw3vmx	106	4	IgG	igg	NN
cord-273505-pcsw3vmx	106	5	has	have	VBZ
cord-273505-pcsw3vmx	106	6	been	be	VBN
cord-273505-pcsw3vmx	106	7	shown	show	VBN
cord-273505-pcsw3vmx	106	8	to	to	IN
cord-273505-pcsw3vmx	106	9	specifically	specifically	RB
cord-273505-pcsw3vmx	106	10	and	and	CC
cord-273505-pcsw3vmx	106	11	completely	completely	RB
cord-273505-pcsw3vmx	106	12	inhibit	inhibit	VB
cord-273505-pcsw3vmx	106	13	TNF	TNF	NNP
cord-273505-pcsw3vmx	106	14	-	-	HYPH
cord-273505-pcsw3vmx	106	15	αinduced	αinduce	VBN
cord-273505-pcsw3vmx	106	16	secretion	secretion	NN
cord-273505-pcsw3vmx	106	17	of	of	IN
cord-273505-pcsw3vmx	106	18	pro	pro	JJ
cord-273505-pcsw3vmx	106	19	-	-	JJ
cord-273505-pcsw3vmx	106	20	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	106	21	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	106	22	(	(	-LRB-
cord-273505-pcsw3vmx	106	23	e.g.	e.g.	RB
cord-273505-pcsw3vmx	106	24	,	,	,
cord-273505-pcsw3vmx	106	25	IL-6	IL-6	NNP
cord-273505-pcsw3vmx	106	26	,	,	,
cord-273505-pcsw3vmx	106	27	G	G	NNP
cord-273505-pcsw3vmx	106	28	-	-	HYPH
cord-273505-pcsw3vmx	106	29	CSF	CSF	NNP
cord-273505-pcsw3vmx	106	30	,	,	,
cord-273505-pcsw3vmx	106	31	and	and	CC
cord-273505-pcsw3vmx	106	32	IL-1β	IL-1β	NNP
cord-273505-pcsw3vmx	106	33	)	)	-RRB-
cord-273505-pcsw3vmx	106	34	and	and	CC
cord-273505-pcsw3vmx	106	35	production	production	NN
cord-273505-pcsw3vmx	106	36	of	of	IN
cord-273505-pcsw3vmx	106	37	E	e	NN
cord-273505-pcsw3vmx	106	38	-	-	NN
cord-273505-pcsw3vmx	106	39	selectin	selectin	NNP
cord-273505-pcsw3vmx	106	40	in	in	IN
cord-273505-pcsw3vmx	106	41	cultured	cultured	JJ
cord-273505-pcsw3vmx	106	42	human	human	JJ
cord-273505-pcsw3vmx	106	43	coronary	coronary	JJ
cord-273505-pcsw3vmx	106	44	artery	artery	NN
cord-273505-pcsw3vmx	106	45	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	106	46	cells	cell	NNS
cord-273505-pcsw3vmx	106	47	(	(	-LRB-
cord-273505-pcsw3vmx	106	48	88	88	CD
cord-273505-pcsw3vmx	106	49	,	,	,
cord-273505-pcsw3vmx	106	50	89	89	CD
cord-273505-pcsw3vmx	106	51	)	)	-RRB-
cord-273505-pcsw3vmx	106	52	.	.	.
cord-273505-pcsw3vmx	107	1	These	these	DT
cord-273505-pcsw3vmx	107	2	effects	effect	NNS
cord-273505-pcsw3vmx	107	3	may	may	MD
cord-273505-pcsw3vmx	107	4	predominantly	predominantly	RB
cord-273505-pcsw3vmx	107	5	be	be	VB
cord-273505-pcsw3vmx	107	6	mediated	mediate	VBN
cord-273505-pcsw3vmx	107	7	by	by	IN
cord-273505-pcsw3vmx	107	8	F(ab	f(ab	NN
cord-273505-pcsw3vmx	107	9	)	)	-RRB-
cord-273505-pcsw3vmx	107	10	′	′	CD
cord-273505-pcsw3vmx	107	11	2	2	CD
cord-273505-pcsw3vmx	107	12	-mediated	-mediated	JJ
cord-273505-pcsw3vmx	107	13	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	107	14	(	(	-LRB-
cord-273505-pcsw3vmx	107	15	88	88	CD
cord-273505-pcsw3vmx	107	16	,	,	,
cord-273505-pcsw3vmx	107	17	89	89	CD
cord-273505-pcsw3vmx	107	18	)	)	-RRB-
cord-273505-pcsw3vmx	107	19	.	.	.
cord-273505-pcsw3vmx	108	1	The	the	DT
cord-273505-pcsw3vmx	108	2	expression	expression	NN
cord-273505-pcsw3vmx	108	3	of	of	IN
cord-273505-pcsw3vmx	108	4	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	108	5	adhesion	adhesion	NN
cord-273505-pcsw3vmx	108	6	molecules	molecule	NNS
cord-273505-pcsw3vmx	108	7	is	be	VBZ
cord-273505-pcsw3vmx	108	8	also	also	RB
cord-273505-pcsw3vmx	108	9	reduced	reduce	VBN
cord-273505-pcsw3vmx	108	10	by	by	IN
cord-273505-pcsw3vmx	108	11	co	co	NN
cord-273505-pcsw3vmx	108	12	-	-	JJ
cord-273505-pcsw3vmx	108	13	culturing	culture	VBG
cord-273505-pcsw3vmx	108	14	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	108	15	cells	cell	NNS
cord-273505-pcsw3vmx	108	16	with	with	IN
cord-273505-pcsw3vmx	108	17	an	an	DT
cord-273505-pcsw3vmx	108	18	IVIg	ivig	JJ
cord-273505-pcsw3vmx	108	19	preparation	preparation	NN
cord-273505-pcsw3vmx	108	20	(	(	-LRB-
cord-273505-pcsw3vmx	108	21	90	90	CD
cord-273505-pcsw3vmx	108	22	)	)	-RRB-
cord-273505-pcsw3vmx	108	23	.	.	.
cord-273505-pcsw3vmx	109	1	Additionally	additionally	RB
cord-273505-pcsw3vmx	109	2	,	,	,
cord-273505-pcsw3vmx	109	3	the	the	DT
cord-273505-pcsw3vmx	109	4	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	109	5	effects	effect	NNS
cord-273505-pcsw3vmx	109	6	of	of	IN
cord-273505-pcsw3vmx	109	7	the	the	DT
cord-273505-pcsw3vmx	109	8	classical	classical	JJ
cord-273505-pcsw3vmx	109	9	complement	complement	NN
cord-273505-pcsw3vmx	109	10	pathway	pathway	NN
cord-273505-pcsw3vmx	109	11	by	by	IN
cord-273505-pcsw3vmx	109	12	high	high	JJ
cord-273505-pcsw3vmx	109	13	-	-	HYPH
cord-273505-pcsw3vmx	109	14	dose	dose	NN
cord-273505-pcsw3vmx	109	15	IVIg	ivig	NN
cord-273505-pcsw3vmx	109	16	may	may	MD
cord-273505-pcsw3vmx	109	17	offer	offer	VB
cord-273505-pcsw3vmx	109	18	a	a	DT
cord-273505-pcsw3vmx	109	19	potential	potential	JJ
cord-273505-pcsw3vmx	109	20	protective	protective	JJ
cord-273505-pcsw3vmx	109	21	effect	effect	NN
cord-273505-pcsw3vmx	109	22	on	on	IN
cord-273505-pcsw3vmx	109	23	virus	virus	NN
cord-273505-pcsw3vmx	109	24	-	-	HYPH
cord-273505-pcsw3vmx	109	25	induced	induce	VBN
cord-273505-pcsw3vmx	109	26	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	109	27	damage	damage	NN
cord-273505-pcsw3vmx	109	28	.	.	.
cord-273505-pcsw3vmx	110	1	Dendritic	dendritic	JJ
cord-273505-pcsw3vmx	110	2	cells	cell	NNS
cord-273505-pcsw3vmx	110	3	(	(	-LRB-
cord-273505-pcsw3vmx	110	4	DCs	DCs	NNP
cord-273505-pcsw3vmx	110	5	)	)	-RRB-
cord-273505-pcsw3vmx	110	6	are	be	VBP
cord-273505-pcsw3vmx	110	7	antigen	antigen	NN
cord-273505-pcsw3vmx	110	8	-	-	HYPH
cord-273505-pcsw3vmx	110	9	presenting	present	VBG
cord-273505-pcsw3vmx	110	10	cells	cell	NNS
cord-273505-pcsw3vmx	110	11	of	of	IN
cord-273505-pcsw3vmx	110	12	the	the	DT
cord-273505-pcsw3vmx	110	13	innate	innate	JJ
cord-273505-pcsw3vmx	110	14	immune	immune	JJ
cord-273505-pcsw3vmx	110	15	system	system	NN
cord-273505-pcsw3vmx	110	16	.	.	.
cord-273505-pcsw3vmx	111	1	Plasmacytoid	Plasmacytoid	NNP
cord-273505-pcsw3vmx	111	2	dendritic	dendritic	JJ
cord-273505-pcsw3vmx	111	3	cells	cell	NNS
cord-273505-pcsw3vmx	111	4	(	(	-LRB-
cord-273505-pcsw3vmx	111	5	pDCs	pDCs	NNP
cord-273505-pcsw3vmx	111	6	)	)	-RRB-
cord-273505-pcsw3vmx	111	7	are	be	VBP
cord-273505-pcsw3vmx	111	8	unique	unique	JJ
cord-273505-pcsw3vmx	111	9	sentinel	sentinel	JJ
cord-273505-pcsw3vmx	111	10	cells	cell	NNS
cord-273505-pcsw3vmx	111	11	that	that	WDT
cord-273505-pcsw3vmx	111	12	can	can	MD
cord-273505-pcsw3vmx	111	13	recognize	recognize	VB
cord-273505-pcsw3vmx	111	14	a	a	DT
cord-273505-pcsw3vmx	111	15	virus	virus	NN
cord-273505-pcsw3vmx	111	16	through	through	IN
cord-273505-pcsw3vmx	111	17	PRRs	prr	NNS
cord-273505-pcsw3vmx	111	18	,	,	,
cord-273505-pcsw3vmx	111	19	and	and	CC
cord-273505-pcsw3vmx	111	20	enhance	enhance	VB
cord-273505-pcsw3vmx	111	21	the	the	DT
cord-273505-pcsw3vmx	111	22	secretion	secretion	NN
cord-273505-pcsw3vmx	111	23	of	of	IN
cord-273505-pcsw3vmx	111	24	IFN	IFN	NNP
cord-273505-pcsw3vmx	111	25	(	(	-LRB-
cord-273505-pcsw3vmx	111	26	91	91	CD
cord-273505-pcsw3vmx	111	27	,	,	,
cord-273505-pcsw3vmx	111	28	92	92	CD
cord-273505-pcsw3vmx	111	29	)	)	-RRB-
cord-273505-pcsw3vmx	111	30	.	.	.
cord-273505-pcsw3vmx	112	1	Data	datum	NNS
cord-273505-pcsw3vmx	112	2	from	from	IN
cord-273505-pcsw3vmx	112	3	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	112	4	patients	patient	NNS
cord-273505-pcsw3vmx	112	5	and	and	CC
cord-273505-pcsw3vmx	112	6	a	a	DT
cord-273505-pcsw3vmx	112	7	ferret	ferret	JJ
cord-273505-pcsw3vmx	112	8	model	model	NN
cord-273505-pcsw3vmx	112	9	reveal	reveal	VB
cord-273505-pcsw3vmx	112	10	low	low	JJ
cord-273505-pcsw3vmx	112	11	levels	level	NNS
cord-273505-pcsw3vmx	112	12	of	of	IN
cord-273505-pcsw3vmx	112	13	IFN	IFN	NNP
cord-273505-pcsw3vmx	112	14	with	with	IN
cord-273505-pcsw3vmx	112	15	contrastingly	contrastingly	RB
cord-273505-pcsw3vmx	112	16	high	high	JJ
cord-273505-pcsw3vmx	112	17	levels	level	NNS
cord-273505-pcsw3vmx	112	18	of	of	IN
cord-273505-pcsw3vmx	112	19	IL-6	IL-6	NNP
cord-273505-pcsw3vmx	112	20	and	and	CC
cord-273505-pcsw3vmx	112	21	a	a	DT
cord-273505-pcsw3vmx	112	22	strong	strong	JJ
cord-273505-pcsw3vmx	112	23	chemokine	chemokine	NN
cord-273505-pcsw3vmx	112	24	response	response	NN
cord-273505-pcsw3vmx	112	25	,	,	,
cord-273505-pcsw3vmx	112	26	suggesting	suggest	VBG
cord-273505-pcsw3vmx	112	27	a	a	DT
cord-273505-pcsw3vmx	112	28	similar	similar	JJ
cord-273505-pcsw3vmx	112	29	hyper	hyper	JJ
cord-273505-pcsw3vmx	112	30	-	-	JJ
cord-273505-pcsw3vmx	112	31	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	112	32	response	response	NN
cord-273505-pcsw3vmx	112	33	pattern	pattern	NN
cord-273505-pcsw3vmx	112	34	to	to	IN
cord-273505-pcsw3vmx	112	35	SARS	SARS	NNP
cord-273505-pcsw3vmx	112	36	and	and	CC
cord-273505-pcsw3vmx	112	37	MERS	MERS	NNP
cord-273505-pcsw3vmx	112	38	(	(	-LRB-
cord-273505-pcsw3vmx	112	39	93	93	CD
cord-273505-pcsw3vmx	112	40	)	)	-RRB-
cord-273505-pcsw3vmx	112	41	.	.	.
cord-273505-pcsw3vmx	113	1	Several	several	JJ
cord-273505-pcsw3vmx	113	2	SARS	SARS	NNP
cord-273505-pcsw3vmx	113	3	-	-	HYPH
cord-273505-pcsw3vmx	113	4	CoV	CoV	NNP
cord-273505-pcsw3vmx	113	5	and	and	CC
cord-273505-pcsw3vmx	113	6	MERS	MERS	NNP
cord-273505-pcsw3vmx	113	7	-	-	HYPH
cord-273505-pcsw3vmx	113	8	CoV	cov	NN
cord-273505-pcsw3vmx	113	9	proteins	protein	NNS
cord-273505-pcsw3vmx	113	10	have	have	VBP
cord-273505-pcsw3vmx	113	11	been	be	VBN
cord-273505-pcsw3vmx	113	12	shown	show	VBN
cord-273505-pcsw3vmx	113	13	to	to	TO
cord-273505-pcsw3vmx	113	14	antagonize	antagonize	VB
cord-273505-pcsw3vmx	113	15	the	the	DT
cord-273505-pcsw3vmx	113	16	IFN	IFN	NNP
cord-273505-pcsw3vmx	113	17	response	response	NN
cord-273505-pcsw3vmx	113	18	in	in	IN
cord-273505-pcsw3vmx	113	19	order	order	NN
cord-273505-pcsw3vmx	113	20	to	to	TO
cord-273505-pcsw3vmx	113	21	reach	reach	VB
cord-273505-pcsw3vmx	113	22	high	high	JJ
cord-273505-pcsw3vmx	113	23	viral	viral	JJ
cord-273505-pcsw3vmx	113	24	titers	titer	NNS
cord-273505-pcsw3vmx	113	25	after	after	IN
cord-273505-pcsw3vmx	113	26	early	early	JJ
cord-273505-pcsw3vmx	113	27	infection	infection	NN
cord-273505-pcsw3vmx	113	28	(	(	-LRB-
cord-273505-pcsw3vmx	113	29	94	94	CD
cord-273505-pcsw3vmx	113	30	)	)	-RRB-
cord-273505-pcsw3vmx	113	31	(	(	-LRB-
cord-273505-pcsw3vmx	113	32	95	95	CD
cord-273505-pcsw3vmx	113	33	)	)	-RRB-
cord-273505-pcsw3vmx	114	1	(	(	-LRB-
cord-273505-pcsw3vmx	114	2	96	96	CD
cord-273505-pcsw3vmx	114	3	)	)	-RRB-
cord-273505-pcsw3vmx	114	4	(	(	-LRB-
cord-273505-pcsw3vmx	114	5	97	97	CD
cord-273505-pcsw3vmx	114	6	)	)	-RRB-
cord-273505-pcsw3vmx	114	7	(	(	-LRB-
cord-273505-pcsw3vmx	114	8	98	98	CD
cord-273505-pcsw3vmx	114	9	)	)	-RRB-
cord-273505-pcsw3vmx	114	10	.	.	.
cord-273505-pcsw3vmx	115	1	Delayed	delayed	JJ
cord-273505-pcsw3vmx	115	2	and	and	CC
cord-273505-pcsw3vmx	115	3	massive	massive	JJ
cord-273505-pcsw3vmx	115	4	IFN	IFN	NNP
cord-273505-pcsw3vmx	115	5	signaling	signaling	NN
cord-273505-pcsw3vmx	115	6	is	be	VBZ
cord-273505-pcsw3vmx	115	7	suggested	suggest	VBN
cord-273505-pcsw3vmx	115	8	to	to	TO
cord-273505-pcsw3vmx	115	9	further	further	RB
cord-273505-pcsw3vmx	115	10	orchestrate	orchestrate	VB
cord-273505-pcsw3vmx	115	11	extensive	extensive	JJ
cord-273505-pcsw3vmx	115	12	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	115	13	monocyte	monocyte	JJ
cord-273505-pcsw3vmx	115	14	-	-	HYPH
cord-273505-pcsw3vmx	115	15	macrophage	macrophage	NN
cord-273505-pcsw3vmx	115	16	responses	response	NNS
cord-273505-pcsw3vmx	115	17	and	and	CC
cord-273505-pcsw3vmx	115	18	induce	induce	VB
cord-273505-pcsw3vmx	115	19	T	T	NNP
cord-273505-pcsw3vmx	115	20	cell	cell	NN
cord-273505-pcsw3vmx	115	21	apoptosis	apoptosis	NN
cord-273505-pcsw3vmx	115	22	,	,	,
cord-273505-pcsw3vmx	115	23	resulting	result	VBG
cord-273505-pcsw3vmx	115	24	in	in	IN
cord-273505-pcsw3vmx	115	25	a	a	DT
cord-273505-pcsw3vmx	115	26	dysfunctional	dysfunctional	JJ
cord-273505-pcsw3vmx	115	27	immune	immune	JJ
cord-273505-pcsw3vmx	115	28	response	response	NN
cord-273505-pcsw3vmx	115	29	and	and	CC
cord-273505-pcsw3vmx	115	30	cytokine	cytokine	NN
cord-273505-pcsw3vmx	115	31	storm	storm	NN
cord-273505-pcsw3vmx	115	32	during	during	IN
cord-273505-pcsw3vmx	115	33	SARS	SARS	NNP
cord-273505-pcsw3vmx	115	34	-	-	HYPH
cord-273505-pcsw3vmx	115	35	CoV	CoV	NNP
cord-273505-pcsw3vmx	115	36	and	and	CC
cord-273505-pcsw3vmx	115	37	MERS	MERS	NNP
cord-273505-pcsw3vmx	115	38	-	-	HYPH
cord-273505-pcsw3vmx	115	39	CoV	CoV	NNP
cord-273505-pcsw3vmx	115	40	infection	infection	NN
cord-273505-pcsw3vmx	115	41	(	(	-LRB-
cord-273505-pcsw3vmx	115	42	99	99	CD
cord-273505-pcsw3vmx	115	43	)	)	-RRB-
cord-273505-pcsw3vmx	115	44	(	(	-LRB-
cord-273505-pcsw3vmx	115	45	100	100	CD
cord-273505-pcsw3vmx	115	46	)	)	-RRB-
cord-273505-pcsw3vmx	115	47	(	(	-LRB-
cord-273505-pcsw3vmx	115	48	101	101	CD
cord-273505-pcsw3vmx	115	49	)	)	-RRB-
cord-273505-pcsw3vmx	115	50	.	.	.
cord-273505-pcsw3vmx	116	1	The	the	DT
cord-273505-pcsw3vmx	116	2	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	116	3	effects	effect	NNS
cord-273505-pcsw3vmx	116	4	of	of	IN
cord-273505-pcsw3vmx	116	5	IVIg	ivig	NN
cord-273505-pcsw3vmx	116	6	on	on	IN
cord-273505-pcsw3vmx	116	7	DCs	dc	NNS
cord-273505-pcsw3vmx	116	8	differ	differ	VBP
cord-273505-pcsw3vmx	116	9	depending	depend	VBG
cord-273505-pcsw3vmx	116	10	on	on	IN
cord-273505-pcsw3vmx	116	11	dosage	dosage	NN
cord-273505-pcsw3vmx	116	12	.	.	.
cord-273505-pcsw3vmx	117	1	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	117	2	accelerates	accelerate	VBZ
cord-273505-pcsw3vmx	117	3	maturation	maturation	NN
cord-273505-pcsw3vmx	117	4	at	at	IN
cord-273505-pcsw3vmx	117	5	physiological	physiological	JJ
cord-273505-pcsw3vmx	117	6	doses	dose	NNS
cord-273505-pcsw3vmx	117	7	,	,	,
cord-273505-pcsw3vmx	117	8	but	but	CC
cord-273505-pcsw3vmx	117	9	inhibits	inhibit	VBZ
cord-273505-pcsw3vmx	117	10	the	the	DT
cord-273505-pcsw3vmx	117	11	maturation	maturation	NN
cord-273505-pcsw3vmx	117	12	,	,	,
cord-273505-pcsw3vmx	117	13	activation	activation	NN
cord-273505-pcsw3vmx	117	14	,	,	,
cord-273505-pcsw3vmx	117	15	and	and	CC
cord-273505-pcsw3vmx	117	16	function	function	VB
cord-273505-pcsw3vmx	117	17	at	at	IN
cord-273505-pcsw3vmx	117	18	therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	117	19	doses	dose	NNS
cord-273505-pcsw3vmx	117	20	(	(	-LRB-
cord-273505-pcsw3vmx	117	21	102	102	CD
cord-273505-pcsw3vmx	117	22	)	)	-RRB-
cord-273505-pcsw3vmx	117	23	.	.	.
cord-273505-pcsw3vmx	118	1	High	high	JJ
cord-273505-pcsw3vmx	118	2	-	-	HYPH
cord-273505-pcsw3vmx	118	3	doses	dose	NNS
cord-273505-pcsw3vmx	118	4	IVIg	ivig	VBP
cord-273505-pcsw3vmx	118	5	treated	treat	VBD
cord-273505-pcsw3vmx	118	6	immature	immature	JJ
cord-273505-pcsw3vmx	118	7	DCs	dc	NNS
cord-273505-pcsw3vmx	118	8	secrete	secrete	JJ
cord-273505-pcsw3vmx	118	9	increased	increase	VBN
cord-273505-pcsw3vmx	118	10	levels	level	NNS
cord-273505-pcsw3vmx	118	11	of	of	IN
cord-273505-pcsw3vmx	118	12	anti	anti	JJ
cord-273505-pcsw3vmx	118	13	-	-	JJ
cord-273505-pcsw3vmx	118	14	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	118	15	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	118	16	,	,	,
cord-273505-pcsw3vmx	118	17	and	and	CC
cord-273505-pcsw3vmx	118	18	decreased	decrease	VBD
cord-273505-pcsw3vmx	118	19	levels	level	NNS
cord-273505-pcsw3vmx	118	20	of	of	IN
cord-273505-pcsw3vmx	118	21	pro	pro	JJ
cord-273505-pcsw3vmx	118	22	-	-	JJ
cord-273505-pcsw3vmx	118	23	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	118	24	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	118	25	(	(	-LRB-
cord-273505-pcsw3vmx	118	26	103	103	CD
cord-273505-pcsw3vmx	118	27	)	)	-RRB-
cord-273505-pcsw3vmx	118	28	.	.	.
cord-273505-pcsw3vmx	119	1	C	c	NN
cord-273505-pcsw3vmx	119	2	-	-	HYPH
cord-273505-pcsw3vmx	119	3	type	type	NN
cord-273505-pcsw3vmx	119	4	lectins	lectin	NNS
cord-273505-pcsw3vmx	119	5	expressed	express	VBN
cord-273505-pcsw3vmx	119	6	on	on	IN
cord-273505-pcsw3vmx	119	7	DCs	dc	NNS
cord-273505-pcsw3vmx	119	8	are	be	VBP
cord-273505-pcsw3vmx	119	9	considered	consider	VBN
cord-273505-pcsw3vmx	119	10	as	as	IN
cord-273505-pcsw3vmx	119	11	possible	possible	JJ
cord-273505-pcsw3vmx	119	12	effector	effector	NN
cord-273505-pcsw3vmx	119	13	targets	target	NNS
cord-273505-pcsw3vmx	119	14	of	of	IN
cord-273505-pcsw3vmx	119	15	IVIg	ivig	JJ
cord-273505-pcsw3vmx	119	16	preparations	preparation	NNS
cord-273505-pcsw3vmx	119	17	,	,	,
cord-273505-pcsw3vmx	119	18	however	however	RB
cord-273505-pcsw3vmx	119	19	,	,	,
cord-273505-pcsw3vmx	119	20	the	the	DT
cord-273505-pcsw3vmx	119	21	exact	exact	JJ
cord-273505-pcsw3vmx	119	22	mechanism	mechanism	NN
cord-273505-pcsw3vmx	119	23	of	of	IN
cord-273505-pcsw3vmx	119	24	action	action	NN
cord-273505-pcsw3vmx	119	25	of	of	IN
cord-273505-pcsw3vmx	119	26	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	119	27	on	on	IN
cord-273505-pcsw3vmx	119	28	DCs	DCs	NNP
cord-273505-pcsw3vmx	119	29	remains	remain	VBZ
cord-273505-pcsw3vmx	119	30	controversial	controversial	JJ
cord-273505-pcsw3vmx	119	31	.	.	.
cord-273505-pcsw3vmx	120	1	As	as	IN
cord-273505-pcsw3vmx	120	2	stated	state	VBN
cord-273505-pcsw3vmx	120	3	,	,	,
cord-273505-pcsw3vmx	120	4	interactions	interaction	NNS
cord-273505-pcsw3vmx	120	5	between	between	IN
cord-273505-pcsw3vmx	120	6	Fc	Fc	NNP
cord-273505-pcsw3vmx	120	7	-	-	HYPH
cord-273505-pcsw3vmx	120	8	sialylated	sialylate	VBN
cord-273505-pcsw3vmx	120	9	IgG	IgG	NNP
cord-273505-pcsw3vmx	120	10	and	and	CC
cord-273505-pcsw3vmx	120	11	DC	DC	NNP
cord-273505-pcsw3vmx	120	12	-	-	HYPH
cord-273505-pcsw3vmx	120	13	SIGN	SIGN	NNP
cord-273505-pcsw3vmx	120	14	failed	fail	VBD
cord-273505-pcsw3vmx	120	15	to	to	TO
cord-273505-pcsw3vmx	120	16	reproduce	reproduce	VB
cord-273505-pcsw3vmx	120	17	in	in	IN
cord-273505-pcsw3vmx	120	18	human	human	JJ
cord-273505-pcsw3vmx	120	19	cells	cell	NNS
cord-273505-pcsw3vmx	120	20	,	,	,
cord-273505-pcsw3vmx	120	21	and	and	CC
cord-273505-pcsw3vmx	120	22	the	the	DT
cord-273505-pcsw3vmx	120	23	expression	expression	NN
cord-273505-pcsw3vmx	120	24	of	of	IN
cord-273505-pcsw3vmx	120	25	FcγRIIB	FcγRIIB	NNP
cord-273505-pcsw3vmx	120	26	remains	remain	VBZ
cord-273505-pcsw3vmx	120	27	stable	stable	JJ
cord-273505-pcsw3vmx	120	28	on	on	IN
cord-273505-pcsw3vmx	120	29	DCs	dc	NNS
cord-273505-pcsw3vmx	120	30	after	after	IN
cord-273505-pcsw3vmx	120	31	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	120	32	treatment	treatment	NN
cord-273505-pcsw3vmx	120	33	(	(	-LRB-
cord-273505-pcsw3vmx	120	34	104	104	CD
cord-273505-pcsw3vmx	120	35	)	)	-RRB-
cord-273505-pcsw3vmx	120	36	.	.	.
cord-273505-pcsw3vmx	121	1	Another	another	DT
cord-273505-pcsw3vmx	121	2	C	c	NN
cord-273505-pcsw3vmx	121	3	-	-	HYPH
cord-273505-pcsw3vmx	121	4	type	type	NN
cord-273505-pcsw3vmx	121	5	lectin	lectin	NN
cord-273505-pcsw3vmx	121	6	,	,	,
cord-273505-pcsw3vmx	121	7	DRIC	DRIC	NNP
cord-273505-pcsw3vmx	121	8	,	,	,
cord-273505-pcsw3vmx	121	9	has	have	VBZ
cord-273505-pcsw3vmx	121	10	also	also	RB
cord-273505-pcsw3vmx	121	11	been	be	VBN
cord-273505-pcsw3vmx	121	12	identified	identify	VBN
cord-273505-pcsw3vmx	121	13	to	to	TO
cord-273505-pcsw3vmx	121	14	bind	bind	VB
cord-273505-pcsw3vmx	121	15	to	to	IN
cord-273505-pcsw3vmx	121	16	Fc	Fc	NNP
cord-273505-pcsw3vmx	121	17	-	-	HYPH
cord-273505-pcsw3vmx	121	18	sialylated	sialylate	VBN
cord-273505-pcsw3vmx	121	19	IgG	igg	NN
cord-273505-pcsw3vmx	121	20	and	and	CC
cord-273505-pcsw3vmx	121	21	further	further	RB
cord-273505-pcsw3vmx	121	22	mediates	mediate	VBZ
cord-273505-pcsw3vmx	121	23	the	the	DT
cord-273505-pcsw3vmx	121	24	induction	induction	NN
cord-273505-pcsw3vmx	121	25	of	of	IN
cord-273505-pcsw3vmx	121	26	Treg	Treg	NNP
cord-273505-pcsw3vmx	121	27	cells	cell	NNS
cord-273505-pcsw3vmx	121	28	in	in	IN
cord-273505-pcsw3vmx	121	29	a	a	DT
cord-273505-pcsw3vmx	121	30	mouse	mouse	NN
cord-273505-pcsw3vmx	121	31	model	model	NN
cord-273505-pcsw3vmx	121	32	(	(	-LRB-
cord-273505-pcsw3vmx	121	33	105	105	CD
cord-273505-pcsw3vmx	121	34	)	)	-RRB-
cord-273505-pcsw3vmx	121	35	.	.	.
cord-273505-pcsw3vmx	122	1	Additionally	additionally	RB
cord-273505-pcsw3vmx	122	2	,	,	,
cord-273505-pcsw3vmx	122	3	an	an	DT
cord-273505-pcsw3vmx	122	4	increased	increase	VBN
cord-273505-pcsw3vmx	122	5	accumulation	accumulation	NN
cord-273505-pcsw3vmx	122	6	of	of	IN
cord-273505-pcsw3vmx	122	7	lipids	lipid	NNS
cord-273505-pcsw3vmx	122	8	and	and	CC
cord-273505-pcsw3vmx	122	9	decreased	decrease	VBD
cord-273505-pcsw3vmx	122	10	expression	expression	NN
cord-273505-pcsw3vmx	122	11	of	of	IN
cord-273505-pcsw3vmx	122	12	MHC	MHC	NNP
cord-273505-pcsw3vmx	122	13	-	-	HYPH
cord-273505-pcsw3vmx	122	14	II	II	NNP
cord-273505-pcsw3vmx	122	15	,	,	,
cord-273505-pcsw3vmx	122	16	CD40	CD40	NNP
cord-273505-pcsw3vmx	122	17	,	,	,
cord-273505-pcsw3vmx	122	18	CD80	CD80	NNP
cord-273505-pcsw3vmx	122	19	/	/	SYM
cord-273505-pcsw3vmx	122	20	CD86	CD86	NNP
cord-273505-pcsw3vmx	122	21	,	,	,
cord-273505-pcsw3vmx	122	22	and	and	CC
cord-273505-pcsw3vmx	122	23	IFN	IFN	NNP
cord-273505-pcsw3vmx	122	24	-	-	HYPH
cord-273505-pcsw3vmx	122	25	γR2	γR2	NNP
cord-273505-pcsw3vmx	122	26	on	on	IN
cord-273505-pcsw3vmx	122	27	DCs	dc	NNS
cord-273505-pcsw3vmx	122	28	upon	upon	IN
cord-273505-pcsw3vmx	122	29	high	high	JJ
cord-273505-pcsw3vmx	122	30	-	-	HYPH
cord-273505-pcsw3vmx	122	31	doses	dose	NNS
cord-273505-pcsw3vmx	122	32	IVIg	ivig	NN
cord-273505-pcsw3vmx	122	33	treatment	treatment	NN
cord-273505-pcsw3vmx	122	34	might	may	MD
cord-273505-pcsw3vmx	122	35	suppress	suppress	VB
cord-273505-pcsw3vmx	122	36	antigen	antigen	NN
cord-273505-pcsw3vmx	122	37	presentation	presentation	NN
cord-273505-pcsw3vmx	122	38	and	and	CC
cord-273505-pcsw3vmx	122	39	allogeneic	allogeneic	IN
cord-273505-pcsw3vmx	122	40	T	t	NN
cord-273505-pcsw3vmx	122	41	-	-	HYPH
cord-273505-pcsw3vmx	122	42	cell	cell	NN
cord-273505-pcsw3vmx	122	43	stimulatory	stimulatory	JJ
cord-273505-pcsw3vmx	122	44	capacity	capacity	NN
cord-273505-pcsw3vmx	122	45	,	,	,
cord-273505-pcsw3vmx	122	46	contributing	contribute	VBG
cord-273505-pcsw3vmx	122	47	to	to	IN
cord-273505-pcsw3vmx	122	48	a	a	DT
cord-273505-pcsw3vmx	122	49	negative	negative	JJ
cord-273505-pcsw3vmx	122	50	regulation	regulation	NN
cord-273505-pcsw3vmx	122	51	of	of	IN
cord-273505-pcsw3vmx	122	52	the	the	DT
cord-273505-pcsw3vmx	122	53	immune	immune	JJ
cord-273505-pcsw3vmx	122	54	response	response	NN
cord-273505-pcsw3vmx	122	55	(	(	-LRB-
cord-273505-pcsw3vmx	122	56	104	104	CD
cord-273505-pcsw3vmx	122	57	,	,	,
cord-273505-pcsw3vmx	122	58	106	106	CD
cord-273505-pcsw3vmx	122	59	,	,	,
cord-273505-pcsw3vmx	122	60	107	107	CD
cord-273505-pcsw3vmx	122	61	)	)	-RRB-
cord-273505-pcsw3vmx	122	62	.	.	.
cord-273505-pcsw3vmx	123	1	Whether	whether	IN
cord-273505-pcsw3vmx	123	2	infiltrating	infiltrate	VBG
cord-273505-pcsw3vmx	123	3	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	123	4	monocyte	monocyte	NN
cord-273505-pcsw3vmx	123	5	-	-	HYPH
cord-273505-pcsw3vmx	123	6	macrophages	macrophage	NNS
cord-273505-pcsw3vmx	123	7	(	(	-LRB-
cord-273505-pcsw3vmx	123	8	IMM	IMM	NNP
cord-273505-pcsw3vmx	123	9	)	)	-RRB-
cord-273505-pcsw3vmx	123	10	are	be	VBP
cord-273505-pcsw3vmx	123	11	beneficial	beneficial	JJ
cord-273505-pcsw3vmx	123	12	or	or	CC
cord-273505-pcsw3vmx	123	13	deleterious	deleterious	JJ
cord-273505-pcsw3vmx	123	14	after	after	IN
cord-273505-pcsw3vmx	123	15	a	a	DT
cord-273505-pcsw3vmx	123	16	viral	viral	JJ
cord-273505-pcsw3vmx	123	17	infection	infection	NN
cord-273505-pcsw3vmx	123	18	is	be	VBZ
cord-273505-pcsw3vmx	123	19	mainly	mainly	RB
cord-273505-pcsw3vmx	123	20	dependent	dependent	JJ
cord-273505-pcsw3vmx	123	21	on	on	IN
cord-273505-pcsw3vmx	123	22	their	-PRON-	PRP$
cord-273505-pcsw3vmx	123	23	ability	ability	NN
cord-273505-pcsw3vmx	123	24	to	to	TO
cord-273505-pcsw3vmx	123	25	secrete	secrete	VB
cord-273505-pcsw3vmx	123	26	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	123	27	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	123	28	and	and	CC
cord-273505-pcsw3vmx	123	29	chemokines	chemokine	NNS
cord-273505-pcsw3vmx	123	30	.	.	.
cord-273505-pcsw3vmx	124	1	A	a	DT
cord-273505-pcsw3vmx	124	2	dysregulated	dysregulated	JJ
cord-273505-pcsw3vmx	124	3	cytokine	cytokine	NN
cord-273505-pcsw3vmx	124	4	response	response	NN
cord-273505-pcsw3vmx	124	5	can	can	MD
cord-273505-pcsw3vmx	124	6	also	also	RB
cord-273505-pcsw3vmx	124	7	promote	promote	VB
cord-273505-pcsw3vmx	124	8	excessive	excessive	JJ
cord-273505-pcsw3vmx	124	9	activation	activation	NN
cord-273505-pcsw3vmx	124	10	of	of	IN
cord-273505-pcsw3vmx	124	11	IMM	IMM	NNP
cord-273505-pcsw3vmx	124	12	,	,	,
cord-273505-pcsw3vmx	124	13	leading	lead	VBG
cord-273505-pcsw3vmx	124	14	to	to	IN
cord-273505-pcsw3vmx	124	15	immunopathological	immunopathological	JJ
cord-273505-pcsw3vmx	124	16	effects	effect	NNS
cord-273505-pcsw3vmx	124	17	on	on	IN
cord-273505-pcsw3vmx	124	18	healthy	healthy	JJ
cord-273505-pcsw3vmx	124	19	tissues	tissue	NNS
cord-273505-pcsw3vmx	124	20	.	.	.
cord-273505-pcsw3vmx	125	1	Macrophage	macrophage	NN
cord-273505-pcsw3vmx	125	2	activation	activation	NN
cord-273505-pcsw3vmx	125	3	syndrome	syndrome	NN
cord-273505-pcsw3vmx	125	4	(	(	-LRB-
cord-273505-pcsw3vmx	125	5	MAS	MAS	NNP
cord-273505-pcsw3vmx	125	6	)	)	-RRB-
cord-273505-pcsw3vmx	125	7	was	be	VBD
cord-273505-pcsw3vmx	125	8	reported	report	VBN
cord-273505-pcsw3vmx	125	9	in	in	IN
cord-273505-pcsw3vmx	125	10	several	several	JJ
cord-273505-pcsw3vmx	125	11	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	125	12	patients	patient	NNS
cord-273505-pcsw3vmx	125	13	with	with	IN
cord-273505-pcsw3vmx	125	14	severe	severe	JJ
cord-273505-pcsw3vmx	125	15	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	125	16	failure	failure	NN
cord-273505-pcsw3vmx	125	17	,	,	,
cord-273505-pcsw3vmx	125	18	and	and	CC
cord-273505-pcsw3vmx	125	19	the	the	DT
cord-273505-pcsw3vmx	125	20	production	production	NN
cord-273505-pcsw3vmx	125	21	of	of	IN
cord-273505-pcsw3vmx	125	22	associated	associated	JJ
cord-273505-pcsw3vmx	125	23	pro	pro	JJ
cord-273505-pcsw3vmx	125	24	-	-	JJ
cord-273505-pcsw3vmx	125	25	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	125	26	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	125	27	(	(	-LRB-
cord-273505-pcsw3vmx	125	28	IL-6	IL-6	NNP
cord-273505-pcsw3vmx	125	29	and	and	CC
cord-273505-pcsw3vmx	125	30	TNFα	TNFα	NNP
cord-273505-pcsw3vmx	125	31	)	)	-RRB-
cord-273505-pcsw3vmx	125	32	might	may	MD
cord-273505-pcsw3vmx	125	33	contribute	contribute	VB
cord-273505-pcsw3vmx	125	34	to	to	IN
cord-273505-pcsw3vmx	125	35	hyper	hyper	JJ
cord-273505-pcsw3vmx	125	36	-	-	JJ
cord-273505-pcsw3vmx	125	37	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	125	38	conditions	condition	NNS
cord-273505-pcsw3vmx	125	39	(	(	-LRB-
cord-273505-pcsw3vmx	125	40	108	108	CD
cord-273505-pcsw3vmx	125	41	)	)	-RRB-
cord-273505-pcsw3vmx	125	42	.	.	.
cord-273505-pcsw3vmx	126	1	It	-PRON-	PRP
cord-273505-pcsw3vmx	126	2	was	be	VBD
cord-273505-pcsw3vmx	126	3	also	also	RB
cord-273505-pcsw3vmx	126	4	detected	detect	VBN
cord-273505-pcsw3vmx	126	5	that	that	IN
cord-273505-pcsw3vmx	126	6	SARS	SARS	NNP
cord-273505-pcsw3vmx	126	7	-	-	HYPH
cord-273505-pcsw3vmx	126	8	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	126	9	infects	infect	VBZ
cord-273505-pcsw3vmx	126	10	macrophages	macrophage	NNS
cord-273505-pcsw3vmx	126	11	and	and	CC
cord-273505-pcsw3vmx	126	12	triggers	trigger	VBZ
cord-273505-pcsw3vmx	126	13	secretion	secretion	NN
cord-273505-pcsw3vmx	126	14	of	of	IN
cord-273505-pcsw3vmx	126	15	IL-6	IL-6	NNP
cord-273505-pcsw3vmx	126	16	,	,	,
cord-273505-pcsw3vmx	126	17	which	which	WDT
cord-273505-pcsw3vmx	126	18	might	may	MD
cord-273505-pcsw3vmx	126	19	contribute	contribute	VB
cord-273505-pcsw3vmx	126	20	to	to	IN
cord-273505-pcsw3vmx	126	21	lymphocyte	lymphocyte	NN
cord-273505-pcsw3vmx	126	22	apoptosis	apoptosis	NN
cord-273505-pcsw3vmx	126	23	,	,	,
cord-273505-pcsw3vmx	126	24	suggesting	suggest	VBG
cord-273505-pcsw3vmx	126	25	an	an	DT
cord-273505-pcsw3vmx	126	26	excessive	excessive	JJ
cord-273505-pcsw3vmx	126	27	infiltration	infiltration	NN
cord-273505-pcsw3vmx	126	28	and	and	CC
cord-273505-pcsw3vmx	126	29	intense	intense	JJ
cord-273505-pcsw3vmx	126	30	pro	pro	JJ
cord-273505-pcsw3vmx	126	31	-	-	JJ
cord-273505-pcsw3vmx	126	32	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	126	33	activity	activity	NN
cord-273505-pcsw3vmx	126	34	of	of	IN
cord-273505-pcsw3vmx	126	35	IMM	IMM	NNP
cord-273505-pcsw3vmx	126	36	in	in	IN
cord-273505-pcsw3vmx	126	37	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	126	38	patients	patient	NNS
cord-273505-pcsw3vmx	126	39	(	(	-LRB-
cord-273505-pcsw3vmx	126	40	109	109	CD
cord-273505-pcsw3vmx	126	41	)	)	-RRB-
cord-273505-pcsw3vmx	126	42	.	.	.
cord-273505-pcsw3vmx	127	1	Increased	increase	VBN
cord-273505-pcsw3vmx	127	2	pathogenic	pathogenic	JJ
cord-273505-pcsw3vmx	127	3	IMM	IMM	NNP
cord-273505-pcsw3vmx	127	4	influx	influx	NN
cord-273505-pcsw3vmx	127	5	has	have	VBZ
cord-273505-pcsw3vmx	127	6	been	be	VBN
cord-273505-pcsw3vmx	127	7	consistently	consistently	RB
cord-273505-pcsw3vmx	127	8	observed	observe	VBN
cord-273505-pcsw3vmx	127	9	in	in	IN
cord-273505-pcsw3vmx	127	10	severe	severe	JJ
cord-273505-pcsw3vmx	127	11	or	or	CC
cord-273505-pcsw3vmx	127	12	lethal	lethal	JJ
cord-273505-pcsw3vmx	127	13	SARS	SARS	NNP
cord-273505-pcsw3vmx	127	14	patients	patient	NNS
cord-273505-pcsw3vmx	127	15	,	,	,
cord-273505-pcsw3vmx	127	16	along	along	IN
cord-273505-pcsw3vmx	127	17	with	with	IN
cord-273505-pcsw3vmx	127	18	mice	mouse	NNS
cord-273505-pcsw3vmx	127	19	and	and	CC
cord-273505-pcsw3vmx	127	20	Chinese	chinese	JJ
cord-273505-pcsw3vmx	127	21	rhesus	rhesu	NNS
cord-273505-pcsw3vmx	127	22	macaque	macaque	NN
cord-273505-pcsw3vmx	127	23	models	model	NNS
cord-273505-pcsw3vmx	127	24	(	(	-LRB-
cord-273505-pcsw3vmx	127	25	101	101	CD
cord-273505-pcsw3vmx	127	26	,	,	,
cord-273505-pcsw3vmx	127	27	110	110	CD
cord-273505-pcsw3vmx	127	28	)	)	-RRB-
cord-273505-pcsw3vmx	127	29	.	.	.
cord-273505-pcsw3vmx	128	1	The	the	DT
cord-273505-pcsw3vmx	128	2	activation	activation	NN
cord-273505-pcsw3vmx	128	3	of	of	IN
cord-273505-pcsw3vmx	128	4	macrophages	macrophage	NNS
cord-273505-pcsw3vmx	128	5	by	by	IN
cord-273505-pcsw3vmx	128	6	SARS	SARS	NNP
cord-273505-pcsw3vmx	128	7	-	-	HYPH
cord-273505-pcsw3vmx	128	8	CoV	CoV	NNP
cord-273505-pcsw3vmx	128	9	occurs	occur	VBZ
cord-273505-pcsw3vmx	128	10	by	by	IN
cord-273505-pcsw3vmx	128	11	TLR2	TLR2	NNP
cord-273505-pcsw3vmx	128	12	ligand	ligand	NN
cord-273505-pcsw3vmx	128	13	recognition	recognition	NN
cord-273505-pcsw3vmx	128	14	,	,	,
cord-273505-pcsw3vmx	128	15	subsequent	subsequent	JJ
cord-273505-pcsw3vmx	128	16	activation	activation	NN
cord-273505-pcsw3vmx	128	17	of	of	IN
cord-273505-pcsw3vmx	128	18	the	the	DT
cord-273505-pcsw3vmx	128	19	NF	nf	NN
cord-273505-pcsw3vmx	128	20	-	-	HYPH
cord-273505-pcsw3vmx	128	21	κB	κB	NNP
cord-273505-pcsw3vmx	128	22	pathway	pathway	NN
cord-273505-pcsw3vmx	128	23	and	and	CC
cord-273505-pcsw3vmx	128	24	secretion	secretion	NN
cord-273505-pcsw3vmx	128	25	of	of	IN
cord-273505-pcsw3vmx	128	26	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	128	27	,	,	,
cord-273505-pcsw3vmx	128	28	contributing	contribute	VBG
cord-273505-pcsw3vmx	128	29	to	to	IN
cord-273505-pcsw3vmx	128	30	the	the	DT
cord-273505-pcsw3vmx	128	31	immunopathology	immunopathology	NN
cord-273505-pcsw3vmx	128	32	of	of	IN
cord-273505-pcsw3vmx	128	33	SARS	SARS	NNP
cord-273505-pcsw3vmx	128	34	(	(	-LRB-
cord-273505-pcsw3vmx	128	35	111	111	CD
cord-273505-pcsw3vmx	128	36	)	)	-RRB-
cord-273505-pcsw3vmx	128	37	(	(	-LRB-
cord-273505-pcsw3vmx	128	38	112	112	CD
cord-273505-pcsw3vmx	128	39	)	)	-RRB-
cord-273505-pcsw3vmx	128	40	(	(	-LRB-
cord-273505-pcsw3vmx	128	41	113	113	CD
cord-273505-pcsw3vmx	128	42	)	)	-RRB-
cord-273505-pcsw3vmx	128	43	.	.	.
cord-273505-pcsw3vmx	129	1	High	high	JJ
cord-273505-pcsw3vmx	129	2	-	-	HYPH
cord-273505-pcsw3vmx	129	3	dose	dose	NN
cord-273505-pcsw3vmx	129	4	IVIg	ivig	NN
cord-273505-pcsw3vmx	129	5	therapy	therapy	NN
cord-273505-pcsw3vmx	129	6	is	be	VBZ
cord-273505-pcsw3vmx	129	7	widely	widely	RB
cord-273505-pcsw3vmx	129	8	used	use	VBN
cord-273505-pcsw3vmx	129	9	for	for	IN
cord-273505-pcsw3vmx	129	10	treatment	treatment	NN
cord-273505-pcsw3vmx	129	11	of	of	IN
cord-273505-pcsw3vmx	129	12	patients	patient	NNS
cord-273505-pcsw3vmx	129	13	with	with	IN
cord-273505-pcsw3vmx	129	14	autoimmune	autoimmune	JJ
cord-273505-pcsw3vmx	129	15	diseases	disease	NNS
cord-273505-pcsw3vmx	129	16	complicated	complicate	VBN
cord-273505-pcsw3vmx	129	17	by	by	IN
cord-273505-pcsw3vmx	129	18	MAS	MAS	NNP
cord-273505-pcsw3vmx	129	19	(	(	-LRB-
cord-273505-pcsw3vmx	129	20	114	114	CD
cord-273505-pcsw3vmx	129	21	)	)	-RRB-
cord-273505-pcsw3vmx	129	22	(	(	-LRB-
cord-273505-pcsw3vmx	129	23	115	115	CD
cord-273505-pcsw3vmx	129	24	)	)	-RRB-
cord-273505-pcsw3vmx	129	25	(	(	-LRB-
cord-273505-pcsw3vmx	129	26	116	116	CD
cord-273505-pcsw3vmx	129	27	)	)	-RRB-
cord-273505-pcsw3vmx	129	28	(	(	-LRB-
cord-273505-pcsw3vmx	129	29	117	117	CD
cord-273505-pcsw3vmx	129	30	)	)	-RRB-
cord-273505-pcsw3vmx	129	31	(	(	-LRB-
cord-273505-pcsw3vmx	129	32	118	118	CD
cord-273505-pcsw3vmx	129	33	)	)	-RRB-
cord-273505-pcsw3vmx	129	34	.	.	.
cord-273505-pcsw3vmx	130	1	For	for	IN
cord-273505-pcsw3vmx	130	2	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	130	3	effects	effect	NNS
cord-273505-pcsw3vmx	130	4	of	of	IN
cord-273505-pcsw3vmx	130	5	IVIgs	IVIgs	NNP
cord-273505-pcsw3vmx	130	6	,	,	,
cord-273505-pcsw3vmx	130	7	functionally	functionally	RB
cord-273505-pcsw3vmx	130	8	activating	activate	VBG
cord-273505-pcsw3vmx	130	9	FcγRs	FcγRs	NNP
cord-273505-pcsw3vmx	130	10	are	be	VBP
cord-273505-pcsw3vmx	130	11	required	require	VBN
cord-273505-pcsw3vmx	130	12	to	to	TO
cord-273505-pcsw3vmx	130	13	acquire	acquire	VB
cord-273505-pcsw3vmx	130	14	a	a	DT
cord-273505-pcsw3vmx	130	15	cross	cross	JJ
cord-273505-pcsw3vmx	130	16	-	-	JJ
cord-273505-pcsw3vmx	130	17	tolerant	tolerant	JJ
cord-273505-pcsw3vmx	130	18	state	state	NN
cord-273505-pcsw3vmx	130	19	of	of	IN
cord-273505-pcsw3vmx	130	20	mouse	mouse	NN
cord-273505-pcsw3vmx	130	21	macrophages	macrophage	NNS
cord-273505-pcsw3vmx	130	22	(	(	-LRB-
cord-273505-pcsw3vmx	130	23	119	119	CD
cord-273505-pcsw3vmx	130	24	)	)	-RRB-
cord-273505-pcsw3vmx	130	25	.	.	.
cord-273505-pcsw3vmx	131	1	In	in	IN
cord-273505-pcsw3vmx	131	2	vitro	vitro	FW
cord-273505-pcsw3vmx	131	3	,	,	,
cord-273505-pcsw3vmx	131	4	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	131	5	inhibits	inhibit	VBZ
cord-273505-pcsw3vmx	131	6	the	the	DT
cord-273505-pcsw3vmx	131	7	production	production	NN
cord-273505-pcsw3vmx	131	8	of	of	IN
cord-273505-pcsw3vmx	131	9	pro	pro	JJ
cord-273505-pcsw3vmx	131	10	-	-	JJ
cord-273505-pcsw3vmx	131	11	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	131	12	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	131	13	by	by	IN
cord-273505-pcsw3vmx	131	14	M1	M1	NNP
cord-273505-pcsw3vmx	131	15	macrophages	macrophage	NNS
cord-273505-pcsw3vmx	131	16	and	and	CC
cord-273505-pcsw3vmx	131	17	triggers	trigger	VBZ
cord-273505-pcsw3vmx	131	18	macrophage	macrophage	NN
cord-273505-pcsw3vmx	131	19	polarization	polarization	NN
cord-273505-pcsw3vmx	131	20	via	via	IN
cord-273505-pcsw3vmx	131	21	FcγRIIImediated	fcγriiimediated	JJ
cord-273505-pcsw3vmx	131	22	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	131	23	(	(	-LRB-
cord-273505-pcsw3vmx	131	24	120	120	CD
cord-273505-pcsw3vmx	131	25	)	)	-RRB-
cord-273505-pcsw3vmx	131	26	.	.	.
cord-273505-pcsw3vmx	132	1	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	132	2	limits	limit	VBZ
cord-273505-pcsw3vmx	132	3	the	the	DT
cord-273505-pcsw3vmx	132	4	differentiation	differentiation	NN
cord-273505-pcsw3vmx	132	5	of	of	IN
cord-273505-pcsw3vmx	132	6	macrophages	macrophage	NNS
cord-273505-pcsw3vmx	132	7	through	through	IN
cord-273505-pcsw3vmx	132	8	inhibition	inhibition	NN
cord-273505-pcsw3vmx	132	9	of	of	IN
cord-273505-pcsw3vmx	132	10	GM	GM	NNP
cord-273505-pcsw3vmx	132	11	-	-	HYPH
cord-273505-pcsw3vmx	132	12	CSF	csf	NN
cord-273505-pcsw3vmx	132	13	-	-	HYPH
cord-273505-pcsw3vmx	132	14	driven	drive	VBN
cord-273505-pcsw3vmx	132	15	STAT5	stat5	NN
cord-273505-pcsw3vmx	132	16	activation	activation	NN
cord-273505-pcsw3vmx	132	17	by	by	IN
cord-273505-pcsw3vmx	132	18	FcγR	fcγr	JJ
cord-273505-pcsw3vmx	132	19	-	-	HYPH
cord-273505-pcsw3vmx	132	20	dependent	dependent	JJ
cord-273505-pcsw3vmx	132	21	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	132	22	(	(	-LRB-
cord-273505-pcsw3vmx	132	23	119	119	CD
cord-273505-pcsw3vmx	132	24	)	)	-RRB-
cord-273505-pcsw3vmx	132	25	.	.	.
cord-273505-pcsw3vmx	133	1	An	an	DT
cord-273505-pcsw3vmx	133	2	increased	increase	VBN
cord-273505-pcsw3vmx	133	3	production	production	NN
cord-273505-pcsw3vmx	133	4	of	of	IN
cord-273505-pcsw3vmx	133	5	anti	anti	JJ
cord-273505-pcsw3vmx	133	6	-	-	JJ
cord-273505-pcsw3vmx	133	7	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	133	8	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	133	9	of	of	IN
cord-273505-pcsw3vmx	133	10	LPS	LPS	NNP
cord-273505-pcsw3vmx	133	11	-	-	HYPH
cord-273505-pcsw3vmx	133	12	stimulated	stimulate	VBN
cord-273505-pcsw3vmx	133	13	monocytes	monocyte	NNS
cord-273505-pcsw3vmx	133	14	(	(	-LRB-
cord-273505-pcsw3vmx	133	15	especially	especially	RB
cord-273505-pcsw3vmx	133	16	IL-10	IL-10	NNP
cord-273505-pcsw3vmx	133	17	)	)	-RRB-
cord-273505-pcsw3vmx	133	18	is	be	VBZ
cord-273505-pcsw3vmx	133	19	further	further	RB
cord-273505-pcsw3vmx	133	20	enhanced	enhance	VBN
cord-273505-pcsw3vmx	133	21	by	by	IN
cord-273505-pcsw3vmx	133	22	IVIg	IVIg	VBN
cord-273505-pcsw3vmx	133	23	through	through	IN
cord-273505-pcsw3vmx	133	24	phosphorylation	phosphorylation	NN
cord-273505-pcsw3vmx	133	25	of	of	IN
cord-273505-pcsw3vmx	133	26	ERK1	ERK1	NNP
cord-273505-pcsw3vmx	133	27	/	/	SYM
cord-273505-pcsw3vmx	133	28	ERK2	ERK2	NNP
cord-273505-pcsw3vmx	133	29	and	and	CC
cord-273505-pcsw3vmx	133	30	P38	P38	NNP
cord-273505-pcsw3vmx	133	31	/	/	SYM
cord-273505-pcsw3vmx	133	32	MAPK	MAPK	NNP
cord-273505-pcsw3vmx	133	33	via	via	IN
cord-273505-pcsw3vmx	133	34	FcγRIIA	fcγriia	NN
cord-273505-pcsw3vmx	133	35	-	-	HYPH
cord-273505-pcsw3vmx	133	36	mediated	mediate	VBN
cord-273505-pcsw3vmx	133	37	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	133	38	(	(	-LRB-
cord-273505-pcsw3vmx	133	39	121	121	CD
cord-273505-pcsw3vmx	133	40	)	)	-RRB-
cord-273505-pcsw3vmx	133	41	.	.	.
cord-273505-pcsw3vmx	134	1	Neutrophils	neutrophil	NNS
cord-273505-pcsw3vmx	134	2	are	be	VBP
cord-273505-pcsw3vmx	134	3	the	the	DT
cord-273505-pcsw3vmx	134	4	most	most	RBS
cord-273505-pcsw3vmx	134	5	abundant	abundant	JJ
cord-273505-pcsw3vmx	134	6	type	type	NN
cord-273505-pcsw3vmx	134	7	of	of	IN
cord-273505-pcsw3vmx	134	8	granulocytes	granulocyte	NNS
cord-273505-pcsw3vmx	134	9	in	in	IN
cord-273505-pcsw3vmx	134	10	peripheral	peripheral	JJ
cord-273505-pcsw3vmx	134	11	blood	blood	NN
cord-273505-pcsw3vmx	134	12	and	and	CC
cord-273505-pcsw3vmx	134	13	constitute	constitute	VB
cord-273505-pcsw3vmx	134	14	an	an	DT
cord-273505-pcsw3vmx	134	15	essential	essential	JJ
cord-273505-pcsw3vmx	134	16	part	part	NN
cord-273505-pcsw3vmx	134	17	of	of	IN
cord-273505-pcsw3vmx	134	18	innate	innate	JJ
cord-273505-pcsw3vmx	134	19	immunity	immunity	NN
cord-273505-pcsw3vmx	134	20	.	.	.
cord-273505-pcsw3vmx	135	1	The	the	DT
cord-273505-pcsw3vmx	135	2	release	release	NN
cord-273505-pcsw3vmx	135	3	of	of	IN
cord-273505-pcsw3vmx	135	4	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	135	5	,	,	,
cord-273505-pcsw3vmx	135	6	nitric	nitric	NN
cord-273505-pcsw3vmx	135	7	oxide	oxide	NN
cord-273505-pcsw3vmx	135	8	,	,	,
cord-273505-pcsw3vmx	135	9	reactive	reactive	JJ
cord-273505-pcsw3vmx	135	10	oxygen	oxygen	NN
cord-273505-pcsw3vmx	135	11	species	specie	NNS
cord-273505-pcsw3vmx	135	12	(	(	-LRB-
cord-273505-pcsw3vmx	135	13	ROS	ROS	NNP
cord-273505-pcsw3vmx	135	14	)	)	-RRB-
cord-273505-pcsw3vmx	135	15	,	,	,
cord-273505-pcsw3vmx	135	16	and	and	CC
cord-273505-pcsw3vmx	135	17	neutrophil	neutrophil	NN
cord-273505-pcsw3vmx	135	18	extracellular	extracellular	JJ
cord-273505-pcsw3vmx	135	19	traps	trap	NNS
cord-273505-pcsw3vmx	135	20	(	(	-LRB-
cord-273505-pcsw3vmx	135	21	NET	net	NN
cord-273505-pcsw3vmx	135	22	)	)	-RRB-
cord-273505-pcsw3vmx	135	23	by	by	IN
cord-273505-pcsw3vmx	135	24	neutrophils	neutrophil	NNS
cord-273505-pcsw3vmx	135	25	can	can	MD
cord-273505-pcsw3vmx	135	26	help	help	VB
cord-273505-pcsw3vmx	135	27	to	to	TO
cord-273505-pcsw3vmx	135	28	neutralize	neutralize	VB
cord-273505-pcsw3vmx	135	29	pathogens	pathogen	NNS
cord-273505-pcsw3vmx	135	30	.	.	.
cord-273505-pcsw3vmx	136	1	Paradoxically	paradoxically	RB
cord-273505-pcsw3vmx	136	2	,	,	,
cord-273505-pcsw3vmx	136	3	however	however	RB
cord-273505-pcsw3vmx	136	4	,	,	,
cord-273505-pcsw3vmx	136	5	neutrophil	neutrophil	NN
cord-273505-pcsw3vmx	136	6	reactivity	reactivity	NN
cord-273505-pcsw3vmx	136	7	can	can	MD
cord-273505-pcsw3vmx	136	8	also	also	RB
cord-273505-pcsw3vmx	136	9	enhance	enhance	VB
cord-273505-pcsw3vmx	136	10	tissue	tissue	NN
cord-273505-pcsw3vmx	136	11	damage	damage	NN
cord-273505-pcsw3vmx	136	12	in	in	IN
cord-273505-pcsw3vmx	136	13	hyper	hyper	JJ
cord-273505-pcsw3vmx	136	14	-	-	JJ
cord-273505-pcsw3vmx	136	15	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	136	16	conditions	condition	NNS
cord-273505-pcsw3vmx	136	17	such	such	JJ
cord-273505-pcsw3vmx	136	18	as	as	IN
cord-273505-pcsw3vmx	136	19	severe	severe	JJ
cord-273505-pcsw3vmx	136	20	virus	virus	NN
cord-273505-pcsw3vmx	136	21	infection	infection	NN
cord-273505-pcsw3vmx	136	22	.	.	.
cord-273505-pcsw3vmx	137	1	Excessive	excessive	JJ
cord-273505-pcsw3vmx	137	2	neutrophils	neutrophil	NNS
cord-273505-pcsw3vmx	137	3	and	and	CC
cord-273505-pcsw3vmx	137	4	NET	net	NN
cord-273505-pcsw3vmx	137	5	production	production	NN
cord-273505-pcsw3vmx	137	6	are	be	VBP
cord-273505-pcsw3vmx	137	7	considered	consider	VBN
cord-273505-pcsw3vmx	137	8	a	a	DT
cord-273505-pcsw3vmx	137	9	potential	potential	JJ
cord-273505-pcsw3vmx	137	10	predictor	predictor	NN
cord-273505-pcsw3vmx	137	11	of	of	IN
cord-273505-pcsw3vmx	137	12	prognosis	prognosis	NN
cord-273505-pcsw3vmx	137	13	in	in	IN
cord-273505-pcsw3vmx	137	14	influenza	influenza	NN
cord-273505-pcsw3vmx	137	15	(	(	-LRB-
cord-273505-pcsw3vmx	137	16	122	122	CD
cord-273505-pcsw3vmx	137	17	,	,	,
cord-273505-pcsw3vmx	137	18	123	123	CD
cord-273505-pcsw3vmx	137	19	)	)	-RRB-
cord-273505-pcsw3vmx	137	20	.	.	.
cord-273505-pcsw3vmx	138	1	Similarly	similarly	RB
cord-273505-pcsw3vmx	138	2	,	,	,
cord-273505-pcsw3vmx	138	3	it	-PRON-	PRP
cord-273505-pcsw3vmx	138	4	has	have	VBZ
cord-273505-pcsw3vmx	138	5	been	be	VBN
cord-273505-pcsw3vmx	138	6	considered	consider	VBN
cord-273505-pcsw3vmx	138	7	that	that	IN
cord-273505-pcsw3vmx	138	8	neutrophils	neutrophil	NNS
cord-273505-pcsw3vmx	138	9	in	in	IN
cord-273505-pcsw3vmx	138	10	SARS	SARS	NNP
cord-273505-pcsw3vmx	138	11	-	-	HYPH
cord-273505-pcsw3vmx	138	12	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	138	13	may	may	MD
cord-273505-pcsw3vmx	138	14	induce	induce	VB
cord-273505-pcsw3vmx	138	15	NETs	net	NNS
cord-273505-pcsw3vmx	138	16	and	and	CC
cord-273505-pcsw3vmx	138	17	contribute	contribute	VB
cord-273505-pcsw3vmx	138	18	to	to	IN
cord-273505-pcsw3vmx	138	19	organ	organ	NN
cord-273505-pcsw3vmx	138	20	damage	damage	NN
cord-273505-pcsw3vmx	138	21	(	(	-LRB-
cord-273505-pcsw3vmx	138	22	124	124	CD
cord-273505-pcsw3vmx	138	23	,	,	,
cord-273505-pcsw3vmx	138	24	125	125	CD
cord-273505-pcsw3vmx	138	25	)	)	-RRB-
cord-273505-pcsw3vmx	138	26	.	.	.
cord-273505-pcsw3vmx	139	1	High	high	JJ
cord-273505-pcsw3vmx	139	2	levels	level	NNS
cord-273505-pcsw3vmx	139	3	of	of	IN
cord-273505-pcsw3vmx	139	4	NET	net	JJ
cord-273505-pcsw3vmx	139	5	biomarkers	biomarker	NNS
cord-273505-pcsw3vmx	139	6	(	(	-LRB-
cord-273505-pcsw3vmx	139	7	e.g.	e.g.	RB
cord-273505-pcsw3vmx	139	8	,	,	,
cord-273505-pcsw3vmx	139	9	cell	cell	NN
cord-273505-pcsw3vmx	139	10	-	-	HYPH
cord-273505-pcsw3vmx	139	11	free	free	JJ
cord-273505-pcsw3vmx	139	12	DNA	dna	NN
cord-273505-pcsw3vmx	139	13	,	,	,
cord-273505-pcsw3vmx	139	14	myeloperoxidase	myeloperoxidase	NN
cord-273505-pcsw3vmx	139	15	-	-	HYPH
cord-273505-pcsw3vmx	139	16	DNA	dna	NN
cord-273505-pcsw3vmx	139	17	,	,	,
cord-273505-pcsw3vmx	139	18	and	and	CC
cord-273505-pcsw3vmx	139	19	citrullinated	citrullinate	VBD
cord-273505-pcsw3vmx	139	20	histone	histone	NN
cord-273505-pcsw3vmx	139	21	H3	H3	NNP
cord-273505-pcsw3vmx	139	22	)	)	-RRB-
cord-273505-pcsw3vmx	139	23	are	be	VBP
cord-273505-pcsw3vmx	139	24	detected	detect	VBN
cord-273505-pcsw3vmx	139	25	in	in	IN
cord-273505-pcsw3vmx	139	26	severe	severe	JJ
cord-273505-pcsw3vmx	139	27	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	139	28	patients	patient	NNS
cord-273505-pcsw3vmx	139	29	and	and	CC
cord-273505-pcsw3vmx	139	30	may	may	MD
cord-273505-pcsw3vmx	139	31	contribute	contribute	VB
cord-273505-pcsw3vmx	139	32	to	to	IN
cord-273505-pcsw3vmx	139	33	cytokine	cytokine	JJ
cord-273505-pcsw3vmx	139	34	storm	storm	NN
cord-273505-pcsw3vmx	139	35	and	and	CC
cord-273505-pcsw3vmx	139	36	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	139	37	failure	failure	NN
cord-273505-pcsw3vmx	139	38	(	(	-LRB-
cord-273505-pcsw3vmx	139	39	125	125	CD
cord-273505-pcsw3vmx	139	40	)	)	-RRB-
cord-273505-pcsw3vmx	139	41	.	.	.
cord-273505-pcsw3vmx	140	1	Both	both	DT
cord-273505-pcsw3vmx	140	2	Fc	Fc	NNP
cord-273505-pcsw3vmx	140	3	and	and	CC
cord-273505-pcsw3vmx	140	4	F(ab	f(ab	NN
cord-273505-pcsw3vmx	140	5	)	)	-RRB-
cord-273505-pcsw3vmx	141	1	′	′	CD
cord-273505-pcsw3vmx	141	2	2	2	CD
cord-273505-pcsw3vmx	141	3	fragments	fragment	NNS
cord-273505-pcsw3vmx	141	4	account	account	VBP
cord-273505-pcsw3vmx	141	5	for	for	IN
cord-273505-pcsw3vmx	141	6	the	the	DT
cord-273505-pcsw3vmx	141	7	antiinflammatory	antiinflammatory	JJ
cord-273505-pcsw3vmx	141	8	activity	activity	NN
cord-273505-pcsw3vmx	141	9	on	on	IN
cord-273505-pcsw3vmx	141	10	neutrophils	neutrophil	NNS
cord-273505-pcsw3vmx	141	11	.	.	.
cord-273505-pcsw3vmx	142	1	In	in	IN
cord-273505-pcsw3vmx	142	2	patients	patient	NNS
cord-273505-pcsw3vmx	142	3	with	with	IN
cord-273505-pcsw3vmx	142	4	Kawasaki	Kawasaki	NNP
cord-273505-pcsw3vmx	142	5	disease	disease	NN
cord-273505-pcsw3vmx	142	6	,	,	,
cord-273505-pcsw3vmx	142	7	IVIg	ivig	JJ
cord-273505-pcsw3vmx	142	8	therapy	therapy	NN
cord-273505-pcsw3vmx	142	9	reduces	reduce	VBZ
cord-273505-pcsw3vmx	142	10	the	the	DT
cord-273505-pcsw3vmx	142	11	activation	activation	NN
cord-273505-pcsw3vmx	142	12	and	and	CC
cord-273505-pcsw3vmx	142	13	nitric	nitric	NN
cord-273505-pcsw3vmx	142	14	oxide	oxide	NN
cord-273505-pcsw3vmx	142	15	production	production	NN
cord-273505-pcsw3vmx	142	16	of	of	IN
cord-273505-pcsw3vmx	142	17	neutrophils	neutrophil	NNS
cord-273505-pcsw3vmx	142	18	(	(	-LRB-
cord-273505-pcsw3vmx	142	19	126	126	CD
cord-273505-pcsw3vmx	142	20	)	)	-RRB-
cord-273505-pcsw3vmx	142	21	.	.	.
cord-273505-pcsw3vmx	143	1	In	in	IN
cord-273505-pcsw3vmx	143	2	vivo	vivo	NNP
cord-273505-pcsw3vmx	143	3	studies	study	NNS
cord-273505-pcsw3vmx	143	4	revealed	reveal	VBD
cord-273505-pcsw3vmx	143	5	that	that	IN
cord-273505-pcsw3vmx	143	6	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	143	7	inhibits	inhibit	VBZ
cord-273505-pcsw3vmx	143	8	neutrophil	neutrophil	NN
cord-273505-pcsw3vmx	143	9	recruitment	recruitment	NN
cord-273505-pcsw3vmx	143	10	and	and	CC
cord-273505-pcsw3vmx	143	11	activation	activation	NN
cord-273505-pcsw3vmx	143	12	through	through	IN
cord-273505-pcsw3vmx	143	13	the	the	DT
cord-273505-pcsw3vmx	143	14	activation	activation	NN
cord-273505-pcsw3vmx	143	15	of	of	IN
cord-273505-pcsw3vmx	143	16	SHP-1	SHP-1	NNP
cord-273505-pcsw3vmx	143	17	via	via	IN
cord-273505-pcsw3vmx	143	18	FcγRIII	fcγriii	NN
cord-273505-pcsw3vmx	143	19	-	-	HYPH
cord-273505-pcsw3vmx	143	20	mediated	mediate	VBN
cord-273505-pcsw3vmx	143	21	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	143	22	(	(	-LRB-
cord-273505-pcsw3vmx	143	23	127	127	CD
cord-273505-pcsw3vmx	143	24	)	)	-RRB-
cord-273505-pcsw3vmx	143	25	.	.	.
cord-273505-pcsw3vmx	144	1	Furthermore	furthermore	RB
cord-273505-pcsw3vmx	144	2	,	,	,
cord-273505-pcsw3vmx	144	3	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	144	4	contains	contain	VBZ
cord-273505-pcsw3vmx	144	5	anti	anti	JJ
cord-273505-pcsw3vmx	144	6	-	-	JJ
cord-273505-pcsw3vmx	144	7	Siglec	Siglec	NNP
cord-273505-pcsw3vmx	144	8	autoantibodies	autoantibody	NNS
cord-273505-pcsw3vmx	144	9	that	that	WDT
cord-273505-pcsw3vmx	144	10	can	can	MD
cord-273505-pcsw3vmx	144	11	regulate	regulate	VB
cord-273505-pcsw3vmx	144	12	neutrophil	neutrophil	NN
cord-273505-pcsw3vmx	144	13	apoptosis	apoptosis	NN
cord-273505-pcsw3vmx	144	14	in	in	IN
cord-273505-pcsw3vmx	144	15	a	a	DT
cord-273505-pcsw3vmx	144	16	dose	dose	NN
cord-273505-pcsw3vmx	144	17	-	-	HYPH
cord-273505-pcsw3vmx	144	18	dependent	dependent	JJ
cord-273505-pcsw3vmx	144	19	cytotoxic	cytotoxic	JJ
cord-273505-pcsw3vmx	144	20	manner	manner	NN
cord-273505-pcsw3vmx	144	21	via	via	IN
cord-273505-pcsw3vmx	144	22	F(ab	f(ab	NN
cord-273505-pcsw3vmx	144	23	)	)	-RRB-
cord-273505-pcsw3vmx	144	24	′	′	CD
cord-273505-pcsw3vmx	144	25	2	2	CD
cord-273505-pcsw3vmx	144	26	-mediated	-mediated	JJ
cord-273505-pcsw3vmx	144	27	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	144	28	(	(	-LRB-
cord-273505-pcsw3vmx	144	29	33	33	CD
cord-273505-pcsw3vmx	144	30	,	,	,
cord-273505-pcsw3vmx	144	31	128	128	CD
cord-273505-pcsw3vmx	144	32	,	,	,
cord-273505-pcsw3vmx	144	33	129	129	CD
cord-273505-pcsw3vmx	144	34	)	)	-RRB-
cord-273505-pcsw3vmx	144	35	.	.	.
cord-273505-pcsw3vmx	145	1	Interestingly	interestingly	RB
cord-273505-pcsw3vmx	145	2	,	,	,
cord-273505-pcsw3vmx	145	3	high	high	JJ
cord-273505-pcsw3vmx	145	4	-	-	HYPH
cord-273505-pcsw3vmx	145	5	dose	dose	NN
cord-273505-pcsw3vmx	145	6	sulfo	sulfo	NN
cord-273505-pcsw3vmx	145	7	-	-	HYPH
cord-273505-pcsw3vmx	145	8	IVIg	ivig	JJ
cord-273505-pcsw3vmx	145	9	preparations	preparation	NNS
cord-273505-pcsw3vmx	145	10	significantly	significantly	RB
cord-273505-pcsw3vmx	145	11	reduce	reduce	VBP
cord-273505-pcsw3vmx	145	12	NET	net	NN
cord-273505-pcsw3vmx	145	13	formation	formation	NN
cord-273505-pcsw3vmx	145	14	in	in	IN
cord-273505-pcsw3vmx	145	15	vitro	vitro	FW
cord-273505-pcsw3vmx	145	16	as	as	RB
cord-273505-pcsw3vmx	145	17	well	well	RB
cord-273505-pcsw3vmx	145	18	as	as	IN
cord-273505-pcsw3vmx	145	19	in	in	IN
cord-273505-pcsw3vmx	145	20	rat	rat	NN
cord-273505-pcsw3vmx	145	21	models	model	NNS
cord-273505-pcsw3vmx	145	22	(	(	-LRB-
cord-273505-pcsw3vmx	145	23	130	130	CD
cord-273505-pcsw3vmx	145	24	)	)	-RRB-
cord-273505-pcsw3vmx	145	25	.	.	.
cord-273505-pcsw3vmx	146	1	Natural	natural	JJ
cord-273505-pcsw3vmx	146	2	killer	killer	NN
cord-273505-pcsw3vmx	146	3	(	(	-LRB-
cord-273505-pcsw3vmx	146	4	NK	NK	NNP
cord-273505-pcsw3vmx	146	5	)	)	-RRB-
cord-273505-pcsw3vmx	146	6	cells	cell	NNS
cord-273505-pcsw3vmx	146	7	are	be	VBP
cord-273505-pcsw3vmx	146	8	innate	innate	JJ
cord-273505-pcsw3vmx	146	9	lymphocytes	lymphocyte	NNS
cord-273505-pcsw3vmx	146	10	that	that	WDT
cord-273505-pcsw3vmx	146	11	play	play	VBP
cord-273505-pcsw3vmx	146	12	an	an	DT
cord-273505-pcsw3vmx	146	13	essential	essential	JJ
cord-273505-pcsw3vmx	146	14	role	role	NN
cord-273505-pcsw3vmx	146	15	in	in	IN
cord-273505-pcsw3vmx	146	16	the	the	DT
cord-273505-pcsw3vmx	146	17	control	control	NN
cord-273505-pcsw3vmx	146	18	of	of	IN
cord-273505-pcsw3vmx	146	19	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	146	20	viral	viral	JJ
cord-273505-pcsw3vmx	146	21	infections	infection	NNS
cord-273505-pcsw3vmx	146	22	.	.	.
cord-273505-pcsw3vmx	147	1	Within	within	IN
cord-273505-pcsw3vmx	147	2	days	day	NNS
cord-273505-pcsw3vmx	147	3	after	after	IN
cord-273505-pcsw3vmx	147	4	a	a	DT
cord-273505-pcsw3vmx	147	5	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	147	6	viral	viral	JJ
cord-273505-pcsw3vmx	147	7	infection	infection	NN
cord-273505-pcsw3vmx	147	8	,	,	,
cord-273505-pcsw3vmx	147	9	NK	NK	NNP
cord-273505-pcsw3vmx	147	10	cells	cell	NNS
cord-273505-pcsw3vmx	147	11	are	be	VBP
cord-273505-pcsw3vmx	147	12	activated	activate	VBN
cord-273505-pcsw3vmx	147	13	,	,	,
cord-273505-pcsw3vmx	147	14	recruited	recruit	VBN
cord-273505-pcsw3vmx	147	15	to	to	IN
cord-273505-pcsw3vmx	147	16	the	the	DT
cord-273505-pcsw3vmx	147	17	lung	lung	NN
cord-273505-pcsw3vmx	147	18	,	,	,
cord-273505-pcsw3vmx	147	19	and	and	CC
cord-273505-pcsw3vmx	147	20	act	act	VB
cord-273505-pcsw3vmx	147	21	as	as	IN
cord-273505-pcsw3vmx	147	22	effector	effector	NN
cord-273505-pcsw3vmx	147	23	cells	cell	NNS
cord-273505-pcsw3vmx	147	24	in	in	IN
cord-273505-pcsw3vmx	147	25	a	a	DT
cord-273505-pcsw3vmx	147	26	classical	classical	JJ
cord-273505-pcsw3vmx	147	27	FcγR	fcγr	NN
cord-273505-pcsw3vmx	147	28	-	-	HYPH
cord-273505-pcsw3vmx	147	29	mediated	mediate	VBN
cord-273505-pcsw3vmx	147	30	function	function	NN
cord-273505-pcsw3vmx	147	31	,	,	,
cord-273505-pcsw3vmx	147	32	namely	namely	RB
cord-273505-pcsw3vmx	147	33	antibody	antibody	NN
cord-273505-pcsw3vmx	147	34	-	-	HYPH
cord-273505-pcsw3vmx	147	35	dependent	dependent	JJ
cord-273505-pcsw3vmx	147	36	cytotoxicity	cytotoxicity	NN
cord-273505-pcsw3vmx	147	37	(	(	-LRB-
cord-273505-pcsw3vmx	147	38	ADCC	ADCC	NNP
cord-273505-pcsw3vmx	147	39	)	)	-RRB-
cord-273505-pcsw3vmx	147	40	.	.	.
cord-273505-pcsw3vmx	148	1	However	however	RB
cord-273505-pcsw3vmx	148	2	,	,	,
cord-273505-pcsw3vmx	148	3	a	a	DT
cord-273505-pcsw3vmx	148	4	dysfunction	dysfunction	NN
cord-273505-pcsw3vmx	148	5	of	of	IN
cord-273505-pcsw3vmx	148	6	NK	NK	NNP
cord-273505-pcsw3vmx	148	7	cells	cell	NNS
cord-273505-pcsw3vmx	148	8	may	may	MD
cord-273505-pcsw3vmx	148	9	also	also	RB
cord-273505-pcsw3vmx	148	10	be	be	VB
cord-273505-pcsw3vmx	148	11	responsible	responsible	JJ
cord-273505-pcsw3vmx	148	12	for	for	IN
cord-273505-pcsw3vmx	148	13	immunopathogenesis	immunopathogenesis	NN
cord-273505-pcsw3vmx	148	14	during	during	IN
cord-273505-pcsw3vmx	148	15	infection	infection	NN
cord-273505-pcsw3vmx	148	16	.	.	.
cord-273505-pcsw3vmx	149	1	Increased	increase	VBN
cord-273505-pcsw3vmx	149	2	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	149	3	receptor	receptor	NN
cord-273505-pcsw3vmx	149	4	NKG2A	nkg2a	CD
cord-273505-pcsw3vmx	149	5	expression	expression	NN
cord-273505-pcsw3vmx	149	6	on	on	IN
cord-273505-pcsw3vmx	149	7	NK	NK	NNP
cord-273505-pcsw3vmx	149	8	cells	cell	NNS
cord-273505-pcsw3vmx	149	9	and	and	CC
cord-273505-pcsw3vmx	149	10	reduced	reduce	VBN
cord-273505-pcsw3vmx	149	11	production	production	NN
cord-273505-pcsw3vmx	149	12	of	of	IN
cord-273505-pcsw3vmx	149	13	CD107a	CD107a	NNP
cord-273505-pcsw3vmx	149	14	,	,	,
cord-273505-pcsw3vmx	149	15	IFN	IFN	NNP
cord-273505-pcsw3vmx	149	16	-	-	HYPH
cord-273505-pcsw3vmx	149	17	γ	γ	NNP
cord-273505-pcsw3vmx	149	18	,	,	,
cord-273505-pcsw3vmx	149	19	IL-2	IL-2	NNP
cord-273505-pcsw3vmx	149	20	,	,	,
cord-273505-pcsw3vmx	149	21	and	and	CC
cord-273505-pcsw3vmx	149	22	TNF	TNF	NNP
cord-273505-pcsw3vmx	149	23	-	-	HYPH
cord-273505-pcsw3vmx	149	24	α	α	NNP
cord-273505-pcsw3vmx	149	25	,	,	,
cord-273505-pcsw3vmx	149	26	indicate	indicate	VBP
cord-273505-pcsw3vmx	149	27	a	a	DT
cord-273505-pcsw3vmx	149	28	functional	functional	JJ
cord-273505-pcsw3vmx	149	29	exhaustion	exhaustion	NN
cord-273505-pcsw3vmx	149	30	of	of	IN
cord-273505-pcsw3vmx	149	31	NK	NK	NNP
cord-273505-pcsw3vmx	149	32	cells	cell	NNS
cord-273505-pcsw3vmx	149	33	during	during	IN
cord-273505-pcsw3vmx	149	34	SARS	SARS	NNP
cord-273505-pcsw3vmx	149	35	-	-	HYPH
cord-273505-pcsw3vmx	149	36	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	149	37	infection	infection	NN
cord-273505-pcsw3vmx	149	38	,	,	,
cord-273505-pcsw3vmx	149	39	similar	similar	JJ
cord-273505-pcsw3vmx	149	40	to	to	IN
cord-273505-pcsw3vmx	149	41	that	that	DT
cord-273505-pcsw3vmx	149	42	observed	observe	VBN
cord-273505-pcsw3vmx	149	43	in	in	IN
cord-273505-pcsw3vmx	149	44	SARS	SARS	NNP
cord-273505-pcsw3vmx	149	45	(	(	-LRB-
cord-273505-pcsw3vmx	149	46	131	131	CD
cord-273505-pcsw3vmx	149	47	)	)	-RRB-
cord-273505-pcsw3vmx	149	48	.	.	.
cord-273505-pcsw3vmx	150	1	In	in	IN
cord-273505-pcsw3vmx	150	2	patients	patient	NNS
cord-273505-pcsw3vmx	150	3	with	with	IN
cord-273505-pcsw3vmx	150	4	severe	severe	JJ
cord-273505-pcsw3vmx	150	5	SARS	SARS	NNP
cord-273505-pcsw3vmx	150	6	,	,	,
cord-273505-pcsw3vmx	150	7	the	the	DT
cord-273505-pcsw3vmx	150	8	number	number	NN
cord-273505-pcsw3vmx	150	9	of	of	IN
cord-273505-pcsw3vmx	150	10	NK	NK	NNP
cord-273505-pcsw3vmx	150	11	cells	cell	NNS
cord-273505-pcsw3vmx	150	12	and	and	CC
cord-273505-pcsw3vmx	150	13	levels	level	NNS
cord-273505-pcsw3vmx	150	14	of	of	IN
cord-273505-pcsw3vmx	150	15	the	the	DT
cord-273505-pcsw3vmx	150	16	functional	functional	JJ
cord-273505-pcsw3vmx	150	17	NK	nk	NN
cord-273505-pcsw3vmx	150	18	-	-	HYPH
cord-273505-pcsw3vmx	150	19	marker	marker	NN
cord-273505-pcsw3vmx	150	20	KIR2DL3	KIR2DL3	NNP
cord-273505-pcsw3vmx	150	21	were	be	VBD
cord-273505-pcsw3vmx	150	22	significantly	significantly	RB
cord-273505-pcsw3vmx	150	23	lower	low	JJR
cord-273505-pcsw3vmx	150	24	than	than	IN
cord-273505-pcsw3vmx	150	25	in	in	IN
cord-273505-pcsw3vmx	150	26	patients	patient	NNS
cord-273505-pcsw3vmx	150	27	with	with	IN
cord-273505-pcsw3vmx	150	28	mild	mild	JJ
cord-273505-pcsw3vmx	150	29	SARS	SARS	NNP
cord-273505-pcsw3vmx	150	30	,	,	,
cord-273505-pcsw3vmx	150	31	mycoplasma	mycoplasma	NN
cord-273505-pcsw3vmx	150	32	pneumonia	pneumonia	NN
cord-273505-pcsw3vmx	150	33	,	,	,
cord-273505-pcsw3vmx	150	34	or	or	CC
cord-273505-pcsw3vmx	150	35	healthy	healthy	JJ
cord-273505-pcsw3vmx	150	36	controls	control	NNS
cord-273505-pcsw3vmx	150	37	,	,	,
cord-273505-pcsw3vmx	150	38	manifesting	manifest	VBG
cord-273505-pcsw3vmx	150	39	a	a	DT
cord-273505-pcsw3vmx	150	40	correlation	correlation	NN
cord-273505-pcsw3vmx	150	41	between	between	IN
cord-273505-pcsw3vmx	150	42	the	the	DT
cord-273505-pcsw3vmx	150	43	severity	severity	NN
cord-273505-pcsw3vmx	150	44	of	of	IN
cord-273505-pcsw3vmx	150	45	SARS	SARS	NNP
cord-273505-pcsw3vmx	150	46	and	and	CC
cord-273505-pcsw3vmx	150	47	the	the	DT
cord-273505-pcsw3vmx	150	48	number	number	NN
cord-273505-pcsw3vmx	150	49	and	and	CC
cord-273505-pcsw3vmx	150	50	function	function	NN
cord-273505-pcsw3vmx	150	51	of	of	IN
cord-273505-pcsw3vmx	150	52	NK	NK	NNP
cord-273505-pcsw3vmx	150	53	cells	cell	NNS
cord-273505-pcsw3vmx	150	54	(	(	-LRB-
cord-273505-pcsw3vmx	150	55	132	132	CD
cord-273505-pcsw3vmx	150	56	)	)	-RRB-
cord-273505-pcsw3vmx	150	57	.	.	.
cord-273505-pcsw3vmx	151	1	During	during	IN
cord-273505-pcsw3vmx	151	2	influenza	influenza	NN
cord-273505-pcsw3vmx	151	3	virus	virus	NN
cord-273505-pcsw3vmx	151	4	and	and	CC
cord-273505-pcsw3vmx	151	5	RSV	RSV	NNP
cord-273505-pcsw3vmx	151	6	infection	infection	NN
cord-273505-pcsw3vmx	151	7	,	,	,
cord-273505-pcsw3vmx	151	8	virus	virus	NN
cord-273505-pcsw3vmx	151	9	-	-	HYPH
cord-273505-pcsw3vmx	151	10	induced	induce	VBN
cord-273505-pcsw3vmx	151	11	apoptosis	apoptosis	NN
cord-273505-pcsw3vmx	151	12	or	or	CC
cord-273505-pcsw3vmx	151	13	modulation	modulation	NN
cord-273505-pcsw3vmx	151	14	of	of	IN
cord-273505-pcsw3vmx	151	15	NK	NK	NNP
cord-273505-pcsw3vmx	151	16	cell	cell	NN
cord-273505-pcsw3vmx	151	17	cytotoxicity	cytotoxicity	NN
cord-273505-pcsw3vmx	151	18	has	have	VBZ
cord-273505-pcsw3vmx	151	19	also	also	RB
cord-273505-pcsw3vmx	151	20	been	be	VBN
cord-273505-pcsw3vmx	151	21	proposed	propose	VBN
cord-273505-pcsw3vmx	151	22	to	to	TO
cord-273505-pcsw3vmx	151	23	serve	serve	VB
cord-273505-pcsw3vmx	151	24	as	as	IN
cord-273505-pcsw3vmx	151	25	a	a	DT
cord-273505-pcsw3vmx	151	26	viral	viral	JJ
cord-273505-pcsw3vmx	151	27	evasion	evasion	NN
cord-273505-pcsw3vmx	151	28	strategy	strategy	NN
cord-273505-pcsw3vmx	151	29	,	,	,
cord-273505-pcsw3vmx	151	30	and	and	CC
cord-273505-pcsw3vmx	151	31	eventually	eventually	RB
cord-273505-pcsw3vmx	151	32	skew	skew	VB
cord-273505-pcsw3vmx	151	33	the	the	DT
cord-273505-pcsw3vmx	151	34	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	151	35	profile	profile	NN
cord-273505-pcsw3vmx	151	36	of	of	IN
cord-273505-pcsw3vmx	151	37	the	the	DT
cord-273505-pcsw3vmx	151	38	immune	immune	JJ
cord-273505-pcsw3vmx	151	39	system	system	NN
cord-273505-pcsw3vmx	151	40	(	(	-LRB-
cord-273505-pcsw3vmx	151	41	133	133	CD
cord-273505-pcsw3vmx	151	42	,	,	,
cord-273505-pcsw3vmx	151	43	134	134	CD
cord-273505-pcsw3vmx	151	44	)	)	-RRB-
cord-273505-pcsw3vmx	151	45	.	.	.
cord-273505-pcsw3vmx	152	1	After	after	IN
cord-273505-pcsw3vmx	152	2	high	high	JJ
cord-273505-pcsw3vmx	152	3	-	-	HYPH
cord-273505-pcsw3vmx	152	4	dose	dose	NN
cord-273505-pcsw3vmx	152	5	IVIg	ivig	NN
cord-273505-pcsw3vmx	152	6	therapy	therapy	NN
cord-273505-pcsw3vmx	152	7	,	,	,
cord-273505-pcsw3vmx	152	8	a	a	DT
cord-273505-pcsw3vmx	152	9	reduction	reduction	NN
cord-273505-pcsw3vmx	152	10	in	in	IN
cord-273505-pcsw3vmx	152	11	number	number	NN
cord-273505-pcsw3vmx	152	12	and	and	CC
cord-273505-pcsw3vmx	152	13	cytotoxic	cytotoxic	JJ
cord-273505-pcsw3vmx	152	14	activity	activity	NN
cord-273505-pcsw3vmx	152	15	of	of	IN
cord-273505-pcsw3vmx	152	16	NK	NK	NNP
cord-273505-pcsw3vmx	152	17	cells	cell	NNS
cord-273505-pcsw3vmx	152	18	is	be	VBZ
cord-273505-pcsw3vmx	152	19	observed	observe	VBN
cord-273505-pcsw3vmx	152	20	in	in	IN
cord-273505-pcsw3vmx	152	21	patients	patient	NNS
cord-273505-pcsw3vmx	152	22	with	with	IN
cord-273505-pcsw3vmx	152	23	autoimmune	autoimmune	JJ
cord-273505-pcsw3vmx	152	24	diseases	disease	NNS
cord-273505-pcsw3vmx	152	25	(	(	-LRB-
cord-273505-pcsw3vmx	152	26	135	135	CD
cord-273505-pcsw3vmx	152	27	)	)	-RRB-
cord-273505-pcsw3vmx	152	28	(	(	-LRB-
cord-273505-pcsw3vmx	152	29	136	136	CD
cord-273505-pcsw3vmx	152	30	)	)	-RRB-
cord-273505-pcsw3vmx	152	31	(	(	-LRB-
cord-273505-pcsw3vmx	152	32	137	137	CD
cord-273505-pcsw3vmx	152	33	)	)	-RRB-
cord-273505-pcsw3vmx	152	34	.	.	.
cord-273505-pcsw3vmx	153	1	The	the	DT
cord-273505-pcsw3vmx	153	2	dose	dose	NN
cord-273505-pcsw3vmx	153	3	-	-	HYPH
cord-273505-pcsw3vmx	153	4	dependent	dependent	JJ
cord-273505-pcsw3vmx	153	5	FcγRIII	fcγriii	NN
cord-273505-pcsw3vmx	153	6	blockade	blockade	NN
cord-273505-pcsw3vmx	153	7	and	and	CC
cord-273505-pcsw3vmx	153	8	circulating	circulate	VBG
cord-273505-pcsw3vmx	153	9	NK	NK	NNP
cord-273505-pcsw3vmx	153	10	cells	cell	NNS
cord-273505-pcsw3vmx	153	11	decline	decline	NN
cord-273505-pcsw3vmx	153	12	occurred	occur	VBD
cord-273505-pcsw3vmx	153	13	following	follow	VBG
cord-273505-pcsw3vmx	153	14	IVIg	ivig	JJ
cord-273505-pcsw3vmx	153	15	treatment	treatment	NN
cord-273505-pcsw3vmx	153	16	,	,	,
cord-273505-pcsw3vmx	153	17	suggesting	suggest	VBG
cord-273505-pcsw3vmx	153	18	that	that	IN
cord-273505-pcsw3vmx	153	19	inhibition	inhibition	NN
cord-273505-pcsw3vmx	153	20	of	of	IN
cord-273505-pcsw3vmx	153	21	NK	NK	NNP
cord-273505-pcsw3vmx	153	22	cells	cell	NNS
cord-273505-pcsw3vmx	153	23	by	by	IN
cord-273505-pcsw3vmx	153	24	highdose	highdose	NN
cord-273505-pcsw3vmx	153	25	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	153	26	is	be	VBZ
cord-273505-pcsw3vmx	153	27	associated	associate	VBN
cord-273505-pcsw3vmx	153	28	with	with	IN
cord-273505-pcsw3vmx	153	29	the	the	DT
cord-273505-pcsw3vmx	153	30	saturation	saturation	NN
cord-273505-pcsw3vmx	153	31	of	of	IN
cord-273505-pcsw3vmx	153	32	activating	activate	VBG
cord-273505-pcsw3vmx	153	33	FcγRs	FcγRs	NNP
cord-273505-pcsw3vmx	153	34	(	(	-LRB-
cord-273505-pcsw3vmx	153	35	135	135	CD
cord-273505-pcsw3vmx	153	36	)	)	-RRB-
cord-273505-pcsw3vmx	153	37	.	.	.
cord-273505-pcsw3vmx	154	1	The	the	DT
cord-273505-pcsw3vmx	154	2	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	154	3	effects	effect	NNS
cord-273505-pcsw3vmx	154	4	of	of	IN
cord-273505-pcsw3vmx	154	5	IVIg	ivig	JJ
cord-273505-pcsw3vmx	154	6	therapy	therapy	NN
cord-273505-pcsw3vmx	154	7	on	on	IN
cord-273505-pcsw3vmx	154	8	NK	NK	NNP
cord-273505-pcsw3vmx	154	9	cells	cell	NNS
cord-273505-pcsw3vmx	154	10	may	may	MD
cord-273505-pcsw3vmx	154	11	,	,	,
cord-273505-pcsw3vmx	154	12	however	however	RB
cord-273505-pcsw3vmx	154	13	,	,	,
cord-273505-pcsw3vmx	154	14	not	not	RB
cord-273505-pcsw3vmx	154	15	impair	impair	VB
cord-273505-pcsw3vmx	154	16	its	-PRON-	PRP$
cord-273505-pcsw3vmx	154	17	functions	function	NNS
cord-273505-pcsw3vmx	154	18	for	for	IN
cord-273505-pcsw3vmx	154	19	controlling	control	VBG
cord-273505-pcsw3vmx	154	20	viral	viral	JJ
cord-273505-pcsw3vmx	154	21	infections	infection	NNS
cord-273505-pcsw3vmx	154	22	and	and	CC
cord-273505-pcsw3vmx	154	23	malignancies	malignancy	NNS
cord-273505-pcsw3vmx	154	24	(	(	-LRB-
cord-273505-pcsw3vmx	154	25	138	138	CD
cord-273505-pcsw3vmx	154	26	)	)	-RRB-
cord-273505-pcsw3vmx	154	27	.	.	.
cord-273505-pcsw3vmx	155	1	Cytokines	cytokine	NNS
cord-273505-pcsw3vmx	155	2	secreted	secrete	VBN
cord-273505-pcsw3vmx	155	3	by	by	IN
cord-273505-pcsw3vmx	155	4	different	different	JJ
cord-273505-pcsw3vmx	155	5	subclasses	subclass	NNS
cord-273505-pcsw3vmx	155	6	of	of	IN
cord-273505-pcsw3vmx	155	7	CD4	CD4	NNP
cord-273505-pcsw3vmx	155	8	+	+	CC
cord-273505-pcsw3vmx	155	9	T	T	NNP
cord-273505-pcsw3vmx	155	10	cells	cell	NNS
cord-273505-pcsw3vmx	155	11	trigger	trigger	VBP
cord-273505-pcsw3vmx	155	12	the	the	DT
cord-273505-pcsw3vmx	155	13	immune	immune	JJ
cord-273505-pcsw3vmx	155	14	response	response	NN
cord-273505-pcsw3vmx	155	15	to	to	IN
cord-273505-pcsw3vmx	155	16	pathogens	pathogen	NNS
cord-273505-pcsw3vmx	155	17	and	and	CC
cord-273505-pcsw3vmx	155	18	maintain	maintain	VB
cord-273505-pcsw3vmx	155	19	immune	immune	JJ
cord-273505-pcsw3vmx	155	20	homeostasis	homeostasis	NN
cord-273505-pcsw3vmx	155	21	.	.	.
cord-273505-pcsw3vmx	156	1	However	however	RB
cord-273505-pcsw3vmx	156	2	,	,	,
cord-273505-pcsw3vmx	156	3	an	an	DT
cord-273505-pcsw3vmx	156	4	imbalance	imbalance	NN
cord-273505-pcsw3vmx	156	5	of	of	IN
cord-273505-pcsw3vmx	156	6	Th1	th1	NN
cord-273505-pcsw3vmx	156	7	,	,	,
cord-273505-pcsw3vmx	156	8	Th2	Th2	NNP
cord-273505-pcsw3vmx	156	9	,	,	,
cord-273505-pcsw3vmx	156	10	Th17	Th17	NNP
cord-273505-pcsw3vmx	156	11	,	,	,
cord-273505-pcsw3vmx	156	12	and	and	CC
cord-273505-pcsw3vmx	156	13	Treg	Treg	NNP
cord-273505-pcsw3vmx	156	14	subclasses	subclass	NNS
cord-273505-pcsw3vmx	156	15	is	be	VBZ
cord-273505-pcsw3vmx	156	16	associated	associate	VBN
cord-273505-pcsw3vmx	156	17	with	with	IN
cord-273505-pcsw3vmx	156	18	dysfunctional	dysfunctional	JJ
cord-273505-pcsw3vmx	156	19	cytokine	cytokine	JJ
cord-273505-pcsw3vmx	156	20	responses	response	NNS
cord-273505-pcsw3vmx	156	21	during	during	IN
cord-273505-pcsw3vmx	156	22	severe	severe	JJ
cord-273505-pcsw3vmx	156	23	viral	viral	JJ
cord-273505-pcsw3vmx	156	24	infections	infection	NNS
cord-273505-pcsw3vmx	156	25	.	.	.
cord-273505-pcsw3vmx	157	1	The	the	DT
cord-273505-pcsw3vmx	157	2	profiles	profile	NNS
cord-273505-pcsw3vmx	157	3	of	of	IN
cord-273505-pcsw3vmx	157	4	serum	serum	NN
cord-273505-pcsw3vmx	157	5	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	157	6	revealed	reveal	VBD
cord-273505-pcsw3vmx	157	7	an	an	DT
cord-273505-pcsw3vmx	157	8	increased	increase	VBN
cord-273505-pcsw3vmx	157	9	concentration	concentration	NN
cord-273505-pcsw3vmx	157	10	of	of	IN
cord-273505-pcsw3vmx	157	11	Th17	Th17	NNP
cord-273505-pcsw3vmx	157	12	cells	cell	NNS
cord-273505-pcsw3vmx	157	13	in	in	IN
cord-273505-pcsw3vmx	157	14	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	157	15	patients	patient	NNS
cord-273505-pcsw3vmx	157	16	(	(	-LRB-
cord-273505-pcsw3vmx	157	17	139	139	CD
cord-273505-pcsw3vmx	157	18	,	,	,
cord-273505-pcsw3vmx	157	19	140	140	CD
cord-273505-pcsw3vmx	157	20	)	)	-RRB-
cord-273505-pcsw3vmx	157	21	.	.	.
cord-273505-pcsw3vmx	158	1	In	in	IN
cord-273505-pcsw3vmx	158	2	severe	severe	JJ
cord-273505-pcsw3vmx	158	3	SARS	SARS	NNP
cord-273505-pcsw3vmx	158	4	patients	patient	NNS
cord-273505-pcsw3vmx	158	5	,	,	,
cord-273505-pcsw3vmx	158	6	the	the	DT
cord-273505-pcsw3vmx	158	7	activation	activation	NN
cord-273505-pcsw3vmx	158	8	of	of	IN
cord-273505-pcsw3vmx	158	9	Th1-related	Th1-related	NNP
cord-273505-pcsw3vmx	158	10	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	158	11	and	and	CC
cord-273505-pcsw3vmx	158	12	chemokines	chemokine	NNS
cord-273505-pcsw3vmx	158	13	(	(	-LRB-
cord-273505-pcsw3vmx	158	14	e.g.	e.g.	RB
cord-273505-pcsw3vmx	158	15	,	,	,
cord-273505-pcsw3vmx	158	16	IL-1	IL-1	NNP
cord-273505-pcsw3vmx	158	17	,	,	,
cord-273505-pcsw3vmx	158	18	IL-6	IL-6	NNP
cord-273505-pcsw3vmx	158	19	,	,	,
cord-273505-pcsw3vmx	158	20	IL-12	IL-12	NNP
cord-273505-pcsw3vmx	158	21	)	)	-RRB-
cord-273505-pcsw3vmx	158	22	was	be	VBD
cord-273505-pcsw3vmx	158	23	involved	involve	VBN
cord-273505-pcsw3vmx	158	24	in	in	IN
cord-273505-pcsw3vmx	158	25	hyperinflammatory	hyperinflammatory	JJ
cord-273505-pcsw3vmx	158	26	conditions	condition	NNS
cord-273505-pcsw3vmx	158	27	(	(	-LRB-
cord-273505-pcsw3vmx	158	28	141	141	CD
cord-273505-pcsw3vmx	158	29	)	)	-RRB-
cord-273505-pcsw3vmx	158	30	.	.	.
cord-273505-pcsw3vmx	159	1	Furthermore	furthermore	RB
cord-273505-pcsw3vmx	159	2	,	,	,
cord-273505-pcsw3vmx	159	3	in	in	IN
cord-273505-pcsw3vmx	159	4	MERS	MERS	NNP
cord-273505-pcsw3vmx	159	5	patients	patient	NNS
cord-273505-pcsw3vmx	159	6	,	,	,
cord-273505-pcsw3vmx	159	7	the	the	DT
cord-273505-pcsw3vmx	159	8	significantly	significantly	RB
cord-273505-pcsw3vmx	159	9	increased	increase	VBN
cord-273505-pcsw3vmx	159	10	release	release	NN
cord-273505-pcsw3vmx	159	11	of	of	IN
cord-273505-pcsw3vmx	159	12	pro	pro	JJ
cord-273505-pcsw3vmx	159	13	-	-	JJ
cord-273505-pcsw3vmx	159	14	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	159	15	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	159	16	from	from	IN
cord-273505-pcsw3vmx	159	17	Th1	th1	NN
cord-273505-pcsw3vmx	159	18	and	and	CC
cord-273505-pcsw3vmx	159	19	Th17	Th17	NNP
cord-273505-pcsw3vmx	159	20	during	during	IN
cord-273505-pcsw3vmx	159	21	the	the	DT
cord-273505-pcsw3vmx	159	22	acute	acute	JJ
cord-273505-pcsw3vmx	159	23	phase	phase	NN
cord-273505-pcsw3vmx	159	24	was	be	VBD
cord-273505-pcsw3vmx	159	25	considered	consider	VBN
cord-273505-pcsw3vmx	159	26	to	to	TO
cord-273505-pcsw3vmx	159	27	be	be	VB
cord-273505-pcsw3vmx	159	28	at	at	IN
cord-273505-pcsw3vmx	159	29	least	least	JJS
cord-273505-pcsw3vmx	159	30	partly	partly	RB
cord-273505-pcsw3vmx	159	31	responsible	responsible	JJ
cord-273505-pcsw3vmx	159	32	for	for	IN
cord-273505-pcsw3vmx	159	33	the	the	DT
cord-273505-pcsw3vmx	159	34	immunopathology	immunopathology	NN
cord-273505-pcsw3vmx	159	35	(	(	-LRB-
cord-273505-pcsw3vmx	159	36	142	142	CD
cord-273505-pcsw3vmx	159	37	)	)	-RRB-
cord-273505-pcsw3vmx	159	38	.	.	.
cord-273505-pcsw3vmx	160	1	Early	early	JJ
cord-273505-pcsw3vmx	160	2	abundant	abundant	JJ
cord-273505-pcsw3vmx	160	3	secretion	secretion	NN
cord-273505-pcsw3vmx	160	4	of	of	IN
cord-273505-pcsw3vmx	160	5	Th1-and	th1-and	NN
cord-273505-pcsw3vmx	160	6	Th17-related	Th17-related	NNP
cord-273505-pcsw3vmx	160	7	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	160	8	(	(	-LRB-
cord-273505-pcsw3vmx	160	9	e.g.	e.g.	RB
cord-273505-pcsw3vmx	160	10	,	,	,
cord-273505-pcsw3vmx	160	11	IL-6	IL-6	NNP
cord-273505-pcsw3vmx	160	12	and	and	CC
cord-273505-pcsw3vmx	160	13	IL-17	IL-17	NNP
cord-273505-pcsw3vmx	160	14	)	)	-RRB-
cord-273505-pcsw3vmx	160	15	has	have	VBZ
cord-273505-pcsw3vmx	160	16	furthermore	furthermore	RB
cord-273505-pcsw3vmx	160	17	been	be	VBN
cord-273505-pcsw3vmx	160	18	associated	associate	VBN
cord-273505-pcsw3vmx	160	19	with	with	IN
cord-273505-pcsw3vmx	160	20	complicated	complicated	JJ
cord-273505-pcsw3vmx	160	21	infections	infection	NNS
cord-273505-pcsw3vmx	160	22	and	and	CC
cord-273505-pcsw3vmx	160	23	mortality	mortality	NN
cord-273505-pcsw3vmx	160	24	in	in	IN
cord-273505-pcsw3vmx	160	25	severe	severe	JJ
cord-273505-pcsw3vmx	160	26	influenza	influenza	NN
cord-273505-pcsw3vmx	160	27	patients	patient	NNS
cord-273505-pcsw3vmx	160	28	(	(	-LRB-
cord-273505-pcsw3vmx	160	29	143	143	CD
cord-273505-pcsw3vmx	160	30	,	,	,
cord-273505-pcsw3vmx	160	31	144	144	CD
cord-273505-pcsw3vmx	160	32	)	)	-RRB-
cord-273505-pcsw3vmx	160	33	.	.	.
cord-273505-pcsw3vmx	161	1	In	in	IN
cord-273505-pcsw3vmx	161	2	addition	addition	NN
cord-273505-pcsw3vmx	161	3	to	to	IN
cord-273505-pcsw3vmx	161	4	mediating	mediate	VBG
cord-273505-pcsw3vmx	161	5	expansion	expansion	NN
cord-273505-pcsw3vmx	161	6	of	of	IN
cord-273505-pcsw3vmx	161	7	Tregs	Tregs	NNP
cord-273505-pcsw3vmx	161	8	,	,	,
cord-273505-pcsw3vmx	161	9	which	which	WDT
cord-273505-pcsw3vmx	161	10	profoundly	profoundly	RB
cord-273505-pcsw3vmx	161	11	impacts	impact	VBZ
cord-273505-pcsw3vmx	161	12	immune	immune	JJ
cord-273505-pcsw3vmx	161	13	cascades	cascade	NNS
cord-273505-pcsw3vmx	161	14	,	,	,
cord-273505-pcsw3vmx	161	15	high	high	JJ
cord-273505-pcsw3vmx	161	16	-	-	HYPH
cord-273505-pcsw3vmx	161	17	dose	dose	NN
cord-273505-pcsw3vmx	161	18	IVIg	ivig	NN
cord-273505-pcsw3vmx	161	19	has	have	VBZ
cord-273505-pcsw3vmx	161	20	also	also	RB
cord-273505-pcsw3vmx	161	21	been	be	VBN
cord-273505-pcsw3vmx	161	22	shown	show	VBN
cord-273505-pcsw3vmx	161	23	to	to	TO
cord-273505-pcsw3vmx	161	24	inhibit	inhibit	VB
cord-273505-pcsw3vmx	161	25	the	the	DT
cord-273505-pcsw3vmx	161	26	activation	activation	NN
cord-273505-pcsw3vmx	161	27	and	and	CC
cord-273505-pcsw3vmx	161	28	subsequent	subsequent	JJ
cord-273505-pcsw3vmx	161	29	production	production	NN
cord-273505-pcsw3vmx	161	30	of	of	IN
cord-273505-pcsw3vmx	161	31	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	161	32	by	by	IN
cord-273505-pcsw3vmx	161	33	Th1	th1	NN
cord-273505-pcsw3vmx	161	34	and	and	CC
cord-273505-pcsw3vmx	161	35	Th17	Th17	NNP
cord-273505-pcsw3vmx	161	36	cells	cell	NNS
cord-273505-pcsw3vmx	161	37	in	in	IN
cord-273505-pcsw3vmx	161	38	several	several	JJ
cord-273505-pcsw3vmx	161	39	clinical	clinical	JJ
cord-273505-pcsw3vmx	161	40	studies	study	NNS
cord-273505-pcsw3vmx	161	41	and	and	CC
cord-273505-pcsw3vmx	161	42	in	in	IN
cord-273505-pcsw3vmx	161	43	vitro	vitro	FW
cord-273505-pcsw3vmx	161	44	experiments	experiment	NNS
cord-273505-pcsw3vmx	161	45	(	(	-LRB-
cord-273505-pcsw3vmx	161	46	145	145	CD
cord-273505-pcsw3vmx	161	47	)	)	-RRB-
cord-273505-pcsw3vmx	161	48	(	(	-LRB-
cord-273505-pcsw3vmx	161	49	146	146	CD
cord-273505-pcsw3vmx	161	50	)	)	-RRB-
cord-273505-pcsw3vmx	161	51	(	(	-LRB-
cord-273505-pcsw3vmx	161	52	147	147	CD
cord-273505-pcsw3vmx	161	53	)	)	-RRB-
cord-273505-pcsw3vmx	161	54	(	(	-LRB-
cord-273505-pcsw3vmx	161	55	148	148	CD
cord-273505-pcsw3vmx	161	56	)	)	-RRB-
cord-273505-pcsw3vmx	161	57	(	(	-LRB-
cord-273505-pcsw3vmx	161	58	149	149	CD
cord-273505-pcsw3vmx	161	59	)	)	-RRB-
cord-273505-pcsw3vmx	162	1	(	(	-LRB-
cord-273505-pcsw3vmx	162	2	150	150	CD
cord-273505-pcsw3vmx	162	3	)	)	-RRB-
cord-273505-pcsw3vmx	162	4	(	(	-LRB-
cord-273505-pcsw3vmx	162	5	151	151	CD
cord-273505-pcsw3vmx	162	6	)	)	-RRB-
cord-273505-pcsw3vmx	162	7	(	(	-LRB-
cord-273505-pcsw3vmx	162	8	152	152	CD
cord-273505-pcsw3vmx	162	9	)	)	-RRB-
cord-273505-pcsw3vmx	162	10	(	(	-LRB-
cord-273505-pcsw3vmx	162	11	153	153	CD
cord-273505-pcsw3vmx	162	12	)	)	-RRB-
cord-273505-pcsw3vmx	162	13	(	(	-LRB-
cord-273505-pcsw3vmx	162	14	154	154	CD
cord-273505-pcsw3vmx	162	15	)	)	-RRB-
cord-273505-pcsw3vmx	162	16	(	(	-LRB-
cord-273505-pcsw3vmx	162	17	155	155	CD
cord-273505-pcsw3vmx	162	18	)	)	-RRB-
cord-273505-pcsw3vmx	162	19	(	(	-LRB-
cord-273505-pcsw3vmx	162	20	156	156	CD
cord-273505-pcsw3vmx	162	21	)	)	-RRB-
cord-273505-pcsw3vmx	162	22	(	(	-LRB-
cord-273505-pcsw3vmx	162	23	157	157	CD
cord-273505-pcsw3vmx	162	24	)	)	-RRB-
cord-273505-pcsw3vmx	162	25	(	(	-LRB-
cord-273505-pcsw3vmx	162	26	158	158	CD
cord-273505-pcsw3vmx	162	27	)	)	-RRB-
cord-273505-pcsw3vmx	162	28	.	.	.
cord-273505-pcsw3vmx	163	1	Moreover	moreover	RB
cord-273505-pcsw3vmx	163	2	,	,	,
cord-273505-pcsw3vmx	163	3	F(ab	f(ab	NN
cord-273505-pcsw3vmx	163	4	)	)	-RRB-
cord-273505-pcsw3vmx	163	5	′	′	CD
cord-273505-pcsw3vmx	163	6	2	2	CD
cord-273505-pcsw3vmx	163	7	fragments	fragment	NNS
cord-273505-pcsw3vmx	163	8	,	,	,
cord-273505-pcsw3vmx	163	9	rather	rather	RB
cord-273505-pcsw3vmx	163	10	than	than	IN
cord-273505-pcsw3vmx	163	11	Fc	Fc	NNP
cord-273505-pcsw3vmx	163	12	fragments	fragment	NNS
cord-273505-pcsw3vmx	163	13	,	,	,
cord-273505-pcsw3vmx	163	14	have	have	VBP
cord-273505-pcsw3vmx	163	15	been	be	VBN
cord-273505-pcsw3vmx	163	16	shown	show	VBN
cord-273505-pcsw3vmx	163	17	to	to	TO
cord-273505-pcsw3vmx	163	18	retain	retain	VB
cord-273505-pcsw3vmx	163	19	the	the	DT
cord-273505-pcsw3vmx	163	20	function	function	NN
cord-273505-pcsw3vmx	163	21	of	of	IN
cord-273505-pcsw3vmx	163	22	intact	intact	JJ
cord-273505-pcsw3vmx	163	23	antibodies	antibody	NNS
cord-273505-pcsw3vmx	163	24	in	in	IN
cord-273505-pcsw3vmx	163	25	inhibiting	inhibit	VBG
cord-273505-pcsw3vmx	163	26	Th1	th1	CD
cord-273505-pcsw3vmx	163	27	and	and	CC
cord-273505-pcsw3vmx	163	28	Th17	Th17	NNP
cord-273505-pcsw3vmx	163	29	(	(	-LRB-
cord-273505-pcsw3vmx	163	30	158	158	CD
cord-273505-pcsw3vmx	163	31	)	)	-RRB-
cord-273505-pcsw3vmx	163	32	.	.	.
cord-273505-pcsw3vmx	164	1	It	-PRON-	PRP
cord-273505-pcsw3vmx	164	2	has	have	VBZ
cord-273505-pcsw3vmx	164	3	been	be	VBN
cord-273505-pcsw3vmx	164	4	proposed	propose	VBN
cord-273505-pcsw3vmx	164	5	that	that	IN
cord-273505-pcsw3vmx	164	6	IVIg	ivig	PRP
cord-273505-pcsw3vmx	164	7	may	may	MD
cord-273505-pcsw3vmx	164	8	neutralize	neutralize	VB
cord-273505-pcsw3vmx	164	9	sphingosine-1-phosphate	sphingosine-1-phosphate	NNP
cord-273505-pcsw3vmx	164	10	(	(	-LRB-
cord-273505-pcsw3vmx	164	11	S1P	s1p	NN
cord-273505-pcsw3vmx	164	12	)	)	-RRB-
cord-273505-pcsw3vmx	164	13	receptors	receptor	NNS
cord-273505-pcsw3vmx	164	14	on	on	IN
cord-273505-pcsw3vmx	164	15	the	the	DT
cord-273505-pcsw3vmx	164	16	CD4	CD4	NNP
cord-273505-pcsw3vmx	164	17	+	+	CC
cord-273505-pcsw3vmx	164	18	T	T	NNP
cord-273505-pcsw3vmx	164	19	cell	cell	NN
cord-273505-pcsw3vmx	164	20	and	and	CC
cord-273505-pcsw3vmx	164	21	downregulate	downregulate	VB
cord-273505-pcsw3vmx	164	22	the	the	DT
cord-273505-pcsw3vmx	164	23	S1P1-mTOR	S1P1-mTOR	NNP
cord-273505-pcsw3vmx	164	24	signaling	signal	VBG
cord-273505-pcsw3vmx	164	25	axis	axis	NN
cord-273505-pcsw3vmx	164	26	,	,	,
cord-273505-pcsw3vmx	164	27	thereby	thereby	RB
cord-273505-pcsw3vmx	164	28	inhibiting	inhibit	VBG
cord-273505-pcsw3vmx	164	29	the	the	DT
cord-273505-pcsw3vmx	164	30	differentiation	differentiation	NN
cord-273505-pcsw3vmx	164	31	and	and	CC
cord-273505-pcsw3vmx	164	32	infiltration	infiltration	NN
cord-273505-pcsw3vmx	164	33	of	of	IN
cord-273505-pcsw3vmx	164	34	Th1	th1	NN
cord-273505-pcsw3vmx	164	35	and	and	CC
cord-273505-pcsw3vmx	164	36	Th17	Th17	NNP
cord-273505-pcsw3vmx	164	37	cells	cell	NNS
cord-273505-pcsw3vmx	164	38	while	while	IN
cord-273505-pcsw3vmx	164	39	favoring	favor	VBG
cord-273505-pcsw3vmx	164	40	Treg	Treg	NNP
cord-273505-pcsw3vmx	164	41	cells	cell	NNS
cord-273505-pcsw3vmx	164	42	(	(	-LRB-
cord-273505-pcsw3vmx	164	43	158	158	CD
cord-273505-pcsw3vmx	164	44	)	)	-RRB-
cord-273505-pcsw3vmx	164	45	.	.	.
cord-273505-pcsw3vmx	165	1	Interestingly	interestingly	RB
cord-273505-pcsw3vmx	165	2	,	,	,
cord-273505-pcsw3vmx	165	3	monomeric	monomeric	JJ
cord-273505-pcsw3vmx	165	4	IgA	IgA	NNP
cord-273505-pcsw3vmx	165	5	(	(	-LRB-
cord-273505-pcsw3vmx	165	6	mIgA	mIgA	NNP
cord-273505-pcsw3vmx	165	7	)	)	-RRB-
cord-273505-pcsw3vmx	165	8	isolated	isolate	VBN
cord-273505-pcsw3vmx	165	9	from	from	IN
cord-273505-pcsw3vmx	165	10	a	a	DT
cord-273505-pcsw3vmx	165	11	IVIg	ivig	JJ
cord-273505-pcsw3vmx	165	12	preparation	preparation	NN
cord-273505-pcsw3vmx	165	13	has	have	VBZ
cord-273505-pcsw3vmx	165	14	been	be	VBN
cord-273505-pcsw3vmx	165	15	revealed	reveal	VBN
cord-273505-pcsw3vmx	165	16	to	to	TO
cord-273505-pcsw3vmx	165	17	interfere	interfere	VB
cord-273505-pcsw3vmx	165	18	with	with	IN
cord-273505-pcsw3vmx	165	19	the	the	DT
cord-273505-pcsw3vmx	165	20	STAT3	STAT3	NNP
cord-273505-pcsw3vmx	165	21	via	via	IN
cord-273505-pcsw3vmx	165	22	its	-PRON-	PRP$
cord-273505-pcsw3vmx	165	23	F(ab	f(ab	NN
cord-273505-pcsw3vmx	165	24	)	)	-RRB-
cord-273505-pcsw3vmx	165	25	′	′	CD
cord-273505-pcsw3vmx	165	26	2	2	CD
cord-273505-pcsw3vmx	165	27	fragments	fragment	NNS
cord-273505-pcsw3vmx	165	28	and	and	CC
cord-273505-pcsw3vmx	165	29	inhibits	inhibit	VBZ
cord-273505-pcsw3vmx	165	30	the	the	DT
cord-273505-pcsw3vmx	165	31	differentiation	differentiation	NN
cord-273505-pcsw3vmx	165	32	and	and	CC
cord-273505-pcsw3vmx	165	33	expansion	expansion	NN
cord-273505-pcsw3vmx	165	34	of	of	IN
cord-273505-pcsw3vmx	165	35	Th17	Th17	NNP
cord-273505-pcsw3vmx	165	36	cells	cell	NNS
cord-273505-pcsw3vmx	165	37	(	(	-LRB-
cord-273505-pcsw3vmx	165	38	159	159	CD
cord-273505-pcsw3vmx	165	39	)	)	-RRB-
cord-273505-pcsw3vmx	165	40	.	.	.
cord-273505-pcsw3vmx	166	1	It	-PRON-	PRP
cord-273505-pcsw3vmx	166	2	is	be	VBZ
cord-273505-pcsw3vmx	166	3	noted	note	VBN
cord-273505-pcsw3vmx	166	4	that	that	IN
cord-273505-pcsw3vmx	166	5	the	the	DT
cord-273505-pcsw3vmx	166	6	proposed	propose	VBN
cord-273505-pcsw3vmx	166	7	mechanism	mechanism	NN
cord-273505-pcsw3vmx	166	8	of	of	IN
cord-273505-pcsw3vmx	166	9	functional	functional	JJ
cord-273505-pcsw3vmx	166	10	T	T	NNP
cord-273505-pcsw3vmx	166	11	cell	cell	NN
cord-273505-pcsw3vmx	166	12	-	-	HYPH
cord-273505-pcsw3vmx	166	13	modulation	modulation	NN
cord-273505-pcsw3vmx	166	14	by	by	IN
cord-273505-pcsw3vmx	166	15	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	166	16	also	also	RB
cord-273505-pcsw3vmx	166	17	includes	include	VBZ
cord-273505-pcsw3vmx	166	18	DC	DC	NNP
cord-273505-pcsw3vmx	166	19	-	-	HYPH
cord-273505-pcsw3vmx	166	20	mediated	mediate	VBN
cord-273505-pcsw3vmx	166	21	effects	effect	NNS
cord-273505-pcsw3vmx	166	22	;	;	:
cord-273505-pcsw3vmx	166	23	IVIg	ivig	NN
cord-273505-pcsw3vmx	166	24	-	-	HYPH
cord-273505-pcsw3vmx	166	25	primed	prime	VBN
cord-273505-pcsw3vmx	166	26	DCs	dc	NNS
cord-273505-pcsw3vmx	166	27	can	can	MD
cord-273505-pcsw3vmx	166	28	steer	steer	VB
cord-273505-pcsw3vmx	166	29	non	non	JJ
cord-273505-pcsw3vmx	166	30	-	-	JJ
cord-273505-pcsw3vmx	166	31	Treg	treg	JJ
cord-273505-pcsw3vmx	166	32	cell	cell	NN
cord-273505-pcsw3vmx	166	33	precursors	precursor	NNS
cord-273505-pcsw3vmx	166	34	toward	toward	IN
cord-273505-pcsw3vmx	166	35	a	a	DT
cord-273505-pcsw3vmx	166	36	Treg	Treg	NNP
cord-273505-pcsw3vmx	166	37	differentiation	differentiation	NN
cord-273505-pcsw3vmx	166	38	,	,	,
cord-273505-pcsw3vmx	166	39	and	and	CC
cord-273505-pcsw3vmx	166	40	C	c	NN
cord-273505-pcsw3vmx	166	41	-	-	HYPH
cord-273505-pcsw3vmx	166	42	type	type	NN
cord-273505-pcsw3vmx	166	43	lectins	lectin	NNS
cord-273505-pcsw3vmx	166	44	expressed	express	VBN
cord-273505-pcsw3vmx	166	45	on	on	IN
cord-273505-pcsw3vmx	166	46	DC	DC	NNP
cord-273505-pcsw3vmx	166	47	cells	cell	NNS
cord-273505-pcsw3vmx	166	48	may	may	MD
cord-273505-pcsw3vmx	166	49	be	be	VB
cord-273505-pcsw3vmx	166	50	critical	critical	JJ
cord-273505-pcsw3vmx	166	51	in	in	IN
cord-273505-pcsw3vmx	166	52	this	this	DT
cord-273505-pcsw3vmx	166	53	process	process	NN
cord-273505-pcsw3vmx	166	54	(	(	-LRB-
cord-273505-pcsw3vmx	166	55	105	105	CD
cord-273505-pcsw3vmx	166	56	,	,	,
cord-273505-pcsw3vmx	166	57	(	(	-LRB-
cord-273505-pcsw3vmx	166	58	160	160	CD
cord-273505-pcsw3vmx	166	59	)	)	-RRB-
cord-273505-pcsw3vmx	166	60	(	(	-LRB-
cord-273505-pcsw3vmx	166	61	161	161	CD
cord-273505-pcsw3vmx	166	62	)	)	-RRB-
cord-273505-pcsw3vmx	166	63	(	(	-LRB-
cord-273505-pcsw3vmx	166	64	162	162	CD
cord-273505-pcsw3vmx	166	65	)	)	-RRB-
cord-273505-pcsw3vmx	166	66	.	.	.
cord-273505-pcsw3vmx	167	1	Novel	Novel	NNP
cord-273505-pcsw3vmx	167	2	Treg	Treg	NNP
cord-273505-pcsw3vmx	167	3	epitope	epitope	NN
cord-273505-pcsw3vmx	167	4	peptides	peptide	NNS
cord-273505-pcsw3vmx	167	5	(	(	-LRB-
cord-273505-pcsw3vmx	167	6	Tregitopes	Tregitopes	NNP
cord-273505-pcsw3vmx	167	7	)	)	-RRB-
cord-273505-pcsw3vmx	167	8	on	on	IN
cord-273505-pcsw3vmx	167	9	IgG	IgG	NNP
cord-273505-pcsw3vmx	167	10	provide	provide	VBP
cord-273505-pcsw3vmx	167	11	a	a	DT
cord-273505-pcsw3vmx	167	12	further	further	JJ
cord-273505-pcsw3vmx	167	13	explanation	explanation	NN
cord-273505-pcsw3vmx	167	14	of	of	IN
cord-273505-pcsw3vmx	167	15	the	the	DT
cord-273505-pcsw3vmx	167	16	regulatory	regulatory	JJ
cord-273505-pcsw3vmx	167	17	effects	effect	NNS
cord-273505-pcsw3vmx	167	18	of	of	IN
cord-273505-pcsw3vmx	167	19	IVIg	ivig	NN
cord-273505-pcsw3vmx	167	20	on	on	IN
cord-273505-pcsw3vmx	167	21	Treg	Treg	NNP
cord-273505-pcsw3vmx	167	22	cells	cell	NNS
cord-273505-pcsw3vmx	167	23	via	via	IN
cord-273505-pcsw3vmx	167	24	DC	DC	NNP
cord-273505-pcsw3vmx	167	25	-	-	HYPH
cord-273505-pcsw3vmx	167	26	mediated	mediate	VBN
cord-273505-pcsw3vmx	167	27	internalization	internalization	NN
cord-273505-pcsw3vmx	167	28	of	of	IN
cord-273505-pcsw3vmx	167	29	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	167	30	(	(	-LRB-
cord-273505-pcsw3vmx	167	31	163	163	CD
cord-273505-pcsw3vmx	167	32	)	)	-RRB-
cord-273505-pcsw3vmx	167	33	.	.	.
cord-273505-pcsw3vmx	168	1	Tregitopes	tregitope	NNS
cord-273505-pcsw3vmx	168	2	are	be	VBP
cord-273505-pcsw3vmx	168	3	natural	natural	JJ
cord-273505-pcsw3vmx	168	4	T	T	NNP
cord-273505-pcsw3vmx	168	5	cell	cell	NN
cord-273505-pcsw3vmx	168	6	epitopes	epitope	NNS
cord-273505-pcsw3vmx	168	7	of	of	IN
cord-273505-pcsw3vmx	168	8	IgG	IgG	NNP
cord-273505-pcsw3vmx	168	9	,	,	,
cord-273505-pcsw3vmx	168	10	and	and	CC
cord-273505-pcsw3vmx	168	11	the	the	DT
cord-273505-pcsw3vmx	168	12	presentation	presentation	NN
cord-273505-pcsw3vmx	168	13	of	of	IN
cord-273505-pcsw3vmx	168	14	Tregitopes	Tregitopes	NNP
cord-273505-pcsw3vmx	168	15	on	on	IN
cord-273505-pcsw3vmx	168	16	DCs	dc	NNS
cord-273505-pcsw3vmx	168	17	in	in	IN
cord-273505-pcsw3vmx	168	18	the	the	DT
cord-273505-pcsw3vmx	168	19	context	context	NN
cord-273505-pcsw3vmx	168	20	of	of	IN
cord-273505-pcsw3vmx	168	21	MHC	MHC	NNP
cord-273505-pcsw3vmx	168	22	-	-	HYPH
cord-273505-pcsw3vmx	168	23	II	II	NNP
cord-273505-pcsw3vmx	168	24	can	can	MD
cord-273505-pcsw3vmx	168	25	lead	lead	VB
cord-273505-pcsw3vmx	168	26	to	to	IN
cord-273505-pcsw3vmx	168	27	the	the	DT
cord-273505-pcsw3vmx	168	28	activation	activation	NN
cord-273505-pcsw3vmx	168	29	and	and	CC
cord-273505-pcsw3vmx	168	30	expansion	expansion	NN
cord-273505-pcsw3vmx	168	31	of	of	IN
cord-273505-pcsw3vmx	168	32	Treg	Treg	NNP
cord-273505-pcsw3vmx	168	33	cells	cell	NNS
cord-273505-pcsw3vmx	168	34	,	,	,
cord-273505-pcsw3vmx	168	35	reinforcing	reinforce	VBG
cord-273505-pcsw3vmx	168	36	the	the	DT
cord-273505-pcsw3vmx	168	37	immunoregulatory	immunoregulatory	JJ
cord-273505-pcsw3vmx	168	38	effects	effect	NNS
cord-273505-pcsw3vmx	168	39	on	on	IN
cord-273505-pcsw3vmx	168	40	other	other	JJ
cord-273505-pcsw3vmx	168	41	conventional	conventional	JJ
cord-273505-pcsw3vmx	168	42	T	t	NN
cord-273505-pcsw3vmx	168	43	cells	cell	NNS
cord-273505-pcsw3vmx	168	44	(	(	-LRB-
cord-273505-pcsw3vmx	168	45	164	164	CD
cord-273505-pcsw3vmx	168	46	,	,	,
cord-273505-pcsw3vmx	168	47	165	165	CD
cord-273505-pcsw3vmx	168	48	)	)	-RRB-
cord-273505-pcsw3vmx	168	49	.	.	.
cord-273505-pcsw3vmx	169	1	CD8	CD8	NNP
cord-273505-pcsw3vmx	169	2	+	+	CC
cord-273505-pcsw3vmx	169	3	T	T	NNP
cord-273505-pcsw3vmx	169	4	cells	cell	NNS
cord-273505-pcsw3vmx	169	5	contribute	contribute	VBP
cord-273505-pcsw3vmx	169	6	to	to	IN
cord-273505-pcsw3vmx	169	7	pathogen	pathogen	NN
cord-273505-pcsw3vmx	169	8	clearance	clearance	NN
cord-273505-pcsw3vmx	169	9	and	and	CC
cord-273505-pcsw3vmx	169	10	immune	immune	JJ
cord-273505-pcsw3vmx	169	11	protection	protection	NN
cord-273505-pcsw3vmx	169	12	.	.	.
cord-273505-pcsw3vmx	170	1	However	however	RB
cord-273505-pcsw3vmx	170	2	,	,	,
cord-273505-pcsw3vmx	170	3	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	170	4	and	and	CC
cord-273505-pcsw3vmx	170	5	cytotoxic	cytotoxic	JJ
cord-273505-pcsw3vmx	170	6	granules	granule	NNS
cord-273505-pcsw3vmx	170	7	produced	produce	VBN
cord-273505-pcsw3vmx	170	8	by	by	IN
cord-273505-pcsw3vmx	170	9	activated	activate	VBN
cord-273505-pcsw3vmx	170	10	CD8	CD8	NNP
cord-273505-pcsw3vmx	170	11	+	+	CC
cord-273505-pcsw3vmx	170	12	T	T	NNP
cord-273505-pcsw3vmx	170	13	cells	cell	NNS
cord-273505-pcsw3vmx	170	14	may	may	MD
cord-273505-pcsw3vmx	170	15	exaggerate	exaggerate	VB
cord-273505-pcsw3vmx	170	16	cytokine	cytokine	JJ
cord-273505-pcsw3vmx	170	17	storms	storm	NNS
cord-273505-pcsw3vmx	170	18	and	and	CC
cord-273505-pcsw3vmx	170	19	are	be	VBP
cord-273505-pcsw3vmx	170	20	partially	partially	RB
cord-273505-pcsw3vmx	170	21	implicated	implicate	VBN
cord-273505-pcsw3vmx	170	22	in	in	IN
cord-273505-pcsw3vmx	170	23	the	the	DT
cord-273505-pcsw3vmx	170	24	immunopathology	immunopathology	NN
cord-273505-pcsw3vmx	170	25	during	during	IN
cord-273505-pcsw3vmx	170	26	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	170	27	viral	viral	JJ
cord-273505-pcsw3vmx	170	28	infections	infection	NNS
cord-273505-pcsw3vmx	170	29	(	(	-LRB-
cord-273505-pcsw3vmx	170	30	166	166	CD
cord-273505-pcsw3vmx	170	31	,	,	,
cord-273505-pcsw3vmx	170	32	167	167	CD
cord-273505-pcsw3vmx	170	33	)	)	-RRB-
cord-273505-pcsw3vmx	170	34	.	.	.
cord-273505-pcsw3vmx	171	1	Both	both	DT
cord-273505-pcsw3vmx	171	2	a	a	DT
cord-273505-pcsw3vmx	171	3	substantial	substantial	JJ
cord-273505-pcsw3vmx	171	4	reduction	reduction	NN
cord-273505-pcsw3vmx	171	5	of	of	IN
cord-273505-pcsw3vmx	171	6	CD8	CD8	NNP
cord-273505-pcsw3vmx	171	7	+	+	CC
cord-273505-pcsw3vmx	171	8	T	T	NNP
cord-273505-pcsw3vmx	171	9	cell	cell	NN
cord-273505-pcsw3vmx	171	10	counts	count	VBZ
cord-273505-pcsw3vmx	171	11	in	in	IN
cord-273505-pcsw3vmx	171	12	peripheral	peripheral	JJ
cord-273505-pcsw3vmx	171	13	blood	blood	NN
cord-273505-pcsw3vmx	171	14	,	,	,
cord-273505-pcsw3vmx	171	15	and	and	CC
cord-273505-pcsw3vmx	171	16	hyperactivation	hyperactivation	VB
cord-273505-pcsw3vmx	171	17	with	with	IN
cord-273505-pcsw3vmx	171	18	extensive	extensive	JJ
cord-273505-pcsw3vmx	171	19	expression	expression	NN
cord-273505-pcsw3vmx	171	20	of	of	IN
cord-273505-pcsw3vmx	171	21	surface	surface	NN
cord-273505-pcsw3vmx	171	22	activation	activation	NN
cord-273505-pcsw3vmx	171	23	markers	marker	NNS
cord-273505-pcsw3vmx	171	24	(	(	-LRB-
cord-273505-pcsw3vmx	171	25	HLA	HLA	NNP
cord-273505-pcsw3vmx	171	26	-	-	HYPH
cord-273505-pcsw3vmx	171	27	DR	DR	NNP
cord-273505-pcsw3vmx	171	28	and	and	CC
cord-273505-pcsw3vmx	171	29	CD38	CD38	NNP
cord-273505-pcsw3vmx	171	30	)	)	-RRB-
cord-273505-pcsw3vmx	171	31	and	and	CC
cord-273505-pcsw3vmx	171	32	cytotoxic	cytotoxic	JJ
cord-273505-pcsw3vmx	171	33	granules	granule	NNS
cord-273505-pcsw3vmx	171	34	in	in	IN
cord-273505-pcsw3vmx	171	35	CD8	CD8	NNP
cord-273505-pcsw3vmx	171	36	+	+	CC
cord-273505-pcsw3vmx	171	37	T	T	NNP
cord-273505-pcsw3vmx	171	38	cells	cell	NNS
cord-273505-pcsw3vmx	171	39	are	be	VBP
cord-273505-pcsw3vmx	171	40	commonly	commonly	RB
cord-273505-pcsw3vmx	171	41	observed	observe	VBN
cord-273505-pcsw3vmx	171	42	in	in	IN
cord-273505-pcsw3vmx	171	43	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	171	44	patients	patient	NNS
cord-273505-pcsw3vmx	171	45	(	(	-LRB-
cord-273505-pcsw3vmx	171	46	139	139	CD
cord-273505-pcsw3vmx	171	47	,	,	,
cord-273505-pcsw3vmx	171	48	168	168	CD
cord-273505-pcsw3vmx	171	49	)	)	-RRB-
cord-273505-pcsw3vmx	171	50	.	.	.
cord-273505-pcsw3vmx	172	1	An	an	DT
cord-273505-pcsw3vmx	172	2	accompanying	accompany	VBG
cord-273505-pcsw3vmx	172	3	functional	functional	JJ
cord-273505-pcsw3vmx	172	4	exhaustion	exhaustion	NN
cord-273505-pcsw3vmx	172	5	of	of	IN
cord-273505-pcsw3vmx	172	6	CD8	CD8	NNP
cord-273505-pcsw3vmx	172	7	+	+	CC
cord-273505-pcsw3vmx	173	1	T	t	NN
cord-273505-pcsw3vmx	173	2	cells	cell	NNS
cord-273505-pcsw3vmx	173	3	is	be	VBZ
cord-273505-pcsw3vmx	173	4	furthermore	furthermore	RB
cord-273505-pcsw3vmx	173	5	detected	detect	VBN
cord-273505-pcsw3vmx	173	6	in	in	IN
cord-273505-pcsw3vmx	173	7	severe	severe	JJ
cord-273505-pcsw3vmx	173	8	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	173	9	patients	patient	NNS
cord-273505-pcsw3vmx	173	10	(	(	-LRB-
cord-273505-pcsw3vmx	173	11	131	131	CD
cord-273505-pcsw3vmx	173	12	)	)	-RRB-
cord-273505-pcsw3vmx	173	13	.	.	.
cord-273505-pcsw3vmx	174	1	Unlike	unlike	IN
cord-273505-pcsw3vmx	174	2	influenza	influenza	NN
cord-273505-pcsw3vmx	174	3	or	or	CC
cord-273505-pcsw3vmx	174	4	RSV	RSV	NNP
cord-273505-pcsw3vmx	174	5	,	,	,
cord-273505-pcsw3vmx	174	6	the	the	DT
cord-273505-pcsw3vmx	174	7	impaired	impaired	JJ
cord-273505-pcsw3vmx	174	8	function	function	NN
cord-273505-pcsw3vmx	174	9	of	of	IN
cord-273505-pcsw3vmx	174	10	CD8	CD8	NNP
cord-273505-pcsw3vmx	174	11	+	+	CC
cord-273505-pcsw3vmx	174	12	T	T	NNP
cord-273505-pcsw3vmx	174	13	cells	cell	NNS
cord-273505-pcsw3vmx	174	14	during	during	IN
cord-273505-pcsw3vmx	174	15	SARS	SARS	NNP
cord-273505-pcsw3vmx	174	16	-	-	HYPH
cord-273505-pcsw3vmx	174	17	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	174	18	infection	infection	NN
cord-273505-pcsw3vmx	174	19	suggests	suggest	VBZ
cord-273505-pcsw3vmx	174	20	that	that	IN
cord-273505-pcsw3vmx	174	21	these	these	DT
cord-273505-pcsw3vmx	174	22	cells	cell	NNS
cord-273505-pcsw3vmx	174	23	may	may	MD
cord-273505-pcsw3vmx	174	24	not	not	RB
cord-273505-pcsw3vmx	174	25	be	be	VB
cord-273505-pcsw3vmx	174	26	major	major	JJ
cord-273505-pcsw3vmx	174	27	contributors	contributor	NNS
cord-273505-pcsw3vmx	174	28	to	to	IN
cord-273505-pcsw3vmx	174	29	the	the	DT
cord-273505-pcsw3vmx	174	30	cytokine	cytokine	NN
cord-273505-pcsw3vmx	174	31	storm	storm	NN
cord-273505-pcsw3vmx	174	32	in	in	IN
cord-273505-pcsw3vmx	174	33	severe	severe	JJ
cord-273505-pcsw3vmx	174	34	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	174	35	patients	patient	NNS
cord-273505-pcsw3vmx	174	36	(	(	-LRB-
cord-273505-pcsw3vmx	174	37	166	166	CD
cord-273505-pcsw3vmx	174	38	,	,	,
cord-273505-pcsw3vmx	174	39	167	167	CD
cord-273505-pcsw3vmx	174	40	,	,	,
cord-273505-pcsw3vmx	174	41	169	169	CD
cord-273505-pcsw3vmx	174	42	)	)	-RRB-
cord-273505-pcsw3vmx	174	43	.	.	.
cord-273505-pcsw3vmx	175	1	However	however	RB
cord-273505-pcsw3vmx	175	2	,	,	,
cord-273505-pcsw3vmx	175	3	overactivation	overactivation	NN
cord-273505-pcsw3vmx	175	4	and	and	CC
cord-273505-pcsw3vmx	175	5	subsequent	subsequent	JJ
cord-273505-pcsw3vmx	175	6	functional	functional	JJ
cord-273505-pcsw3vmx	175	7	exhaustion	exhaustion	NN
cord-273505-pcsw3vmx	175	8	of	of	IN
cord-273505-pcsw3vmx	175	9	CD8	CD8	NNP
cord-273505-pcsw3vmx	175	10	+	+	CC
cord-273505-pcsw3vmx	175	11	T	T	NNP
cord-273505-pcsw3vmx	175	12	cells	cell	NNS
cord-273505-pcsw3vmx	175	13	may	may	MD
cord-273505-pcsw3vmx	175	14	correlate	correlate	VB
cord-273505-pcsw3vmx	175	15	with	with	IN
cord-273505-pcsw3vmx	175	16	disease	disease	NN
cord-273505-pcsw3vmx	175	17	progression	progression	NN
cord-273505-pcsw3vmx	175	18	(	(	-LRB-
cord-273505-pcsw3vmx	175	19	131	131	CD
cord-273505-pcsw3vmx	175	20	)	)	-RRB-
cord-273505-pcsw3vmx	175	21	.	.	.
cord-273505-pcsw3vmx	176	1	After	after	IN
cord-273505-pcsw3vmx	176	2	effective	effective	JJ
cord-273505-pcsw3vmx	176	3	high	high	JJ
cord-273505-pcsw3vmx	176	4	-	-	HYPH
cord-273505-pcsw3vmx	176	5	dose	dose	NN
cord-273505-pcsw3vmx	176	6	IVIg	ivig	NN
cord-273505-pcsw3vmx	176	7	therapy	therapy	NN
cord-273505-pcsw3vmx	176	8	,	,	,
cord-273505-pcsw3vmx	176	9	the	the	DT
cord-273505-pcsw3vmx	176	10	expression	expression	NN
cord-273505-pcsw3vmx	176	11	of	of	IN
cord-273505-pcsw3vmx	176	12	HLA	HLA	NNP
cord-273505-pcsw3vmx	176	13	-	-	HYPH
cord-273505-pcsw3vmx	176	14	DR	DR	NNP
cord-273505-pcsw3vmx	176	15	and	and	CC
cord-273505-pcsw3vmx	176	16	the	the	DT
cord-273505-pcsw3vmx	176	17	proportion	proportion	NN
cord-273505-pcsw3vmx	176	18	of	of	IN
cord-273505-pcsw3vmx	176	19	extensive	extensive	JJ
cord-273505-pcsw3vmx	176	20	highly	highly	RB
cord-273505-pcsw3vmx	176	21	activated	activate	VBN
cord-273505-pcsw3vmx	176	22	Vβ	Vβ	NNP
cord-273505-pcsw3vmx	176	23	elements	element	NNS
cord-273505-pcsw3vmx	176	24	of	of	IN
cord-273505-pcsw3vmx	176	25	CD8	CD8	NNP
cord-273505-pcsw3vmx	176	26	+	+	CC
cord-273505-pcsw3vmx	176	27	T	T	NNP
cord-273505-pcsw3vmx	176	28	cells	cell	NNS
cord-273505-pcsw3vmx	176	29	decrease	decrease	VBP
cord-273505-pcsw3vmx	176	30	in	in	IN
cord-273505-pcsw3vmx	176	31	patients	patient	NNS
cord-273505-pcsw3vmx	176	32	with	with	IN
cord-273505-pcsw3vmx	176	33	autoimmune	autoimmune	JJ
cord-273505-pcsw3vmx	176	34	diseases	disease	NNS
cord-273505-pcsw3vmx	176	35	(	(	-LRB-
cord-273505-pcsw3vmx	176	36	170	170	CD
cord-273505-pcsw3vmx	176	37	,	,	,
cord-273505-pcsw3vmx	176	38	171	171	CD
cord-273505-pcsw3vmx	176	39	)	)	-RRB-
cord-273505-pcsw3vmx	176	40	.	.	.
cord-273505-pcsw3vmx	177	1	In	in	IN
cord-273505-pcsw3vmx	177	2	vitro	vitro	FW
cord-273505-pcsw3vmx	177	3	and	and	CC
cord-273505-pcsw3vmx	177	4	animal	animal	NN
cord-273505-pcsw3vmx	177	5	model	model	NN
cord-273505-pcsw3vmx	177	6	studies	study	NNS
cord-273505-pcsw3vmx	177	7	report	report	VBP
cord-273505-pcsw3vmx	177	8	similar	similar	JJ
cord-273505-pcsw3vmx	177	9	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	177	10	effects	effect	NNS
cord-273505-pcsw3vmx	177	11	(	(	-LRB-
cord-273505-pcsw3vmx	177	12	172	172	CD
cord-273505-pcsw3vmx	177	13	,	,	,
cord-273505-pcsw3vmx	177	14	173	173	CD
cord-273505-pcsw3vmx	177	15	)	)	-RRB-
cord-273505-pcsw3vmx	177	16	.	.	.
cord-273505-pcsw3vmx	178	1	As	as	IN
cord-273505-pcsw3vmx	178	2	no	no	DT
cord-273505-pcsw3vmx	178	3	FcγRs	FcγRs	NNP
cord-273505-pcsw3vmx	178	4	are	be	VBP
cord-273505-pcsw3vmx	178	5	expressed	express	VBN
cord-273505-pcsw3vmx	178	6	on	on	IN
cord-273505-pcsw3vmx	178	7	T	T	NNP
cord-273505-pcsw3vmx	178	8	cells	cell	NNS
cord-273505-pcsw3vmx	178	9	,	,	,
cord-273505-pcsw3vmx	178	10	the	the	DT
cord-273505-pcsw3vmx	178	11	modulation	modulation	NN
cord-273505-pcsw3vmx	178	12	of	of	IN
cord-273505-pcsw3vmx	178	13	IVIg	ivig	NN
cord-273505-pcsw3vmx	178	14	on	on	IN
cord-273505-pcsw3vmx	178	15	CD8	CD8	NNP
cord-273505-pcsw3vmx	178	16	+	+	CC
cord-273505-pcsw3vmx	178	17	T	T	NNP
cord-273505-pcsw3vmx	178	18	cells	cell	NNS
cord-273505-pcsw3vmx	178	19	may	may	MD
cord-273505-pcsw3vmx	178	20	largely	largely	RB
cord-273505-pcsw3vmx	178	21	depend	depend	VB
cord-273505-pcsw3vmx	178	22	on	on	IN
cord-273505-pcsw3vmx	178	23	specific	specific	JJ
cord-273505-pcsw3vmx	178	24	antibodies	antibody	NNS
cord-273505-pcsw3vmx	178	25	present	present	JJ
cord-273505-pcsw3vmx	178	26	in	in	IN
cord-273505-pcsw3vmx	178	27	the	the	DT
cord-273505-pcsw3vmx	178	28	IVIg	ivig	JJ
cord-273505-pcsw3vmx	178	29	preparation	preparation	NN
cord-273505-pcsw3vmx	178	30	,	,	,
cord-273505-pcsw3vmx	178	31	which	which	WDT
cord-273505-pcsw3vmx	178	32	directly	directly	RB
cord-273505-pcsw3vmx	178	33	bind	bind	VBP
cord-273505-pcsw3vmx	178	34	to	to	IN
cord-273505-pcsw3vmx	178	35	T	t	NN
cord-273505-pcsw3vmx	178	36	cells	cell	NNS
cord-273505-pcsw3vmx	178	37	,	,	,
cord-273505-pcsw3vmx	178	38	or	or	CC
cord-273505-pcsw3vmx	178	39	through	through	IN
cord-273505-pcsw3vmx	178	40	interactions	interaction	NNS
cord-273505-pcsw3vmx	178	41	between	between	IN
cord-273505-pcsw3vmx	178	42	APC	APC	NNP
cord-273505-pcsw3vmx	178	43	and	and	CC
cord-273505-pcsw3vmx	178	44	TCR	TCR	NNP
cord-273505-pcsw3vmx	178	45	signaling	signal	VBG
cord-273505-pcsw3vmx	178	46	(	(	-LRB-
cord-273505-pcsw3vmx	178	47	174	174	CD
cord-273505-pcsw3vmx	178	48	)	)	-RRB-
cord-273505-pcsw3vmx	178	49	.	.	.
cord-273505-pcsw3vmx	179	1	For	for	IN
cord-273505-pcsw3vmx	179	2	example	example	NN
cord-273505-pcsw3vmx	179	3	,	,	,
cord-273505-pcsw3vmx	179	4	it	-PRON-	PRP
cord-273505-pcsw3vmx	179	5	has	have	VBZ
cord-273505-pcsw3vmx	179	6	been	be	VBN
cord-273505-pcsw3vmx	179	7	shown	show	VBN
cord-273505-pcsw3vmx	179	8	that	that	IN
cord-273505-pcsw3vmx	179	9	the	the	DT
cord-273505-pcsw3vmx	179	10	anti	anti	JJ
cord-273505-pcsw3vmx	179	11	-	-	JJ
cord-273505-pcsw3vmx	179	12	B07.75	b07.75	JJ
cord-273505-pcsw3vmx	179	13	-	-	HYPH
cord-273505-pcsw3vmx	179	14	84	84	CD
cord-273505-pcsw3vmx	179	15	peptide	peptide	NN
cord-273505-pcsw3vmx	179	16	antibodies	antibody	NNS
cord-273505-pcsw3vmx	179	17	in	in	IN
cord-273505-pcsw3vmx	179	18	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	179	19	may	may	MD
cord-273505-pcsw3vmx	179	20	be	be	VB
cord-273505-pcsw3vmx	179	21	able	able	JJ
cord-273505-pcsw3vmx	179	22	to	to	TO
cord-273505-pcsw3vmx	179	23	inhibit	inhibit	VB
cord-273505-pcsw3vmx	179	24	HLA	HLA	NNP
cord-273505-pcsw3vmx	179	25	class	class	NN
cord-273505-pcsw3vmx	179	26	I	i	NN
cord-273505-pcsw3vmx	179	27	-	-	HYPH
cord-273505-pcsw3vmx	179	28	restricted	restrict	VBN
cord-273505-pcsw3vmx	179	29	cytotoxicity	cytotoxicity	NN
cord-273505-pcsw3vmx	179	30	of	of	IN
cord-273505-pcsw3vmx	179	31	CD8	CD8	NNP
cord-273505-pcsw3vmx	179	32	+	+	CC
cord-273505-pcsw3vmx	179	33	T	T	NNP
cord-273505-pcsw3vmx	179	34	cells	cell	NNS
cord-273505-pcsw3vmx	179	35	via	via	IN
cord-273505-pcsw3vmx	179	36	their	-PRON-	PRP$
cord-273505-pcsw3vmx	179	37	F(ab	f(ab	NN
cord-273505-pcsw3vmx	179	38	)	)	-RRB-
cord-273505-pcsw3vmx	179	39	′	′	CD
cord-273505-pcsw3vmx	179	40	2	2	CD
cord-273505-pcsw3vmx	179	41	fragment	fragment	NN
cord-273505-pcsw3vmx	179	42	(	(	-LRB-
cord-273505-pcsw3vmx	179	43	175	175	CD
cord-273505-pcsw3vmx	179	44	)	)	-RRB-
cord-273505-pcsw3vmx	179	45	.	.	.
cord-273505-pcsw3vmx	180	1	Apart	apart	RB
cord-273505-pcsw3vmx	180	2	from	from	IN
cord-273505-pcsw3vmx	180	3	that	that	DT
cord-273505-pcsw3vmx	180	4	,	,	,
cord-273505-pcsw3vmx	180	5	a	a	DT
cord-273505-pcsw3vmx	180	6	saturation	saturation	NN
cord-273505-pcsw3vmx	180	7	of	of	IN
cord-273505-pcsw3vmx	180	8	activating	activate	VBG
cord-273505-pcsw3vmx	180	9	FcγRs	FcγRs	NNP
cord-273505-pcsw3vmx	180	10	on	on	IN
cord-273505-pcsw3vmx	180	11	APC	APC	NNP
cord-273505-pcsw3vmx	180	12	results	result	NNS
cord-273505-pcsw3vmx	180	13	in	in	IN
cord-273505-pcsw3vmx	180	14	reduced	reduce	VBN
cord-273505-pcsw3vmx	180	15	immune	immune	JJ
cord-273505-pcsw3vmx	180	16	complex	complex	JJ
cord-273505-pcsw3vmx	180	17	internalization	internalization	NN
cord-273505-pcsw3vmx	180	18	and	and	CC
cord-273505-pcsw3vmx	180	19	presentation	presentation	NN
cord-273505-pcsw3vmx	180	20	,	,	,
cord-273505-pcsw3vmx	180	21	further	further	RB
cord-273505-pcsw3vmx	180	22	contributing	contribute	VBG
cord-273505-pcsw3vmx	180	23	to	to	IN
cord-273505-pcsw3vmx	180	24	the	the	DT
cord-273505-pcsw3vmx	180	25	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	180	26	effects	effect	NNS
cord-273505-pcsw3vmx	180	27	of	of	IN
cord-273505-pcsw3vmx	180	28	high	high	JJ
cord-273505-pcsw3vmx	180	29	-	-	HYPH
cord-273505-pcsw3vmx	180	30	dose	dose	NN
cord-273505-pcsw3vmx	180	31	IVIg	ivig	NN
cord-273505-pcsw3vmx	180	32	on	on	IN
cord-273505-pcsw3vmx	180	33	CD8	CD8	NNP
cord-273505-pcsw3vmx	180	34	+	+	CC
cord-273505-pcsw3vmx	180	35	T	T	NNP
cord-273505-pcsw3vmx	180	36	cells	cell	NNS
cord-273505-pcsw3vmx	180	37	(	(	-LRB-
cord-273505-pcsw3vmx	180	38	172	172	CD
cord-273505-pcsw3vmx	180	39	,	,	,
cord-273505-pcsw3vmx	180	40	173	173	CD
cord-273505-pcsw3vmx	180	41	)	)	-RRB-
cord-273505-pcsw3vmx	180	42	.	.	.
cord-273505-pcsw3vmx	181	1	With	with	IN
cord-273505-pcsw3vmx	181	2	assistance	assistance	NN
cord-273505-pcsw3vmx	181	3	from	from	IN
cord-273505-pcsw3vmx	181	4	helper	helper	NN
cord-273505-pcsw3vmx	181	5	T	T	NNP
cord-273505-pcsw3vmx	181	6	cells	cell	NNS
cord-273505-pcsw3vmx	181	7	and	and	CC
cord-273505-pcsw3vmx	181	8	stimulation	stimulation	NN
cord-273505-pcsw3vmx	181	9	from	from	IN
cord-273505-pcsw3vmx	181	10	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	181	11	,	,	,
cord-273505-pcsw3vmx	181	12	B	b	NN
cord-273505-pcsw3vmx	181	13	cells	cell	NNS
cord-273505-pcsw3vmx	181	14	are	be	VBP
cord-273505-pcsw3vmx	181	15	activated	activate	VBN
cord-273505-pcsw3vmx	181	16	and	and	CC
cord-273505-pcsw3vmx	181	17	differentiated	differentiate	VBN
cord-273505-pcsw3vmx	181	18	into	into	IN
cord-273505-pcsw3vmx	181	19	plasma	plasma	NN
cord-273505-pcsw3vmx	181	20	cells	cell	NNS
cord-273505-pcsw3vmx	181	21	to	to	TO
cord-273505-pcsw3vmx	181	22	produce	produce	VB
cord-273505-pcsw3vmx	181	23	antibodies	antibody	NNS
cord-273505-pcsw3vmx	181	24	and	and	CC
cord-273505-pcsw3vmx	181	25	contribute	contribute	VB
cord-273505-pcsw3vmx	181	26	to	to	IN
cord-273505-pcsw3vmx	181	27	humoral	humoral	JJ
cord-273505-pcsw3vmx	181	28	immunity	immunity	NN
cord-273505-pcsw3vmx	181	29	(	(	-LRB-
cord-273505-pcsw3vmx	181	30	169	169	CD
cord-273505-pcsw3vmx	181	31	,	,	,
cord-273505-pcsw3vmx	181	32	176	176	CD
cord-273505-pcsw3vmx	181	33	)	)	-RRB-
cord-273505-pcsw3vmx	181	34	.	.	.
cord-273505-pcsw3vmx	182	1	Apart	apart	RB
cord-273505-pcsw3vmx	182	2	from	from	IN
cord-273505-pcsw3vmx	182	3	the	the	DT
cord-273505-pcsw3vmx	182	4	generation	generation	NN
cord-273505-pcsw3vmx	182	5	of	of	IN
cord-273505-pcsw3vmx	182	6	antibodies	antibody	NNS
cord-273505-pcsw3vmx	182	7	,	,	,
cord-273505-pcsw3vmx	182	8	IL-6	IL-6	NNP
cord-273505-pcsw3vmx	182	9	produced	produce	VBN
cord-273505-pcsw3vmx	182	10	by	by	IN
cord-273505-pcsw3vmx	182	11	activated	activate	VBN
cord-273505-pcsw3vmx	182	12	B	B	NNP
cord-273505-pcsw3vmx	182	13	cells	cell	NNS
cord-273505-pcsw3vmx	182	14	is	be	VBZ
cord-273505-pcsw3vmx	182	15	also	also	RB
cord-273505-pcsw3vmx	182	16	considered	consider	VBN
cord-273505-pcsw3vmx	182	17	as	as	IN
cord-273505-pcsw3vmx	182	18	a	a	DT
cord-273505-pcsw3vmx	182	19	possible	possible	JJ
cord-273505-pcsw3vmx	182	20	booster	booster	NN
cord-273505-pcsw3vmx	182	21	of	of	IN
cord-273505-pcsw3vmx	182	22	the	the	DT
cord-273505-pcsw3vmx	182	23	cytokine	cytokine	NN
cord-273505-pcsw3vmx	182	24	storm	storm	NN
cord-273505-pcsw3vmx	182	25	and	and	CC
cord-273505-pcsw3vmx	182	26	immunopathology	immunopathology	NN
cord-273505-pcsw3vmx	182	27	in	in	IN
cord-273505-pcsw3vmx	182	28	autoimmune	autoimmune	JJ
cord-273505-pcsw3vmx	182	29	disease	disease	NN
cord-273505-pcsw3vmx	182	30	(	(	-LRB-
cord-273505-pcsw3vmx	182	31	177	177	CD
cord-273505-pcsw3vmx	182	32	,	,	,
cord-273505-pcsw3vmx	182	33	178	178	CD
cord-273505-pcsw3vmx	182	34	)	)	-RRB-
cord-273505-pcsw3vmx	182	35	.	.	.
cord-273505-pcsw3vmx	183	1	The	the	DT
cord-273505-pcsw3vmx	183	2	rapid	rapid	JJ
cord-273505-pcsw3vmx	183	3	reduction	reduction	NN
cord-273505-pcsw3vmx	183	4	of	of	IN
cord-273505-pcsw3vmx	183	5	peripheral	peripheral	JJ
cord-273505-pcsw3vmx	183	6	B	b	NN
cord-273505-pcsw3vmx	183	7	cells	cell	NNS
cord-273505-pcsw3vmx	183	8	is	be	VBZ
cord-273505-pcsw3vmx	183	9	also	also	RB
cord-273505-pcsw3vmx	183	10	a	a	DT
cord-273505-pcsw3vmx	183	11	significant	significant	JJ
cord-273505-pcsw3vmx	183	12	characteristic	characteristic	NN
cord-273505-pcsw3vmx	183	13	of	of	IN
cord-273505-pcsw3vmx	183	14	severe	severe	JJ
cord-273505-pcsw3vmx	183	15	COIVD-19	coivd-19	JJ
cord-273505-pcsw3vmx	183	16	patients	patient	NNS
cord-273505-pcsw3vmx	183	17	,	,	,
cord-273505-pcsw3vmx	183	18	yet	yet	CC
cord-273505-pcsw3vmx	183	19	the	the	DT
cord-273505-pcsw3vmx	183	20	exact	exact	JJ
cord-273505-pcsw3vmx	183	21	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	183	22	underlying	underlie	VBG
cord-273505-pcsw3vmx	184	1	this	this	DT
cord-273505-pcsw3vmx	184	2	accelerated	accelerated	JJ
cord-273505-pcsw3vmx	184	3	lymphocyte	lymphocyte	NN
cord-273505-pcsw3vmx	184	4	loss	loss	NN
cord-273505-pcsw3vmx	184	5	remain	remain	VBP
cord-273505-pcsw3vmx	184	6	unclear	unclear	JJ
cord-273505-pcsw3vmx	184	7	(	(	-LRB-
cord-273505-pcsw3vmx	184	8	17	17	CD
cord-273505-pcsw3vmx	184	9	,	,	,
cord-273505-pcsw3vmx	184	10	179	179	CD
cord-273505-pcsw3vmx	184	11	)	)	-RRB-
cord-273505-pcsw3vmx	184	12	.	.	.
cord-273505-pcsw3vmx	185	1	Although	although	IN
cord-273505-pcsw3vmx	185	2	there	there	EX
cord-273505-pcsw3vmx	185	3	is	be	VBZ
cord-273505-pcsw3vmx	185	4	so	so	RB
cord-273505-pcsw3vmx	185	5	far	far	RB
cord-273505-pcsw3vmx	185	6	no	no	DT
cord-273505-pcsw3vmx	185	7	reliable	reliable	JJ
cord-273505-pcsw3vmx	185	8	evidence	evidence	NN
cord-273505-pcsw3vmx	185	9	correlating	correlate	VBG
cord-273505-pcsw3vmx	185	10	an	an	DT
cord-273505-pcsw3vmx	185	11	overactivation	overactivation	NN
cord-273505-pcsw3vmx	185	12	of	of	IN
cord-273505-pcsw3vmx	185	13	B	b	NN
cord-273505-pcsw3vmx	185	14	cells	cell	NNS
cord-273505-pcsw3vmx	185	15	with	with	IN
cord-273505-pcsw3vmx	185	16	the	the	DT
cord-273505-pcsw3vmx	185	17	development	development	NN
cord-273505-pcsw3vmx	185	18	of	of	IN
cord-273505-pcsw3vmx	185	19	cytokine	cytokine	JJ
cord-273505-pcsw3vmx	185	20	storms	storm	NNS
cord-273505-pcsw3vmx	185	21	during	during	IN
cord-273505-pcsw3vmx	185	22	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	185	23	viral	viral	JJ
cord-273505-pcsw3vmx	185	24	infections	infection	NNS
cord-273505-pcsw3vmx	185	25	,	,	,
cord-273505-pcsw3vmx	185	26	the	the	DT
cord-273505-pcsw3vmx	185	27	production	production	NN
cord-273505-pcsw3vmx	185	28	of	of	IN
cord-273505-pcsw3vmx	185	29	pro	pro	JJ
cord-273505-pcsw3vmx	185	30	-	-	JJ
cord-273505-pcsw3vmx	185	31	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	185	32	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	185	33	by	by	IN
cord-273505-pcsw3vmx	185	34	B	b	NN
cord-273505-pcsw3vmx	185	35	cells	cell	NNS
cord-273505-pcsw3vmx	185	36	has	have	VBZ
cord-273505-pcsw3vmx	185	37	been	be	VBN
cord-273505-pcsw3vmx	185	38	proposed	propose	VBN
cord-273505-pcsw3vmx	185	39	to	to	TO
cord-273505-pcsw3vmx	185	40	play	play	VB
cord-273505-pcsw3vmx	185	41	a	a	DT
cord-273505-pcsw3vmx	185	42	key	key	JJ
cord-273505-pcsw3vmx	185	43	role	role	NN
cord-273505-pcsw3vmx	185	44	in	in	IN
cord-273505-pcsw3vmx	185	45	the	the	DT
cord-273505-pcsw3vmx	185	46	cytokine	cytokine	NN
cord-273505-pcsw3vmx	185	47	cascade	cascade	NN
cord-273505-pcsw3vmx	185	48	in	in	IN
cord-273505-pcsw3vmx	185	49	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	185	50	(	(	-LRB-
cord-273505-pcsw3vmx	185	51	180	180	CD
cord-273505-pcsw3vmx	185	52	)	)	-RRB-
cord-273505-pcsw3vmx	185	53	(	(	-LRB-
cord-273505-pcsw3vmx	185	54	181	181	CD
cord-273505-pcsw3vmx	185	55	)	)	-RRB-
cord-273505-pcsw3vmx	185	56	(	(	-LRB-
cord-273505-pcsw3vmx	185	57	182	182	CD
cord-273505-pcsw3vmx	185	58	)	)	-RRB-
cord-273505-pcsw3vmx	185	59	.	.	.
cord-273505-pcsw3vmx	186	1	Effects	effect	NNS
cord-273505-pcsw3vmx	186	2	of	of	IN
cord-273505-pcsw3vmx	186	3	IVIg	ivig	NN
cord-273505-pcsw3vmx	186	4	on	on	IN
cord-273505-pcsw3vmx	186	5	B	b	NN
cord-273505-pcsw3vmx	186	6	cells	cell	NNS
cord-273505-pcsw3vmx	186	7	vary	vary	VBP
cord-273505-pcsw3vmx	186	8	with	with	IN
cord-273505-pcsw3vmx	186	9	the	the	DT
cord-273505-pcsw3vmx	186	10	dosage	dosage	NN
cord-273505-pcsw3vmx	186	11	:	:	:
cord-273505-pcsw3vmx	186	12	at	at	IN
cord-273505-pcsw3vmx	186	13	low	low	JJ
cord-273505-pcsw3vmx	186	14	doses	dose	NNS
cord-273505-pcsw3vmx	186	15	,	,	,
cord-273505-pcsw3vmx	186	16	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	186	17	induces	induce	VBZ
cord-273505-pcsw3vmx	186	18	proliferation	proliferation	NN
cord-273505-pcsw3vmx	186	19	of	of	IN
cord-273505-pcsw3vmx	186	20	B	b	NN
cord-273505-pcsw3vmx	186	21	cells	cell	NNS
cord-273505-pcsw3vmx	186	22	and	and	CC
cord-273505-pcsw3vmx	186	23	the	the	DT
cord-273505-pcsw3vmx	186	24	production	production	NN
cord-273505-pcsw3vmx	186	25	of	of	IN
cord-273505-pcsw3vmx	186	26	antibodies	antibody	NNS
cord-273505-pcsw3vmx	186	27	(	(	-LRB-
cord-273505-pcsw3vmx	186	28	183	183	CD
cord-273505-pcsw3vmx	186	29	,	,	,
cord-273505-pcsw3vmx	186	30	184	184	CD
cord-273505-pcsw3vmx	186	31	)	)	-RRB-
cord-273505-pcsw3vmx	186	32	.	.	.
cord-273505-pcsw3vmx	187	1	On	on	IN
cord-273505-pcsw3vmx	187	2	the	the	DT
cord-273505-pcsw3vmx	187	3	contrary	contrary	JJ
cord-273505-pcsw3vmx	187	4	,	,	,
cord-273505-pcsw3vmx	187	5	high	high	JJ
cord-273505-pcsw3vmx	187	6	-	-	HYPH
cord-273505-pcsw3vmx	187	7	dose	dose	NN
cord-273505-pcsw3vmx	187	8	IVIg	ivig	NN
cord-273505-pcsw3vmx	187	9	inhibits	inhibit	VBZ
cord-273505-pcsw3vmx	187	10	the	the	DT
cord-273505-pcsw3vmx	187	11	activation	activation	NN
cord-273505-pcsw3vmx	187	12	of	of	IN
cord-273505-pcsw3vmx	187	13	B	b	NN
cord-273505-pcsw3vmx	187	14	cells	cell	NNS
cord-273505-pcsw3vmx	187	15	via	via	IN
cord-273505-pcsw3vmx	187	16	both	both	DT
cord-273505-pcsw3vmx	187	17	F(ab	f(ab	NN
cord-273505-pcsw3vmx	187	18	)	)	-RRB-
cord-273505-pcsw3vmx	187	19	′	′	CD
cord-273505-pcsw3vmx	187	20	2	2	CD
cord-273505-pcsw3vmx	187	21	-mediated	-mediated	JJ
cord-273505-pcsw3vmx	187	22	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	187	23	(	(	-LRB-
cord-273505-pcsw3vmx	187	24	e.g.	e.g.	RB
cord-273505-pcsw3vmx	187	25	,	,	,
cord-273505-pcsw3vmx	187	26	neutralizing	neutralize	VBG
cord-273505-pcsw3vmx	187	27	APRIL	APRIL	NNP
cord-273505-pcsw3vmx	187	28	,	,	,
cord-273505-pcsw3vmx	187	29	BAFF	BAFF	NNP
cord-273505-pcsw3vmx	187	30	,	,	,
cord-273505-pcsw3vmx	187	31	and	and	CC
cord-273505-pcsw3vmx	187	32	Fas	Fas	NNP
cord-273505-pcsw3vmx	187	33	)	)	-RRB-
cord-273505-pcsw3vmx	187	34	and	and	CC
cord-273505-pcsw3vmx	187	35	Fc	Fc	NNP
cord-273505-pcsw3vmx	187	36	-	-	HYPH
cord-273505-pcsw3vmx	187	37	mediated	mediate	VBN
cord-273505-pcsw3vmx	187	38	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	187	39	acting	act	VBG
cord-273505-pcsw3vmx	187	40	on	on	IN
cord-273505-pcsw3vmx	187	41	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	187	42	FcRs	FcRs	NNP
cord-273505-pcsw3vmx	187	43	(	(	-LRB-
cord-273505-pcsw3vmx	187	44	e.g.	e.g.	RB
cord-273505-pcsw3vmx	187	45	,	,	,
cord-273505-pcsw3vmx	187	46	FcγRIIB	FcγRIIB	NNP
cord-273505-pcsw3vmx	187	47	and	and	CC
cord-273505-pcsw3vmx	187	48	CD22	CD22	NNP
cord-273505-pcsw3vmx	187	49	)	)	-RRB-
cord-273505-pcsw3vmx	187	50	,	,	,
cord-273505-pcsw3vmx	187	51	as	as	RB
cord-273505-pcsw3vmx	187	52	well	well	RB
cord-273505-pcsw3vmx	187	53	as	as	IN
cord-273505-pcsw3vmx	187	54	the	the	DT
cord-273505-pcsw3vmx	187	55	TLR-9	TLR-9	NNP
cord-273505-pcsw3vmx	187	56	signaling	signal	VBG
cord-273505-pcsw3vmx	187	57	cascade	cascade	NN
cord-273505-pcsw3vmx	187	58	.	.	.
cord-273505-pcsw3vmx	188	1	FcγRIIB	FcγRIIB	NNP
cord-273505-pcsw3vmx	188	2	is	be	VBZ
cord-273505-pcsw3vmx	188	3	the	the	DT
cord-273505-pcsw3vmx	188	4	only	only	JJ
cord-273505-pcsw3vmx	188	5	classical	classical	JJ
cord-273505-pcsw3vmx	188	6	FcγR	FcγR	NNP
cord-273505-pcsw3vmx	188	7	expressed	express	VBN
cord-273505-pcsw3vmx	188	8	on	on	IN
cord-273505-pcsw3vmx	188	9	B	b	NN
cord-273505-pcsw3vmx	188	10	cells	cell	NNS
cord-273505-pcsw3vmx	188	11	,	,	,
cord-273505-pcsw3vmx	188	12	and	and	CC
cord-273505-pcsw3vmx	188	13	its	-PRON-	PRP$
cord-273505-pcsw3vmx	188	14	elevated	elevated	JJ
cord-273505-pcsw3vmx	188	15	expression	expression	NN
cord-273505-pcsw3vmx	188	16	levels	level	NNS
cord-273505-pcsw3vmx	188	17	after	after	IN
cord-273505-pcsw3vmx	188	18	effective	effective	JJ
cord-273505-pcsw3vmx	188	19	high	high	JJ
cord-273505-pcsw3vmx	188	20	-	-	HYPH
cord-273505-pcsw3vmx	188	21	dose	dose	NN
cord-273505-pcsw3vmx	188	22	IVIg	ivig	NN
cord-273505-pcsw3vmx	188	23	therapy	therapy	NN
cord-273505-pcsw3vmx	188	24	may	may	MD
cord-273505-pcsw3vmx	188	25	be	be	VB
cord-273505-pcsw3vmx	188	26	involved	involve	VBN
cord-273505-pcsw3vmx	188	27	in	in	IN
cord-273505-pcsw3vmx	188	28	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	188	29	effects	effect	NNS
cord-273505-pcsw3vmx	188	30	of	of	IN
cord-273505-pcsw3vmx	188	31	IVIg	ivig	NN
cord-273505-pcsw3vmx	188	32	on	on	IN
cord-273505-pcsw3vmx	188	33	B	b	NN
cord-273505-pcsw3vmx	188	34	cells	cell	NNS
cord-273505-pcsw3vmx	188	35	(	(	-LRB-
cord-273505-pcsw3vmx	188	36	61	61	CD
cord-273505-pcsw3vmx	188	37	,	,	,
cord-273505-pcsw3vmx	188	38	185	185	CD
cord-273505-pcsw3vmx	188	39	,	,	,
cord-273505-pcsw3vmx	188	40	186	186	CD
cord-273505-pcsw3vmx	188	41	)	)	-RRB-
cord-273505-pcsw3vmx	188	42	.	.	.
cord-273505-pcsw3vmx	189	1	However	however	RB
cord-273505-pcsw3vmx	189	2	,	,	,
cord-273505-pcsw3vmx	189	3	IVIg	ivig	NN
cord-273505-pcsw3vmx	189	4	-	-	HYPH
cord-273505-pcsw3vmx	189	5	induced	induce	VBN
cord-273505-pcsw3vmx	189	6	upregulation	upregulation	NN
cord-273505-pcsw3vmx	189	7	of	of	IN
cord-273505-pcsw3vmx	189	8	FcγRIIB	fcγriib	NN
cord-273505-pcsw3vmx	189	9	in	in	IN
cord-273505-pcsw3vmx	189	10	B	b	NN
cord-273505-pcsw3vmx	189	11	cells	cell	NNS
cord-273505-pcsw3vmx	189	12	is	be	VBZ
cord-273505-pcsw3vmx	189	13	independent	independent	JJ
cord-273505-pcsw3vmx	189	14	of	of	IN
cord-273505-pcsw3vmx	189	15	classical	classical	JJ
cord-273505-pcsw3vmx	189	16	FcγRIIB	FcγRIIB	NNP
cord-273505-pcsw3vmx	189	17	signaling	signal	VBG
cord-273505-pcsw3vmx	189	18	intermediates	intermediate	NNS
cord-273505-pcsw3vmx	189	19	,	,	,
cord-273505-pcsw3vmx	189	20	suggesting	suggest	VBG
cord-273505-pcsw3vmx	189	21	that	that	IN
cord-273505-pcsw3vmx	189	22	it	-PRON-	PRP
cord-273505-pcsw3vmx	189	23	is	be	VBZ
cord-273505-pcsw3vmx	189	24	likely	likely	RB
cord-273505-pcsw3vmx	189	25	a	a	DT
cord-273505-pcsw3vmx	189	26	consequence	consequence	NN
cord-273505-pcsw3vmx	189	27	rather	rather	RB
cord-273505-pcsw3vmx	189	28	than	than	IN
cord-273505-pcsw3vmx	189	29	a	a	DT
cord-273505-pcsw3vmx	189	30	cause	cause	NN
cord-273505-pcsw3vmx	189	31	of	of	IN
cord-273505-pcsw3vmx	189	32	high	high	JJ
cord-273505-pcsw3vmx	189	33	-	-	HYPH
cord-273505-pcsw3vmx	189	34	dose	dose	NN
cord-273505-pcsw3vmx	189	35	IVIg	ivig	NN
cord-273505-pcsw3vmx	189	36	therapy	therapy	NN
cord-273505-pcsw3vmx	189	37	(	(	-LRB-
cord-273505-pcsw3vmx	189	38	187	187	CD
cord-273505-pcsw3vmx	189	39	,	,	,
cord-273505-pcsw3vmx	189	40	188	188	CD
cord-273505-pcsw3vmx	189	41	)	)	-RRB-
cord-273505-pcsw3vmx	189	42	.	.	.
cord-273505-pcsw3vmx	190	1	It	-PRON-	PRP
cord-273505-pcsw3vmx	190	2	has	have	VBZ
cord-273505-pcsw3vmx	190	3	been	be	VBN
cord-273505-pcsw3vmx	190	4	proposed	propose	VBN
cord-273505-pcsw3vmx	190	5	that	that	IN
cord-273505-pcsw3vmx	190	6	sialylated	sialylated	JJ
cord-273505-pcsw3vmx	190	7	IgG	IgG	NNP
cord-273505-pcsw3vmx	190	8	binds	bind	VBZ
cord-273505-pcsw3vmx	190	9	to	to	IN
cord-273505-pcsw3vmx	190	10	DC	DC	NNP
cord-273505-pcsw3vmx	190	11	-	-	HYPH
cord-273505-pcsw3vmx	190	12	SIGN	SIGN	NNP
cord-273505-pcsw3vmx	190	13	in	in	IN
cord-273505-pcsw3vmx	190	14	addition	addition	NN
cord-273505-pcsw3vmx	190	15	to	to	IN
cord-273505-pcsw3vmx	190	16	CD23	CD23	NNP
cord-273505-pcsw3vmx	190	17	,	,	,
cord-273505-pcsw3vmx	190	18	a	a	DT
cord-273505-pcsw3vmx	190	19	C	c	NN
cord-273505-pcsw3vmx	190	20	-	-	HYPH
cord-273505-pcsw3vmx	190	21	type	type	NN
cord-273505-pcsw3vmx	190	22	lectin	lectin	NN
cord-273505-pcsw3vmx	190	23	which	which	WDT
cord-273505-pcsw3vmx	190	24	is	be	VBZ
cord-273505-pcsw3vmx	190	25	also	also	RB
cord-273505-pcsw3vmx	190	26	a	a	DT
cord-273505-pcsw3vmx	190	27	known	know	VBN
cord-273505-pcsw3vmx	190	28	low	low	JJ
cord-273505-pcsw3vmx	190	29	-	-	HYPH
cord-273505-pcsw3vmx	190	30	affinity	affinity	NN
cord-273505-pcsw3vmx	190	31	IgE	IgE	NNP
cord-273505-pcsw3vmx	190	32	receptor	receptor	NN
cord-273505-pcsw3vmx	190	33	characteristically	characteristically	RB
cord-273505-pcsw3vmx	190	34	expressed	express	VBN
cord-273505-pcsw3vmx	190	35	on	on	IN
cord-273505-pcsw3vmx	190	36	B	b	NN
cord-273505-pcsw3vmx	190	37	cells	cell	NNS
cord-273505-pcsw3vmx	190	38	,	,	,
cord-273505-pcsw3vmx	190	39	inducing	induce	VBG
cord-273505-pcsw3vmx	190	40	the	the	DT
cord-273505-pcsw3vmx	190	41	suppression	suppression	NN
cord-273505-pcsw3vmx	190	42	of	of	IN
cord-273505-pcsw3vmx	190	43	B	b	NN
cord-273505-pcsw3vmx	190	44	cells	cell	NNS
cord-273505-pcsw3vmx	190	45	(	(	-LRB-
cord-273505-pcsw3vmx	190	46	189	189	CD
cord-273505-pcsw3vmx	190	47	)	)	-RRB-
cord-273505-pcsw3vmx	190	48	.	.	.
cord-273505-pcsw3vmx	191	1	However	however	RB
cord-273505-pcsw3vmx	191	2	,	,	,
cord-273505-pcsw3vmx	191	3	there	there	EX
cord-273505-pcsw3vmx	191	4	has	have	VBZ
cord-273505-pcsw3vmx	191	5	been	be	VBN
cord-273505-pcsw3vmx	191	6	disagreement	disagreement	NN
cord-273505-pcsw3vmx	191	7	as	as	IN
cord-273505-pcsw3vmx	191	8	to	to	IN
cord-273505-pcsw3vmx	191	9	whether	whether	IN
cord-273505-pcsw3vmx	191	10	there	there	EX
cord-273505-pcsw3vmx	191	11	is	be	VBZ
cord-273505-pcsw3vmx	191	12	a	a	DT
cord-273505-pcsw3vmx	191	13	direct	direct	JJ
cord-273505-pcsw3vmx	191	14	interaction	interaction	NN
cord-273505-pcsw3vmx	191	15	between	between	IN
cord-273505-pcsw3vmx	191	16	IgG	IgG	NNP
cord-273505-pcsw3vmx	191	17	and	and	CC
cord-273505-pcsw3vmx	191	18	DC	DC	NNP
cord-273505-pcsw3vmx	191	19	-	-	HYPH
cord-273505-pcsw3vmx	191	20	SIGN	SIGN	NNP
cord-273505-pcsw3vmx	191	21	/	/	SYM
cord-273505-pcsw3vmx	191	22	CD23	CD23	NNP
cord-273505-pcsw3vmx	191	23	(	(	-LRB-
cord-273505-pcsw3vmx	191	24	67	67	CD
cord-273505-pcsw3vmx	191	25	,	,	,
cord-273505-pcsw3vmx	191	26	190	190	CD
cord-273505-pcsw3vmx	191	27	)	)	-RRB-
cord-273505-pcsw3vmx	191	28	.	.	.
cord-273505-pcsw3vmx	192	1	A	a	DT
cord-273505-pcsw3vmx	192	2	further	further	RB
cord-273505-pcsw3vmx	192	3	proposed	propose	VBN
cord-273505-pcsw3vmx	192	4	mechanism	mechanism	NN
cord-273505-pcsw3vmx	192	5	of	of	IN
cord-273505-pcsw3vmx	192	6	action	action	NN
cord-273505-pcsw3vmx	192	7	of	of	IN
cord-273505-pcsw3vmx	192	8	high	high	JJ
cord-273505-pcsw3vmx	192	9	-	-	HYPH
cord-273505-pcsw3vmx	192	10	dose	dose	NN
cord-273505-pcsw3vmx	192	11	IVIg	ivig	NN
cord-273505-pcsw3vmx	192	12	is	be	VBZ
cord-273505-pcsw3vmx	192	13	the	the	DT
cord-273505-pcsw3vmx	192	14	interaction	interaction	NN
cord-273505-pcsw3vmx	192	15	between	between	IN
cord-273505-pcsw3vmx	192	16	the	the	DT
cord-273505-pcsw3vmx	192	17	sialylated	sialylated	JJ
cord-273505-pcsw3vmx	192	18	Fc	Fc	NNP
cord-273505-pcsw3vmx	192	19	fragment	fragment	NN
cord-273505-pcsw3vmx	192	20	of	of	IN
cord-273505-pcsw3vmx	192	21	IgG	igg	NN
cord-273505-pcsw3vmx	192	22	and	and	CC
cord-273505-pcsw3vmx	192	23	CD22	CD22	NNP
cord-273505-pcsw3vmx	192	24	,	,	,
cord-273505-pcsw3vmx	192	25	an	an	DT
cord-273505-pcsw3vmx	192	26	I	i	NN
cord-273505-pcsw3vmx	192	27	-	-	HYPH
cord-273505-pcsw3vmx	192	28	type	type	NN
cord-273505-pcsw3vmx	192	29	lectin	lectin	NN
cord-273505-pcsw3vmx	192	30	expressed	express	VBN
cord-273505-pcsw3vmx	192	31	on	on	IN
cord-273505-pcsw3vmx	192	32	B	b	NN
cord-273505-pcsw3vmx	192	33	cells	cell	NNS
cord-273505-pcsw3vmx	192	34	,	,	,
cord-273505-pcsw3vmx	192	35	which	which	WDT
cord-273505-pcsw3vmx	192	36	results	result	VBZ
cord-273505-pcsw3vmx	192	37	in	in	IN
cord-273505-pcsw3vmx	192	38	the	the	DT
cord-273505-pcsw3vmx	192	39	activation	activation	NN
cord-273505-pcsw3vmx	192	40	of	of	IN
cord-273505-pcsw3vmx	192	41	the	the	DT
cord-273505-pcsw3vmx	192	42	ITIM	ITIM	NNP
cord-273505-pcsw3vmx	192	43	signaling	signal	VBG
cord-273505-pcsw3vmx	192	44	cascade	cascade	NN
cord-273505-pcsw3vmx	192	45	,	,	,
cord-273505-pcsw3vmx	192	46	subsequently	subsequently	RB
cord-273505-pcsw3vmx	192	47	promoting	promote	VBG
cord-273505-pcsw3vmx	192	48	B	b	NN
cord-273505-pcsw3vmx	192	49	cell	cell	NN
cord-273505-pcsw3vmx	192	50	apoptosis	apoptosis	NN
cord-273505-pcsw3vmx	192	51	(	(	-LRB-
cord-273505-pcsw3vmx	192	52	183	183	CD
cord-273505-pcsw3vmx	192	53	,	,	,
cord-273505-pcsw3vmx	192	54	191	191	CD
cord-273505-pcsw3vmx	192	55	,	,	,
cord-273505-pcsw3vmx	192	56	192	192	CD
cord-273505-pcsw3vmx	192	57	)	)	-RRB-
cord-273505-pcsw3vmx	192	58	.	.	.
cord-273505-pcsw3vmx	193	1	Except	except	IN
cord-273505-pcsw3vmx	193	2	for	for	IN
cord-273505-pcsw3vmx	193	3	FcRs	FcRs	NNP
cord-273505-pcsw3vmx	193	4	,	,	,
cord-273505-pcsw3vmx	193	5	the	the	DT
cord-273505-pcsw3vmx	193	6	TLR-9	TLR-9	NNP
cord-273505-pcsw3vmx	193	7	signaling	signal	VBG
cord-273505-pcsw3vmx	193	8	cascade	cascade	NN
cord-273505-pcsw3vmx	193	9	may	may	MD
cord-273505-pcsw3vmx	193	10	also	also	RB
cord-273505-pcsw3vmx	193	11	be	be	VB
cord-273505-pcsw3vmx	193	12	involved	involve	VBN
cord-273505-pcsw3vmx	193	13	in	in	IN
cord-273505-pcsw3vmx	193	14	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	193	15	effects	effect	NNS
cord-273505-pcsw3vmx	193	16	.	.	.
cord-273505-pcsw3vmx	194	1	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	194	2	could	could	MD
cord-273505-pcsw3vmx	194	3	mimic	mimic	VB
cord-273505-pcsw3vmx	194	4	the	the	DT
cord-273505-pcsw3vmx	194	5	effects	effect	NNS
cord-273505-pcsw3vmx	194	6	of	of	IN
cord-273505-pcsw3vmx	194	7	MyD88	myd88	JJ
cord-273505-pcsw3vmx	194	8	inhibitors	inhibitor	NNS
cord-273505-pcsw3vmx	194	9	and	and	CC
cord-273505-pcsw3vmx	194	10	result	result	VB
cord-273505-pcsw3vmx	194	11	in	in	IN
cord-273505-pcsw3vmx	194	12	the	the	DT
cord-273505-pcsw3vmx	194	13	suppression	suppression	NN
cord-273505-pcsw3vmx	194	14	of	of	IN
cord-273505-pcsw3vmx	194	15	the	the	DT
cord-273505-pcsw3vmx	194	16	TLR	TLR	NNP
cord-273505-pcsw3vmx	194	17	-	-	HYPH
cord-273505-pcsw3vmx	194	18	induced	induce	VBN
cord-273505-pcsw3vmx	194	19	NF	nf	NN
cord-273505-pcsw3vmx	194	20	-	-	HYPH
cord-273505-pcsw3vmx	194	21	κB	κB	NNP
cord-273505-pcsw3vmx	194	22	signaling	signal	VBG
cord-273505-pcsw3vmx	194	23	pathway	pathway	NN
cord-273505-pcsw3vmx	194	24	and	and	CC
cord-273505-pcsw3vmx	194	25	downstream	downstream	JJ
cord-273505-pcsw3vmx	194	26	production	production	NN
cord-273505-pcsw3vmx	194	27	of	of	IN
cord-273505-pcsw3vmx	194	28	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	194	29	(	(	-LRB-
cord-273505-pcsw3vmx	194	30	193	193	CD
cord-273505-pcsw3vmx	194	31	,	,	,
cord-273505-pcsw3vmx	194	32	194	194	CD
cord-273505-pcsw3vmx	194	33	)	)	-RRB-
cord-273505-pcsw3vmx	194	34	.	.	.
cord-273505-pcsw3vmx	195	1	A	a	DT
cord-273505-pcsw3vmx	195	2	"	"	``
cord-273505-pcsw3vmx	195	3	paradoxical	paradoxical	JJ
cord-273505-pcsw3vmx	195	4	"	"	''
cord-273505-pcsw3vmx	195	5	phenomenon	phenomenon	NN
cord-273505-pcsw3vmx	195	6	has	have	VBZ
cord-273505-pcsw3vmx	195	7	been	be	VBN
cord-273505-pcsw3vmx	195	8	observed	observe	VBN
cord-273505-pcsw3vmx	195	9	,	,	,
cord-273505-pcsw3vmx	195	10	where	where	WRB
cord-273505-pcsw3vmx	195	11	large	large	JJ
cord-273505-pcsw3vmx	195	12	amounts	amount	NNS
cord-273505-pcsw3vmx	195	13	of	of	IN
cord-273505-pcsw3vmx	195	14	immature	immature	JJ
cord-273505-pcsw3vmx	195	15	plasma	plasma	NN
cord-273505-pcsw3vmx	195	16	cells	cell	NNS
cord-273505-pcsw3vmx	195	17	were	be	VBD
cord-273505-pcsw3vmx	195	18	mobilized	mobilize	VBN
cord-273505-pcsw3vmx	195	19	after	after	IN
cord-273505-pcsw3vmx	195	20	high	high	JJ
cord-273505-pcsw3vmx	195	21	-	-	HYPH
cord-273505-pcsw3vmx	195	22	dose	dose	NN
cord-273505-pcsw3vmx	195	23	IVIg	ivig	NN
cord-273505-pcsw3vmx	195	24	therapy	therapy	NN
cord-273505-pcsw3vmx	195	25	in	in	IN
cord-273505-pcsw3vmx	195	26	patients	patient	NNS
cord-273505-pcsw3vmx	195	27	with	with	IN
cord-273505-pcsw3vmx	195	28	autoimmune	autoimmune	JJ
cord-273505-pcsw3vmx	195	29	diseases	disease	NNS
cord-273505-pcsw3vmx	195	30	,	,	,
cord-273505-pcsw3vmx	195	31	suggesting	suggest	VBG
cord-273505-pcsw3vmx	195	32	de	de	IN
cord-273505-pcsw3vmx	195	33	novo	novo	NNP
cord-273505-pcsw3vmx	195	34	B	B	NNP
cord-273505-pcsw3vmx	195	35	cell	cell	NN
cord-273505-pcsw3vmx	195	36	activation	activation	NN
cord-273505-pcsw3vmx	195	37	.	.	.
cord-273505-pcsw3vmx	196	1	This	this	DT
cord-273505-pcsw3vmx	196	2	is	be	VBZ
cord-273505-pcsw3vmx	196	3	consistent	consistent	JJ
cord-273505-pcsw3vmx	196	4	with	with	IN
cord-273505-pcsw3vmx	196	5	the	the	DT
cord-273505-pcsw3vmx	196	6	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	196	7	functions	function	NNS
cord-273505-pcsw3vmx	196	8	of	of	IN
cord-273505-pcsw3vmx	196	9	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	196	10	at	at	IN
cord-273505-pcsw3vmx	196	11	low	low	JJ
cord-273505-pcsw3vmx	196	12	doses	dose	NNS
cord-273505-pcsw3vmx	196	13	(	(	-LRB-
cord-273505-pcsw3vmx	196	14	184	184	CD
cord-273505-pcsw3vmx	196	15	,	,	,
cord-273505-pcsw3vmx	196	16	195	195	CD
cord-273505-pcsw3vmx	196	17	,	,	,
cord-273505-pcsw3vmx	196	18	196	196	CD
cord-273505-pcsw3vmx	196	19	)	)	-RRB-
cord-273505-pcsw3vmx	196	20	.	.	.
cord-273505-pcsw3vmx	197	1	Although	although	IN
cord-273505-pcsw3vmx	197	2	the	the	DT
cord-273505-pcsw3vmx	197	3	potential	potential	JJ
cord-273505-pcsw3vmx	197	4	roles	role	NNS
cord-273505-pcsw3vmx	197	5	of	of	IN
cord-273505-pcsw3vmx	197	6	plasma	plasma	NN
cord-273505-pcsw3vmx	197	7	blasts	blast	NNS
cord-273505-pcsw3vmx	197	8	under	under	IN
cord-273505-pcsw3vmx	197	9	different	different	JJ
cord-273505-pcsw3vmx	197	10	disease	disease	NN
cord-273505-pcsw3vmx	197	11	conditions	condition	NNS
cord-273505-pcsw3vmx	197	12	remain	remain	VBP
cord-273505-pcsw3vmx	197	13	unclear	unclear	JJ
cord-273505-pcsw3vmx	197	14	,	,	,
cord-273505-pcsw3vmx	197	15	this	this	DT
cord-273505-pcsw3vmx	197	16	phenomenon	phenomenon	NN
cord-273505-pcsw3vmx	197	17	highlights	highlight	VBZ
cord-273505-pcsw3vmx	197	18	binary	binary	JJ
cord-273505-pcsw3vmx	197	19	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	197	20	effects	effect	NNS
cord-273505-pcsw3vmx	197	21	of	of	IN
cord-273505-pcsw3vmx	197	22	high	high	JJ
cord-273505-pcsw3vmx	197	23	-	-	HYPH
cord-273505-pcsw3vmx	197	24	dose	dose	NN
cord-273505-pcsw3vmx	197	25	IVIg	ivig	NN
cord-273505-pcsw3vmx	197	26	to	to	IN
cord-273505-pcsw3vmx	197	27	humoral	humoral	JJ
cord-273505-pcsw3vmx	197	28	immunity	immunity	NN
cord-273505-pcsw3vmx	197	29	.	.	.
cord-273505-pcsw3vmx	198	1	To	to	TO
cord-273505-pcsw3vmx	198	2	summarize	summarize	VB
cord-273505-pcsw3vmx	198	3	,	,	,
cord-273505-pcsw3vmx	198	4	the	the	DT
cord-273505-pcsw3vmx	198	5	cytokine	cytokine	NN
cord-273505-pcsw3vmx	198	6	storm	storm	NN
cord-273505-pcsw3vmx	198	7	observed	observe	VBD
cord-273505-pcsw3vmx	198	8	during	during	IN
cord-273505-pcsw3vmx	198	9	severe	severe	JJ
cord-273505-pcsw3vmx	198	10	viral	viral	JJ
cord-273505-pcsw3vmx	198	11	infection	infection	NN
cord-273505-pcsw3vmx	198	12	is	be	VBZ
cord-273505-pcsw3vmx	198	13	associated	associate	VBN
cord-273505-pcsw3vmx	198	14	with	with	IN
cord-273505-pcsw3vmx	198	15	various	various	JJ
cord-273505-pcsw3vmx	198	16	immune	immune	JJ
cord-273505-pcsw3vmx	198	17	dysfunctions	dysfunction	NNS
cord-273505-pcsw3vmx	198	18	.	.	.
cord-273505-pcsw3vmx	199	1	Several	several	JJ
cord-273505-pcsw3vmx	199	2	therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	199	3	interventions	intervention	NNS
cord-273505-pcsw3vmx	199	4	targeting	target	VBG
cord-273505-pcsw3vmx	199	5	the	the	DT
cord-273505-pcsw3vmx	199	6	host	host	NN
cord-273505-pcsw3vmx	199	7	immune	immune	JJ
cord-273505-pcsw3vmx	199	8	response	response	NN
cord-273505-pcsw3vmx	199	9	have	have	VBP
cord-273505-pcsw3vmx	199	10	been	be	VBN
cord-273505-pcsw3vmx	199	11	attempted	attempt	VBN
cord-273505-pcsw3vmx	199	12	.	.	.
cord-273505-pcsw3vmx	200	1	Although	although	IN
cord-273505-pcsw3vmx	200	2	the	the	DT
cord-273505-pcsw3vmx	200	3	proposed	propose	VBN
cord-273505-pcsw3vmx	200	4	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	200	5	of	of	IN
cord-273505-pcsw3vmx	200	6	high	high	JJ
cord-273505-pcsw3vmx	200	7	-	-	HYPH
cord-273505-pcsw3vmx	200	8	dose	dose	NN
cord-273505-pcsw3vmx	200	9	IVIg	ivig	NN
cord-273505-pcsw3vmx	200	10	on	on	IN
cord-273505-pcsw3vmx	200	11	the	the	DT
cord-273505-pcsw3vmx	200	12	modulation	modulation	NN
cord-273505-pcsw3vmx	200	13	immune	immune	JJ
cord-273505-pcsw3vmx	200	14	cells	cell	NNS
cord-273505-pcsw3vmx	200	15	and	and	CC
cord-273505-pcsw3vmx	200	16	cytokine	cytokine	NN
cord-273505-pcsw3vmx	200	17	cascades	cascade	NNS
cord-273505-pcsw3vmx	200	18	are	be	VBP
cord-273505-pcsw3vmx	200	19	mainly	mainly	RB
cord-273505-pcsw3vmx	200	20	derived	derive	VBN
cord-273505-pcsw3vmx	200	21	from	from	IN
cord-273505-pcsw3vmx	200	22	research	research	NN
cord-273505-pcsw3vmx	200	23	into	into	IN
cord-273505-pcsw3vmx	200	24	autoimmune	autoimmune	JJ
cord-273505-pcsw3vmx	200	25	diseases	disease	NNS
cord-273505-pcsw3vmx	200	26	,	,	,
cord-273505-pcsw3vmx	200	27	its	-PRON-	PRP$
cord-273505-pcsw3vmx	200	28	use	use	NN
cord-273505-pcsw3vmx	200	29	in	in	IN
cord-273505-pcsw3vmx	200	30	reversing	reverse	VBG
cord-273505-pcsw3vmx	200	31	a	a	DT
cord-273505-pcsw3vmx	200	32	cytokine	cytokine	NN
cord-273505-pcsw3vmx	200	33	storm	storm	NN
cord-273505-pcsw3vmx	200	34	,	,	,
cord-273505-pcsw3vmx	200	35	in	in	IN
cord-273505-pcsw3vmx	200	36	addition	addition	NN
cord-273505-pcsw3vmx	200	37	to	to	IN
cord-273505-pcsw3vmx	200	38	providing	provide	VBG
cord-273505-pcsw3vmx	200	39	passive	passive	JJ
cord-273505-pcsw3vmx	200	40	immunity	immunity	NN
cord-273505-pcsw3vmx	200	41	during	during	IN
cord-273505-pcsw3vmx	200	42	severe	severe	JJ
cord-273505-pcsw3vmx	200	43	viral	viral	JJ
cord-273505-pcsw3vmx	200	44	infection	infection	NN
cord-273505-pcsw3vmx	200	45	,	,	,
cord-273505-pcsw3vmx	200	46	is	be	VBZ
cord-273505-pcsw3vmx	200	47	supported	support	VBN
cord-273505-pcsw3vmx	200	48	by	by	IN
cord-273505-pcsw3vmx	200	49	recent	recent	JJ
cord-273505-pcsw3vmx	200	50	evidence	evidence	NN
cord-273505-pcsw3vmx	200	51	.	.	.
cord-273505-pcsw3vmx	201	1	The	the	DT
cord-273505-pcsw3vmx	201	2	humoral	humoral	JJ
cord-273505-pcsw3vmx	201	3	immune	immune	JJ
cord-273505-pcsw3vmx	201	4	response	response	NN
cord-273505-pcsw3vmx	201	5	to	to	IN
cord-273505-pcsw3vmx	201	6	invading	invade	VBG
cord-273505-pcsw3vmx	201	7	pathogens	pathogen	NNS
cord-273505-pcsw3vmx	201	8	by	by	IN
cord-273505-pcsw3vmx	201	9	producing	produce	VBG
cord-273505-pcsw3vmx	201	10	neutralizing	neutralize	VBG
cord-273505-pcsw3vmx	201	11	antibodies	antibody	NNS
cord-273505-pcsw3vmx	201	12	is	be	VBZ
cord-273505-pcsw3vmx	201	13	crucial	crucial	JJ
cord-273505-pcsw3vmx	201	14	in	in	IN
cord-273505-pcsw3vmx	201	15	the	the	DT
cord-273505-pcsw3vmx	201	16	host	host	NN
cord-273505-pcsw3vmx	201	17	adaptive	adaptive	JJ
cord-273505-pcsw3vmx	201	18	immune	immune	JJ
cord-273505-pcsw3vmx	201	19	system	system	NN
cord-273505-pcsw3vmx	201	20	.	.	.
cord-273505-pcsw3vmx	202	1	Paradoxically	paradoxically	RB
cord-273505-pcsw3vmx	202	2	,	,	,
cord-273505-pcsw3vmx	202	3	antibodies	antibody	NNS
cord-273505-pcsw3vmx	202	4	may	may	MD
cord-273505-pcsw3vmx	202	5	provide	provide	VB
cord-273505-pcsw3vmx	202	6	an	an	DT
cord-273505-pcsw3vmx	202	7	attractive	attractive	JJ
cord-273505-pcsw3vmx	202	8	means	mean	NNS
cord-273505-pcsw3vmx	202	9	for	for	IN
cord-273505-pcsw3vmx	202	10	a	a	DT
cord-273505-pcsw3vmx	202	11	variety	variety	NN
cord-273505-pcsw3vmx	202	12	of	of	IN
cord-273505-pcsw3vmx	202	13	viruses	virus	NNS
cord-273505-pcsw3vmx	202	14	to	to	TO
cord-273505-pcsw3vmx	202	15	enhance	enhance	VB
cord-273505-pcsw3vmx	202	16	viral	viral	JJ
cord-273505-pcsw3vmx	202	17	entry	entry	NN
cord-273505-pcsw3vmx	202	18	and	and	CC
cord-273505-pcsw3vmx	202	19	replication	replication	NN
cord-273505-pcsw3vmx	202	20	in	in	IN
cord-273505-pcsw3vmx	202	21	some	some	DT
cord-273505-pcsw3vmx	202	22	cell	cell	NN
cord-273505-pcsw3vmx	202	23	types	type	NNS
cord-273505-pcsw3vmx	202	24	under	under	IN
cord-273505-pcsw3vmx	202	25	certain	certain	JJ
cord-273505-pcsw3vmx	202	26	conditions	condition	NNS
cord-273505-pcsw3vmx	202	27	.	.	.
cord-273505-pcsw3vmx	203	1	The	the	DT
cord-273505-pcsw3vmx	203	2	unique	unique	JJ
cord-273505-pcsw3vmx	203	3	phenomenon	phenomenon	NN
cord-273505-pcsw3vmx	203	4	that	that	IN
cord-273505-pcsw3vmx	203	5	preexisting	preexist	VBG
cord-273505-pcsw3vmx	203	6	poor	poor	JJ
cord-273505-pcsw3vmx	203	7	neutralizing	neutralize	VBG
cord-273505-pcsw3vmx	203	8	antibodies	antibody	NNS
cord-273505-pcsw3vmx	203	9	facilitate	facilitate	VBP
cord-273505-pcsw3vmx	203	10	viral	viral	JJ
cord-273505-pcsw3vmx	203	11	access	access	NN
cord-273505-pcsw3vmx	203	12	to	to	IN
cord-273505-pcsw3vmx	203	13	FcγRs	FcγRs	NNP
cord-273505-pcsw3vmx	203	14	and	and	CC
cord-273505-pcsw3vmx	203	15	lead	lead	VB
cord-273505-pcsw3vmx	203	16	to	to	IN
cord-273505-pcsw3vmx	203	17	enhanced	enhance	VBN
cord-273505-pcsw3vmx	203	18	infection	infection	NN
cord-273505-pcsw3vmx	203	19	or	or	CC
cord-273505-pcsw3vmx	203	20	immunopathology	immunopathology	NN
cord-273505-pcsw3vmx	203	21	is	be	VBZ
cord-273505-pcsw3vmx	203	22	also	also	RB
cord-273505-pcsw3vmx	203	23	referred	refer	VBN
cord-273505-pcsw3vmx	203	24	to	to	IN
cord-273505-pcsw3vmx	203	25	as	as	IN
cord-273505-pcsw3vmx	203	26	antibodydependent	antibodydependent	NN
cord-273505-pcsw3vmx	203	27	enhancement	enhancement	NN
cord-273505-pcsw3vmx	203	28	(	(	-LRB-
cord-273505-pcsw3vmx	203	29	ADE	ADE	NNP
cord-273505-pcsw3vmx	203	30	)	)	-RRB-
cord-273505-pcsw3vmx	203	31	.	.	.
cord-273505-pcsw3vmx	204	1	ADE	ADE	NNP
cord-273505-pcsw3vmx	204	2	has	have	VBZ
cord-273505-pcsw3vmx	204	3	been	be	VBN
cord-273505-pcsw3vmx	204	4	implicated	implicate	VBN
cord-273505-pcsw3vmx	204	5	widely	widely	RB
cord-273505-pcsw3vmx	204	6	in	in	IN
cord-273505-pcsw3vmx	204	7	flavivirus	flavivirus	JJ
cord-273505-pcsw3vmx	204	8	infections	infection	NNS
cord-273505-pcsw3vmx	204	9	,	,	,
cord-273505-pcsw3vmx	204	10	such	such	JJ
cord-273505-pcsw3vmx	204	11	as	as	IN
cord-273505-pcsw3vmx	204	12	WNV	WNV	NNP
cord-273505-pcsw3vmx	204	13	and	and	CC
cord-273505-pcsw3vmx	204	14	DENV	DENV	NNP
cord-273505-pcsw3vmx	204	15	,	,	,
cord-273505-pcsw3vmx	204	16	and	and	CC
cord-273505-pcsw3vmx	204	17	highdose	highdose	NN
cord-273505-pcsw3vmx	204	18	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	204	19	is	be	VBZ
cord-273505-pcsw3vmx	204	20	commonly	commonly	RB
cord-273505-pcsw3vmx	204	21	used	use	VBN
cord-273505-pcsw3vmx	204	22	in	in	IN
cord-273505-pcsw3vmx	204	23	treating	treat	VBG
cord-273505-pcsw3vmx	204	24	WNV	WNV	NNP
cord-273505-pcsw3vmx	204	25	encephalitis	encephalitis	RB
cord-273505-pcsw3vmx	204	26	with	with	IN
cord-273505-pcsw3vmx	204	27	satisfactory	satisfactory	JJ
cord-273505-pcsw3vmx	204	28	effect	effect	NN
cord-273505-pcsw3vmx	204	29	.	.	.
cord-273505-pcsw3vmx	205	1	However	however	RB
cord-273505-pcsw3vmx	205	2	,	,	,
cord-273505-pcsw3vmx	205	3	little	little	JJ
cord-273505-pcsw3vmx	205	4	is	be	VBZ
cord-273505-pcsw3vmx	205	5	known	know	VBN
cord-273505-pcsw3vmx	205	6	about	about	IN
cord-273505-pcsw3vmx	205	7	ADE	ADE	NNP
cord-273505-pcsw3vmx	205	8	in	in	IN
cord-273505-pcsw3vmx	205	9	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	205	10	virus	virus	NN
cord-273505-pcsw3vmx	205	11	infection	infection	NN
cord-273505-pcsw3vmx	205	12	(	(	-LRB-
cord-273505-pcsw3vmx	205	13	197	197	CD
cord-273505-pcsw3vmx	205	14	)	)	-RRB-
cord-273505-pcsw3vmx	205	15	(	(	-LRB-
cord-273505-pcsw3vmx	205	16	198	198	CD
cord-273505-pcsw3vmx	205	17	)	)	-RRB-
cord-273505-pcsw3vmx	205	18	(	(	-LRB-
cord-273505-pcsw3vmx	205	19	199	199	CD
cord-273505-pcsw3vmx	205	20	)	)	-RRB-
cord-273505-pcsw3vmx	205	21	.	.	.
cord-273505-pcsw3vmx	206	1	ADE	ADE	NNP
cord-273505-pcsw3vmx	206	2	is	be	VBZ
cord-273505-pcsw3vmx	206	3	currently	currently	RB
cord-273505-pcsw3vmx	206	4	being	be	VBG
cord-273505-pcsw3vmx	206	5	considered	consider	VBN
cord-273505-pcsw3vmx	206	6	as	as	IN
cord-273505-pcsw3vmx	206	7	a	a	DT
cord-273505-pcsw3vmx	206	8	potential	potential	JJ
cord-273505-pcsw3vmx	206	9	contributor	contributor	NN
cord-273505-pcsw3vmx	206	10	to	to	IN
cord-273505-pcsw3vmx	206	11	the	the	DT
cord-273505-pcsw3vmx	206	12	immunopathology	immunopathology	NN
cord-273505-pcsw3vmx	206	13	of	of	IN
cord-273505-pcsw3vmx	206	14	SARS	SARS	NNP
cord-273505-pcsw3vmx	206	15	.	.	.
cord-273505-pcsw3vmx	207	1	People	People	NNS
cord-273505-pcsw3vmx	207	2	who	who	WP
cord-273505-pcsw3vmx	207	3	succumbed	succumb	VBD
cord-273505-pcsw3vmx	207	4	to	to	IN
cord-273505-pcsw3vmx	207	5	SARS	SARS	NNP
cord-273505-pcsw3vmx	207	6	had	have	VBD
cord-273505-pcsw3vmx	207	7	significantly	significantly	RB
cord-273505-pcsw3vmx	207	8	higher	high	JJR
cord-273505-pcsw3vmx	207	9	S	S	NNP
cord-273505-pcsw3vmx	207	10	glycoprotein	glycoprotein	NN
cord-273505-pcsw3vmx	207	11	-	-	HYPH
cord-273505-pcsw3vmx	207	12	specific	specific	JJ
cord-273505-pcsw3vmx	207	13	neutralizing	neutralize	VBG
cord-273505-pcsw3vmx	207	14	antibodies	antibody	NNS
cord-273505-pcsw3vmx	207	15	in	in	IN
cord-273505-pcsw3vmx	207	16	serum	serum	NN
cord-273505-pcsw3vmx	207	17	during	during	IN
cord-273505-pcsw3vmx	207	18	the	the	DT
cord-273505-pcsw3vmx	207	19	early	early	JJ
cord-273505-pcsw3vmx	207	20	stage	stage	NN
cord-273505-pcsw3vmx	207	21	of	of	IN
cord-273505-pcsw3vmx	207	22	infection	infection	NN
cord-273505-pcsw3vmx	207	23	,	,	,
cord-273505-pcsw3vmx	207	24	indicating	indicate	VBG
cord-273505-pcsw3vmx	207	25	the	the	DT
cord-273505-pcsw3vmx	207	26	possible	possible	JJ
cord-273505-pcsw3vmx	207	27	presence	presence	NN
cord-273505-pcsw3vmx	207	28	of	of	IN
cord-273505-pcsw3vmx	207	29	ADE	ADE	NNP
cord-273505-pcsw3vmx	207	30	(	(	-LRB-
cord-273505-pcsw3vmx	207	31	200	200	CD
cord-273505-pcsw3vmx	207	32	)	)	-RRB-
cord-273505-pcsw3vmx	207	33	.	.	.
cord-273505-pcsw3vmx	208	1	Similarly	similarly	RB
cord-273505-pcsw3vmx	208	2	,	,	,
cord-273505-pcsw3vmx	208	3	recent	recent	JJ
cord-273505-pcsw3vmx	208	4	results	result	NNS
cord-273505-pcsw3vmx	208	5	in	in	IN
cord-273505-pcsw3vmx	208	6	SARS	SARS	NNP
cord-273505-pcsw3vmx	208	7	-	-	HYPH
cord-273505-pcsw3vmx	208	8	CoV	CoV	NNP
cord-273505-pcsw3vmx	208	9	-	-	HYPH
cord-273505-pcsw3vmx	208	10	infected	infect	VBN
cord-273505-pcsw3vmx	208	11	Chinese	chinese	JJ
cord-273505-pcsw3vmx	208	12	rhesus	rhesu	NNS
cord-273505-pcsw3vmx	208	13	macaques	macaque	NNS
cord-273505-pcsw3vmx	208	14	consistently	consistently	RB
cord-273505-pcsw3vmx	208	15	showed	show	VBD
cord-273505-pcsw3vmx	208	16	that	that	IN
cord-273505-pcsw3vmx	208	17	anti	anti	JJ
cord-273505-pcsw3vmx	208	18	-	-	JJ
cord-273505-pcsw3vmx	208	19	spike	spike	JJ
cord-273505-pcsw3vmx	208	20	IgG	igg	NN
cord-273505-pcsw3vmx	208	21	significantly	significantly	RB
cord-273505-pcsw3vmx	208	22	amplified	amplify	VBD
cord-273505-pcsw3vmx	208	23	pro	pro	JJ
cord-273505-pcsw3vmx	208	24	-	-	JJ
cord-273505-pcsw3vmx	208	25	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	208	26	cytokine	cytokine	NN
cord-273505-pcsw3vmx	208	27	production	production	NN
cord-273505-pcsw3vmx	208	28	in	in	IN
cord-273505-pcsw3vmx	208	29	activated	activate	VBN
cord-273505-pcsw3vmx	208	30	macrophages	macrophage	NNS
cord-273505-pcsw3vmx	208	31	and	and	CC
cord-273505-pcsw3vmx	208	32	enhanced	enhanced	JJ
cord-273505-pcsw3vmx	208	33	pulmonary	pulmonary	JJ
cord-273505-pcsw3vmx	208	34	pathology	pathology	NN
cord-273505-pcsw3vmx	208	35	.	.	.
cord-273505-pcsw3vmx	209	1	These	these	DT
cord-273505-pcsw3vmx	209	2	effects	effect	NNS
cord-273505-pcsw3vmx	209	3	could	could	MD
cord-273505-pcsw3vmx	209	4	be	be	VB
cord-273505-pcsw3vmx	209	5	reduced	reduce	VBN
cord-273505-pcsw3vmx	209	6	by	by	IN
cord-273505-pcsw3vmx	209	7	the	the	DT
cord-273505-pcsw3vmx	209	8	FcγRII	FcγRII	NNP
cord-273505-pcsw3vmx	209	9	blocking	block	VBG
cord-273505-pcsw3vmx	209	10	antibody	antibody	NN
cord-273505-pcsw3vmx	209	11	(	(	-LRB-
cord-273505-pcsw3vmx	209	12	110	110	CD
cord-273505-pcsw3vmx	209	13	)	)	-RRB-
cord-273505-pcsw3vmx	209	14	.	.	.
cord-273505-pcsw3vmx	210	1	Similarly	similarly	RB
cord-273505-pcsw3vmx	210	2	,	,	,
cord-273505-pcsw3vmx	210	3	it	-PRON-	PRP
cord-273505-pcsw3vmx	210	4	has	have	VBZ
cord-273505-pcsw3vmx	210	5	been	be	VBN
cord-273505-pcsw3vmx	210	6	shown	show	VBN
cord-273505-pcsw3vmx	210	7	that	that	IN
cord-273505-pcsw3vmx	210	8	infection	infection	NN
cord-273505-pcsw3vmx	210	9	of	of	IN
cord-273505-pcsw3vmx	210	10	macrophages	macrophage	NNS
cord-273505-pcsw3vmx	210	11	is	be	VBZ
cord-273505-pcsw3vmx	210	12	enhanced	enhance	VBN
cord-273505-pcsw3vmx	210	13	by	by	IN
cord-273505-pcsw3vmx	210	14	anti	anti	JJ
cord-273505-pcsw3vmx	210	15	-	-	JJ
cord-273505-pcsw3vmx	210	16	SARS	SARS	NNP
cord-273505-pcsw3vmx	210	17	-	-	HYPH
cord-273505-pcsw3vmx	210	18	CoV	CoV	NNP
cord-273505-pcsw3vmx	210	19	spike	spike	NN
cord-273505-pcsw3vmx	210	20	immune	immune	JJ
cord-273505-pcsw3vmx	210	21	serum	serum	NN
cord-273505-pcsw3vmx	210	22	but	but	CC
cord-273505-pcsw3vmx	210	23	eliminated	eliminate	VBN
cord-273505-pcsw3vmx	210	24	by	by	IN
cord-273505-pcsw3vmx	210	25	the	the	DT
cord-273505-pcsw3vmx	210	26	FcγRII	FcγRII	NNP
cord-273505-pcsw3vmx	210	27	antibody	antibody	NN
cord-273505-pcsw3vmx	210	28	,	,	,
cord-273505-pcsw3vmx	210	29	suggesting	suggest	VBG
cord-273505-pcsw3vmx	210	30	an	an	DT
cord-273505-pcsw3vmx	210	31	FcγRII	fcγrii	JJ
cord-273505-pcsw3vmx	210	32	-	-	HYPH
cord-273505-pcsw3vmx	210	33	dependent	dependent	JJ
cord-273505-pcsw3vmx	210	34	ADE	ade	NN
cord-273505-pcsw3vmx	210	35	of	of	IN
cord-273505-pcsw3vmx	210	36	SARS	SARS	NNP
cord-273505-pcsw3vmx	210	37	-	-	HYPH
cord-273505-pcsw3vmx	210	38	CoV	CoV	NNP
cord-273505-pcsw3vmx	210	39	(	(	-LRB-
cord-273505-pcsw3vmx	210	40	201	201	CD
cord-273505-pcsw3vmx	210	41	)	)	-RRB-
cord-273505-pcsw3vmx	210	42	.	.	.
cord-273505-pcsw3vmx	211	1	Molecular	molecular	JJ
cord-273505-pcsw3vmx	211	2	signaling	signal	VBG
cord-273505-pcsw3vmx	211	3	analyses	analysis	NNS
cord-273505-pcsw3vmx	211	4	investigating	investigate	VBG
cord-273505-pcsw3vmx	211	5	FcγRIImediated	fcγriimediated	JJ
cord-273505-pcsw3vmx	211	6	infection	infection	NN
cord-273505-pcsw3vmx	211	7	by	by	IN
cord-273505-pcsw3vmx	211	8	SARS	SARS	NNP
cord-273505-pcsw3vmx	211	9	-	-	HYPH
cord-273505-pcsw3vmx	211	10	CoV	CoV	NNP
cord-273505-pcsw3vmx	212	1	revealed	reveal	VBD
cord-273505-pcsw3vmx	212	2	that	that	IN
cord-273505-pcsw3vmx	212	3	an	an	DT
cord-273505-pcsw3vmx	212	4	intact	intact	JJ
cord-273505-pcsw3vmx	212	5	cytosolic	cytosolic	JJ
cord-273505-pcsw3vmx	212	6	domain	domain	NN
cord-273505-pcsw3vmx	212	7	of	of	IN
cord-273505-pcsw3vmx	212	8	FcγR	FcγR	NNP
cord-273505-pcsw3vmx	212	9	was	be	VBD
cord-273505-pcsw3vmx	212	10	required	require	VBN
cord-273505-pcsw3vmx	212	11	,	,	,
cord-273505-pcsw3vmx	212	12	and	and	CC
cord-273505-pcsw3vmx	212	13	FcγRIIA	FcγRIIA	NNP
cord-273505-pcsw3vmx	212	14	was	be	VBD
cord-273505-pcsw3vmx	212	15	more	more	RBR
cord-273505-pcsw3vmx	212	16	prone	prone	JJ
cord-273505-pcsw3vmx	212	17	to	to	IN
cord-273505-pcsw3vmx	212	18	ADE	ADE	NNP
cord-273505-pcsw3vmx	212	19	than	than	IN
cord-273505-pcsw3vmx	212	20	FcγRIIB	FcγRIIB	NNP
cord-273505-pcsw3vmx	212	21	(	(	-LRB-
cord-273505-pcsw3vmx	212	22	202	202	CD
cord-273505-pcsw3vmx	212	23	)	)	-RRB-
cord-273505-pcsw3vmx	212	24	.	.	.
cord-273505-pcsw3vmx	213	1	Although	although	IN
cord-273505-pcsw3vmx	213	2	in	in	IN
cord-273505-pcsw3vmx	213	3	vivo	vivo	NN
cord-273505-pcsw3vmx	213	4	evidence	evidence	NN
cord-273505-pcsw3vmx	213	5	of	of	IN
cord-273505-pcsw3vmx	213	6	ADE	ADE	NNP
cord-273505-pcsw3vmx	213	7	in	in	IN
cord-273505-pcsw3vmx	213	8	MERS	MERS	NNP
cord-273505-pcsw3vmx	213	9	is	be	VBZ
cord-273505-pcsw3vmx	213	10	lacking	lack	VBG
cord-273505-pcsw3vmx	213	11	,	,	,
cord-273505-pcsw3vmx	213	12	it	-PRON-	PRP
cord-273505-pcsw3vmx	213	13	has	have	VBZ
cord-273505-pcsw3vmx	213	14	been	be	VBN
cord-273505-pcsw3vmx	213	15	shown	show	VBN
cord-273505-pcsw3vmx	213	16	that	that	IN
cord-273505-pcsw3vmx	213	17	MERS	MERS	NNP
cord-273505-pcsw3vmx	213	18	-	-	HYPH
cord-273505-pcsw3vmx	213	19	CoV	cov	NN
cord-273505-pcsw3vmx	213	20	infections	infection	NNS
cord-273505-pcsw3vmx	213	21	depended	depend	VBD
cord-273505-pcsw3vmx	213	22	on	on	IN
cord-273505-pcsw3vmx	213	23	monoclonal	monoclonal	JJ
cord-273505-pcsw3vmx	213	24	antibody	antibody	NN
cord-273505-pcsw3vmx	213	25	(	(	-LRB-
cord-273505-pcsw3vmx	213	26	MAb	MAb	NNS
cord-273505-pcsw3vmx	213	27	)	)	-RRB-
cord-273505-pcsw3vmx	213	28	concentration	concentration	NN
cord-273505-pcsw3vmx	213	29	,	,	,
cord-273505-pcsw3vmx	213	30	binding	bind	VBG
cord-273505-pcsw3vmx	213	31	affinity	affinity	NN
cord-273505-pcsw3vmx	213	32	of	of	IN
cord-273505-pcsw3vmx	213	33	MAb	MAb	NNS
cord-273505-pcsw3vmx	213	34	for	for	IN
cord-273505-pcsw3vmx	213	35	the	the	DT
cord-273505-pcsw3vmx	213	36	viral	viral	JJ
cord-273505-pcsw3vmx	213	37	receptor	receptor	NN
cord-273505-pcsw3vmx	213	38	DPP4	DPP4	NNP
cord-273505-pcsw3vmx	213	39	,	,	,
cord-273505-pcsw3vmx	213	40	and	and	CC
cord-273505-pcsw3vmx	213	41	tissue	tissue	NN
cord-273505-pcsw3vmx	213	42	expressions	expression	NNS
cord-273505-pcsw3vmx	213	43	of	of	IN
cord-273505-pcsw3vmx	213	44	DPP4	DPP4	NNP
cord-273505-pcsw3vmx	213	45	and	and	CC
cord-273505-pcsw3vmx	213	46	FcγR	FcγR	NNP
cord-273505-pcsw3vmx	213	47	,	,	,
cord-273505-pcsw3vmx	213	48	providing	provide	VBG
cord-273505-pcsw3vmx	213	49	a	a	DT
cord-273505-pcsw3vmx	213	50	molecular	molecular	JJ
cord-273505-pcsw3vmx	213	51	basis	basis	NN
cord-273505-pcsw3vmx	213	52	of	of	IN
cord-273505-pcsw3vmx	213	53	ADE	ADE	NNP
cord-273505-pcsw3vmx	213	54	in	in	IN
cord-273505-pcsw3vmx	213	55	MERS	MERS	NNP
cord-273505-pcsw3vmx	213	56	-	-	HYPH
cord-273505-pcsw3vmx	213	57	CoV	CoV	NNP
cord-273505-pcsw3vmx	213	58	(	(	-LRB-
cord-273505-pcsw3vmx	213	59	203	203	CD
cord-273505-pcsw3vmx	213	60	)	)	-RRB-
cord-273505-pcsw3vmx	213	61	.	.	.
cord-273505-pcsw3vmx	214	1	Likewise	likewise	RB
cord-273505-pcsw3vmx	214	2	,	,	,
cord-273505-pcsw3vmx	214	3	the	the	DT
cord-273505-pcsw3vmx	214	4	presence	presence	NN
cord-273505-pcsw3vmx	214	5	of	of	IN
cord-273505-pcsw3vmx	214	6	sub	sub	NN
cord-273505-pcsw3vmx	214	7	-	-	JJ
cord-273505-pcsw3vmx	214	8	neutralizing	neutralize	VBG
cord-273505-pcsw3vmx	214	9	titers	titer	NNS
cord-273505-pcsw3vmx	214	10	of	of	IN
cord-273505-pcsw3vmx	214	11	antibodies	antibody	NNS
cord-273505-pcsw3vmx	214	12	is	be	VBZ
cord-273505-pcsw3vmx	214	13	also	also	RB
cord-273505-pcsw3vmx	214	14	a	a	DT
cord-273505-pcsw3vmx	214	15	contributing	contribute	VBG
cord-273505-pcsw3vmx	214	16	factor	factor	NN
cord-273505-pcsw3vmx	214	17	to	to	IN
cord-273505-pcsw3vmx	214	18	the	the	DT
cord-273505-pcsw3vmx	214	19	unfavorable	unfavorable	JJ
cord-273505-pcsw3vmx	214	20	outcome	outcome	NN
cord-273505-pcsw3vmx	214	21	in	in	IN
cord-273505-pcsw3vmx	214	22	influenza	influenza	NN
cord-273505-pcsw3vmx	214	23	infection	infection	NN
cord-273505-pcsw3vmx	214	24	.	.	.
cord-273505-pcsw3vmx	215	1	Prophylactic	prophylactic	JJ
cord-273505-pcsw3vmx	215	2	treatment	treatment	NN
cord-273505-pcsw3vmx	215	3	with	with	IN
cord-273505-pcsw3vmx	215	4	monoclonal	monoclonal	JJ
cord-273505-pcsw3vmx	215	5	antibodies	antibody	NNS
cord-273505-pcsw3vmx	215	6	at	at	IN
cord-273505-pcsw3vmx	215	7	a	a	DT
cord-273505-pcsw3vmx	215	8	low	low	JJ
cord-273505-pcsw3vmx	215	9	dose	dose	NN
cord-273505-pcsw3vmx	215	10	following	follow	VBG
cord-273505-pcsw3vmx	215	11	the	the	DT
cord-273505-pcsw3vmx	215	12	H3N2	H3N2	NNP
cord-273505-pcsw3vmx	215	13	virus	virus	NN
cord-273505-pcsw3vmx	215	14	challenge	challenge	NN
cord-273505-pcsw3vmx	215	15	in	in	IN
cord-273505-pcsw3vmx	215	16	mice	mouse	NNS
cord-273505-pcsw3vmx	215	17	has	have	VBZ
cord-273505-pcsw3vmx	215	18	shown	show	VBN
cord-273505-pcsw3vmx	215	19	enhanced	enhance	VBN
cord-273505-pcsw3vmx	215	20	cellular	cellular	JJ
cord-273505-pcsw3vmx	215	21	infiltration	infiltration	NN
cord-273505-pcsw3vmx	215	22	and	and	CC
cord-273505-pcsw3vmx	215	23	lung	lung	NN
cord-273505-pcsw3vmx	215	24	pathology	pathology	NN
cord-273505-pcsw3vmx	215	25	compared	compare	VBN
cord-273505-pcsw3vmx	215	26	to	to	IN
cord-273505-pcsw3vmx	215	27	the	the	DT
cord-273505-pcsw3vmx	215	28	control	control	NN
cord-273505-pcsw3vmx	215	29	group	group	NN
cord-273505-pcsw3vmx	215	30	(	(	-LRB-
cord-273505-pcsw3vmx	215	31	204	204	CD
cord-273505-pcsw3vmx	215	32	)	)	-RRB-
cord-273505-pcsw3vmx	215	33	.	.	.
cord-273505-pcsw3vmx	216	1	In	in	IN
cord-273505-pcsw3vmx	216	2	contrast	contrast	NN
cord-273505-pcsw3vmx	216	3	,	,	,
cord-273505-pcsw3vmx	216	4	a	a	DT
cord-273505-pcsw3vmx	216	5	high	high	JJ
cord-273505-pcsw3vmx	216	6	dose	dose	NN
cord-273505-pcsw3vmx	216	7	prophylaxis	prophylaxis	NN
cord-273505-pcsw3vmx	216	8	showed	show	VBD
cord-273505-pcsw3vmx	216	9	protective	protective	JJ
cord-273505-pcsw3vmx	216	10	effects	effect	NNS
cord-273505-pcsw3vmx	216	11	(	(	-LRB-
cord-273505-pcsw3vmx	216	12	204	204	CD
cord-273505-pcsw3vmx	216	13	)	)	-RRB-
cord-273505-pcsw3vmx	216	14	.	.	.
cord-273505-pcsw3vmx	217	1	Vaccinating	vaccinate	VBG
cord-273505-pcsw3vmx	217	2	pigs	pig	NNS
cord-273505-pcsw3vmx	217	3	against	against	IN
cord-273505-pcsw3vmx	217	4	H1N2	H1N2	NNP
cord-273505-pcsw3vmx	217	5	resulted	result	VBD
cord-273505-pcsw3vmx	217	6	in	in	IN
cord-273505-pcsw3vmx	217	7	the	the	DT
cord-273505-pcsw3vmx	217	8	generation	generation	NN
cord-273505-pcsw3vmx	217	9	of	of	IN
cord-273505-pcsw3vmx	217	10	cross	cross	JJ
cord-273505-pcsw3vmx	217	11	-	-	JJ
cord-273505-pcsw3vmx	217	12	reactive	reactive	JJ
cord-273505-pcsw3vmx	217	13	anti	anti	JJ
cord-273505-pcsw3vmx	217	14	-	-	NNP
cord-273505-pcsw3vmx	217	15	pH1N1	pH1N1	NNP
cord-273505-pcsw3vmx	217	16	HA2	HA2	NNP
cord-273505-pcsw3vmx	217	17	antibodies	antibody	NNS
cord-273505-pcsw3vmx	217	18	,	,	,
cord-273505-pcsw3vmx	217	19	which	which	WDT
cord-273505-pcsw3vmx	217	20	exhibited	exhibit	VBD
cord-273505-pcsw3vmx	217	21	poor	poor	JJ
cord-273505-pcsw3vmx	217	22	neutralizing	neutralize	VBG
cord-273505-pcsw3vmx	217	23	ability	ability	NN
cord-273505-pcsw3vmx	217	24	to	to	IN
cord-273505-pcsw3vmx	217	25	the	the	DT
cord-273505-pcsw3vmx	217	26	HA1	HA1	NNP
cord-273505-pcsw3vmx	217	27	domain	domain	NN
cord-273505-pcsw3vmx	217	28	and	and	CC
cord-273505-pcsw3vmx	217	29	enhanced	enhance	VBD
cord-273505-pcsw3vmx	217	30	pH1N1	pH1N1	NNP
cord-273505-pcsw3vmx	217	31	infection	infection	NN
cord-273505-pcsw3vmx	217	32	and	and	CC
cord-273505-pcsw3vmx	217	33	lung	lung	NN
cord-273505-pcsw3vmx	217	34	pathology	pathology	NN
cord-273505-pcsw3vmx	217	35	(	(	-LRB-
cord-273505-pcsw3vmx	217	36	205	205	CD
cord-273505-pcsw3vmx	217	37	)	)	-RRB-
cord-273505-pcsw3vmx	217	38	.	.	.
cord-273505-pcsw3vmx	218	1	Besides	besides	IN
cord-273505-pcsw3vmx	218	2	influenza	influenza	NN
cord-273505-pcsw3vmx	218	3	and	and	CC
cord-273505-pcsw3vmx	218	4	potentially	potentially	RB
cord-273505-pcsw3vmx	218	5	MERS	MERS	NNPS
cord-273505-pcsw3vmx	218	6	,	,	,
cord-273505-pcsw3vmx	218	7	the	the	DT
cord-273505-pcsw3vmx	218	8	ADE	ADE	NNP
cord-273505-pcsw3vmx	218	9	phenomenon	phenomenon	NN
cord-273505-pcsw3vmx	218	10	has	have	VBZ
cord-273505-pcsw3vmx	218	11	also	also	RB
cord-273505-pcsw3vmx	218	12	been	be	VBN
cord-273505-pcsw3vmx	218	13	observed	observe	VBN
cord-273505-pcsw3vmx	218	14	in	in	IN
cord-273505-pcsw3vmx	218	15	RSV	RSV	NNP
cord-273505-pcsw3vmx	218	16	infection	infection	NN
cord-273505-pcsw3vmx	218	17	(	(	-LRB-
cord-273505-pcsw3vmx	218	18	206	206	CD
cord-273505-pcsw3vmx	218	19	)	)	-RRB-
cord-273505-pcsw3vmx	218	20	.	.	.
cord-273505-pcsw3vmx	219	1	It	-PRON-	PRP
cord-273505-pcsw3vmx	219	2	has	have	VBZ
cord-273505-pcsw3vmx	219	3	been	be	VBN
cord-273505-pcsw3vmx	219	4	shown	show	VBN
cord-273505-pcsw3vmx	219	5	that	that	IN
cord-273505-pcsw3vmx	219	6	RSV	RSV	NNP
cord-273505-pcsw3vmx	219	7	infections	infection	NNS
cord-273505-pcsw3vmx	219	8	are	be	VBP
cord-273505-pcsw3vmx	219	9	significantly	significantly	RB
cord-273505-pcsw3vmx	219	10	enhanced	enhance	VBN
cord-273505-pcsw3vmx	219	11	in	in	IN
cord-273505-pcsw3vmx	219	12	NK	NK	NNP
cord-273505-pcsw3vmx	219	13	cells	cell	NNS
cord-273505-pcsw3vmx	219	14	previously	previously	RB
cord-273505-pcsw3vmx	219	15	incubated	incubate	VBN
cord-273505-pcsw3vmx	219	16	with	with	IN
cord-273505-pcsw3vmx	219	17	sub	sub	NN
cord-273505-pcsw3vmx	219	18	-	-	JJ
cord-273505-pcsw3vmx	219	19	neutralizing	neutralize	VBG
cord-273505-pcsw3vmx	219	20	titers	titer	NNS
cord-273505-pcsw3vmx	219	21	of	of	IN
cord-273505-pcsw3vmx	219	22	RSV	RSV	NNP
cord-273505-pcsw3vmx	219	23	-	-	HYPH
cord-273505-pcsw3vmx	219	24	specific	specific	JJ
cord-273505-pcsw3vmx	219	25	antibodies	antibody	NNS
cord-273505-pcsw3vmx	219	26	in	in	IN
cord-273505-pcsw3vmx	219	27	vitro	vitro	FW
cord-273505-pcsw3vmx	219	28	,	,	,
cord-273505-pcsw3vmx	219	29	promoting	promote	VBG
cord-273505-pcsw3vmx	219	30	IFN	IFN	NNP
cord-273505-pcsw3vmx	219	31	-	-	HYPH
cord-273505-pcsw3vmx	219	32	γ	γ	NN
cord-273505-pcsw3vmx	219	33	production	production	NN
cord-273505-pcsw3vmx	219	34	of	of	IN
cord-273505-pcsw3vmx	219	35	NK	NK	NNP
cord-273505-pcsw3vmx	219	36	cells	cell	NNS
cord-273505-pcsw3vmx	219	37	(	(	-LRB-
cord-273505-pcsw3vmx	219	38	207	207	CD
cord-273505-pcsw3vmx	219	39	)	)	-RRB-
cord-273505-pcsw3vmx	219	40	.	.	.
cord-273505-pcsw3vmx	220	1	It	-PRON-	PRP
cord-273505-pcsw3vmx	220	2	remains	remain	VBZ
cord-273505-pcsw3vmx	220	3	unclear	unclear	JJ
cord-273505-pcsw3vmx	220	4	whether	whether	IN
cord-273505-pcsw3vmx	220	5	such	such	JJ
cord-273505-pcsw3vmx	220	6	in	in	IN
cord-273505-pcsw3vmx	220	7	vitro	vitro	FW
cord-273505-pcsw3vmx	220	8	enhancement	enhancement	NN
cord-273505-pcsw3vmx	220	9	of	of	IN
cord-273505-pcsw3vmx	220	10	RSV	RSV	NNP
cord-273505-pcsw3vmx	220	11	infection	infection	NN
cord-273505-pcsw3vmx	220	12	has	have	VBZ
cord-273505-pcsw3vmx	220	13	a	a	DT
cord-273505-pcsw3vmx	220	14	correlation	correlation	NN
cord-273505-pcsw3vmx	220	15	with	with	IN
cord-273505-pcsw3vmx	220	16	in	in	IN
cord-273505-pcsw3vmx	220	17	vivo	vivo	NN
cord-273505-pcsw3vmx	220	18	disease	disease	NN
cord-273505-pcsw3vmx	220	19	.	.	.
cord-273505-pcsw3vmx	221	1	Nevertheless	nevertheless	RB
cord-273505-pcsw3vmx	221	2	,	,	,
cord-273505-pcsw3vmx	221	3	the	the	DT
cord-273505-pcsw3vmx	221	4	Fc	Fc	NNP
cord-273505-pcsw3vmx	221	5	-	-	HYPH
cord-273505-pcsw3vmx	221	6	mediated	mediate	VBN
cord-273505-pcsw3vmx	221	7	antibody	antibody	NN
cord-273505-pcsw3vmx	221	8	effector	effector	NN
cord-273505-pcsw3vmx	221	9	functions	function	NNS
cord-273505-pcsw3vmx	221	10	are	be	VBP
cord-273505-pcsw3vmx	221	11	believed	believe	VBN
cord-273505-pcsw3vmx	221	12	to	to	TO
cord-273505-pcsw3vmx	221	13	participate	participate	VB
cord-273505-pcsw3vmx	221	14	in	in	IN
cord-273505-pcsw3vmx	221	15	the	the	DT
cord-273505-pcsw3vmx	221	16	antibody	antibody	NN
cord-273505-pcsw3vmx	221	17	-	-	HYPH
cord-273505-pcsw3vmx	221	18	dependent	dependent	JJ
cord-273505-pcsw3vmx	221	19	enhancement	enhancement	NN
cord-273505-pcsw3vmx	221	20	of	of	IN
cord-273505-pcsw3vmx	221	21	RSV	RSV	NNP
cord-273505-pcsw3vmx	221	22	disease	disease	NN
cord-273505-pcsw3vmx	221	23	(	(	-LRB-
cord-273505-pcsw3vmx	221	24	206	206	CD
cord-273505-pcsw3vmx	221	25	,	,	,
cord-273505-pcsw3vmx	221	26	208	208	CD
cord-273505-pcsw3vmx	221	27	)	)	-RRB-
cord-273505-pcsw3vmx	221	28	.	.	.
cord-273505-pcsw3vmx	222	1	To	to	IN
cord-273505-pcsw3vmx	222	2	date	date	NN
cord-273505-pcsw3vmx	222	3	,	,	,
cord-273505-pcsw3vmx	222	4	the	the	DT
cord-273505-pcsw3vmx	222	5	exact	exact	JJ
cord-273505-pcsw3vmx	222	6	role	role	NN
cord-273505-pcsw3vmx	222	7	of	of	IN
cord-273505-pcsw3vmx	222	8	ADE	ADE	NNP
cord-273505-pcsw3vmx	222	9	in	in	IN
cord-273505-pcsw3vmx	222	10	SARS	SARS	NNP
cord-273505-pcsw3vmx	222	11	-	-	HYPH
cord-273505-pcsw3vmx	222	12	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	222	13	infection	infection	NN
cord-273505-pcsw3vmx	222	14	remains	remain	VBZ
cord-273505-pcsw3vmx	222	15	unclear	unclear	JJ
cord-273505-pcsw3vmx	222	16	.	.	.
cord-273505-pcsw3vmx	223	1	Regarding	regard	VBG
cord-273505-pcsw3vmx	223	2	concerns	concern	NNS
cord-273505-pcsw3vmx	223	3	that	that	IN
cord-273505-pcsw3vmx	223	4	reappearance	reappearance	NN
cord-273505-pcsw3vmx	223	5	of	of	IN
cord-273505-pcsw3vmx	223	6	cross	cross	JJ
cord-273505-pcsw3vmx	223	7	-	-	JJ
cord-273505-pcsw3vmx	223	8	reactive	reactive	JJ
cord-273505-pcsw3vmx	223	9	antibodies	antibody	NNS
cord-273505-pcsw3vmx	223	10	from	from	IN
cord-273505-pcsw3vmx	223	11	other	other	JJ
cord-273505-pcsw3vmx	223	12	serotypes	serotype	NNS
cord-273505-pcsw3vmx	223	13	of	of	IN
cord-273505-pcsw3vmx	223	14	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	223	15	may	may	MD
cord-273505-pcsw3vmx	223	16	enhance	enhance	VB
cord-273505-pcsw3vmx	223	17	the	the	DT
cord-273505-pcsw3vmx	223	18	current	current	JJ
cord-273505-pcsw3vmx	223	19	infection	infection	NN
cord-273505-pcsw3vmx	223	20	,	,	,
cord-273505-pcsw3vmx	223	21	the	the	DT
cord-273505-pcsw3vmx	223	22	risk	risk	NN
cord-273505-pcsw3vmx	223	23	of	of	IN
cord-273505-pcsw3vmx	223	24	ADE	ADE	NNP
cord-273505-pcsw3vmx	223	25	needs	need	VBZ
cord-273505-pcsw3vmx	223	26	to	to	TO
cord-273505-pcsw3vmx	223	27	be	be	VB
cord-273505-pcsw3vmx	223	28	clarified	clarify	VBN
cord-273505-pcsw3vmx	223	29	when	when	WRB
cord-273505-pcsw3vmx	223	30	treating	treat	VBG
cord-273505-pcsw3vmx	223	31	COVID-19	COVID-19	JJR
cord-273505-pcsw3vmx	223	32	patients	patient	NNS
cord-273505-pcsw3vmx	223	33	(	(	-LRB-
cord-273505-pcsw3vmx	223	34	203	203	CD
cord-273505-pcsw3vmx	223	35	,	,	,
cord-273505-pcsw3vmx	223	36	209	209	CD
cord-273505-pcsw3vmx	223	37	)	)	-RRB-
cord-273505-pcsw3vmx	223	38	.	.	.
cord-273505-pcsw3vmx	224	1	As	as	IN
cord-273505-pcsw3vmx	224	2	described	describe	VBN
cord-273505-pcsw3vmx	224	3	above	above	RB
cord-273505-pcsw3vmx	224	4	,	,	,
cord-273505-pcsw3vmx	224	5	the	the	DT
cord-273505-pcsw3vmx	224	6	occurrence	occurrence	NN
cord-273505-pcsw3vmx	224	7	of	of	IN
cord-273505-pcsw3vmx	224	8	ADE	ADE	NNP
cord-273505-pcsw3vmx	224	9	requires	require	VBZ
cord-273505-pcsw3vmx	224	10	binding	binding	NN
cord-273505-pcsw3vmx	224	11	of	of	IN
cord-273505-pcsw3vmx	224	12	the	the	DT
cord-273505-pcsw3vmx	224	13	virion	virion	NN
cord-273505-pcsw3vmx	224	14	to	to	IN
cord-273505-pcsw3vmx	224	15	antibodies	antibody	NNS
cord-273505-pcsw3vmx	224	16	at	at	IN
cord-273505-pcsw3vmx	224	17	a	a	DT
cord-273505-pcsw3vmx	224	18	sub	sub	NN
cord-273505-pcsw3vmx	224	19	-	-	JJ
cord-273505-pcsw3vmx	224	20	neutralizing	neutralize	VBG
cord-273505-pcsw3vmx	224	21	concentration	concentration	NN
cord-273505-pcsw3vmx	224	22	and	and	CC
cord-273505-pcsw3vmx	224	23	subsequent	subsequent	JJ
cord-273505-pcsw3vmx	224	24	uptake	uptake	NN
cord-273505-pcsw3vmx	224	25	by	by	IN
cord-273505-pcsw3vmx	224	26	FcγR	fcγr	NN
cord-273505-pcsw3vmx	224	27	-	-	HYPH
cord-273505-pcsw3vmx	224	28	bearing	bear	VBG
cord-273505-pcsw3vmx	224	29	cells	cell	NNS
cord-273505-pcsw3vmx	224	30	(	(	-LRB-
cord-273505-pcsw3vmx	224	31	210	210	CD
cord-273505-pcsw3vmx	224	32	)	)	-RRB-
cord-273505-pcsw3vmx	224	33	.	.	.
cord-273505-pcsw3vmx	225	1	To	to	TO
cord-273505-pcsw3vmx	225	2	inhibit	inhibit	VB
cord-273505-pcsw3vmx	225	3	potential	potential	JJ
cord-273505-pcsw3vmx	225	4	phenomenon	phenomenon	NN
cord-273505-pcsw3vmx	225	5	of	of	IN
cord-273505-pcsw3vmx	225	6	ADE	ADE	NNP
cord-273505-pcsw3vmx	225	7	in	in	IN
cord-273505-pcsw3vmx	225	8	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	225	9	,	,	,
cord-273505-pcsw3vmx	225	10	high	high	JJ
cord-273505-pcsw3vmx	225	11	-	-	HYPH
cord-273505-pcsw3vmx	225	12	dose	dose	NN
cord-273505-pcsw3vmx	225	13	IVIg	ivig	NN
cord-273505-pcsw3vmx	225	14	therapy	therapy	NN
cord-273505-pcsw3vmx	225	15	is	be	VBZ
cord-273505-pcsw3vmx	225	16	therefore	therefore	RB
cord-273505-pcsw3vmx	225	17	proposed	propose	VBN
cord-273505-pcsw3vmx	225	18	(	(	-LRB-
cord-273505-pcsw3vmx	225	19	211	211	CD
cord-273505-pcsw3vmx	225	20	)	)	-RRB-
cord-273505-pcsw3vmx	225	21	.	.	.
cord-273505-pcsw3vmx	226	1	First	first	RB
cord-273505-pcsw3vmx	226	2	,	,	,
cord-273505-pcsw3vmx	226	3	it	-PRON-	PRP
cord-273505-pcsw3vmx	226	4	is	be	VBZ
cord-273505-pcsw3vmx	226	5	unlikely	unlikely	JJ
cord-273505-pcsw3vmx	226	6	to	to	TO
cord-273505-pcsw3vmx	226	7	have	have	VB
cord-273505-pcsw3vmx	226	8	preexisting	preexisting	JJ
cord-273505-pcsw3vmx	226	9	anti	anti	JJ
cord-273505-pcsw3vmx	226	10	-	-	JJ
cord-273505-pcsw3vmx	226	11	SARS	SARS	NNP
cord-273505-pcsw3vmx	226	12	-	-	HYPH
cord-273505-pcsw3vmx	226	13	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	226	14	antibodies	antibody	NNS
cord-273505-pcsw3vmx	226	15	in	in	IN
cord-273505-pcsw3vmx	226	16	IVIg	ivig	JJ
cord-273505-pcsw3vmx	226	17	preparations	preparation	NNS
cord-273505-pcsw3vmx	226	18	early	early	RB
cord-273505-pcsw3vmx	226	19	in	in	IN
cord-273505-pcsw3vmx	226	20	the	the	DT
cord-273505-pcsw3vmx	226	21	novel	novel	JJ
cord-273505-pcsw3vmx	226	22	epidemic	epidemic	NN
cord-273505-pcsw3vmx	226	23	.	.	.
cord-273505-pcsw3vmx	227	1	Additionally	additionally	RB
cord-273505-pcsw3vmx	227	2	,	,	,
cord-273505-pcsw3vmx	227	3	a	a	DT
cord-273505-pcsw3vmx	227	4	high	high	JJ
cord-273505-pcsw3vmx	227	5	concentration	concentration	NN
cord-273505-pcsw3vmx	227	6	of	of	IN
cord-273505-pcsw3vmx	227	7	non	non	JJ
cord-273505-pcsw3vmx	227	8	-	-	JJ
cord-273505-pcsw3vmx	227	9	neutralizing	neutralize	VBG
cord-273505-pcsw3vmx	227	10	antibodies	antibody	NNS
cord-273505-pcsw3vmx	227	11	,	,	,
cord-273505-pcsw3vmx	227	12	rather	rather	RB
cord-273505-pcsw3vmx	227	13	than	than	IN
cord-273505-pcsw3vmx	227	14	a	a	DT
cord-273505-pcsw3vmx	227	15	regular	regular	JJ
cord-273505-pcsw3vmx	227	16	or	or	CC
cord-273505-pcsw3vmx	227	17	diluted	diluted	JJ
cord-273505-pcsw3vmx	227	18	dose	dose	NN
cord-273505-pcsw3vmx	227	19	,	,	,
cord-273505-pcsw3vmx	227	20	would	would	MD
cord-273505-pcsw3vmx	227	21	integrally	integrally	RB
cord-273505-pcsw3vmx	227	22	saturate	saturate	VB
cord-273505-pcsw3vmx	227	23	activating	activate	VBG
cord-273505-pcsw3vmx	227	24	FcγRs	FcγRs	NNP
cord-273505-pcsw3vmx	227	25	and	and	CC
cord-273505-pcsw3vmx	227	26	FcRn	FcRn	NNP
cord-273505-pcsw3vmx	227	27	,	,	,
cord-273505-pcsw3vmx	227	28	which	which	WDT
cord-273505-pcsw3vmx	227	29	is	be	VBZ
cord-273505-pcsw3vmx	227	30	beneficial	beneficial	JJ
cord-273505-pcsw3vmx	227	31	to	to	TO
cord-273505-pcsw3vmx	227	32	limit	limit	VB
cord-273505-pcsw3vmx	227	33	access	access	NN
cord-273505-pcsw3vmx	227	34	of	of	IN
cord-273505-pcsw3vmx	227	35	immune	immune	JJ
cord-273505-pcsw3vmx	227	36	complexes	complex	NNS
cord-273505-pcsw3vmx	227	37	and	and	CC
cord-273505-pcsw3vmx	227	38	enhance	enhance	VB
cord-273505-pcsw3vmx	227	39	clearance	clearance	NN
cord-273505-pcsw3vmx	227	40	of	of	IN
cord-273505-pcsw3vmx	227	41	inimical	inimical	JJ
cord-273505-pcsw3vmx	227	42	antibodies	antibody	NNS
cord-273505-pcsw3vmx	227	43	,	,	,
cord-273505-pcsw3vmx	227	44	to	to	TO
cord-273505-pcsw3vmx	227	45	ultimately	ultimately	RB
cord-273505-pcsw3vmx	227	46	provide	provide	VB
cord-273505-pcsw3vmx	227	47	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	227	48	effects	effect	NNS
cord-273505-pcsw3vmx	227	49	in	in	IN
cord-273505-pcsw3vmx	227	50	severe	severe	JJ
cord-273505-pcsw3vmx	227	51	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	227	52	patients	patient	NNS
cord-273505-pcsw3vmx	227	53	(	(	-LRB-
cord-273505-pcsw3vmx	227	54	211	211	CD
cord-273505-pcsw3vmx	227	55	,	,	,
cord-273505-pcsw3vmx	227	56	212	212	CD
cord-273505-pcsw3vmx	227	57	)	)	-RRB-
cord-273505-pcsw3vmx	227	58	.	.	.
cord-273505-pcsw3vmx	228	1	Based	base	VBN
cord-273505-pcsw3vmx	228	2	on	on	IN
cord-273505-pcsw3vmx	228	3	its	-PRON-	PRP$
cord-273505-pcsw3vmx	228	4	efficacy	efficacy	NN
cord-273505-pcsw3vmx	228	5	and	and	CC
cord-273505-pcsw3vmx	228	6	supporting	support	VBG
cord-273505-pcsw3vmx	228	7	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	228	8	in	in	IN
cord-273505-pcsw3vmx	228	9	modulating	modulate	VBG
cord-273505-pcsw3vmx	228	10	the	the	DT
cord-273505-pcsw3vmx	228	11	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	228	12	response	response	NN
cord-273505-pcsw3vmx	228	13	and	and	CC
cord-273505-pcsw3vmx	228	14	improving	improve	VBG
cord-273505-pcsw3vmx	228	15	serum	serum	NN
cord-273505-pcsw3vmx	228	16	IgG	igg	NN
cord-273505-pcsw3vmx	228	17	levels	level	NNS
cord-273505-pcsw3vmx	228	18	,	,	,
cord-273505-pcsw3vmx	228	19	high	high	JJ
cord-273505-pcsw3vmx	228	20	-	-	HYPH
cord-273505-pcsw3vmx	228	21	dose	dose	NN
cord-273505-pcsw3vmx	228	22	IVIg	ivig	NN
cord-273505-pcsw3vmx	228	23	therapy	therapy	NN
cord-273505-pcsw3vmx	228	24	is	be	VBZ
cord-273505-pcsw3vmx	228	25	considered	consider	VBN
cord-273505-pcsw3vmx	228	26	for	for	IN
cord-273505-pcsw3vmx	228	27	treatment	treatment	NN
cord-273505-pcsw3vmx	228	28	of	of	IN
cord-273505-pcsw3vmx	228	29	several	several	JJ
cord-273505-pcsw3vmx	228	30	severe	severe	JJ
cord-273505-pcsw3vmx	228	31	viral	viral	JJ
cord-273505-pcsw3vmx	228	32	infections	infection	NNS
cord-273505-pcsw3vmx	228	33	.	.	.
cord-273505-pcsw3vmx	229	1	Potential	potential	JJ
cord-273505-pcsw3vmx	229	2	protective	protective	JJ
cord-273505-pcsw3vmx	229	3	effects	effect	NNS
cord-273505-pcsw3vmx	229	4	of	of	IN
cord-273505-pcsw3vmx	229	5	IVIg	ivig	JJ
cord-273505-pcsw3vmx	229	6	preparations	preparation	NNS
cord-273505-pcsw3vmx	229	7	were	be	VBD
cord-273505-pcsw3vmx	229	8	previously	previously	RB
cord-273505-pcsw3vmx	229	9	shown	show	VBN
cord-273505-pcsw3vmx	229	10	in	in	IN
cord-273505-pcsw3vmx	229	11	influenza	influenza	NN
cord-273505-pcsw3vmx	229	12	-	-	HYPH
cord-273505-pcsw3vmx	229	13	and	and	CC
cord-273505-pcsw3vmx	229	14	RSVinfected	rsvinfected	JJ
cord-273505-pcsw3vmx	229	15	animal	animal	NN
cord-273505-pcsw3vmx	229	16	models	model	NNS
cord-273505-pcsw3vmx	229	17	(	(	-LRB-
cord-273505-pcsw3vmx	229	18	213	213	CD
cord-273505-pcsw3vmx	229	19	)	)	-RRB-
cord-273505-pcsw3vmx	229	20	(	(	-LRB-
cord-273505-pcsw3vmx	229	21	214	214	CD
cord-273505-pcsw3vmx	229	22	)	)	-RRB-
cord-273505-pcsw3vmx	229	23	(	(	-LRB-
cord-273505-pcsw3vmx	229	24	215	215	CD
cord-273505-pcsw3vmx	229	25	)	)	-RRB-
cord-273505-pcsw3vmx	229	26	(	(	-LRB-
cord-273505-pcsw3vmx	229	27	216	216	CD
cord-273505-pcsw3vmx	229	28	)	)	-RRB-
cord-273505-pcsw3vmx	229	29	(	(	-LRB-
cord-273505-pcsw3vmx	229	30	217	217	CD
cord-273505-pcsw3vmx	229	31	)	)	-RRB-
cord-273505-pcsw3vmx	229	32	(	(	-LRB-
cord-273505-pcsw3vmx	229	33	218	218	CD
cord-273505-pcsw3vmx	229	34	)	)	-RRB-
cord-273505-pcsw3vmx	229	35	.	.	.
cord-273505-pcsw3vmx	230	1	In	in	IN
cord-273505-pcsw3vmx	230	2	this	this	DT
cord-273505-pcsw3vmx	230	3	section	section	NN
cord-273505-pcsw3vmx	230	4	,	,	,
cord-273505-pcsw3vmx	230	5	we	-PRON-	PRP
cord-273505-pcsw3vmx	230	6	review	review	VBP
cord-273505-pcsw3vmx	230	7	the	the	DT
cord-273505-pcsw3vmx	230	8	previous	previous	JJ
cord-273505-pcsw3vmx	230	9	clinical	clinical	JJ
cord-273505-pcsw3vmx	230	10	application	application	NN
cord-273505-pcsw3vmx	230	11	of	of	IN
cord-273505-pcsw3vmx	230	12	high	high	JJ
cord-273505-pcsw3vmx	230	13	-	-	HYPH
cord-273505-pcsw3vmx	230	14	dose	dose	NN
cord-273505-pcsw3vmx	230	15	IVIg	ivig	NN
cord-273505-pcsw3vmx	230	16	therapy	therapy	NN
cord-273505-pcsw3vmx	230	17	in	in	IN
cord-273505-pcsw3vmx	230	18	treating	treat	VBG
cord-273505-pcsw3vmx	230	19	viral	viral	JJ
cord-273505-pcsw3vmx	230	20	pneumonia	pneumonia	NN
cord-273505-pcsw3vmx	230	21	such	such	JJ
cord-273505-pcsw3vmx	230	22	as	as	IN
cord-273505-pcsw3vmx	230	23	SARS	SARS	NNP
cord-273505-pcsw3vmx	230	24	,	,	,
cord-273505-pcsw3vmx	230	25	MERS	MERS	NNP
cord-273505-pcsw3vmx	230	26	,	,	,
cord-273505-pcsw3vmx	230	27	influenza	influenza	NN
cord-273505-pcsw3vmx	230	28	and	and	CC
cord-273505-pcsw3vmx	230	29	RSV	RSV	NNP
cord-273505-pcsw3vmx	230	30	disease	disease	NN
cord-273505-pcsw3vmx	230	31	,	,	,
cord-273505-pcsw3vmx	230	32	as	as	RB
cord-273505-pcsw3vmx	230	33	well	well	RB
cord-273505-pcsw3vmx	230	34	as	as	IN
cord-273505-pcsw3vmx	230	35	its	-PRON-	PRP$
cord-273505-pcsw3vmx	230	36	current	current	JJ
cord-273505-pcsw3vmx	230	37	application	application	NN
cord-273505-pcsw3vmx	230	38	in	in	IN
cord-273505-pcsw3vmx	230	39	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	230	40	(	(	-LRB-
cord-273505-pcsw3vmx	230	41	Table	Table	NNP
cord-273505-pcsw3vmx	230	42	2	2	CD
cord-273505-pcsw3vmx	230	43	)	)	-RRB-
cord-273505-pcsw3vmx	230	44	.	.	.
cord-273505-pcsw3vmx	231	1	During	during	IN
cord-273505-pcsw3vmx	231	2	the	the	DT
cord-273505-pcsw3vmx	231	3	global	global	JJ
cord-273505-pcsw3vmx	231	4	outbreak	outbreak	NN
cord-273505-pcsw3vmx	231	5	of	of	IN
cord-273505-pcsw3vmx	231	6	SARS	SARS	NNP
cord-273505-pcsw3vmx	231	7	in	in	IN
cord-273505-pcsw3vmx	231	8	2003	2003	CD
cord-273505-pcsw3vmx	231	9	caused	cause	VBN
cord-273505-pcsw3vmx	231	10	by	by	IN
cord-273505-pcsw3vmx	231	11	SARS	SARS	NNP
cord-273505-pcsw3vmx	231	12	-	-	HYPH
cord-273505-pcsw3vmx	231	13	CoV	CoV	NNP
cord-273505-pcsw3vmx	231	14	,	,	,
cord-273505-pcsw3vmx	231	15	different	different	JJ
cord-273505-pcsw3vmx	231	16	therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	231	17	modalities	modality	NNS
cord-273505-pcsw3vmx	231	18	(	(	-LRB-
cord-273505-pcsw3vmx	231	19	e.g.	e.g.	RB
cord-273505-pcsw3vmx	231	20	,	,	,
cord-273505-pcsw3vmx	231	21	α	α	NN
cord-273505-pcsw3vmx	231	22	-	-	HYPH
cord-273505-pcsw3vmx	231	23	interferon	interferon	NN
cord-273505-pcsw3vmx	231	24	,	,	,
cord-273505-pcsw3vmx	232	1	ribavirin	ribavirin	RB
cord-273505-pcsw3vmx	232	2	,	,	,
cord-273505-pcsw3vmx	232	3	LPV	LPV	NNP
cord-273505-pcsw3vmx	232	4	/	/	SYM
cord-273505-pcsw3vmx	232	5	r	r	NN
cord-273505-pcsw3vmx	232	6	,	,	,
cord-273505-pcsw3vmx	232	7	corticosteroids	corticosteroid	NNS
cord-273505-pcsw3vmx	232	8	,	,	,
cord-273505-pcsw3vmx	232	9	convalescent	convalescent	JJ
cord-273505-pcsw3vmx	232	10	plasma	plasma	NN
cord-273505-pcsw3vmx	232	11	,	,	,
cord-273505-pcsw3vmx	232	12	and	and	CC
cord-273505-pcsw3vmx	232	13	IVIg	ivig	ADD
cord-273505-pcsw3vmx	232	14	)	)	-RRB-
cord-273505-pcsw3vmx	232	15	were	be	VBD
cord-273505-pcsw3vmx	232	16	empirically	empirically	RB
cord-273505-pcsw3vmx	232	17	used	use	VBN
cord-273505-pcsw3vmx	232	18	(	(	-LRB-
cord-273505-pcsw3vmx	232	19	233	233	CD
cord-273505-pcsw3vmx	232	20	)	)	-RRB-
cord-273505-pcsw3vmx	232	21	.	.	.
cord-273505-pcsw3vmx	233	1	Although	although	IN
cord-273505-pcsw3vmx	233	2	strong	strong	JJ
cord-273505-pcsw3vmx	233	3	evidence	evidence	NN
cord-273505-pcsw3vmx	233	4	recommending	recommend	VBG
cord-273505-pcsw3vmx	233	5	the	the	DT
cord-273505-pcsw3vmx	233	6	administration	administration	NN
cord-273505-pcsw3vmx	233	7	of	of	IN
cord-273505-pcsw3vmx	233	8	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	233	9	therapy	therapy	NN
cord-273505-pcsw3vmx	233	10	is	be	VBZ
cord-273505-pcsw3vmx	233	11	lacking	lack	VBG
cord-273505-pcsw3vmx	233	12	and	and	CC
cord-273505-pcsw3vmx	233	13	a	a	DT
cord-273505-pcsw3vmx	233	14	previous	previous	JJ
cord-273505-pcsw3vmx	233	15	systemic	systemic	JJ
cord-273505-pcsw3vmx	233	16	review	review	NN
cord-273505-pcsw3vmx	233	17	concluded	conclude	VBD
cord-273505-pcsw3vmx	233	18	that	that	IN
cord-273505-pcsw3vmx	233	19	the	the	DT
cord-273505-pcsw3vmx	233	20	evidence	evidence	NN
cord-273505-pcsw3vmx	233	21	for	for	IN
cord-273505-pcsw3vmx	233	22	efficacy	efficacy	NN
cord-273505-pcsw3vmx	233	23	of	of	IN
cord-273505-pcsw3vmx	233	24	improving	improve	VBG
cord-273505-pcsw3vmx	233	25	prognosis	prognosis	NN
cord-273505-pcsw3vmx	233	26	with	with	IN
cord-273505-pcsw3vmx	233	27	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	233	28	therapy	therapy	NN
cord-273505-pcsw3vmx	233	29	remained	remain	VBD
cord-273505-pcsw3vmx	233	30	inconclusive	inconclusive	JJ
cord-273505-pcsw3vmx	233	31	,	,	,
cord-273505-pcsw3vmx	233	32	some	some	DT
cord-273505-pcsw3vmx	233	33	studies	study	NNS
cord-273505-pcsw3vmx	233	34	commented	comment	VBD
cord-273505-pcsw3vmx	233	35	that	that	IN
cord-273505-pcsw3vmx	233	36	patients	patient	NNS
cord-273505-pcsw3vmx	233	37	seemed	seem	VBD
cord-273505-pcsw3vmx	233	38	to	to	TO
cord-273505-pcsw3vmx	233	39	improve	improve	VB
cord-273505-pcsw3vmx	233	40	upon	upon	IN
cord-273505-pcsw3vmx	233	41	IVIg	ivig	JJ
cord-273505-pcsw3vmx	233	42	treatment	treatment	NN
cord-273505-pcsw3vmx	233	43	(	(	-LRB-
cord-273505-pcsw3vmx	233	44	233	233	CD
cord-273505-pcsw3vmx	233	45	,	,	,
cord-273505-pcsw3vmx	233	46	234	234	CD
cord-273505-pcsw3vmx	233	47	)	)	-RRB-
cord-273505-pcsw3vmx	233	48	.	.	.
cord-273505-pcsw3vmx	234	1	In	in	IN
cord-273505-pcsw3vmx	234	2	a	a	DT
cord-273505-pcsw3vmx	234	3	randomized	randomized	JJ
cord-273505-pcsw3vmx	234	4	controlled	control	VBN
cord-273505-pcsw3vmx	234	5	trial	trial	NN
cord-273505-pcsw3vmx	234	6	,	,	,
cord-273505-pcsw3vmx	234	7	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	234	8	therapy	therapy	NN
cord-273505-pcsw3vmx	234	9	efficiently	efficiently	RB
cord-273505-pcsw3vmx	234	10	improved	improve	VBD
cord-273505-pcsw3vmx	234	11	the	the	DT
cord-273505-pcsw3vmx	234	12	serum	serum	NN
cord-273505-pcsw3vmx	234	13	IgG	igg	NN
cord-273505-pcsw3vmx	234	14	concentration	concentration	NN
cord-273505-pcsw3vmx	234	15	of	of	IN
cord-273505-pcsw3vmx	234	16	severe	severe	JJ
cord-273505-pcsw3vmx	234	17	SARS	SARS	NNP
cord-273505-pcsw3vmx	234	18	patients	patient	NNS
cord-273505-pcsw3vmx	234	19	compared	compare	VBN
cord-273505-pcsw3vmx	234	20	to	to	IN
cord-273505-pcsw3vmx	234	21	the	the	DT
cord-273505-pcsw3vmx	234	22	control	control	NN
cord-273505-pcsw3vmx	234	23	group	group	NN
cord-273505-pcsw3vmx	234	24	(	(	-LRB-
cord-273505-pcsw3vmx	234	25	222	222	CD
cord-273505-pcsw3vmx	234	26	)	)	-RRB-
cord-273505-pcsw3vmx	234	27	.	.	.
cord-273505-pcsw3vmx	235	1	However	however	RB
cord-273505-pcsw3vmx	235	2	,	,	,
cord-273505-pcsw3vmx	235	3	possibly	possibly	RB
cord-273505-pcsw3vmx	235	4	due	due	IN
cord-273505-pcsw3vmx	235	5	to	to	IN
cord-273505-pcsw3vmx	235	6	the	the	DT
cord-273505-pcsw3vmx	235	7	inadequately	inadequately	RB
cord-273505-pcsw3vmx	235	8	controlled	control	VBN
cord-273505-pcsw3vmx	235	9	dosage	dosage	NN
cord-273505-pcsw3vmx	235	10	of	of	IN
cord-273505-pcsw3vmx	235	11	glucocorticoids	glucocorticoid	NNS
cord-273505-pcsw3vmx	235	12	and	and	CC
cord-273505-pcsw3vmx	235	13	IVIg	ivig	JJ
cord-273505-pcsw3vmx	235	14	therapy	therapy	NN
cord-273505-pcsw3vmx	235	15	,	,	,
cord-273505-pcsw3vmx	235	16	which	which	WDT
cord-273505-pcsw3vmx	235	17	were	be	VBD
cord-273505-pcsw3vmx	235	18	given	give	VBN
cord-273505-pcsw3vmx	235	19	at	at	IN
cord-273505-pcsw3vmx	235	20	the	the	DT
cord-273505-pcsw3vmx	235	21	discretion	discretion	NN
cord-273505-pcsw3vmx	235	22	of	of	IN
cord-273505-pcsw3vmx	235	23	clinicians	clinician	NNS
cord-273505-pcsw3vmx	235	24	,	,	,
cord-273505-pcsw3vmx	235	25	there	there	EX
cord-273505-pcsw3vmx	235	26	were	be	VBD
cord-273505-pcsw3vmx	235	27	no	no	DT
cord-273505-pcsw3vmx	235	28	significant	significant	JJ
cord-273505-pcsw3vmx	235	29	differences	difference	NNS
cord-273505-pcsw3vmx	235	30	in	in	IN
cord-273505-pcsw3vmx	235	31	the	the	DT
cord-273505-pcsw3vmx	235	32	fatality	fatality	NN
cord-273505-pcsw3vmx	235	33	rates	rate	NNS
cord-273505-pcsw3vmx	235	34	and	and	CC
cord-273505-pcsw3vmx	235	35	the	the	DT
cord-273505-pcsw3vmx	235	36	rates	rate	NNS
cord-273505-pcsw3vmx	235	37	of	of	IN
cord-273505-pcsw3vmx	235	38	nosocomial	nosocomial	JJ
cord-273505-pcsw3vmx	235	39	infection	infection	NN
cord-273505-pcsw3vmx	235	40	of	of	IN
cord-273505-pcsw3vmx	235	41	severe	severe	JJ
cord-273505-pcsw3vmx	235	42	SARS	SARS	NNP
cord-273505-pcsw3vmx	235	43	patients	patient	NNS
cord-273505-pcsw3vmx	235	44	between	between	IN
cord-273505-pcsw3vmx	235	45	the	the	DT
cord-273505-pcsw3vmx	235	46	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	235	47	group	group	NN
cord-273505-pcsw3vmx	235	48	and	and	CC
cord-273505-pcsw3vmx	235	49	the	the	DT
cord-273505-pcsw3vmx	235	50	control	control	NN
cord-273505-pcsw3vmx	235	51	group	group	NN
cord-273505-pcsw3vmx	235	52	(	(	-LRB-
cord-273505-pcsw3vmx	235	53	222	222	CD
cord-273505-pcsw3vmx	235	54	)	)	-RRB-
cord-273505-pcsw3vmx	235	55	.	.	.
cord-273505-pcsw3vmx	236	1	Apart	apart	RB
cord-273505-pcsw3vmx	236	2	from	from	IN
cord-273505-pcsw3vmx	236	3	hypogammaglobulinemia	hypogammaglobulinemia	NN
cord-273505-pcsw3vmx	236	4	,	,	,
cord-273505-pcsw3vmx	236	5	two	two	CD
cord-273505-pcsw3vmx	236	6	further	further	JJ
cord-273505-pcsw3vmx	236	7	common	common	JJ
cord-273505-pcsw3vmx	236	8	features	feature	NNS
cord-273505-pcsw3vmx	236	9	of	of	IN
cord-273505-pcsw3vmx	236	10	severe	severe	JJ
cord-273505-pcsw3vmx	236	11	SARS	SARS	NNP
cord-273505-pcsw3vmx	236	12	are	be	VBP
cord-273505-pcsw3vmx	236	13	leukopenia	leukopenia	NN
cord-273505-pcsw3vmx	236	14	and	and	CC
cord-273505-pcsw3vmx	236	15	thrombocytopenia	thrombocytopenia	NN
cord-273505-pcsw3vmx	236	16	,	,	,
cord-273505-pcsw3vmx	236	17	and	and	CC
cord-273505-pcsw3vmx	236	18	these	these	DT
cord-273505-pcsw3vmx	236	19	features	feature	NNS
cord-273505-pcsw3vmx	236	20	seemed	seem	VBD
cord-273505-pcsw3vmx	236	21	to	to	TO
cord-273505-pcsw3vmx	236	22	improve	improve	VB
cord-273505-pcsw3vmx	236	23	in	in	IN
cord-273505-pcsw3vmx	236	24	SARS	SARS	NNP
cord-273505-pcsw3vmx	236	25	patients	patient	NNS
cord-273505-pcsw3vmx	236	26	upon	upon	IN
cord-273505-pcsw3vmx	236	27	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	236	28	therapy	therapy	NN
cord-273505-pcsw3vmx	236	29	(	(	-LRB-
cord-273505-pcsw3vmx	236	30	223	223	CD
cord-273505-pcsw3vmx	236	31	,	,	,
cord-273505-pcsw3vmx	236	32	234	234	CD
cord-273505-pcsw3vmx	236	33	)	)	-RRB-
cord-273505-pcsw3vmx	236	34	.	.	.
cord-273505-pcsw3vmx	237	1	The	the	DT
cord-273505-pcsw3vmx	237	2	peripheral	peripheral	JJ
cord-273505-pcsw3vmx	237	3	WBC	WBC	NNP
cord-273505-pcsw3vmx	237	4	and	and	CC
cord-273505-pcsw3vmx	237	5	platelet	platelet	NN
cord-273505-pcsw3vmx	237	6	count	count	NN
cord-273505-pcsw3vmx	237	7	of	of	IN
cord-273505-pcsw3vmx	237	8	severe	severe	JJ
cord-273505-pcsw3vmx	237	9	SARS	SARS	NNP
cord-273505-pcsw3vmx	237	10	patients	patient	NNS
cord-273505-pcsw3vmx	237	11	significantly	significantly	RB
cord-273505-pcsw3vmx	237	12	increased	increase	VBD
cord-273505-pcsw3vmx	237	13	after	after	IN
cord-273505-pcsw3vmx	237	14	receiving	receive	VBG
cord-273505-pcsw3vmx	237	15	IVIg	ivig	JJ
cord-273505-pcsw3vmx	237	16	therapy	therapy	NN
cord-273505-pcsw3vmx	237	17	without	without	IN
cord-273505-pcsw3vmx	237	18	steroids	steroid	NNS
cord-273505-pcsw3vmx	237	19	,	,	,
cord-273505-pcsw3vmx	237	20	suggesting	suggest	VBG
cord-273505-pcsw3vmx	237	21	a	a	DT
cord-273505-pcsw3vmx	237	22	potential	potential	JJ
cord-273505-pcsw3vmx	237	23	role	role	NN
cord-273505-pcsw3vmx	237	24	of	of	IN
cord-273505-pcsw3vmx	237	25	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	237	26	in	in	IN
cord-273505-pcsw3vmx	237	27	controlling	control	VBG
cord-273505-pcsw3vmx	237	28	leukopenia	leukopenia	NN
cord-273505-pcsw3vmx	237	29	and	and	CC
cord-273505-pcsw3vmx	237	30	thrombocytopenia	thrombocytopenia	NN
cord-273505-pcsw3vmx	237	31	in	in	IN
cord-273505-pcsw3vmx	237	32	SARS	SARS	NNP
cord-273505-pcsw3vmx	237	33	patients	patient	NNS
cord-273505-pcsw3vmx	237	34	(	(	-LRB-
cord-273505-pcsw3vmx	237	35	224	224	CD
cord-273505-pcsw3vmx	237	36	)	)	-RRB-
cord-273505-pcsw3vmx	237	37	.	.	.
cord-273505-pcsw3vmx	238	1	Furthermore	furthermore	RB
cord-273505-pcsw3vmx	238	2	,	,	,
cord-273505-pcsw3vmx	238	3	significant	significant	JJ
cord-273505-pcsw3vmx	238	4	clinical	clinical	JJ
cord-273505-pcsw3vmx	238	5	improvement	improvement	NN
cord-273505-pcsw3vmx	238	6	in	in	IN
cord-273505-pcsw3vmx	238	7	pediatric	pediatric	JJ
cord-273505-pcsw3vmx	238	8	SARS	SARS	NNP
cord-273505-pcsw3vmx	238	9	patients	patient	NNS
cord-273505-pcsw3vmx	238	10	was	be	VBD
cord-273505-pcsw3vmx	238	11	noted	note	VBN
cord-273505-pcsw3vmx	238	12	after	after	IN
cord-273505-pcsw3vmx	238	13	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	238	14	therapy	therapy	NN
cord-273505-pcsw3vmx	238	15	(	(	-LRB-
cord-273505-pcsw3vmx	238	16	224	224	CD
cord-273505-pcsw3vmx	238	17	)	)	-RRB-
cord-273505-pcsw3vmx	238	18	.	.	.
cord-273505-pcsw3vmx	239	1	A	a	DT
cord-273505-pcsw3vmx	239	2	declining	decline	VBG
cord-273505-pcsw3vmx	239	3	WBC	WBC	NNP
cord-273505-pcsw3vmx	239	4	significantly	significantly	RB
cord-273505-pcsw3vmx	239	5	recovered	recover	VBD
cord-273505-pcsw3vmx	239	6	after	after	IN
cord-273505-pcsw3vmx	239	7	IVIg	ivig	NN
cord-273505-pcsw3vmx	239	8	therapy	therapy	NN
cord-273505-pcsw3vmx	239	9	,	,	,
cord-273505-pcsw3vmx	239	10	and	and	CC
cord-273505-pcsw3vmx	239	11	the	the	DT
cord-273505-pcsw3vmx	239	12	temperature	temperature	NN
cord-273505-pcsw3vmx	239	13	of	of	IN
cord-273505-pcsw3vmx	239	14	most	most	JJS
cord-273505-pcsw3vmx	239	15	patients	patient	NNS
cord-273505-pcsw3vmx	239	16	normalized	normalize	VBN
cord-273505-pcsw3vmx	239	17	within	within	IN
cord-273505-pcsw3vmx	239	18	3	3	CD
cord-273505-pcsw3vmx	239	19	days	day	NNS
cord-273505-pcsw3vmx	239	20	.	.	.
cord-273505-pcsw3vmx	240	1	Compared	compare	VBN
cord-273505-pcsw3vmx	240	2	to	to	IN
cord-273505-pcsw3vmx	240	3	the	the	DT
cord-273505-pcsw3vmx	240	4	historical	historical	JJ
cord-273505-pcsw3vmx	240	5	controlled	control	VBN
cord-273505-pcsw3vmx	240	6	group	group	NN
cord-273505-pcsw3vmx	240	7	,	,	,
cord-273505-pcsw3vmx	240	8	a	a	DT
cord-273505-pcsw3vmx	240	9	significantly	significantly	RB
cord-273505-pcsw3vmx	240	10	shorter	short	JJR
cord-273505-pcsw3vmx	240	11	time	time	NN
cord-273505-pcsw3vmx	240	12	of	of	IN
cord-273505-pcsw3vmx	240	13	chest	chest	NN
cord-273505-pcsw3vmx	240	14	radiographic	radiographic	JJ
cord-273505-pcsw3vmx	240	15	absorption	absorption	NN
cord-273505-pcsw3vmx	240	16	in	in	IN
cord-273505-pcsw3vmx	240	17	these	these	DT
cord-273505-pcsw3vmx	240	18	patients	patient	NNS
cord-273505-pcsw3vmx	240	19	was	be	VBD
cord-273505-pcsw3vmx	240	20	observed	observe	VBN
cord-273505-pcsw3vmx	240	21	and	and	CC
cord-273505-pcsw3vmx	240	22	indicated	indicate	VBD
cord-273505-pcsw3vmx	240	23	the	the	DT
cord-273505-pcsw3vmx	240	24	potential	potential	JJ
cord-273505-pcsw3vmx	240	25	efficacy	efficacy	NN
cord-273505-pcsw3vmx	240	26	of	of	IN
cord-273505-pcsw3vmx	240	27	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	240	28	in	in	IN
cord-273505-pcsw3vmx	240	29	clinical	clinical	JJ
cord-273505-pcsw3vmx	240	30	improvement	improvement	NN
cord-273505-pcsw3vmx	240	31	and	and	CC
cord-273505-pcsw3vmx	240	32	absorption	absorption	NN
cord-273505-pcsw3vmx	240	33	of	of	IN
cord-273505-pcsw3vmx	240	34	lung	lung	NN
cord-273505-pcsw3vmx	240	35	lesions	lesion	NNS
cord-273505-pcsw3vmx	240	36	.	.	.
cord-273505-pcsw3vmx	241	1	Interestingly	interestingly	RB
cord-273505-pcsw3vmx	241	2	,	,	,
cord-273505-pcsw3vmx	241	3	an	an	DT
cord-273505-pcsw3vmx	241	4	IgM	igm	NN
cord-273505-pcsw3vmx	241	5	-	-	HYPH
cord-273505-pcsw3vmx	241	6	enriched	enrich	VBN
cord-273505-pcsw3vmx	241	7	IVIg	ivig	NN
cord-273505-pcsw3vmx	241	8	preparation	preparation	NN
cord-273505-pcsw3vmx	241	9	also	also	RB
cord-273505-pcsw3vmx	241	10	showed	show	VBD
cord-273505-pcsw3vmx	241	11	significant	significant	JJ
cord-273505-pcsw3vmx	241	12	beneficial	beneficial	JJ
cord-273505-pcsw3vmx	241	13	effects	effect	NNS
cord-273505-pcsw3vmx	241	14	in	in	IN
cord-273505-pcsw3vmx	241	15	deteriorating	deteriorate	VBG
cord-273505-pcsw3vmx	241	16	SARS	SARS	NNP
cord-273505-pcsw3vmx	241	17	patients	patient	NNS
cord-273505-pcsw3vmx	241	18	who	who	WP
cord-273505-pcsw3vmx	241	19	failed	fail	VBD
cord-273505-pcsw3vmx	241	20	corticosteroid	corticosteroid	NN
cord-273505-pcsw3vmx	241	21	and	and	CC
cord-273505-pcsw3vmx	241	22	ribavirin	ribavirin	NN
cord-273505-pcsw3vmx	241	23	treatment	treatment	NN
cord-273505-pcsw3vmx	241	24	(	(	-LRB-
cord-273505-pcsw3vmx	241	25	225	225	CD
cord-273505-pcsw3vmx	241	26	)	)	-RRB-
cord-273505-pcsw3vmx	241	27	.	.	.
cord-273505-pcsw3vmx	242	1	A	a	DT
cord-273505-pcsw3vmx	242	2	significant	significant	JJ
cord-273505-pcsw3vmx	242	3	improvement	improvement	NN
cord-273505-pcsw3vmx	242	4	regarding	regard	VBG
cord-273505-pcsw3vmx	242	5	the	the	DT
cord-273505-pcsw3vmx	242	6	oxygen	oxygen	NN
cord-273505-pcsw3vmx	242	7	requirements	requirement	NNS
cord-273505-pcsw3vmx	242	8	and	and	CC
cord-273505-pcsw3vmx	242	9	radiographic	radiographic	JJ
cord-273505-pcsw3vmx	242	10	scores	score	NNS
cord-273505-pcsw3vmx	242	11	were	be	VBD
cord-273505-pcsw3vmx	242	12	observed	observe	VBN
cord-273505-pcsw3vmx	242	13	after	after	IN
cord-273505-pcsw3vmx	242	14	pentaglobin	pentaglobin	NNP
cord-273505-pcsw3vmx	242	15	therapy	therapy	NN
cord-273505-pcsw3vmx	242	16	,	,	,
cord-273505-pcsw3vmx	242	17	and	and	CC
cord-273505-pcsw3vmx	242	18	most	most	JJS
cord-273505-pcsw3vmx	242	19	patients	patient	NNS
cord-273505-pcsw3vmx	242	20	recovered	recover	VBD
cord-273505-pcsw3vmx	242	21	.	.	.
cord-273505-pcsw3vmx	243	1	It	-PRON-	PRP
cord-273505-pcsw3vmx	243	2	has	have	VBZ
cord-273505-pcsw3vmx	243	3	been	be	VBN
cord-273505-pcsw3vmx	243	4	proposed	propose	VBN
cord-273505-pcsw3vmx	243	5	that	that	IN
cord-273505-pcsw3vmx	243	6	abnormal	abnormal	JJ
cord-273505-pcsw3vmx	243	7	cytokine	cytokine	NN
cord-273505-pcsw3vmx	243	8	levels	level	NNS
cord-273505-pcsw3vmx	243	9	(	(	-LRB-
cord-273505-pcsw3vmx	243	10	e.g.	e.g.	RB
cord-273505-pcsw3vmx	243	11	,	,	,
cord-273505-pcsw3vmx	243	12	IL-6	IL-6	NNP
cord-273505-pcsw3vmx	243	13	and	and	CC
cord-273505-pcsw3vmx	243	14	TNF	TNF	NNP
cord-273505-pcsw3vmx	243	15	-	-	HYPH
cord-273505-pcsw3vmx	243	16	α	α	NNP
cord-273505-pcsw3vmx	243	17	)	)	-RRB-
cord-273505-pcsw3vmx	243	18	are	be	VBP
cord-273505-pcsw3vmx	243	19	correlated	correlate	VBN
cord-273505-pcsw3vmx	243	20	with	with	IN
cord-273505-pcsw3vmx	243	21	poor	poor	JJ
cord-273505-pcsw3vmx	243	22	prognosis	prognosis	NN
cord-273505-pcsw3vmx	243	23	in	in	IN
cord-273505-pcsw3vmx	243	24	SARS	SARS	NNP
cord-273505-pcsw3vmx	243	25	patients	patient	NNS
cord-273505-pcsw3vmx	243	26	,	,	,
cord-273505-pcsw3vmx	243	27	and	and	CC
cord-273505-pcsw3vmx	243	28	that	that	IN
cord-273505-pcsw3vmx	243	29	the	the	DT
cord-273505-pcsw3vmx	243	30	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	243	31	effects	effect	NNS
cord-273505-pcsw3vmx	243	32	of	of	IN
cord-273505-pcsw3vmx	243	33	pentaglobin	pentaglobin	NN
cord-273505-pcsw3vmx	243	34	on	on	IN
cord-273505-pcsw3vmx	243	35	cytokine	cytokine	NN
cord-273505-pcsw3vmx	243	36	release	release	NN
cord-273505-pcsw3vmx	243	37	might	may	MD
cord-273505-pcsw3vmx	243	38	represent	represent	VB
cord-273505-pcsw3vmx	243	39	an	an	DT
cord-273505-pcsw3vmx	243	40	essential	essential	JJ
cord-273505-pcsw3vmx	243	41	mechanism	mechanism	NN
cord-273505-pcsw3vmx	243	42	of	of	IN
cord-273505-pcsw3vmx	243	43	action	action	NN
cord-273505-pcsw3vmx	243	44	in	in	IN
cord-273505-pcsw3vmx	243	45	the	the	DT
cord-273505-pcsw3vmx	243	46	treatment	treatment	NN
cord-273505-pcsw3vmx	243	47	of	of	IN
cord-273505-pcsw3vmx	243	48	SARS	SARS	NNP
cord-273505-pcsw3vmx	243	49	(	(	-LRB-
cord-273505-pcsw3vmx	243	50	225	225	CD
cord-273505-pcsw3vmx	243	51	,	,	,
cord-273505-pcsw3vmx	243	52	235	235	CD
cord-273505-pcsw3vmx	243	53	)	)	-RRB-
cord-273505-pcsw3vmx	243	54	.	.	.
cord-273505-pcsw3vmx	244	1	MERS	MERS	NNP
cord-273505-pcsw3vmx	244	2	is	be	VBZ
cord-273505-pcsw3vmx	244	3	a	a	DT
cord-273505-pcsw3vmx	244	4	highly	highly	RB
cord-273505-pcsw3vmx	244	5	fatal	fatal	JJ
cord-273505-pcsw3vmx	244	6	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	244	7	disease	disease	NN
cord-273505-pcsw3vmx	244	8	caused	cause	VBN
cord-273505-pcsw3vmx	244	9	by	by	IN
cord-273505-pcsw3vmx	244	10	MERS	MERS	NNP
cord-273505-pcsw3vmx	244	11	-	-	HYPH
cord-273505-pcsw3vmx	244	12	CoV	CoV	NNP
cord-273505-pcsw3vmx	244	13	,	,	,
cord-273505-pcsw3vmx	244	14	with	with	IN
cord-273505-pcsw3vmx	244	15	two	two	CD
cord-273505-pcsw3vmx	244	16	major	major	JJ
cord-273505-pcsw3vmx	244	17	historic	historic	JJ
cord-273505-pcsw3vmx	244	18	outbreaks	outbreak	NNS
cord-273505-pcsw3vmx	244	19	in	in	IN
cord-273505-pcsw3vmx	244	20	2012	2012	CD
cord-273505-pcsw3vmx	244	21	and	and	CC
cord-273505-pcsw3vmx	244	22	2015	2015	CD
cord-273505-pcsw3vmx	244	23	.	.	.
cord-273505-pcsw3vmx	245	1	The	the	DT
cord-273505-pcsw3vmx	245	2	rapid	rapid	JJ
cord-273505-pcsw3vmx	245	3	deterioration	deterioration	NN
cord-273505-pcsw3vmx	245	4	of	of	IN
cord-273505-pcsw3vmx	245	5	health	health	NN
cord-273505-pcsw3vmx	245	6	in	in	IN
cord-273505-pcsw3vmx	245	7	a	a	DT
cord-273505-pcsw3vmx	245	8	large	large	JJ
cord-273505-pcsw3vmx	245	9	number	number	NN
cord-273505-pcsw3vmx	245	10	of	of	IN
cord-273505-pcsw3vmx	245	11	patients	patient	NNS
cord-273505-pcsw3vmx	245	12	made	make	VBD
cord-273505-pcsw3vmx	245	13	it	-PRON-	PRP
cord-273505-pcsw3vmx	245	14	unrealistic	unrealistic	JJ
cord-273505-pcsw3vmx	245	15	and	and	CC
cord-273505-pcsw3vmx	245	16	unethical	unethical	JJ
cord-273505-pcsw3vmx	245	17	to	to	TO
cord-273505-pcsw3vmx	245	18	perform	perform	VB
cord-273505-pcsw3vmx	245	19	randomized	randomize	VBN
cord-273505-pcsw3vmx	245	20	controlled	control	VBN
cord-273505-pcsw3vmx	245	21	treatment	treatment	NN
cord-273505-pcsw3vmx	245	22	trials	trial	NNS
cord-273505-pcsw3vmx	245	23	.	.	.
cord-273505-pcsw3vmx	246	1	Therefore	therefore	RB
cord-273505-pcsw3vmx	246	2	,	,	,
cord-273505-pcsw3vmx	246	3	the	the	DT
cord-273505-pcsw3vmx	246	4	current	current	JJ
cord-273505-pcsw3vmx	246	5	availability	availability	NN
cord-273505-pcsw3vmx	246	6	of	of	IN
cord-273505-pcsw3vmx	246	7	strong	strong	JJ
cord-273505-pcsw3vmx	246	8	evidence	evidence	NN
cord-273505-pcsw3vmx	246	9	is	be	VBZ
cord-273505-pcsw3vmx	246	10	minimal	minimal	JJ
cord-273505-pcsw3vmx	246	11	,	,	,
cord-273505-pcsw3vmx	246	12	and	and	CC
cord-273505-pcsw3vmx	246	13	only	only	RB
cord-273505-pcsw3vmx	246	14	a	a	DT
cord-273505-pcsw3vmx	246	15	few	few	JJ
cord-273505-pcsw3vmx	246	16	case	case	NN
cord-273505-pcsw3vmx	246	17	series	series	NN
cord-273505-pcsw3vmx	246	18	reported	report	VBD
cord-273505-pcsw3vmx	246	19	administration	administration	NN
cord-273505-pcsw3vmx	246	20	of	of	IN
cord-273505-pcsw3vmx	246	21	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	246	22	late	late	RB
cord-273505-pcsw3vmx	246	23	in	in	IN
cord-273505-pcsw3vmx	246	24	the	the	DT
cord-273505-pcsw3vmx	246	25	course	course	NN
cord-273505-pcsw3vmx	246	26	of	of	IN
cord-273505-pcsw3vmx	246	27	MERS	MERS	NNPS
cord-273505-pcsw3vmx	246	28	.	.	.
cord-273505-pcsw3vmx	247	1	These	these	DT
cord-273505-pcsw3vmx	247	2	studies	study	NNS
cord-273505-pcsw3vmx	247	3	discussed	discuss	VBD
cord-273505-pcsw3vmx	247	4	the	the	DT
cord-273505-pcsw3vmx	247	5	possible	possible	JJ
cord-273505-pcsw3vmx	247	6	efficacy	efficacy	NN
cord-273505-pcsw3vmx	247	7	of	of	IN
cord-273505-pcsw3vmx	247	8	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	247	9	in	in	IN
cord-273505-pcsw3vmx	247	10	reversing	reverse	VBG
cord-273505-pcsw3vmx	247	11	severe	severe	JJ
cord-273505-pcsw3vmx	247	12	thrombocytopenia	thrombocytopenia	NN
cord-273505-pcsw3vmx	247	13	through	through	IN
cord-273505-pcsw3vmx	247	14	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	247	15	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	247	16	(	(	-LRB-
cord-273505-pcsw3vmx	247	17	226	226	CD
cord-273505-pcsw3vmx	247	18	,	,	,
cord-273505-pcsw3vmx	247	19	236	236	CD
cord-273505-pcsw3vmx	247	20	)	)	-RRB-
cord-273505-pcsw3vmx	247	21	.	.	.
cord-273505-pcsw3vmx	248	1	Although	although	IN
cord-273505-pcsw3vmx	248	2	influenza	influenza	NN
cord-273505-pcsw3vmx	248	3	has	have	VBZ
cord-273505-pcsw3vmx	248	4	been	be	VBN
cord-273505-pcsw3vmx	248	5	around	around	RB
cord-273505-pcsw3vmx	248	6	for	for	IN
cord-273505-pcsw3vmx	248	7	centuries	century	NNS
cord-273505-pcsw3vmx	248	8	,	,	,
cord-273505-pcsw3vmx	248	9	severe	severe	JJ
cord-273505-pcsw3vmx	248	10	influenza	influenza	NN
cord-273505-pcsw3vmx	248	11	remains	remain	VBZ
cord-273505-pcsw3vmx	248	12	a	a	DT
cord-273505-pcsw3vmx	248	13	health	health	NN
cord-273505-pcsw3vmx	248	14	challenge	challenge	NN
cord-273505-pcsw3vmx	248	15	for	for	IN
cord-273505-pcsw3vmx	248	16	humans	human	NNS
cord-273505-pcsw3vmx	248	17	.	.	.
cord-273505-pcsw3vmx	249	1	The	the	DT
cord-273505-pcsw3vmx	249	2	complications	complication	NNS
cord-273505-pcsw3vmx	249	3	or	or	CC
cord-273505-pcsw3vmx	249	4	deaths	death	NNS
cord-273505-pcsw3vmx	249	5	are	be	VBP
cord-273505-pcsw3vmx	249	6	usually	usually	RB
cord-273505-pcsw3vmx	249	7	associated	associate	VBN
cord-273505-pcsw3vmx	249	8	with	with	IN
cord-273505-pcsw3vmx	249	9	the	the	DT
cord-273505-pcsw3vmx	249	10	extensive	extensive	JJ
cord-273505-pcsw3vmx	249	11	induction	induction	NN
cord-273505-pcsw3vmx	249	12	of	of	IN
cord-273505-pcsw3vmx	249	13	pro	pro	JJ
cord-273505-pcsw3vmx	249	14	-	-	JJ
cord-273505-pcsw3vmx	249	15	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	249	16	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	249	17	in	in	IN
cord-273505-pcsw3vmx	249	18	severely	severely	RB
cord-273505-pcsw3vmx	249	19	affected	affect	VBN
cord-273505-pcsw3vmx	249	20	influenza	influenza	NN
cord-273505-pcsw3vmx	249	21	patients	patient	NNS
cord-273505-pcsw3vmx	249	22	(	(	-LRB-
cord-273505-pcsw3vmx	249	23	166	166	CD
cord-273505-pcsw3vmx	249	24	)	)	-RRB-
cord-273505-pcsw3vmx	249	25	.	.	.
cord-273505-pcsw3vmx	250	1	Immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	250	2	strategies	strategy	NNS
cord-273505-pcsw3vmx	250	3	or	or	CC
cord-273505-pcsw3vmx	250	4	treatments	treatment	NNS
cord-273505-pcsw3vmx	250	5	,	,	,
cord-273505-pcsw3vmx	250	6	including	include	VBG
cord-273505-pcsw3vmx	250	7	amongst	amongst	IN
cord-273505-pcsw3vmx	250	8	others	other	NNS
cord-273505-pcsw3vmx	250	9	corticosteroids	corticosteroid	NNS
cord-273505-pcsw3vmx	250	10	,	,	,
cord-273505-pcsw3vmx	250	11	PPARs	ppar	NNS
cord-273505-pcsw3vmx	250	12	agonists	agonist	NNS
cord-273505-pcsw3vmx	250	13	,	,	,
cord-273505-pcsw3vmx	250	14	S1P1	S1P1	NNP
cord-273505-pcsw3vmx	250	15	receptor	receptor	NN
cord-273505-pcsw3vmx	250	16	1	1	CD
cord-273505-pcsw3vmx	250	17	agonists	agonist	NNS
cord-273505-pcsw3vmx	250	18	,	,	,
cord-273505-pcsw3vmx	250	19	antioxidants	antioxidant	NNS
cord-273505-pcsw3vmx	250	20	,	,	,
cord-273505-pcsw3vmx	250	21	and	and	CC
cord-273505-pcsw3vmx	250	22	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	250	23	 	 	_SP
cord-273505-pcsw3vmx	250	24	Frontiers	Frontiers	NNP
cord-273505-pcsw3vmx	250	25	in	in	IN
cord-273505-pcsw3vmx	250	26	Immunology	Immunology	NNP
cord-273505-pcsw3vmx	250	27	|	|	NNP
cord-273505-pcsw3vmx	250	28	www.frontiersin.org	www.frontiersin.org	IN
cord-273505-pcsw3vmx	250	29	ARDS	ARDS	NNP
cord-273505-pcsw3vmx	250	30	,	,	,
cord-273505-pcsw3vmx	250	31	acute	acute	JJ
cord-273505-pcsw3vmx	250	32	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	250	33	distress	distress	NN
cord-273505-pcsw3vmx	250	34	syndrome	syndrome	NN
cord-273505-pcsw3vmx	250	35	;	;	:
cord-273505-pcsw3vmx	250	36	N.D.	North Dakota	NNP
cord-273505-pcsw3vmx	250	37	,	,	,
cord-273505-pcsw3vmx	250	38	no	no	DT
cord-273505-pcsw3vmx	250	39	data	data	NN
cord-273505-pcsw3vmx	250	40	;	;	:
cord-273505-pcsw3vmx	250	41	SPO	SPO	NNP
cord-273505-pcsw3vmx	250	42	2	2	CD
cord-273505-pcsw3vmx	250	43	,	,	,
cord-273505-pcsw3vmx	250	44	surplus	surplus	JJ
cord-273505-pcsw3vmx	250	45	pulse	pulse	NN
cord-273505-pcsw3vmx	250	46	O	o	NN
cord-273505-pcsw3vmx	250	47	2	2	CD
cord-273505-pcsw3vmx	250	48	;	;	:
cord-273505-pcsw3vmx	250	49	CRP	CRP	NNP
cord-273505-pcsw3vmx	250	50	,	,	,
cord-273505-pcsw3vmx	250	51	C	c	NN
cord-273505-pcsw3vmx	250	52	-	-	HYPH
cord-273505-pcsw3vmx	250	53	reaction	reaction	NN
cord-273505-pcsw3vmx	250	54	protein	protein	NN
cord-273505-pcsw3vmx	250	55	;	;	:
cord-273505-pcsw3vmx	250	56	APACHE	APACHE	NNP
cord-273505-pcsw3vmx	250	57	II	II	NNP
cord-273505-pcsw3vmx	250	58	,	,	,
cord-273505-pcsw3vmx	250	59	acute	acute	JJ
cord-273505-pcsw3vmx	250	60	physiology	physiology	NN
cord-273505-pcsw3vmx	250	61	and	and	CC
cord-273505-pcsw3vmx	250	62	chronic	chronic	JJ
cord-273505-pcsw3vmx	250	63	health	health	NN
cord-273505-pcsw3vmx	250	64	evaluation	evaluation	NN
cord-273505-pcsw3vmx	250	65	score	score	NN
cord-273505-pcsw3vmx	250	66	;	;	:
cord-273505-pcsw3vmx	250	67	URTI	URTI	NNP
cord-273505-pcsw3vmx	250	68	,	,	,
cord-273505-pcsw3vmx	250	69	upper	upper	JJ
cord-273505-pcsw3vmx	250	70	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	250	71	tract	tract	NN
cord-273505-pcsw3vmx	250	72	infection	infection	NN
cord-273505-pcsw3vmx	250	73	;	;	:
cord-273505-pcsw3vmx	250	74	LRTI	LRTI	NNS
cord-273505-pcsw3vmx	250	75	,	,	,
cord-273505-pcsw3vmx	250	76	lower	low	JJR
cord-273505-pcsw3vmx	250	77	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	250	78	tract	tract	NN
cord-273505-pcsw3vmx	250	79	infection	infection	NN
cord-273505-pcsw3vmx	250	80	.	.	.
cord-273505-pcsw3vmx	251	1	*	*	NFP
cord-273505-pcsw3vmx	251	2	All	all	DT
cord-273505-pcsw3vmx	251	3	patients	patient	NNS
cord-273505-pcsw3vmx	251	4	were	be	VBD
cord-273505-pcsw3vmx	251	5	treated	treat	VBN
cord-273505-pcsw3vmx	251	6	with	with	IN
cord-273505-pcsw3vmx	251	7	Arbidol	Arbidol	NNP
cord-273505-pcsw3vmx	251	8	.	.	.
cord-273505-pcsw3vmx	252	1	†	†	NN
cord-273505-pcsw3vmx	252	2	95	95	CD
cord-273505-pcsw3vmx	252	3	%	%	NN
cord-273505-pcsw3vmx	252	4	patients	patient	NNS
cord-273505-pcsw3vmx	252	5	were	be	VBD
cord-273505-pcsw3vmx	252	6	treated	treat	VBN
cord-273505-pcsw3vmx	252	7	with	with	IN
cord-273505-pcsw3vmx	252	8	Ribavirin	Ribavirin	NNP
cord-273505-pcsw3vmx	252	9	,	,	,
cord-273505-pcsw3vmx	252	10	26	26	CD
cord-273505-pcsw3vmx	252	11	%	%	NN
cord-273505-pcsw3vmx	252	12	with	with	IN
cord-273505-pcsw3vmx	252	13	Oseltamivir	Oseltamivir	NNP
cord-273505-pcsw3vmx	252	14	,	,	,
cord-273505-pcsw3vmx	252	15	and	and	CC
cord-273505-pcsw3vmx	252	16	16	16	CD
cord-273505-pcsw3vmx	252	17	%	%	NN
cord-273505-pcsw3vmx	252	18	with	with	IN
cord-273505-pcsw3vmx	252	19	Arbidol	Arbidol	NNP
cord-273505-pcsw3vmx	252	20	.	.	.
cord-273505-pcsw3vmx	253	1	‡	‡	NN
cord-273505-pcsw3vmx	253	2	80	80	CD
cord-273505-pcsw3vmx	253	3	%	%	NN
cord-273505-pcsw3vmx	253	4	patients	patient	NNS
cord-273505-pcsw3vmx	253	5	were	be	VBD
cord-273505-pcsw3vmx	253	6	treated	treat	VBN
cord-273505-pcsw3vmx	253	7	with	with	IN
cord-273505-pcsw3vmx	253	8	Lopinavir	Lopinavir	NNP
cord-273505-pcsw3vmx	253	9	/	/	SYM
cord-273505-pcsw3vmx	253	10	ritonavir	ritonavir	NNS
cord-273505-pcsw3vmx	253	11	,	,	,
cord-273505-pcsw3vmx	253	12	60	60	CD
cord-273505-pcsw3vmx	253	13	%	%	NN
cord-273505-pcsw3vmx	253	14	with	with	IN
cord-273505-pcsw3vmx	253	15	interferon	interferon	NN
cord-273505-pcsw3vmx	253	16	,	,	,
cord-273505-pcsw3vmx	253	17	and	and	CC
cord-273505-pcsw3vmx	253	18	30	30	CD
cord-273505-pcsw3vmx	253	19	%	%	NN
cord-273505-pcsw3vmx	253	20	with	with	IN
cord-273505-pcsw3vmx	253	21	Arbidol	Arbidol	NNP
cord-273505-pcsw3vmx	253	22	.	.	.
cord-273505-pcsw3vmx	254	1	§	§	.
cord-273505-pcsw3vmx	255	1	Patients	patient	NNS
cord-273505-pcsw3vmx	255	2	1	1	CD
cord-273505-pcsw3vmx	255	3	were	be	VBD
cord-273505-pcsw3vmx	255	4	treated	treat	VBN
cord-273505-pcsw3vmx	255	5	with	with	IN
cord-273505-pcsw3vmx	255	6	Oseltamivir	Oseltamivir	NNP
cord-273505-pcsw3vmx	255	7	,	,	,
cord-273505-pcsw3vmx	255	8	and	and	CC
cord-273505-pcsw3vmx	255	9	Patients	Patients	NNP
cord-273505-pcsw3vmx	255	10	3	3	CD
cord-273505-pcsw3vmx	255	11	with	with	IN
cord-273505-pcsw3vmx	255	12	steroids	steroid	NNS
cord-273505-pcsw3vmx	255	13	and	and	CC
cord-273505-pcsw3vmx	255	14	Lopinavir	Lopinavir	NNP
cord-273505-pcsw3vmx	255	15	/	/	SYM
cord-273505-pcsw3vmx	255	16	ritonavir	ritonavir	NNS
cord-273505-pcsw3vmx	255	17	.	.	.
cord-273505-pcsw3vmx	256	1	¶	¶	NFP
cord-273505-pcsw3vmx	257	1	Patients	patient	NNS
cord-273505-pcsw3vmx	257	2	received	receive	VBD
cord-273505-pcsw3vmx	257	3	IVIg	IVIg	NNS
cord-273505-pcsw3vmx	257	4	at	at	IN
cord-273505-pcsw3vmx	257	5	2.5	2.5	CD
cord-273505-pcsw3vmx	257	6	-	-	SYM
cord-273505-pcsw3vmx	257	7	10	10	CD
cord-273505-pcsw3vmx	257	8	g	g	NN
cord-273505-pcsw3vmx	257	9	/	/	SYM
cord-273505-pcsw3vmx	257	10	d	d	NN
cord-273505-pcsw3vmx	257	11	for	for	IN
cord-273505-pcsw3vmx	257	12	2	2	CD
cord-273505-pcsw3vmx	257	13	-	-	SYM
cord-273505-pcsw3vmx	257	14	13	13	CD
cord-273505-pcsw3vmx	257	15	d	d	NN
cord-273505-pcsw3vmx	257	16	,	,	,
cord-273505-pcsw3vmx	257	17	average	average	JJ
cord-273505-pcsw3vmx	257	18	to	to	IN
cord-273505-pcsw3vmx	257	19	5	5	CD
cord-273505-pcsw3vmx	257	20	g	g	NN
cord-273505-pcsw3vmx	257	21	/	/	SYM
cord-273505-pcsw3vmx	257	22	d	d	NN
cord-273505-pcsw3vmx	257	23	for	for	IN
cord-273505-pcsw3vmx	257	24	5	5	CD
cord-273505-pcsw3vmx	257	25	d.	d.	NNP
cord-273505-pcsw3vmx	258	1	These	these	DT
cord-273505-pcsw3vmx	258	2	patients	patient	NNS
cord-273505-pcsw3vmx	258	3	were	be	VBD
cord-273505-pcsw3vmx	258	4	treated	treat	VBN
cord-273505-pcsw3vmx	258	5	with	with	IN
cord-273505-pcsw3vmx	258	6	Ribavirin	Ribavirin	NNP
cord-273505-pcsw3vmx	258	7	.	.	.
cord-273505-pcsw3vmx	259	1	*	*	NFP
cord-273505-pcsw3vmx	260	1	*	*	NFP
cord-273505-pcsw3vmx	260	2	All	all	DT
cord-273505-pcsw3vmx	260	3	patients	patient	NNS
cord-273505-pcsw3vmx	260	4	were	be	VBD
cord-273505-pcsw3vmx	260	5	treated	treat	VBN
cord-273505-pcsw3vmx	260	6	with	with	IN
cord-273505-pcsw3vmx	260	7	Oseltamivir	Oseltamivir	NNP
cord-273505-pcsw3vmx	260	8	,	,	,
cord-273505-pcsw3vmx	260	9	and	and	CC
cord-273505-pcsw3vmx	260	10	8.8	8.8	CD
cord-273505-pcsw3vmx	260	11	%	%	NN
cord-273505-pcsw3vmx	260	12	with	with	IN
cord-273505-pcsw3vmx	260	13	zanamivir	zanamivir	NNP
cord-273505-pcsw3vmx	260	14	.	.	.
cord-273505-pcsw3vmx	261	1	†	†	UH
cord-273505-pcsw3vmx	261	2	†	†	NN
cord-273505-pcsw3vmx	262	1	All	all	DT
cord-273505-pcsw3vmx	262	2	patients	patient	NNS
cord-273505-pcsw3vmx	262	3	were	be	VBD
cord-273505-pcsw3vmx	262	4	treated	treat	VBN
cord-273505-pcsw3vmx	262	5	with	with	IN
cord-273505-pcsw3vmx	262	6	Oseltamivir	Oseltamivir	NNP
cord-273505-pcsw3vmx	262	7	.	.	.
cord-273505-pcsw3vmx	263	1	Frontiers	frontier	NNS
cord-273505-pcsw3vmx	263	2	in	in	IN
cord-273505-pcsw3vmx	263	3	Immunology	Immunology	NNP
cord-273505-pcsw3vmx	263	4	|	|	NNP
cord-273505-pcsw3vmx	263	5	www.frontiersin.org	www.frontiersin.org	NN
cord-273505-pcsw3vmx	263	6	therapy	therapy	NN
cord-273505-pcsw3vmx	263	7	,	,	,
cord-273505-pcsw3vmx	263	8	have	have	VBP
cord-273505-pcsw3vmx	263	9	been	be	VBN
cord-273505-pcsw3vmx	263	10	widely	widely	RB
cord-273505-pcsw3vmx	263	11	considered	consider	VBN
cord-273505-pcsw3vmx	263	12	as	as	IN
cord-273505-pcsw3vmx	263	13	adjunctive	adjunctive	JJ
cord-273505-pcsw3vmx	263	14	treatments	treatment	NNS
cord-273505-pcsw3vmx	263	15	for	for	IN
cord-273505-pcsw3vmx	263	16	cytokine	cytokine	JJ
cord-273505-pcsw3vmx	263	17	storms	storm	NNS
cord-273505-pcsw3vmx	263	18	in	in	IN
cord-273505-pcsw3vmx	263	19	influenza	influenza	NN
cord-273505-pcsw3vmx	263	20	(	(	-LRB-
cord-273505-pcsw3vmx	263	21	237	237	CD
cord-273505-pcsw3vmx	263	22	)	)	-RRB-
cord-273505-pcsw3vmx	263	23	.	.	.
cord-273505-pcsw3vmx	264	1	In	in	IN
cord-273505-pcsw3vmx	264	2	a	a	DT
cord-273505-pcsw3vmx	264	3	previous	previous	JJ
cord-273505-pcsw3vmx	264	4	randomized	randomized	JJ
cord-273505-pcsw3vmx	264	5	controlled	control	VBN
cord-273505-pcsw3vmx	264	6	trial	trial	NN
cord-273505-pcsw3vmx	264	7	,	,	,
cord-273505-pcsw3vmx	264	8	patients	patient	NNS
cord-273505-pcsw3vmx	264	9	infected	infect	VBN
cord-273505-pcsw3vmx	264	10	with	with	IN
cord-273505-pcsw3vmx	264	11	the	the	DT
cord-273505-pcsw3vmx	264	12	severe	severe	JJ
cord-273505-pcsw3vmx	264	13	2009	2009	CD
cord-273505-pcsw3vmx	264	14	pandemic	pandemic	NN
cord-273505-pcsw3vmx	264	15	influenza	influenza	NN
cord-273505-pcsw3vmx	264	16	A	A	NNP
cord-273505-pcsw3vmx	264	17	(	(	-LRB-
cord-273505-pcsw3vmx	264	18	H1N1	H1N1	NNP
cord-273505-pcsw3vmx	264	19	)	)	-RRB-
cord-273505-pcsw3vmx	264	20	were	be	VBD
cord-273505-pcsw3vmx	264	21	randomized	randomize	VBN
cord-273505-pcsw3vmx	264	22	to	to	TO
cord-273505-pcsw3vmx	264	23	receive	receive	VB
cord-273505-pcsw3vmx	264	24	0.4	0.4	CD
cord-273505-pcsw3vmx	264	25	g	g	NN
cord-273505-pcsw3vmx	264	26	/	/	SYM
cord-273505-pcsw3vmx	264	27	kg	kg	NN
cord-273505-pcsw3vmx	264	28	for	for	IN
cord-273505-pcsw3vmx	264	29	one	one	CD
cord-273505-pcsw3vmx	264	30	dose	dose	NN
cord-273505-pcsw3vmx	264	31	of	of	IN
cord-273505-pcsw3vmx	264	32	Flu	Flu	NNP
cord-273505-pcsw3vmx	264	33	-	-	HYPH
cord-273505-pcsw3vmx	264	34	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	264	35	(	(	-LRB-
cord-273505-pcsw3vmx	264	36	antiinfluenza	antiinfluenza	NNP
cord-273505-pcsw3vmx	264	37	hyperimmune	hyperimmune	NNP
cord-273505-pcsw3vmx	264	38	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	264	39	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	264	40	with	with	IN
cord-273505-pcsw3vmx	264	41	high	high	JJ
cord-273505-pcsw3vmx	264	42	HAI	HAI	NNP
cord-273505-pcsw3vmx	264	43	antibodies	antibody	NNS
cord-273505-pcsw3vmx	264	44	level	level	NN
cord-273505-pcsw3vmx	264	45	)	)	-RRB-
cord-273505-pcsw3vmx	264	46	or	or	CC
cord-273505-pcsw3vmx	264	47	IVIg	ivig	NN
cord-273505-pcsw3vmx	264	48	therapy	therapy	NN
cord-273505-pcsw3vmx	264	49	(	(	-LRB-
cord-273505-pcsw3vmx	264	50	227	227	CD
cord-273505-pcsw3vmx	264	51	)	)	-RRB-
cord-273505-pcsw3vmx	264	52	.	.	.
cord-273505-pcsw3vmx	265	1	Patients	patient	NNS
cord-273505-pcsw3vmx	265	2	who	who	WP
cord-273505-pcsw3vmx	265	3	received	receive	VBD
cord-273505-pcsw3vmx	265	4	Flu	Flu	NNP
cord-273505-pcsw3vmx	265	5	-	-	HYPH
cord-273505-pcsw3vmx	265	6	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	265	7	showed	show	VBD
cord-273505-pcsw3vmx	265	8	a	a	DT
cord-273505-pcsw3vmx	265	9	greater	great	JJR
cord-273505-pcsw3vmx	265	10	rate	rate	NN
cord-273505-pcsw3vmx	265	11	of	of	IN
cord-273505-pcsw3vmx	265	12	viral	viral	JJ
cord-273505-pcsw3vmx	265	13	load	load	NN
cord-273505-pcsw3vmx	265	14	reduction	reduction	NN
cord-273505-pcsw3vmx	265	15	than	than	IN
cord-273505-pcsw3vmx	265	16	the	the	DT
cord-273505-pcsw3vmx	265	17	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	265	18	group	group	NN
cord-273505-pcsw3vmx	265	19	.	.	.
cord-273505-pcsw3vmx	266	1	However	however	RB
cord-273505-pcsw3vmx	266	2	,	,	,
cord-273505-pcsw3vmx	266	3	there	there	EX
cord-273505-pcsw3vmx	266	4	was	be	VBD
cord-273505-pcsw3vmx	266	5	no	no	DT
cord-273505-pcsw3vmx	266	6	significant	significant	JJ
cord-273505-pcsw3vmx	266	7	difference	difference	NN
cord-273505-pcsw3vmx	266	8	in	in	IN
cord-273505-pcsw3vmx	266	9	the	the	DT
cord-273505-pcsw3vmx	266	10	cytokine	cytokine	NN
cord-273505-pcsw3vmx	266	11	profiles	profile	NNS
cord-273505-pcsw3vmx	266	12	(	(	-LRB-
cord-273505-pcsw3vmx	266	13	e.g.	e.g.	RB
cord-273505-pcsw3vmx	266	14	,	,	,
cord-273505-pcsw3vmx	266	15	IFN	IFN	NNP
cord-273505-pcsw3vmx	266	16	-	-	HYPH
cord-273505-pcsw3vmx	266	17	α2	α2	NNP
cord-273505-pcsw3vmx	266	18	,	,	,
cord-273505-pcsw3vmx	266	19	IL-1α	IL-1α	NNP
cord-273505-pcsw3vmx	266	20	,	,	,
cord-273505-pcsw3vmx	266	21	IL-6	IL-6	NNP
cord-273505-pcsw3vmx	266	22	,	,	,
cord-273505-pcsw3vmx	266	23	IL-10	IL-10	NNP
cord-273505-pcsw3vmx	266	24	,	,	,
cord-273505-pcsw3vmx	266	25	IL-15	IL-15	NNP
cord-273505-pcsw3vmx	266	26	,	,	,
cord-273505-pcsw3vmx	266	27	IL-1ra	IL-1ra	NNP
cord-273505-pcsw3vmx	266	28	,	,	,
cord-273505-pcsw3vmx	266	29	MCP-1	MCP-1	NNP
cord-273505-pcsw3vmx	266	30	,	,	,
cord-273505-pcsw3vmx	266	31	MIP-1α	MIP-1α	NNP
cord-273505-pcsw3vmx	266	32	,	,	,
cord-273505-pcsw3vmx	266	33	GM	GM	NNP
cord-273505-pcsw3vmx	266	34	-	-	HYPH
cord-273505-pcsw3vmx	266	35	CSF	CSF	NNP
cord-273505-pcsw3vmx	266	36	,	,	,
cord-273505-pcsw3vmx	266	37	TNF	TNF	NNP
cord-273505-pcsw3vmx	266	38	-	-	HYPH
cord-273505-pcsw3vmx	266	39	α	α	NNP
cord-273505-pcsw3vmx	266	40	)	)	-RRB-
cord-273505-pcsw3vmx	266	41	between	between	IN
cord-273505-pcsw3vmx	266	42	the	the	DT
cord-273505-pcsw3vmx	266	43	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	266	44	and	and	CC
cord-273505-pcsw3vmx	266	45	Flu	Flu	NNP
cord-273505-pcsw3vmx	266	46	-	-	HYPH
cord-273505-pcsw3vmx	266	47	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	266	48	group	group	NN
cord-273505-pcsw3vmx	266	49	on	on	IN
cord-273505-pcsw3vmx	266	50	day	day	NN
cord-273505-pcsw3vmx	266	51	5	5	CD
cord-273505-pcsw3vmx	266	52	.	.	.
cord-273505-pcsw3vmx	267	1	Subgroup	subgroup	NN
cord-273505-pcsw3vmx	267	2	multivariate	multivariate	JJ
cord-273505-pcsw3vmx	267	3	analysis	analysis	NN
cord-273505-pcsw3vmx	267	4	of	of	IN
cord-273505-pcsw3vmx	267	5	patients	patient	NNS
cord-273505-pcsw3vmx	267	6	receiving	receive	VBG
cord-273505-pcsw3vmx	267	7	treatment	treatment	NN
cord-273505-pcsw3vmx	267	8	within	within	IN
cord-273505-pcsw3vmx	267	9	5	5	CD
cord-273505-pcsw3vmx	267	10	days	day	NNS
cord-273505-pcsw3vmx	267	11	of	of	IN
cord-273505-pcsw3vmx	267	12	symptom	symptom	NN
cord-273505-pcsw3vmx	267	13	onset	onset	NN
cord-273505-pcsw3vmx	267	14	revealed	reveal	VBD
cord-273505-pcsw3vmx	267	15	that	that	IN
cord-273505-pcsw3vmx	267	16	Flu	Flu	NNP
cord-273505-pcsw3vmx	267	17	-	-	HYPH
cord-273505-pcsw3vmx	267	18	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	267	19	therapy	therapy	NN
cord-273505-pcsw3vmx	267	20	,	,	,
cord-273505-pcsw3vmx	267	21	rather	rather	RB
cord-273505-pcsw3vmx	267	22	than	than	IN
cord-273505-pcsw3vmx	267	23	IVIg	ivig	NN
cord-273505-pcsw3vmx	267	24	therapy	therapy	NN
cord-273505-pcsw3vmx	267	25	,	,	,
cord-273505-pcsw3vmx	267	26	was	be	VBD
cord-273505-pcsw3vmx	267	27	the	the	DT
cord-273505-pcsw3vmx	267	28	only	only	JJ
cord-273505-pcsw3vmx	267	29	factor	factor	NN
cord-273505-pcsw3vmx	267	30	that	that	WDT
cord-273505-pcsw3vmx	267	31	independently	independently	RB
cord-273505-pcsw3vmx	267	32	reduced	reduce	VBN
cord-273505-pcsw3vmx	267	33	mortality	mortality	NN
cord-273505-pcsw3vmx	267	34	.	.	.
cord-273505-pcsw3vmx	268	1	In	in	IN
cord-273505-pcsw3vmx	268	2	contrast	contrast	NN
cord-273505-pcsw3vmx	268	3	,	,	,
cord-273505-pcsw3vmx	268	4	other	other	JJ
cord-273505-pcsw3vmx	268	5	RCTs	rct	NNS
cord-273505-pcsw3vmx	268	6	using	use	VBG
cord-273505-pcsw3vmx	268	7	IVIg	ivig	JJ
cord-273505-pcsw3vmx	268	8	treatment	treatment	NN
cord-273505-pcsw3vmx	268	9	at	at	IN
cord-273505-pcsw3vmx	268	10	high	high	JJ
cord-273505-pcsw3vmx	268	11	doses	dose	NNS
cord-273505-pcsw3vmx	268	12	have	have	VBP
cord-273505-pcsw3vmx	268	13	shown	show	VBN
cord-273505-pcsw3vmx	268	14	improved	improve	VBN
cord-273505-pcsw3vmx	268	15	survival	survival	NN
cord-273505-pcsw3vmx	268	16	.	.	.
cord-273505-pcsw3vmx	269	1	In	in	IN
cord-273505-pcsw3vmx	269	2	two	two	CD
cord-273505-pcsw3vmx	269	3	similar	similar	JJ
cord-273505-pcsw3vmx	269	4	studies	study	NNS
cord-273505-pcsw3vmx	269	5	,	,	,
cord-273505-pcsw3vmx	269	6	pediatric	pediatric	JJ
cord-273505-pcsw3vmx	269	7	patients	patient	NNS
cord-273505-pcsw3vmx	269	8	with	with	IN
cord-273505-pcsw3vmx	269	9	the	the	DT
cord-273505-pcsw3vmx	269	10	severe	severe	JJ
cord-273505-pcsw3vmx	269	11	2009	2009	CD
cord-273505-pcsw3vmx	269	12	pandemic	pandemic	NN
cord-273505-pcsw3vmx	269	13	influenza	influenza	NN
cord-273505-pcsw3vmx	269	14	A	A	NNP
cord-273505-pcsw3vmx	269	15	(	(	-LRB-
cord-273505-pcsw3vmx	269	16	H1N1	H1N1	NNP
cord-273505-pcsw3vmx	269	17	)	)	-RRB-
cord-273505-pcsw3vmx	269	18	were	be	VBD
cord-273505-pcsw3vmx	269	19	randomized	randomize	VBN
cord-273505-pcsw3vmx	269	20	to	to	TO
cord-273505-pcsw3vmx	269	21	receive	receive	VB
cord-273505-pcsw3vmx	269	22	standard	standard	JJ
cord-273505-pcsw3vmx	269	23	care	care	NN
cord-273505-pcsw3vmx	269	24	or	or	CC
cord-273505-pcsw3vmx	269	25	standard	standard	JJ
cord-273505-pcsw3vmx	269	26	care	care	NN
cord-273505-pcsw3vmx	269	27	plus	plus	CC
cord-273505-pcsw3vmx	269	28	1	1	CD
cord-273505-pcsw3vmx	269	29	g	g	NN
cord-273505-pcsw3vmx	269	30	/	/	SYM
cord-273505-pcsw3vmx	269	31	kg	kg	NNP
cord-273505-pcsw3vmx	269	32	/	/	SYM
cord-273505-pcsw3vmx	269	33	d	d	DT
cord-273505-pcsw3vmx	269	34	high	high	JJ
cord-273505-pcsw3vmx	269	35	-	-	HYPH
cord-273505-pcsw3vmx	269	36	dose	dose	NN
cord-273505-pcsw3vmx	269	37	IVIg	ivig	NN
cord-273505-pcsw3vmx	269	38	for	for	IN
cord-273505-pcsw3vmx	269	39	2	2	CD
cord-273505-pcsw3vmx	269	40	days	day	NNS
cord-273505-pcsw3vmx	269	41	(	(	-LRB-
cord-273505-pcsw3vmx	269	42	228	228	CD
cord-273505-pcsw3vmx	269	43	,	,	,
cord-273505-pcsw3vmx	269	44	229	229	CD
cord-273505-pcsw3vmx	269	45	)	)	-RRB-
cord-273505-pcsw3vmx	269	46	.	.	.
cord-273505-pcsw3vmx	270	1	Significant	significant	JJ
cord-273505-pcsw3vmx	270	2	clinical	clinical	JJ
cord-273505-pcsw3vmx	270	3	improvement	improvement	NN
cord-273505-pcsw3vmx	270	4	with	with	IN
cord-273505-pcsw3vmx	270	5	regards	regard	NNS
cord-273505-pcsw3vmx	270	6	to	to	IN
cord-273505-pcsw3vmx	270	7	temperature	temperature	NN
cord-273505-pcsw3vmx	270	8	normalization	normalization	NN
cord-273505-pcsw3vmx	270	9	,	,	,
cord-273505-pcsw3vmx	270	10	reduction	reduction	NN
cord-273505-pcsw3vmx	270	11	of	of	IN
cord-273505-pcsw3vmx	270	12	cough	cough	NN
cord-273505-pcsw3vmx	270	13	,	,	,
cord-273505-pcsw3vmx	270	14	rhinorrhea	rhinorrhea	NNP
cord-273505-pcsw3vmx	270	15	,	,	,
cord-273505-pcsw3vmx	270	16	tachypnea	tachypnea	NNP
cord-273505-pcsw3vmx	270	17	,	,	,
cord-273505-pcsw3vmx	270	18	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	270	19	sounds	sound	NNS
cord-273505-pcsw3vmx	270	20	(	(	-LRB-
cord-273505-pcsw3vmx	270	21	namely	namely	RB
cord-273505-pcsw3vmx	270	22	wheeze	wheeze	NN
cord-273505-pcsw3vmx	270	23	or	or	CC
cord-273505-pcsw3vmx	270	24	rhonchi	rhonchi	NNP
cord-273505-pcsw3vmx	270	25	)	)	-RRB-
cord-273505-pcsw3vmx	270	26	,	,	,
cord-273505-pcsw3vmx	270	27	and	and	CC
cord-273505-pcsw3vmx	270	28	chest	chest	NN
cord-273505-pcsw3vmx	270	29	radiographic	radiographic	JJ
cord-273505-pcsw3vmx	270	30	lesions	lesion	NNS
cord-273505-pcsw3vmx	270	31	were	be	VBD
cord-273505-pcsw3vmx	270	32	observed	observe	VBN
cord-273505-pcsw3vmx	270	33	in	in	IN
cord-273505-pcsw3vmx	270	34	the	the	DT
cord-273505-pcsw3vmx	270	35	IVIg	ivig	JJ
cord-273505-pcsw3vmx	270	36	group	group	NN
cord-273505-pcsw3vmx	270	37	compared	compare	VBN
cord-273505-pcsw3vmx	270	38	to	to	IN
cord-273505-pcsw3vmx	270	39	the	the	DT
cord-273505-pcsw3vmx	270	40	control	control	NN
cord-273505-pcsw3vmx	270	41	group	group	NN
cord-273505-pcsw3vmx	270	42	,	,	,
cord-273505-pcsw3vmx	270	43	revealing	reveal	VBG
cord-273505-pcsw3vmx	270	44	a	a	DT
cord-273505-pcsw3vmx	270	45	possible	possible	JJ
cord-273505-pcsw3vmx	270	46	clinical	clinical	JJ
cord-273505-pcsw3vmx	270	47	benefit	benefit	NN
cord-273505-pcsw3vmx	270	48	of	of	IN
cord-273505-pcsw3vmx	270	49	high	high	JJ
cord-273505-pcsw3vmx	270	50	-	-	HYPH
cord-273505-pcsw3vmx	270	51	dose	dose	NN
cord-273505-pcsw3vmx	270	52	IVIg	ivig	NN
cord-273505-pcsw3vmx	270	53	therapy	therapy	NN
cord-273505-pcsw3vmx	270	54	for	for	IN
cord-273505-pcsw3vmx	270	55	the	the	DT
cord-273505-pcsw3vmx	270	56	improvement	improvement	NN
cord-273505-pcsw3vmx	270	57	of	of	IN
cord-273505-pcsw3vmx	270	58	clinical	clinical	JJ
cord-273505-pcsw3vmx	270	59	symptoms	symptom	NNS
cord-273505-pcsw3vmx	270	60	in	in	IN
cord-273505-pcsw3vmx	270	61	pediatric	pediatric	JJ
cord-273505-pcsw3vmx	270	62	patients	patient	NNS
cord-273505-pcsw3vmx	270	63	with	with	IN
cord-273505-pcsw3vmx	270	64	severe	severe	JJ
cord-273505-pcsw3vmx	270	65	influenza	influenza	NN
cord-273505-pcsw3vmx	271	1	A	a	DT
cord-273505-pcsw3vmx	271	2	H1N1	H1N1	NNP
cord-273505-pcsw3vmx	271	3	(	(	-LRB-
cord-273505-pcsw3vmx	271	4	228	228	CD
cord-273505-pcsw3vmx	271	5	,	,	,
cord-273505-pcsw3vmx	271	6	229	229	CD
cord-273505-pcsw3vmx	271	7	)	)	-RRB-
cord-273505-pcsw3vmx	271	8	.	.	.
cord-273505-pcsw3vmx	272	1	RSV	RSV	NNP
cord-273505-pcsw3vmx	272	2	is	be	VBZ
cord-273505-pcsw3vmx	272	3	a	a	DT
cord-273505-pcsw3vmx	272	4	major	major	JJ
cord-273505-pcsw3vmx	272	5	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	272	6	pathogen	pathogen	NN
cord-273505-pcsw3vmx	272	7	that	that	WDT
cord-273505-pcsw3vmx	272	8	causes	cause	VBZ
cord-273505-pcsw3vmx	272	9	extensive	extensive	JJ
cord-273505-pcsw3vmx	272	10	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	272	11	symptoms	symptom	NNS
cord-273505-pcsw3vmx	272	12	,	,	,
cord-273505-pcsw3vmx	272	13	including	include	VBG
cord-273505-pcsw3vmx	272	14	both	both	CC
cord-273505-pcsw3vmx	272	15	upper	upper	JJ
cord-273505-pcsw3vmx	272	16	and	and	CC
cord-273505-pcsw3vmx	272	17	severe	severe	JJ
cord-273505-pcsw3vmx	272	18	lower	low	JJR
cord-273505-pcsw3vmx	272	19	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	272	20	tract	tract	NN
cord-273505-pcsw3vmx	272	21	infection	infection	NN
cord-273505-pcsw3vmx	272	22	(	(	-LRB-
cord-273505-pcsw3vmx	272	23	URTI	URTI	NNP
cord-273505-pcsw3vmx	272	24	/	/	SYM
cord-273505-pcsw3vmx	272	25	LRTI	LRTI	NNP
cord-273505-pcsw3vmx	272	26	)	)	-RRB-
cord-273505-pcsw3vmx	272	27	in	in	IN
cord-273505-pcsw3vmx	272	28	infants	infant	NNS
cord-273505-pcsw3vmx	272	29	,	,	,
cord-273505-pcsw3vmx	272	30	the	the	DT
cord-273505-pcsw3vmx	272	31	elderly	elderly	JJ
cord-273505-pcsw3vmx	272	32	,	,	,
cord-273505-pcsw3vmx	272	33	and	and	CC
cord-273505-pcsw3vmx	272	34	immunocompromised	immunocompromised	JJ
cord-273505-pcsw3vmx	272	35	individuals	individual	NNS
cord-273505-pcsw3vmx	272	36	(	(	-LRB-
cord-273505-pcsw3vmx	272	37	238	238	CD
cord-273505-pcsw3vmx	272	38	)	)	-RRB-
cord-273505-pcsw3vmx	272	39	.	.	.
cord-273505-pcsw3vmx	273	1	Available	available	JJ
cord-273505-pcsw3vmx	273	2	therapies	therapy	NNS
cord-273505-pcsw3vmx	273	3	are	be	VBP
cord-273505-pcsw3vmx	273	4	limited	limit	VBN
cord-273505-pcsw3vmx	273	5	to	to	IN
cord-273505-pcsw3vmx	273	6	RBV	RBV	NNP
cord-273505-pcsw3vmx	273	7	,	,	,
cord-273505-pcsw3vmx	273	8	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	273	9	,	,	,
cord-273505-pcsw3vmx	273	10	and	and	CC
cord-273505-pcsw3vmx	273	11	palivizumab	palivizumab	NNS
cord-273505-pcsw3vmx	273	12	,	,	,
cord-273505-pcsw3vmx	273	13	but	but	CC
cord-273505-pcsw3vmx	273	14	the	the	DT
cord-273505-pcsw3vmx	273	15	use	use	NN
cord-273505-pcsw3vmx	273	16	of	of	IN
cord-273505-pcsw3vmx	273	17	IVIg	ivig	NN
cord-273505-pcsw3vmx	273	18	for	for	IN
cord-273505-pcsw3vmx	273	19	treatment	treatment	NN
cord-273505-pcsw3vmx	273	20	of	of	IN
cord-273505-pcsw3vmx	273	21	RSV	RSV	NNP
cord-273505-pcsw3vmx	273	22	infections	infection	NNS
cord-273505-pcsw3vmx	273	23	remains	remain	VBZ
cord-273505-pcsw3vmx	273	24	controversial	controversial	JJ
cord-273505-pcsw3vmx	273	25	(	(	-LRB-
cord-273505-pcsw3vmx	273	26	239	239	CD
cord-273505-pcsw3vmx	273	27	)	)	-RRB-
cord-273505-pcsw3vmx	273	28	.	.	.
cord-273505-pcsw3vmx	274	1	A	a	DT
cord-273505-pcsw3vmx	274	2	study	study	NN
cord-273505-pcsw3vmx	274	3	showed	show	VBD
cord-273505-pcsw3vmx	274	4	that	that	IN
cord-273505-pcsw3vmx	274	5	hypogammaglobulinemia	hypogammaglobulinemia	NN
cord-273505-pcsw3vmx	274	6	was	be	VBD
cord-273505-pcsw3vmx	274	7	a	a	DT
cord-273505-pcsw3vmx	274	8	significant	significant	JJ
cord-273505-pcsw3vmx	274	9	risk	risk	NN
cord-273505-pcsw3vmx	274	10	factor	factor	NN
cord-273505-pcsw3vmx	274	11	for	for	IN
cord-273505-pcsw3vmx	274	12	fatal	fatal	JJ
cord-273505-pcsw3vmx	274	13	outcomes	outcome	NNS
cord-273505-pcsw3vmx	274	14	of	of	IN
cord-273505-pcsw3vmx	274	15	RSV	RSV	NNP
cord-273505-pcsw3vmx	274	16	infections	infection	NNS
cord-273505-pcsw3vmx	274	17	in	in	IN
cord-273505-pcsw3vmx	274	18	a	a	DT
cord-273505-pcsw3vmx	274	19	hematology	hematology	NN
cord-273505-pcsw3vmx	274	20	and	and	CC
cord-273505-pcsw3vmx	274	21	transplant	transplant	NN
cord-273505-pcsw3vmx	274	22	unit	unit	NN
cord-273505-pcsw3vmx	274	23	,	,	,
cord-273505-pcsw3vmx	274	24	and	and	CC
cord-273505-pcsw3vmx	274	25	treatment	treatment	NN
cord-273505-pcsw3vmx	274	26	with	with	IN
cord-273505-pcsw3vmx	274	27	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	274	28	at	at	IN
cord-273505-pcsw3vmx	274	29	regular	regular	JJ
cord-273505-pcsw3vmx	274	30	doses	dose	NNS
cord-273505-pcsw3vmx	274	31	was	be	VBD
cord-273505-pcsw3vmx	274	32	unable	unable	JJ
cord-273505-pcsw3vmx	274	33	to	to	TO
cord-273505-pcsw3vmx	274	34	reverse	reverse	VB
cord-273505-pcsw3vmx	274	35	the	the	DT
cord-273505-pcsw3vmx	274	36	poor	poor	JJ
cord-273505-pcsw3vmx	274	37	prognosis	prognosis	NN
cord-273505-pcsw3vmx	274	38	(	(	-LRB-
cord-273505-pcsw3vmx	274	39	230	230	CD
cord-273505-pcsw3vmx	274	40	)	)	-RRB-
cord-273505-pcsw3vmx	274	41	.	.	.
cord-273505-pcsw3vmx	275	1	By	by	IN
cord-273505-pcsw3vmx	275	2	contrast	contrast	NN
cord-273505-pcsw3vmx	275	3	,	,	,
cord-273505-pcsw3vmx	275	4	oral	oral	JJ
cord-273505-pcsw3vmx	275	5	RBV	RBV	NNP
cord-273505-pcsw3vmx	275	6	in	in	IN
cord-273505-pcsw3vmx	275	7	combination	combination	NN
cord-273505-pcsw3vmx	275	8	with	with	IN
cord-273505-pcsw3vmx	275	9	high	high	JJ
cord-273505-pcsw3vmx	275	10	-	-	HYPH
cord-273505-pcsw3vmx	275	11	dose	dose	NN
cord-273505-pcsw3vmx	275	12	IVIg	ivig	NN
cord-273505-pcsw3vmx	275	13	therapy	therapy	NN
cord-273505-pcsw3vmx	275	14	(	(	-LRB-
cord-273505-pcsw3vmx	275	15	rather	rather	RB
cord-273505-pcsw3vmx	275	16	than	than	IN
cord-273505-pcsw3vmx	275	17	lower	low	JJR
cord-273505-pcsw3vmx	275	18	doses	dose	NNS
cord-273505-pcsw3vmx	275	19	)	)	-RRB-
cord-273505-pcsw3vmx	275	20	,	,	,
cord-273505-pcsw3vmx	275	21	have	have	VBP
cord-273505-pcsw3vmx	275	22	been	be	VBN
cord-273505-pcsw3vmx	275	23	potentially	potentially	RB
cord-273505-pcsw3vmx	275	24	attributed	attribute	VBN
cord-273505-pcsw3vmx	275	25	to	to	IN
cord-273505-pcsw3vmx	275	26	the	the	DT
cord-273505-pcsw3vmx	275	27	improvement	improvement	NN
cord-273505-pcsw3vmx	275	28	of	of	IN
cord-273505-pcsw3vmx	275	29	survival	survival	NN
cord-273505-pcsw3vmx	275	30	in	in	IN
cord-273505-pcsw3vmx	275	31	RSV	RSV	NNP
cord-273505-pcsw3vmx	275	32	-	-	HYPH
cord-273505-pcsw3vmx	275	33	infected	infect	VBN
cord-273505-pcsw3vmx	275	34	allogeneic	allogeneic	NN
cord-273505-pcsw3vmx	275	35	hematopoietic	hematopoietic	JJ
cord-273505-pcsw3vmx	275	36	stem	stem	NN
cord-273505-pcsw3vmx	275	37	cell	cell	NN
cord-273505-pcsw3vmx	275	38	transplanted	transplant	VBN
cord-273505-pcsw3vmx	275	39	(	(	-LRB-
cord-273505-pcsw3vmx	275	40	HSCT	HSCT	NNP
cord-273505-pcsw3vmx	275	41	)	)	-RRB-
cord-273505-pcsw3vmx	275	42	patients	patient	NNS
cord-273505-pcsw3vmx	275	43	(	(	-LRB-
cord-273505-pcsw3vmx	275	44	231	231	CD
cord-273505-pcsw3vmx	275	45	)	)	-RRB-
cord-273505-pcsw3vmx	275	46	.	.	.
cord-273505-pcsw3vmx	276	1	The	the	DT
cord-273505-pcsw3vmx	276	2	dosage	dosage	NN
cord-273505-pcsw3vmx	276	3	of	of	IN
cord-273505-pcsw3vmx	276	4	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	276	5	might	may	MD
cord-273505-pcsw3vmx	276	6	be	be	VB
cord-273505-pcsw3vmx	276	7	the	the	DT
cord-273505-pcsw3vmx	276	8	critical	critical	JJ
cord-273505-pcsw3vmx	276	9	factor	factor	NN
cord-273505-pcsw3vmx	276	10	for	for	IN
cord-273505-pcsw3vmx	276	11	efficacy	efficacy	NN
cord-273505-pcsw3vmx	276	12	of	of	IN
cord-273505-pcsw3vmx	276	13	therapy	therapy	NN
cord-273505-pcsw3vmx	276	14	,	,	,
cord-273505-pcsw3vmx	276	15	since	since	IN
cord-273505-pcsw3vmx	276	16	the	the	DT
cord-273505-pcsw3vmx	276	17	combination	combination	NN
cord-273505-pcsw3vmx	276	18	of	of	IN
cord-273505-pcsw3vmx	276	19	high	high	JJ
cord-273505-pcsw3vmx	276	20	-	-	HYPH
cord-273505-pcsw3vmx	276	21	dose	dose	NN
cord-273505-pcsw3vmx	276	22	IVIg	ivig	NN
cord-273505-pcsw3vmx	276	23	and	and	CC
cord-273505-pcsw3vmx	276	24	aerosolized	aerosolize	VBN
cord-273505-pcsw3vmx	276	25	RBV	RBV	NNP
cord-273505-pcsw3vmx	276	26	therapy	therapy	NN
cord-273505-pcsw3vmx	276	27	has	have	VBZ
cord-273505-pcsw3vmx	276	28	also	also	RB
cord-273505-pcsw3vmx	276	29	been	be	VBN
cord-273505-pcsw3vmx	276	30	shown	show	VBN
cord-273505-pcsw3vmx	276	31	to	to	TO
cord-273505-pcsw3vmx	276	32	be	be	VB
cord-273505-pcsw3vmx	276	33	a	a	DT
cord-273505-pcsw3vmx	276	34	safe	safe	JJ
cord-273505-pcsw3vmx	276	35	and	and	CC
cord-273505-pcsw3vmx	276	36	promising	promising	JJ
cord-273505-pcsw3vmx	276	37	approach	approach	NN
cord-273505-pcsw3vmx	276	38	to	to	TO
cord-273505-pcsw3vmx	276	39	prevent	prevent	VB
cord-273505-pcsw3vmx	276	40	progression	progression	NN
cord-273505-pcsw3vmx	276	41	of	of	IN
cord-273505-pcsw3vmx	276	42	RSV	RSV	NNP
cord-273505-pcsw3vmx	276	43	infections	infection	NNS
cord-273505-pcsw3vmx	276	44	immunocompromised	immunocompromise	VBN
cord-273505-pcsw3vmx	276	45	patients	patient	NNS
cord-273505-pcsw3vmx	276	46	(	(	-LRB-
cord-273505-pcsw3vmx	276	47	232	232	CD
cord-273505-pcsw3vmx	276	48	)	)	-RRB-
cord-273505-pcsw3vmx	276	49	.	.	.
cord-273505-pcsw3vmx	277	1	Several	several	JJ
cord-273505-pcsw3vmx	277	2	published	publish	VBN
cord-273505-pcsw3vmx	277	3	studies	study	NNS
cord-273505-pcsw3vmx	277	4	suggest	suggest	VBP
cord-273505-pcsw3vmx	277	5	that	that	IN
cord-273505-pcsw3vmx	277	6	a	a	DT
cord-273505-pcsw3vmx	277	7	combined	combine	VBN
cord-273505-pcsw3vmx	277	8	therapy	therapy	NN
cord-273505-pcsw3vmx	277	9	of	of	IN
cord-273505-pcsw3vmx	277	10	RBV	RBV	NNP
cord-273505-pcsw3vmx	277	11	and	and	CC
cord-273505-pcsw3vmx	277	12	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	277	13	improves	improve	VBZ
cord-273505-pcsw3vmx	277	14	the	the	DT
cord-273505-pcsw3vmx	277	15	outcome	outcome	NN
cord-273505-pcsw3vmx	277	16	of	of	IN
cord-273505-pcsw3vmx	277	17	HSCT	HSCT	NNP
cord-273505-pcsw3vmx	277	18	and	and	CC
cord-273505-pcsw3vmx	277	19	leukemia	leukemia	NN
cord-273505-pcsw3vmx	277	20	patients	patient	NNS
cord-273505-pcsw3vmx	277	21	with	with	IN
cord-273505-pcsw3vmx	277	22	RSV	RSV	NNP
cord-273505-pcsw3vmx	277	23	-	-	HYPH
cord-273505-pcsw3vmx	277	24	URTI	URTI	NNP
cord-273505-pcsw3vmx	277	25	,	,	,
cord-273505-pcsw3vmx	277	26	and	and	CC
cord-273505-pcsw3vmx	277	27	additional	additional	JJ
cord-273505-pcsw3vmx	277	28	recommendations	recommendation	NNS
cord-273505-pcsw3vmx	277	29	are	be	VBP
cord-273505-pcsw3vmx	277	30	given	give	VBN
cord-273505-pcsw3vmx	277	31	for	for	IN
cord-273505-pcsw3vmx	277	32	high	high	JJ
cord-273505-pcsw3vmx	277	33	-	-	HYPH
cord-273505-pcsw3vmx	277	34	risk	risk	NN
cord-273505-pcsw3vmx	277	35	patients	patient	NNS
cord-273505-pcsw3vmx	277	36	with	with	IN
cord-273505-pcsw3vmx	277	37	RSV	RSV	NNP
cord-273505-pcsw3vmx	277	38	-	-	HYPH
cord-273505-pcsw3vmx	277	39	LRTI	LRTI	NNP
cord-273505-pcsw3vmx	277	40	(	(	-LRB-
cord-273505-pcsw3vmx	277	41	240	240	CD
cord-273505-pcsw3vmx	277	42	)	)	-RRB-
cord-273505-pcsw3vmx	277	43	(	(	-LRB-
cord-273505-pcsw3vmx	277	44	241	241	CD
cord-273505-pcsw3vmx	277	45	)	)	-RRB-
cord-273505-pcsw3vmx	277	46	(	(	-LRB-
cord-273505-pcsw3vmx	277	47	242	242	CD
cord-273505-pcsw3vmx	277	48	)	)	-RRB-
cord-273505-pcsw3vmx	277	49	.	.	.
cord-273505-pcsw3vmx	278	1	However	however	RB
cord-273505-pcsw3vmx	278	2	,	,	,
cord-273505-pcsw3vmx	278	3	it	-PRON-	PRP
cord-273505-pcsw3vmx	278	4	is	be	VBZ
cord-273505-pcsw3vmx	278	5	noted	note	VBN
cord-273505-pcsw3vmx	278	6	that	that	IN
cord-273505-pcsw3vmx	278	7	most	most	JJS
cord-273505-pcsw3vmx	278	8	studies	study	NNS
cord-273505-pcsw3vmx	278	9	on	on	IN
cord-273505-pcsw3vmx	278	10	IVIg	ivig	JJ
cord-273505-pcsw3vmx	278	11	efficacy	efficacy	NN
cord-273505-pcsw3vmx	278	12	are	be	VBP
cord-273505-pcsw3vmx	278	13	limited	limit	VBN
cord-273505-pcsw3vmx	278	14	to	to	IN
cord-273505-pcsw3vmx	278	15	pediatric	pediatric	JJ
cord-273505-pcsw3vmx	278	16	or	or	CC
cord-273505-pcsw3vmx	278	17	HSCT	HSCT	NNP
cord-273505-pcsw3vmx	278	18	patients	patient	NNS
cord-273505-pcsw3vmx	278	19	,	,	,
cord-273505-pcsw3vmx	278	20	which	which	WDT
cord-273505-pcsw3vmx	278	21	may	may	MD
cord-273505-pcsw3vmx	278	22	not	not	RB
cord-273505-pcsw3vmx	278	23	explicitly	explicitly	RB
cord-273505-pcsw3vmx	278	24	be	be	VB
cord-273505-pcsw3vmx	278	25	recommended	recommend	VBN
cord-273505-pcsw3vmx	278	26	in	in	IN
cord-273505-pcsw3vmx	278	27	all	all	DT
cord-273505-pcsw3vmx	278	28	situations	situation	NNS
cord-273505-pcsw3vmx	278	29	(	(	-LRB-
cord-273505-pcsw3vmx	278	30	243	243	CD
cord-273505-pcsw3vmx	278	31	)	)	-RRB-
cord-273505-pcsw3vmx	278	32	.	.	.
cord-273505-pcsw3vmx	279	1	In	in	IN
cord-273505-pcsw3vmx	279	2	summary	summary	NN
cord-273505-pcsw3vmx	279	3	,	,	,
cord-273505-pcsw3vmx	279	4	IVIg	ivig	JJ
cord-273505-pcsw3vmx	279	5	therapy	therapy	NN
cord-273505-pcsw3vmx	279	6	exhibits	exhibit	VBZ
cord-273505-pcsw3vmx	279	7	different	different	JJ
cord-273505-pcsw3vmx	279	8	levels	level	NNS
cord-273505-pcsw3vmx	279	9	of	of	IN
cord-273505-pcsw3vmx	279	10	potential	potential	JJ
cord-273505-pcsw3vmx	279	11	clinical	clinical	JJ
cord-273505-pcsw3vmx	279	12	benefits	benefit	NNS
cord-273505-pcsw3vmx	279	13	in	in	IN
cord-273505-pcsw3vmx	279	14	SARS	SARS	NNP
cord-273505-pcsw3vmx	279	15	,	,	,
cord-273505-pcsw3vmx	279	16	MERS	MERS	NNP
cord-273505-pcsw3vmx	279	17	,	,	,
cord-273505-pcsw3vmx	279	18	influenza	influenza	NN
cord-273505-pcsw3vmx	279	19	,	,	,
cord-273505-pcsw3vmx	279	20	and	and	CC
cord-273505-pcsw3vmx	279	21	RSV	RSV	NNP
cord-273505-pcsw3vmx	279	22	infections	infection	NNS
cord-273505-pcsw3vmx	279	23	,	,	,
cord-273505-pcsw3vmx	279	24	though	though	IN
cord-273505-pcsw3vmx	279	25	currently	currently	RB
cord-273505-pcsw3vmx	279	26	there	there	EX
cord-273505-pcsw3vmx	279	27	is	be	VBZ
cord-273505-pcsw3vmx	279	28	no	no	DT
cord-273505-pcsw3vmx	279	29	high	high	JJ
cord-273505-pcsw3vmx	279	30	-	-	HYPH
cord-273505-pcsw3vmx	279	31	level	level	NN
cord-273505-pcsw3vmx	279	32	evidence	evidence	NN
cord-273505-pcsw3vmx	279	33	to	to	TO
cord-273505-pcsw3vmx	279	34	support	support	VB
cord-273505-pcsw3vmx	279	35	IVIg	ivig	VB
cord-273505-pcsw3vmx	279	36	use	use	NN
cord-273505-pcsw3vmx	279	37	in	in	IN
cord-273505-pcsw3vmx	279	38	these	these	DT
cord-273505-pcsw3vmx	279	39	infections	infection	NNS
cord-273505-pcsw3vmx	279	40	.	.	.
cord-273505-pcsw3vmx	280	1	Of	of	IN
cord-273505-pcsw3vmx	280	2	note	note	NN
cord-273505-pcsw3vmx	280	3	,	,	,
cord-273505-pcsw3vmx	280	4	the	the	DT
cord-273505-pcsw3vmx	280	5	presented	present	VBN
cord-273505-pcsw3vmx	280	6	results	result	NNS
cord-273505-pcsw3vmx	280	7	are	be	VBP
cord-273505-pcsw3vmx	280	8	partly	partly	RB
cord-273505-pcsw3vmx	280	9	limited	limited	JJ
cord-273505-pcsw3vmx	280	10	to	to	IN
cord-273505-pcsw3vmx	280	11	pediatric	pediatric	JJ
cord-273505-pcsw3vmx	280	12	and	and	CC
cord-273505-pcsw3vmx	280	13	immunocompromised	immunocompromised	JJ
cord-273505-pcsw3vmx	280	14	patients	patient	NNS
cord-273505-pcsw3vmx	280	15	,	,	,
cord-273505-pcsw3vmx	280	16	and	and	CC
cord-273505-pcsw3vmx	280	17	the	the	DT
cord-273505-pcsw3vmx	280	18	clinical	clinical	JJ
cord-273505-pcsw3vmx	280	19	benefits	benefit	NNS
cord-273505-pcsw3vmx	280	20	of	of	IN
cord-273505-pcsw3vmx	280	21	IVIg	ivig	JJ
cord-273505-pcsw3vmx	280	22	therapy	therapy	NN
cord-273505-pcsw3vmx	280	23	may	may	MD
cord-273505-pcsw3vmx	280	24	vary	vary	VB
cord-273505-pcsw3vmx	280	25	in	in	IN
cord-273505-pcsw3vmx	280	26	different	different	JJ
cord-273505-pcsw3vmx	280	27	patient	patient	NN
cord-273505-pcsw3vmx	280	28	populations	population	NNS
cord-273505-pcsw3vmx	280	29	(	(	-LRB-
cord-273505-pcsw3vmx	280	30	e.g.	e.g.	RB
cord-273505-pcsw3vmx	280	31	,	,	,
cord-273505-pcsw3vmx	280	32	infants	infant	NNS
cord-273505-pcsw3vmx	280	33	,	,	,
cord-273505-pcsw3vmx	280	34	the	the	DT
cord-273505-pcsw3vmx	280	35	elderly	elderly	JJ
cord-273505-pcsw3vmx	280	36	,	,	,
cord-273505-pcsw3vmx	280	37	and	and	CC
cord-273505-pcsw3vmx	280	38	immunocompromised	immunocompromised	JJ
cord-273505-pcsw3vmx	280	39	individuals	individual	NNS
cord-273505-pcsw3vmx	280	40	)	)	-RRB-
cord-273505-pcsw3vmx	280	41	.	.	.
cord-273505-pcsw3vmx	281	1	It	-PRON-	PRP
cord-273505-pcsw3vmx	281	2	is	be	VBZ
cord-273505-pcsw3vmx	281	3	also	also	RB
cord-273505-pcsw3vmx	281	4	noteworthy	noteworthy	JJ
cord-273505-pcsw3vmx	281	5	that	that	IN
cord-273505-pcsw3vmx	281	6	most	most	JJS
cord-273505-pcsw3vmx	281	7	studies	study	NNS
cord-273505-pcsw3vmx	281	8	for	for	IN
cord-273505-pcsw3vmx	281	9	these	these	DT
cord-273505-pcsw3vmx	281	10	viral	viral	JJ
cord-273505-pcsw3vmx	281	11	infections	infection	NNS
cord-273505-pcsw3vmx	281	12	show	show	VBP
cord-273505-pcsw3vmx	281	13	possible	possible	JJ
cord-273505-pcsw3vmx	281	14	benefits	benefit	NNS
cord-273505-pcsw3vmx	281	15	from	from	IN
cord-273505-pcsw3vmx	281	16	IVIg	ivig	JJ
cord-273505-pcsw3vmx	281	17	therapy	therapy	NN
cord-273505-pcsw3vmx	281	18	at	at	IN
cord-273505-pcsw3vmx	281	19	higher	high	JJR
cord-273505-pcsw3vmx	281	20	doses	dose	NNS
cord-273505-pcsw3vmx	281	21	,	,	,
cord-273505-pcsw3vmx	281	22	which	which	WDT
cord-273505-pcsw3vmx	281	23	indicates	indicate	VBZ
cord-273505-pcsw3vmx	281	24	that	that	IN
cord-273505-pcsw3vmx	281	25	a	a	DT
cord-273505-pcsw3vmx	281	26	high	high	JJ
cord-273505-pcsw3vmx	281	27	dosage	dosage	NN
cord-273505-pcsw3vmx	281	28	might	may	MD
cord-273505-pcsw3vmx	281	29	be	be	VB
cord-273505-pcsw3vmx	281	30	key	key	JJ
cord-273505-pcsw3vmx	281	31	for	for	IN
cord-273505-pcsw3vmx	281	32	clinical	clinical	JJ
cord-273505-pcsw3vmx	281	33	efficacy	efficacy	NN
cord-273505-pcsw3vmx	281	34	.	.	.
cord-273505-pcsw3vmx	282	1	Considering	consider	VBG
cord-273505-pcsw3vmx	282	2	the	the	DT
cord-273505-pcsw3vmx	282	3	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	282	4	effects	effect	NNS
cord-273505-pcsw3vmx	282	5	of	of	IN
cord-273505-pcsw3vmx	282	6	highdose	highdose	NN
cord-273505-pcsw3vmx	282	7	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	282	8	on	on	IN
cord-273505-pcsw3vmx	282	9	the	the	DT
cord-273505-pcsw3vmx	282	10	excessive	excessive	JJ
cord-273505-pcsw3vmx	282	11	immune	immune	JJ
cord-273505-pcsw3vmx	282	12	cascade	cascade	NN
cord-273505-pcsw3vmx	282	13	,	,	,
cord-273505-pcsw3vmx	282	14	high	high	JJ
cord-273505-pcsw3vmx	282	15	-	-	HYPH
cord-273505-pcsw3vmx	282	16	dose	dose	NN
cord-273505-pcsw3vmx	282	17	IVIg	ivig	NN
cord-273505-pcsw3vmx	282	18	therapy	therapy	NN
cord-273505-pcsw3vmx	282	19	,	,	,
cord-273505-pcsw3vmx	282	20	as	as	IN
cord-273505-pcsw3vmx	282	21	stated	state	VBN
cord-273505-pcsw3vmx	282	22	above	above	RB
cord-273505-pcsw3vmx	282	23	,	,	,
cord-273505-pcsw3vmx	282	24	may	may	MD
cord-273505-pcsw3vmx	282	25	be	be	VB
cord-273505-pcsw3vmx	282	26	considered	consider	VBN
cord-273505-pcsw3vmx	282	27	a	a	DT
cord-273505-pcsw3vmx	282	28	potential	potential	JJ
cord-273505-pcsw3vmx	282	29	adjunctive	adjunctive	JJ
cord-273505-pcsw3vmx	282	30	treatment	treatment	NN
cord-273505-pcsw3vmx	282	31	for	for	IN
cord-273505-pcsw3vmx	282	32	severe	severe	JJ
cord-273505-pcsw3vmx	282	33	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	282	34	patients	patient	NNS
cord-273505-pcsw3vmx	282	35	.	.	.
cord-273505-pcsw3vmx	283	1	The	the	DT
cord-273505-pcsw3vmx	283	2	national	national	JJ
cord-273505-pcsw3vmx	283	3	diagnosis	diagnosis	NN
cord-273505-pcsw3vmx	283	4	and	and	CC
cord-273505-pcsw3vmx	283	5	treatment	treatment	NN
cord-273505-pcsw3vmx	283	6	protocol	protocol	NN
cord-273505-pcsw3vmx	283	7	for	for	IN
cord-273505-pcsw3vmx	283	8	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	284	1	(	(	-LRB-
cord-273505-pcsw3vmx	284	2	Trial	Trial	NNP
cord-273505-pcsw3vmx	284	3	Version	Version	NNP
cord-273505-pcsw3vmx	284	4	7	7	CD
cord-273505-pcsw3vmx	284	5	)	)	-RRB-
cord-273505-pcsw3vmx	284	6	and	and	CC
cord-273505-pcsw3vmx	284	7	recommendations	recommendation	NNS
cord-273505-pcsw3vmx	284	8	from	from	IN
cord-273505-pcsw3vmx	284	9	the	the	DT
cord-273505-pcsw3vmx	284	10	Peking	Peking	NNP
cord-273505-pcsw3vmx	284	11	Union	Union	NNP
cord-273505-pcsw3vmx	284	12	Medical	Medical	NNP
cord-273505-pcsw3vmx	284	13	College	College	NNP
cord-273505-pcsw3vmx	284	14	Hospital	Hospital	NNP
cord-273505-pcsw3vmx	284	15	have	have	VBP
cord-273505-pcsw3vmx	284	16	suggested	suggest	VBN
cord-273505-pcsw3vmx	284	17	the	the	DT
cord-273505-pcsw3vmx	284	18	application	application	NN
cord-273505-pcsw3vmx	284	19	of	of	IN
cord-273505-pcsw3vmx	284	20	IVIg	ivig	JJ
cord-273505-pcsw3vmx	284	21	therapy	therapy	NN
cord-273505-pcsw3vmx	284	22	in	in	IN
cord-273505-pcsw3vmx	284	23	severe	severe	JJ
cord-273505-pcsw3vmx	284	24	and	and	CC
cord-273505-pcsw3vmx	284	25	critically	critically	RB
cord-273505-pcsw3vmx	284	26	ill	ill	RB
cord-273505-pcsw3vmx	284	27	COVID-19	covid-19	CD
cord-273505-pcsw3vmx	284	28	patients	patient	NNS
cord-273505-pcsw3vmx	284	29	(	(	-LRB-
cord-273505-pcsw3vmx	284	30	4	4	CD
cord-273505-pcsw3vmx	284	31	,	,	,
cord-273505-pcsw3vmx	284	32	18	18	CD
cord-273505-pcsw3vmx	284	33	)	)	-RRB-
cord-273505-pcsw3vmx	284	34	.	.	.
cord-273505-pcsw3vmx	285	1	Several	several	JJ
cord-273505-pcsw3vmx	285	2	observational	observational	JJ
cord-273505-pcsw3vmx	285	3	and	and	CC
cord-273505-pcsw3vmx	285	4	interventional	interventional	JJ
cord-273505-pcsw3vmx	285	5	studies	study	NNS
cord-273505-pcsw3vmx	285	6	were	be	VBD
cord-273505-pcsw3vmx	285	7	conducted	conduct	VBN
cord-273505-pcsw3vmx	285	8	to	to	TO
cord-273505-pcsw3vmx	285	9	evaluate	evaluate	VB
cord-273505-pcsw3vmx	285	10	the	the	DT
cord-273505-pcsw3vmx	285	11	efficacy	efficacy	NN
cord-273505-pcsw3vmx	285	12	of	of	IN
cord-273505-pcsw3vmx	285	13	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	285	14	.	.	.
cord-273505-pcsw3vmx	286	1	A	a	DT
cord-273505-pcsw3vmx	286	2	retrospective	retrospective	JJ
cord-273505-pcsw3vmx	286	3	study	study	NN
cord-273505-pcsw3vmx	286	4	(	(	-LRB-
cord-273505-pcsw3vmx	286	5	n	n	NN
cord-273505-pcsw3vmx	286	6	=	=	SYM
cord-273505-pcsw3vmx	286	7	58	58	CD
cord-273505-pcsw3vmx	286	8	)	)	-RRB-
cord-273505-pcsw3vmx	286	9	in	in	IN
cord-273505-pcsw3vmx	286	10	China	China	NNP
cord-273505-pcsw3vmx	286	11	included	include	VBD
cord-273505-pcsw3vmx	286	12	severe	severe	JJ
cord-273505-pcsw3vmx	286	13	and	and	CC
cord-273505-pcsw3vmx	286	14	critical	critical	JJ
cord-273505-pcsw3vmx	286	15	ill	ill	RB
cord-273505-pcsw3vmx	287	1	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	287	2	patients	patient	NNS
cord-273505-pcsw3vmx	287	3	that	that	WDT
cord-273505-pcsw3vmx	287	4	were	be	VBD
cord-273505-pcsw3vmx	287	5	administered	administer	VBN
cord-273505-pcsw3vmx	287	6	IVIg	ivig	JJ
cord-273505-pcsw3vmx	287	7	therapy	therapy	NN
cord-273505-pcsw3vmx	287	8	after	after	IN
cord-273505-pcsw3vmx	287	9	admission	admission	NN
cord-273505-pcsw3vmx	287	10	(	(	-LRB-
cord-273505-pcsw3vmx	287	11	219	219	CD
cord-273505-pcsw3vmx	287	12	)	)	-RRB-
cord-273505-pcsw3vmx	287	13	.	.	.
cord-273505-pcsw3vmx	288	1	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	288	2	therapy	therapy	NN
cord-273505-pcsw3vmx	288	3	was	be	VBD
cord-273505-pcsw3vmx	288	4	given	give	VBN
cord-273505-pcsw3vmx	288	5	at	at	IN
cord-273505-pcsw3vmx	288	6	20	20	CD
cord-273505-pcsw3vmx	288	7	g	g	NN
cord-273505-pcsw3vmx	288	8	daily	daily	NN
cord-273505-pcsw3vmx	288	9	,	,	,
cord-273505-pcsw3vmx	288	10	and	and	CC
cord-273505-pcsw3vmx	288	11	23	23	CD
cord-273505-pcsw3vmx	288	12	of	of	IN
cord-273505-pcsw3vmx	288	13	58	58	CD
cord-273505-pcsw3vmx	288	14	(	(	-LRB-
cord-273505-pcsw3vmx	288	15	39.6	39.6	CD
cord-273505-pcsw3vmx	288	16	%	%	NN
cord-273505-pcsw3vmx	288	17	)	)	-RRB-
cord-273505-pcsw3vmx	288	18	patients	patient	NNS
cord-273505-pcsw3vmx	288	19	died	die	VBD
cord-273505-pcsw3vmx	288	20	within	within	IN
cord-273505-pcsw3vmx	288	21	28	28	CD
cord-273505-pcsw3vmx	288	22	days	day	NNS
cord-273505-pcsw3vmx	288	23	.	.	.
cord-273505-pcsw3vmx	289	1	For	for	IN
cord-273505-pcsw3vmx	289	2	retrospective	retrospective	JJ
cord-273505-pcsw3vmx	289	3	analysis	analysis	NN
cord-273505-pcsw3vmx	289	4	,	,	,
cord-273505-pcsw3vmx	289	5	patients	patient	NNS
cord-273505-pcsw3vmx	289	6	were	be	VBD
cord-273505-pcsw3vmx	289	7	split	split	VBN
cord-273505-pcsw3vmx	289	8	into	into	IN
cord-273505-pcsw3vmx	289	9	two	two	CD
cord-273505-pcsw3vmx	289	10	groups	group	NNS
cord-273505-pcsw3vmx	289	11	,	,	,
cord-273505-pcsw3vmx	289	12	based	base	VBN
cord-273505-pcsw3vmx	289	13	on	on	IN
cord-273505-pcsw3vmx	289	14	whether	whether	IN
cord-273505-pcsw3vmx	289	15	they	-PRON-	PRP
cord-273505-pcsw3vmx	289	16	received	receive	VBD
cord-273505-pcsw3vmx	289	17	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	289	18	administration	administration	NN
cord-273505-pcsw3vmx	289	19	within	within	IN
cord-273505-pcsw3vmx	289	20	or	or	CC
cord-273505-pcsw3vmx	289	21	after	after	IN
cord-273505-pcsw3vmx	289	22	48	48	CD
cord-273505-pcsw3vmx	289	23	h	h	NN
cord-273505-pcsw3vmx	289	24	of	of	IN
cord-273505-pcsw3vmx	289	25	admission	admission	NN
cord-273505-pcsw3vmx	289	26	to	to	IN
cord-273505-pcsw3vmx	289	27	the	the	DT
cord-273505-pcsw3vmx	289	28	intensive	intensive	JJ
cord-273505-pcsw3vmx	289	29	care	care	NN
cord-273505-pcsw3vmx	289	30	unit	unit	NN
cord-273505-pcsw3vmx	289	31	(	(	-LRB-
cord-273505-pcsw3vmx	289	32	ICU	ICU	NNP
cord-273505-pcsw3vmx	289	33	)	)	-RRB-
cord-273505-pcsw3vmx	289	34	.	.	.
cord-273505-pcsw3vmx	290	1	The	the	DT
cord-273505-pcsw3vmx	290	2	results	result	NNS
cord-273505-pcsw3vmx	290	3	showed	show	VBD
cord-273505-pcsw3vmx	290	4	that	that	IN
cord-273505-pcsw3vmx	290	5	application	application	NN
cord-273505-pcsw3vmx	290	6	of	of	IN
cord-273505-pcsw3vmx	290	7	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	290	8	within	within	IN
cord-273505-pcsw3vmx	290	9	48	48	CD
cord-273505-pcsw3vmx	290	10	h	h	NN
cord-273505-pcsw3vmx	290	11	of	of	IN
cord-273505-pcsw3vmx	290	12	admission	admission	NN
cord-273505-pcsw3vmx	290	13	to	to	IN
cord-273505-pcsw3vmx	290	14	ICU	ICU	NNP
cord-273505-pcsw3vmx	290	15	reduced	reduce	VBD
cord-273505-pcsw3vmx	290	16	the	the	DT
cord-273505-pcsw3vmx	290	17	use	use	NN
cord-273505-pcsw3vmx	290	18	of	of	IN
cord-273505-pcsw3vmx	290	19	mechanical	mechanical	JJ
cord-273505-pcsw3vmx	290	20	ventilation	ventilation	NN
cord-273505-pcsw3vmx	290	21	,	,	,
cord-273505-pcsw3vmx	290	22	shortened	shorten	VBN
cord-273505-pcsw3vmx	290	23	duration	duration	NN
cord-273505-pcsw3vmx	290	24	of	of	IN
cord-273505-pcsw3vmx	290	25	ICU	ICU	NNP
cord-273505-pcsw3vmx	290	26	and	and	CC
cord-273505-pcsw3vmx	290	27	hospital	hospital	NN
cord-273505-pcsw3vmx	290	28	stay	stay	NN
cord-273505-pcsw3vmx	290	29	,	,	,
cord-273505-pcsw3vmx	290	30	and	and	CC
cord-273505-pcsw3vmx	290	31	improved	improve	VBN
cord-273505-pcsw3vmx	290	32	28-day	28-day	CD
cord-273505-pcsw3vmx	290	33	survival	survival	NN
cord-273505-pcsw3vmx	290	34	(	(	-LRB-
cord-273505-pcsw3vmx	290	35	219	219	CD
cord-273505-pcsw3vmx	290	36	)	)	-RRB-
cord-273505-pcsw3vmx	290	37	.	.	.
cord-273505-pcsw3vmx	291	1	The	the	DT
cord-273505-pcsw3vmx	291	2	28-day	28-day	CD
cord-273505-pcsw3vmx	291	3	mortality	mortality	NN
cord-273505-pcsw3vmx	291	4	of	of	IN
cord-273505-pcsw3vmx	291	5	the	the	DT
cord-273505-pcsw3vmx	291	6	two	two	CD
cord-273505-pcsw3vmx	291	7	groups	group	NNS
cord-273505-pcsw3vmx	291	8	(	(	-LRB-
cord-273505-pcsw3vmx	291	9	IVIg	ivig	VBP
cord-273505-pcsw3vmx	291	10	within	within	IN
cord-273505-pcsw3vmx	291	11	or	or	CC
cord-273505-pcsw3vmx	291	12	after	after	IN
cord-273505-pcsw3vmx	291	13	48	48	CD
cord-273505-pcsw3vmx	291	14	h	h	NN
cord-273505-pcsw3vmx	291	15	)	)	-RRB-
cord-273505-pcsw3vmx	291	16	was	be	VBD
cord-273505-pcsw3vmx	291	17	23.3	23.3	CD
cord-273505-pcsw3vmx	291	18	%	%	NN
cord-273505-pcsw3vmx	291	19	(	(	-LRB-
cord-273505-pcsw3vmx	291	20	within	within	IN
cord-273505-pcsw3vmx	291	21	48	48	CD
cord-273505-pcsw3vmx	291	22	h	h	NN
cord-273505-pcsw3vmx	291	23	)	)	-RRB-
cord-273505-pcsw3vmx	291	24	and	and	CC
cord-273505-pcsw3vmx	291	25	57.1	57.1	CD
cord-273505-pcsw3vmx	291	26	%	%	NN
cord-273505-pcsw3vmx	291	27	(	(	-LRB-
cord-273505-pcsw3vmx	291	28	after	after	IN
cord-273505-pcsw3vmx	291	29	48	48	CD
cord-273505-pcsw3vmx	291	30	h	h	NN
cord-273505-pcsw3vmx	291	31	)	)	-RRB-
cord-273505-pcsw3vmx	291	32	,	,	,
cord-273505-pcsw3vmx	291	33	indicating	indicate	VBG
cord-273505-pcsw3vmx	291	34	that	that	IN
cord-273505-pcsw3vmx	291	35	early	early	JJ
cord-273505-pcsw3vmx	291	36	initiation	initiation	NN
cord-273505-pcsw3vmx	291	37	of	of	IN
cord-273505-pcsw3vmx	291	38	high	high	JJ
cord-273505-pcsw3vmx	291	39	-	-	HYPH
cord-273505-pcsw3vmx	291	40	dose	dose	NN
cord-273505-pcsw3vmx	291	41	IVIg	ivig	NN
cord-273505-pcsw3vmx	291	42	therapy	therapy	NN
cord-273505-pcsw3vmx	291	43	may	may	MD
cord-273505-pcsw3vmx	291	44	be	be	VB
cord-273505-pcsw3vmx	291	45	beneficial	beneficial	JJ
cord-273505-pcsw3vmx	291	46	in	in	IN
cord-273505-pcsw3vmx	291	47	severe	severe	JJ
cord-273505-pcsw3vmx	291	48	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	291	49	patients	patient	NNS
cord-273505-pcsw3vmx	291	50	.	.	.
cord-273505-pcsw3vmx	292	1	On	on	IN
cord-273505-pcsw3vmx	292	2	the	the	DT
cord-273505-pcsw3vmx	292	3	contrary	contrary	NN
cord-273505-pcsw3vmx	292	4	,	,	,
cord-273505-pcsw3vmx	292	5	there	there	EX
cord-273505-pcsw3vmx	292	6	were	be	VBD
cord-273505-pcsw3vmx	292	7	no	no	DT
cord-273505-pcsw3vmx	292	8	significant	significant	JJ
cord-273505-pcsw3vmx	292	9	effects	effect	NNS
cord-273505-pcsw3vmx	292	10	of	of	IN
cord-273505-pcsw3vmx	292	11	IVIg	ivig	JJ
cord-273505-pcsw3vmx	292	12	therapy	therapy	NN
cord-273505-pcsw3vmx	292	13	on	on	IN
cord-273505-pcsw3vmx	292	14	the	the	DT
cord-273505-pcsw3vmx	292	15	survival	survival	NN
cord-273505-pcsw3vmx	292	16	of	of	IN
cord-273505-pcsw3vmx	292	17	severe	severe	JJ
cord-273505-pcsw3vmx	292	18	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	292	19	patients	patient	NNS
cord-273505-pcsw3vmx	292	20	who	who	WP
cord-273505-pcsw3vmx	292	21	developed	develop	VBD
cord-273505-pcsw3vmx	292	22	ARDS	ARDS	NNP
cord-273505-pcsw3vmx	292	23	in	in	IN
cord-273505-pcsw3vmx	292	24	another	another	DT
cord-273505-pcsw3vmx	292	25	study	study	NN
cord-273505-pcsw3vmx	292	26	;	;	:
cord-273505-pcsw3vmx	292	27	here	here	RB
cord-273505-pcsw3vmx	292	28	,	,	,
cord-273505-pcsw3vmx	292	29	the	the	DT
cord-273505-pcsw3vmx	292	30	insufficient	insufficient	JJ
cord-273505-pcsw3vmx	292	31	effects	effect	NNS
cord-273505-pcsw3vmx	292	32	of	of	IN
cord-273505-pcsw3vmx	292	33	IVIg	ivig	JJ
cord-273505-pcsw3vmx	292	34	therapy	therapy	NN
cord-273505-pcsw3vmx	292	35	may	may	MD
cord-273505-pcsw3vmx	292	36	potentially	potentially	RB
cord-273505-pcsw3vmx	292	37	be	be	VB
cord-273505-pcsw3vmx	292	38	a	a	DT
cord-273505-pcsw3vmx	292	39	result	result	NN
cord-273505-pcsw3vmx	292	40	of	of	IN
cord-273505-pcsw3vmx	292	41	timing	timing	NN
cord-273505-pcsw3vmx	292	42	and	and	CC
cord-273505-pcsw3vmx	292	43	dosage	dosage	NN
cord-273505-pcsw3vmx	292	44	of	of	IN
cord-273505-pcsw3vmx	292	45	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	292	46	administration	administration	NNP
cord-273505-pcsw3vmx	292	47	(	(	-LRB-
cord-273505-pcsw3vmx	292	48	220	220	CD
cord-273505-pcsw3vmx	292	49	)	)	-RRB-
cord-273505-pcsw3vmx	292	50	.	.	.
cord-273505-pcsw3vmx	293	1	In	in	IN
cord-273505-pcsw3vmx	293	2	another	another	DT
cord-273505-pcsw3vmx	293	3	study	study	NN
cord-273505-pcsw3vmx	293	4	,	,	,
cord-273505-pcsw3vmx	293	5	a	a	DT
cord-273505-pcsw3vmx	293	6	combination	combination	NN
cord-273505-pcsw3vmx	293	7	therapy	therapy	NN
cord-273505-pcsw3vmx	293	8	of	of	IN
cord-273505-pcsw3vmx	293	9	a	a	DT
cord-273505-pcsw3vmx	293	10	high	high	JJ
cord-273505-pcsw3vmx	293	11	dose	dose	NN
cord-273505-pcsw3vmx	293	12	of	of	IN
cord-273505-pcsw3vmx	293	13	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	293	14	(	(	-LRB-
cord-273505-pcsw3vmx	293	15	20	20	CD
cord-273505-pcsw3vmx	293	16	g	g	NN
cord-273505-pcsw3vmx	293	17	/	/	SYM
cord-273505-pcsw3vmx	293	18	d	d	NN
cord-273505-pcsw3vmx	293	19	)	)	-RRB-
cord-273505-pcsw3vmx	293	20	and	and	CC
cord-273505-pcsw3vmx	293	21	corticosteroid	corticosteroid	NNP
cord-273505-pcsw3vmx	293	22	(	(	-LRB-
cord-273505-pcsw3vmx	293	23	160	160	CD
cord-273505-pcsw3vmx	293	24	mg	mg	NNP
cord-273505-pcsw3vmx	293	25	/	/	SYM
cord-273505-pcsw3vmx	293	26	d	d	NN
cord-273505-pcsw3vmx	293	27	)	)	-RRB-
cord-273505-pcsw3vmx	293	28	succeeded	succeed	VBD
cord-273505-pcsw3vmx	293	29	in	in	IN
cord-273505-pcsw3vmx	293	30	reversing	reverse	VBG
cord-273505-pcsw3vmx	293	31	the	the	DT
cord-273505-pcsw3vmx	293	32	deteriorating	deteriorate	VBG
cord-273505-pcsw3vmx	293	33	condition	condition	NN
cord-273505-pcsw3vmx	293	34	of	of	IN
cord-273505-pcsw3vmx	293	35	severe	severe	JJ
cord-273505-pcsw3vmx	293	36	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	293	37	patients	patient	NNS
cord-273505-pcsw3vmx	293	38	who	who	WP
cord-273505-pcsw3vmx	293	39	had	have	VBD
cord-273505-pcsw3vmx	293	40	previously	previously	RB
cord-273505-pcsw3vmx	293	41	failed	fail	VBN
cord-273505-pcsw3vmx	293	42	low	low	JJ
cord-273505-pcsw3vmx	293	43	-	-	HYPH
cord-273505-pcsw3vmx	293	44	dose	dose	NN
cord-273505-pcsw3vmx	293	45	IVIg	IVIg	NNS
cord-273505-pcsw3vmx	293	46	(	(	-LRB-
cord-273505-pcsw3vmx	293	47	10	10	CD
cord-273505-pcsw3vmx	293	48	g	g	NN
cord-273505-pcsw3vmx	293	49	/	/	SYM
cord-273505-pcsw3vmx	293	50	d	d	NN
cord-273505-pcsw3vmx	293	51	)	)	-RRB-
cord-273505-pcsw3vmx	293	52	and	and	CC
cord-273505-pcsw3vmx	293	53	corticosteroid	corticosteroid	NN
cord-273505-pcsw3vmx	293	54	treatment	treatment	NN
cord-273505-pcsw3vmx	293	55	(	(	-LRB-
cord-273505-pcsw3vmx	293	56	221	221	CD
cord-273505-pcsw3vmx	293	57	)	)	-RRB-
cord-273505-pcsw3vmx	293	58	.	.	.
cord-273505-pcsw3vmx	294	1	However	however	RB
cord-273505-pcsw3vmx	294	2	,	,	,
cord-273505-pcsw3vmx	294	3	as	as	IN
cord-273505-pcsw3vmx	294	4	this	this	DT
cord-273505-pcsw3vmx	294	5	study	study	NN
cord-273505-pcsw3vmx	294	6	investigated	investigate	VBD
cord-273505-pcsw3vmx	294	7	a	a	DT
cord-273505-pcsw3vmx	294	8	combined	combine	VBN
cord-273505-pcsw3vmx	294	9	therapy	therapy	NN
cord-273505-pcsw3vmx	294	10	,	,	,
cord-273505-pcsw3vmx	294	11	it	-PRON-	PRP
cord-273505-pcsw3vmx	294	12	is	be	VBZ
cord-273505-pcsw3vmx	294	13	not	not	RB
cord-273505-pcsw3vmx	294	14	possible	possible	JJ
cord-273505-pcsw3vmx	294	15	to	to	TO
cord-273505-pcsw3vmx	294	16	estimate	estimate	VB
cord-273505-pcsw3vmx	294	17	the	the	DT
cord-273505-pcsw3vmx	294	18	exact	exact	JJ
cord-273505-pcsw3vmx	294	19	effect	effect	NN
cord-273505-pcsw3vmx	294	20	of	of	IN
cord-273505-pcsw3vmx	294	21	high	high	JJ
cord-273505-pcsw3vmx	294	22	IVIg	ivig	JJ
cord-273505-pcsw3vmx	294	23	doses	dose	NNS
cord-273505-pcsw3vmx	294	24	in	in	IN
cord-273505-pcsw3vmx	294	25	this	this	DT
cord-273505-pcsw3vmx	294	26	group	group	NN
cord-273505-pcsw3vmx	294	27	of	of	IN
cord-273505-pcsw3vmx	294	28	patients	patient	NNS
cord-273505-pcsw3vmx	294	29	.	.	.
cord-273505-pcsw3vmx	295	1	The	the	DT
cord-273505-pcsw3vmx	295	2	administration	administration	NN
cord-273505-pcsw3vmx	295	3	of	of	IN
cord-273505-pcsw3vmx	295	4	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	295	5	therapy	therapy	NN
cord-273505-pcsw3vmx	295	6	(	(	-LRB-
cord-273505-pcsw3vmx	295	7	25	25	CD
cord-273505-pcsw3vmx	295	8	g	g	NN
cord-273505-pcsw3vmx	295	9	/	/	SYM
cord-273505-pcsw3vmx	295	10	d	d	NN
cord-273505-pcsw3vmx	295	11	for	for	IN
cord-273505-pcsw3vmx	295	12	5	5	CD
cord-273505-pcsw3vmx	295	13	days	day	NNS
cord-273505-pcsw3vmx	295	14	)	)	-RRB-
cord-273505-pcsw3vmx	295	15	at	at	IN
cord-273505-pcsw3vmx	295	16	the	the	DT
cord-273505-pcsw3vmx	295	17	time	time	NN
cord-273505-pcsw3vmx	295	18	of	of	IN
cord-273505-pcsw3vmx	295	19	initiation	initiation	NN
cord-273505-pcsw3vmx	295	20	of	of	IN
cord-273505-pcsw3vmx	295	21	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	295	22	distress	distress	NN
cord-273505-pcsw3vmx	295	23	of	of	IN
cord-273505-pcsw3vmx	295	24	severe	severe	JJ
cord-273505-pcsw3vmx	295	25	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	295	26	patients	patient	NNS
cord-273505-pcsw3vmx	295	27	may	may	MD
cord-273505-pcsw3vmx	295	28	improve	improve	VB
cord-273505-pcsw3vmx	295	29	the	the	DT
cord-273505-pcsw3vmx	295	30	prognosis	prognosis	NN
cord-273505-pcsw3vmx	295	31	(	(	-LRB-
cord-273505-pcsw3vmx	295	32	16	16	CD
cord-273505-pcsw3vmx	295	33	)	)	-RRB-
cord-273505-pcsw3vmx	295	34	.	.	.
cord-273505-pcsw3vmx	296	1	It	-PRON-	PRP
cord-273505-pcsw3vmx	296	2	is	be	VBZ
cord-273505-pcsw3vmx	296	3	noted	note	VBN
cord-273505-pcsw3vmx	296	4	that	that	IN
cord-273505-pcsw3vmx	296	5	only	only	RB
cord-273505-pcsw3vmx	296	6	one	one	CD
cord-273505-pcsw3vmx	296	7	of	of	IN
cord-273505-pcsw3vmx	296	8	three	three	CD
cord-273505-pcsw3vmx	296	9	patients	patient	NNS
cord-273505-pcsw3vmx	296	10	received	receive	VBD
cord-273505-pcsw3vmx	296	11	corticosteroids	corticosteroid	NNS
cord-273505-pcsw3vmx	296	12	,	,	,
cord-273505-pcsw3vmx	296	13	and	and	CC
cord-273505-pcsw3vmx	296	14	these	these	DT
cord-273505-pcsw3vmx	296	15	observations	observation	NNS
cord-273505-pcsw3vmx	296	16	suggest	suggest	VBP
cord-273505-pcsw3vmx	296	17	that	that	IN
cord-273505-pcsw3vmx	296	18	high	high	JJ
cord-273505-pcsw3vmx	296	19	-	-	HYPH
cord-273505-pcsw3vmx	296	20	dose	dose	NN
cord-273505-pcsw3vmx	296	21	IVIg	ivig	NN
cord-273505-pcsw3vmx	296	22	therapy	therapy	NN
cord-273505-pcsw3vmx	296	23	may	may	MD
cord-273505-pcsw3vmx	296	24	be	be	VB
cord-273505-pcsw3vmx	296	25	the	the	DT
cord-273505-pcsw3vmx	296	26	main	main	JJ
cord-273505-pcsw3vmx	296	27	contributor	contributor	NN
cord-273505-pcsw3vmx	296	28	to	to	IN
cord-273505-pcsw3vmx	296	29	successful	successful	JJ
cord-273505-pcsw3vmx	296	30	recovery	recovery	NN
cord-273505-pcsw3vmx	296	31	from	from	IN
cord-273505-pcsw3vmx	296	32	deteriorating	deteriorate	VBG
cord-273505-pcsw3vmx	296	33	conditions	condition	NNS
cord-273505-pcsw3vmx	296	34	.	.	.
cord-273505-pcsw3vmx	297	1	However	however	RB
cord-273505-pcsw3vmx	297	2	,	,	,
cord-273505-pcsw3vmx	297	3	more	more	RBR
cord-273505-pcsw3vmx	297	4	controlled	control	VBN
cord-273505-pcsw3vmx	297	5	trials	trial	NNS
cord-273505-pcsw3vmx	297	6	of	of	IN
cord-273505-pcsw3vmx	297	7	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	297	8	therapy	therapy	NN
cord-273505-pcsw3vmx	297	9	are	be	VBP
cord-273505-pcsw3vmx	297	10	needed	need	VBN
cord-273505-pcsw3vmx	297	11	to	to	TO
cord-273505-pcsw3vmx	297	12	provide	provide	VB
cord-273505-pcsw3vmx	297	13	strong	strong	JJ
cord-273505-pcsw3vmx	297	14	evidence	evidence	NN
cord-273505-pcsw3vmx	297	15	for	for	IN
cord-273505-pcsw3vmx	297	16	its	-PRON-	PRP$
cord-273505-pcsw3vmx	297	17	beneficial	beneficial	JJ
cord-273505-pcsw3vmx	297	18	effects	effect	NNS
cord-273505-pcsw3vmx	297	19	in	in	IN
cord-273505-pcsw3vmx	297	20	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	297	21	.	.	.
cord-273505-pcsw3vmx	298	1	Based	base	VBN
cord-273505-pcsw3vmx	298	2	on	on	IN
cord-273505-pcsw3vmx	298	3	these	these	DT
cord-273505-pcsw3vmx	298	4	clinical	clinical	JJ
cord-273505-pcsw3vmx	298	5	observations	observation	NNS
cord-273505-pcsw3vmx	298	6	,	,	,
cord-273505-pcsw3vmx	298	7	the	the	DT
cord-273505-pcsw3vmx	298	8	administration	administration	NN
cord-273505-pcsw3vmx	298	9	of	of	IN
cord-273505-pcsw3vmx	298	10	high	high	JJ
cord-273505-pcsw3vmx	298	11	-	-	HYPH
cord-273505-pcsw3vmx	298	12	dose	dose	NN
cord-273505-pcsw3vmx	298	13	IVIg	ivig	NN
cord-273505-pcsw3vmx	298	14	therapy	therapy	NN
cord-273505-pcsw3vmx	298	15	at	at	IN
cord-273505-pcsw3vmx	298	16	the	the	DT
cord-273505-pcsw3vmx	298	17	appropriate	appropriate	JJ
cord-273505-pcsw3vmx	298	18	point	point	NN
cord-273505-pcsw3vmx	298	19	may	may	MD
cord-273505-pcsw3vmx	298	20	be	be	VB
cord-273505-pcsw3vmx	298	21	able	able	JJ
cord-273505-pcsw3vmx	298	22	to	to	TO
cord-273505-pcsw3vmx	298	23	prevent	prevent	VB
cord-273505-pcsw3vmx	298	24	disease	disease	NN
cord-273505-pcsw3vmx	298	25	progression	progression	NN
cord-273505-pcsw3vmx	298	26	and	and	CC
cord-273505-pcsw3vmx	298	27	improve	improve	VB
cord-273505-pcsw3vmx	298	28	the	the	DT
cord-273505-pcsw3vmx	298	29	prognosis	prognosis	NN
cord-273505-pcsw3vmx	298	30	of	of	IN
cord-273505-pcsw3vmx	298	31	patients	patient	NNS
cord-273505-pcsw3vmx	298	32	with	with	IN
cord-273505-pcsw3vmx	298	33	severe	severe	JJ
cord-273505-pcsw3vmx	298	34	COVID-19	covid-19	NN
cord-273505-pcsw3vmx	298	35	.	.	.
cord-273505-pcsw3vmx	299	1	Currently	currently	RB
cord-273505-pcsw3vmx	299	2	ongoing	ongoing	JJ
cord-273505-pcsw3vmx	299	3	randomized	randomized	JJ
cord-273505-pcsw3vmx	299	4	controlled	control	VBN
cord-273505-pcsw3vmx	299	5	trials	trial	NNS
cord-273505-pcsw3vmx	299	6	of	of	IN
cord-273505-pcsw3vmx	299	7	high	high	JJ
cord-273505-pcsw3vmx	299	8	-	-	HYPH
cord-273505-pcsw3vmx	299	9	dose	dose	NN
cord-273505-pcsw3vmx	299	10	IVIg	ivig	NN
cord-273505-pcsw3vmx	299	11	therapy	therapy	NN
cord-273505-pcsw3vmx	299	12	in	in	IN
cord-273505-pcsw3vmx	299	13	severe	severe	JJ
cord-273505-pcsw3vmx	299	14	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	299	15	patients	patient	NNS
cord-273505-pcsw3vmx	299	16	are	be	VBP
cord-273505-pcsw3vmx	299	17	evaluating	evaluate	VBG
cord-273505-pcsw3vmx	299	18	the	the	DT
cord-273505-pcsw3vmx	299	19	benefit	benefit	NN
cord-273505-pcsw3vmx	299	20	of	of	IN
cord-273505-pcsw3vmx	299	21	IVIg	IVIg	NNS
cord-273505-pcsw3vmx	299	22	compared	compare	VBN
cord-273505-pcsw3vmx	299	23	to	to	IN
cord-273505-pcsw3vmx	299	24	standard	standard	JJ
cord-273505-pcsw3vmx	299	25	care	care	NN
cord-273505-pcsw3vmx	299	26	(	(	-LRB-
cord-273505-pcsw3vmx	299	27	NCT04261426	NCT04261426	NNP
cord-273505-pcsw3vmx	299	28	and	and	CC
cord-273505-pcsw3vmx	299	29	NCT04350580	NCT04350580	NNP
cord-273505-pcsw3vmx	299	30	)	)	-RRB-
cord-273505-pcsw3vmx	299	31	and	and	CC
cord-273505-pcsw3vmx	299	32	will	will	MD
cord-273505-pcsw3vmx	299	33	be	be	VB
cord-273505-pcsw3vmx	299	34	able	able	JJ
cord-273505-pcsw3vmx	299	35	to	to	TO
cord-273505-pcsw3vmx	299	36	further	further	RB
cord-273505-pcsw3vmx	299	37	provide	provide	VB
cord-273505-pcsw3vmx	299	38	more	more	JJR
cord-273505-pcsw3vmx	299	39	information	information	NN
cord-273505-pcsw3vmx	299	40	about	about	IN
cord-273505-pcsw3vmx	299	41	the	the	DT
cord-273505-pcsw3vmx	299	42	clinical	clinical	JJ
cord-273505-pcsw3vmx	299	43	effects	effect	NNS
cord-273505-pcsw3vmx	299	44	of	of	IN
cord-273505-pcsw3vmx	299	45	IVIg	ivig	JJ
cord-273505-pcsw3vmx	299	46	therapy	therapy	NN
cord-273505-pcsw3vmx	299	47	in	in	IN
cord-273505-pcsw3vmx	299	48	COVID-	covid-	NN
cord-273505-pcsw3vmx	299	49	19	19	CD
cord-273505-pcsw3vmx	299	50	.	.	.
cord-273505-pcsw3vmx	300	1	Although	although	IN
cord-273505-pcsw3vmx	300	2	a	a	DT
cord-273505-pcsw3vmx	300	3	large	large	JJ
cord-273505-pcsw3vmx	300	4	number	number	NN
cord-273505-pcsw3vmx	300	5	of	of	IN
cord-273505-pcsw3vmx	300	6	clinical	clinical	JJ
cord-273505-pcsw3vmx	300	7	trials	trial	NNS
cord-273505-pcsw3vmx	300	8	have	have	VBP
cord-273505-pcsw3vmx	300	9	demonstrated	demonstrate	VBN
cord-273505-pcsw3vmx	300	10	that	that	IN
cord-273505-pcsw3vmx	300	11	IVIg	ivig	NN
cord-273505-pcsw3vmx	300	12	therapy	therapy	NN
cord-273505-pcsw3vmx	300	13	is	be	VBZ
cord-273505-pcsw3vmx	300	14	well	well	RB
cord-273505-pcsw3vmx	300	15	-	-	HYPH
cord-273505-pcsw3vmx	300	16	tolerated	tolerate	VBN
cord-273505-pcsw3vmx	300	17	,	,	,
cord-273505-pcsw3vmx	300	18	various	various	JJ
cord-273505-pcsw3vmx	300	19	side	side	NN
cord-273505-pcsw3vmx	300	20	effects	effect	NNS
cord-273505-pcsw3vmx	300	21	have	have	VBP
cord-273505-pcsw3vmx	300	22	been	be	VBN
cord-273505-pcsw3vmx	300	23	reported	report	VBN
cord-273505-pcsw3vmx	300	24	(	(	-LRB-
cord-273505-pcsw3vmx	300	25	244	244	CD
cord-273505-pcsw3vmx	300	26	)	)	-RRB-
cord-273505-pcsw3vmx	300	27	.	.	.
cord-273505-pcsw3vmx	301	1	The	the	DT
cord-273505-pcsw3vmx	301	2	majority	majority	NN
cord-273505-pcsw3vmx	301	3	of	of	IN
cord-273505-pcsw3vmx	301	4	these	these	DT
cord-273505-pcsw3vmx	301	5	effects	effect	NNS
cord-273505-pcsw3vmx	301	6	are	be	VBP
cord-273505-pcsw3vmx	301	7	mild	mild	JJ
cord-273505-pcsw3vmx	301	8	and	and	CC
cord-273505-pcsw3vmx	301	9	transient	transient	JJ
cord-273505-pcsw3vmx	301	10	,	,	,
cord-273505-pcsw3vmx	301	11	yet	yet	CC
cord-273505-pcsw3vmx	301	12	clinicians	clinician	NNS
cord-273505-pcsw3vmx	301	13	need	need	VBP
cord-273505-pcsw3vmx	301	14	to	to	TO
cord-273505-pcsw3vmx	301	15	be	be	VB
cord-273505-pcsw3vmx	301	16	vigilant	vigilant	JJ
cord-273505-pcsw3vmx	301	17	about	about	IN
cord-273505-pcsw3vmx	301	18	rare	rare	JJ
cord-273505-pcsw3vmx	301	19	but	but	CC
cord-273505-pcsw3vmx	301	20	serious	serious	JJ
cord-273505-pcsw3vmx	301	21	adverse	adverse	JJ
cord-273505-pcsw3vmx	301	22	effects	effect	NNS
cord-273505-pcsw3vmx	301	23	such	such	JJ
cord-273505-pcsw3vmx	301	24	as	as	IN
cord-273505-pcsw3vmx	301	25	aseptic	aseptic	JJ
cord-273505-pcsw3vmx	301	26	meningitis	meningitis	NN
cord-273505-pcsw3vmx	301	27	,	,	,
cord-273505-pcsw3vmx	301	28	renal	renal	JJ
cord-273505-pcsw3vmx	301	29	impairment	impairment	NN
cord-273505-pcsw3vmx	301	30	,	,	,
cord-273505-pcsw3vmx	301	31	thrombosis	thrombosis	NN
cord-273505-pcsw3vmx	301	32	,	,	,
cord-273505-pcsw3vmx	301	33	and	and	CC
cord-273505-pcsw3vmx	301	34	hemolytic	hemolytic	JJ
cord-273505-pcsw3vmx	301	35	anemia	anemia	NN
cord-273505-pcsw3vmx	301	36	(	(	-LRB-
cord-273505-pcsw3vmx	301	37	244	244	CD
cord-273505-pcsw3vmx	301	38	)	)	-RRB-
cord-273505-pcsw3vmx	301	39	.	.	.
cord-273505-pcsw3vmx	302	1	It	-PRON-	PRP
cord-273505-pcsw3vmx	302	2	is	be	VBZ
cord-273505-pcsw3vmx	302	3	noted	note	VBN
cord-273505-pcsw3vmx	302	4	that	that	IN
cord-273505-pcsw3vmx	302	5	thrombosis	thrombosis	NN
cord-273505-pcsw3vmx	302	6	is	be	VBZ
cord-273505-pcsw3vmx	302	7	common	common	JJ
cord-273505-pcsw3vmx	302	8	in	in	IN
cord-273505-pcsw3vmx	302	9	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	302	10	,	,	,
cord-273505-pcsw3vmx	302	11	and	and	CC
cord-273505-pcsw3vmx	302	12	whether	whether	IN
cord-273505-pcsw3vmx	302	13	highdose	highdose	NN
cord-273505-pcsw3vmx	302	14	IVIg	ivig	NN
cord-273505-pcsw3vmx	302	15	therapy	therapy	NN
cord-273505-pcsw3vmx	302	16	would	would	MD
cord-273505-pcsw3vmx	302	17	further	far	RBR
cord-273505-pcsw3vmx	302	18	increase	increase	VB
cord-273505-pcsw3vmx	302	19	the	the	DT
cord-273505-pcsw3vmx	302	20	risk	risk	NN
cord-273505-pcsw3vmx	302	21	of	of	IN
cord-273505-pcsw3vmx	302	22	thrombosis	thrombosis	NN
cord-273505-pcsw3vmx	302	23	remains	remain	VBZ
cord-273505-pcsw3vmx	302	24	unclear	unclear	JJ
cord-273505-pcsw3vmx	302	25	(	(	-LRB-
cord-273505-pcsw3vmx	302	26	17	17	CD
cord-273505-pcsw3vmx	302	27	,	,	,
cord-273505-pcsw3vmx	302	28	245	245	CD
cord-273505-pcsw3vmx	302	29	)	)	-RRB-
cord-273505-pcsw3vmx	302	30	.	.	.
cord-273505-pcsw3vmx	303	1	However	however	RB
cord-273505-pcsw3vmx	303	2	,	,	,
cord-273505-pcsw3vmx	303	3	the	the	DT
cord-273505-pcsw3vmx	303	4	combined	combined	JJ
cord-273505-pcsw3vmx	303	5	treatment	treatment	NN
cord-273505-pcsw3vmx	303	6	of	of	IN
cord-273505-pcsw3vmx	303	7	low	low	JJ
cord-273505-pcsw3vmx	303	8	molecular	molecular	JJ
cord-273505-pcsw3vmx	303	9	weight	weight	NN
cord-273505-pcsw3vmx	303	10	heparin	heparin	NN
cord-273505-pcsw3vmx	303	11	and	and	CC
cord-273505-pcsw3vmx	303	12	high	high	JJ
cord-273505-pcsw3vmx	303	13	-	-	HYPH
cord-273505-pcsw3vmx	303	14	dose	dose	NN
cord-273505-pcsw3vmx	303	15	IVIg	ivig	NN
cord-273505-pcsw3vmx	303	16	therapy	therapy	NN
cord-273505-pcsw3vmx	303	17	at	at	IN
cord-273505-pcsw3vmx	303	18	0.3	0.3	CD
cord-273505-pcsw3vmx	303	19	-	-	SYM
cord-273505-pcsw3vmx	303	20	0.5	0.5	CD
cord-273505-pcsw3vmx	303	21	g	g	NN
cord-273505-pcsw3vmx	303	22	/	/	SYM
cord-273505-pcsw3vmx	303	23	kg	kg	NN
cord-273505-pcsw3vmx	303	24	/	/	SYM
cord-273505-pcsw3vmx	303	25	d	d	NN
cord-273505-pcsw3vmx	303	26	for	for	IN
cord-273505-pcsw3vmx	303	27	5	5	CD
cord-273505-pcsw3vmx	303	28	days	day	NNS
cord-273505-pcsw3vmx	303	29	in	in	IN
cord-273505-pcsw3vmx	303	30	the	the	DT
cord-273505-pcsw3vmx	303	31	early	early	JJ
cord-273505-pcsw3vmx	303	32	phase	phase	NN
cord-273505-pcsw3vmx	303	33	has	have	VBZ
cord-273505-pcsw3vmx	303	34	been	be	VBN
cord-273505-pcsw3vmx	303	35	suggested	suggest	VBN
cord-273505-pcsw3vmx	303	36	to	to	TO
cord-273505-pcsw3vmx	303	37	have	have	VB
cord-273505-pcsw3vmx	303	38	proper	proper	JJ
cord-273505-pcsw3vmx	303	39	efficacy	efficacy	NN
cord-273505-pcsw3vmx	303	40	in	in	IN
cord-273505-pcsw3vmx	303	41	treating	treat	VBG
cord-273505-pcsw3vmx	303	42	severe	severe	JJ
cord-273505-pcsw3vmx	303	43	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	303	44	patients	patient	NNS
cord-273505-pcsw3vmx	303	45	(	(	-LRB-
cord-273505-pcsw3vmx	303	46	17	17	CD
cord-273505-pcsw3vmx	303	47	)	)	-RRB-
cord-273505-pcsw3vmx	303	48	.	.	.
cord-273505-pcsw3vmx	304	1	The	the	DT
cord-273505-pcsw3vmx	304	2	IVIg	ivig	JJ
cord-273505-pcsw3vmx	304	3	preparation	preparation	NN
cord-273505-pcsw3vmx	304	4	is	be	VBZ
cord-273505-pcsw3vmx	304	5	a	a	DT
cord-273505-pcsw3vmx	304	6	widely	widely	RB
cord-273505-pcsw3vmx	304	7	used	use	VBN
cord-273505-pcsw3vmx	304	8	pooled	pool	VBN
cord-273505-pcsw3vmx	304	9	human	human	JJ
cord-273505-pcsw3vmx	304	10	blood	blood	NN
cord-273505-pcsw3vmx	304	11	product	product	NN
cord-273505-pcsw3vmx	304	12	that	that	WDT
cord-273505-pcsw3vmx	304	13	can	can	MD
cord-273505-pcsw3vmx	304	14	provide	provide	VB
cord-273505-pcsw3vmx	304	15	passive	passive	JJ
cord-273505-pcsw3vmx	304	16	immunity	immunity	NN
cord-273505-pcsw3vmx	304	17	and	and	CC
cord-273505-pcsw3vmx	304	18	modulate	modulate	VB
cord-273505-pcsw3vmx	304	19	the	the	DT
cord-273505-pcsw3vmx	304	20	immune	immune	JJ
cord-273505-pcsw3vmx	304	21	functions	function	NNS
cord-273505-pcsw3vmx	304	22	.	.	.
cord-273505-pcsw3vmx	305	1	Although	although	IN
cord-273505-pcsw3vmx	305	2	,	,	,
cord-273505-pcsw3vmx	305	3	for	for	IN
cord-273505-pcsw3vmx	305	4	COIVD-19	COIVD-19	VBG
cord-273505-pcsw3vmx	305	5	the	the	DT
cord-273505-pcsw3vmx	305	6	pathogenspecific	pathogenspecific	NN
cord-273505-pcsw3vmx	305	7	effects	effect	NNS
cord-273505-pcsw3vmx	305	8	of	of	IN
cord-273505-pcsw3vmx	305	9	IVIg	IVIg	NNS
cord-273505-pcsw3vmx	305	10	are	be	VBP
cord-273505-pcsw3vmx	305	11	not	not	RB
cord-273505-pcsw3vmx	305	12	relevant	relevant	JJ
cord-273505-pcsw3vmx	305	13	yet	yet	RB
cord-273505-pcsw3vmx	305	14	,	,	,
cord-273505-pcsw3vmx	305	15	since	since	IN
cord-273505-pcsw3vmx	305	16	available	available	JJ
cord-273505-pcsw3vmx	305	17	preparations	preparation	NNS
cord-273505-pcsw3vmx	305	18	were	be	VBD
cord-273505-pcsw3vmx	305	19	collected	collect	VBN
cord-273505-pcsw3vmx	305	20	from	from	IN
cord-273505-pcsw3vmx	305	21	healthy	healthy	JJ
cord-273505-pcsw3vmx	305	22	donors	donor	NNS
cord-273505-pcsw3vmx	305	23	without	without	IN
cord-273505-pcsw3vmx	305	24	preexisting	preexist	VBG
cord-273505-pcsw3vmx	305	25	immunity	immunity	NN
cord-273505-pcsw3vmx	305	26	early	early	RB
cord-273505-pcsw3vmx	305	27	before	before	IN
cord-273505-pcsw3vmx	305	28	the	the	DT
cord-273505-pcsw3vmx	305	29	pandemic	pandemic	NN
cord-273505-pcsw3vmx	305	30	began	begin	VBD
cord-273505-pcsw3vmx	305	31	.	.	.
cord-273505-pcsw3vmx	306	1	The	the	DT
cord-273505-pcsw3vmx	306	2	anti	anti	JJ
cord-273505-pcsw3vmx	306	3	-	-	JJ
cord-273505-pcsw3vmx	306	4	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	306	5	and	and	CC
cord-273505-pcsw3vmx	306	6	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	306	7	effects	effect	NNS
cord-273505-pcsw3vmx	306	8	on	on	IN
cord-273505-pcsw3vmx	306	9	the	the	DT
cord-273505-pcsw3vmx	306	10	various	various	JJ
cord-273505-pcsw3vmx	306	11	immune	immune	JJ
cord-273505-pcsw3vmx	306	12	cells	cell	NNS
cord-273505-pcsw3vmx	306	13	of	of	IN
cord-273505-pcsw3vmx	306	14	high	high	JJ
cord-273505-pcsw3vmx	306	15	-	-	HYPH
cord-273505-pcsw3vmx	306	16	dose	dose	NN
cord-273505-pcsw3vmx	306	17	IVIg	ivig	NN
cord-273505-pcsw3vmx	306	18	may	may	MD
cord-273505-pcsw3vmx	306	19	account	account	VB
cord-273505-pcsw3vmx	306	20	for	for	IN
cord-273505-pcsw3vmx	306	21	its	-PRON-	PRP$
cord-273505-pcsw3vmx	306	22	clinical	clinical	JJ
cord-273505-pcsw3vmx	306	23	benefits	benefit	NNS
cord-273505-pcsw3vmx	306	24	.	.	.
cord-273505-pcsw3vmx	307	1	Based	base	VBN
cord-273505-pcsw3vmx	307	2	on	on	IN
cord-273505-pcsw3vmx	307	3	these	these	DT
cord-273505-pcsw3vmx	307	4	potential	potential	JJ
cord-273505-pcsw3vmx	307	5	supportive	supportive	JJ
cord-273505-pcsw3vmx	307	6	F(ab	f(ab	NN
cord-273505-pcsw3vmx	307	7	)	)	-RRB-
cord-273505-pcsw3vmx	307	8	′	′	CD
cord-273505-pcsw3vmx	307	9	2	2	CD
cord-273505-pcsw3vmx	307	10	and	and	CC
cord-273505-pcsw3vmx	307	11	Fc	Fc	NNP
cord-273505-pcsw3vmx	307	12	mediated	mediate	VBD
cord-273505-pcsw3vmx	307	13	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	307	14	and	and	CC
cord-273505-pcsw3vmx	307	15	the	the	DT
cord-273505-pcsw3vmx	307	16	known	know	VBN
cord-273505-pcsw3vmx	307	17	clinical	clinical	JJ
cord-273505-pcsw3vmx	307	18	effects	effect	NNS
cord-273505-pcsw3vmx	307	19	in	in	IN
cord-273505-pcsw3vmx	307	20	treating	treat	VBG
cord-273505-pcsw3vmx	307	21	severe	severe	JJ
cord-273505-pcsw3vmx	307	22	virus	virus	NN
cord-273505-pcsw3vmx	307	23	pneumonia	pneumonia	NN
cord-273505-pcsw3vmx	307	24	such	such	JJ
cord-273505-pcsw3vmx	307	25	as	as	IN
cord-273505-pcsw3vmx	307	26	SARS	SARS	NNP
cord-273505-pcsw3vmx	307	27	,	,	,
cord-273505-pcsw3vmx	307	28	MERS	MERS	NNP
cord-273505-pcsw3vmx	307	29	,	,	,
cord-273505-pcsw3vmx	307	30	influenza	influenza	NN
cord-273505-pcsw3vmx	307	31	,	,	,
cord-273505-pcsw3vmx	307	32	and	and	CC
cord-273505-pcsw3vmx	307	33	RSV	RSV	NNP
cord-273505-pcsw3vmx	307	34	disease	disease	NN
cord-273505-pcsw3vmx	307	35	,	,	.
cord-273505-pcsw3vmx	308	1	the	the	DT
cord-273505-pcsw3vmx	308	2	early	early	JJ
cord-273505-pcsw3vmx	308	3	application	application	NN
cord-273505-pcsw3vmx	308	4	of	of	IN
cord-273505-pcsw3vmx	308	5	high	high	JJ
cord-273505-pcsw3vmx	308	6	-	-	HYPH
cord-273505-pcsw3vmx	308	7	dose	dose	NN
cord-273505-pcsw3vmx	308	8	IVIg	ivig	NN
cord-273505-pcsw3vmx	308	9	therapy	therapy	NN
cord-273505-pcsw3vmx	308	10	may	may	MD
cord-273505-pcsw3vmx	308	11	be	be	VB
cord-273505-pcsw3vmx	308	12	considered	consider	VBN
cord-273505-pcsw3vmx	308	13	in	in	IN
cord-273505-pcsw3vmx	308	14	the	the	DT
cord-273505-pcsw3vmx	308	15	management	management	NN
cord-273505-pcsw3vmx	308	16	of	of	IN
cord-273505-pcsw3vmx	308	17	severe	severe	JJ
cord-273505-pcsw3vmx	308	18	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	308	19	patients	patient	NNS
cord-273505-pcsw3vmx	308	20	.	.	.
cord-273505-pcsw3vmx	309	1	Currently	currently	RB
cord-273505-pcsw3vmx	309	2	,	,	,
cord-273505-pcsw3vmx	309	3	limited	limited	JJ
cord-273505-pcsw3vmx	309	4	clinical	clinical	JJ
cord-273505-pcsw3vmx	309	5	practice	practice	NN
cord-273505-pcsw3vmx	309	6	of	of	IN
cord-273505-pcsw3vmx	309	7	high	high	JJ
cord-273505-pcsw3vmx	309	8	-	-	HYPH
cord-273505-pcsw3vmx	309	9	dose	dose	NN
cord-273505-pcsw3vmx	309	10	IVIg	ivig	NN
cord-273505-pcsw3vmx	309	11	in	in	IN
cord-273505-pcsw3vmx	309	12	treating	treat	VBG
cord-273505-pcsw3vmx	309	13	SARS	SARS	NNP
cord-273505-pcsw3vmx	309	14	-	-	HYPH
cord-273505-pcsw3vmx	309	15	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	309	16	infection	infection	NN
cord-273505-pcsw3vmx	309	17	has	have	VBZ
cord-273505-pcsw3vmx	309	18	been	be	VBN
cord-273505-pcsw3vmx	309	19	reported	report	VBN
cord-273505-pcsw3vmx	309	20	to	to	TO
cord-273505-pcsw3vmx	309	21	show	show	VB
cord-273505-pcsw3vmx	309	22	potential	potential	JJ
cord-273505-pcsw3vmx	309	23	clinical	clinical	JJ
cord-273505-pcsw3vmx	309	24	benefits	benefit	NNS
cord-273505-pcsw3vmx	309	25	.	.	.
cord-273505-pcsw3vmx	310	1	Still	still	RB
cord-273505-pcsw3vmx	310	2	,	,	,
cord-273505-pcsw3vmx	310	3	more	more	JJR
cord-273505-pcsw3vmx	310	4	research	research	NN
cord-273505-pcsw3vmx	310	5	is	be	VBZ
cord-273505-pcsw3vmx	310	6	needed	need	VBN
cord-273505-pcsw3vmx	310	7	but	but	CC
cord-273505-pcsw3vmx	310	8	these	these	DT
cord-273505-pcsw3vmx	310	9	inferences	inference	NNS
cord-273505-pcsw3vmx	310	10	may	may	MD
cord-273505-pcsw3vmx	310	11	provide	provide	VB
cord-273505-pcsw3vmx	310	12	relevant	relevant	JJ
cord-273505-pcsw3vmx	310	13	and	and	CC
cord-273505-pcsw3vmx	310	14	useful	useful	JJ
cord-273505-pcsw3vmx	310	15	insights	insight	NNS
cord-273505-pcsw3vmx	310	16	and	and	CC
cord-273505-pcsw3vmx	310	17	help	help	NN
cord-273505-pcsw3vmx	310	18	in	in	IN
cord-273505-pcsw3vmx	310	19	confronting	confront	VBG
cord-273505-pcsw3vmx	310	20	the	the	DT
cord-273505-pcsw3vmx	310	21	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	310	22	epidemic	epidemic	NN
cord-273505-pcsw3vmx	310	23	.	.	.
cord-273505-pcsw3vmx	311	1	XL	XL	NNP
cord-273505-pcsw3vmx	311	2	conceived	conceive	VBD
cord-273505-pcsw3vmx	311	3	and	and	CC
cord-273505-pcsw3vmx	311	4	wrote	write	VBD
cord-273505-pcsw3vmx	311	5	the	the	DT
cord-273505-pcsw3vmx	311	6	manuscript	manuscript	NN
cord-273505-pcsw3vmx	311	7	and	and	CC
cord-273505-pcsw3vmx	311	8	prepared	prepared	JJ
cord-273505-pcsw3vmx	311	9	figures	figure	NNS
cord-273505-pcsw3vmx	311	10	.	.	.
cord-273505-pcsw3vmx	312	1	WC	WC	NNP
cord-273505-pcsw3vmx	312	2	and	and	CC
cord-273505-pcsw3vmx	312	3	TL	TL	NNP
cord-273505-pcsw3vmx	312	4	contributed	contribute	VBD
cord-273505-pcsw3vmx	312	5	to	to	IN
cord-273505-pcsw3vmx	312	6	the	the	DT
cord-273505-pcsw3vmx	312	7	modification	modification	NN
cord-273505-pcsw3vmx	312	8	and	and	CC
cord-273505-pcsw3vmx	312	9	revision	revision	NN
cord-273505-pcsw3vmx	312	10	of	of	IN
cord-273505-pcsw3vmx	312	11	the	the	DT
cord-273505-pcsw3vmx	312	12	manuscript	manuscript	NN
cord-273505-pcsw3vmx	312	13	.	.	.
cord-273505-pcsw3vmx	313	1	All	all	DT
cord-273505-pcsw3vmx	313	2	authors	author	NNS
cord-273505-pcsw3vmx	313	3	contributed	contribute	VBD
cord-273505-pcsw3vmx	313	4	to	to	IN
cord-273505-pcsw3vmx	313	5	the	the	DT
cord-273505-pcsw3vmx	313	6	article	article	NN
cord-273505-pcsw3vmx	313	7	and	and	CC
cord-273505-pcsw3vmx	313	8	approved	approve	VBD
cord-273505-pcsw3vmx	313	9	the	the	DT
cord-273505-pcsw3vmx	313	10	submitted	submit	VBN
cord-273505-pcsw3vmx	313	11	version	version	NN
cord-273505-pcsw3vmx	313	12	.	.	.
cord-273505-pcsw3vmx	313	13	 	 	_SP
cord-273505-pcsw3vmx	314	1	Available	available	JJ
cord-273505-pcsw3vmx	314	2	oline	oline	NN
cord-273505-pcsw3vmx	314	3	at	at	IN
cord-273505-pcsw3vmx	314	4	Clinical	clinical	JJ
cord-273505-pcsw3vmx	314	5	features	feature	NNS
cord-273505-pcsw3vmx	314	6	of	of	IN
cord-273505-pcsw3vmx	314	7	patients	patient	NNS
cord-273505-pcsw3vmx	314	8	infected	infect	VBN
cord-273505-pcsw3vmx	314	9	with	with	IN
cord-273505-pcsw3vmx	314	10	2019	2019	CD
cord-273505-pcsw3vmx	314	11	novel	novel	JJ
cord-273505-pcsw3vmx	314	12	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	314	13	in	in	IN
cord-273505-pcsw3vmx	314	14	Wuhan	Wuhan	NNP
cord-273505-pcsw3vmx	314	15	Current	current	JJ
cord-273505-pcsw3vmx	314	16	drugs	drug	NNS
cord-273505-pcsw3vmx	314	17	with	with	IN
cord-273505-pcsw3vmx	314	18	potential	potential	NN
cord-273505-pcsw3vmx	314	19	for	for	IN
cord-273505-pcsw3vmx	314	20	treatment	treatment	NN
cord-273505-pcsw3vmx	314	21	of	of	IN
cord-273505-pcsw3vmx	314	22	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	314	23	:	:	:
cord-273505-pcsw3vmx	314	24	a	a	DT
cord-273505-pcsw3vmx	314	25	literature	literature	NN
cord-273505-pcsw3vmx	314	26	review	review	NN
cord-273505-pcsw3vmx	314	27	Diagnosis	Diagnosis	NNP
cord-273505-pcsw3vmx	314	28	and	and	CC
cord-273505-pcsw3vmx	314	29	Treatment	Treatment	NNP
cord-273505-pcsw3vmx	314	30	of	of	IN
cord-273505-pcsw3vmx	314	31	Pneumonia	Pneumonia	NNP
cord-273505-pcsw3vmx	314	32	Infected	infect	VBN
cord-273505-pcsw3vmx	314	33	by	by	IN
cord-273505-pcsw3vmx	314	34	Novel	Novel	NNP
cord-273505-pcsw3vmx	314	35	Coronavirus	Coronavirus	NNP
cord-273505-pcsw3vmx	315	1	(	(	-LRB-
cord-273505-pcsw3vmx	315	2	Trial	Trial	NNP
cord-273505-pcsw3vmx	315	3	Version	Version	NNP
cord-273505-pcsw3vmx	315	4	Clinical	clinical	JJ
cord-273505-pcsw3vmx	315	5	evidence	evidence	NN
cord-273505-pcsw3vmx	315	6	does	do	VBZ
cord-273505-pcsw3vmx	315	7	not	not	RB
cord-273505-pcsw3vmx	315	8	support	support	VB
cord-273505-pcsw3vmx	315	9	corticosteroid	corticosteroid	NN
cord-273505-pcsw3vmx	315	10	treatment	treatment	NN
cord-273505-pcsw3vmx	315	11	for	for	IN
cord-273505-pcsw3vmx	315	12	2019-nCoV	2019-ncov	CD
cord-273505-pcsw3vmx	315	13	lung	lung	NN
cord-273505-pcsw3vmx	315	14	injury	injury	NN
cord-273505-pcsw3vmx	316	1	Corticosteroid	Corticosteroid	NNP
cord-273505-pcsw3vmx	316	2	guidance	guidance	NN
cord-273505-pcsw3vmx	316	3	for	for	IN
cord-273505-pcsw3vmx	316	4	pregnancy	pregnancy	NN
cord-273505-pcsw3vmx	316	5	during	during	IN
cord-273505-pcsw3vmx	316	6	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	316	7	pandemic	pandemic	NN
cord-273505-pcsw3vmx	316	8	Remdesivir	Remdesivir	NNP
cord-273505-pcsw3vmx	316	9	in	in	IN
cord-273505-pcsw3vmx	316	10	adults	adult	NNS
cord-273505-pcsw3vmx	316	11	with	with	IN
cord-273505-pcsw3vmx	316	12	severe	severe	JJ
cord-273505-pcsw3vmx	316	13	COVID-19	covid-19	NN
cord-273505-pcsw3vmx	316	14	:	:	:
cord-273505-pcsw3vmx	316	15	a	a	DT
cord-273505-pcsw3vmx	316	16	randomised	randomised	JJ
cord-273505-pcsw3vmx	316	17	,	,	,
cord-273505-pcsw3vmx	316	18	double	double	JJ
cord-273505-pcsw3vmx	316	19	-	-	HYPH
cord-273505-pcsw3vmx	316	20	blind	blind	JJ
cord-273505-pcsw3vmx	316	21	,	,	,
cord-273505-pcsw3vmx	316	22	placebo	placebo	NN
cord-273505-pcsw3vmx	316	23	-	-	HYPH
cord-273505-pcsw3vmx	316	24	controlled	control	VBN
cord-273505-pcsw3vmx	316	25	,	,	,
cord-273505-pcsw3vmx	316	26	multicentre	multicentre	NNP
cord-273505-pcsw3vmx	316	27	trial	trial	NN
cord-273505-pcsw3vmx	316	28	Outcomes	Outcomes	NNPS
cord-273505-pcsw3vmx	316	29	of	of	IN
cord-273505-pcsw3vmx	316	30	hydroxychloroquine	hydroxychloroquine	NN
cord-273505-pcsw3vmx	316	31	usage	usage	NN
cord-273505-pcsw3vmx	316	32	in	in	IN
cord-273505-pcsw3vmx	316	33	United	United	NNP
cord-273505-pcsw3vmx	316	34	States	States	NNP
cord-273505-pcsw3vmx	316	35	veterans	veteran	NNS
cord-273505-pcsw3vmx	316	36	hospitalized	hospitalize	VBN
cord-273505-pcsw3vmx	316	37	with	with	IN
cord-273505-pcsw3vmx	316	38	Covid19	Covid19	NNP
cord-273505-pcsw3vmx	316	39	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-273505-pcsw3vmx	316	40	in	in	IN
cord-273505-pcsw3vmx	316	41	patients	patient	NNS
cord-273505-pcsw3vmx	316	42	with	with	IN
cord-273505-pcsw3vmx	316	43	mainly	mainly	RB
cord-273505-pcsw3vmx	316	44	mild	mild	JJ
cord-273505-pcsw3vmx	316	45	to	to	IN
cord-273505-pcsw3vmx	316	46	moderate	moderate	JJ
cord-273505-pcsw3vmx	316	47	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	316	48	disease	disease	NN
cord-273505-pcsw3vmx	316	49	2019	2019	CD
cord-273505-pcsw3vmx	316	50	:	:	:
cord-273505-pcsw3vmx	316	51	open	open	JJ
cord-273505-pcsw3vmx	316	52	label	label	NN
cord-273505-pcsw3vmx	316	53	,	,	,
cord-273505-pcsw3vmx	316	54	randomised	randomised	JJ
cord-273505-pcsw3vmx	316	55	controlled	control	VBN
cord-273505-pcsw3vmx	316	56	trial	trial	NN
cord-273505-pcsw3vmx	316	57	Favipiravir	Favipiravir	NNP
cord-273505-pcsw3vmx	316	58	versus	versus	IN
cord-273505-pcsw3vmx	316	59	arbidol	arbidol	NN
cord-273505-pcsw3vmx	316	60	for	for	IN
cord-273505-pcsw3vmx	316	61	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	316	62	:	:	:
cord-273505-pcsw3vmx	316	63	a	a	DT
cord-273505-pcsw3vmx	316	64	randomized	randomized	JJ
cord-273505-pcsw3vmx	316	65	clinical	clinical	JJ
cord-273505-pcsw3vmx	316	66	trial	trial	NN
cord-273505-pcsw3vmx	316	67	.	.	.
cord-273505-pcsw3vmx	317	1	medRxiv	medRxiv	NNS
cord-273505-pcsw3vmx	317	2	A	a	DT
cord-273505-pcsw3vmx	317	3	trial	trial	NN
cord-273505-pcsw3vmx	317	4	of	of	IN
cord-273505-pcsw3vmx	317	5	lopinavirritonavir	lopinavirritonavir	NNS
cord-273505-pcsw3vmx	317	6	in	in	IN
cord-273505-pcsw3vmx	317	7	adults	adult	NNS
cord-273505-pcsw3vmx	317	8	hospitalized	hospitalize	VBN
cord-273505-pcsw3vmx	317	9	with	with	IN
cord-273505-pcsw3vmx	317	10	severe	severe	JJ
cord-273505-pcsw3vmx	317	11	Covid-19	covid-19	NN
cord-273505-pcsw3vmx	317	12	The	the	DT
cord-273505-pcsw3vmx	317	13	host	host	NN
cord-273505-pcsw3vmx	317	14	immune	immune	JJ
cord-273505-pcsw3vmx	317	15	response	response	NN
cord-273505-pcsw3vmx	317	16	in	in	IN
cord-273505-pcsw3vmx	317	17	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	317	18	virus	virus	NN
cord-273505-pcsw3vmx	317	19	infection	infection	NN
cord-273505-pcsw3vmx	317	20	:	:	:
cord-273505-pcsw3vmx	317	21	balancing	balance	VBG
cord-273505-pcsw3vmx	317	22	virus	virus	NN
cord-273505-pcsw3vmx	317	23	clearance	clearance	NN
cord-273505-pcsw3vmx	317	24	and	and	CC
cord-273505-pcsw3vmx	317	25	immunopathology	immunopathology	NN
cord-273505-pcsw3vmx	317	26	In	in	IN
cord-273505-pcsw3vmx	317	27	the	the	DT
cord-273505-pcsw3vmx	317	28	eye	eye	NN
cord-273505-pcsw3vmx	317	29	of	of	IN
cord-273505-pcsw3vmx	317	30	the	the	DT
cord-273505-pcsw3vmx	317	31	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	317	32	cytokine	cytokine	NN
cord-273505-pcsw3vmx	317	33	storm	storm	NN
cord-273505-pcsw3vmx	318	1	The	the	DT
cord-273505-pcsw3vmx	318	2	use	use	NN
cord-273505-pcsw3vmx	318	3	of	of	IN
cord-273505-pcsw3vmx	318	4	antiinflammatory	antiinflammatory	JJ
cord-273505-pcsw3vmx	318	5	drugs	drug	NNS
cord-273505-pcsw3vmx	318	6	in	in	IN
cord-273505-pcsw3vmx	318	7	the	the	DT
cord-273505-pcsw3vmx	318	8	treatment	treatment	NN
cord-273505-pcsw3vmx	318	9	of	of	IN
cord-273505-pcsw3vmx	318	10	people	people	NNS
cord-273505-pcsw3vmx	318	11	with	with	IN
cord-273505-pcsw3vmx	318	12	severe	severe	JJ
cord-273505-pcsw3vmx	318	13	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	318	14	disease	disease	NN
cord-273505-pcsw3vmx	318	15	2019	2019	CD
cord-273505-pcsw3vmx	318	16	(	(	-LRB-
cord-273505-pcsw3vmx	318	17	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	318	18	)	)	-RRB-
cord-273505-pcsw3vmx	318	19	:	:	:
cord-273505-pcsw3vmx	318	20	The	the	DT
cord-273505-pcsw3vmx	318	21	Perspectives	perspective	NNS
cord-273505-pcsw3vmx	318	22	of	of	IN
cord-273505-pcsw3vmx	318	23	clinical	clinical	JJ
cord-273505-pcsw3vmx	318	24	immunologists	immunologist	NNS
cord-273505-pcsw3vmx	318	25	from	from	IN
cord-273505-pcsw3vmx	318	26	China	China	NNP
cord-273505-pcsw3vmx	319	1	The	the	DT
cord-273505-pcsw3vmx	319	2	role	role	NN
cord-273505-pcsw3vmx	319	3	of	of	IN
cord-273505-pcsw3vmx	319	4	adjuvant	adjuvant	JJ
cord-273505-pcsw3vmx	319	5	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	319	6	agents	agent	NNS
cord-273505-pcsw3vmx	319	7	for	for	IN
cord-273505-pcsw3vmx	319	8	treatment	treatment	NN
cord-273505-pcsw3vmx	319	9	of	of	IN
cord-273505-pcsw3vmx	319	10	severe	severe	JJ
cord-273505-pcsw3vmx	319	11	influenza	influenza	NN
cord-273505-pcsw3vmx	319	12	High	high	JJ
cord-273505-pcsw3vmx	319	13	-	-	HYPH
cord-273505-pcsw3vmx	319	14	dose	dose	NN
cord-273505-pcsw3vmx	319	15	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	319	16	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	319	17	as	as	IN
cord-273505-pcsw3vmx	319	18	a	a	DT
cord-273505-pcsw3vmx	319	19	therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	319	20	option	option	NN
cord-273505-pcsw3vmx	319	21	for	for	IN
cord-273505-pcsw3vmx	319	22	deteriorating	deteriorate	VBG
cord-273505-pcsw3vmx	319	23	patients	patient	NNS
cord-273505-pcsw3vmx	319	24	with	with	IN
cord-273505-pcsw3vmx	319	25	Coronavirus	Coronavirus	NNP
cord-273505-pcsw3vmx	319	26	Disease	Disease	NNP
cord-273505-pcsw3vmx	319	27	Hypothesis	Hypothesis	NNP
cord-273505-pcsw3vmx	319	28	for	for	IN
cord-273505-pcsw3vmx	319	29	potential	potential	JJ
cord-273505-pcsw3vmx	319	30	pathogenesis	pathogenesis	NN
cord-273505-pcsw3vmx	319	31	of	of	IN
cord-273505-pcsw3vmx	319	32	SARS	SARS	NNP
cord-273505-pcsw3vmx	319	33	-	-	HYPH
cord-273505-pcsw3vmx	319	34	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	319	35	infection	infection	NN
cord-273505-pcsw3vmx	319	36	-	-	:
cord-273505-pcsw3vmx	319	37	a	a	DT
cord-273505-pcsw3vmx	319	38	review	review	NN
cord-273505-pcsw3vmx	319	39	of	of	IN
cord-273505-pcsw3vmx	319	40	immune	immune	JJ
cord-273505-pcsw3vmx	319	41	changes	change	NNS
cord-273505-pcsw3vmx	319	42	in	in	IN
cord-273505-pcsw3vmx	319	43	patients	patient	NNS
cord-273505-pcsw3vmx	319	44	with	with	IN
cord-273505-pcsw3vmx	319	45	viral	viral	JJ
cord-273505-pcsw3vmx	319	46	pneumonia	pneumonia	NN
cord-273505-pcsw3vmx	319	47	Diagnosis	diagnosis	NN
cord-273505-pcsw3vmx	319	48	and	and	CC
cord-273505-pcsw3vmx	319	49	clinical	clinical	JJ
cord-273505-pcsw3vmx	319	50	management	management	NN
cord-273505-pcsw3vmx	319	51	of	of	IN
cord-273505-pcsw3vmx	319	52	severe	severe	JJ
cord-273505-pcsw3vmx	319	53	acute	acute	JJ
cord-273505-pcsw3vmx	319	54	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	319	55	syndrome	syndrome	NN
cord-273505-pcsw3vmx	319	56	Coronavirus	Coronavirus	NNP
cord-273505-pcsw3vmx	319	57	2	2	CD
cord-273505-pcsw3vmx	320	1	(	(	-LRB-
cord-273505-pcsw3vmx	320	2	SARS	SARS	NNP
cord-273505-pcsw3vmx	320	3	-	-	HYPH
cord-273505-pcsw3vmx	320	4	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	320	5	)	)	-RRB-
cord-273505-pcsw3vmx	320	6	infection	infection	NN
cord-273505-pcsw3vmx	320	7	:	:	:
cord-273505-pcsw3vmx	321	1	an	an	DT
cord-273505-pcsw3vmx	321	2	operational	operational	JJ
cord-273505-pcsw3vmx	321	3	recommendation	recommendation	NN
cord-273505-pcsw3vmx	321	4	of	of	IN
cord-273505-pcsw3vmx	321	5	Peking	Peking	NNP
cord-273505-pcsw3vmx	321	6	Union	Union	NNP
cord-273505-pcsw3vmx	321	7	Medical	Medical	NNP
cord-273505-pcsw3vmx	321	8	College	College	NNP
cord-273505-pcsw3vmx	321	9	Hospital	Hospital	NNP
cord-273505-pcsw3vmx	321	10	Is	be	VBZ
cord-273505-pcsw3vmx	321	11	dosing	dosing	NN
cord-273505-pcsw3vmx	321	12	of	of	IN
cord-273505-pcsw3vmx	321	13	therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	321	14	immunoglobulins	immunoglobulin	NNS
cord-273505-pcsw3vmx	321	15	optimal	optimal	JJ
cord-273505-pcsw3vmx	321	16	?	?	.
cord-273505-pcsw3vmx	322	1	A	a	DT
cord-273505-pcsw3vmx	322	2	review	review	NN
cord-273505-pcsw3vmx	322	3	of	of	IN
cord-273505-pcsw3vmx	322	4	a	a	DT
cord-273505-pcsw3vmx	322	5	three	three	CD
cord-273505-pcsw3vmx	322	6	-	-	HYPH
cord-273505-pcsw3vmx	322	7	decade	decade	NN
cord-273505-pcsw3vmx	322	8	long	long	JJ
cord-273505-pcsw3vmx	322	9	debate	debate	NN
cord-273505-pcsw3vmx	322	10	in	in	IN
cord-273505-pcsw3vmx	322	11	europe	europe	NNP
cord-273505-pcsw3vmx	322	12	Evidence	evidence	NN
cord-273505-pcsw3vmx	322	13	for	for	IN
cord-273505-pcsw3vmx	322	14	the	the	DT
cord-273505-pcsw3vmx	322	15	use	use	NN
cord-273505-pcsw3vmx	322	16	of	of	IN
cord-273505-pcsw3vmx	322	17	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	322	18	immunoglobulins	immunoglobulin	NNS
cord-273505-pcsw3vmx	322	19	-	-	:
cord-273505-pcsw3vmx	322	20	a	a	DT
cord-273505-pcsw3vmx	322	21	review	review	NN
cord-273505-pcsw3vmx	322	22	of	of	IN
cord-273505-pcsw3vmx	322	23	the	the	DT
cord-273505-pcsw3vmx	322	24	literature	literature	NN
cord-273505-pcsw3vmx	322	25	Identification	identification	NN
cord-273505-pcsw3vmx	322	26	of	of	IN
cord-273505-pcsw3vmx	322	27	the	the	DT
cord-273505-pcsw3vmx	322	28	Streptococcus	Streptococcus	NNP
cord-273505-pcsw3vmx	322	29	pyogenes	pyogene	NNS
cord-273505-pcsw3vmx	322	30	surface	surface	NN
cord-273505-pcsw3vmx	322	31	antigens	antigen	NNS
cord-273505-pcsw3vmx	322	32	skin	skin	NN
cord-273505-pcsw3vmx	322	33	blistering	blister	VBG
cord-273505-pcsw3vmx	322	34	diseases	disease	NNS
cord-273505-pcsw3vmx	322	35	Influence	influence	NN
cord-273505-pcsw3vmx	322	36	of	of	IN
cord-273505-pcsw3vmx	322	37	FCRN	FCRN	NNP
cord-273505-pcsw3vmx	322	38	expression	expression	NN
cord-273505-pcsw3vmx	322	39	on	on	IN
cord-273505-pcsw3vmx	322	40	lung	lung	NN
cord-273505-pcsw3vmx	322	41	decline	decline	NN
cord-273505-pcsw3vmx	322	42	and	and	CC
cord-273505-pcsw3vmx	322	43	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	322	44	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	322	45	catabolism	catabolism	NN
cord-273505-pcsw3vmx	322	46	in	in	IN
cord-273505-pcsw3vmx	322	47	common	common	JJ
cord-273505-pcsw3vmx	322	48	variable	variable	JJ
cord-273505-pcsw3vmx	322	49	immunodeficiency	immunodeficiency	NN
cord-273505-pcsw3vmx	322	50	patients	patient	NNS
cord-273505-pcsw3vmx	322	51	Efficiency	Efficiency	NNP
cord-273505-pcsw3vmx	322	52	of	of	IN
cord-273505-pcsw3vmx	322	53	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	322	54	G	g	NN
cord-273505-pcsw3vmx	322	55	replacement	replacement	NN
cord-273505-pcsw3vmx	322	56	therapy	therapy	NN
cord-273505-pcsw3vmx	322	57	in	in	IN
cord-273505-pcsw3vmx	322	58	common	common	JJ
cord-273505-pcsw3vmx	322	59	variable	variable	JJ
cord-273505-pcsw3vmx	322	60	immunodeficiency	immunodeficiency	NN
cord-273505-pcsw3vmx	322	61	:	:	:
cord-273505-pcsw3vmx	322	62	correlations	correlation	NNS
cord-273505-pcsw3vmx	322	63	with	with	IN
cord-273505-pcsw3vmx	322	64	clinical	clinical	JJ
cord-273505-pcsw3vmx	322	65	phenotype	phenotype	NN
cord-273505-pcsw3vmx	322	66	and	and	CC
cord-273505-pcsw3vmx	322	67	polymorphism	polymorphism	NN
cord-273505-pcsw3vmx	322	68	of	of	IN
cord-273505-pcsw3vmx	322	69	the	the	DT
cord-273505-pcsw3vmx	322	70	neonatal	neonatal	JJ
cord-273505-pcsw3vmx	322	71	Fc	Fc	NNP
cord-273505-pcsw3vmx	322	72	receptor	receptor	NN
cord-273505-pcsw3vmx	322	73	Pharmacokinetic	Pharmacokinetic	NNP
cord-273505-pcsw3vmx	322	74	models	model	NNS
cord-273505-pcsw3vmx	322	75	for	for	IN
cord-273505-pcsw3vmx	322	76	FcRn	FcRn	NNP
cord-273505-pcsw3vmx	322	77	-	-	HYPH
cord-273505-pcsw3vmx	322	78	mediated	mediate	VBN
cord-273505-pcsw3vmx	322	79	IgG	igg	NN
cord-273505-pcsw3vmx	322	80	disposition	disposition	NN
cord-273505-pcsw3vmx	322	81	Augmented	augment	VBN
cord-273505-pcsw3vmx	322	82	humoral	humoral	JJ
cord-273505-pcsw3vmx	322	83	and	and	CC
cord-273505-pcsw3vmx	322	84	anaphylactic	anaphylactic	JJ
cord-273505-pcsw3vmx	322	85	responses	response	NNS
cord-273505-pcsw3vmx	322	86	in	in	IN
cord-273505-pcsw3vmx	322	87	Fc	Fc	NNP
cord-273505-pcsw3vmx	322	88	gamma	gamma	NN
cord-273505-pcsw3vmx	322	89	RII	rii	NN
cord-273505-pcsw3vmx	322	90	-	-	HYPH
cord-273505-pcsw3vmx	322	91	deficient	deficient	JJ
cord-273505-pcsw3vmx	322	92	mice	mouse	NNS
cord-273505-pcsw3vmx	323	1	Impaired	impaired	JJ
cord-273505-pcsw3vmx	323	2	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	323	3	Fcgamma	Fcgamma	NNP
cord-273505-pcsw3vmx	323	4	receptor	receptor	NN
cord-273505-pcsw3vmx	323	5	IIB	IIB	NNP
cord-273505-pcsw3vmx	323	6	expression	expression	NN
cord-273505-pcsw3vmx	323	7	on	on	IN
cord-273505-pcsw3vmx	323	8	B	b	NN
cord-273505-pcsw3vmx	323	9	cells	cell	NNS
cord-273505-pcsw3vmx	323	10	in	in	IN
cord-273505-pcsw3vmx	323	11	chronic	chronic	JJ
cord-273505-pcsw3vmx	323	12	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	323	13	demyelinating	demyelinating	NN
cord-273505-pcsw3vmx	323	14	polyneuropathy	polyneuropathy	NN
cord-273505-pcsw3vmx	323	15	Recapitulation	recapitulation	NN
cord-273505-pcsw3vmx	323	16	of	of	IN
cord-273505-pcsw3vmx	323	17	IVIG	IVIG	NNP
cord-273505-pcsw3vmx	323	18	anti	anti	JJ
cord-273505-pcsw3vmx	323	19	-	-	JJ
cord-273505-pcsw3vmx	323	20	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	323	21	activity	activity	NN
cord-273505-pcsw3vmx	323	22	with	with	IN
cord-273505-pcsw3vmx	323	23	a	a	DT
cord-273505-pcsw3vmx	323	24	recombinant	recombinant	JJ
cord-273505-pcsw3vmx	323	25	IgG	igg	NN
cord-273505-pcsw3vmx	323	26	Fc	Fc	NNP
cord-273505-pcsw3vmx	323	27	Identification	Identification	NNP
cord-273505-pcsw3vmx	323	28	of	of	IN
cord-273505-pcsw3vmx	323	29	a	a	DT
cord-273505-pcsw3vmx	323	30	receptor	receptor	NN
cord-273505-pcsw3vmx	323	31	required	require	VBN
cord-273505-pcsw3vmx	323	32	for	for	IN
cord-273505-pcsw3vmx	323	33	the	the	DT
cord-273505-pcsw3vmx	323	34	anti	anti	JJ
cord-273505-pcsw3vmx	323	35	-	-	JJ
cord-273505-pcsw3vmx	323	36	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	323	37	activity	activity	NN
cord-273505-pcsw3vmx	323	38	of	of	IN
cord-273505-pcsw3vmx	323	39	IVIG	IVIG	NNP
cord-273505-pcsw3vmx	323	40	Intravenous	Intravenous	NNP
cord-273505-pcsw3vmx	323	41	gammaglobulin	gammaglobulin	NN
cord-273505-pcsw3vmx	323	42	suppresses	suppress	VBZ
cord-273505-pcsw3vmx	323	43	inflammation	inflammation	NN
cord-273505-pcsw3vmx	323	44	through	through	IN
cord-273505-pcsw3vmx	323	45	a	a	DT
cord-273505-pcsw3vmx	323	46	novel	novel	JJ
cord-273505-pcsw3vmx	323	47	T(H)2	t(h)2	NN
cord-273505-pcsw3vmx	323	48	pathway	pathway	NN
cord-273505-pcsw3vmx	323	49	Intravenous	Intravenous	NNP
cord-273505-pcsw3vmx	323	50	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	323	51	therapy	therapy	NN
cord-273505-pcsw3vmx	323	52	:	:	:
cord-273505-pcsw3vmx	323	53	how	how	WRB
cord-273505-pcsw3vmx	323	54	does	do	VBZ
cord-273505-pcsw3vmx	323	55	IgG	IgG	NNP
cord-273505-pcsw3vmx	323	56	modulate	modulate	VB
cord-273505-pcsw3vmx	323	57	the	the	DT
cord-273505-pcsw3vmx	323	58	immune	immune	JJ
cord-273505-pcsw3vmx	323	59	system	system	NN
cord-273505-pcsw3vmx	323	60	?	?	.
cord-273505-pcsw3vmx	324	1	Dissecting	dissect	VBG
cord-273505-pcsw3vmx	324	2	the	the	DT
cord-273505-pcsw3vmx	324	3	molecular	molecular	JJ
cord-273505-pcsw3vmx	324	4	mechanism	mechanism	NN
cord-273505-pcsw3vmx	324	5	of	of	IN
cord-273505-pcsw3vmx	324	6	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	324	7	therapy	therapy	NN
cord-273505-pcsw3vmx	324	8	:	:	:
cord-273505-pcsw3vmx	324	9	the	the	DT
cord-273505-pcsw3vmx	324	10	interaction	interaction	NN
cord-273505-pcsw3vmx	324	11	between	between	IN
cord-273505-pcsw3vmx	324	12	serum	serum	NN
cord-273505-pcsw3vmx	324	13	IgG	IgG	NNP
cord-273505-pcsw3vmx	324	14	and	and	CC
cord-273505-pcsw3vmx	324	15	DC	DC	NNP
cord-273505-pcsw3vmx	324	16	-	-	HYPH
cord-273505-pcsw3vmx	324	17	SIGN	SIGN	NNP
cord-273505-pcsw3vmx	324	18	is	be	VBZ
cord-273505-pcsw3vmx	324	19	independent	independent	JJ
cord-273505-pcsw3vmx	324	20	of	of	IN
cord-273505-pcsw3vmx	324	21	antibody	antibody	NN
cord-273505-pcsw3vmx	324	22	glycoform	glycoform	NNP
cord-273505-pcsw3vmx	324	23	or	or	CC
cord-273505-pcsw3vmx	324	24	Fc	Fc	NNP
cord-273505-pcsw3vmx	324	25	domain	domain	NN
cord-273505-pcsw3vmx	324	26	Human	Human	NNP
cord-273505-pcsw3vmx	324	27	DC	DC	NNP
cord-273505-pcsw3vmx	324	28	-	-	HYPH
cord-273505-pcsw3vmx	324	29	SIGN	sign	NN
cord-273505-pcsw3vmx	325	1	and	and	CC
cord-273505-pcsw3vmx	325	2	CD23	CD23	NNP
cord-273505-pcsw3vmx	325	3	do	do	VBP
cord-273505-pcsw3vmx	325	4	not	not	RB
cord-273505-pcsw3vmx	325	5	interact	interact	VB
cord-273505-pcsw3vmx	325	6	with	with	IN
cord-273505-pcsw3vmx	325	7	human	human	JJ
cord-273505-pcsw3vmx	325	8	DC	DC	NNP
cord-273505-pcsw3vmx	325	9	-	-	HYPH
cord-273505-pcsw3vmx	325	10	SIGN	SIGN	NNP
cord-273505-pcsw3vmx	325	11	and	and	CC
cord-273505-pcsw3vmx	325	12	alpha2,6-sialylated	alpha2,6-sialylated	JJ
cord-273505-pcsw3vmx	325	13	IgG	igg	NN
cord-273505-pcsw3vmx	325	14	Fc	Fc	NNP
cord-273505-pcsw3vmx	325	15	interaction	interaction	NN
cord-273505-pcsw3vmx	326	1	is	be	VBZ
cord-273505-pcsw3vmx	326	2	dispensable	dispensable	JJ
cord-273505-pcsw3vmx	326	3	for	for	IN
cord-273505-pcsw3vmx	326	4	the	the	DT
cord-273505-pcsw3vmx	326	5	anti	anti	JJ
cord-273505-pcsw3vmx	326	6	-	-	JJ
cord-273505-pcsw3vmx	326	7	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	326	8	activity	activity	NN
cord-273505-pcsw3vmx	326	9	of	of	IN
cord-273505-pcsw3vmx	326	10	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	326	11	on	on	IN
cord-273505-pcsw3vmx	326	12	human	human	JJ
cord-273505-pcsw3vmx	326	13	dendritic	dendritic	JJ
cord-273505-pcsw3vmx	326	14	cells	cell	NNS
cord-273505-pcsw3vmx	326	15	Analysis	Analysis	NNP
cord-273505-pcsw3vmx	326	16	and	and	CC
cord-273505-pcsw3vmx	326	17	functional	functional	JJ
cord-273505-pcsw3vmx	326	18	consequences	consequence	NNS
cord-273505-pcsw3vmx	326	19	of	of	IN
cord-273505-pcsw3vmx	326	20	increased	increase	VBN
cord-273505-pcsw3vmx	326	21	Fab	fab	JJ
cord-273505-pcsw3vmx	326	22	-	-	HYPH
cord-273505-pcsw3vmx	326	23	sialylation	sialylation	NN
cord-273505-pcsw3vmx	326	24	of	of	IN
cord-273505-pcsw3vmx	326	25	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	326	26	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	326	27	(	(	-LRB-
cord-273505-pcsw3vmx	326	28	IVIG	IVIG	NNP
cord-273505-pcsw3vmx	326	29	)	)	-RRB-
cord-273505-pcsw3vmx	326	30	after	after	IN
cord-273505-pcsw3vmx	326	31	lectin	lectin	NN
cord-273505-pcsw3vmx	326	32	fractionation	fractionation	NN
cord-273505-pcsw3vmx	326	33	Therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	326	34	effect	effect	NN
cord-273505-pcsw3vmx	326	35	of	of	IN
cord-273505-pcsw3vmx	326	36	IVIG	IVIG	NNP
cord-273505-pcsw3vmx	326	37	on	on	IN
cord-273505-pcsw3vmx	326	38	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	326	39	arthritis	arthritis	NN
cord-273505-pcsw3vmx	326	40	in	in	IN
cord-273505-pcsw3vmx	326	41	mice	mice	NN
cord-273505-pcsw3vmx	326	42	is	be	VBZ
cord-273505-pcsw3vmx	326	43	dependent	dependent	JJ
cord-273505-pcsw3vmx	326	44	on	on	IN
cord-273505-pcsw3vmx	326	45	the	the	DT
cord-273505-pcsw3vmx	326	46	Fc	Fc	NNP
cord-273505-pcsw3vmx	326	47	portion	portion	NN
cord-273505-pcsw3vmx	326	48	and	and	CC
cord-273505-pcsw3vmx	326	49	independent	independent	JJ
cord-273505-pcsw3vmx	326	50	of	of	IN
cord-273505-pcsw3vmx	326	51	sialylation	sialylation	NN
cord-273505-pcsw3vmx	326	52	or	or	CC
cord-273505-pcsw3vmx	327	1	basophils	basophils	NNP
cord-273505-pcsw3vmx	327	2	Inhibition	Inhibition	NNP
cord-273505-pcsw3vmx	327	3	of	of	IN
cord-273505-pcsw3vmx	327	4	FcgammaR	FcgammaR	NNP
cord-273505-pcsw3vmx	327	5	-	-	HYPH
cord-273505-pcsw3vmx	327	6	mediated	mediate	VBN
cord-273505-pcsw3vmx	327	7	phagocytosis	phagocytosis	NN
cord-273505-pcsw3vmx	327	8	by	by	IN
cord-273505-pcsw3vmx	327	9	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	327	10	is	be	VBZ
cord-273505-pcsw3vmx	327	11	independent	independent	JJ
cord-273505-pcsw3vmx	327	12	of	of	IN
cord-273505-pcsw3vmx	327	13	IgG	IgG	NNP
cord-273505-pcsw3vmx	327	14	-	-	HYPH
cord-273505-pcsw3vmx	327	15	Fc	Fc	NNP
cord-273505-pcsw3vmx	327	16	sialylation	sialylation	NN
cord-273505-pcsw3vmx	327	17	and	and	CC
cord-273505-pcsw3vmx	328	1	FcgammaRIIb	fcgammariib	RB
cord-273505-pcsw3vmx	328	2	in	in	IN
cord-273505-pcsw3vmx	328	3	human	human	JJ
cord-273505-pcsw3vmx	328	4	macrophages	macrophage	NNS
cord-273505-pcsw3vmx	328	5	Sialylation	sialylation	NN
cord-273505-pcsw3vmx	328	6	-	-	HYPH
cord-273505-pcsw3vmx	328	7	independent	independent	JJ
cord-273505-pcsw3vmx	328	8	mechanism	mechanism	NN
cord-273505-pcsw3vmx	328	9	involved	involve	VBN
cord-273505-pcsw3vmx	328	10	in	in	IN
cord-273505-pcsw3vmx	328	11	the	the	DT
cord-273505-pcsw3vmx	328	12	amelioration	amelioration	NN
cord-273505-pcsw3vmx	328	13	of	of	IN
cord-273505-pcsw3vmx	328	14	murine	murine	JJ
cord-273505-pcsw3vmx	328	15	immune	immune	JJ
cord-273505-pcsw3vmx	328	16	thrombocytopenia	thrombocytopenia	NN
cord-273505-pcsw3vmx	328	17	using	use	VBG
cord-273505-pcsw3vmx	328	18	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	328	19	gammaglobulin	gammaglobulin	NNP
cord-273505-pcsw3vmx	328	20	High	high	JJ
cord-273505-pcsw3vmx	328	21	-	-	HYPH
cord-273505-pcsw3vmx	328	22	dose	dose	NN
cord-273505-pcsw3vmx	328	23	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	328	24	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	328	25	exerts	exert	VBZ
cord-273505-pcsw3vmx	328	26	its	-PRON-	PRP$
cord-273505-pcsw3vmx	328	27	beneficial	beneficial	JJ
cord-273505-pcsw3vmx	328	28	effect	effect	NN
cord-273505-pcsw3vmx	328	29	in	in	IN
cord-273505-pcsw3vmx	328	30	patients	patient	NNS
cord-273505-pcsw3vmx	328	31	with	with	IN
cord-273505-pcsw3vmx	328	32	dermatomyositis	dermatomyositis	NN
cord-273505-pcsw3vmx	328	33	by	by	IN
cord-273505-pcsw3vmx	328	34	blocking	block	VBG
cord-273505-pcsw3vmx	328	35	endomysial	endomysial	JJ
cord-273505-pcsw3vmx	328	36	deposition	deposition	NN
cord-273505-pcsw3vmx	328	37	of	of	IN
cord-273505-pcsw3vmx	328	38	activated	activate	VBN
cord-273505-pcsw3vmx	328	39	complement	complement	NN
cord-273505-pcsw3vmx	328	40	fragments	fragment	NNS
cord-273505-pcsw3vmx	328	41	Intravenously	intravenously	RB
cord-273505-pcsw3vmx	328	42	applied	apply	VBD
cord-273505-pcsw3vmx	328	43	IgG	igg	NN
cord-273505-pcsw3vmx	328	44	stimulates	stimulate	VBZ
cord-273505-pcsw3vmx	328	45	complement	complement	JJ
cord-273505-pcsw3vmx	328	46	attenuation	attenuation	NN
cord-273505-pcsw3vmx	328	47	in	in	IN
cord-273505-pcsw3vmx	328	48	a	a	DT
cord-273505-pcsw3vmx	328	49	complement	complement	NN
cord-273505-pcsw3vmx	328	50	-	-	HYPH
cord-273505-pcsw3vmx	328	51	dependent	dependent	JJ
cord-273505-pcsw3vmx	328	52	autoimmune	autoimmune	JJ
cord-273505-pcsw3vmx	328	53	disease	disease	NN
cord-273505-pcsw3vmx	328	54	at	at	IN
cord-273505-pcsw3vmx	328	55	the	the	DT
cord-273505-pcsw3vmx	328	56	amplifying	amplify	VBG
cord-273505-pcsw3vmx	328	57	C3	c3	NN
cord-273505-pcsw3vmx	328	58	convertase	convertase	NN
cord-273505-pcsw3vmx	328	59	level	level	NN
cord-273505-pcsw3vmx	328	60	Intravenous	Intravenous	NNP
cord-273505-pcsw3vmx	328	61	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	328	62	(	(	-LRB-
cord-273505-pcsw3vmx	328	63	IVIG	IVIG	NNP
cord-273505-pcsw3vmx	328	64	)	)	-RRB-
cord-273505-pcsw3vmx	328	65	protects	protect	VBZ
cord-273505-pcsw3vmx	328	66	the	the	DT
cord-273505-pcsw3vmx	328	67	brain	brain	NN
cord-273505-pcsw3vmx	328	68	against	against	IN
cord-273505-pcsw3vmx	328	69	experimental	experimental	JJ
cord-273505-pcsw3vmx	328	70	stroke	stroke	NN
cord-273505-pcsw3vmx	328	71	by	by	IN
cord-273505-pcsw3vmx	328	72	preventing	prevent	VBG
cord-273505-pcsw3vmx	328	73	complement	complement	NN
cord-273505-pcsw3vmx	328	74	-	-	HYPH
cord-273505-pcsw3vmx	328	75	mediated	mediate	VBN
cord-273505-pcsw3vmx	328	76	neuronal	neuronal	JJ
cord-273505-pcsw3vmx	328	77	cell	cell	NN
cord-273505-pcsw3vmx	328	78	death	death	NN
cord-273505-pcsw3vmx	328	79	Immunoglobulin	Immunoglobulin	NNP
cord-273505-pcsw3vmx	328	80	in	in	IN
cord-273505-pcsw3vmx	328	81	the	the	DT
cord-273505-pcsw3vmx	328	82	control	control	NN
cord-273505-pcsw3vmx	328	83	of	of	IN
cord-273505-pcsw3vmx	328	84	complement	complement	JJ
cord-273505-pcsw3vmx	328	85	action	action	NN
cord-273505-pcsw3vmx	329	1	The	the	DT
cord-273505-pcsw3vmx	329	2	binding	binding	NN
cord-273505-pcsw3vmx	329	3	site	site	NN
cord-273505-pcsw3vmx	329	4	for	for	IN
cord-273505-pcsw3vmx	329	5	C1q	C1q	NNP
cord-273505-pcsw3vmx	329	6	on	on	IN
cord-273505-pcsw3vmx	329	7	IgG	IgG	NNP
cord-273505-pcsw3vmx	329	8	Fc	Fc	NNP
cord-273505-pcsw3vmx	329	9	-	-	HYPH
cord-273505-pcsw3vmx	329	10	Galactosylation	Galactosylation	NNP
cord-273505-pcsw3vmx	329	11	of	of	IN
cord-273505-pcsw3vmx	329	12	human	human	JJ
cord-273505-pcsw3vmx	329	13	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	329	14	gamma	gamma	NNP
cord-273505-pcsw3vmx	329	15	isotypes	isotypes	NNP
cord-273505-pcsw3vmx	329	16	improves	improve	VBZ
cord-273505-pcsw3vmx	329	17	C1q	C1q	NNP
cord-273505-pcsw3vmx	329	18	binding	binding	NN
cord-273505-pcsw3vmx	329	19	and	and	CC
cord-273505-pcsw3vmx	329	20	enhances	enhance	VBZ
cord-273505-pcsw3vmx	329	21	complement	complement	NN
cord-273505-pcsw3vmx	329	22	-	-	HYPH
cord-273505-pcsw3vmx	329	23	dependent	dependent	JJ
cord-273505-pcsw3vmx	329	24	cytotoxicity	cytotoxicity	NN
cord-273505-pcsw3vmx	329	25	Endothelial	endothelial	JJ
cord-273505-pcsw3vmx	329	26	cell	cell	NN
cord-273505-pcsw3vmx	329	27	infection	infection	NN
cord-273505-pcsw3vmx	329	28	and	and	CC
cord-273505-pcsw3vmx	329	29	endotheliitis	endotheliitis	NN
cord-273505-pcsw3vmx	329	30	in	in	IN
cord-273505-pcsw3vmx	329	31	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	329	32	Complement	Complement	NNP
cord-273505-pcsw3vmx	329	33	associated	associate	VBD
cord-273505-pcsw3vmx	329	34	microvascular	microvascular	JJ
cord-273505-pcsw3vmx	329	35	injury	injury	NN
cord-273505-pcsw3vmx	329	36	and	and	CC
cord-273505-pcsw3vmx	329	37	thrombosis	thrombosis	NN
cord-273505-pcsw3vmx	329	38	in	in	IN
cord-273505-pcsw3vmx	329	39	the	the	DT
cord-273505-pcsw3vmx	329	40	pathogenesis	pathogenesis	NN
cord-273505-pcsw3vmx	329	41	of	of	IN
cord-273505-pcsw3vmx	329	42	severe	severe	JJ
cord-273505-pcsw3vmx	329	43	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	329	44	infection	infection	NN
cord-273505-pcsw3vmx	329	45	:	:	:
cord-273505-pcsw3vmx	329	46	a	a	DT
cord-273505-pcsw3vmx	329	47	report	report	NN
cord-273505-pcsw3vmx	329	48	of	of	IN
cord-273505-pcsw3vmx	329	49	five	five	CD
cord-273505-pcsw3vmx	329	50	cases	case	NNS
cord-273505-pcsw3vmx	330	1	The	the	DT
cord-273505-pcsw3vmx	330	2	clinical	clinical	JJ
cord-273505-pcsw3vmx	330	3	pathology	pathology	NN
cord-273505-pcsw3vmx	330	4	of	of	IN
cord-273505-pcsw3vmx	330	5	severe	severe	JJ
cord-273505-pcsw3vmx	330	6	acute	acute	JJ
cord-273505-pcsw3vmx	330	7	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	330	8	syndrome	syndrome	NN
cord-273505-pcsw3vmx	330	9	(	(	-LRB-
cord-273505-pcsw3vmx	330	10	SARS	SARS	NNP
cord-273505-pcsw3vmx	330	11	)	)	-RRB-
cord-273505-pcsw3vmx	330	12	:	:	:
cord-273505-pcsw3vmx	330	13	a	a	DT
cord-273505-pcsw3vmx	330	14	report	report	NN
cord-273505-pcsw3vmx	330	15	from	from	IN
cord-273505-pcsw3vmx	330	16	China	China	NNP
cord-273505-pcsw3vmx	330	17	Exploring	explore	VBG
cord-273505-pcsw3vmx	330	18	the	the	DT
cord-273505-pcsw3vmx	330	19	pathogenesis	pathogenesis	NN
cord-273505-pcsw3vmx	330	20	of	of	IN
cord-273505-pcsw3vmx	330	21	severe	severe	JJ
cord-273505-pcsw3vmx	330	22	acute	acute	JJ
cord-273505-pcsw3vmx	330	23	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	330	24	syndrome	syndrome	NN
cord-273505-pcsw3vmx	330	25	(	(	-LRB-
cord-273505-pcsw3vmx	330	26	SARS	SARS	NNP
cord-273505-pcsw3vmx	330	27	)	)	-RRB-
cord-273505-pcsw3vmx	330	28	:	:	:
cord-273505-pcsw3vmx	330	29	the	the	DT
cord-273505-pcsw3vmx	330	30	tissue	tissue	NN
cord-273505-pcsw3vmx	330	31	distribution	distribution	NN
cord-273505-pcsw3vmx	330	32	of	of	IN
cord-273505-pcsw3vmx	330	33	the	the	DT
cord-273505-pcsw3vmx	330	34	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	330	35	(	(	-LRB-
cord-273505-pcsw3vmx	330	36	SARS	SARS	NNP
cord-273505-pcsw3vmx	330	37	-	-	HYPH
cord-273505-pcsw3vmx	330	38	CoV	CoV	NNP
cord-273505-pcsw3vmx	330	39	)	)	-RRB-
cord-273505-pcsw3vmx	330	40	and	and	CC
cord-273505-pcsw3vmx	330	41	its	-PRON-	PRP$
cord-273505-pcsw3vmx	330	42	putative	putative	JJ
cord-273505-pcsw3vmx	330	43	receptor	receptor	NN
cord-273505-pcsw3vmx	330	44	,	,	,
cord-273505-pcsw3vmx	330	45	angiotensin	angiotensin	NN
cord-273505-pcsw3vmx	330	46	-	-	HYPH
cord-273505-pcsw3vmx	330	47	converting	convert	VBG
cord-273505-pcsw3vmx	330	48	enzyme	enzyme	NN
cord-273505-pcsw3vmx	330	49	2	2	CD
cord-273505-pcsw3vmx	331	1	(	(	-LRB-
cord-273505-pcsw3vmx	331	2	ACE2	ACE2	NNP
cord-273505-pcsw3vmx	331	3	)	)	-RRB-
cord-273505-pcsw3vmx	331	4	Autoantibodies	Autoantibodies	NNP
cord-273505-pcsw3vmx	331	5	against	against	IN
cord-273505-pcsw3vmx	331	6	human	human	JJ
cord-273505-pcsw3vmx	331	7	epithelial	epithelial	JJ
cord-273505-pcsw3vmx	331	8	cells	cell	NNS
cord-273505-pcsw3vmx	331	9	and	and	CC
cord-273505-pcsw3vmx	331	10	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	331	11	cells	cell	NNS
cord-273505-pcsw3vmx	331	12	after	after	IN
cord-273505-pcsw3vmx	331	13	severe	severe	JJ
cord-273505-pcsw3vmx	331	14	acute	acute	JJ
cord-273505-pcsw3vmx	331	15	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	331	16	syndrome	syndrome	NN
cord-273505-pcsw3vmx	331	17	(	(	-LRB-
cord-273505-pcsw3vmx	331	18	SARS)-associated	sars)-associated	CD
cord-273505-pcsw3vmx	331	19	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	331	20	infection	infection	NN
cord-273505-pcsw3vmx	331	21	Endothelial	endothelial	JJ
cord-273505-pcsw3vmx	331	22	cells	cell	NNS
cord-273505-pcsw3vmx	331	23	are	be	VBP
cord-273505-pcsw3vmx	331	24	central	central	JJ
cord-273505-pcsw3vmx	331	25	orchestrators	orchestrator	NNS
cord-273505-pcsw3vmx	331	26	of	of	IN
cord-273505-pcsw3vmx	331	27	cytokine	cytokine	NN
cord-273505-pcsw3vmx	331	28	amplification	amplification	NN
cord-273505-pcsw3vmx	331	29	during	during	IN
cord-273505-pcsw3vmx	331	30	influenza	influenza	NN
cord-273505-pcsw3vmx	331	31	virus	virus	NN
cord-273505-pcsw3vmx	331	32	infection	infection	NN
cord-273505-pcsw3vmx	331	33	Influenza	Influenza	NNP
cord-273505-pcsw3vmx	331	34	viruscytokine	viruscytokine	NN
cord-273505-pcsw3vmx	331	35	-	-	HYPH
cord-273505-pcsw3vmx	331	36	protease	protease	NN
cord-273505-pcsw3vmx	331	37	cycle	cycle	NN
cord-273505-pcsw3vmx	331	38	in	in	IN
cord-273505-pcsw3vmx	331	39	the	the	DT
cord-273505-pcsw3vmx	331	40	pathogenesis	pathogenesis	NN
cord-273505-pcsw3vmx	331	41	of	of	IN
cord-273505-pcsw3vmx	331	42	vascular	vascular	JJ
cord-273505-pcsw3vmx	331	43	hyperpermeability	hyperpermeability	NN
cord-273505-pcsw3vmx	331	44	in	in	IN
cord-273505-pcsw3vmx	331	45	severe	severe	JJ
cord-273505-pcsw3vmx	331	46	influenza	influenza	NN
cord-273505-pcsw3vmx	331	47	Influenza	Influenza	NNP
cord-273505-pcsw3vmx	331	48	virus	virus	NN
cord-273505-pcsw3vmx	331	49	and	and	CC
cord-273505-pcsw3vmx	331	50	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	331	51	cells	cell	NNS
cord-273505-pcsw3vmx	331	52	:	:	:
cord-273505-pcsw3vmx	331	53	a	a	DT
cord-273505-pcsw3vmx	331	54	species	species	NN
cord-273505-pcsw3vmx	331	55	specific	specific	JJ
cord-273505-pcsw3vmx	331	56	relationship	relationship	NN
cord-273505-pcsw3vmx	331	57	Anti	anti	JJ
cord-273505-pcsw3vmx	331	58	-	-	JJ
cord-273505-pcsw3vmx	331	59	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	331	60	effects	effect	NNS
cord-273505-pcsw3vmx	331	61	of	of	IN
cord-273505-pcsw3vmx	331	62	high	high	JJ
cord-273505-pcsw3vmx	331	63	-	-	HYPH
cord-273505-pcsw3vmx	331	64	dose	dose	NN
cord-273505-pcsw3vmx	331	65	IgG	igg	NN
cord-273505-pcsw3vmx	331	66	on	on	IN
cord-273505-pcsw3vmx	331	67	TNF	TNF	NNP
cord-273505-pcsw3vmx	331	68	-	-	HYPH
cord-273505-pcsw3vmx	331	69	alpha	alpha	NN
cord-273505-pcsw3vmx	331	70	-	-	HYPH
cord-273505-pcsw3vmx	331	71	activated	activate	VBN
cord-273505-pcsw3vmx	331	72	human	human	JJ
cord-273505-pcsw3vmx	331	73	coronary	coronary	JJ
cord-273505-pcsw3vmx	331	74	artery	artery	NN
cord-273505-pcsw3vmx	331	75	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	331	76	cells	cell	NNS
cord-273505-pcsw3vmx	332	1	Anti	anti	JJ
cord-273505-pcsw3vmx	332	2	-	-	JJ
cord-273505-pcsw3vmx	332	3	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	332	4	effect	effect	NN
cord-273505-pcsw3vmx	332	5	of	of	IN
cord-273505-pcsw3vmx	332	6	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	332	7	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	332	8	in	in	IN
cord-273505-pcsw3vmx	332	9	comparison	comparison	NN
cord-273505-pcsw3vmx	332	10	with	with	IN
cord-273505-pcsw3vmx	332	11	dexamethasone	dexamethasone	NN
cord-273505-pcsw3vmx	332	12	in	in	IN
cord-273505-pcsw3vmx	332	13	vitro	vitro	FW
cord-273505-pcsw3vmx	332	14	:	:	:
cord-273505-pcsw3vmx	332	15	implication	implication	NN
cord-273505-pcsw3vmx	332	16	for	for	IN
cord-273505-pcsw3vmx	332	17	treatment	treatment	NN
cord-273505-pcsw3vmx	332	18	of	of	IN
cord-273505-pcsw3vmx	332	19	Kawasaki	Kawasaki	NNP
cord-273505-pcsw3vmx	332	20	disease	disease	NN
cord-273505-pcsw3vmx	332	21	Effect	Effect	NNP
cord-273505-pcsw3vmx	332	22	of	of	IN
cord-273505-pcsw3vmx	332	23	maternal	maternal	JJ
cord-273505-pcsw3vmx	332	24	anti	anti	NNP
cord-273505-pcsw3vmx	332	25	-	-	NNP
cord-273505-pcsw3vmx	332	26	HPA-1a	HPA-1a	NNP
cord-273505-pcsw3vmx	332	27	antibodies	antibody	NNS
cord-273505-pcsw3vmx	332	28	and	and	CC
cord-273505-pcsw3vmx	332	29	polyclonal	polyclonal	JJ
cord-273505-pcsw3vmx	332	30	IVIG	ivig	NN
cord-273505-pcsw3vmx	332	31	on	on	IN
cord-273505-pcsw3vmx	332	32	the	the	DT
cord-273505-pcsw3vmx	332	33	activation	activation	NN
cord-273505-pcsw3vmx	332	34	status	status	NN
cord-273505-pcsw3vmx	332	35	of	of	IN
cord-273505-pcsw3vmx	332	36	vascular	vascular	JJ
cord-273505-pcsw3vmx	332	37	endothelial	endothelial	JJ
cord-273505-pcsw3vmx	332	38	cells	cell	NNS
cord-273505-pcsw3vmx	333	1	IRF-7	IRF-7	NNP
cord-273505-pcsw3vmx	333	2	is	be	VBZ
cord-273505-pcsw3vmx	333	3	the	the	DT
cord-273505-pcsw3vmx	333	4	master	master	NN
cord-273505-pcsw3vmx	333	5	regulator	regulator	NN
cord-273505-pcsw3vmx	333	6	of	of	IN
cord-273505-pcsw3vmx	333	7	type-	type-	NNP
cord-273505-pcsw3vmx	334	1	I	-PRON-	PRP
cord-273505-pcsw3vmx	334	2	interferon	interferon	NN
cord-273505-pcsw3vmx	334	3	-	-	HYPH
cord-273505-pcsw3vmx	334	4	dependent	dependent	JJ
cord-273505-pcsw3vmx	334	5	immune	immune	JJ
cord-273505-pcsw3vmx	334	6	responses	response	NNS
cord-273505-pcsw3vmx	335	1	Spatiotemporal	spatiotemporal	JJ
cord-273505-pcsw3vmx	335	2	regulation	regulation	NN
cord-273505-pcsw3vmx	335	3	of	of	IN
cord-273505-pcsw3vmx	335	4	MyD88-IRF-7	MyD88-IRF-7	NNS
cord-273505-pcsw3vmx	335	5	signalling	signal	VBG
cord-273505-pcsw3vmx	335	6	for	for	IN
cord-273505-pcsw3vmx	335	7	robust	robust	JJ
cord-273505-pcsw3vmx	335	8	type	type	NN
cord-273505-pcsw3vmx	335	9	-	-	:
cord-273505-pcsw3vmx	335	10	I	i	NN
cord-273505-pcsw3vmx	336	1	interferon	interferon	NNP
cord-273505-pcsw3vmx	336	2	induction	induction	NN
cord-273505-pcsw3vmx	336	3	Imbalanced	imbalanced	JJ
cord-273505-pcsw3vmx	336	4	host	host	NN
cord-273505-pcsw3vmx	336	5	response	response	NN
cord-273505-pcsw3vmx	336	6	to	to	IN
cord-273505-pcsw3vmx	336	7	SARS	SARS	NNP
cord-273505-pcsw3vmx	336	8	-	-	HYPH
cord-273505-pcsw3vmx	336	9	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	336	10	drives	drive	VBZ
cord-273505-pcsw3vmx	336	11	development	development	NN
cord-273505-pcsw3vmx	336	12	of	of	IN
cord-273505-pcsw3vmx	336	13	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	336	14	Severe	severe	JJ
cord-273505-pcsw3vmx	336	15	acute	acute	JJ
cord-273505-pcsw3vmx	336	16	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	336	17	syndrome	syndrome	NN
cord-273505-pcsw3vmx	336	18	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	336	19	ORF6	ORF6	NNP
cord-273505-pcsw3vmx	337	1	antagonizes	antagonize	VBZ
cord-273505-pcsw3vmx	337	2	STAT1	stat1	NN
cord-273505-pcsw3vmx	337	3	function	function	NN
cord-273505-pcsw3vmx	337	4	by	by	IN
cord-273505-pcsw3vmx	337	5	sequestering	sequester	VBG
cord-273505-pcsw3vmx	337	6	nuclear	nuclear	JJ
cord-273505-pcsw3vmx	337	7	import	import	NN
cord-273505-pcsw3vmx	337	8	factors	factor	NNS
cord-273505-pcsw3vmx	337	9	on	on	IN
cord-273505-pcsw3vmx	337	10	the	the	DT
cord-273505-pcsw3vmx	337	11	rough	rough	JJ
cord-273505-pcsw3vmx	337	12	endoplasmic	endoplasmic	NN
cord-273505-pcsw3vmx	337	13	reticulum/	reticulum/	NN
cord-273505-pcsw3vmx	338	1	Golgi	Golgi	NNP
cord-273505-pcsw3vmx	338	2	membrane	membrane	NN
cord-273505-pcsw3vmx	338	3	Severe	severe	JJ
cord-273505-pcsw3vmx	338	4	acute	acute	JJ
cord-273505-pcsw3vmx	338	5	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	338	6	syndrome	syndrome	NN
cord-273505-pcsw3vmx	338	7	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	338	8	nsp1	nsp1	CD
cord-273505-pcsw3vmx	338	9	suppresses	suppress	VBZ
cord-273505-pcsw3vmx	338	10	host	host	NN
cord-273505-pcsw3vmx	338	11	gene	gene	NN
cord-273505-pcsw3vmx	338	12	expression	expression	NN
cord-273505-pcsw3vmx	338	13	,	,	,
cord-273505-pcsw3vmx	338	14	including	include	VBG
cord-273505-pcsw3vmx	338	15	that	that	DT
cord-273505-pcsw3vmx	338	16	of	of	IN
cord-273505-pcsw3vmx	338	17	type	type	NN
cord-273505-pcsw3vmx	339	1	I	-PRON-	PRP
cord-273505-pcsw3vmx	339	2	interferon	interferon	RB
cord-273505-pcsw3vmx	340	1	,	,	,
cord-273505-pcsw3vmx	340	2	in	in	IN
cord-273505-pcsw3vmx	340	3	infected	infected	JJ
cord-273505-pcsw3vmx	340	4	cells	cell	NNS
cord-273505-pcsw3vmx	340	5	Coronavirus	Coronavirus	NNP
cord-273505-pcsw3vmx	341	1	papain	papain	NN
cord-273505-pcsw3vmx	341	2	-	-	HYPH
cord-273505-pcsw3vmx	341	3	like	like	JJ
cord-273505-pcsw3vmx	341	4	proteases	protease	NNS
cord-273505-pcsw3vmx	341	5	negatively	negatively	RB
cord-273505-pcsw3vmx	341	6	regulate	regulate	VBP
cord-273505-pcsw3vmx	341	7	antiviral	antiviral	JJ
cord-273505-pcsw3vmx	341	8	innate	innate	JJ
cord-273505-pcsw3vmx	341	9	immune	immune	JJ
cord-273505-pcsw3vmx	341	10	response	response	NN
cord-273505-pcsw3vmx	341	11	through	through	IN
cord-273505-pcsw3vmx	341	12	disruption	disruption	NN
cord-273505-pcsw3vmx	341	13	of	of	IN
cord-273505-pcsw3vmx	341	14	STING	sting	NN
cord-273505-pcsw3vmx	341	15	-	-	HYPH
cord-273505-pcsw3vmx	341	16	mediated	mediate	VBN
cord-273505-pcsw3vmx	341	17	signaling	signal	VBG
cord-273505-pcsw3vmx	341	18	Severe	severe	JJ
cord-273505-pcsw3vmx	341	19	acute	acute	JJ
cord-273505-pcsw3vmx	341	20	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	341	21	syndrome	syndrome	NN
cord-273505-pcsw3vmx	341	22	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	341	23	open	open	JJ
cord-273505-pcsw3vmx	341	24	reading	reading	NN
cord-273505-pcsw3vmx	341	25	frame	frame	NN
cord-273505-pcsw3vmx	341	26	(	(	-LRB-
cord-273505-pcsw3vmx	341	27	ORF	ORF	NNP
cord-273505-pcsw3vmx	341	28	)	)	-RRB-
cord-273505-pcsw3vmx	341	29	3b	3b	NNP
cord-273505-pcsw3vmx	341	30	,	,	,
cord-273505-pcsw3vmx	341	31	ORF	ORF	NNP
cord-273505-pcsw3vmx	341	32	6	6	CD
cord-273505-pcsw3vmx	341	33	,	,	,
cord-273505-pcsw3vmx	341	34	and	and	CC
cord-273505-pcsw3vmx	341	35	nucleocapsid	nucleocapsid	NN
cord-273505-pcsw3vmx	341	36	proteins	protein	NNS
cord-273505-pcsw3vmx	341	37	function	function	VBP
cord-273505-pcsw3vmx	341	38	as	as	IN
cord-273505-pcsw3vmx	341	39	interferon	interferon	NN
cord-273505-pcsw3vmx	341	40	antagonists	antagonist	NNS
cord-273505-pcsw3vmx	341	41	MERS	MERS	NNP
cord-273505-pcsw3vmx	341	42	-	-	HYPH
cord-273505-pcsw3vmx	341	43	CoV	CoV	NNP
cord-273505-pcsw3vmx	341	44	accessory	accessory	NN
cord-273505-pcsw3vmx	341	45	ORFs	orfs	NN
cord-273505-pcsw3vmx	341	46	play	play	VBP
cord-273505-pcsw3vmx	341	47	key	key	JJ
cord-273505-pcsw3vmx	341	48	role	role	NN
cord-273505-pcsw3vmx	341	49	for	for	IN
cord-273505-pcsw3vmx	341	50	infection	infection	NN
cord-273505-pcsw3vmx	341	51	and	and	CC
cord-273505-pcsw3vmx	341	52	pathogenesis	pathogenesis	NN
cord-273505-pcsw3vmx	341	53	High	high	JJ
cord-273505-pcsw3vmx	341	54	secretion	secretion	NN
cord-273505-pcsw3vmx	341	55	of	of	IN
cord-273505-pcsw3vmx	341	56	interferons	interferon	NNS
cord-273505-pcsw3vmx	341	57	by	by	IN
cord-273505-pcsw3vmx	341	58	human	human	JJ
cord-273505-pcsw3vmx	341	59	plasmacytoid	plasmacytoid	NN
cord-273505-pcsw3vmx	341	60	dendritic	dendritic	JJ
cord-273505-pcsw3vmx	341	61	cells	cell	NNS
cord-273505-pcsw3vmx	341	62	upon	upon	IN
cord-273505-pcsw3vmx	341	63	recognition	recognition	NN
cord-273505-pcsw3vmx	341	64	of	of	IN
cord-273505-pcsw3vmx	341	65	Middle	Middle	NNP
cord-273505-pcsw3vmx	341	66	East	East	NNP
cord-273505-pcsw3vmx	341	67	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	341	68	syndrome	syndrome	NN
cord-273505-pcsw3vmx	341	69	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	341	70	Control	Control	NNP
cord-273505-pcsw3vmx	341	71	of	of	IN
cord-273505-pcsw3vmx	341	72	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	341	73	infection	infection	NN
cord-273505-pcsw3vmx	341	74	through	through	IN
cord-273505-pcsw3vmx	341	75	plasmacytoid	plasmacytoid	JJ
cord-273505-pcsw3vmx	341	76	dendritic	dendritic	JJ
cord-273505-pcsw3vmx	341	77	-	-	HYPH
cord-273505-pcsw3vmx	341	78	cell	cell	NN
cord-273505-pcsw3vmx	341	79	-	-	HYPH
cord-273505-pcsw3vmx	341	80	derived	derive	VBN
cord-273505-pcsw3vmx	341	81	type	type	NN
cord-273505-pcsw3vmx	342	1	I	-PRON-	PRP
cord-273505-pcsw3vmx	342	2	interferon	interferon	VBD
cord-273505-pcsw3vmx	342	3	Dysregulated	Dysregulated	NNP
cord-273505-pcsw3vmx	342	4	type	type	NN
cord-273505-pcsw3vmx	343	1	I	-PRON-	PRP
cord-273505-pcsw3vmx	343	2	interferon	interferon	VBD
cord-273505-pcsw3vmx	343	3	and	and	CC
cord-273505-pcsw3vmx	343	4	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	343	5	monocyte	monocyte	JJ
cord-273505-pcsw3vmx	343	6	-	-	HYPH
cord-273505-pcsw3vmx	343	7	macrophage	macrophage	NN
cord-273505-pcsw3vmx	343	8	responses	response	NNS
cord-273505-pcsw3vmx	343	9	cause	cause	VBP
cord-273505-pcsw3vmx	343	10	lethal	lethal	JJ
cord-273505-pcsw3vmx	343	11	pneumonia	pneumonia	NN
cord-273505-pcsw3vmx	343	12	in	in	IN
cord-273505-pcsw3vmx	343	13	SARS	SARS	NNP
cord-273505-pcsw3vmx	343	14	-	-	HYPH
cord-273505-pcsw3vmx	343	15	CoV	CoV	NNP
cord-273505-pcsw3vmx	343	16	-	-	HYPH
cord-273505-pcsw3vmx	343	17	infected	infect	VBN
cord-273505-pcsw3vmx	343	18	mice	mouse	NNS
cord-273505-pcsw3vmx	344	1	Dose	dose	NN
cord-273505-pcsw3vmx	344	2	-	-	HYPH
cord-273505-pcsw3vmx	344	3	related	relate	VBN
cord-273505-pcsw3vmx	344	4	regulatory	regulatory	JJ
cord-273505-pcsw3vmx	344	5	effect	effect	NN
cord-273505-pcsw3vmx	344	6	of	of	IN
cord-273505-pcsw3vmx	344	7	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	344	8	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	344	9	on	on	IN
cord-273505-pcsw3vmx	344	10	dendritic	dendritic	JJ
cord-273505-pcsw3vmx	344	11	cells	cell	NNS
cord-273505-pcsw3vmx	344	12	-	-	HYPH
cord-273505-pcsw3vmx	344	13	mediated	mediate	VBN
cord-273505-pcsw3vmx	344	14	immune	immune	JJ
cord-273505-pcsw3vmx	344	15	response	response	NN
cord-273505-pcsw3vmx	344	16	Inhibition	inhibition	NN
cord-273505-pcsw3vmx	344	17	of	of	IN
cord-273505-pcsw3vmx	344	18	maturation	maturation	NN
cord-273505-pcsw3vmx	344	19	and	and	CC
cord-273505-pcsw3vmx	344	20	function	function	NN
cord-273505-pcsw3vmx	344	21	of	of	IN
cord-273505-pcsw3vmx	344	22	dendritic	dendritic	JJ
cord-273505-pcsw3vmx	344	23	cells	cell	NNS
cord-273505-pcsw3vmx	344	24	by	by	IN
cord-273505-pcsw3vmx	344	25	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	344	26	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	344	27	Intravenous	Intravenous	NNP
cord-273505-pcsw3vmx	344	28	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	344	29	treatment	treatment	NN
cord-273505-pcsw3vmx	344	30	in	in	IN
cord-273505-pcsw3vmx	344	31	humans	human	NNS
cord-273505-pcsw3vmx	344	32	suppresses	suppress	VBZ
cord-273505-pcsw3vmx	344	33	dendritic	dendritic	JJ
cord-273505-pcsw3vmx	344	34	cell	cell	NN
cord-273505-pcsw3vmx	344	35	function	function	NN
cord-273505-pcsw3vmx	344	36	via	via	IN
cord-273505-pcsw3vmx	344	37	stimulation	stimulation	NN
cord-273505-pcsw3vmx	344	38	of	of	IN
cord-273505-pcsw3vmx	344	39	IL-4	IL-4	NNP
cord-273505-pcsw3vmx	344	40	and	and	CC
cord-273505-pcsw3vmx	344	41	IL-13	IL-13	NNP
cord-273505-pcsw3vmx	344	42	production	production	NN
cord-273505-pcsw3vmx	344	43	Dendritic	dendritic	JJ
cord-273505-pcsw3vmx	344	44	cell	cell	NN
cord-273505-pcsw3vmx	344	45	immunoreceptor	immunoreceptor	NN
cord-273505-pcsw3vmx	344	46	:	:	:
cord-273505-pcsw3vmx	345	1	a	a	DT
cord-273505-pcsw3vmx	345	2	novel	novel	JJ
cord-273505-pcsw3vmx	345	3	receptor	receptor	NN
cord-273505-pcsw3vmx	345	4	for	for	IN
cord-273505-pcsw3vmx	345	5	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	345	6	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	345	7	mediates	mediate	VBZ
cord-273505-pcsw3vmx	345	8	induction	induction	NN
cord-273505-pcsw3vmx	345	9	of	of	IN
cord-273505-pcsw3vmx	345	10	regulatory	regulatory	JJ
cord-273505-pcsw3vmx	345	11	T	t	NN
cord-273505-pcsw3vmx	345	12	cells	cell	NNS
cord-273505-pcsw3vmx	345	13	Effect	effect	NN
cord-273505-pcsw3vmx	345	14	of	of	IN
cord-273505-pcsw3vmx	345	15	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	345	16	on	on	IN
cord-273505-pcsw3vmx	345	17	human	human	JJ
cord-273505-pcsw3vmx	345	18	dendritic	dendritic	JJ
cord-273505-pcsw3vmx	345	19	cell	cell	NN
cord-273505-pcsw3vmx	345	20	-	-	HYPH
cord-273505-pcsw3vmx	345	21	mediated	mediate	VBN
cord-273505-pcsw3vmx	345	22	antigen	antigen	NN
cord-273505-pcsw3vmx	345	23	uptake	uptake	NN
cord-273505-pcsw3vmx	345	24	and	and	CC
cord-273505-pcsw3vmx	345	25	presentation	presentation	NN
cord-273505-pcsw3vmx	345	26	:	:	:
cord-273505-pcsw3vmx	345	27	role	role	NN
cord-273505-pcsw3vmx	345	28	of	of	IN
cord-273505-pcsw3vmx	345	29	lipid	lipid	NN
cord-273505-pcsw3vmx	345	30	accumulation	accumulation	NN
cord-273505-pcsw3vmx	345	31	Superior	Superior	NNP
cord-273505-pcsw3vmx	345	32	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	345	33	effects	effect	NNS
cord-273505-pcsw3vmx	345	34	of	of	IN
cord-273505-pcsw3vmx	345	35	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	345	36	immunoglobulins	immunoglobulin	NNS
cord-273505-pcsw3vmx	345	37	on	on	IN
cord-273505-pcsw3vmx	345	38	human	human	JJ
cord-273505-pcsw3vmx	345	39	T	t	NN
cord-273505-pcsw3vmx	345	40	-	-	HYPH
cord-273505-pcsw3vmx	345	41	cells	cell	NNS
cord-273505-pcsw3vmx	345	42	and	and	CC
cord-273505-pcsw3vmx	345	43	dendritic	dendritic	JJ
cord-273505-pcsw3vmx	345	44	cells	cell	NNS
cord-273505-pcsw3vmx	345	45	:	:	:
cord-273505-pcsw3vmx	345	46	comparison	comparison	NN
cord-273505-pcsw3vmx	345	47	to	to	IN
cord-273505-pcsw3vmx	345	48	calcineurin	calcineurin	NN
cord-273505-pcsw3vmx	345	49	inhibitors	inhibitor	NNS
cord-273505-pcsw3vmx	345	50	Complex	complex	JJ
cord-273505-pcsw3vmx	345	51	immune	immune	JJ
cord-273505-pcsw3vmx	345	52	dysregulation	dysregulation	NN
cord-273505-pcsw3vmx	345	53	in	in	IN
cord-273505-pcsw3vmx	345	54	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	345	55	patients	patient	NNS
cord-273505-pcsw3vmx	345	56	with	with	IN
cord-273505-pcsw3vmx	345	57	severe	severe	JJ
cord-273505-pcsw3vmx	345	58	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	345	59	failure	failure	NN
cord-273505-pcsw3vmx	346	1	The	the	DT
cord-273505-pcsw3vmx	346	2	novel	novel	JJ
cord-273505-pcsw3vmx	346	3	severe	severe	JJ
cord-273505-pcsw3vmx	346	4	acute	acute	JJ
cord-273505-pcsw3vmx	346	5	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	346	6	syndrome	syndrome	NN
cord-273505-pcsw3vmx	346	7	Coronavirus	Coronavirus	NNP
cord-273505-pcsw3vmx	346	8	2	2	CD
cord-273505-pcsw3vmx	347	1	(	(	-LRB-
cord-273505-pcsw3vmx	347	2	SARS	SARS	NNP
cord-273505-pcsw3vmx	347	3	-	-	HYPH
cord-273505-pcsw3vmx	347	4	CoV-2	CoV-2	NNP
cord-273505-pcsw3vmx	347	5	)	)	-RRB-
cord-273505-pcsw3vmx	347	6	directly	directly	RB
cord-273505-pcsw3vmx	347	7	decimates	decimate	VBZ
cord-273505-pcsw3vmx	347	8	human	human	JJ
cord-273505-pcsw3vmx	347	9	spleens	spleen	NNS
cord-273505-pcsw3vmx	347	10	and	and	CC
cord-273505-pcsw3vmx	347	11	lymph	lymph	NN
cord-273505-pcsw3vmx	347	12	nodes	node	NNS
cord-273505-pcsw3vmx	347	13	.	.	.
cord-273505-pcsw3vmx	348	1	medRxiv	medRxiv	NNP
cord-273505-pcsw3vmx	348	2	Antispike	Antispike	NNP
cord-273505-pcsw3vmx	348	3	IgG	igg	NN
cord-273505-pcsw3vmx	348	4	causes	cause	VBZ
cord-273505-pcsw3vmx	348	5	severe	severe	JJ
cord-273505-pcsw3vmx	348	6	acute	acute	JJ
cord-273505-pcsw3vmx	348	7	lung	lung	NN
cord-273505-pcsw3vmx	348	8	injury	injury	NN
cord-273505-pcsw3vmx	348	9	by	by	IN
cord-273505-pcsw3vmx	348	10	skewing	skew	VBG
cord-273505-pcsw3vmx	348	11	macrophage	macrophage	NN
cord-273505-pcsw3vmx	348	12	responses	response	NNS
cord-273505-pcsw3vmx	348	13	during	during	IN
cord-273505-pcsw3vmx	348	14	acute	acute	JJ
cord-273505-pcsw3vmx	348	15	SARS	SARS	NNP
cord-273505-pcsw3vmx	348	16	-	-	HYPH
cord-273505-pcsw3vmx	348	17	CoV	CoV	NNP
cord-273505-pcsw3vmx	348	18	infection	infection	NN
cord-273505-pcsw3vmx	348	19	Cytokine	cytokine	NN
cord-273505-pcsw3vmx	348	20	responses	response	NNS
cord-273505-pcsw3vmx	348	21	in	in	IN
cord-273505-pcsw3vmx	348	22	severe	severe	JJ
cord-273505-pcsw3vmx	348	23	acute	acute	JJ
cord-273505-pcsw3vmx	348	24	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	348	25	syndrome	syndrome	NN
cord-273505-pcsw3vmx	348	26	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	348	27	-	-	HYPH
cord-273505-pcsw3vmx	348	28	infected	infect	VBN
cord-273505-pcsw3vmx	348	29	macrophages	macrophage	NNS
cord-273505-pcsw3vmx	348	30	in	in	IN
cord-273505-pcsw3vmx	348	31	vitro	vitro	FW
cord-273505-pcsw3vmx	348	32	:	:	:
cord-273505-pcsw3vmx	348	33	possible	possible	JJ
cord-273505-pcsw3vmx	348	34	relevance	relevance	NN
cord-273505-pcsw3vmx	348	35	to	to	TO
cord-273505-pcsw3vmx	348	36	pathogenesis	pathogenesis	VB
cord-273505-pcsw3vmx	348	37	Up	up	RP
cord-273505-pcsw3vmx	348	38	-	-	HYPH
cord-273505-pcsw3vmx	348	39	regulation	regulation	NN
cord-273505-pcsw3vmx	348	40	of	of	IN
cord-273505-pcsw3vmx	348	41	IL-6	IL-6	NNP
cord-273505-pcsw3vmx	348	42	and	and	CC
cord-273505-pcsw3vmx	348	43	TNF	TNF	NNP
cord-273505-pcsw3vmx	348	44	-	-	HYPH
cord-273505-pcsw3vmx	348	45	alpha	alpha	NN
cord-273505-pcsw3vmx	348	46	induced	induce	VBN
cord-273505-pcsw3vmx	348	47	by	by	IN
cord-273505-pcsw3vmx	348	48	SARS	SARS	NNP
cord-273505-pcsw3vmx	348	49	-	-	HYPH
cord-273505-pcsw3vmx	348	50	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	348	51	spike	spike	NN
cord-273505-pcsw3vmx	348	52	protein	protein	NN
cord-273505-pcsw3vmx	348	53	in	in	IN
cord-273505-pcsw3vmx	348	54	murine	murine	JJ
cord-273505-pcsw3vmx	348	55	macrophages	macrophage	NNS
cord-273505-pcsw3vmx	348	56	via	via	IN
cord-273505-pcsw3vmx	349	1	NF	NF	NNP
cord-273505-pcsw3vmx	349	2	-	-	HYPH
cord-273505-pcsw3vmx	349	3	kappaB	kappaB	NNP
cord-273505-pcsw3vmx	349	4	pathway	pathway	NN
cord-273505-pcsw3vmx	349	5	SARS	SARS	NNP
cord-273505-pcsw3vmx	349	6	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	349	7	spike	spike	NN
cord-273505-pcsw3vmx	349	8	protein	protein	NN
cord-273505-pcsw3vmx	349	9	-	-	HYPH
cord-273505-pcsw3vmx	349	10	induced	induce	VBN
cord-273505-pcsw3vmx	349	11	innate	innate	JJ
cord-273505-pcsw3vmx	349	12	immune	immune	JJ
cord-273505-pcsw3vmx	349	13	response	response	NN
cord-273505-pcsw3vmx	349	14	occurs	occur	VBZ
cord-273505-pcsw3vmx	349	15	via	via	IN
cord-273505-pcsw3vmx	349	16	activation	activation	NN
cord-273505-pcsw3vmx	349	17	of	of	IN
cord-273505-pcsw3vmx	349	18	the	the	DT
cord-273505-pcsw3vmx	349	19	NF	NF	NNP
cord-273505-pcsw3vmx	349	20	-	-	HYPH
cord-273505-pcsw3vmx	349	21	kappaB	kappaB	NNP
cord-273505-pcsw3vmx	349	22	pathway	pathway	NN
cord-273505-pcsw3vmx	349	23	in	in	IN
cord-273505-pcsw3vmx	349	24	human	human	JJ
cord-273505-pcsw3vmx	349	25	monocyte	monocyte	NNP
cord-273505-pcsw3vmx	349	26	macrophages	macrophage	NNS
cord-273505-pcsw3vmx	349	27	in	in	IN
cord-273505-pcsw3vmx	349	28	vitro	vitro	FW
cord-273505-pcsw3vmx	349	29	Monocyte	Monocyte	NNP
cord-273505-pcsw3vmx	349	30	-	-	HYPH
cord-273505-pcsw3vmx	349	31	macrophage	macrophage	NN
cord-273505-pcsw3vmx	349	32	system	system	NN
cord-273505-pcsw3vmx	349	33	as	as	IN
cord-273505-pcsw3vmx	349	34	targets	target	NNS
cord-273505-pcsw3vmx	349	35	for	for	IN
cord-273505-pcsw3vmx	349	36	immunomodulation	immunomodulation	NN
cord-273505-pcsw3vmx	349	37	by	by	IN
cord-273505-pcsw3vmx	349	38	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	349	39	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	349	40	Macrophage	Macrophage	NNP
cord-273505-pcsw3vmx	349	41	activation	activation	NN
cord-273505-pcsw3vmx	349	42	syndrome	syndrome	NN
cord-273505-pcsw3vmx	349	43	in	in	IN
cord-273505-pcsw3vmx	349	44	systemic	systemic	JJ
cord-273505-pcsw3vmx	349	45	lupus	lupus	NN
cord-273505-pcsw3vmx	349	46	erythematosus	erythematosus	NN
cord-273505-pcsw3vmx	349	47	:	:	:
cord-273505-pcsw3vmx	349	48	a	a	DT
cord-273505-pcsw3vmx	349	49	multicenter	multicenter	NN
cord-273505-pcsw3vmx	349	50	,	,	,
cord-273505-pcsw3vmx	349	51	case	case	NN
cord-273505-pcsw3vmx	349	52	-	-	HYPH
cord-273505-pcsw3vmx	349	53	control	control	NN
cord-273505-pcsw3vmx	349	54	study	study	NN
cord-273505-pcsw3vmx	349	55	in	in	IN
cord-273505-pcsw3vmx	349	56	China	China	NNP
cord-273505-pcsw3vmx	349	57	Clinical	clinical	JJ
cord-273505-pcsw3vmx	349	58	characteristics	characteristic	NNS
cord-273505-pcsw3vmx	349	59	and	and	CC
cord-273505-pcsw3vmx	349	60	treatment	treatment	NN
cord-273505-pcsw3vmx	349	61	outcomes	outcome	NNS
cord-273505-pcsw3vmx	349	62	of	of	IN
cord-273505-pcsw3vmx	349	63	macrophage	macrophage	NN
cord-273505-pcsw3vmx	349	64	activation	activation	NN
cord-273505-pcsw3vmx	349	65	syndrome	syndrome	NN
cord-273505-pcsw3vmx	349	66	in	in	IN
cord-273505-pcsw3vmx	349	67	adults	adult	NNS
cord-273505-pcsw3vmx	349	68	:	:	:
cord-273505-pcsw3vmx	349	69	a	a	DT
cord-273505-pcsw3vmx	349	70	case	case	NN
cord-273505-pcsw3vmx	349	71	series	series	NN
cord-273505-pcsw3vmx	349	72	of	of	IN
cord-273505-pcsw3vmx	349	73	67	67	CD
cord-273505-pcsw3vmx	349	74	patients	patient	NNS
cord-273505-pcsw3vmx	349	75	Beijing	Beijing	NNP
cord-273505-pcsw3vmx	349	76	Da	Da	NNP
cord-273505-pcsw3vmx	349	77	Xue	Xue	NNP
cord-273505-pcsw3vmx	349	78	Xue	Xue	NNP
cord-273505-pcsw3vmx	349	79	Bao	Bao	NNP
cord-273505-pcsw3vmx	349	80	Yi	Yi	NNP
cord-273505-pcsw3vmx	349	81	Xue	Xue	NNP
cord-273505-pcsw3vmx	350	1	Ban	Ban	NNP
cord-273505-pcsw3vmx	350	2	Kawasaki	Kawasaki	NNP
cord-273505-pcsw3vmx	350	3	disease	disease	NN
cord-273505-pcsw3vmx	350	4	complicated	complicate	VBN
cord-273505-pcsw3vmx	350	5	with	with	IN
cord-273505-pcsw3vmx	350	6	macrophage	macrophage	NN
cord-273505-pcsw3vmx	350	7	activation	activation	NN
cord-273505-pcsw3vmx	350	8	syndrome	syndrome	NN
cord-273505-pcsw3vmx	350	9	:	:	:
cord-273505-pcsw3vmx	350	10	case	case	NN
cord-273505-pcsw3vmx	350	11	reports	report	NNS
cord-273505-pcsw3vmx	350	12	and	and	CC
cord-273505-pcsw3vmx	350	13	literature	literature	NN
cord-273505-pcsw3vmx	350	14	review	review	NN
cord-273505-pcsw3vmx	350	15	Macrophage	Macrophage	NNP
cord-273505-pcsw3vmx	350	16	activation	activation	NN
cord-273505-pcsw3vmx	350	17	syndrome	syndrome	NN
cord-273505-pcsw3vmx	350	18	IVIg	ivig	VBP
cord-273505-pcsw3vmx	350	19	promote	promote	VBP
cord-273505-pcsw3vmx	350	20	cross	cross	NN
cord-273505-pcsw3vmx	350	21	-	-	NN
cord-273505-pcsw3vmx	350	22	tolerance	tolerance	NN
cord-273505-pcsw3vmx	350	23	against	against	IN
cord-273505-pcsw3vmx	350	24	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	350	25	stimuli	stimulus	NNS
cord-273505-pcsw3vmx	350	26	in	in	IN
cord-273505-pcsw3vmx	350	27	vitro	vitro	FW
cord-273505-pcsw3vmx	350	28	and	and	CC
cord-273505-pcsw3vmx	350	29	in	in	IN
cord-273505-pcsw3vmx	350	30	vivo	vivo	NN
cord-273505-pcsw3vmx	351	1	Intravenous	intravenous	JJ
cord-273505-pcsw3vmx	351	2	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	351	3	promotes	promote	VBZ
cord-273505-pcsw3vmx	351	4	antitumor	antitumor	JJ
cord-273505-pcsw3vmx	351	5	responses	response	NNS
cord-273505-pcsw3vmx	351	6	by	by	IN
cord-273505-pcsw3vmx	351	7	modulating	modulate	VBG
cord-273505-pcsw3vmx	351	8	macrophage	macrophage	NN
cord-273505-pcsw3vmx	351	9	polarization	polarization	NN
cord-273505-pcsw3vmx	351	10	IVIg	ivig	NN
cord-273505-pcsw3vmx	351	11	and	and	CC
cord-273505-pcsw3vmx	351	12	LPS	LPS	NNP
cord-273505-pcsw3vmx	351	13	co	co	NN
cord-273505-pcsw3vmx	351	14	-	-	NN
cord-273505-pcsw3vmx	351	15	stimulation	stimulation	NN
cord-273505-pcsw3vmx	351	16	induces	induce	VBZ
cord-273505-pcsw3vmx	352	1	IL-10	IL-10	NNP
cord-273505-pcsw3vmx	352	2	production	production	NN
cord-273505-pcsw3vmx	352	3	by	by	IN
cord-273505-pcsw3vmx	352	4	human	human	JJ
cord-273505-pcsw3vmx	352	5	monocytes	monocyte	NNS
cord-273505-pcsw3vmx	352	6	,	,	,
cord-273505-pcsw3vmx	352	7	which	which	WDT
cord-273505-pcsw3vmx	352	8	is	be	VBZ
cord-273505-pcsw3vmx	352	9	compromised	compromise	VBN
cord-273505-pcsw3vmx	352	10	by	by	IN
cord-273505-pcsw3vmx	352	11	an	an	DT
cord-273505-pcsw3vmx	352	12	FcgammaRIIA	FcgammaRIIA	NNP
cord-273505-pcsw3vmx	352	13	disease	disease	NN
cord-273505-pcsw3vmx	352	14	-	-	HYPH
cord-273505-pcsw3vmx	352	15	associated	associate	VBN
cord-273505-pcsw3vmx	352	16	gene	gene	NN
cord-273505-pcsw3vmx	352	17	variant	variant	NN
cord-273505-pcsw3vmx	352	18	Excessive	excessive	JJ
cord-273505-pcsw3vmx	352	19	neutrophils	neutrophil	NNS
cord-273505-pcsw3vmx	352	20	and	and	CC
cord-273505-pcsw3vmx	352	21	neutrophil	neutrophil	NN
cord-273505-pcsw3vmx	352	22	extracellular	extracellular	JJ
cord-273505-pcsw3vmx	352	23	traps	trap	NNS
cord-273505-pcsw3vmx	352	24	contribute	contribute	VBP
cord-273505-pcsw3vmx	352	25	to	to	IN
cord-273505-pcsw3vmx	352	26	acute	acute	JJ
cord-273505-pcsw3vmx	352	27	lung	lung	NN
cord-273505-pcsw3vmx	352	28	injury	injury	NN
cord-273505-pcsw3vmx	352	29	of	of	IN
cord-273505-pcsw3vmx	352	30	influenza	influenza	NN
cord-273505-pcsw3vmx	352	31	pneumonitis	pneumonitis	NN
cord-273505-pcsw3vmx	352	32	High	high	JJ
cord-273505-pcsw3vmx	352	33	level	level	NN
cord-273505-pcsw3vmx	352	34	of	of	IN
cord-273505-pcsw3vmx	352	35	neutrophil	neutrophil	NN
cord-273505-pcsw3vmx	352	36	extracellular	extracellular	JJ
cord-273505-pcsw3vmx	352	37	traps	trap	NNS
cord-273505-pcsw3vmx	352	38	correlates	correlate	VBZ
cord-273505-pcsw3vmx	352	39	with	with	IN
cord-273505-pcsw3vmx	352	40	poor	poor	JJ
cord-273505-pcsw3vmx	352	41	prognosis	prognosis	NN
cord-273505-pcsw3vmx	352	42	of	of	IN
cord-273505-pcsw3vmx	352	43	severe	severe	JJ
cord-273505-pcsw3vmx	352	44	influenza	influenza	NN
cord-273505-pcsw3vmx	352	45	a	a	DT
cord-273505-pcsw3vmx	352	46	infection	infection	NN
cord-273505-pcsw3vmx	352	47	Targeting	target	VBG
cord-273505-pcsw3vmx	352	48	potential	potential	JJ
cord-273505-pcsw3vmx	352	49	drivers	driver	NNS
cord-273505-pcsw3vmx	352	50	of	of	IN
cord-273505-pcsw3vmx	352	51	COVID-19	covid-19	NN
cord-273505-pcsw3vmx	352	52	:	:	:
cord-273505-pcsw3vmx	352	53	neutrophil	neutrophil	NN
cord-273505-pcsw3vmx	352	54	extracellular	extracellular	JJ
cord-273505-pcsw3vmx	352	55	traps	trap	NNS
cord-273505-pcsw3vmx	353	1	Neutrophil	Neutrophil	NNP
cord-273505-pcsw3vmx	353	2	extracellular	extracellular	JJ
cord-273505-pcsw3vmx	353	3	traps	trap	NNS
cord-273505-pcsw3vmx	353	4	in	in	IN
cord-273505-pcsw3vmx	353	5	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	353	6	Decreased	decrease	VBN
cord-273505-pcsw3vmx	353	7	nitric	nitric	JJ
cord-273505-pcsw3vmx	353	8	oxide	oxide	NN
cord-273505-pcsw3vmx	353	9	production	production	NN
cord-273505-pcsw3vmx	353	10	after	after	IN
cord-273505-pcsw3vmx	353	11	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	353	12	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	353	13	treatment	treatment	NN
cord-273505-pcsw3vmx	353	14	in	in	IN
cord-273505-pcsw3vmx	353	15	patients	patient	NNS
cord-273505-pcsw3vmx	353	16	with	with	IN
cord-273505-pcsw3vmx	353	17	Kawasaki	Kawasaki	NNP
cord-273505-pcsw3vmx	353	18	disease	disease	NN
cord-273505-pcsw3vmx	353	19	Intravenous	intravenous	JJ
cord-273505-pcsw3vmx	353	20	immunoglobulins	immunoglobulin	NNS
cord-273505-pcsw3vmx	353	21	modulate	modulate	VBP
cord-273505-pcsw3vmx	353	22	neutrophil	neutrophil	NN
cord-273505-pcsw3vmx	353	23	activation	activation	NN
cord-273505-pcsw3vmx	353	24	and	and	CC
cord-273505-pcsw3vmx	353	25	vascular	vascular	JJ
cord-273505-pcsw3vmx	353	26	injury	injury	NN
cord-273505-pcsw3vmx	353	27	through	through	IN
cord-273505-pcsw3vmx	353	28	FcγRIII	fcγriii	NN
cord-273505-pcsw3vmx	353	29	and	and	CC
cord-273505-pcsw3vmx	353	30	SHP-1	SHP-1	NNP
cord-273505-pcsw3vmx	353	31	IVIG	IVIG	NNP
cord-273505-pcsw3vmx	353	32	regulates	regulate	VBZ
cord-273505-pcsw3vmx	353	33	the	the	DT
cord-273505-pcsw3vmx	353	34	survival	survival	NN
cord-273505-pcsw3vmx	353	35	of	of	IN
cord-273505-pcsw3vmx	353	36	human	human	NN
cord-273505-pcsw3vmx	353	37	but	but	CC
cord-273505-pcsw3vmx	353	38	not	not	RB
cord-273505-pcsw3vmx	353	39	mouse	mouse	NN
cord-273505-pcsw3vmx	353	40	neutrophils	neutrophil	NNS
cord-273505-pcsw3vmx	353	41	.	.	.
cord-273505-pcsw3vmx	354	1	Sci	Sci	NNP
cord-273505-pcsw3vmx	354	2	Rep	Rep	NNP
cord-273505-pcsw3vmx	354	3	Granulocyte	Granulocyte	NNP
cord-273505-pcsw3vmx	354	4	death	death	NN
cord-273505-pcsw3vmx	354	5	mediated	mediate	VBN
cord-273505-pcsw3vmx	354	6	by	by	IN
cord-273505-pcsw3vmx	354	7	specific	specific	JJ
cord-273505-pcsw3vmx	354	8	antibodies	antibody	NNS
cord-273505-pcsw3vmx	354	9	in	in	IN
cord-273505-pcsw3vmx	354	10	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	354	11	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	354	12	(	(	-LRB-
cord-273505-pcsw3vmx	354	13	IVIG	IVIG	NNP
cord-273505-pcsw3vmx	354	14	)	)	-RRB-
cord-273505-pcsw3vmx	355	1	Pharmaceutical	pharmaceutical	JJ
cord-273505-pcsw3vmx	355	2	immunoglobulins	immunoglobulin	NNS
cord-273505-pcsw3vmx	355	3	reduce	reduce	VBP
cord-273505-pcsw3vmx	355	4	neutrophil	neutrophil	NN
cord-273505-pcsw3vmx	355	5	extracellular	extracellular	JJ
cord-273505-pcsw3vmx	355	6	trap	trap	NN
cord-273505-pcsw3vmx	355	7	formation	formation	NN
cord-273505-pcsw3vmx	355	8	and	and	CC
cord-273505-pcsw3vmx	355	9	ameliorate	ameliorate	VB
cord-273505-pcsw3vmx	355	10	the	the	DT
cord-273505-pcsw3vmx	355	11	development	development	NN
cord-273505-pcsw3vmx	355	12	of	of	IN
cord-273505-pcsw3vmx	355	13	MPO	MPO	NNP
cord-273505-pcsw3vmx	355	14	-	-	HYPH
cord-273505-pcsw3vmx	355	15	ANCA	ANCA	NNP
cord-273505-pcsw3vmx	355	16	-	-	HYPH
cord-273505-pcsw3vmx	355	17	associated	associate	VBN
cord-273505-pcsw3vmx	355	18	vasculitis	vasculitis	NN
cord-273505-pcsw3vmx	355	19	Functional	functional	JJ
cord-273505-pcsw3vmx	355	20	exhaustion	exhaustion	NN
cord-273505-pcsw3vmx	355	21	of	of	IN
cord-273505-pcsw3vmx	355	22	antiviral	antiviral	JJ
cord-273505-pcsw3vmx	355	23	lymphocytes	lymphocyte	NNS
cord-273505-pcsw3vmx	355	24	in	in	IN
cord-273505-pcsw3vmx	355	25	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	355	26	patients	patient	NNS
cord-273505-pcsw3vmx	355	27	National	National	NNP
cord-273505-pcsw3vmx	355	28	Research	Research	NNP
cord-273505-pcsw3vmx	355	29	Project	Project	NNP
cord-273505-pcsw3vmx	355	30	for	for	IN
cord-273505-pcsw3vmx	355	31	SARS	SARS	NNP
cord-273505-pcsw3vmx	355	32	BG	BG	NNP
cord-273505-pcsw3vmx	355	33	.	.	.
cord-273505-pcsw3vmx	356	1	The	the	DT
cord-273505-pcsw3vmx	356	2	involvement	involvement	NN
cord-273505-pcsw3vmx	356	3	of	of	IN
cord-273505-pcsw3vmx	356	4	natural	natural	JJ
cord-273505-pcsw3vmx	356	5	killer	killer	NN
cord-273505-pcsw3vmx	356	6	cells	cell	NNS
cord-273505-pcsw3vmx	356	7	in	in	IN
cord-273505-pcsw3vmx	356	8	the	the	DT
cord-273505-pcsw3vmx	356	9	pathogenesis	pathogenesis	NN
cord-273505-pcsw3vmx	356	10	of	of	IN
cord-273505-pcsw3vmx	356	11	severe	severe	JJ
cord-273505-pcsw3vmx	356	12	acute	acute	JJ
cord-273505-pcsw3vmx	356	13	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	356	14	syndrome	syndrome	NN
cord-273505-pcsw3vmx	356	15	Viral	viral	JJ
cord-273505-pcsw3vmx	356	16	infection	infection	NN
cord-273505-pcsw3vmx	356	17	of	of	IN
cord-273505-pcsw3vmx	356	18	human	human	JJ
cord-273505-pcsw3vmx	356	19	natural	natural	JJ
cord-273505-pcsw3vmx	356	20	killer	killer	NN
cord-273505-pcsw3vmx	356	21	cells	cell	NNS
cord-273505-pcsw3vmx	356	22	Influenza	Influenza	NNP
cord-273505-pcsw3vmx	356	23	virus	virus	NN
cord-273505-pcsw3vmx	356	24	directly	directly	RB
cord-273505-pcsw3vmx	356	25	infects	infect	VBZ
cord-273505-pcsw3vmx	356	26	human	human	JJ
cord-273505-pcsw3vmx	356	27	natural	natural	JJ
cord-273505-pcsw3vmx	356	28	killer	killer	NN
cord-273505-pcsw3vmx	356	29	cells	cell	NNS
cord-273505-pcsw3vmx	356	30	and	and	CC
cord-273505-pcsw3vmx	356	31	induces	induce	VBZ
cord-273505-pcsw3vmx	357	1	cell	cell	NN
cord-273505-pcsw3vmx	357	2	apoptosis	apoptosis	NN
cord-273505-pcsw3vmx	358	1	The	the	DT
cord-273505-pcsw3vmx	358	2	effect	effect	NN
cord-273505-pcsw3vmx	358	3	of	of	IN
cord-273505-pcsw3vmx	358	4	IgG	igg	NN
cord-273505-pcsw3vmx	358	5	levels	level	NNS
cord-273505-pcsw3vmx	358	6	on	on	IN
cord-273505-pcsw3vmx	358	7	the	the	DT
cord-273505-pcsw3vmx	358	8	number	number	NN
cord-273505-pcsw3vmx	358	9	of	of	IN
cord-273505-pcsw3vmx	358	10	natural	natural	JJ
cord-273505-pcsw3vmx	358	11	killer	killer	NN
cord-273505-pcsw3vmx	358	12	cells	cell	NNS
cord-273505-pcsw3vmx	358	13	and	and	CC
cord-273505-pcsw3vmx	358	14	their	-PRON-	PRP$
cord-273505-pcsw3vmx	358	15	Fc	Fc	NNP
cord-273505-pcsw3vmx	358	16	receptors	receptor	NNS
cord-273505-pcsw3vmx	358	17	in	in	IN
cord-273505-pcsw3vmx	358	18	chronic	chronic	JJ
cord-273505-pcsw3vmx	358	19	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	358	20	demyelinating	demyelinating	NN
cord-273505-pcsw3vmx	358	21	polyradiculoneuropathy	polyradiculoneuropathy	NNP
cord-273505-pcsw3vmx	358	22	NK	NK	NNP
cord-273505-pcsw3vmx	358	23	cell	cell	NN
cord-273505-pcsw3vmx	358	24	compartment	compartment	NN
cord-273505-pcsw3vmx	358	25	in	in	IN
cord-273505-pcsw3vmx	358	26	the	the	DT
cord-273505-pcsw3vmx	358	27	peripheral	peripheral	JJ
cord-273505-pcsw3vmx	358	28	blood	blood	NN
cord-273505-pcsw3vmx	358	29	and	and	CC
cord-273505-pcsw3vmx	358	30	spleen	spleen	NNS
cord-273505-pcsw3vmx	358	31	in	in	IN
cord-273505-pcsw3vmx	358	32	adult	adult	NN
cord-273505-pcsw3vmx	358	33	patients	patient	NNS
cord-273505-pcsw3vmx	358	34	with	with	IN
cord-273505-pcsw3vmx	358	35	primary	primary	JJ
cord-273505-pcsw3vmx	358	36	immune	immune	JJ
cord-273505-pcsw3vmx	358	37	thrombocytopenia	thrombocytopenia	NN
cord-273505-pcsw3vmx	358	38	NK	NK	NNP
cord-273505-pcsw3vmx	358	39	cell	cell	NN
cord-273505-pcsw3vmx	358	40	frequency	frequency	NN
cord-273505-pcsw3vmx	358	41	and	and	CC
cord-273505-pcsw3vmx	358	42	cytotoxicity	cytotoxicity	NN
cord-273505-pcsw3vmx	358	43	in	in	IN
cord-273505-pcsw3vmx	358	44	correlation	correlation	NN
cord-273505-pcsw3vmx	358	45	to	to	IN
cord-273505-pcsw3vmx	358	46	pregnancy	pregnancy	NN
cord-273505-pcsw3vmx	358	47	outcome	outcome	NN
cord-273505-pcsw3vmx	358	48	and	and	CC
cord-273505-pcsw3vmx	358	49	response	response	NN
cord-273505-pcsw3vmx	358	50	to	to	IN
cord-273505-pcsw3vmx	358	51	IVIG	IVIG	NNP
cord-273505-pcsw3vmx	358	52	therapy	therapy	NN
cord-273505-pcsw3vmx	358	53	among	among	IN
cord-273505-pcsw3vmx	358	54	women	woman	NNS
cord-273505-pcsw3vmx	358	55	with	with	IN
cord-273505-pcsw3vmx	358	56	recurrent	recurrent	JJ
cord-273505-pcsw3vmx	358	57	pregnancy	pregnancy	NN
cord-273505-pcsw3vmx	358	58	loss	loss	NN
cord-273505-pcsw3vmx	358	59	Effect	effect	NN
cord-273505-pcsw3vmx	358	60	of	of	IN
cord-273505-pcsw3vmx	358	61	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	358	62	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	358	63	G	g	NN
cord-273505-pcsw3vmx	358	64	therapy	therapy	NN
cord-273505-pcsw3vmx	358	65	on	on	IN
cord-273505-pcsw3vmx	358	66	natural	natural	JJ
cord-273505-pcsw3vmx	358	67	killer	killer	NN
cord-273505-pcsw3vmx	358	68	cell	cell	NN
cord-273505-pcsw3vmx	358	69	function	function	NN
cord-273505-pcsw3vmx	358	70	related	relate	VBN
cord-273505-pcsw3vmx	358	71	to	to	IN
cord-273505-pcsw3vmx	358	72	Fc	Fc	NNP
cord-273505-pcsw3vmx	358	73	gamma	gamma	NN
cord-273505-pcsw3vmx	358	74	receptor	receptor	NN
cord-273505-pcsw3vmx	358	75	gene	gene	NN
cord-273505-pcsw3vmx	358	76	expression	expression	NN
cord-273505-pcsw3vmx	358	77	Pathological	pathological	JJ
cord-273505-pcsw3vmx	358	78	findings	finding	NNS
cord-273505-pcsw3vmx	358	79	of	of	IN
cord-273505-pcsw3vmx	358	80	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	358	81	associated	associate	VBN
cord-273505-pcsw3vmx	358	82	with	with	IN
cord-273505-pcsw3vmx	358	83	acute	acute	JJ
cord-273505-pcsw3vmx	358	84	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	358	85	distress	distress	NN
cord-273505-pcsw3vmx	358	86	syndrome	syndrome	NN
cord-273505-pcsw3vmx	359	1	TH17	TH17	NNP
cord-273505-pcsw3vmx	359	2	responses	response	NNS
cord-273505-pcsw3vmx	359	3	in	in	IN
cord-273505-pcsw3vmx	359	4	cytokine	cytokine	NN
cord-273505-pcsw3vmx	359	5	storm	storm	NN
cord-273505-pcsw3vmx	359	6	of	of	IN
cord-273505-pcsw3vmx	359	7	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	359	8	:	:	:
cord-273505-pcsw3vmx	359	9	an	an	DT
cord-273505-pcsw3vmx	359	10	emerging	emerge	VBG
cord-273505-pcsw3vmx	359	11	target	target	NN
cord-273505-pcsw3vmx	359	12	of	of	IN
cord-273505-pcsw3vmx	359	13	JAK2	JAK2	NNP
cord-273505-pcsw3vmx	359	14	inhibitor	inhibitor	NN
cord-273505-pcsw3vmx	359	15	Fedratinib	Fedratinib	NNP
cord-273505-pcsw3vmx	359	16	Plasma	Plasma	NNP
cord-273505-pcsw3vmx	359	17	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	359	18	cytokines	cytokine	NNS
cord-273505-pcsw3vmx	359	19	and	and	CC
cord-273505-pcsw3vmx	359	20	chemokines	chemokine	NNS
cord-273505-pcsw3vmx	359	21	in	in	IN
cord-273505-pcsw3vmx	359	22	severe	severe	JJ
cord-273505-pcsw3vmx	359	23	acute	acute	JJ
cord-273505-pcsw3vmx	359	24	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	359	25	syndrome	syndrome	NN
cord-273505-pcsw3vmx	359	26	MERS	MERS	NNP
cord-273505-pcsw3vmx	359	27	-	-	HYPH
cord-273505-pcsw3vmx	359	28	CoV	cov	NN
cord-273505-pcsw3vmx	359	29	infection	infection	NN
cord-273505-pcsw3vmx	359	30	in	in	IN
cord-273505-pcsw3vmx	359	31	humans	human	NNS
cord-273505-pcsw3vmx	359	32	is	be	VBZ
cord-273505-pcsw3vmx	359	33	associated	associate	VBN
cord-273505-pcsw3vmx	359	34	with	with	IN
cord-273505-pcsw3vmx	359	35	a	a	DT
cord-273505-pcsw3vmx	359	36	proinflammatory	proinflammatory	JJ
cord-273505-pcsw3vmx	359	37	Th1	th1	NN
cord-273505-pcsw3vmx	359	38	and	and	CC
cord-273505-pcsw3vmx	359	39	Th17	Th17	NNP
cord-273505-pcsw3vmx	359	40	cytokine	cytokine	NN
cord-273505-pcsw3vmx	359	41	profile	profile	NN
cord-273505-pcsw3vmx	359	42	Severe	severe	JJ
cord-273505-pcsw3vmx	359	43	influenza	influenza	NN
cord-273505-pcsw3vmx	359	44	:	:	:
cord-273505-pcsw3vmx	359	45	overview	overview	VB
cord-273505-pcsw3vmx	359	46	in	in	IN
cord-273505-pcsw3vmx	359	47	critically	critically	RB
cord-273505-pcsw3vmx	359	48	ill	ill	JJ
cord-273505-pcsw3vmx	359	49	patients	patient	NNS
cord-273505-pcsw3vmx	359	50	Th1	Th1	NNP
cord-273505-pcsw3vmx	359	51	and	and	CC
cord-273505-pcsw3vmx	359	52	Th17	Th17	NNP
cord-273505-pcsw3vmx	359	53	hypercytokinemia	hypercytokinemia	NNP
cord-273505-pcsw3vmx	359	54	as	as	IN
cord-273505-pcsw3vmx	359	55	early	early	JJ
cord-273505-pcsw3vmx	359	56	host	host	NN
cord-273505-pcsw3vmx	359	57	response	response	NN
cord-273505-pcsw3vmx	359	58	signature	signature	NN
cord-273505-pcsw3vmx	359	59	in	in	IN
cord-273505-pcsw3vmx	359	60	severe	severe	JJ
cord-273505-pcsw3vmx	359	61	pandemic	pandemic	NN
cord-273505-pcsw3vmx	359	62	influenza	influenza	NN
cord-273505-pcsw3vmx	359	63	Elevated	elevate	VBN
cord-273505-pcsw3vmx	359	64	Th1	Th1	NNP
cord-273505-pcsw3vmx	359	65	/	/	SYM
cord-273505-pcsw3vmx	359	66	Th2	th2	CD
cord-273505-pcsw3vmx	359	67	cell	cell	NN
cord-273505-pcsw3vmx	359	68	ratios	ratio	NNS
cord-273505-pcsw3vmx	359	69	in	in	IN
cord-273505-pcsw3vmx	359	70	a	a	DT
cord-273505-pcsw3vmx	359	71	pregnant	pregnant	JJ
cord-273505-pcsw3vmx	359	72	woman	woman	NN
cord-273505-pcsw3vmx	359	73	with	with	IN
cord-273505-pcsw3vmx	359	74	a	a	DT
cord-273505-pcsw3vmx	359	75	history	history	NN
cord-273505-pcsw3vmx	359	76	of	of	IN
cord-273505-pcsw3vmx	359	77	RSA	RSA	NNP
cord-273505-pcsw3vmx	359	78	,	,	,
cord-273505-pcsw3vmx	359	79	secondary	secondary	JJ
cord-273505-pcsw3vmx	359	80	Sjogren	Sjogren	NNP
cord-273505-pcsw3vmx	359	81	's	's	POS
cord-273505-pcsw3vmx	359	82	syndrome	syndrome	NN
cord-273505-pcsw3vmx	359	83	and	and	CC
cord-273505-pcsw3vmx	359	84	rheumatoid	rheumatoid	NN
cord-273505-pcsw3vmx	359	85	arthritis	arthritis	NN
cord-273505-pcsw3vmx	359	86	complicated	complicate	VBN
cord-273505-pcsw3vmx	359	87	with	with	IN
cord-273505-pcsw3vmx	359	88	one	one	CD
cord-273505-pcsw3vmx	359	89	fetal	fetal	JJ
cord-273505-pcsw3vmx	359	90	demise	demise	NN
cord-273505-pcsw3vmx	359	91	of	of	IN
cord-273505-pcsw3vmx	359	92	twin	twin	JJ
cord-273505-pcsw3vmx	359	93	pregnancy	pregnancy	NN
cord-273505-pcsw3vmx	359	94	Evaluation	Evaluation	NNP
cord-273505-pcsw3vmx	359	95	of	of	IN
cord-273505-pcsw3vmx	359	96	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	359	97	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	359	98	resistance	resistance	NN
cord-273505-pcsw3vmx	359	99	and	and	CC
cord-273505-pcsw3vmx	359	100	coronary	coronary	JJ
cord-273505-pcsw3vmx	359	101	artery	artery	NN
cord-273505-pcsw3vmx	359	102	lesions	lesion	NNS
cord-273505-pcsw3vmx	359	103	in	in	IN
cord-273505-pcsw3vmx	359	104	relation	relation	NN
cord-273505-pcsw3vmx	359	105	to	to	IN
cord-273505-pcsw3vmx	359	106	Th1	th1	CD
cord-273505-pcsw3vmx	359	107	/	/	SYM
cord-273505-pcsw3vmx	359	108	Th2	th2	CD
cord-273505-pcsw3vmx	359	109	cytokine	cytokine	NN
cord-273505-pcsw3vmx	359	110	profiles	profile	NNS
cord-273505-pcsw3vmx	359	111	in	in	IN
cord-273505-pcsw3vmx	359	112	patients	patient	NNS
cord-273505-pcsw3vmx	359	113	with	with	IN
cord-273505-pcsw3vmx	359	114	Kawasaki	Kawasaki	NNP
cord-273505-pcsw3vmx	359	115	disease	disease	NN
cord-273505-pcsw3vmx	359	116	Effect	effect	NN
cord-273505-pcsw3vmx	359	117	of	of	IN
cord-273505-pcsw3vmx	359	118	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	359	119	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	359	120	treatment	treatment	NN
cord-273505-pcsw3vmx	359	121	on	on	IN
cord-273505-pcsw3vmx	359	122	the	the	DT
cord-273505-pcsw3vmx	359	123	Th1	th1	CD
cord-273505-pcsw3vmx	359	124	/	/	SYM
cord-273505-pcsw3vmx	359	125	Th2	th2	CD
cord-273505-pcsw3vmx	359	126	balance	balance	NN
cord-273505-pcsw3vmx	359	127	in	in	IN
cord-273505-pcsw3vmx	359	128	women	woman	NNS
cord-273505-pcsw3vmx	359	129	with	with	IN
cord-273505-pcsw3vmx	359	130	recurrent	recurrent	JJ
cord-273505-pcsw3vmx	359	131	spontaneous	spontaneous	JJ
cord-273505-pcsw3vmx	359	132	abortions	abortion	NNS
cord-273505-pcsw3vmx	359	133	Expression	expression	NN
cord-273505-pcsw3vmx	359	134	patterns	pattern	NNS
cord-273505-pcsw3vmx	359	135	of	of	IN
cord-273505-pcsw3vmx	359	136	Th1	th1	NN
cord-273505-pcsw3vmx	359	137	and	and	CC
cord-273505-pcsw3vmx	359	138	Th2	th2	CD
cord-273505-pcsw3vmx	359	139	cytokine	cytokine	NN
cord-273505-pcsw3vmx	359	140	genes	gene	NNS
cord-273505-pcsw3vmx	359	141	in	in	IN
cord-273505-pcsw3vmx	359	142	childhood	childhood	NN
cord-273505-pcsw3vmx	359	143	idiopathic	idiopathic	JJ
cord-273505-pcsw3vmx	359	144	thrombocytopenic	thrombocytopenic	JJ
cord-273505-pcsw3vmx	359	145	purpura	purpura	NN
cord-273505-pcsw3vmx	359	146	(	(	-LRB-
cord-273505-pcsw3vmx	359	147	ITP	ITP	NNP
cord-273505-pcsw3vmx	359	148	)	)	-RRB-
cord-273505-pcsw3vmx	359	149	at	at	IN
cord-273505-pcsw3vmx	359	150	presentation	presentation	NN
cord-273505-pcsw3vmx	359	151	and	and	CC
cord-273505-pcsw3vmx	359	152	their	-PRON-	PRP$
cord-273505-pcsw3vmx	359	153	modulation	modulation	NN
cord-273505-pcsw3vmx	359	154	by	by	IN
cord-273505-pcsw3vmx	359	155	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	359	156	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	359	157	G	g	NN
cord-273505-pcsw3vmx	359	158	(	(	-LRB-
cord-273505-pcsw3vmx	359	159	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	359	160	)	)	-RRB-
cord-273505-pcsw3vmx	359	161	treatment	treatment	NN
cord-273505-pcsw3vmx	359	162	:	:	:
cord-273505-pcsw3vmx	360	1	their	-PRON-	PRP$
cord-273505-pcsw3vmx	360	2	role	role	NN
cord-273505-pcsw3vmx	360	3	in	in	IN
cord-273505-pcsw3vmx	360	4	prognosis	prognosis	NN
cord-273505-pcsw3vmx	360	5	Effect	effect	NN
cord-273505-pcsw3vmx	360	6	of	of	IN
cord-273505-pcsw3vmx	360	7	Intravenous	Intravenous	NNP
cord-273505-pcsw3vmx	360	8	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	360	9	on	on	IN
cord-273505-pcsw3vmx	360	10	Th1	th1	CD
cord-273505-pcsw3vmx	360	11	and	and	CC
cord-273505-pcsw3vmx	360	12	Th2	Th2	NNP
cord-273505-pcsw3vmx	360	13	lymphocytes	lymphocyte	NNS
cord-273505-pcsw3vmx	360	14	and	and	CC
cord-273505-pcsw3vmx	360	15	improvement	improvement	NN
cord-273505-pcsw3vmx	360	16	of	of	IN
cord-273505-pcsw3vmx	360	17	pregnancy	pregnancy	NN
cord-273505-pcsw3vmx	360	18	outcome	outcome	NN
cord-273505-pcsw3vmx	360	19	in	in	IN
cord-273505-pcsw3vmx	360	20	recurrent	recurrent	JJ
cord-273505-pcsw3vmx	360	21	pregnancy	pregnancy	NN
cord-273505-pcsw3vmx	360	22	loss	loss	NN
cord-273505-pcsw3vmx	360	23	(	(	-LRB-
cord-273505-pcsw3vmx	360	24	RPL	rpl	NN
cord-273505-pcsw3vmx	360	25	)	)	-RRB-
cord-273505-pcsw3vmx	361	1	Intravenous	intravenous	JJ
cord-273505-pcsw3vmx	361	2	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	361	3	G	g	NN
cord-273505-pcsw3vmx	361	4	treatment	treatment	NN
cord-273505-pcsw3vmx	361	5	increases	increase	VBZ
cord-273505-pcsw3vmx	361	6	live	live	VBP
cord-273505-pcsw3vmx	361	7	birth	birth	NN
cord-273505-pcsw3vmx	361	8	rate	rate	NN
cord-273505-pcsw3vmx	361	9	in	in	IN
cord-273505-pcsw3vmx	361	10	women	woman	NNS
cord-273505-pcsw3vmx	361	11	with	with	IN
cord-273505-pcsw3vmx	361	12	recurrent	recurrent	JJ
cord-273505-pcsw3vmx	361	13	miscarriage	miscarriage	NN
cord-273505-pcsw3vmx	361	14	and	and	CC
cord-273505-pcsw3vmx	361	15	modulates	modulate	VBZ
cord-273505-pcsw3vmx	361	16	regulatory	regulatory	JJ
cord-273505-pcsw3vmx	361	17	and	and	CC
cord-273505-pcsw3vmx	361	18	exhausted	exhausted	JJ
cord-273505-pcsw3vmx	361	19	regulatory	regulatory	JJ
cord-273505-pcsw3vmx	361	20	T	t	NN
cord-273505-pcsw3vmx	361	21	cells	cell	NNS
cord-273505-pcsw3vmx	361	22	frequency	frequency	NN
cord-273505-pcsw3vmx	361	23	and	and	CC
cord-273505-pcsw3vmx	361	24	function	function	VB
cord-273505-pcsw3vmx	361	25	Modulatory	modulatory	JJ
cord-273505-pcsw3vmx	361	26	effect	effect	NN
cord-273505-pcsw3vmx	361	27	of	of	IN
cord-273505-pcsw3vmx	361	28	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	361	29	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	361	30	on	on	IN
cord-273505-pcsw3vmx	361	31	Th17	Th17	NNP
cord-273505-pcsw3vmx	361	32	/	/	SYM
cord-273505-pcsw3vmx	361	33	Treg	Treg	NNP
cord-273505-pcsw3vmx	361	34	cell	cell	NN
cord-273505-pcsw3vmx	361	35	balance	balance	NN
cord-273505-pcsw3vmx	361	36	in	in	IN
cord-273505-pcsw3vmx	361	37	women	woman	NNS
cord-273505-pcsw3vmx	361	38	with	with	IN
cord-273505-pcsw3vmx	362	1	unexplained	unexplained	JJ
cord-273505-pcsw3vmx	362	2	recurrent	recurrent	JJ
cord-273505-pcsw3vmx	362	3	spontaneous	spontaneous	JJ
cord-273505-pcsw3vmx	362	4	abortion	abortion	NN
cord-273505-pcsw3vmx	362	5	Intravenous	Intravenous	NNP
cord-273505-pcsw3vmx	362	6	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	362	7	(	(	-LRB-
cord-273505-pcsw3vmx	362	8	IVIG	IVIG	NNP
cord-273505-pcsw3vmx	362	9	)	)	-RRB-
cord-273505-pcsw3vmx	362	10	treatment	treatment	NN
cord-273505-pcsw3vmx	362	11	modulates	modulate	VBZ
cord-273505-pcsw3vmx	362	12	peripheral	peripheral	JJ
cord-273505-pcsw3vmx	362	13	blood	blood	NN
cord-273505-pcsw3vmx	362	14	Th17	Th17	NNP
cord-273505-pcsw3vmx	362	15	and	and	CC
cord-273505-pcsw3vmx	362	16	regulatory	regulatory	JJ
cord-273505-pcsw3vmx	362	17	T	t	NN
cord-273505-pcsw3vmx	362	18	cells	cell	NNS
cord-273505-pcsw3vmx	362	19	in	in	IN
cord-273505-pcsw3vmx	362	20	recurrent	recurrent	JJ
cord-273505-pcsw3vmx	362	21	miscarriage	miscarriage	NN
cord-273505-pcsw3vmx	362	22	patients	patient	NNS
cord-273505-pcsw3vmx	362	23	:	:	:
cord-273505-pcsw3vmx	362	24	non	non	JJ
cord-273505-pcsw3vmx	362	25	randomized	randomized	JJ
cord-273505-pcsw3vmx	362	26	,	,	,
cord-273505-pcsw3vmx	362	27	open	open	JJ
cord-273505-pcsw3vmx	362	28	-	-	HYPH
cord-273505-pcsw3vmx	362	29	label	label	NN
cord-273505-pcsw3vmx	362	30	clinical	clinical	JJ
cord-273505-pcsw3vmx	362	31	trial	trial	NN
cord-273505-pcsw3vmx	362	32	Regulatory	Regulatory	NNP
cord-273505-pcsw3vmx	362	33	T	T	NNP
cord-273505-pcsw3vmx	362	34	cells	cell	NNS
cord-273505-pcsw3vmx	362	35	improve	improve	VBP
cord-273505-pcsw3vmx	362	36	pregnancy	pregnancy	NN
cord-273505-pcsw3vmx	362	37	rate	rate	NN
cord-273505-pcsw3vmx	362	38	in	in	IN
cord-273505-pcsw3vmx	362	39	RIF	RIF	NNP
cord-273505-pcsw3vmx	362	40	patients	patient	NNS
cord-273505-pcsw3vmx	362	41	after	after	IN
cord-273505-pcsw3vmx	362	42	additional	additional	JJ
cord-273505-pcsw3vmx	362	43	IVIG	IVIG	NNP
cord-273505-pcsw3vmx	362	44	treatment	treatment	NN
cord-273505-pcsw3vmx	362	45	Th17-and	Th17-and	NNP
cord-273505-pcsw3vmx	362	46	Treg	Treg	NNP
cord-273505-pcsw3vmx	362	47	-	-	HYPH
cord-273505-pcsw3vmx	362	48	related	relate	VBN
cord-273505-pcsw3vmx	362	49	cytokine	cytokine	NN
cord-273505-pcsw3vmx	362	50	and	and	CC
cord-273505-pcsw3vmx	362	51	mRNA	mrna	NN
cord-273505-pcsw3vmx	362	52	expression	expression	NN
cord-273505-pcsw3vmx	362	53	are	be	VBP
cord-273505-pcsw3vmx	362	54	associated	associate	VBN
cord-273505-pcsw3vmx	362	55	with	with	IN
cord-273505-pcsw3vmx	362	56	acute	acute	JJ
cord-273505-pcsw3vmx	362	57	and	and	CC
cord-273505-pcsw3vmx	362	58	resolving	resolve	VBG
cord-273505-pcsw3vmx	362	59	Kawasaki	Kawasaki	NNP
cord-273505-pcsw3vmx	362	60	disease	disease	NN
cord-273505-pcsw3vmx	363	1	Intravenous	intravenous	JJ
cord-273505-pcsw3vmx	363	2	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	363	3	exerts	exert	VBZ
cord-273505-pcsw3vmx	363	4	reciprocal	reciprocal	JJ
cord-273505-pcsw3vmx	363	5	regulation	regulation	NN
cord-273505-pcsw3vmx	363	6	of	of	IN
cord-273505-pcsw3vmx	363	7	Th1	th1	CD
cord-273505-pcsw3vmx	363	8	/	/	SYM
cord-273505-pcsw3vmx	363	9	Th17	th17	CD
cord-273505-pcsw3vmx	363	10	cells	cell	NNS
cord-273505-pcsw3vmx	363	11	and	and	CC
cord-273505-pcsw3vmx	363	12	regulatory	regulatory	JJ
cord-273505-pcsw3vmx	363	13	T	t	NN
cord-273505-pcsw3vmx	363	14	cells	cell	NNS
cord-273505-pcsw3vmx	363	15	in	in	IN
cord-273505-pcsw3vmx	363	16	Guillain	Guillain	NNP
cord-273505-pcsw3vmx	363	17	-	-	HYPH
cord-273505-pcsw3vmx	363	18	Barre	Barre	NNP
cord-273505-pcsw3vmx	363	19	syndrome	syndrome	NN
cord-273505-pcsw3vmx	363	20	patients	patient	VBZ
cord-273505-pcsw3vmx	363	21	High	high	JJ
cord-273505-pcsw3vmx	363	22	-	-	HYPH
cord-273505-pcsw3vmx	363	23	dose	dose	NN
cord-273505-pcsw3vmx	363	24	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	363	25	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	363	26	therapy	therapy	NN
cord-273505-pcsw3vmx	363	27	for	for	IN
cord-273505-pcsw3vmx	363	28	eosinophilic	eosinophilic	JJ
cord-273505-pcsw3vmx	363	29	granulomatosis	granulomatosis	NN
cord-273505-pcsw3vmx	363	30	with	with	IN
cord-273505-pcsw3vmx	363	31	polyangiitis	polyangiitis	NNP
cord-273505-pcsw3vmx	363	32	Sialylation	Sialylation	NNP
cord-273505-pcsw3vmx	363	33	may	may	MD
cord-273505-pcsw3vmx	363	34	be	be	VB
cord-273505-pcsw3vmx	363	35	dispensable	dispensable	JJ
cord-273505-pcsw3vmx	363	36	for	for	IN
cord-273505-pcsw3vmx	363	37	reciprocal	reciprocal	JJ
cord-273505-pcsw3vmx	363	38	modulation	modulation	NN
cord-273505-pcsw3vmx	363	39	of	of	IN
cord-273505-pcsw3vmx	363	40	helper	helper	NN
cord-273505-pcsw3vmx	363	41	T	t	NN
cord-273505-pcsw3vmx	363	42	cells	cell	NNS
cord-273505-pcsw3vmx	363	43	by	by	IN
cord-273505-pcsw3vmx	363	44	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	363	45	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	363	46	Intravenous	Intravenous	NNP
cord-273505-pcsw3vmx	363	47	gammaglobulin	gammaglobulin	NNP
cord-273505-pcsw3vmx	363	48	inhibits	inhibit	VBZ
cord-273505-pcsw3vmx	363	49	encephalitogenic	encephalitogenic	NNP
cord-273505-pcsw3vmx	363	50	potential	potential	NN
cord-273505-pcsw3vmx	363	51	of	of	IN
cord-273505-pcsw3vmx	363	52	pathogenic	pathogenic	JJ
cord-273505-pcsw3vmx	363	53	T	t	NN
cord-273505-pcsw3vmx	363	54	cells	cell	NNS
cord-273505-pcsw3vmx	363	55	and	and	CC
cord-273505-pcsw3vmx	363	56	interferes	interfere	VBZ
cord-273505-pcsw3vmx	363	57	with	with	IN
cord-273505-pcsw3vmx	363	58	their	-PRON-	PRP$
cord-273505-pcsw3vmx	363	59	trafficking	trafficking	NN
cord-273505-pcsw3vmx	363	60	to	to	IN
cord-273505-pcsw3vmx	363	61	the	the	DT
cord-273505-pcsw3vmx	363	62	central	central	JJ
cord-273505-pcsw3vmx	363	63	nervous	nervous	JJ
cord-273505-pcsw3vmx	363	64	system	system	NN
cord-273505-pcsw3vmx	363	65	,	,	,
cord-273505-pcsw3vmx	363	66	implicating	implicate	VBG
cord-273505-pcsw3vmx	363	67	sphingosine-1	sphingosine-1	NNP
cord-273505-pcsw3vmx	363	68	phosphate	phosphate	NN
cord-273505-pcsw3vmx	363	69	receptor	receptor	NN
cord-273505-pcsw3vmx	363	70	1-mammalian	1-mammalian	CD
cord-273505-pcsw3vmx	363	71	target	target	NN
cord-273505-pcsw3vmx	363	72	of	of	IN
cord-273505-pcsw3vmx	363	73	rapamycin	rapamycin	NN
cord-273505-pcsw3vmx	363	74	axis	axis	NN
cord-273505-pcsw3vmx	363	75	Monomeric	Monomeric	NNP
cord-273505-pcsw3vmx	363	76	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	363	77	a	a	DT
cord-273505-pcsw3vmx	363	78	from	from	IN
cord-273505-pcsw3vmx	363	79	plasma	plasma	NN
cord-273505-pcsw3vmx	363	80	inhibits	inhibit	VBZ
cord-273505-pcsw3vmx	363	81	human	human	JJ
cord-273505-pcsw3vmx	363	82	th17	th17	NN
cord-273505-pcsw3vmx	363	83	responses	response	NNS
cord-273505-pcsw3vmx	363	84	in	in	IN
cord-273505-pcsw3vmx	363	85	vitro	vitro	FW
cord-273505-pcsw3vmx	363	86	independent	independent	JJ
cord-273505-pcsw3vmx	363	87	of	of	IN
cord-273505-pcsw3vmx	363	88	FcalphaRI	FcalphaRI	NNP
cord-273505-pcsw3vmx	363	89	and	and	CC
cord-273505-pcsw3vmx	363	90	DC	DC	NNP
cord-273505-pcsw3vmx	363	91	-	-	HYPH
cord-273505-pcsw3vmx	363	92	SIGN	SIGN	NNP
cord-273505-pcsw3vmx	363	93	.	.	.
cord-273505-pcsw3vmx	364	1	Front	Front	NNP
cord-273505-pcsw3vmx	364	2	Immunol	Immunol	NNP
cord-273505-pcsw3vmx	364	3	Intravenous	Intravenous	NNP
cord-273505-pcsw3vmx	364	4	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	364	5	attenuates	attenuate	VBZ
cord-273505-pcsw3vmx	364	6	airway	airway	JJ
cord-273505-pcsw3vmx	364	7	inflammation	inflammation	NN
cord-273505-pcsw3vmx	364	8	through	through	IN
cord-273505-pcsw3vmx	364	9	induction	induction	NN
cord-273505-pcsw3vmx	364	10	of	of	IN
cord-273505-pcsw3vmx	364	11	forkhead	forkhead	NNP
cord-273505-pcsw3vmx	364	12	box	box	NNP
cord-273505-pcsw3vmx	364	13	protein	protein	NNP
cord-273505-pcsw3vmx	364	14	3-positive	3-positive	CD
cord-273505-pcsw3vmx	364	15	regulatory	regulatory	JJ
cord-273505-pcsw3vmx	364	16	T	t	NN
cord-273505-pcsw3vmx	364	17	cells	cell	NNS
cord-273505-pcsw3vmx	365	1	Intravenous	intravenous	JJ
cord-273505-pcsw3vmx	365	2	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	365	3	expands	expand	VBZ
cord-273505-pcsw3vmx	365	4	regulatory	regulatory	JJ
cord-273505-pcsw3vmx	365	5	T	t	NN
cord-273505-pcsw3vmx	365	6	cells	cell	NNS
cord-273505-pcsw3vmx	365	7	via	via	IN
cord-273505-pcsw3vmx	365	8	induction	induction	NN
cord-273505-pcsw3vmx	365	9	of	of	IN
cord-273505-pcsw3vmx	365	10	cyclooxygenase-2-dependent	cyclooxygenase-2-dependent	NNP
cord-273505-pcsw3vmx	365	11	prostaglandin	prostaglandin	NN
cord-273505-pcsw3vmx	365	12	E2	E2	NNP
cord-273505-pcsw3vmx	365	13	in	in	IN
cord-273505-pcsw3vmx	365	14	human	human	JJ
cord-273505-pcsw3vmx	365	15	dendritic	dendritic	JJ
cord-273505-pcsw3vmx	365	16	cells	cell	NNS
cord-273505-pcsw3vmx	366	1	Contrasting	contrast	VBG
cord-273505-pcsw3vmx	366	2	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	366	3	of	of	IN
cord-273505-pcsw3vmx	366	4	interferon	interferon	NN
cord-273505-pcsw3vmx	366	5	-	-	HYPH
cord-273505-pcsw3vmx	366	6	alpha	alpha	NN
cord-273505-pcsw3vmx	366	7	inhibition	inhibition	NN
cord-273505-pcsw3vmx	366	8	by	by	IN
cord-273505-pcsw3vmx	366	9	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	366	10	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	366	11	after	after	IN
cord-273505-pcsw3vmx	366	12	induction	induction	NN
cord-273505-pcsw3vmx	366	13	by	by	IN
cord-273505-pcsw3vmx	366	14	immune	immune	JJ
cord-273505-pcsw3vmx	366	15	complexes	complex	NNS
cord-273505-pcsw3vmx	366	16	versus	versus	IN
cord-273505-pcsw3vmx	366	17	Toll	toll	NN
cord-273505-pcsw3vmx	366	18	-	-	HYPH
cord-273505-pcsw3vmx	366	19	like	like	JJ
cord-273505-pcsw3vmx	366	20	receptor	receptor	NN
cord-273505-pcsw3vmx	366	21	agonists	agonist	NNS
cord-273505-pcsw3vmx	367	1	Tregitope	Tregitope	NNP
cord-273505-pcsw3vmx	367	2	update	update	NN
cord-273505-pcsw3vmx	367	3	:	:	:
cord-273505-pcsw3vmx	367	4	mechanism	mechanism	NN
cord-273505-pcsw3vmx	367	5	of	of	IN
cord-273505-pcsw3vmx	367	6	action	action	NN
cord-273505-pcsw3vmx	367	7	parallels	parallel	NNS
cord-273505-pcsw3vmx	367	8	IVIg	ivig	VBP
cord-273505-pcsw3vmx	367	9	Mechanisms	Mechanisms	NNPS
cord-273505-pcsw3vmx	367	10	of	of	IN
cord-273505-pcsw3vmx	367	11	immune	immune	JJ
cord-273505-pcsw3vmx	367	12	regulation	regulation	NN
cord-273505-pcsw3vmx	367	13	by	by	IN
cord-273505-pcsw3vmx	367	14	IVIG	IVIG	NNP
cord-273505-pcsw3vmx	367	15	Tregitope	Tregitope	NNP
cord-273505-pcsw3vmx	367	16	peptides	peptide	NNS
cord-273505-pcsw3vmx	367	17	:	:	:
cord-273505-pcsw3vmx	367	18	the	the	DT
cord-273505-pcsw3vmx	367	19	active	active	JJ
cord-273505-pcsw3vmx	367	20	pharmaceutical	pharmaceutical	JJ
cord-273505-pcsw3vmx	367	21	ingredient	ingredient	NN
cord-273505-pcsw3vmx	367	22	of	of	IN
cord-273505-pcsw3vmx	367	23	IVIG	IVIG	NNP
cord-273505-pcsw3vmx	367	24	?	?	.
cord-273505-pcsw3vmx	368	1	New	new	JJ
cord-273505-pcsw3vmx	368	2	fronts	front	NNS
cord-273505-pcsw3vmx	368	3	emerge	emerge	VBP
cord-273505-pcsw3vmx	368	4	in	in	IN
cord-273505-pcsw3vmx	368	5	the	the	DT
cord-273505-pcsw3vmx	368	6	influenza	influenza	NN
cord-273505-pcsw3vmx	368	7	cytokine	cytokine	NN
cord-273505-pcsw3vmx	368	8	storm	storm	NN
cord-273505-pcsw3vmx	368	9	Animal	Animal	NNP
cord-273505-pcsw3vmx	368	10	model	model	NN
cord-273505-pcsw3vmx	368	11	of	of	IN
cord-273505-pcsw3vmx	368	12	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	368	13	syncytial	syncytial	JJ
cord-273505-pcsw3vmx	368	14	virus	virus	NN
cord-273505-pcsw3vmx	368	15	:	:	:
cord-273505-pcsw3vmx	368	16	CD8	CD8	NNP
cord-273505-pcsw3vmx	368	17	+	+	CC
cord-273505-pcsw3vmx	368	18	T	T	NNP
cord-273505-pcsw3vmx	368	19	cells	cell	NNS
cord-273505-pcsw3vmx	368	20	cause	cause	VBP
cord-273505-pcsw3vmx	368	21	a	a	DT
cord-273505-pcsw3vmx	368	22	cytokine	cytokine	NN
cord-273505-pcsw3vmx	368	23	storm	storm	NN
cord-273505-pcsw3vmx	368	24	that	that	WDT
cord-273505-pcsw3vmx	368	25	is	be	VBZ
cord-273505-pcsw3vmx	368	26	chemically	chemically	RB
cord-273505-pcsw3vmx	368	27	tractable	tractable	JJ
cord-273505-pcsw3vmx	368	28	by	by	IN
cord-273505-pcsw3vmx	368	29	sphingosine-1-phosphate	sphingosine-1-phosphate	NNP
cord-273505-pcsw3vmx	368	30	1	1	CD
cord-273505-pcsw3vmx	368	31	receptor	receptor	NN
cord-273505-pcsw3vmx	368	32	agonist	agonist	NN
cord-273505-pcsw3vmx	368	33	therapy	therapy	NN
cord-273505-pcsw3vmx	368	34	Increased	increase	VBN
cord-273505-pcsw3vmx	368	35	expression	expression	NN
cord-273505-pcsw3vmx	368	36	of	of	IN
cord-273505-pcsw3vmx	368	37	CD8	CD8	NNP
cord-273505-pcsw3vmx	368	38	marker	marker	NN
cord-273505-pcsw3vmx	368	39	on	on	IN
cord-273505-pcsw3vmx	368	40	T	T	NNP
cord-273505-pcsw3vmx	368	41	-	-	HYPH
cord-273505-pcsw3vmx	368	42	cells	cell	NNS
cord-273505-pcsw3vmx	368	43	in	in	IN
cord-273505-pcsw3vmx	368	44	COVID-19	covid-19	CD
cord-273505-pcsw3vmx	368	45	patients	patient	NNS
cord-273505-pcsw3vmx	369	1	The	the	DT
cord-273505-pcsw3vmx	369	2	cytokine	cytokine	NN
cord-273505-pcsw3vmx	369	3	release	release	NN
cord-273505-pcsw3vmx	369	4	syndrome	syndrome	NN
cord-273505-pcsw3vmx	369	5	(	(	-LRB-
cord-273505-pcsw3vmx	369	6	CRS	CRS	NNP
cord-273505-pcsw3vmx	369	7	)	)	-RRB-
cord-273505-pcsw3vmx	369	8	of	of	IN
cord-273505-pcsw3vmx	369	9	severe	severe	JJ
cord-273505-pcsw3vmx	369	10	COVID-19	covid-19	NN
cord-273505-pcsw3vmx	369	11	and	and	CC
cord-273505-pcsw3vmx	369	12	Interleukin-6	Interleukin-6	NNP
cord-273505-pcsw3vmx	370	1	receptor	receptor	NN
cord-273505-pcsw3vmx	370	2	(	(	-LRB-
cord-273505-pcsw3vmx	370	3	IL-6R	IL-6R	NNP
cord-273505-pcsw3vmx	370	4	)	)	-RRB-
cord-273505-pcsw3vmx	370	5	antagonist	antagonist	NN
cord-273505-pcsw3vmx	371	1	Tocilizumab	Tocilizumab	NNP
cord-273505-pcsw3vmx	371	2	may	may	MD
cord-273505-pcsw3vmx	371	3	be	be	VB
cord-273505-pcsw3vmx	371	4	the	the	DT
cord-273505-pcsw3vmx	371	5	key	key	NN
cord-273505-pcsw3vmx	371	6	to	to	TO
cord-273505-pcsw3vmx	371	7	reduce	reduce	VB
cord-273505-pcsw3vmx	371	8	the	the	DT
cord-273505-pcsw3vmx	371	9	mortality	mortality	NN
cord-273505-pcsw3vmx	372	1	Intravenous	intravenous	JJ
cord-273505-pcsw3vmx	372	2	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	372	3	treatment	treatment	NN
cord-273505-pcsw3vmx	372	4	responsiveness	responsiveness	NN
cord-273505-pcsw3vmx	372	5	depends	depend	VBZ
cord-273505-pcsw3vmx	372	6	on	on	IN
cord-273505-pcsw3vmx	372	7	the	the	DT
cord-273505-pcsw3vmx	372	8	degree	degree	NN
cord-273505-pcsw3vmx	372	9	of	of	IN
cord-273505-pcsw3vmx	372	10	CD8	CD8	NNP
cord-273505-pcsw3vmx	372	11	+	+	CC
cord-273505-pcsw3vmx	372	12	T	T	NNP
cord-273505-pcsw3vmx	372	13	cell	cell	NN
cord-273505-pcsw3vmx	372	14	activation	activation	NN
cord-273505-pcsw3vmx	372	15	in	in	IN
cord-273505-pcsw3vmx	372	16	Kawasaki	Kawasaki	NNP
cord-273505-pcsw3vmx	372	17	disease	disease	NN
cord-273505-pcsw3vmx	372	18	Recovery	Recovery	NNP
cord-273505-pcsw3vmx	372	19	of	of	IN
cord-273505-pcsw3vmx	372	20	the	the	DT
cord-273505-pcsw3vmx	372	21	T	t	NN
cord-273505-pcsw3vmx	372	22	-	-	HYPH
cord-273505-pcsw3vmx	372	23	cell	cell	NN
cord-273505-pcsw3vmx	372	24	repertoire	repertoire	NN
cord-273505-pcsw3vmx	372	25	in	in	IN
cord-273505-pcsw3vmx	372	26	CIDP	CIDP	NNP
cord-273505-pcsw3vmx	372	27	by	by	IN
cord-273505-pcsw3vmx	372	28	IV	IV	NNP
cord-273505-pcsw3vmx	372	29	immunoglobulins	immunoglobulin	NNS
cord-273505-pcsw3vmx	372	30	Intravenous	intravenous	JJ
cord-273505-pcsw3vmx	372	31	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	372	32	(	(	-LRB-
cord-273505-pcsw3vmx	372	33	IVIg	ivig	ADD
cord-273505-pcsw3vmx	372	34	)	)	-RRB-
cord-273505-pcsw3vmx	372	35	inhibits	inhibit	VBZ
cord-273505-pcsw3vmx	372	36	CD8	CD8	NNP
cord-273505-pcsw3vmx	372	37	cytotoxic	cytotoxic	JJ
cord-273505-pcsw3vmx	372	38	T	T	NNP
cord-273505-pcsw3vmx	372	39	-	-	HYPH
cord-273505-pcsw3vmx	372	40	cell	cell	NN
cord-273505-pcsw3vmx	372	41	activation	activation	NN
cord-273505-pcsw3vmx	373	1	Intravenous	intravenous	JJ
cord-273505-pcsw3vmx	373	2	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	373	3	modulates	modulate	VBZ
cord-273505-pcsw3vmx	373	4	the	the	DT
cord-273505-pcsw3vmx	373	5	expansion	expansion	NN
cord-273505-pcsw3vmx	373	6	and	and	CC
cord-273505-pcsw3vmx	373	7	cytotoxicity	cytotoxicity	NN
cord-273505-pcsw3vmx	373	8	of	of	IN
cord-273505-pcsw3vmx	373	9	CD8	CD8	NNP
cord-273505-pcsw3vmx	373	10	+	+	CC
cord-273505-pcsw3vmx	373	11	T	T	NNP
cord-273505-pcsw3vmx	373	12	cells	cell	NNS
cord-273505-pcsw3vmx	374	1	Exogenous	exogenous	JJ
cord-273505-pcsw3vmx	374	2	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	374	3	downregulates	downregulate	VBZ
cord-273505-pcsw3vmx	374	4	T	t	NN
cord-273505-pcsw3vmx	374	5	-	-	HYPH
cord-273505-pcsw3vmx	374	6	cell	cell	NN
cord-273505-pcsw3vmx	374	7	receptor	receptor	NN
cord-273505-pcsw3vmx	374	8	signaling	signal	VBG
cord-273505-pcsw3vmx	374	9	and	and	CC
cord-273505-pcsw3vmx	374	10	cytokine	cytokine	NN
cord-273505-pcsw3vmx	374	11	production	production	NN
cord-273505-pcsw3vmx	374	12	Antibodies	antibody	NNS
cord-273505-pcsw3vmx	374	13	to	to	IN
cord-273505-pcsw3vmx	374	14	a	a	DT
cord-273505-pcsw3vmx	374	15	conserved	conserved	JJ
cord-273505-pcsw3vmx	374	16	region	region	NN
cord-273505-pcsw3vmx	374	17	of	of	IN
cord-273505-pcsw3vmx	374	18	HLA	HLA	NNP
cord-273505-pcsw3vmx	374	19	class	class	NN
cord-273505-pcsw3vmx	374	20	I	-PRON-	PRP
cord-273505-pcsw3vmx	374	21	molecules	molecule	NNS
cord-273505-pcsw3vmx	374	22	,	,	,
cord-273505-pcsw3vmx	374	23	capable	capable	JJ
cord-273505-pcsw3vmx	374	24	of	of	IN
cord-273505-pcsw3vmx	374	25	modulating	modulate	VBG
cord-273505-pcsw3vmx	374	26	CD8	CD8	NNP
cord-273505-pcsw3vmx	374	27	T	T	NNP
cord-273505-pcsw3vmx	374	28	cell	cell	NN
cord-273505-pcsw3vmx	374	29	-	-	HYPH
cord-273505-pcsw3vmx	374	30	mediated	mediate	VBN
cord-273505-pcsw3vmx	374	31	function	function	NN
cord-273505-pcsw3vmx	374	32	,	,	,
cord-273505-pcsw3vmx	374	33	are	be	VBP
cord-273505-pcsw3vmx	374	34	present	present	JJ
cord-273505-pcsw3vmx	374	35	in	in	IN
cord-273505-pcsw3vmx	374	36	pooled	pool	VBN
cord-273505-pcsw3vmx	374	37	normal	normal	JJ
cord-273505-pcsw3vmx	374	38	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	374	39	for	for	IN
cord-273505-pcsw3vmx	374	40	therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	374	41	use	use	NN
cord-273505-pcsw3vmx	374	42	IL-6	IL-6	NNP
cord-273505-pcsw3vmx	374	43	in	in	IN
cord-273505-pcsw3vmx	374	44	inflammation	inflammation	NN
cord-273505-pcsw3vmx	374	45	,	,	,
cord-273505-pcsw3vmx	374	46	immunity	immunity	NN
cord-273505-pcsw3vmx	374	47	,	,	,
cord-273505-pcsw3vmx	374	48	and	and	CC
cord-273505-pcsw3vmx	374	49	disease	disease	NN
cord-273505-pcsw3vmx	374	50	Relationships	relationship	NNS
cord-273505-pcsw3vmx	374	51	between	between	IN
cord-273505-pcsw3vmx	374	52	B	b	NN
cord-273505-pcsw3vmx	374	53	cell	cell	NN
cord-273505-pcsw3vmx	374	54	cytokine	cytokine	NN
cord-273505-pcsw3vmx	374	55	production	production	NN
cord-273505-pcsw3vmx	374	56	in	in	IN
cord-273505-pcsw3vmx	374	57	secondary	secondary	JJ
cord-273505-pcsw3vmx	374	58	lymphoid	lymphoid	JJ
cord-273505-pcsw3vmx	374	59	follicles	follicle	NNS
cord-273505-pcsw3vmx	374	60	and	and	CC
cord-273505-pcsw3vmx	374	61	apoptosis	apoptosis	NN
cord-273505-pcsw3vmx	374	62	of	of	IN
cord-273505-pcsw3vmx	374	63	germinal	germinal	JJ
cord-273505-pcsw3vmx	374	64	center	center	NN
cord-273505-pcsw3vmx	374	65	B	B	NNP
cord-273505-pcsw3vmx	374	66	lymphocytes	lymphocyte	NNS
cord-273505-pcsw3vmx	374	67	B	b	NN
cord-273505-pcsw3vmx	374	68	cell	cell	NN
cord-273505-pcsw3vmx	374	69	-	-	HYPH
cord-273505-pcsw3vmx	374	70	derived	derive	VBN
cord-273505-pcsw3vmx	374	71	IL-6	IL-6	NNP
cord-273505-pcsw3vmx	374	72	initiates	initiate	VBZ
cord-273505-pcsw3vmx	374	73	spontaneous	spontaneous	JJ
cord-273505-pcsw3vmx	374	74	germinal	germinal	JJ
cord-273505-pcsw3vmx	374	75	center	center	NN
cord-273505-pcsw3vmx	374	76	formation	formation	NN
cord-273505-pcsw3vmx	374	77	during	during	IN
cord-273505-pcsw3vmx	374	78	systemic	systemic	JJ
cord-273505-pcsw3vmx	374	79	autoimmunity	autoimmunity	IN
cord-273505-pcsw3vmx	374	80	Dysregulation	Dysregulation	NNP
cord-273505-pcsw3vmx	374	81	of	of	IN
cord-273505-pcsw3vmx	374	82	immune	immune	JJ
cord-273505-pcsw3vmx	374	83	response	response	NN
cord-273505-pcsw3vmx	374	84	in	in	IN
cord-273505-pcsw3vmx	374	85	patients	patient	NNS
cord-273505-pcsw3vmx	374	86	with	with	IN
cord-273505-pcsw3vmx	374	87	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	374	88	in	in	IN
cord-273505-pcsw3vmx	374	89	Wuhan	Wuhan	NNP
cord-273505-pcsw3vmx	374	90	,	,	,
cord-273505-pcsw3vmx	374	91	China	China	NNP
cord-273505-pcsw3vmx	374	92	Immune	Immune	NNP
cord-273505-pcsw3vmx	374	93	cell	cell	NN
cord-273505-pcsw3vmx	374	94	profiling	profiling	NN
cord-273505-pcsw3vmx	374	95	of	of	IN
cord-273505-pcsw3vmx	374	96	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	374	97	patients	patient	NNS
cord-273505-pcsw3vmx	374	98	in	in	IN
cord-273505-pcsw3vmx	374	99	the	the	DT
cord-273505-pcsw3vmx	374	100	recovery	recovery	NN
cord-273505-pcsw3vmx	374	101	stage	stage	NN
cord-273505-pcsw3vmx	374	102	by	by	IN
cord-273505-pcsw3vmx	374	103	singlecell	singlecell	NNP
cord-273505-pcsw3vmx	374	104	sequencing	sequencing	NN
cord-273505-pcsw3vmx	374	105	.	.	.
cord-273505-pcsw3vmx	375	1	medRxiv	medRxiv	NNS
cord-273505-pcsw3vmx	376	1	A	a	DT
cord-273505-pcsw3vmx	376	2	possible	possible	JJ
cord-273505-pcsw3vmx	376	3	role	role	NN
cord-273505-pcsw3vmx	376	4	for	for	IN
cord-273505-pcsw3vmx	376	5	B	b	NN
cord-273505-pcsw3vmx	376	6	cells	cell	NNS
cord-273505-pcsw3vmx	376	7	in	in	IN
cord-273505-pcsw3vmx	376	8	COVID-19	covid-19	NN
cord-273505-pcsw3vmx	376	9	?	?	.
cord-273505-pcsw3vmx	377	1	Lesson	lesson	NN
cord-273505-pcsw3vmx	377	2	from	from	IN
cord-273505-pcsw3vmx	377	3	patients	patient	NNS
cord-273505-pcsw3vmx	377	4	with	with	IN
cord-273505-pcsw3vmx	377	5	agammaglobulinemia	agammaglobulinemia	NN
cord-273505-pcsw3vmx	377	6	Two	two	CD
cord-273505-pcsw3vmx	377	7	X	x	NN
cord-273505-pcsw3vmx	377	8	-	-	HYPH
cord-273505-pcsw3vmx	377	9	linked	link	VBN
cord-273505-pcsw3vmx	377	10	agammaglobulinemia	agammaglobulinemia	NN
cord-273505-pcsw3vmx	377	11	patients	patient	NNS
cord-273505-pcsw3vmx	377	12	develop	develop	VBP
cord-273505-pcsw3vmx	377	13	pneumonia	pneumonia	NN
cord-273505-pcsw3vmx	377	14	as	as	IN
cord-273505-pcsw3vmx	377	15	COVID-19	covid-19	JJ
cord-273505-pcsw3vmx	377	16	manifestation	manifestation	NN
cord-273505-pcsw3vmx	377	17	but	but	CC
cord-273505-pcsw3vmx	377	18	recover	recover	VB
cord-273505-pcsw3vmx	377	19	Review	review	NN
cord-273505-pcsw3vmx	377	20	:	:	:
cord-273505-pcsw3vmx	378	1	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	378	2	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	378	3	and	and	CC
cord-273505-pcsw3vmx	378	4	B	b	NN
cord-273505-pcsw3vmx	378	5	cells	cell	NNS
cord-273505-pcsw3vmx	378	6	:	:	:
cord-273505-pcsw3vmx	378	7	when	when	WRB
cord-273505-pcsw3vmx	378	8	the	the	DT
cord-273505-pcsw3vmx	378	9	product	product	NN
cord-273505-pcsw3vmx	378	10	regulates	regulate	VBZ
cord-273505-pcsw3vmx	378	11	the	the	DT
cord-273505-pcsw3vmx	378	12	producer	producer	NN
cord-273505-pcsw3vmx	378	13	Intravenous	Intravenous	NNP
cord-273505-pcsw3vmx	378	14	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	378	15	induces	induce	VBZ
cord-273505-pcsw3vmx	378	16	proliferation	proliferation	NN
cord-273505-pcsw3vmx	378	17	and	and	CC
cord-273505-pcsw3vmx	378	18	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	378	19	synthesis	synthesis	NN
cord-273505-pcsw3vmx	378	20	from	from	IN
cord-273505-pcsw3vmx	378	21	B	b	NN
cord-273505-pcsw3vmx	378	22	cells	cell	NNS
cord-273505-pcsw3vmx	378	23	of	of	IN
cord-273505-pcsw3vmx	378	24	patients	patient	NNS
cord-273505-pcsw3vmx	378	25	with	with	IN
cord-273505-pcsw3vmx	378	26	common	common	JJ
cord-273505-pcsw3vmx	378	27	variable	variable	JJ
cord-273505-pcsw3vmx	378	28	immunodeficiency	immunodeficiency	NN
cord-273505-pcsw3vmx	378	29	:	:	:
cord-273505-pcsw3vmx	378	30	a	a	DT
cord-273505-pcsw3vmx	378	31	mechanism	mechanism	NN
cord-273505-pcsw3vmx	378	32	underlying	underlie	VBG
cord-273505-pcsw3vmx	378	33	the	the	DT
cord-273505-pcsw3vmx	378	34	beneficial	beneficial	JJ
cord-273505-pcsw3vmx	378	35	effect	effect	NN
cord-273505-pcsw3vmx	378	36	of	of	IN
cord-273505-pcsw3vmx	378	37	IVIg	ivig	NN
cord-273505-pcsw3vmx	378	38	in	in	IN
cord-273505-pcsw3vmx	378	39	primary	primary	JJ
cord-273505-pcsw3vmx	378	40	immunodeficiencies	immunodeficiency	NNS
cord-273505-pcsw3vmx	379	1	Intravenous	intravenous	JJ
cord-273505-pcsw3vmx	379	2	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	379	3	up	up	RB
cord-273505-pcsw3vmx	379	4	-	-	HYPH
cord-273505-pcsw3vmx	379	5	regulates	regulate	VBZ
cord-273505-pcsw3vmx	379	6	the	the	DT
cord-273505-pcsw3vmx	379	7	expression	expression	NN
cord-273505-pcsw3vmx	379	8	of	of	IN
cord-273505-pcsw3vmx	379	9	the	the	DT
cord-273505-pcsw3vmx	379	10	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	379	11	FcgammaIIB	FcgammaIIB	NNP
cord-273505-pcsw3vmx	379	12	receptor	receptor	NN
cord-273505-pcsw3vmx	379	13	on	on	IN
cord-273505-pcsw3vmx	379	14	B	b	NN
cord-273505-pcsw3vmx	379	15	cells	cell	NNS
cord-273505-pcsw3vmx	380	1	FcgammaRIIb	fcgammariib	JJ
cord-273505-pcsw3vmx	380	2	expression	expression	NN
cord-273505-pcsw3vmx	380	3	on	on	IN
cord-273505-pcsw3vmx	380	4	B	b	NN
cord-273505-pcsw3vmx	380	5	cells	cell	NNS
cord-273505-pcsw3vmx	380	6	is	be	VBZ
cord-273505-pcsw3vmx	380	7	associated	associate	VBN
cord-273505-pcsw3vmx	380	8	with	with	IN
cord-273505-pcsw3vmx	380	9	treatment	treatment	NN
cord-273505-pcsw3vmx	380	10	efficacy	efficacy	NN
cord-273505-pcsw3vmx	380	11	for	for	IN
cord-273505-pcsw3vmx	380	12	acute	acute	JJ
cord-273505-pcsw3vmx	380	13	rejection	rejection	NN
cord-273505-pcsw3vmx	380	14	after	after	IN
cord-273505-pcsw3vmx	380	15	kidney	kidney	NN
cord-273505-pcsw3vmx	380	16	transplantation	transplantation	NN
cord-273505-pcsw3vmx	380	17	IVIg	ivig	NN
cord-273505-pcsw3vmx	380	18	-	-	HYPH
cord-273505-pcsw3vmx	380	19	mediated	mediate	VBN
cord-273505-pcsw3vmx	380	20	amelioration	amelioration	NN
cord-273505-pcsw3vmx	380	21	of	of	IN
cord-273505-pcsw3vmx	380	22	murine	murine	JJ
cord-273505-pcsw3vmx	380	23	ITP	ITP	NNP
cord-273505-pcsw3vmx	380	24	via	via	IN
cord-273505-pcsw3vmx	380	25	FcgammaRIIB	FcgammaRIIB	NNP
cord-273505-pcsw3vmx	380	26	is	be	VBZ
cord-273505-pcsw3vmx	380	27	independent	independent	JJ
cord-273505-pcsw3vmx	380	28	of	of	IN
cord-273505-pcsw3vmx	380	29	SHIP1	SHIP1	NNP
cord-273505-pcsw3vmx	380	30	,	,	,
cord-273505-pcsw3vmx	380	31	SHP-1	SHP-1	NNP
cord-273505-pcsw3vmx	380	32	,	,	,
cord-273505-pcsw3vmx	380	33	and	and	CC
cord-273505-pcsw3vmx	381	1	Btk	btk	NN
cord-273505-pcsw3vmx	381	2	activity	activity	NN
cord-273505-pcsw3vmx	381	3	Suppression	suppression	NN
cord-273505-pcsw3vmx	381	4	of	of	IN
cord-273505-pcsw3vmx	381	5	IL-4-and	IL-4-and	NNP
cord-273505-pcsw3vmx	381	6	CD40-induced	CD40-induced	NNP
cord-273505-pcsw3vmx	381	7	B	b	NN
cord-273505-pcsw3vmx	381	8	-	-	HYPH
cord-273505-pcsw3vmx	381	9	lymphocyte	lymphocyte	NN
cord-273505-pcsw3vmx	381	10	activation	activation	NN
cord-273505-pcsw3vmx	381	11	by	by	IN
cord-273505-pcsw3vmx	381	12	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	381	13	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	381	14	is	be	VBZ
cord-273505-pcsw3vmx	381	15	not	not	RB
cord-273505-pcsw3vmx	381	16	mediated	mediate	VBN
cord-273505-pcsw3vmx	381	17	through	through	IN
cord-273505-pcsw3vmx	381	18	the	the	DT
cord-273505-pcsw3vmx	381	19	inhibitory	inhibitory	JJ
cord-273505-pcsw3vmx	381	20	IgG	igg	NN
cord-273505-pcsw3vmx	381	21	receptor	receptor	NN
cord-273505-pcsw3vmx	381	22	FcgammaRIIb	FcgammaRIIb	NNP
cord-273505-pcsw3vmx	381	23	General	General	NNP
cord-273505-pcsw3vmx	381	24	mechanism	mechanism	NN
cord-273505-pcsw3vmx	381	25	for	for	IN
cord-273505-pcsw3vmx	381	26	modulating	modulate	VBG
cord-273505-pcsw3vmx	381	27	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	381	28	effector	effector	NN
cord-273505-pcsw3vmx	381	29	function	function	NN
cord-273505-pcsw3vmx	381	30	Crystal	Crystal	NNP
cord-273505-pcsw3vmx	381	31	structure	structure	NN
cord-273505-pcsw3vmx	381	32	of	of	IN
cord-273505-pcsw3vmx	381	33	sialylated	sialylated	JJ
cord-273505-pcsw3vmx	381	34	IgG	IgG	NNP
cord-273505-pcsw3vmx	381	35	Fc	Fc	NNP
cord-273505-pcsw3vmx	381	36	:	:	:
cord-273505-pcsw3vmx	381	37	implications	implication	NNS
cord-273505-pcsw3vmx	381	38	for	for	IN
cord-273505-pcsw3vmx	381	39	the	the	DT
cord-273505-pcsw3vmx	381	40	mechanism	mechanism	NN
cord-273505-pcsw3vmx	381	41	of	of	IN
cord-273505-pcsw3vmx	381	42	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	381	43	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	381	44	therapy	therapy	NN
cord-273505-pcsw3vmx	381	45	IVIg	IVIg	NNP
cord-273505-pcsw3vmx	381	46	modulates	modulate	VBZ
cord-273505-pcsw3vmx	381	47	BCR	BCR	NNP
cord-273505-pcsw3vmx	381	48	signaling	signal	VBG
cord-273505-pcsw3vmx	381	49	through	through	IN
cord-273505-pcsw3vmx	381	50	CD22	CD22	NNP
cord-273505-pcsw3vmx	381	51	and	and	CC
cord-273505-pcsw3vmx	381	52	promotes	promote	VBZ
cord-273505-pcsw3vmx	381	53	apoptosis	apoptosis	NN
cord-273505-pcsw3vmx	381	54	in	in	IN
cord-273505-pcsw3vmx	381	55	mature	mature	JJ
cord-273505-pcsw3vmx	381	56	human	human	JJ
cord-273505-pcsw3vmx	381	57	B	b	NN
cord-273505-pcsw3vmx	381	58	lymphocytes	lymphocyte	NNS
cord-273505-pcsw3vmx	382	1	Sialic	Sialic	NNP
cord-273505-pcsw3vmx	382	2	acid	acid	NN
cord-273505-pcsw3vmx	382	3	-	-	HYPH
cord-273505-pcsw3vmx	382	4	IVIg	ivig	JJ
cord-273505-pcsw3vmx	382	5	targeting	target	VBG
cord-273505-pcsw3vmx	382	6	CD22	CD22	NNP
cord-273505-pcsw3vmx	382	7	IVIg	ivig	NN
cord-273505-pcsw3vmx	382	8	attenuates	attenuate	VBZ
cord-273505-pcsw3vmx	382	9	TLR-9	TLR-9	NNP
cord-273505-pcsw3vmx	382	10	activation	activation	NN
cord-273505-pcsw3vmx	382	11	in	in	IN
cord-273505-pcsw3vmx	382	12	B	b	NN
cord-273505-pcsw3vmx	382	13	cells	cell	NNS
cord-273505-pcsw3vmx	382	14	from	from	IN
cord-273505-pcsw3vmx	382	15	SLE	SLE	NNP
cord-273505-pcsw3vmx	382	16	patients	patient	NNS
cord-273505-pcsw3vmx	383	1	TLR9	tlr9	JJ
cord-273505-pcsw3vmx	383	2	responses	response	NNS
cord-273505-pcsw3vmx	383	3	of	of	IN
cord-273505-pcsw3vmx	383	4	B	b	NN
cord-273505-pcsw3vmx	383	5	cells	cell	NNS
cord-273505-pcsw3vmx	383	6	are	be	VBP
cord-273505-pcsw3vmx	383	7	repressed	repress	VBN
cord-273505-pcsw3vmx	383	8	by	by	IN
cord-273505-pcsw3vmx	383	9	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	383	10	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	383	11	through	through	IN
cord-273505-pcsw3vmx	383	12	the	the	DT
cord-273505-pcsw3vmx	383	13	recruitment	recruitment	NN
cord-273505-pcsw3vmx	383	14	of	of	IN
cord-273505-pcsw3vmx	383	15	phosphatase	phosphatase	NN
cord-273505-pcsw3vmx	383	16	Prominent	Prominent	NNP
cord-273505-pcsw3vmx	383	17	plasmacytosis	plasmacytosis	NN
cord-273505-pcsw3vmx	383	18	following	follow	VBG
cord-273505-pcsw3vmx	383	19	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	383	20	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	383	21	correlates	correlate	VBZ
cord-273505-pcsw3vmx	383	22	with	with	IN
cord-273505-pcsw3vmx	383	23	clinical	clinical	JJ
cord-273505-pcsw3vmx	383	24	improvement	improvement	NN
cord-273505-pcsw3vmx	383	25	in	in	IN
cord-273505-pcsw3vmx	383	26	Guillain	Guillain	NNP
cord-273505-pcsw3vmx	383	27	-	-	HYPH
cord-273505-pcsw3vmx	383	28	Barré	Barré	NNP
cord-273505-pcsw3vmx	383	29	syndrome	syndrome	NN
cord-273505-pcsw3vmx	383	30	IVIg	ivig	NN
cord-273505-pcsw3vmx	383	31	-	-	HYPH
cord-273505-pcsw3vmx	383	32	induced	induce	VBN
cord-273505-pcsw3vmx	383	33	plasmablasts	plasmablast	NNS
cord-273505-pcsw3vmx	383	34	in	in	IN
cord-273505-pcsw3vmx	383	35	patients	patient	NNS
cord-273505-pcsw3vmx	383	36	with	with	IN
cord-273505-pcsw3vmx	383	37	Guillain	Guillain	NNP
cord-273505-pcsw3vmx	383	38	-	-	HYPH
cord-273505-pcsw3vmx	383	39	Barre	Barre	NNP
cord-273505-pcsw3vmx	383	40	syndrome	syndrome	NN
cord-273505-pcsw3vmx	383	41	Modulation	modulation	NN
cord-273505-pcsw3vmx	383	42	of	of	IN
cord-273505-pcsw3vmx	383	43	dengue	dengue	NN
cord-273505-pcsw3vmx	383	44	/	/	SYM
cord-273505-pcsw3vmx	383	45	zika	zika	NNP
cord-273505-pcsw3vmx	383	46	virus	virus	NN
cord-273505-pcsw3vmx	383	47	pathogenicity	pathogenicity	NN
cord-273505-pcsw3vmx	383	48	by	by	IN
cord-273505-pcsw3vmx	383	49	antibody	antibody	NN
cord-273505-pcsw3vmx	383	50	-	-	HYPH
cord-273505-pcsw3vmx	383	51	dependent	dependent	JJ
cord-273505-pcsw3vmx	383	52	enhancement	enhancement	NN
cord-273505-pcsw3vmx	383	53	and	and	CC
cord-273505-pcsw3vmx	383	54	strategies	strategy	NNS
cord-273505-pcsw3vmx	383	55	to	to	TO
cord-273505-pcsw3vmx	383	56	protect	protect	VB
cord-273505-pcsw3vmx	383	57	against	against	IN
cord-273505-pcsw3vmx	383	58	enhancement	enhancement	NN
cord-273505-pcsw3vmx	383	59	in	in	IN
cord-273505-pcsw3vmx	383	60	zika	zika	NNP
cord-273505-pcsw3vmx	383	61	virus	virus	NN
cord-273505-pcsw3vmx	383	62	infection	infection	NN
cord-273505-pcsw3vmx	383	63	Ross	Ross	NNP
cord-273505-pcsw3vmx	383	64	River	River	NNP
cord-273505-pcsw3vmx	383	65	virus	virus	NN
cord-273505-pcsw3vmx	383	66	:	:	:
cord-273505-pcsw3vmx	383	67	molecular	molecular	JJ
cord-273505-pcsw3vmx	383	68	and	and	CC
cord-273505-pcsw3vmx	383	69	cellular	cellular	JJ
cord-273505-pcsw3vmx	383	70	aspects	aspect	NNS
cord-273505-pcsw3vmx	383	71	of	of	IN
cord-273505-pcsw3vmx	383	72	disease	disease	NN
cord-273505-pcsw3vmx	383	73	pathogenesis	pathogenesis	NN
cord-273505-pcsw3vmx	383	74	Fc	Fc	NNP
cord-273505-pcsw3vmx	383	75	receptors	receptor	NNS
cord-273505-pcsw3vmx	383	76	in	in	IN
cord-273505-pcsw3vmx	383	77	antibody	antibody	NN
cord-273505-pcsw3vmx	383	78	-	-	HYPH
cord-273505-pcsw3vmx	383	79	dependent	dependent	JJ
cord-273505-pcsw3vmx	383	80	enhancement	enhancement	NN
cord-273505-pcsw3vmx	383	81	of	of	IN
cord-273505-pcsw3vmx	383	82	viral	viral	JJ
cord-273505-pcsw3vmx	383	83	infections	infection	NNS
cord-273505-pcsw3vmx	383	84	Antibody	Antibody	NNP
cord-273505-pcsw3vmx	383	85	responses	response	NNS
cord-273505-pcsw3vmx	383	86	against	against	IN
cord-273505-pcsw3vmx	383	87	SARS	SARS	NNP
cord-273505-pcsw3vmx	383	88	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	383	89	are	be	VBP
cord-273505-pcsw3vmx	383	90	correlated	correlate	VBN
cord-273505-pcsw3vmx	383	91	with	with	IN
cord-273505-pcsw3vmx	383	92	disease	disease	NN
cord-273505-pcsw3vmx	383	93	outcome	outcome	NN
cord-273505-pcsw3vmx	383	94	of	of	IN
cord-273505-pcsw3vmx	383	95	infected	infected	JJ
cord-273505-pcsw3vmx	383	96	individuals	individual	NNS
cord-273505-pcsw3vmx	383	97	Mechanism	Mechanism	NNP
cord-273505-pcsw3vmx	383	98	of	of	IN
cord-273505-pcsw3vmx	383	99	antibody	antibody	NN
cord-273505-pcsw3vmx	383	100	-	-	HYPH
cord-273505-pcsw3vmx	383	101	dependent	dependent	JJ
cord-273505-pcsw3vmx	383	102	enhancement	enhancement	NN
cord-273505-pcsw3vmx	383	103	in	in	IN
cord-273505-pcsw3vmx	383	104	severe	severe	JJ
cord-273505-pcsw3vmx	383	105	acute	acute	JJ
cord-273505-pcsw3vmx	383	106	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	383	107	syndrome	syndrome	NN
cord-273505-pcsw3vmx	383	108	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	383	109	infection	infection	NN
cord-273505-pcsw3vmx	383	110	(	(	-LRB-
cord-273505-pcsw3vmx	383	111	dissertation	dissertation	NN
cord-273505-pcsw3vmx	383	112	)	)	-RRB-
cord-273505-pcsw3vmx	383	113	.	.	.
cord-273505-pcsw3vmx	384	1	The	the	DT
cord-273505-pcsw3vmx	384	2	University	University	NNP
cord-273505-pcsw3vmx	384	3	of	of	IN
cord-273505-pcsw3vmx	384	4	Hong	Hong	NNP
cord-273505-pcsw3vmx	384	5	Kong	Kong	NNP
cord-273505-pcsw3vmx	384	6	Antibodydependent	Antibodydependent	NNP
cord-273505-pcsw3vmx	384	7	infection	infection	NN
cord-273505-pcsw3vmx	384	8	of	of	IN
cord-273505-pcsw3vmx	384	9	human	human	JJ
cord-273505-pcsw3vmx	384	10	macrophages	macrophage	NNS
cord-273505-pcsw3vmx	384	11	by	by	IN
cord-273505-pcsw3vmx	384	12	severe	severe	JJ
cord-273505-pcsw3vmx	384	13	acute	acute	JJ
cord-273505-pcsw3vmx	384	14	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	384	15	syndrome	syndrome	NN
cord-273505-pcsw3vmx	384	16	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	384	17	Molecular	molecular	JJ
cord-273505-pcsw3vmx	384	18	mechanism	mechanism	NN
cord-273505-pcsw3vmx	384	19	for	for	IN
cord-273505-pcsw3vmx	384	20	antibody	antibody	NN
cord-273505-pcsw3vmx	384	21	-	-	HYPH
cord-273505-pcsw3vmx	384	22	dependent	dependent	JJ
cord-273505-pcsw3vmx	384	23	enhancement	enhancement	NN
cord-273505-pcsw3vmx	384	24	of	of	IN
cord-273505-pcsw3vmx	384	25	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	384	26	entry	entry	NN
cord-273505-pcsw3vmx	384	27	Antibody	antibody	NN
cord-273505-pcsw3vmx	384	28	-	-	HYPH
cord-273505-pcsw3vmx	384	29	dependent	dependent	JJ
cord-273505-pcsw3vmx	384	30	enhancement	enhancement	NN
cord-273505-pcsw3vmx	384	31	of	of	IN
cord-273505-pcsw3vmx	384	32	influenza	influenza	NN
cord-273505-pcsw3vmx	384	33	disease	disease	NN
cord-273505-pcsw3vmx	384	34	promoted	promote	VBN
cord-273505-pcsw3vmx	384	35	by	by	IN
cord-273505-pcsw3vmx	384	36	increase	increase	NN
cord-273505-pcsw3vmx	384	37	in	in	IN
cord-273505-pcsw3vmx	384	38	hemagglutinin	hemagglutinin	NN
cord-273505-pcsw3vmx	384	39	stem	stem	NN
cord-273505-pcsw3vmx	384	40	flexibility	flexibility	NN
cord-273505-pcsw3vmx	384	41	and	and	CC
cord-273505-pcsw3vmx	385	1	virus	virus	NN
cord-273505-pcsw3vmx	385	2	fusion	fusion	NN
cord-273505-pcsw3vmx	385	3	kinetics	kinetics	NNP
cord-273505-pcsw3vmx	385	4	Vaccine	Vaccine	NNP
cord-273505-pcsw3vmx	385	5	-	-	HYPH
cord-273505-pcsw3vmx	385	6	induced	induce	VBN
cord-273505-pcsw3vmx	385	7	anti	anti	NNP
cord-273505-pcsw3vmx	385	8	-	-	JJ
cord-273505-pcsw3vmx	385	9	HA2	ha2	JJ
cord-273505-pcsw3vmx	385	10	antibodies	antibody	NNS
cord-273505-pcsw3vmx	385	11	promote	promote	VBP
cord-273505-pcsw3vmx	385	12	virus	virus	NN
cord-273505-pcsw3vmx	385	13	fusion	fusion	NN
cord-273505-pcsw3vmx	385	14	and	and	CC
cord-273505-pcsw3vmx	385	15	enhance	enhance	VB
cord-273505-pcsw3vmx	385	16	influenza	influenza	NN
cord-273505-pcsw3vmx	385	17	virus	virus	NN
cord-273505-pcsw3vmx	385	18	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	385	19	disease	disease	NN
cord-273505-pcsw3vmx	385	20	Fc	Fc	NNP
cord-273505-pcsw3vmx	385	21	-	-	HYPH
cord-273505-pcsw3vmx	385	22	Mediated	mediate	VBN
cord-273505-pcsw3vmx	385	23	antibody	antibody	NN
cord-273505-pcsw3vmx	385	24	effector	effector	NN
cord-273505-pcsw3vmx	385	25	functions	function	NNS
cord-273505-pcsw3vmx	385	26	during	during	IN
cord-273505-pcsw3vmx	385	27	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	385	28	syncytial	syncytial	JJ
cord-273505-pcsw3vmx	385	29	virus	virus	NN
cord-273505-pcsw3vmx	385	30	infection	infection	NN
cord-273505-pcsw3vmx	385	31	and	and	CC
cord-273505-pcsw3vmx	385	32	disease	disease	NN
cord-273505-pcsw3vmx	385	33	Respiratory	respiratory	JJ
cord-273505-pcsw3vmx	385	34	syncytial	syncytial	JJ
cord-273505-pcsw3vmx	385	35	virus	virus	NN
cord-273505-pcsw3vmx	385	36	infects	infect	VBZ
cord-273505-pcsw3vmx	385	37	primary	primary	JJ
cord-273505-pcsw3vmx	385	38	neonatal	neonatal	NN
cord-273505-pcsw3vmx	385	39	and	and	CC
cord-273505-pcsw3vmx	385	40	adult	adult	NN
cord-273505-pcsw3vmx	385	41	natural	natural	JJ
cord-273505-pcsw3vmx	385	42	killer	killer	NN
cord-273505-pcsw3vmx	385	43	cells	cell	NNS
cord-273505-pcsw3vmx	385	44	and	and	CC
cord-273505-pcsw3vmx	385	45	affects	affect	VBZ
cord-273505-pcsw3vmx	385	46	their	-PRON-	PRP$
cord-273505-pcsw3vmx	385	47	antiviral	antiviral	JJ
cord-273505-pcsw3vmx	385	48	effector	effector	NN
cord-273505-pcsw3vmx	385	49	function	function	NN
cord-273505-pcsw3vmx	386	1	In	in	IN
cord-273505-pcsw3vmx	386	2	vitro	vitro	FW
cord-273505-pcsw3vmx	386	3	enhancement	enhancement	NN
cord-273505-pcsw3vmx	386	4	of	of	IN
cord-273505-pcsw3vmx	386	5	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	386	6	syncytial	syncytial	JJ
cord-273505-pcsw3vmx	386	7	virus	virus	NN
cord-273505-pcsw3vmx	386	8	infection	infection	NN
cord-273505-pcsw3vmx	386	9	by	by	IN
cord-273505-pcsw3vmx	386	10	maternal	maternal	JJ
cord-273505-pcsw3vmx	386	11	antibodies	antibody	NNS
cord-273505-pcsw3vmx	386	12	does	do	VBZ
cord-273505-pcsw3vmx	386	13	not	not	RB
cord-273505-pcsw3vmx	386	14	explain	explain	VB
cord-273505-pcsw3vmx	386	15	disease	disease	NN
cord-273505-pcsw3vmx	386	16	severity	severity	NN
cord-273505-pcsw3vmx	386	17	in	in	IN
cord-273505-pcsw3vmx	386	18	infants	infant	NNS
cord-273505-pcsw3vmx	387	1	The	the	DT
cord-273505-pcsw3vmx	387	2	potential	potential	JJ
cord-273505-pcsw3vmx	387	3	danger	danger	NN
cord-273505-pcsw3vmx	387	4	of	of	IN
cord-273505-pcsw3vmx	387	5	suboptimal	suboptimal	JJ
cord-273505-pcsw3vmx	387	6	antibody	antibody	NN
cord-273505-pcsw3vmx	387	7	responses	response	NNS
cord-273505-pcsw3vmx	387	8	in	in	IN
cord-273505-pcsw3vmx	387	9	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	387	10	Viral	Viral	NNP
cord-273505-pcsw3vmx	387	11	-	-	HYPH
cord-273505-pcsw3vmx	387	12	induced	induce	VBN
cord-273505-pcsw3vmx	387	13	enhanced	enhanced	JJ
cord-273505-pcsw3vmx	387	14	disease	disease	NN
cord-273505-pcsw3vmx	387	15	illness	illness	NN
cord-273505-pcsw3vmx	388	1	Understanding	understand	VBG
cord-273505-pcsw3vmx	388	2	SARS	SARS	NNP
cord-273505-pcsw3vmx	388	3	-	-	HYPH
cord-273505-pcsw3vmx	388	4	CoV-2-mediated	cov-2-mediate	VBN
cord-273505-pcsw3vmx	388	5	inflammatory	inflammatory	JJ
cord-273505-pcsw3vmx	388	6	responses	response	NNS
cord-273505-pcsw3vmx	388	7	:	:	:
cord-273505-pcsw3vmx	388	8	from	from	IN
cord-273505-pcsw3vmx	388	9	mechanisms	mechanism	NNS
cord-273505-pcsw3vmx	388	10	to	to	IN
cord-273505-pcsw3vmx	388	11	potential	potential	JJ
cord-273505-pcsw3vmx	388	12	therapeutic	therapeutic	JJ
cord-273505-pcsw3vmx	388	13	tools	tool	NNS
cord-273505-pcsw3vmx	388	14	Impact	impact	NN
cord-273505-pcsw3vmx	388	15	of	of	IN
cord-273505-pcsw3vmx	388	16	immune	immune	JJ
cord-273505-pcsw3vmx	388	17	enhancement	enhancement	NN
cord-273505-pcsw3vmx	388	18	on	on	IN
cord-273505-pcsw3vmx	388	19	Covid-19	covid-19	JJ
cord-273505-pcsw3vmx	388	20	polyclonal	polyclonal	JJ
cord-273505-pcsw3vmx	388	21	hyperimmune	hyperimmune	NNP
cord-273505-pcsw3vmx	388	22	globulin	globulin	NNP
cord-273505-pcsw3vmx	388	23	therapy	therapy	NN
cord-273505-pcsw3vmx	388	24	and	and	CC
cord-273505-pcsw3vmx	388	25	vaccine	vaccine	NN
cord-273505-pcsw3vmx	388	26	development	development	NN
cord-273505-pcsw3vmx	388	27	Effective	effective	JJ
cord-273505-pcsw3vmx	388	28	prophylaxis	prophylaxis	NN
cord-273505-pcsw3vmx	388	29	of	of	IN
cord-273505-pcsw3vmx	388	30	influenza	influenza	NN
cord-273505-pcsw3vmx	388	31	A	a	DT
cord-273505-pcsw3vmx	388	32	virus	virus	NN
cord-273505-pcsw3vmx	388	33	pneumonia	pneumonia	NN
cord-273505-pcsw3vmx	388	34	in	in	IN
cord-273505-pcsw3vmx	388	35	mice	mouse	NNS
cord-273505-pcsw3vmx	388	36	by	by	IN
cord-273505-pcsw3vmx	388	37	topical	topical	JJ
cord-273505-pcsw3vmx	388	38	passive	passive	JJ
cord-273505-pcsw3vmx	388	39	immunotherapy	immunotherapy	NN
cord-273505-pcsw3vmx	388	40	with	with	IN
cord-273505-pcsw3vmx	388	41	polyvalent	polyvalent	JJ
cord-273505-pcsw3vmx	388	42	human	human	JJ
cord-273505-pcsw3vmx	388	43	immunoglobulins	immunoglobulin	NNS
cord-273505-pcsw3vmx	388	44	or	or	CC
cord-273505-pcsw3vmx	389	1	F(ab')2	f(ab')2	CD
cord-273505-pcsw3vmx	389	2	fragments	fragment	NNS
cord-273505-pcsw3vmx	390	1	Intravenous	intravenous	JJ
cord-273505-pcsw3vmx	390	2	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	390	3	protects	protect	VBZ
cord-273505-pcsw3vmx	390	4	against	against	IN
cord-273505-pcsw3vmx	390	5	severe	severe	JJ
cord-273505-pcsw3vmx	390	6	pandemic	pandemic	NN
cord-273505-pcsw3vmx	390	7	influenza	influenza	NN
cord-273505-pcsw3vmx	390	8	infection	infection	NN
cord-273505-pcsw3vmx	391	1	Topically	topically	RB
cord-273505-pcsw3vmx	391	2	administered	administer	VBN
cord-273505-pcsw3vmx	391	3	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	391	4	reduces	reduce	VBZ
cord-273505-pcsw3vmx	391	5	pulmonary	pulmonary	JJ
cord-273505-pcsw3vmx	391	6	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	391	7	syncytial	syncytial	JJ
cord-273505-pcsw3vmx	391	8	virus	virus	NN
cord-273505-pcsw3vmx	391	9	shedding	shed	VBG
cord-273505-pcsw3vmx	391	10	in	in	IN
cord-273505-pcsw3vmx	391	11	owl	owl	NN
cord-273505-pcsw3vmx	391	12	monkeys	monkeys	NNP
cord-273505-pcsw3vmx	391	13	Studies	Studies	NNPS
cord-273505-pcsw3vmx	391	14	of	of	IN
cord-273505-pcsw3vmx	391	15	passive	passive	JJ
cord-273505-pcsw3vmx	391	16	immunotherapy	immunotherapy	NN
cord-273505-pcsw3vmx	391	17	for	for	IN
cord-273505-pcsw3vmx	391	18	infections	infection	NNS
cord-273505-pcsw3vmx	391	19	of	of	IN
cord-273505-pcsw3vmx	391	20	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	391	21	syncytial	syncytial	JJ
cord-273505-pcsw3vmx	391	22	virus	virus	NN
cord-273505-pcsw3vmx	391	23	in	in	IN
cord-273505-pcsw3vmx	391	24	the	the	DT
cord-273505-pcsw3vmx	391	25	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	391	26	tract	tract	NN
cord-273505-pcsw3vmx	391	27	of	of	IN
cord-273505-pcsw3vmx	391	28	a	a	DT
cord-273505-pcsw3vmx	391	29	primate	primate	JJ
cord-273505-pcsw3vmx	391	30	model	model	NN
cord-273505-pcsw3vmx	391	31	Effectiveness	Effectiveness	NNP
cord-273505-pcsw3vmx	391	32	of	of	IN
cord-273505-pcsw3vmx	391	33	topically	topically	RB
cord-273505-pcsw3vmx	391	34	administered	administer	VBN
cord-273505-pcsw3vmx	391	35	neutralizing	neutralize	VBG
cord-273505-pcsw3vmx	391	36	antibodies	antibody	NNS
cord-273505-pcsw3vmx	391	37	in	in	IN
cord-273505-pcsw3vmx	391	38	experimental	experimental	JJ
cord-273505-pcsw3vmx	391	39	immunotherapy	immunotherapy	NN
cord-273505-pcsw3vmx	391	40	of	of	IN
cord-273505-pcsw3vmx	391	41	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	391	42	syncytial	syncytial	JJ
cord-273505-pcsw3vmx	391	43	virus	virus	NN
cord-273505-pcsw3vmx	391	44	infection	infection	NN
cord-273505-pcsw3vmx	391	45	in	in	IN
cord-273505-pcsw3vmx	391	46	cotton	cotton	NN
cord-273505-pcsw3vmx	391	47	rats	rat	NNS
cord-273505-pcsw3vmx	392	1	Effect	effect	NN
cord-273505-pcsw3vmx	392	2	of	of	IN
cord-273505-pcsw3vmx	392	3	regular	regular	JJ
cord-273505-pcsw3vmx	392	4	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	392	5	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	392	6	therapy	therapy	NN
cord-273505-pcsw3vmx	392	7	on	on	IN
cord-273505-pcsw3vmx	392	8	prognosis	prognosis	NN
cord-273505-pcsw3vmx	392	9	of	of	IN
cord-273505-pcsw3vmx	392	10	severe	severe	JJ
cord-273505-pcsw3vmx	392	11	pneumonia	pneumonia	NN
cord-273505-pcsw3vmx	392	12	in	in	IN
cord-273505-pcsw3vmx	392	13	patients	patient	NNS
cord-273505-pcsw3vmx	392	14	with	with	IN
cord-273505-pcsw3vmx	392	15	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	392	16	Clinical	clinical	JJ
cord-273505-pcsw3vmx	392	17	features	feature	NNS
cord-273505-pcsw3vmx	392	18	and	and	CC
cord-273505-pcsw3vmx	392	19	progression	progression	NN
cord-273505-pcsw3vmx	392	20	of	of	IN
cord-273505-pcsw3vmx	392	21	acute	acute	JJ
cord-273505-pcsw3vmx	392	22	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	392	23	distress	distress	NN
cord-273505-pcsw3vmx	392	24	syndrome	syndrome	NN
cord-273505-pcsw3vmx	392	25	in	in	IN
cord-273505-pcsw3vmx	392	26	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	392	27	disease	disease	NN
cord-273505-pcsw3vmx	392	28	2019	2019	CD
cord-273505-pcsw3vmx	392	29	.	.	.
cord-273505-pcsw3vmx	393	1	medRxiv	medRxiv	NNP
cord-273505-pcsw3vmx	393	2	Shortterm	shortterm	JJ
cord-273505-pcsw3vmx	393	3	moderate	moderate	JJ
cord-273505-pcsw3vmx	393	4	-	-	HYPH
cord-273505-pcsw3vmx	393	5	dose	dose	NN
cord-273505-pcsw3vmx	393	6	corticosteroid	corticosteroid	NN
cord-273505-pcsw3vmx	393	7	plus	plus	CC
cord-273505-pcsw3vmx	393	8	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	393	9	effectively	effectively	RB
cord-273505-pcsw3vmx	393	10	reverses	reverse	VBZ
cord-273505-pcsw3vmx	393	11	COVID-19	COVID-19	JJR
cord-273505-pcsw3vmx	393	12	patients	patient	NNS
cord-273505-pcsw3vmx	393	13	who	who	WP
cord-273505-pcsw3vmx	393	14	have	have	VBP
cord-273505-pcsw3vmx	393	15	failed	fail	VBN
cord-273505-pcsw3vmx	393	16	low	low	JJ
cord-273505-pcsw3vmx	393	17	-	-	HYPH
cord-273505-pcsw3vmx	393	18	dose	dose	NN
cord-273505-pcsw3vmx	393	19	therapy	therapy	NN
cord-273505-pcsw3vmx	393	20	Clinical	clinical	JJ
cord-273505-pcsw3vmx	393	21	manifestations	manifestation	NNS
cord-273505-pcsw3vmx	393	22	,	,	,
cord-273505-pcsw3vmx	393	23	laboratory	laboratory	NN
cord-273505-pcsw3vmx	393	24	findings	finding	NNS
cord-273505-pcsw3vmx	393	25	,	,	,
cord-273505-pcsw3vmx	393	26	and	and	CC
cord-273505-pcsw3vmx	393	27	treatment	treatment	NN
cord-273505-pcsw3vmx	393	28	outcomes	outcome	NNS
cord-273505-pcsw3vmx	393	29	of	of	IN
cord-273505-pcsw3vmx	393	30	SARS	SARS	NNP
cord-273505-pcsw3vmx	393	31	patients	patient	NNS
cord-273505-pcsw3vmx	393	32	Pentaglobin	Pentaglobin	NNP
cord-273505-pcsw3vmx	393	33	in	in	IN
cord-273505-pcsw3vmx	393	34	steroid	steroid	JJ
cord-273505-pcsw3vmx	393	35	-	-	HYPH
cord-273505-pcsw3vmx	393	36	resistant	resistant	JJ
cord-273505-pcsw3vmx	393	37	severe	severe	JJ
cord-273505-pcsw3vmx	393	38	acute	acute	JJ
cord-273505-pcsw3vmx	393	39	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	393	40	syndrome	syndrome	NN
cord-273505-pcsw3vmx	393	41	Clinical	clinical	JJ
cord-273505-pcsw3vmx	393	42	and	and	CC
cord-273505-pcsw3vmx	393	43	laboratory	laboratory	NN
cord-273505-pcsw3vmx	393	44	findings	finding	NNS
cord-273505-pcsw3vmx	393	45	of	of	IN
cord-273505-pcsw3vmx	393	46	the	the	DT
cord-273505-pcsw3vmx	393	47	first	first	JJ
cord-273505-pcsw3vmx	393	48	imported	import	VBN
cord-273505-pcsw3vmx	393	49	case	case	NN
cord-273505-pcsw3vmx	393	50	of	of	IN
cord-273505-pcsw3vmx	393	51	Middle	Middle	NNP
cord-273505-pcsw3vmx	393	52	East	East	NNP
cord-273505-pcsw3vmx	393	53	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	393	54	syndrome	syndrome	NN
cord-273505-pcsw3vmx	393	55	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	393	56	to	to	IN
cord-273505-pcsw3vmx	393	57	the	the	DT
cord-273505-pcsw3vmx	393	58	United	United	NNP
cord-273505-pcsw3vmx	393	59	States	States	NNP
cord-273505-pcsw3vmx	393	60	Hyperimmune	Hyperimmune	NNP
cord-273505-pcsw3vmx	393	61	IV	IV	NNP
cord-273505-pcsw3vmx	393	62	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	393	63	treatment	treatment	NN
cord-273505-pcsw3vmx	393	64	:	:	:
cord-273505-pcsw3vmx	393	65	a	a	DT
cord-273505-pcsw3vmx	393	66	multicenter	multicenter	JJ
cord-273505-pcsw3vmx	393	67	double	double	JJ
cord-273505-pcsw3vmx	393	68	-	-	HYPH
cord-273505-pcsw3vmx	393	69	blind	blind	JJ
cord-273505-pcsw3vmx	393	70	randomized	randomize	VBN
cord-273505-pcsw3vmx	393	71	controlled	control	VBN
cord-273505-pcsw3vmx	393	72	trial	trial	NN
cord-273505-pcsw3vmx	393	73	for	for	IN
cord-273505-pcsw3vmx	393	74	patients	patient	NNS
cord-273505-pcsw3vmx	393	75	with	with	IN
cord-273505-pcsw3vmx	393	76	severe	severe	JJ
cord-273505-pcsw3vmx	393	77	2009	2009	CD
cord-273505-pcsw3vmx	393	78	influenza	influenza	NN
cord-273505-pcsw3vmx	393	79	A(H1N1	a(h1n1	NN
cord-273505-pcsw3vmx	393	80	)	)	-RRB-
cord-273505-pcsw3vmx	393	81	infection	infection	NN
cord-273505-pcsw3vmx	393	82	High	high	JJ
cord-273505-pcsw3vmx	393	83	-	-	HYPH
cord-273505-pcsw3vmx	393	84	dose	dose	NN
cord-273505-pcsw3vmx	393	85	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	393	86	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	393	87	for	for	IN
cord-273505-pcsw3vmx	393	88	children	child	NNS
cord-273505-pcsw3vmx	393	89	with	with	IN
cord-273505-pcsw3vmx	393	90	severe	severe	JJ
cord-273505-pcsw3vmx	393	91	H1N1	H1N1	NNP
cord-273505-pcsw3vmx	393	92	influenza	influenza	NN
cord-273505-pcsw3vmx	393	93	infection	infection	NN
cord-273505-pcsw3vmx	393	94	Risk	risk	NN
cord-273505-pcsw3vmx	393	95	factors	factor	NNS
cord-273505-pcsw3vmx	393	96	and	and	CC
cord-273505-pcsw3vmx	393	97	containment	containment	NN
cord-273505-pcsw3vmx	393	98	of	of	IN
cord-273505-pcsw3vmx	393	99	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	393	100	syncytial	syncytial	JJ
cord-273505-pcsw3vmx	393	101	virus	virus	NN
cord-273505-pcsw3vmx	393	102	outbreak	outbreak	NN
cord-273505-pcsw3vmx	393	103	in	in	IN
cord-273505-pcsw3vmx	393	104	a	a	DT
cord-273505-pcsw3vmx	393	105	hematology	hematology	NN
cord-273505-pcsw3vmx	393	106	and	and	CC
cord-273505-pcsw3vmx	393	107	transplant	transplant	NN
cord-273505-pcsw3vmx	393	108	unit	unit	NN
cord-273505-pcsw3vmx	393	109	Treatment	treatment	NN
cord-273505-pcsw3vmx	393	110	stratification	stratification	NN
cord-273505-pcsw3vmx	393	111	of	of	IN
cord-273505-pcsw3vmx	393	112	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	393	113	syncytial	syncytial	JJ
cord-273505-pcsw3vmx	393	114	virus	virus	NN
cord-273505-pcsw3vmx	393	115	infection	infection	NN
cord-273505-pcsw3vmx	393	116	in	in	IN
cord-273505-pcsw3vmx	393	117	allogeneic	allogeneic	NN
cord-273505-pcsw3vmx	393	118	stem	stem	NN
cord-273505-pcsw3vmx	393	119	cell	cell	NN
cord-273505-pcsw3vmx	393	120	transplantation	transplantation	NN
cord-273505-pcsw3vmx	393	121	Respiratory	respiratory	JJ
cord-273505-pcsw3vmx	393	122	syncytial	syncytial	JJ
cord-273505-pcsw3vmx	393	123	virus	virus	NN
cord-273505-pcsw3vmx	393	124	upper	upper	JJ
cord-273505-pcsw3vmx	393	125	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	393	126	tract	tract	NN
cord-273505-pcsw3vmx	393	127	illnesses	illness	NNS
cord-273505-pcsw3vmx	393	128	in	in	IN
cord-273505-pcsw3vmx	393	129	adult	adult	NN
cord-273505-pcsw3vmx	393	130	blood	blood	NN
cord-273505-pcsw3vmx	393	131	and	and	CC
cord-273505-pcsw3vmx	393	132	marrow	marrow	NN
cord-273505-pcsw3vmx	393	133	transplant	transplant	NN
cord-273505-pcsw3vmx	393	134	recipients	recipient	NNS
cord-273505-pcsw3vmx	393	135	:	:	:
cord-273505-pcsw3vmx	393	136	combination	combination	NN
cord-273505-pcsw3vmx	393	137	therapy	therapy	NN
cord-273505-pcsw3vmx	393	138	with	with	IN
cord-273505-pcsw3vmx	393	139	aerosolized	aerosolized	JJ
cord-273505-pcsw3vmx	393	140	ribavirin	ribavirin	NN
cord-273505-pcsw3vmx	393	141	and	and	CC
cord-273505-pcsw3vmx	393	142	intravenous	intravenous	JJ
cord-273505-pcsw3vmx	393	143	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	393	144	Treatment	treatment	NN
cord-273505-pcsw3vmx	393	145	of	of	IN
cord-273505-pcsw3vmx	393	146	severe	severe	JJ
cord-273505-pcsw3vmx	393	147	acute	acute	JJ
cord-273505-pcsw3vmx	393	148	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	393	149	syndrome	syndrome	NN
cord-273505-pcsw3vmx	393	150	SARS	SARS	NNP
cord-273505-pcsw3vmx	393	151	:	:	:
cord-273505-pcsw3vmx	393	152	systematic	systematic	JJ
cord-273505-pcsw3vmx	393	153	review	review	NN
cord-273505-pcsw3vmx	393	154	of	of	IN
cord-273505-pcsw3vmx	393	155	treatment	treatment	NN
cord-273505-pcsw3vmx	393	156	effects	effect	NNS
cord-273505-pcsw3vmx	393	157	Effects	effect	NNS
cord-273505-pcsw3vmx	393	158	of	of	IN
cord-273505-pcsw3vmx	393	159	pentoxifyllin	pentoxifyllin	NN
cord-273505-pcsw3vmx	393	160	and	and	CC
cord-273505-pcsw3vmx	393	161	pentaglobinO	pentaglobinO	NNP
cord-273505-pcsw3vmx	393	162	on	on	IN
cord-273505-pcsw3vmx	393	163	TNF	TNF	NNP
cord-273505-pcsw3vmx	393	164	and	and	CC
cord-273505-pcsw3vmx	393	165	IL-6	IL-6	NNP
cord-273505-pcsw3vmx	393	166	production	production	NN
cord-273505-pcsw3vmx	393	167	in	in	IN
cord-273505-pcsw3vmx	393	168	septic	septic	JJ
cord-273505-pcsw3vmx	393	169	patients	patient	NNS
cord-273505-pcsw3vmx	394	1	Clinical	clinical	JJ
cord-273505-pcsw3vmx	394	2	course	course	NN
cord-273505-pcsw3vmx	394	3	and	and	CC
cord-273505-pcsw3vmx	394	4	outcomes	outcome	NNS
cord-273505-pcsw3vmx	394	5	of	of	IN
cord-273505-pcsw3vmx	394	6	critically	critically	RB
cord-273505-pcsw3vmx	394	7	ill	ill	JJ
cord-273505-pcsw3vmx	394	8	patients	patient	NNS
cord-273505-pcsw3vmx	394	9	with	with	IN
cord-273505-pcsw3vmx	394	10	Middle	Middle	NNP
cord-273505-pcsw3vmx	394	11	East	East	NNP
cord-273505-pcsw3vmx	394	12	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	394	13	syndrome	syndrome	NN
cord-273505-pcsw3vmx	394	14	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	394	15	infection	infection	NN
cord-273505-pcsw3vmx	395	1	The	the	DT
cord-273505-pcsw3vmx	395	2	cytokine	cytokine	NN
cord-273505-pcsw3vmx	395	3	storm	storm	NN
cord-273505-pcsw3vmx	395	4	of	of	IN
cord-273505-pcsw3vmx	395	5	severe	severe	JJ
cord-273505-pcsw3vmx	395	6	influenza	influenza	NN
cord-273505-pcsw3vmx	395	7	and	and	CC
cord-273505-pcsw3vmx	395	8	development	development	NN
cord-273505-pcsw3vmx	395	9	of	of	IN
cord-273505-pcsw3vmx	395	10	immunomodulatory	immunomodulatory	JJ
cord-273505-pcsw3vmx	395	11	therapy	therapy	NN
cord-273505-pcsw3vmx	395	12	Respiratory	respiratory	JJ
cord-273505-pcsw3vmx	395	13	syncytial	syncytial	JJ
cord-273505-pcsw3vmx	395	14	virus	virus	NN
cord-273505-pcsw3vmx	395	15	:	:	:
cord-273505-pcsw3vmx	395	16	prospects	prospect	NNS
cord-273505-pcsw3vmx	395	17	for	for	IN
cord-273505-pcsw3vmx	395	18	new	new	JJ
cord-273505-pcsw3vmx	395	19	and	and	CC
cord-273505-pcsw3vmx	395	20	emerging	emerge	VBG
cord-273505-pcsw3vmx	395	21	therapeutics	therapeutic	NNS
cord-273505-pcsw3vmx	395	22	Management	Management	NNP
cord-273505-pcsw3vmx	395	23	of	of	IN
cord-273505-pcsw3vmx	395	24	RSV	RSV	NNP
cord-273505-pcsw3vmx	395	25	infections	infection	NNS
cord-273505-pcsw3vmx	395	26	in	in	IN
cord-273505-pcsw3vmx	395	27	adult	adult	NN
cord-273505-pcsw3vmx	395	28	recipients	recipient	NNS
cord-273505-pcsw3vmx	395	29	of	of	IN
cord-273505-pcsw3vmx	395	30	hematopoietic	hematopoietic	JJ
cord-273505-pcsw3vmx	395	31	stem	stem	NN
cord-273505-pcsw3vmx	395	32	cell	cell	NN
cord-273505-pcsw3vmx	395	33	transplantation	transplantation	NN
cord-273505-pcsw3vmx	395	34	Impact	impact	NN
cord-273505-pcsw3vmx	395	35	of	of	IN
cord-273505-pcsw3vmx	395	36	aerosolized	aerosolize	VBN
cord-273505-pcsw3vmx	395	37	ribavirin	ribavirin	NN
cord-273505-pcsw3vmx	395	38	on	on	IN
cord-273505-pcsw3vmx	395	39	mortality	mortality	NN
cord-273505-pcsw3vmx	395	40	in	in	IN
cord-273505-pcsw3vmx	395	41	280	280	CD
cord-273505-pcsw3vmx	395	42	allogeneic	allogeneic	IN
cord-273505-pcsw3vmx	395	43	haematopoietic	haematopoietic	JJ
cord-273505-pcsw3vmx	395	44	stem	stem	NN
cord-273505-pcsw3vmx	395	45	cell	cell	NN
cord-273505-pcsw3vmx	395	46	transplant	transplant	NN
cord-273505-pcsw3vmx	395	47	recipients	recipient	NNS
cord-273505-pcsw3vmx	395	48	with	with	IN
cord-273505-pcsw3vmx	395	49	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	395	50	syncytial	syncytial	JJ
cord-273505-pcsw3vmx	395	51	virus	virus	NN
cord-273505-pcsw3vmx	395	52	infections	infection	NNS
cord-273505-pcsw3vmx	395	53	ECIL-4	ECIL-4	NNP
cord-273505-pcsw3vmx	395	54	)	)	-RRB-
cord-273505-pcsw3vmx	395	55	:	:	:
cord-273505-pcsw3vmx	395	56	guidelines	guideline	NNS
cord-273505-pcsw3vmx	395	57	for	for	IN
cord-273505-pcsw3vmx	395	58	diagnosis	diagnosis	NN
cord-273505-pcsw3vmx	395	59	and	and	CC
cord-273505-pcsw3vmx	395	60	treatment	treatment	NN
cord-273505-pcsw3vmx	395	61	of	of	IN
cord-273505-pcsw3vmx	395	62	human	human	JJ
cord-273505-pcsw3vmx	395	63	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	395	64	syncytial	syncytial	JJ
cord-273505-pcsw3vmx	395	65	virus	virus	NN
cord-273505-pcsw3vmx	395	66	,	,	,
cord-273505-pcsw3vmx	395	67	parainfluenza	parainfluenza	NNP
cord-273505-pcsw3vmx	395	68	virus	virus	NNP
cord-273505-pcsw3vmx	395	69	,	,	,
cord-273505-pcsw3vmx	395	70	metapneumovirus	metapneumovirus	NNP
cord-273505-pcsw3vmx	395	71	,	,	,
cord-273505-pcsw3vmx	395	72	rhinovirus	rhinovirus	NN
cord-273505-pcsw3vmx	395	73	,	,	,
cord-273505-pcsw3vmx	395	74	and	and	CC
cord-273505-pcsw3vmx	395	75	coronavirus	coronavirus	NN
cord-273505-pcsw3vmx	395	76	Effective	effective	JJ
cord-273505-pcsw3vmx	395	77	use	use	NN
cord-273505-pcsw3vmx	395	78	of	of	IN
cord-273505-pcsw3vmx	395	79	oral	oral	JJ
cord-273505-pcsw3vmx	395	80	ribavirin	ribavirin	NN
cord-273505-pcsw3vmx	395	81	for	for	IN
cord-273505-pcsw3vmx	395	82	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	395	83	syncytial	syncytial	JJ
cord-273505-pcsw3vmx	395	84	viral	viral	JJ
cord-273505-pcsw3vmx	395	85	infections	infection	NNS
cord-273505-pcsw3vmx	395	86	in	in	IN
cord-273505-pcsw3vmx	395	87	allogeneic	allogeneic	JJ
cord-273505-pcsw3vmx	395	88	haematopoietic	haematopoietic	JJ
cord-273505-pcsw3vmx	395	89	stem	stem	NN
cord-273505-pcsw3vmx	395	90	cell	cell	NN
cord-273505-pcsw3vmx	395	91	transplant	transplant	NN
cord-273505-pcsw3vmx	395	92	recipients	recipient	NNS
cord-273505-pcsw3vmx	395	93	Community	Community	NNP
cord-273505-pcsw3vmx	395	94	acquired	acquire	VBD
cord-273505-pcsw3vmx	395	95	respiratory	respiratory	JJ
cord-273505-pcsw3vmx	395	96	virus	virus	NN
cord-273505-pcsw3vmx	395	97	infections	infection	NNS
cord-273505-pcsw3vmx	395	98	in	in	IN
cord-273505-pcsw3vmx	395	99	cancer	cancer	NN
cord-273505-pcsw3vmx	395	100	patients	patient	NNS
cord-273505-pcsw3vmx	395	101	-	-	:
cord-273505-pcsw3vmx	395	102	Guideline	Guideline	NNP
cord-273505-pcsw3vmx	395	103	on	on	IN
cord-273505-pcsw3vmx	395	104	diagnosis	diagnosis	NN
cord-273505-pcsw3vmx	395	105	and	and	CC
cord-273505-pcsw3vmx	395	106	management	management	NN
cord-273505-pcsw3vmx	395	107	by	by	IN
cord-273505-pcsw3vmx	395	108	the	the	DT
cord-273505-pcsw3vmx	395	109	Infectious	Infectious	NNP
cord-273505-pcsw3vmx	395	110	Diseases	Diseases	NNPS
cord-273505-pcsw3vmx	395	111	Working	Working	NNP
cord-273505-pcsw3vmx	395	112	Party	Party	NNP
cord-273505-pcsw3vmx	395	113	of	of	IN
cord-273505-pcsw3vmx	395	114	the	the	DT
cord-273505-pcsw3vmx	395	115	German	German	NNP
cord-273505-pcsw3vmx	395	116	Society	Society	NNP
cord-273505-pcsw3vmx	395	117	for	for	IN
cord-273505-pcsw3vmx	395	118	haematology	haematology	NNP
cord-273505-pcsw3vmx	395	119	and	and	CC
cord-273505-pcsw3vmx	395	120	Medical	Medical	NNP
cord-273505-pcsw3vmx	395	121	Oncology	Oncology	NNP
cord-273505-pcsw3vmx	395	122	Adverse	adverse	JJ
cord-273505-pcsw3vmx	395	123	effects	effect	NNS
cord-273505-pcsw3vmx	395	124	of	of	IN
cord-273505-pcsw3vmx	395	125	immunoglobulin	immunoglobulin	NN
cord-273505-pcsw3vmx	395	126	therapy	therapy	NN
cord-273505-pcsw3vmx	395	127	COVID-19	COVID-19	NNP
cord-273505-pcsw3vmx	395	128	and	and	CC
cord-273505-pcsw3vmx	395	129	thrombotic	thrombotic	JJ
cord-273505-pcsw3vmx	395	130	or	or	CC
cord-273505-pcsw3vmx	395	131	thromboembolic	thromboembolic	JJ
cord-273505-pcsw3vmx	395	132	disease	disease	NN
cord-273505-pcsw3vmx	395	133	:	:	:
cord-273505-pcsw3vmx	395	134	implications	implication	NNS
cord-273505-pcsw3vmx	395	135	for	for	IN
cord-273505-pcsw3vmx	395	136	prevention	prevention	NN
cord-273505-pcsw3vmx	395	137	,	,	,
cord-273505-pcsw3vmx	395	138	antithrombotic	antithrombotic	JJ
cord-273505-pcsw3vmx	395	139	therapy	therapy	NN
cord-273505-pcsw3vmx	395	140	,	,	,
cord-273505-pcsw3vmx	395	141	and	and	CC
cord-273505-pcsw3vmx	395	142	follow	follow	NN
cord-273505-pcsw3vmx	395	143	-	-	HYPH
cord-273505-pcsw3vmx	395	144	up	up	NN
cord-273505-pcsw3vmx	396	1	The	the	DT
cord-273505-pcsw3vmx	396	2	authors	author	NNS
cord-273505-pcsw3vmx	396	3	declare	declare	VBP
cord-273505-pcsw3vmx	396	4	that	that	IN
cord-273505-pcsw3vmx	396	5	the	the	DT
cord-273505-pcsw3vmx	396	6	research	research	NN
cord-273505-pcsw3vmx	396	7	was	be	VBD
cord-273505-pcsw3vmx	396	8	conducted	conduct	VBN
cord-273505-pcsw3vmx	396	9	in	in	IN
cord-273505-pcsw3vmx	396	10	the	the	DT
cord-273505-pcsw3vmx	396	11	absence	absence	NN
cord-273505-pcsw3vmx	396	12	of	of	IN
cord-273505-pcsw3vmx	396	13	any	any	DT
cord-273505-pcsw3vmx	396	14	commercial	commercial	JJ
cord-273505-pcsw3vmx	396	15	or	or	CC
cord-273505-pcsw3vmx	396	16	financial	financial	JJ
cord-273505-pcsw3vmx	396	17	relationships	relationship	NNS
cord-273505-pcsw3vmx	396	18	that	that	WDT
cord-273505-pcsw3vmx	396	19	could	could	MD
cord-273505-pcsw3vmx	396	20	be	be	VB
cord-273505-pcsw3vmx	396	21	construed	construe	VBN
cord-273505-pcsw3vmx	396	22	as	as	IN
cord-273505-pcsw3vmx	396	23	a	a	DT
cord-273505-pcsw3vmx	396	24	potential	potential	JJ
cord-273505-pcsw3vmx	396	25	conflict	conflict	NN
cord-273505-pcsw3vmx	396	26	of	of	IN
cord-273505-pcsw3vmx	396	27	interest	interest	NN
cord-273505-pcsw3vmx	396	28	.	.	.
cord-273505-pcsw3vmx	397	1	Copyright	copyright	NN
cord-273505-pcsw3vmx	397	2	©	©	NNP
cord-273505-pcsw3vmx	397	3	2020	2020	CD
cord-273505-pcsw3vmx	397	4	Liu	Liu	NNP
cord-273505-pcsw3vmx	397	5	,	,	,
cord-273505-pcsw3vmx	397	6	Cao	Cao	NNP
cord-273505-pcsw3vmx	397	7	and	and	CC
cord-273505-pcsw3vmx	397	8	Li	Li	NNP
cord-273505-pcsw3vmx	397	9	.	.	.
cord-273505-pcsw3vmx	398	1	This	this	DT
cord-273505-pcsw3vmx	398	2	is	be	VBZ
cord-273505-pcsw3vmx	398	3	an	an	DT
cord-273505-pcsw3vmx	398	4	open	open	JJ
cord-273505-pcsw3vmx	398	5	-	-	HYPH
cord-273505-pcsw3vmx	398	6	access	access	NN
cord-273505-pcsw3vmx	398	7	article	article	NN
cord-273505-pcsw3vmx	398	8	distributed	distribute	VBN
cord-273505-pcsw3vmx	398	9	under	under	IN
cord-273505-pcsw3vmx	398	10	the	the	DT
cord-273505-pcsw3vmx	398	11	terms	term	NNS
cord-273505-pcsw3vmx	398	12	of	of	IN
cord-273505-pcsw3vmx	398	13	the	the	DT
cord-273505-pcsw3vmx	398	14	Creative	Creative	NNP
cord-273505-pcsw3vmx	398	15	Commons	Commons	NNP
cord-273505-pcsw3vmx	398	16	Attribution	Attribution	NNP
cord-273505-pcsw3vmx	398	17	License	License	NNP
cord-273505-pcsw3vmx	398	18	(	(	-LRB-
cord-273505-pcsw3vmx	398	19	CC	CC	NNP
cord-273505-pcsw3vmx	398	20	BY	BY	NNP
cord-273505-pcsw3vmx	398	21	)	)	-RRB-
cord-273505-pcsw3vmx	398	22	.	.	.
cord-273505-pcsw3vmx	399	1	The	the	DT
cord-273505-pcsw3vmx	399	2	use	use	NN
cord-273505-pcsw3vmx	399	3	,	,	,
cord-273505-pcsw3vmx	399	4	distribution	distribution	NN
cord-273505-pcsw3vmx	399	5	or	or	CC
cord-273505-pcsw3vmx	399	6	reproduction	reproduction	NN
cord-273505-pcsw3vmx	399	7	in	in	IN
cord-273505-pcsw3vmx	399	8	other	other	JJ
cord-273505-pcsw3vmx	399	9	forums	forum	NNS
cord-273505-pcsw3vmx	399	10	is	be	VBZ
cord-273505-pcsw3vmx	399	11	permitted	permit	VBN
cord-273505-pcsw3vmx	399	12	,	,	,
cord-273505-pcsw3vmx	399	13	provided	provide	VBD
cord-273505-pcsw3vmx	399	14	the	the	DT
cord-273505-pcsw3vmx	399	15	original	original	JJ
cord-273505-pcsw3vmx	399	16	author(s	author(s	NNP
cord-273505-pcsw3vmx	399	17	)	)	-RRB-
cord-273505-pcsw3vmx	399	18	and	and	CC
cord-273505-pcsw3vmx	399	19	the	the	DT
cord-273505-pcsw3vmx	399	20	copyright	copyright	NN
cord-273505-pcsw3vmx	399	21	owner(s	owner(s	NNP
cord-273505-pcsw3vmx	399	22	)	)	-RRB-
cord-273505-pcsw3vmx	399	23	are	be	VBP
cord-273505-pcsw3vmx	399	24	credited	credit	VBN
cord-273505-pcsw3vmx	399	25	and	and	CC
cord-273505-pcsw3vmx	399	26	that	that	IN
cord-273505-pcsw3vmx	399	27	the	the	DT
cord-273505-pcsw3vmx	399	28	original	original	JJ
cord-273505-pcsw3vmx	399	29	publication	publication	NN
cord-273505-pcsw3vmx	399	30	in	in	IN
cord-273505-pcsw3vmx	399	31	this	this	DT
cord-273505-pcsw3vmx	399	32	journal	journal	NN
cord-273505-pcsw3vmx	399	33	is	be	VBZ
cord-273505-pcsw3vmx	399	34	cited	cite	VBN
cord-273505-pcsw3vmx	399	35	,	,	,
cord-273505-pcsw3vmx	399	36	in	in	IN
cord-273505-pcsw3vmx	399	37	accordance	accordance	NN
cord-273505-pcsw3vmx	399	38	with	with	IN
cord-273505-pcsw3vmx	399	39	accepted	accepted	JJ
cord-273505-pcsw3vmx	399	40	academic	academic	JJ
cord-273505-pcsw3vmx	399	41	practice	practice	NN
cord-273505-pcsw3vmx	399	42	.	.	.
cord-273505-pcsw3vmx	400	1	No	no	DT
cord-273505-pcsw3vmx	400	2	use	use	NN
cord-273505-pcsw3vmx	400	3	,	,	,
cord-273505-pcsw3vmx	400	4	distribution	distribution	NN
cord-273505-pcsw3vmx	400	5	or	or	CC
cord-273505-pcsw3vmx	400	6	reproduction	reproduction	NN
cord-273505-pcsw3vmx	400	7	is	be	VBZ
cord-273505-pcsw3vmx	400	8	permitted	permit	VBN
cord-273505-pcsw3vmx	400	9	which	which	WDT
cord-273505-pcsw3vmx	400	10	does	do	VBZ
cord-273505-pcsw3vmx	400	11	not	not	RB
cord-273505-pcsw3vmx	400	12	comply	comply	VB
cord-273505-pcsw3vmx	400	13	with	with	IN
cord-273505-pcsw3vmx	400	14	these	these	DT
cord-273505-pcsw3vmx	400	15	terms	term	NNS
cord-273505-pcsw3vmx	400	16	.	.	.